PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zeng, H; Yang, K; Cloer, C; Neale, G; Vogel, P; Chi, HB				Zeng, Hu; Yang, Kai; Cloer, Caryn; Neale, Geoffrey; Vogel, Peter; Chi, Hongbo			mTORC1 couples immune signals and metabolic programming to establish T-reg-cell function	NATURE			English	Article							CUTTING EDGE; DIFFERENTIATION; ACTIVATION; EFFECTOR; DISEASE; CTLA-4; AKT; SUPPRESSION; HOMEOSTASIS; EXPRESSION	The mechanistic target of rapamycin (mTOR) pathway integrates diverse environmental inputs, including immune signals and metabolic cues, to direct T-cell fate decisions(1). The activation of mTOR, which is the catalytic subunit of the mTORC1 and mTORC2 complexes, delivers an obligatory signal for the proper activation and differentiation of effector CD4(+) T cells(2,3), whereas in the regulatory T-cell (T-reg) compartment, the Akt-mTOR axis is widely acknowledged as a crucial negative regulator of T-reg-cell de novo differentiation(4-8) and population expansion(9). However, whether mTOR signalling affects the homeostasis and function of T-reg cells remains largely unexplored. Here we show that mTORC1 signalling is a pivotal positive determinant of T-reg-cell function in mice. T-reg cells have elevated steady-state mTORC1 activity compared to naive T cells. Signals through the T-cell antigen receptor (TCR) and interleukin-2 (IL-2) provide major inputs for mTORC1 activation, which in turn programs the suppressive function of T-reg cells. Disruption of mTORC1 through T-reg-specific deletion of the essential component raptor leads to a profound loss of T-reg-cell suppressive activity in vivo and the development of a fatal early onset inflammatory disorder. Mechanistically, raptor/mTORC1 signalling in T-reg cells promotes cholesterol and lipid metabolism, with the mevalonate pathway particularly important for coordinating T-reg-cell proliferation and upregulation of the suppressive molecules CTLA4 and ICOS to establish T-reg-cell functional competency. By contrast, mTORC1 does not directly affect the expression of Foxp3 or anti-and pro-inflammatory cytokines in T-reg cells, suggesting a non-conventional mechanism for T-reg-cell functional regulation. Finally, we provide evidence that mTORC1 maintains T-reg-cell function partly through inhibiting the mTORC2 pathway. Our results demonstrate that mTORC1 acts as a fundamental 'rheostat' in T-reg cells to link immunological signals from TCR and IL-2 to lipogenic pathways and functional fitness, and highlight a central role of metabolic programming of T-reg-cell suppressive activity in immune homeostasis and tolerance.	[Zeng, Hu; Yang, Kai; Cloer, Caryn; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Zeng, Hu/AAA-2706-2020; Vogel, Peter/N-2490-2018; Chi, Hongbo/M-9397-2018	Zeng, Hu/0000-0002-9909-7732; Vogel, Peter/0000-0002-7535-0545; Chi, Hongbo/0000-0002-9997-2496	US National Institutes of Health [K01 AR053573, R21 AI094089, R01 AI101407, R01 NS064599]; Lupus Research Institute; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094089, R01AI101407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Rudensky for Foxp3<SUP>YFP-Cre</SUP> mice, D. Green for help with metabolic assays, N. Brydon for animal colony management, Y. Wang for editing of the manuscript, and the St Jude Immunology FACS core facility for cell sorting. This work was supported by the US National Institutes of Health (K01 AR053573, R21 AI094089, R01 AI101407 and R01 NS064599), the Lupus Research Institute, and the American Lebanese Syrian Associated Charities (all to H.C.).	Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Corse E, 2012, J IMMUNOL, V189, P1123, DOI 10.4049/jimmunol.1200695; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tai XG, 2012, BLOOD, V119, P5155, DOI 10.1182/blood-2011-11-388918; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068	32	523	547	4	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					485	+		10.1038/nature12297	http://dx.doi.org/10.1038/nature12297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23812589	Green Accepted			2022-12-28	WOS:000322157900042
J	Gomersall, CD; Joynt, GM				Gomersall, Charles D.; Joynt, Gavin M.			Middle East respiratory syndrome: new disease, old lessons	LANCET			English	Editorial Material							CORONAVIRUS		[Gomersall, Charles D.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anaesthesia & Intens Care, Shatin, Hong Kong, Peoples R China; Univ Queensland, Discipline Anaesthesiol & Crit Care, Sch Med, Brisbane, Qld, Australia	Chinese University of Hong Kong; Prince of Wales Hospital; University of Queensland	Gomersall, CD (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anaesthesia & Intens Care, Shatin, Hong Kong, Peoples R China.	gomersall@cuhk.edu.hk	Joynt, Gavin M/C-7606-2009; Gomersall, Charles D/J-1540-2012	Joynt, Gavin M/0000-0002-5823-3435; Gomersall, Charles D/0000-0002-8494-8063				[Anonymous], MIDD E RESP SYNDR CO; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Buchholz U, 2013, EUROSURVEILLANCE, V18, P6; Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Public Health England, 2013, INF CONTR ADV NOV CO; Tahir M, 2013, EUROSURVEILLANCE, V18, P4; World Health Organization, NOV COR INF; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	9	6	6	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2229	2230		10.1016/S0140-6736(13)61412-9	http://dx.doi.org/10.1016/S0140-6736(13)61412-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173SU	23809548	Bronze, Green Published			2022-12-28	WOS:000321100300006
J	Zhou, J; Lancaster, L; Donohue, JP; Noller, HF				Zhou, Jie; Lancaster, Laura; Donohue, John Paul; Noller, Harry F.			Crystal Structures of EF-G-Ribosome Complexes Trapped in Intermediate States of Translocation	SCIENCE			English	Article							ELONGATION-FACTOR-G; TRANSFER-RNA BINDING; MESSENGER-RNA; HYBRID-STATE; BACTERIAL RIBOSOME; GTPASE ACTIVATION; TRANSLATION; ROTATION; TU; MOVEMENT	Translocation of messenger and transfer RNA (mRNA and tRNA) through the ribosome is a crucial step in protein synthesis, whose mechanism is not yet understood. The crystal structures of three Thermus ribosome-tRNA-mRNA-EF-G complexes trapped with beta,gamma-imidoguanosine 5'-triphosphate (GDPNP) or fusidic acid reveal conformational changes occurring during intermediate states of translocation, including large-scale rotation of the 30S subunit head and body. In all complexes, the tRNA acceptor ends occupy the 50S subunit E site, while their anticodon stem loops move with the head of the 30S subunit to positions between the P and E sites, forming chimeric intermediate states. Two universally conserved bases of 16S ribosomal RNA that intercalate between bases of the mRNA may act as "pawls" of a translocational ratchet. These findings provide new insights into the molecular mechanism of ribosomal translocation.	[Noller, Harry F.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu		Zhou, Jie/0000-0001-6521-1384	NIH [GM-17129, GM-59140, Y1-CO-1020, Y1-GM-1104, GM-105404, P41-GM-103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM017129, R01GM105404, R01GM059140, R01GM017129, P41GM103393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Amiri for critical reading of the manuscript, S. Mohan for helpful discussions, and the synchtrotron beamline staffs at the ALS, APS, and SSRL for expert help with data collection. Supported by NIH grants GM-17129 and GM-59140. Synchrotron facilities were supported by the U.S. Department of Energy and by NIH grants Y1-CO-1020 and Y1-GM-1104 (to the APS), and GM-105404 (to the ALS), and P41-GM-103393 (to the SSRL). Coordinates and structure factors have been deposited with the following PDB accession codes: (GDPNP-I) 4KCY, 4KCZ, 4KD0, 4KD2; (GDPNP-2) 4KBT, 4KBU, 4KBV, 4KBW; (Fus-3.6) 4KD8, 4KD9, 4KDA, 4KDB; (Fus-4.2) 4KDG, 4KDH, 4KDJ, 4KDK.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; BODLEY JW, 1969, BIOCHEM BIOPH RES CO, V37, P437, DOI 10.1016/0006-291X(69)90934-6; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2012, CURR OPIN STRUC BIOL, V22, P778, DOI 10.1016/j.sbi.2012.08.001; Gao HX, 2004, J STRUCT BIOL, V147, P283, DOI 10.1016/j.jsb.2004.02.008; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Guo ZJ, 2012, P NATL ACAD SCI USA, V109, P20391, DOI 10.1073/pnas.1218999109; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Korostelev A, 2007, J MOL BIOL, V373, P1058, DOI 10.1016/j.jmb.2007.08.054; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LASA I, 1992, MOL MICROBIOL, V6, P1555, DOI 10.1111/j.1365-2958.1992.tb00877.x; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 2011, BIOCHEM SOC T, V39, P658, DOI 10.1042/BST0390658; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; WOESE C, 1970, NATURE, V226, P817, DOI 10.1038/226817a0; Zhou J, 2012, RNA, V18, P230, DOI 10.1261/rna.031187.111	45	166	168	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1543	+	1236086	10.1126/science.1236086	http://dx.doi.org/10.1126/science.1236086			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812722	Green Accepted			2022-12-28	WOS:000321007000032
J	Malhotra, A				Malhotra, Aseem			It's time to ban junk food on hospital premises	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUGAR-SWEETENED BEVERAGES; CARDIOVASCULAR-DISEASE; OBESITY; WEIGHT; HEALTH; TRIAL		Royal Free Hosp, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Malhotra, A (corresponding author), Royal Free Hosp, London, England.	aseem_malhotra@hotmail.com						Arnold SV, 2013, PRED MET SYNDR 2013; Bunim J., 2013, AFRICAN AM LATINOCHI; Capewell S, 2011, EUR HEART J, V32, P1187, DOI 10.1093/eurheartj/ehr049; Cohen DA, 2012, NEW ENGL J MED, V367, P1381, DOI 10.1056/NEJMp1209443; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Malik VS, 2011, AM J CLIN NUTR, V94, P1161, DOI 10.3945/ajcn.111.025676; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Marteau TM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d228; National Institute for Health and Clinical Excellence, 2012, OB WORK LOC COMM COS; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Quaas J., 2010, MEDITERRANEAN DIET S; Royal College of Physicians, 2013, ACT OB COMPR CAR ALL; Sahud HB, 2006, PEDIATRICS, V118, P2290, DOI 10.1542/peds.2006-1228; Singh G, 2013, EPIN PAM 2013 NEW OR; SustainWeb, 20 YEARS HOSP FOOD F; Telethon Institute for Child Health Research, 2013, SUG DRINKS TEENS LIN; Tucker ME, 2013, DIABETES COST US 245; von Bibra H, 2013, PRED MET SYNDR 2013; Wang YC, 2012, HEALTH AFFAIR, V31, P199, DOI 10.1377/hlthaff.2011.0410; Weiss R, 2013, ANN NY ACAD SCI, V1281, P123, DOI 10.1111/nyas.12030; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	24	3	4	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2013	346								f3932	10.1136/bmj.f3932	http://dx.doi.org/10.1136/bmj.f3932			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179AA	23803757				2022-12-28	WOS:000321487300004
J	Smith, AK; White, DB; Arnold, RM				Smith, Alexander K.; White, Douglas B.; Arnold, Robert M.			Uncertainty - The Other Side of Prognosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Smith, Alexander K.] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA; [Smith, Alexander K.] San Francisco VA Med Ctr, San Francisco, CA USA; [White, Douglas B.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Arnold, Robert M.] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smith, AK (corresponding author), Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE ON AGING [K23AG040772] Funding Source: NIH RePORTER; NIA NIH HHS [K23 AG040772] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; Loewenstein G, 2005, HEALTH PSYCHOL, V24, pS49, DOI 10.1037/0278-6133.24.4.S49; Smith AK, 2011, NEW ENGL J MED, V365, P2149, DOI 10.1056/NEJMp1109990; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	5	125	127	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2448	2450		10.1056/NEJMp1303295	http://dx.doi.org/10.1056/NEJMp1303295			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KQ	23802514	Green Accepted			2022-12-28	WOS:000320926900004
J	Davies, E				Davies, Edward			ASSISTED DYING Assisted dying: what happens after Vermont?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								\				edavies@bmj.com						[Anonymous], 2012, BOSTON GLOBE; Canadian Press, 2012, NATIONAL POST   0613; Giglio C., 2013, LIFENEWS; Gram D, 2013, BURLINGTON FREE PRES; Johnson K., 2009, NY TIMES; Leffler SM, 2013, PATIENT CHOICE END L; McCarthy M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3210; Montana Legislature, 2013, DET BILL INF; State of Connecticut, 2013, ACT DEATH DIGN; Turner D, 2012, LA TIMES        1106	10	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2013	346								f4041	10.1136/bmj.f4041	http://dx.doi.org/10.1136/bmj.f4041			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QH	23798734				2022-12-28	WOS:000321245800005
J	Luitse, MJA; van Asch, CJJ; Klijn, CJM				Luitse, Merel J. A.; van Asch, Charlotte J. J.; Klijn, Catharina J. M.			Deep coma and diffuse white matter abnormalities caused by sepsis-associated encephalopathy	LANCET			English	Editorial Material									[Luitse, Merel J. A.; van Asch, Charlotte J. J.; Klijn, Catharina J. M.] Univ Med Ctr, Dept Neurol, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Luitse, MJA (corresponding author), Univ Med Ctr, Dept Neurol G03 228, POB 85500, NL-3508 GA Utrecht, Netherlands.	m.luitse-2@umcutrecht.nl	Klijn, C.J.M./E-1700-2016	Klijn, C.J.M./0000-0002-8495-4578				Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; Iacobone Emanuele, 2009, Crit Care Med, V37, pS331, DOI 10.1097/CCM.0b013e3181b6ed58; Kondo A, 2009, NEUROPEDIATRICS, V40, P157, DOI 10.1055/s-0029-1243626; McKinney AM, 2009, AM J ROENTGENOL, V193, P192, DOI 10.2214/AJR.08.1176; Zhang LN, 2012, CHINESE MED J-PEKING, V125, P828, DOI 10.3760/cma.j.issn.0366-6999.2012.05.018	5	20	23	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	2013	381	9884					2222	2222		10.1016/S0140-6736(13)60682-0	http://dx.doi.org/10.1016/S0140-6736(13)60682-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KH	23791345				2022-12-28	WOS:000320925600039
J	Lin, HH; Chu, LA; Fu, TF; Dickson, BJ; Chiang, AS				Lin, Hui-Hao; Chu, Li-An; Fu, Tsai-Feng; Dickson, Barry J.; Chiang, Ann-Shyn			Parallel Neural Pathways Mediate CO2 Avoidance Responses in Drosophila	SCIENCE			English	Article							REPRESENTATION; NEURONS; MAP; BEHAVIOR; GFP	Different stimulus intensities elicit distinct perceptions, implying that input signals are either conveyed through an overlapping but distinct subpopulation of sensory neurons or channeled into divergent brain circuits according to intensity. In Drosophila, carbon dioxide (CO2) is detected by a single type of olfactory sensory neuron, but information is conveyed to higher brain centers through second-order projection neurons (PNs). Two distinct pathways, PNv-1 and PNv-2, are necessary and sufficient for avoidance responses to low and high CO2 concentrations, respectively. Whereas low concentrations activate PNv-1, high concentrations activate both PN(v)s and GABAergic PNv-3, which may inhibit PNv-1 pathway-mediated avoidance behavior. Channeling a sensory input into distinct neural pathways allows the perception of an odor to be further modulated by both stimulus intensity and context.	[Lin, Hui-Hao; Chu, Li-An; Chiang, Ann-Shyn] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan; [Fu, Tsai-Feng] Natl Chi Nan Univ, Dept Appl Chem, Puli 545, Nantou, Taiwan; [Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Chiang, Ann-Shyn] Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu 30013, Taiwan; [Chiang, Ann-Shyn] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chiang, Ann-Shyn] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	National Tsing Hua University; National Chi Nan University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); National Tsing Hua University; Academia Sinica - Taiwan; University of California System; University of California San Diego	Chiang, AS (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.	aschiang@life.nthu.edu.tw		Dickson, Barry/0000-0003-0715-892X; Fu, Tsai-Feng/0000-0002-0343-3018; Chiang, Ann-Shyn/0000-0001-9668-7115	National Science Council; Ministry of Education in Taiwan; Direct For Computer & Info Scie & Enginr [1212778] Funding Source: National Science Foundation	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education in Taiwan(Ministry of Education, Taiwan); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank J. Lippincott-Schwartz, D. F. Reiff, K. Scott, T. Lee, G. Struhl, A. Fiala, and the Bloomington Stock Center for fly stocks. We also thank G. S. B. Suh for helpful comments on the manuscript, Y.-T. Huang and S.-T. Wu for generating and testing Brainbow flies, and the National Center for High-performance Computing for FlyCircuit images. This work was supported by grants from the National Science Council and Ministry of Education in Taiwan.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lee T, 1999, DEVELOPMENT, V126, P4065; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wasserman S, 2013, CURR BIOL, V23, P301, DOI 10.1016/j.cub.2012.12.038; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	25	46	46	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1338	1341		10.1126/science.1236693	http://dx.doi.org/10.1126/science.1236693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766327				2022-12-28	WOS:000320320200047
J	Phillips, MR				Phillips, Michael R.			Can China's new mental health law substantially reduce the burden of illness attributable to mental disorders?	LANCET			English	Editorial Material									[Phillips, Michael R.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 201108, Peoples R China; [Phillips, Michael R.] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA; [Phillips, Michael R.] Emory Univ, Sch Med, Dept Global Hlth, Atlanta, GA USA	Shanghai Jiao Tong University; Emory University; Emory University	Phillips, MR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 201108, Peoples R China.	phillipschina@yahoo.com	Phillips, Michael Robert/AAE-7585-2021	Phillips, Michael Robert/0000-0002-5973-2439				[Anonymous], 2013, DRAFT COMPREHENSIVE; Chen HH, 2013, SHANGHAI ARCH PSYCHI, V24, P305; Eleventh National People's Congress Standing Committee, 2012, MENTAL HEALTH LAW OF; Murray CJL, 1996, THE GLOBAL BURDEN OF; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Tang YL, 2013, B WORLD HEALTH ORGAN, V91, P270, DOI 10.2471/BLT.12.107318; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	8	36	36	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 8	2013	381	9882					1964	1966		10.1016/S0140-6736(13)61177-0	http://dx.doi.org/10.1016/S0140-6736(13)61177-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171JY	23746885				2022-12-28	WOS:000320924400007
J	Correll, CU; De Hert, M				Correll, Christoph U.; De Hert, Marc			Antipsychotics for acute schizophrenia: making choices	LANCET			English	Editorial Material							EFFICACY		[Correll, Christoph U.] North Shore LIJ Hlth Syst, Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY 11004 USA; [Correll, Christoph U.] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA; [Correll, Christoph U.] Feinstein Inst Med Res, Manhasset, NY USA; [Correll, Christoph U.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [De Hert, Marc] Katholieke Univ Leuven, Univ Psychiat Ctr, Kortenberg, Belgium; [De Hert, Marc] Katholieke Univ Leuven, Dept Neurosci, Louvain, Belgium	Northwell Health; Hofstra University; Northwell Health; Northwell Health; Yeshiva University; Albert Einstein College of Medicine; KU Leuven; KU Leuven	Correll, CU (corresponding author), North Shore LIJ Hlth Syst, Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY 11004 USA.	ccorrell@lij.edu	Correll, Christoph/D-3530-2011; Correll, Christoph U/AAY-3179-2021; De Hert, Marc/AAH-6090-2021	Correll, Christoph/0000-0002-7254-5646; De Hert, Marc/0000-0003-4255-5920				Alphs L, 2012, INT J NEUROPSYCHOPH, V15, P1003, DOI 10.1017/S1461145711001738; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Correll Christoph U, 2011, Dialogues Clin Neurosci, V13, P155; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Glick ID, 2011, J CLIN PSYCHIAT, V72, P1616, DOI 10.4088/JCP.11r06927; Leucht S., 2013, LANCET; Leucht S, 2009, AM J PSYCHIAT, V166, P152, DOI 10.1176/appi.ajp.2008.08030368; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2010, STAT MED, V29, P2369, DOI 10.1002/sim.4001; Zhang JP, 2013, INT J NEUROPSYCHOPH, V16, P1205, DOI 10.1017/S1461145712001277	12	10	10	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2013	382	9896					919	920		10.1016/S0140-6736(13)61032-6	http://dx.doi.org/10.1016/S0140-6736(13)61032-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VD	23810018				2022-12-28	WOS:000324238000006
J	McInnes, IB; Kavanaugh, A; Gottlieb, AB; Puig, L; Rahman, P; Ritchlin, C; Brodmerkel, C; Li, S; Wang, YH; Mendelsohn, AM; Doyle, MK				McInnes, Iain B.; Kavanaugh, Arthur; Gottlieb, Alice B.; Puig, Lluis; Rahman, Proton; Ritchlin, Christopher; Brodmerkel, Carrie; Li, Shu; Wang, Yuhua; Mendelsohn, Alan M.; Doyle, Mittie K.		PSUMMIT 1 Study Grp	Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial	LANCET			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; DISEASE-ACTIVITY; RHEUMATOID-ARTHRITIS; EUROPEAN LEAGUE; CLINICAL-TRIALS; RECOMMENDATIONS; IMPROVEMENT; VALIDATION; MANAGEMENT; MORTALITY	Background Many patients with psoriasis develop psoriatic arthritis, a chronic inflammatory disease that afflicts peripheral synovial, axial, and entheseal structures. The fully human monoclonal antibody ustekinumab is an efficacious treatment for moderate-to-severe plaque psoriasis. We did a randomised, placebo-controlled, phase 3 trial to assess the safety and efficacy of ustekinumab in patients with active psoriatic arthritis. Methods In this phase 3, multicentre, double-blind, placebo-controlled trial at 104 sites in Europe, North America, and Asia-Pacific, adults with active psoriatic arthritis (>= 5 tender and >= 5 swollen joints, C-reactive protein >= 3.0 mg/L) were randomly assigned (1:1:1, by dynamic central randomisation based on an algorithm implemented by an interactive voice-web response system) to 45 mg ustekinumab, 90 mg ustekinumab, or placebo at week 0, week 4, and every 12 weeks thereafter. At week 16, patients with less than 5% improvement in both tender and swollen joint counts entered masked early-escape and were given 45 mg ustekinumab (if in the placebo group) or 90 mg ustekinumab (if in the 45 mg group). At week 24, all remaining patients in the placebo group received ustekinumab 45 mg, which they continued at week 28 and every 12 weeks thereafter. Our primary endpoint was 20% or greater improvement in American College of Rheumatology (ACR20) criteria at week 24. This trial is registered with ClinicalTrials.gov (NCT01009086) and EudraCT (2009-012264-14). Findings Between Nov 30, 2009, and March 30, 2011, 615 patients were randomly assigned-206 to placebo, 205 to 45 mg ustekinumab, and 204 to 90 mg ustekinumab. More ustekinumab-treated (87 of 205 [42.4%] in the 45 mg group and 101 of 204 [49.5%] in the 90 mg group) than placebo-treated (47 of 206 [22.8%]) patients achieved ACR20 at week 24 (p<0.0001 for both comparisons); responses were maintained at week 52. At week 16, proportions of patients with adverse events were similar in the ustekinumab and placebo groups (171 of 409 [41.8%] vs 86 of 205 [42.0%]). Interpretation Ustekinumab significantly improved active psoriatic arthritis compared with placebo, and might off er an alternative therapeutic mechanism of action to approved biological treatments.	[McInnes, Iain B.] Univ Glasgow, Glasgow Biomed Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Kavanaugh, Arthur] Univ Calif San Diego, San Diego, CA 92103 USA; [Gottlieb, Alice B.] Tufts Med Ctr, Boston, MA USA; [Puig, Lluis] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Rahman, Proton] Mem Univ Newfoundland, St Clares Mercy Hosp, St John, NF, Canada; [Ritchlin, Christopher] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Brodmerkel, Carrie; Li, Shu; Wang, Yuhua; Mendelsohn, Alan M.] Janssen Res & Dev, Spring House, PA USA; [Doyle, Mittie K.] Alex Pharmaceut, Translat Med Grp, Cambridge, MA USA	University of Glasgow; University of California System; University of California San Diego; Tufts Medical Center; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Memorial University Newfoundland; University of Rochester; Johnson & Johnson; Janssen Pharmaceuticals	McInnes, IB (corresponding author), Univ Glasgow, Glasgow Biomed Res Ctr, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	iain.mcinnes@glasgow.ac.uk	Maslyanskiy, Alexey L/G-7691-2018; Thaci, Prof. Dr Diamant/K-5455-2012; Khraishi, Majed/HDN-4826-2022; Queiro, Rubén/D-5358-2016; Shirinsky, Valery/I-5653-2018; Kubanov, Alexey/L-3008-2014	Maslyanskiy, Alexey L/0000-0003-2427-4148; Khraishi, Majed/0000-0003-0293-5128; Queiro, Rubén/0000-0002-8418-7145; Shirinsky, Valery/0000-0002-4922-9303; Puig, Luis/0000-0001-6083-0952; Bakulev, Andrej/0000-0002-1450-4942; Taylor, William/0000-0001-6075-8479; Graninger, Winfried/0000-0002-3489-3439; McInnes, Iain/0000-0002-6462-4280; Thaci, Diamant/0000-0001-8513-550X; Papp, Kim A./0000-0001-9557-3642; ritchlin, christopher/0000-0002-2602-1219; Kubanov, Alexey/0000-0002-7625-0503; Vender, Ronald/0000-0002-2624-2724	Janssen Research Development	Janssen Research Development	Janssen Research & Development.	Aletaha D, 2008, ARTHRIT RHEUM-ARTHR, V59, P1371, DOI 10.1002/art.24123; ALONSO JCT, 1991, BRIT J RHEUMATOL, V30, P245; Antoni C, 2005, ANN RHEUM DIS, V64, P1150, DOI 10.1136/ard.2004.032268; Ash Z, 2012, ANN RHEUM DIS, V71, P319, DOI 10.1136/ard.2011.150995; Celis R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3817; Chu TW, 2012, GIORN ITAL DERMAT V, V147, P189; CONOVER W. J, 1980, PRACTICAL NONPARAMET; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Filer C, 2008, ARTHRITIS RHEUM-US, V58, P3705, DOI 10.1002/art.24128; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Gladman DD, 1998, ARTHRITIS RHEUM-US, V41, P1103, DOI 10.1002/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N; Gossec L, 2012, ANN RHEUM DIS, V71, P4, DOI 10.1136/annrheumdis-2011-200350; Gottlieb A, 2009, LANCET, V373, P633, DOI 10.1016/S0140-6736(09)60140-9; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Heusch-Dorenbosch L, 2003, ANN RHEUM DIS, V62, P127; Kavanaugh A, 2012, ARTHRITIS RHEUM-US, V64, P2504, DOI 10.1002/art.34436; Khraishi M, 2011, CLIN RHEUMATOL, V30, P877, DOI 10.1007/s10067-011-1692-7; Krausz S, 2012, ARTHRITIS RHEUM-US, V64, P1750, DOI 10.1002/art.34339; LEONARD DG, 1978, MAYO CLIN PROC, V53, P511; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Mease PJ, 2004, ANN RHEUM DIS, V63, P391; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Park Y, 2010, J IMMUNOL, V185, P1476, DOI 10.4049/jimmunol.1000425; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Reich K, 2012, J DRUGS DERMATOL, V11, P300; Scott DL, 2000, EULAR HDB CLIN ASSES; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Sokoll KB, 2001, J RHEUMATOL, V28, P1842; Toichi E, 2006, J IMMUNOL, V177, P4917, DOI 10.4049/jimmunol.177.7.4917; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; Wong K, 1997, ARTHRITIS RHEUM-US, V40, P1868, DOI 10.1002/art.1780401021; Zachariae H, 2003, AM J CLIN DERMATOL, V4, P441, DOI 10.2165/00128071-200304070-00001	41	551	576	0	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2013	382	9894					780	789		10.1016/S0140-6736(13)60594-2	http://dx.doi.org/10.1016/S0140-6736(13)60594-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VP	23769296				2022-12-28	WOS:000324239200028
J	Cook-Deegan, R				Cook-Deegan, Robert			Are Human Genes Patentable?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Cook-Deegan, Robert] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Cook-Deegan, Robert] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University; Duke University	Cook-Deegan, R (corresponding author), Duke Univ, Box 90141,304 Res Dr,North Bldg,Room 242, Durham, NC 27708 USA.	bob.cd@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237	National Human Genome Research Institute [P50 HG003391]; Ewing Marion Kauffman Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Ewing Marion Kauffman Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Grant Support: In part by the National Human Genome Research Institute (grant P50 HG003391) and the Ewing Marion Kauffman Foundation.	Caulfield T, 2007, GENET MED, V9, P850, DOI 10.1097/GIM.0b013e31815bf965	1	3	3	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					298	+		10.7326/0003-4819-159-4-201308200-00668	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00668			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	23752709	Green Accepted			2022-12-28	WOS:000323421700021
J	Ezraty, B; Vergnes, A; Banzhaf, M; Duverger, Y; Huguenot, A; Brochado, AR; Su, SY; Espinosa, L; Loiseau, L; Py, B; Typas, A; Barras, F				Ezraty, Benjamin; Vergnes, Alexandra; Banzhaf, Manuel; Duverger, Yohann; Huguenot, Allison; Brochado, Ana Rita; Su, Shu-Yi; Espinosa, Leon; Loiseau, Laurent; Py, Beatrice; Typas, Athanasios; Barras, Frederic			Fe-S Cluster Biosynthesis Controls Uptake of Aminoglycosides in a ROS-Less Death Pathway	SCIENCE			English	Article							ESCHERICHIA-COLI; BACTERICIDAL ANTIBIOTICS; PROTEINS; BINDING; IRON; GENTAMICIN; EXPRESSION; MECHANISM; ISCR	All bactericidal antibiotics were recently proposed to kill by inducing reactive oxygen species (ROS) production, causing destabilization of iron-sulfur (Fe-S) clusters and generating Fenton chemistry. We find that the ROS response is dispensable upon treatment with bactericidal antibiotics. Furthermore, we demonstrate that Fe-S clusters are required for killing only by aminoglycosides. In contrast to cells, using the major Fe-S cluster biosynthesis machinery, ISC, cells using the alternative machinery, SUF, cannot efficiently mature respiratory complexes I and II, resulting in impendence of the proton motive force (PMF), which is required for bactericidal aminoglycoside uptake. Similarly, during iron limitation, cells become intrinsically resistant to aminoglycosides by switching from ISC to SUF and down-regulating both respiratory complexes. We conclude that Fe-S proteins promote aminoglycoside killing by enabling their uptake.	[Ezraty, Benjamin; Vergnes, Alexandra; Duverger, Yohann; Huguenot, Allison; Espinosa, Leon; Loiseau, Laurent; Py, Beatrice; Barras, Frederic] Aix Marseille Univ, CNRS, Chim Bacterienne Lab, Inst Microbiol Mediterranee,UMR 7283, F-13009 Marseille, France; [Banzhaf, Manuel; Brochado, Ana Rita; Su, Shu-Yi; Typas, Athanasios] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; European Molecular Biology Laboratory (EMBL)	Barras, F (corresponding author), Aix Marseille Univ, CNRS, Chim Bacterienne Lab, Inst Microbiol Mediterranee,UMR 7283, 31 Chemin Joseph Aiguier, F-13009 Marseille, France.	barras@imm.cnrs.fr	Vergnes, Alexandra/AAM-2842-2020; Espinosa, Leon/V-8410-2017	Typas, Athanasios/0000-0002-0797-9018; Ezraty, Benjamin/0000-0003-3818-6907; Banzhaf, Manuel/0000-0002-4682-1037; Barras, Frederic/0000-0003-3458-2574; Brochado, Ana Rita/0000-0003-1703-383X	Agence Nationale Recherche [ANR Blanc SPV 05511]; Institut Universitaire de France; Fondation pour la Recherche Medicale; European Molecular Biology Laboratory	Agence Nationale Recherche(French National Research Agency (ANR)); Institut Universitaire de France; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Molecular Biology Laboratory	We are grateful to C. Gross (University of California, San Francisco, USA) for critically reading the manuscript and providing feedback. We thank T. Friedrich (Freiburg University, Germany), T. Yagi and J. Torres Bacete (La Jolla, CA, USA), E. Bouveret (Laboratoire d'Ingenierie des Systemes Macromoleculaires, Marseille, France), J. Armitage (Oxford, UK), and P. Moreau and T. Mignot (Laboratoire de Chimie Bacterienne, Marseille, France) for providing materials and strains. This work was supported by grants from Agence Nationale Recherche (ANR Blanc SPV 05511), the Institut Universitaire de France, the Fondation pour la Recherche Medicale, and European Molecular Biology Laboratory. Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/dryad.3062c.	BRYAN LE, 1983, ANTIMICROB AGENTS CH, V23, P835, DOI 10.1128/AAC.23.6.835; Chen Z, 2007, NUCLEIC ACIDS RES, V35, P6762, DOI 10.1093/nar/gkm631; DAMPER PD, 1981, ANTIMICROB AGENTS CH, V20, P803, DOI 10.1128/AAC.20.6.803; DAVIS BD, 1986, P NATL ACAD SCI USA, V83, P6164, DOI 10.1073/pnas.83.16.6164; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; MATES SM, 1982, P NATL ACAD SCI-BIOL, V79, P6693, DOI 10.1073/pnas.79.21.6693; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Simon J, 2008, BBA-BIOENERGETICS, V1777, P1480, DOI 10.1016/j.bbabio.2008.09.008; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Vento S, 2006, LANCET INFECT DIS, V6, P226, DOI 10.1016/S1473-3099(06)70437-6; Vinella D, 2013, MOL MICROBIOL, V87, P493, DOI 10.1111/mmi.12135; Walter JM, 2007, P NATL ACAD SCI USA, V104, P2408, DOI 10.1073/pnas.0611035104; Yao ZZ, 2012, MOL CELL, V48, P705, DOI 10.1016/j.molcel.2012.09.016	26	146	153	7	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1583	1587		10.1126/science.1238328	http://dx.doi.org/10.1126/science.1238328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812717				2022-12-28	WOS:000321007000045
J	Chen, AH; Murphy, EJ; Yee, HF				Chen, Alice Hm; Murphy, Elizabeth J.; Yee, Hal F., Jr.			eReferral - A New Model for Integrated Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REFERRALS		[Chen, Alice Hm; Murphy, Elizabeth J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Chen, Alice Hm] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA; [Murphy, Elizabeth J.] San Francisco Gen Hosp, Div Endocrinol, San Francisco, CA 94110 USA; [Chen, Alice Hm; Murphy, Elizabeth J.; Yee, Hal F., Jr.] San Francisco Gen Hosp, Ctr Innovat Access & Qual, San Francisco, CA 94110 USA; [Yee, Hal F., Jr.] Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; San Francisco General Hospital Medical Center; San Francisco General Hospital Medical Center	Chen, AH (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.							Barnett ML, 2012, ARCH INTERN MED, V172, P163, DOI 10.1001/archinternmed.2011.722; Bindman AB, 2009, AM J MANAG CARE, V15, P747; Felt-Lisk S, 2002, HEALTH AFFAIR, V21, P277, DOI 10.1377/hlthaff.21.5.277; Kim-Hwang JE, 2010, J GEN INTERN MED, V25, P1123, DOI 10.1007/s11606-010-1402-1; Straus Susan G, 2011, AMIA Annu Symp Proc, V2011, P1337	5	133	133	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2450	2453		10.1056/NEJMp1215594	http://dx.doi.org/10.1056/NEJMp1215594			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KQ	23802515				2022-12-28	WOS:000320926900005
J	Zhu, JW; Wang, JY				Zhu, Jian-Wei; Wang, Jian-You			Eyelid Swelling and Primary Sjogren's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zhu, Jian-Wei; Wang, Jian-You] Zhejiang Univ, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhu, JW (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	wangjianyou2004@163.com							0	3	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2501	2501		10.1056/NEJMicm1210527	http://dx.doi.org/10.1056/NEJMicm1210527			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23802517				2022-12-28	WOS:000320926900011
J	Afzal, MR; Wilson, JH				Afzal, Muhammad Rizwan; Wilson, John H.			Lung Herniation after Cardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Afzal, Muhammad Rizwan; Wilson, John H.] Good Samaritan Hosp, Cincinnati, OH USA	Good Samaritan Hospital - Cincinnati	Afzal, MR (corresponding author), Good Samaritan Hosp, Cincinnati, OH USA.	rafzal@kumc.edu							0	2	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					E35	E35		10.1056/NEJMicm1204602	http://dx.doi.org/10.1056/NEJMicm1204602			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782203				2022-12-28	WOS:000320601700012
J	Courchet, J; Lewis, TL; Lee, S; Courchet, V; Liou, DY; Aizawa, S; Polleux, F				Courchet, Julien; Lewis, Tommy L., Jr.; Lee, Sohyon; Courchet, Virginie; Liou, Deng-Yuan; Aizawa, Shinichi; Polleux, Franck			Terminal Axon Branching Is Regulated by the LKB1-NUAK1 Kinase Pathway via Presynaptic Mitochondrial Capture	CELL			English	Article							ACTIVATED PROTEIN-KINASE; NEURONAL POLARIZATION; PYRAMIDAL NEURONS; NEURAL ACTIVITY; SAD KINASES; GROWTH CONE; LKB1; MECHANISMS; NEOCORTEX; GUIDANCE	The molecular mechanisms underlying the axon arborization of mammalian neurons are poorly understood but are critical for the establishment of functional neural circuits. We identified a pathway defined by two kinases, LKB1 and NUAK1, required for cortical axon branching in vivo. Conditional deletion of LKB1 after axon specification or knockdown of NUAK1 drastically reduced axon branching in vivo, whereas their overexpression was sufficient to increase axon branching. The LKB1-NUAK1 pathway controls mitochondria immobilization in axons. Using manipulation of Syntaphilin, a protein necessary and sufficient to arrest mitochondrial transport specifically in the axon, we demonstrate that the LKB1-NUAK1 kinase pathway regulates axon branching by promoting mitochondria immobilization. Finally, we show that LKB1 and NUAK1 are necessary and sufficient to immobilize mitochondria specifically at nascent presynaptic sites. Our results unravel a link between presynaptic mitochondrial capture and axon branching.	[Courchet, Julien; Lewis, Tommy L., Jr.; Lee, Sohyon; Courchet, Virginie; Liou, Deng-Yuan; Polleux, Franck] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Courchet, Julien; Lewis, Tommy L., Jr.; Lee, Sohyon; Courchet, Virginie; Liou, Deng-Yuan; Polleux, Franck] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Aizawa, Shinichi] Riken Inst Phys & Chem Res, Chuo Ku, Kobe, Hyogo 6500047, Japan	Scripps Research Institute; Scripps Research Institute; RIKEN	Polleux, F (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	polleux@scripps.edu	COURCHET, JULIEN/E-9645-2016; Polleux, Franck/H-9948-2014; Courchet, Virginie/G-9431-2017	COURCHET, JULIEN/0000-0002-1199-9329; Courchet, Virginie/0000-0002-7186-3669; Lee, Sohyon/0000-0003-4790-4990; Polleux, Franck/0000-0003-4313-0481; Lewis, Tommy/0000-0001-7033-7010; Liou, Deng-Yuan/0000-0001-8466-2033	NIH [R01AG031524, 5F32NS080464]; ADI-Novartis funds; Fondation pour la Recherche Medicale; Philippe Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089456, F32NS080464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031524] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADI-Novartis funds; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Philippe Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank members of the Polleux lab and Sandra Encalada for useful discussions. We thank Kathy Spencer for excellent help with microscopy and Trevor Sauerbrey for technical help. We would also like to thank Brendan Lilley, Ulrich Muller, Anton Maximov, and Sandra Encalada for critical reading of the manuscript. We thank Joshua Sanes, Zu-Hang Shen, Ulrich Muller, Etienne Herzog, and Don Arnold for sharing reagents. This work was funded by NIH R01AG031524 (F.P.), ADI-Novartis funds (F.P.), Fondation pour la Recherche Medicale (J.C.), Philippe Foundation (J.C.), and NIH 5F32NS080464 (T.L.). J.C, T.L., and F. P. conceived the experiments and interpreted the results, and J.C., T.L., S.L., V.C., and D.-Y.L. performed the experiments. S.A. provided the NUAK1 knockout mice. J.C., T.L., and F.P. prepared the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Brickley K, 2011, J BIOL CHEM, V286, P18079, DOI 10.1074/jbc.M111.236018; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Donahoo ALS, 2009, SEMIN PEDIATR NEUROL, V16, P127, DOI 10.1016/j.spen.2009.07.003; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Gallo G, 2011, DEV NEUROBIOL, V71, P201, DOI 10.1002/dneu.20852; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hand R, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-30; Harris KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005587; Herzog E, 2011, J NEUROSCI, V31, P15544, DOI 10.1523/JNEUROSCI.2073-11.2011; Hirano M, 2006, DEV DYNAM, V235, P2229, DOI 10.1002/dvdy.20823; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Mian I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031583; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Mizuno H, 2010, EUR J NEUROSCI, V31, P410, DOI 10.1111/j.1460-9568.2009.07070.x; Nishimura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041413; Polleux F, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001925; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Sabo SL, 2006, J NEUROSCI, V26, P10813, DOI 10.1523/JNEUROSCI.2052-06.2006; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Uesaka N, 2006, NEUROSCIENTIST, V12, P102, DOI 10.1177/1073858405281673; Vos Melissa, 2010, Front Synaptic Neurosci, V2, P139, DOI 10.3389/fnsyn.2010.00139; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Watts JL, 2000, DEVELOPMENT, V127, P1467; Williams T, 2011, P NATL ACAD SCI USA, V108, P5849, DOI 10.1073/pnas.1013660108; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	53	212	215	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1510	1525		10.1016/j.cell.2013.05.021	http://dx.doi.org/10.1016/j.cell.2013.05.021			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791179	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000320722000019
J	Olenchock, BA; Vander Heiden, MG				Olenchock, Benjamin A.; Vander Heiden, Matthew G.			Pyruvate as a Pivot Point for Oncogene-Induced Senescence	CELL			English	Editorial Material							CANCER		[Olenchock, Benjamin A.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Olenchock, Benjamin A.; Vander Heiden, Matthew G.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Olenchock, Benjamin A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mvh@mit.edu			NATIONAL CANCER INSTITUTE [R01CA168653] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604, K08HL119355] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA168653] Funding Source: Medline; NHLBI NIH HHS [K08 HL119355, T32 HL007604] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Kaplon J, 2013, NATURE; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Metallo C.M., 2011, NATURE; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	9	12	12	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1429	1430		10.1016/j.cell.2013.06.001	http://dx.doi.org/10.1016/j.cell.2013.06.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791173	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000320722000011
J	Patel, MM; Patzi, M; Pastor, D; Nina, A; Roca, Y; Alvarez, L; Iniguez, V; Rivera, R; Tam, KI; Quaye, O; Bowen, M; Parashar, U; De Oliveira, LH				Patel, Manish M.; Patzi, Maritza; Pastor, Desiree; Nina, Aleida; Roca, Yelin; Alvarez, Leovigildo; Iniguez, Volga; Rivera, Rosario; Tam, Ka Ian; Quaye, Osbourne; Bowen, Michael; Parashar, Umesh; De Oliveira, Lucia Helena			Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							1ST 2 YEARS; SEVERE DIARRHEA; DOUBLE-BLIND; EFFICACY; SAFETY; GASTROENTERITIS; SURVEILLANCE; CHILDREN; LIFE	Objective To evaluate the effectiveness of two doses of a monovalent rotavirus vaccine (RV1) against hospital admission for rotavirus in Bolivia. Design Case-control study. Setting Six hospitals in Bolivia, between March 2010 and June 2011. Participants 400 hospital admissions for rotavirus, 1200 non-diarrhea hospital controls, and 718 rotavirus negative hospital controls. Main outcome measures Odds of antecedent vaccination between case patients and controls; effectiveness of vaccination ((1-adjusted odds ratio) x100), adjusted for age and other confounders; and stratified effectiveness by dose, disease severity, age group, and serotype. Results In comparison with non-diarrhea controls, case patients were more likely to be male and attend day care but less likely to have chronic underlying illness, higher level maternal education, and telephones and computers in their home. Rotavirus negative controls were somewhat more similar to case patients but also were more likely to be male and attend day care and less likely to have higher level maternal education and computers in their homes. The adjusted effectiveness of RV1 against hospital admission for rotavirus was 69% (95% confidence interval 54% to 79%) with rotavirus negative controls and 77% (65% to 84%) with non-diarrhea controls. The effectiveness of one dose of RV1 was 36% and 56%, respectively. With both control groups, protection was sustained through two years of life, with similar efficacy against hospital admission among children under 1 year (64% and 77%) and over 1 year of age (72% and 76%). RV1 provided significant protection against diverse serotypes, partially and fully heterotypic to the G1P[8] vaccine. Effectiveness using the two control groups was 80% and 85% against G9P[8], 74% and 93%% against G3P[8], 59% and 69% against G2P[4], and 80% and 87% against G9P[6] strains. Conclusion The monovalent rotavirus vaccine conferred high protection against hospital admission for diarrhea due to rotavirus in Bolivian children. Protection was sustained through two years of life against diverse serotypes different from the vaccine strain.	[Patel, Manish M.; Tam, Ka Ian; Quaye, Osbourne; Bowen, Michael; Parashar, Umesh] Ctr Dis Control & Prevent, Viral Gastroenteritis Team, DVD, NCIRD, Atlanta, GA 30333 USA; [Patzi, Maritza] Minist Salud, La Paz, Bolivia; [Pastor, Desiree] PanAmer Hlth Org, La Paz, Bolivia; [Nina, Aleida] Minist Salud & Deportes, Virol Lab, INLASA, La Paz, Bolivia; [Roca, Yelin] CENETROP, Natl Reference Lab, Santa Cruz, Bolivia; [Alvarez, Leovigildo] Virol Lab, Cochababma, Bolivia; [Iniguez, Volga; Rivera, Rosario] Univ Mayor San Andres, Inst Biol Mol & Biotecnol, La Paz, Bolivia; [De Oliveira, Lucia Helena] PanAmer Hlth Org, Washington, DC USA	Centers for Disease Control & Prevention - USA; Universidad Mayor de San Andres	Patel, MM (corresponding author), Ctr Dis Control & Prevent, Viral Gastroenteritis Team, DVD, NCIRD, MS A34,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	Aul3@CDC.GOV		Quaye, Osbourne/0000-0002-0621-876X	Program for Appropriate Technology in Health (PATH); Global Alliance for Vaccines and Immunisation (GAVI)	Program for Appropriate Technology in Health (PATH); Global Alliance for Vaccines and Immunisation (GAVI)	Support for this project was provided by the Program for Appropriate Technology in Health (PATH) through funding from the Global Alliance for Vaccines and Immunisation (GAVI). The views expressed by the authors do not necessarily reflect the views of GAVI or PATH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P533; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Bahl R, 2005, J INFECT DIS, V192, pS114, DOI 10.1086/431497; Boom JA, 2010, PEDIATR INFECT DIS J, V29, P1133, DOI 10.1097/INF.0b013e3181ed18ab; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Bresee JS, 2005, J INFECT DIS, V192, pS1, DOI 10.1086/431515; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; Cunliffe NA, 2012, VACCINE, V30, pA36, DOI 10.1016/j.vaccine.2011.09.120; de Palma O, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2825; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hull JJ, 2011, PEDIATR INFECT DIS J, V30, pS42, DOI 10.1097/INF.0b013e3181fefd78; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Madhi S, 2008, 8 INT ROT S JUN 3 IS; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Patel M, 2012, PEDIATRICS, V130, pE365, DOI 10.1542/peds.2011-3478; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Patel MM, 2012, LANCET INFECT DIS, V12, P561, DOI 10.1016/S1473-3099(12)70029-4; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Rivera L, 2011, VACCINE, V29, P9508, DOI 10.1016/j.vaccine.2011.10.015; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Ruiz-Palacios GM, 2012, 10 INT ROT S 19 21 S; SATTEN GA, 1990, J CLIN EPIDEMIOL, V43, P55, DOI 10.1016/0895-4356(90)90056-U; Snelling TL, 2011, CLIN INFECT DIS, V52, P191, DOI 10.1093/cid/ciq101; Staat MA, 2011, PEDIATRICS, V128, pE267, DOI 10.1542/peds.2010-3722; United Nations Children's Fund, 2012, ANN NUMB BIRTHS; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; World Health Organisation, 2003, WORLD HLTH REP, P182; World Health Organization, 2009, GEN PROT MON IMP ROT; World Health Organization, 2002, GEN PROT HOSP BAS SU; World Health Organization, 2012, WHO UNICEF EST ROT L; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	34	63	64	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2013	346								f3726	10.1136/bmj.f3726	http://dx.doi.org/10.1136/bmj.f3726			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171QB	23783434	hybrid, Green Published			2022-12-28	WOS:000320943000003
J	Sokol, DK				Sokol, Daniel K.			Patients we don't like	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, London, England	University of London; King's College London	Sokol, DK (corresponding author), Kings Coll London, London, England.	daniel.sokol@talk21.com						Selzer R., 1998, DOCTOR STORIES	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2013	346								f3956	10.1136/bmj.f3956	http://dx.doi.org/10.1136/bmj.f3956			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171QB	23783359				2022-12-28	WOS:000320943000007
J	Brott, BC				Brott, Brigitta C.			Adding aspirin to clopidogrel worsened outcomes in PCI patients receiving oral anticoagulants	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Alabama Birmingham, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Brott, BC (corresponding author), Univ Alabama Birmingham, Birmingham, AL USA.			Brott, Brigitta/0000-0002-9707-7500				Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12							JC6	10.7326/0003-4819-158-12-201306180-02006	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778930				2022-12-28	WOS:000320645000005
J	Periyannan, S; Moore, J; Ayliffe, M; Bansal, U; Wang, XJ; Huang, L; Deal, K; Luo, MC; Kong, XY; Bariana, H; Mago, R; McIntosh, R; Dodds, P; Dvorak, J; Lagudah, E				Periyannan, Sambasivam; Moore, John; Ayliffe, Michael; Bansal, Urmil; Wang, Xiaojing; Huang, Li; Deal, Karin; Luo, Mingcheng; Kong, Xiuying; Bariana, Harbans; Mago, Rohit; McIntosh, Robert; Dodds, Peter; Dvorak, Jan; Lagudah, Evans			The Gene Sr33, an Ortholog of Barley Mla Genes, Encodes Resistance to Wheat Stem Rust Race Ug99	SCIENCE			English	Article							POWDERY MILDEW; AEGILOPS-TAUSCHII; HEXAPLOID WHEAT; LEAF RUST; GENOME; LOCUS; LINES	Wheat stem rust, caused by the fungus Puccinia graminis f. sp. tritici, afflicts bread wheat (Triticum aestivum). New virulent races collectively referred to as "Ug99" have emerged, which threaten global wheat production. The wheat gene Sr33, introgressed from the wild relative Aegilops tauschii into bread wheat, confers resistance to diverse stem rust races, including the Ug99 race group. We cloned Sr33, which encodes a coiled-coil, nucleotide-binding, leucine-rich repeat protein. Sr33 is orthologous to the barley (Hordeum vulgare) Mla mildew resistance genes that confer resistance to Blumeria graminis f. sp. hordei. The wheat Sr33 gene functions independently of RAR1, SGT1, and HSP90 chaperones. Haplotype analysis from diverse collections of Ae. tauschii placed the origin of Sr33 resistance near the southern coast of the Caspian Sea.	[Periyannan, Sambasivam; Moore, John; Ayliffe, Michael; Mago, Rohit; Dodds, Peter; Lagudah, Evans] Commonwealth Sci & Ind Res Org CSIRO Plant Ind, Canberra, ACT 2601, Australia; [Bansal, Urmil; Bariana, Harbans; McIntosh, Robert] Univ Sydney, Plant Breeding Inst Cobbitty, Narellan, NSW 2567, Australia; [Deal, Karin; Luo, Mingcheng; Dvorak, Jan] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Wang, Xiaojing; Huang, Li] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Kong, Xiuying] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Wang, Xiaojing] Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Wang, Xiaojing] Northwest Agr & Forestry Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney; University of California System; University of California Davis; Montana State University System; Montana State University Bozeman; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Northwest A&F University - China; Northwest A&F University - China	Lagudah, E (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Plant Ind, Gen POB 1600, Canberra, ACT 2601, Australia.	evans.lagudah@csiro.au	Mago, Rohit/D-3927-2009; Bansal, Urmil/AAI-4039-2020; Mago, Rohit/AAB-7878-2022; Lagudah, Evans/A-2007-2010; Periyannan, Sambasivam/C-1722-2014; Ayliffe, Michael A/A-2089-2010; Dodds, Peter/D-1181-2009	Mago, Rohit/0000-0001-5286-073X; Bansal, Urmil/0000-0003-1119-4464; Lagudah, Evans/0000-0002-6234-1789; Periyannan, Sambasivam/0000-0002-5421-2872; Dodds, Peter/0000-0003-0620-5923; Luo, Ming-Cheng/0000-0002-9744-5887	Borlaug Global Rust Initiative (BGRI) Durable Rust Resistance in Wheat (DRRW) Project; Bill & Melinda Gates Foundation; UK Department for International Development; Office of the Chief Executive (OCE) Post Doctoral Fellowship of CSIRO, Australia; Grains Research and Development Corporation, Australia; Endeavor International Postgraduate Research Scholarship of Department of Education, Science and Training (DEST) and Sydney University, Australia; Australian Centre for International Agricultural Research project [CIM2007/084]; Basic Research to Enable Agricultural Development Program of the National Science Foundation (NSF) of the United States [IOS-0965429]; NSF Plant Genome Research Program [DBI-0701916]	Borlaug Global Rust Initiative (BGRI) Durable Rust Resistance in Wheat (DRRW) Project; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Department for International Development; Office of the Chief Executive (OCE) Post Doctoral Fellowship of CSIRO, Australia; Grains Research and Development Corporation, Australia(Grains R&D Corp); Endeavor International Postgraduate Research Scholarship of Department of Education, Science and Training (DEST) and Sydney University, Australia; Australian Centre for International Agricultural Research project; Basic Research to Enable Agricultural Development Program of the National Science Foundation (NSF) of the United States(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported in part by funds provided through a grant from the Borlaug Global Rust Initiative (BGRI) Durable Rust Resistance in Wheat (DRRW) Project (administered by Cornell University with a grant from the Bill & Melinda Gates Foundation and the UK Department for International Development); Office of the Chief Executive (OCE) Post Doctoral Fellowship of CSIRO, Australia; Grains Research and Development Corporation, Australia; Endeavor International Postgraduate Research Scholarship of Department of Education, Science and Training (DEST) and Sydney University, Australia; Australian Centre for International Agricultural Research project (CIM2007/084). X. W. acknowledges support from the Basic Research to Enable Agricultural Development Program of the National Science Foundation (NSF) of the United States (IOS-0965429) and partial support from NSF Plant Genome Research Program grant DBI-0701916 (J.D. is principal investigator). We are grateful to M. Rouse (USDA-ARS Cereal Disease Laboratory) for the tests with Ug99 and derived races. We thank N. Upadhyaya, A. Ashton, S. Chandramohan, L. Viccars, T. Richardson, K. Newell, H. Miah, and X. Xia for technical assistance. Sequences of Resistance Gene Analog (RGA) genes from Ae. tauschii and hexaploid wheats were deposited in GenBank under accession numbers KF031279 to KF031303.	Ayliffe M, 2013, MOL PLANT MICROBE IN, V26, P658, DOI 10.1094/MPMI-12-12-0291-R; Jin Y, 2006, PLANT DIS, V90, P476, DOI 10.1094/PD-90-0476; JONES SS, 1991, GENOME, V34, P505, DOI 10.1139/g91-077; Jordan T, 2011, PLANT J, V65, P610, DOI 10.1111/j.1365-313X.2010.04445.x; KERBER ER, 1987, CROP SCI, V27, P204, DOI 10.2135/cropsci1987.0011183X002700020013x; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Mago R, 2002, THEOR APPL GENET, V104, P1317, DOI 10.1007/s00122-002-0879-3; Moullet O, 1999, THEOR APPL GENET, V99, P305, DOI 10.1007/s001220051237; Olson EL, 2013, THEOR APPL GENET, V126, P1179, DOI 10.1007/s00122-013-2045-5; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; Rouse MN, 2011, CROP SCI, V51, P2074, DOI 10.2135/cropsci2010.12.0719; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Seeholzer S, 2010, MOL PLANT MICROBE IN, V23, P497, DOI 10.1094/MPMI-23-4-0497; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Wei FS, 2002, PLANT CELL, V14, P1903, DOI 10.1105/tpc.002238	18	246	264	4	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					786	788		10.1126/science.1239028	http://dx.doi.org/10.1126/science.1239028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23811228				2022-12-28	WOS:000323122200048
J	Fuchs, Y; Brown, S; Gorenc, T; Rodriguez, J; Fuchs, E; Steller, H				Fuchs, Yaron; Brown, Samara; Gorenc, Travis; Rodriguez, Joe; Fuchs, Elaine; Steller, Hermann			Sept4/ARTS Regulates Stem Cell Apoptosis and Skin Regeneration	SCIENCE			English	Article							HAIR FOLLICLE; TISSUE REGENERATION; TARGETED THERAPIES; CANCER; NICHE; XIAP; ARTS; HOMEOSTASIS; PROGENY; PROTEIN	Adult stem cells are essential for tissue homeostasis and wound repair. Their proliferative capacity must be tightly regulated to prevent the emergence of unwanted and potentially dangerous cells, such as cancer cells. We found that mice deficient for the proapoptotic Sept4/ARTS gene have elevated numbers of hair follicle stem cells (HFSCs) that are protected against apoptosis. Sept4/ARTS(-/-) mice display marked improvement in wound healing and regeneration of hair follicles. These phenotypes depend on HFSCs, as indicated by lineage tracing. Inactivation of XIAP, a direct target of ARTS, abrogated these phenotypes and impaired wound healing. Our results indicate that apoptosis plays an important role in regulating stem cell-dependent regeneration and suggest that this pathway may be a target for regenerative medicine.	[Fuchs, Yaron; Brown, Samara; Gorenc, Travis; Rodriguez, Joe; Steller, Hermann] Rockefeller Univ, Howard Hughes Med Inst, Strang Lab Apoptosis & Canc Biol, New York, NY 10065 USA; [Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu; steller@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NIH [RO1GM60124, R01-AR050452]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to colleagues whose contributions we could not adequately cite because of space constraints. We thank B. Keyes, Y. C. Hsu, N. Stokes, and I. Shachrai for discussion, advice, and technical assistance; S. Mazel, X. Li, S. Semova, and S. Tadesse for FACS sorting; the Comparative Biology Center (AAALAC-accredited) for health care to our mice; and members of the Steller lab. H. S. and E. F. are Investigators of the Howard Hughes Medical Institute. Supported by NIH grants RO1GM60124 (H. S.) and R01-AR050452 (E. F.). The Sept4/ARTS and XIAP mouse mutant strains used in this study are available from the Rockefeller University to academic groups through a materials transfer agreement and to for-profit groups through a license.	Bergmann A, 2003, CURR OPIN CELL BIOL, V15, P717, DOI 10.1016/j.ceb.2003.10.002; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Edison N, 2012, CELL DEATH DIFFER, V19, P356, DOI 10.1038/cdd.2011.112; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Garcia-Fernandez M, 2010, GENE DEV, V24, P2282, DOI 10.1101/gad.1970110; Garrison JB, 2011, MOL CELL, V41, P107, DOI 10.1016/j.molcel.2010.12.002; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jahoda CAB, 2011, CELL, V146, P678, DOI 10.1016/j.cell.2011.08.020; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Woo WM, 2011, CELL, V146, P334, DOI 10.1016/j.cell.2011.07.001	31	60	60	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					286	289		10.1126/science.1233029	http://dx.doi.org/10.1126/science.1233029			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23788729	Green Accepted			2022-12-28	WOS:000321959300046
J	Berggren, G; Adamska, A; Lambertz, C; Simmons, TR; Esselborn, J; Atta, M; Gambarelli, S; Mouesca, JM; Reijerse, E; Lubitz, W; Happe, T; Artero, V; Fontecave, M				Berggren, G.; Adamska, A.; Lambertz, C.; Simmons, T. R.; Esselborn, J.; Atta, M.; Gambarelli, S.; Mouesca, J. -M.; Reijerse, E.; Lubitz, W.; Happe, T.; Artero, V.; Fontecave, M.			Biomimetic assembly and activation of [FeFe]-hydrogenases	NATURE			English	Article							FE-ONLY HYDROGENASE; ACTIVE-SITE; H-CLUSTER; DESULFOVIBRIO-DESULFURICANS; CHLAMYDOMONAS-REINHARDTII; S-ADENOSYLMETHIONINE; LINKAGE ISOMERISM; BIOFUEL CELL; IRON; COORDINATION	Hydrogenases are the most active molecular catalysts for hydrogen production and uptake(1,2), and could therefore facilitate the development of new types of fuel cell(3-5). In [FeFe]-hydrogenases, catalysis takes place at a unique di-iron centre (the [2Fe] subsite), which contains a bridging dithiolate ligand, three CO ligands and two CN- ligands(6,7). Through a complex multienzymatic biosynthetic process, this [2Fe] subsite is first assembled on a maturation enzyme, HydF, and then delivered to the apo-hydrogenase for activation(8). Synthetic chemistry has been used to prepare remarkably similar mimics of that subsite(1), but it has failed to reproduce the natural enzymatic activities thus far. Here we show that three synthetic mimics (containing different bridging dithiolate ligands) can be loaded onto bacterial Thermotoga maritima HydF and then transferred to apo-HydA1, one of the hydrogenases of Chlamy-domonas reinhardtii algae. Full activation of HydA1 was achieved only when using the HydF hybrid protein containing the mimic with an azadithiolate bridge, confirming the presence of this ligand in the active site of native [FeFe]-hydrogenases(9,10). This is an example of controlled metalloenzyme activation using the combination of a specific protein scaffold and active-site synthetic analogues. This simple methodology provides both new mechanistic and structural insight into hydrogenase maturation and a unique tool for producing recombinant wild-type and variant [FeFe]-hydrogenases, with no requirement for the complete maturation machinery.	[Berggren, G.; Simmons, T. R.; Atta, M.; Artero, V.; Fontecave, M.] Univ Grenoble 1, CNRS, CEA, Lab Chim & Biol Met, F-38054 Grenoble 9, France; [Berggren, G.; Fontecave, M.] Coll France, F-75231 Paris 5, France; [Adamska, A.; Reijerse, E.; Lubitz, W.] Max Planck Inst Chem Energiekonvers, D-45470 Mulheim, Germany; [Lambertz, C.; Esselborn, J.; Happe, T.] Ruhr Univ Bochum, AG Photobiotechnol, Lehrstuhl Biochem Pflanzen, D-44801 Bochum, Germany; [Gambarelli, S.; Mouesca, J. -M.] Univ Grenoble 1, CEA INAC, Lab Chim Inorgan & Biol, UMR E 3, F-38054 Grenoble 9, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; College de France; Max Planck Society; Ruhr University Bochum; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fontecave, M (corresponding author), Univ Grenoble 1, CNRS, CEA, Lab Chim & Biol Met, 17 Rue Martyrs, F-38054 Grenoble 9, France.	marc.fontecave@cea.fr	Simmons, Trevor/B-8182-2016; Berggren, Gustav/H-8659-2013; Artero, Vincent/C-6853-2008	Simmons, Trevor/0000-0002-6057-7704; Berggren, Gustav/0000-0002-6717-6612; Artero, Vincent/0000-0002-6148-8471; Esselborn, Julian/0000-0002-3499-8417; Happe, Thomas/0000-0003-1206-5234	Bengt Lundqvist Minnesfond, FORMAS [213-2010-563]; Swedish Royal Academy of Sciences; French National Research Agency (ANR) [07-BLAN-0298-01]; Labex programme (ARCANE) [11-LABX-003]; European Research Council under the European Union's Seventh Framework Programme [306398]; Deutsche Forschungsgemeinschaft [HA 255/2-1]; BMBF [Bio-H2]; Volkswagen foundation [LigH2t]; Max Planck Society	Bengt Lundqvist Minnesfond, FORMAS; Swedish Royal Academy of Sciences; French National Research Agency (ANR)(French National Research Agency (ANR)); Labex programme (ARCANE); European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Volkswagen foundation(Volkswagen); Max Planck Society(Max Planck Society)	G. B. acknowledges support from the Bengt Lundqvist Minnesfond, FORMAS (contract number 213-2010-563) and the Swedish Royal Academy of Sciences. This work was supported by the French National Research Agency (ANR) through grant 07-BLAN-0298-01 and the Labex programme (ARCANE, 11-LABX-003). V. A. acknowledges support from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013/ERC Grant Agreement no. 306398). T. H. was supported by the Deutsche Forschungsgemeinschaft (HA 255/2-1), the BMBF (Bio-H2) and the Volkswagen foundation (LigH2t). A. A., E. R. and W. L. thank the Max Planck Society for financial support, and A. Silakov for providing the FTIR processing software.	Adamska A, 2012, ANGEW CHEM INT EDIT, V51, P11458, DOI 10.1002/anie.201204800; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Chen DW, 2003, J AM CHEM SOC, V125, P11788, DOI 10.1021/ja036120z; Ciaccafava A, 2012, ELECTROCHEM COMMUN, V23, P25, DOI 10.1016/j.elecom.2012.06.035; Coronado E, 2005, J AM CHEM SOC, V127, P4580, DOI 10.1021/ja043166z; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Darensbourg MY, 2003, P NATL ACAD SCI USA, V100, P3683, DOI 10.1073/pnas.0536955100; Fiedler AT, 2005, INORG CHEM, V44, P1794, DOI 10.1021/ic048739n; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Gambarelli S, 2005, CHEMBIOCHEM, V6, P1960, DOI 10.1002/cbic.200500182; Geiss A, 2000, INORG CHEM, V39, P4029, DOI 10.1021/ic0001412; Hambourger M, 2008, J AM CHEM SOC, V130, P2015, DOI 10.1021/ja077691k; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; Hemschemeier A, 2009, PHOTOSYNTH RES, V102, P523, DOI 10.1007/s11120-009-9415-5; Hubrich M, 1996, J CHEM PHYS, V104, P2172, DOI 10.1063/1.470973; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; Krishnan S, 2012, CHEM SCI, V3, P1015, DOI 10.1039/c2sc01103d; Kuchenreuther JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015491; Le Cloirec A, 1999, CHEM COMMUN, P2285; Li HX, 2002, J AM CHEM SOC, V124, P726, DOI 10.1021/ja016964n; Lyon EJ, 1999, ANGEW CHEM INT EDIT, V38, P3178, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3178::AID-ANIE3178>3.3.CO;2-W; Mertens R, 2004, CURR OPIN BIOTECH, V15, P343, DOI 10.1016/j.copbio.2004.06.010; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Schmidt M, 1999, J AM CHEM SOC, V121, P9736, DOI 10.1021/ja9924187; Shatruk M, 2007, J AM CHEM SOC, V129, P6104, DOI 10.1021/ja066273x; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Song LC, 2004, ORGANOMETALLICS, V23, P3082, DOI 10.1021/om049752i; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; Sybirna K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-73; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q	36	489	491	11	575	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2013	499	7456					66	+		10.1038/nature12239	http://dx.doi.org/10.1038/nature12239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23803769	Green Accepted			2022-12-28	WOS:000321285600034
J	Nouvini, R; Hapani, S				Nouvini, Rosa; Hapani, Sanjaykumar			Enlarged Spleen with a Heterogeneous Pattern	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nouvini, Rosa; Hapani, Sanjaykumar] SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Nouvini, R (corresponding author), SUNY Stony Brook, Med Ctr, Stony Brook, NY 11794 USA.	rosa.nouvini@stonybrookmedicine.edu							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					E37	E37		10.1056/NEJMicm1210836	http://dx.doi.org/10.1056/NEJMicm1210836			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23802540				2022-12-28	WOS:000320926900001
J	Thor, S				Thor, Stefan			NEUROSCIENCE Stem cells in multiple time zones	NATURE			English	Editorial Material							TRANSCRIPTION FACTORS; NEUROBLAST LINEAGES; TEMPORAL IDENTITY; PROGENITOR CELLS; DROSOPHILA CNS; NERVOUS-SYSTEM; SPECIFICATION; NUMB; PROLIFERATION; HUNCHBACK		Linkoping Univ, Dept Clin & Expt Med, S-58185 Linkoping, Sweden	Linkoping University	Thor, S (corresponding author), Linkoping Univ, Dept Clin & Expt Med, S-58185 Linkoping, Sweden.	stefan.thor@liu.se		Thor, Stefan/0000-0001-5095-541X				Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Bayraktar OA, 2013, NATURE, V498, P449, DOI 10.1038/nature12266; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jacob J, 2008, DEVELOPMENT, V135, P3481, DOI 10.1242/dev.016931; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Li X, 2013, NATURE, V498, P456, DOI 10.1038/nature12319; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Novotny T, 2002, DEVELOPMENT, V129, P1027; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9	18	2	2	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					441	443		10.1038/nature12261	http://dx.doi.org/10.1038/nature12261			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23783512				2022-12-28	WOS:000320929400039
J	Bhaumik, S				Bhaumik, Soumyadeep			WORKFORCE PLANNING Why is India short of nurses and what can we do about it?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												soumyadeepbhaumik@rediffmail.com		Bhaumik, Soumyadeep/0000-0001-9579-4453				[Anonymous], 2012, INDIAN EXPRESS; Bagga R, 2012, STUDY NURSING MIDWIF; Evans C, 2013, BMC NURS, V12, DOI 10.1186/1472-6955-12-8; Express news service, 2013, NEW INDIAN EXPR 0219; Government of India Ministry of Health and Family Welfare, 2013, NAT WORKSH INTR NAT; Indian Nursing Council, STAT WIS DISTR NURS; Issac A, 2009, MIGRATION HLTH CARE; Ministry of Health and Family Welfare Government of India, 2005, REP NAT COMM MACR HL; Nair S, PROFESSION MARGINS S; Planning Commission of India, 2011, HIGH LEV EXP GROUP R; Press Information Bureau, 2007, NURS AR SHEET ANCH O; Telegraph (India), 2012, TELEGRAPH INDIA 0716; TNN News, 2013, TIMES INDIA     0430	13	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2013	346								f4024	10.1136/bmj.f4024	http://dx.doi.org/10.1136/bmj.f4024			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QI	23801690				2022-12-28	WOS:000321245900012
J	Dennis, KM; Liao, QH; Wu, P; Gao, ZC; Cao, B; Feng, LZ; Xu, XL; Jiang, H; Li, M; Bao, J; Zheng, JD; Zhang, Q; Chang, ZR; Li, Y; Yu, JX; Liu, FF; Ni, MY; Wu, JT; Cowling, BJ; Yang, WZ; Leung, GM; Yu, HJ				Dennis, K. M.; Liao, Qiaohong; Wu, Peng; Gao, Zhancheng; Cao, Bin; Feng, Luzhao; Xu, Xiaoling; Jiang, Hui; Li, Ming; Bao, Jing; Zheng, Jiandong; Zhang, Qian; Chang, Zhaorui; Li, Yu; Yu, Jianxing; Liu, Fengfeng; Ni, Michael Y.; Wu, Joseph T.; Cowling, Benjamin J.; Yang, Weizhong; Leung, Gabriel M.; Yu, Hongjie			Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISEASE; POULTRY; VIRUS; MARCH	Objective To characterise the complete case series of influenza A/H7N9 infections as of 27 May 2013, detected by China's national sentinel surveillance system for influenza-like illness. Design Case series. Setting Outpatient clinics and emergency departments of 554 sentinel hospitals across 31 provinces in mainland China. Cases Infected individuals were identified through cross-referencing people who had laboratory confirmed A/H7N9 infection with people detected by the sentinel surveillance system for influenza-like illness, where patients meeting the World Health Organization's definition of influenza-like illness undergo weekly surveillance, and 10-15 nasopharyngeal swabs are collected each week from a subset of patients with influenza-like illness in each hospital for virological testing. We extracted relevant epidemiological data from public health investigations by the Centers for Disease Control and Prevention at the local, provincial, and national level; and clinical and laboratory data from chart review. Main outcome measure Epidemiological, clinical, and laboratory profiles of the case series. Results Of 130 people with laboratory confirmed A/H7N9 infection as of 27 May 2013, five (4%) were detected through the sentinel surveillance system for influenza-like illness. Mean age was 13 years (range 2-26), and none had any underlying medical conditions. Exposure history, geographical location, and timing of symptom onset of these five patients were otherwise similar to the general cohort of laboratory confirmed cases so far. Only two of the five patients needed hospitalisation, and all five had mild or moderate disease with an uneventful course of recovery. Conclusion Our findings support the existence of a "clinical iceberg" phenomenon in influenza A/H7N9 infections, and reinforce the need for vigilance to the diverse presentation that can be associated with A/H7N9 infection. At the public health level, indirect evidence suggests a substantial proportion of mild disease in A/H7N9 infections.	[Dennis, K. M.; Wu, Peng; Ni, Michael Y.; Wu, Joseph T.; Cowling, Benjamin J.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China; [Liao, Qiaohong; Feng, Luzhao; Jiang, Hui; Li, Ming; Zheng, Jiandong; Zhang, Qian; Chang, Zhaorui; Li, Yu; Yu, Jianxing; Liu, Fengfeng; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing 102206, Peoples R China; [Gao, Zhancheng; Bao, Jing] Peking Univ, Peoples Hosp, Dept Resp & Crit Care Med, Beijing 100871, Peoples R China; [Cao, Bin] Capital Med Univ, Beijing Inst Resp Med, Beijing Chao Yang Hosp, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China; [Xu, Xiaoling] Anhui Prov Hosp, Dept Resp Med, Hefei, Peoples R China; [Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Off Director, Beijing, Peoples R China	University of Hong Kong; Chinese Center for Disease Control & Prevention; Peking University; Capital Medical University; Chinese Center for Disease Control & Prevention	Leung, GM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China.	gmleung@hku.hk; yuhj@chinacdc.cn	Yu, Hongjie/GZK-5351-2022; Wu, Joseph/ABD-5880-2021; Cowling, Benjamin John/C-4263-2009; Ip, Dennis Kai Ming/C-4283-2009	Cowling, Benjamin John/0000-0002-6297-7154; Leung, Gabriel/0000-0002-2503-6283; Ni, Michael/0000-0002-1217-5858; Wu, Peng/0000-0003-1157-9401; Ip, Dennis Kai Ming/0000-0003-3592-8709; YU, Jianxing/0000-0002-9696-2460	US National Institutes of Health (Comprehensive International Program for Research on AIDS) [U19 AI51915]; China-US collaborative program on emerging and re-emerging infectious diseases; Chinese Ministry of Science and Technology [2012 ZX10004-201]; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Research Fund for the Control of Infectious Disease, Food, and Health Bureau (government of the Hong Kong Special Administrative Region); Hong Kong University [AoE/M-12/06]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	US National Institutes of Health (Comprehensive International Program for Research on AIDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China-US collaborative program on emerging and re-emerging infectious diseases; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Research Fund for the Control of Infectious Disease, Food, and Health Bureau (government of the Hong Kong Special Administrative Region); Hong Kong University(University of Hong Kong); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study received funding from the US National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19 AI51915); the China-US collaborative program on emerging and re-emerging infectious diseases. The study was also funded by grants from the Chinese Ministry of Science and Technology (2012 ZX10004-201); the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant U54 GM088558); the Research Fund for the Control of Infectious Disease, Food, and Health Bureau (government of the Hong Kong Special Administrative Region), and the area of excellence scheme of the Hong Kong University grants committee (grant AoE/M-12/06). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.	[Anonymous], CHIN WHO JOINT MISS; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, EUROSURVEILLANCE, V18, P2; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Han J, 2013, EUROSURVEILLANCE, V18, P6; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Lu SH, 2013, EMERG INFECT DIS, V19, P1142, DOI [10.3201/eid1907.130612, 10.3201/eid.1907.130612]; Meijer A, 2006, J VIROL METHODS, V132, P113, DOI 10.1016/j.jviromet.2005.10.001; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; Wu JT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001103; Xu CL, 2013, EMERG INFECT DIS, V19, P1289, DOI 10.3201/eid1908.130662; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang Wenyi, 2013, Clin Infect Dis, V57, P619, DOI 10.1093/cid/cit277	17	65	69	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2013	346								f3693	10.1136/bmj.f3693	http://dx.doi.org/10.1136/bmj.f3693			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QH	23798720	Green Published, hybrid			2022-12-28	WOS:000321245800001
J	Blobel, G				Blobel, Guenter			Christian de Duve (1917-2013)	NATURE			English	Biographical-Item									[Blobel, Guenter] Rockefeller Univ, New York, NY 10021 USA; [Blobel, Guenter] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Blobel, G (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	blobel@mail.rockefeller.edu						DEDUVE C, PUBLICATION LIST	1	5	6	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					300	300		10.1038/498300a	http://dx.doi.org/10.1038/498300a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23783621	Bronze			2022-12-28	WOS:000320592900021
J	Bradley, A; Sheridan, P				Bradley, Alastair; Sheridan, Paul			10-MINUTE CONSULTATION Atrial fibrillation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STROKE; RISK		[Bradley, Alastair] No Gen Hosp, Acad Unit Primary Med Care, Sheffield S5 7AU, S Yorkshire, England; [Sheridan, Paul] Sheffield Teaching Hosp NHS Fdn Trust, No Gen Hosp, Sheffield, S Yorkshire, England	Northern General Hospital; Northern General Hospital; University of Sheffield	Bradley, A (corresponding author), No Gen Hosp, Acad Unit Primary Med Care, Sheffield S5 7AU, S Yorkshire, England.	a.bradley@sheffield.ac.uk			Department of Health [IAT/I-PF/010/003] Funding Source: Medline; National Institute for Health Research [IAT/I-PF/010/003] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Lip GYH, 2007, LANCET, V370, P604, DOI 10.1016/S0140-6736(07)61300-2; Lip GYH, 2010, AM J MED, V123, P484, DOI 10.1016/j.amjmed.2009.12.013; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134	5	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2013	346								f3719	10.1136/bmj.f3719	http://dx.doi.org/10.1136/bmj.f3719			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171OV	23775800				2022-12-28	WOS:000320939700002
J	Lenzer, J				Lenzer, Jeanne			Why we can't trust clinical guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPINAL-CORD-INJURY; TISSUE-PLASMINOGEN ACTIVATOR; EMERGENCY PHYSICIANS; OF-INTEREST; STROKE; METHYLPREDNISOLONE; THROMBOLYSIS; FAILURE; CLAIMS					jeanne.lenzer@gmail.com						Abramson JE, 2004, E PETITION NATL I HT; American College of Emergency Physicians, 2013, Ann Emerg Med, V61, P225, DOI 10.1016/j.annemergmed.2012.11.005; [Anonymous], 2013, POLL SUPP NEW GUID T; Armstrong D., 2006, WALL STREET J; Bracken MB., 2009, COCHRANE DB SYST REV, V1; Brown DL, 2005, ANN EMERG MED, V46, P56, DOI 10.1016/j.annemergmed.2004.12.025; Canadian Association of Emergency Physicians, 2003, CJEM, V5, P7; Coleman WP, 2000, J SPINAL DISORD, V13, P185, DOI 10.1097/00002517-200006000-00001; Cundiff D., 2010, STORY WHISTLEBLOWER; Fatovich DM, 2012, EMERG MED AUSTRALAS, V24, P477, DOI 10.1111/j.1742-6723.2012.01605.x; Fatovich DM, 2012, EMERG MED J, V29, P82, DOI 10.1136/emermed-2011-200476; Gale EAM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5728; Garber AM, 2005, HEALTH AFFAIR, V24, P174, DOI 10.1377/hlthaff.24.1.174; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Hoffman JR, 2012, EMERG MED AUSTRALAS, V24, P473, DOI 10.1111/j.1742-6723.2012.01604.x; Hoffman JR, 2009, ANN EMERG MED, V54, P329, DOI 10.1016/j.annemergmed.2009.03.019; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Institute of Medicine, 2011, CLIN PRACT GUID WE C; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Klauer K., 2012, EMERG PHYS MONTH NOV; Kolata G., 2007, NY TIMES; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Lenzer J, 2002, BRIT MED J, V324, P723, DOI 10.1136/bmj.324.7339.723; Lenzer J., 2006, NEW REPUBLIC; Lenzer Jeanne, 2012, WASHINGTON MONTHLY; LYONS MK, 1990, NEW ENGL J MED, V323, P1207; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Molloy S, 2002, INJURY, V33, P575, DOI 10.1016/S0020-1383(02)00142-0; Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021; Newman D., 2013, SCI MED RES TRA 0417; Newman D., 2012, THROMBOLYTICS ACUTE; Newman DH, 2012, LANCET, V380, P1053, DOI 10.1016/S0140-6736(12)61593-1; Radecki RP, 2012, NAT REV NEUROL, V8, P176, DOI 10.1038/nrneurol.2011.89-c1; Ransohoff DF, 2013, JAMA-J AM MED ASSOC, V309, P139, DOI 10.1001/jama.2012.156703; Scott PA, 2010, STROKE, V41, P2026, DOI 10.1161/STROKEAHA.110.581942; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Sloane EP., CLIN USE TPA ACUTE I; Timmermans S, 2005, HEALTH AFFAIR, V24, P18, DOI 10.1377/hlthaff.24.1.18; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2	39	110	115	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2013	346								f3830	10.1136/bmj.f3830	http://dx.doi.org/10.1136/bmj.f3830			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166XQ	23771225				2022-12-28	WOS:000320593900009
J	Zhang, YLV; Ni, JF; Montell, C				Zhang, Yali V.; Ni, Jinfei; Montell, Craig			The Molecular Basis for Attractive Salt-Taste Coding in Drosophila	SCIENCE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; BITTER TASTE; MELANOGASTER; EXPRESSION; GENES; ARCHITECTURE; NEURONS; CHANNEL; MICE	Below a certain level, table salt (NaCl) is beneficial for animals, whereas excessive salt is harmful. However, it remains unclear how low- and high-salt taste perceptions are differentially encoded. We identified a salt-taste coding mechanism in Drosophila melanogaster. Flies use distinct types of gustatory receptor neurons (GRNs) to respond to different concentrations of salt. We demonstrated that a member of the newly discovered ionotropic glutamate receptor (IR) family, IR76b, functioned in the detection of low salt and was a Na+ channel. The loss of IR76b selectively impaired the attractive pathway, leaving salt-aversive GRNs unaffected. Consequently, low salt became aversive. Our work demonstrated that the opposing behavioral responses to low and high salt were determined largely by an elegant bimodal switch system operating in GRNs.	[Montell, Craig] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93110 USA; [Montell, Craig] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93110 USA; [Zhang, Yali V.; Ni, Jinfei; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Zhang, Yali V.; Ni, Jinfei; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93110 USA.	craig.montell@lifesci.ucsb.edu	Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Zhang, Yali/0000-0003-4083-4352	National Institute on Deafness and Other Communication Disorders [DC007864]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007864] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by a grant to C.M. from the National Institute on Deafness and Other Communication Disorders (DC007864).	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; BALAKRISHNAN R, 1991, J EXP BIOL, V157, P161; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; DESIMONE JA, 1981, SCIENCE, V214, P1039, DOI 10.1126/science.7302576; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Nakamura M, 2002, J NEUROSCI, V22, P3463; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	26	195	203	12	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1334	1338		10.1126/science.1234133	http://dx.doi.org/10.1126/science.1234133			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766326	Green Accepted			2022-12-28	WOS:000320320200046
J	de Jonge, A; Mesman, JAJM; Mannien, J; Zwart, JJ; van Dillen, J; van Roosmalen, J				de Jonge, Ank; Mesman, Jeanette A. J. M.; Mannien, Judith; Zwart, Joost J.; van Dillen, Jeroen; van Roosmalen, Jos			Severe adverse maternal outcomes among low risk women with planned home versus hospital births in the Netherlands: nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MORBIDITY; DELIVERY	Objectives To test the hypothesis that low risk women at the onset of labour with planned home birth have a higher rate of severe acute maternal morbidity than women with planned hospital birth, and to compare the rate of postpartum haemorrhage and manual removal of placenta. Design Cohort study using a linked dataset. Setting Information on all cases of severe acute maternal morbidity in the Netherlands collected by the national study into ethnic determinants of maternal morbidity in the netherlands (LEMMoN study), 1 August 2004 to 1 August 2006, merged with data from the Netherlands perinatal register of all births occurring during the same period. Participants 146 752 low risk women in primary care at the onset of labour. Main outcome measures Severe acute maternal morbidity (admission to an intensive care unit, eclampsia, blood transfusion of four or more packed cells, and other serious events), postpartum haemorrhage, and manual removal of placenta. Results Overall, 92 333 (62.9%) women had a planned home birth and 54 419 (37.1%) a planned hospital birth. The rate of severe acute maternal morbidity among planned primary care births was 2.0 per 1000 births. For nulliparous women the rate for planned home versus planned hospital birth was 2.3 versus 3.1 per 1000 births (adjusted odds ratio 0.77, 95% confidence interval 0.56 to 1.06), relative risk reduction 25.7% (95% confidence interval -0.1% to 53.5%), the rate of postpartum haemorrhage was 43.1 versus 43.3 (0.92, 0.85 to 1.00 and 0.5%, -6.8% to 7.9%), and the rate of manual removal of placenta was 29.0 versus 29.8 (0.91, 0.83 to 1.00 and 2.8%, -6.1% to 11.8%). For parous women the rate of severe acute maternal morbidity for planned home versus planned hospital birth was 1.0 versus 2.3 per 1000 births (0.43, 0.29 to 0.63 and 58.3%, 33.2% to 87.5%), the rate of postpartum haemorrhage was 19.6 versus 37.6 (0.50, 0.46 to 0.55 and 47.9%, 41.2% to 54.7%), and the rate of manual removal of placenta was 8.5 versus 19.6 (0.41, 0.36 to 0.47 and 56.9%, 47.9% to 66.3%). Conclusions Low risk women in primary care at the onset of labour with planned home birth had lower rates of severe acute maternal morbidity, postpartum haemorrhage, and manual removal of placenta than those with planned hospital birth. For parous women these differences were statistically significant. Absolute risks were small in both groups. There was no evidence that planned home birth among low risk women leads to an increased risk of severe adverse maternal outcomes in a maternity care system with well trained midwives and a good referral and transportation system.	[de Jonge, Ank; Mannien, Judith] AVAG, Dept Midwifery Sci, Amsterdam, Netherlands; [de Jonge, Ank; Mannien, Judith] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Mesman, Jeanette A. J. M.; van Roosmalen, Jos] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; [Zwart, Joost J.] Deventer Hosp, Deventer, Netherlands; [van Dillen, Jeroen] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Roosmalen, Jos] Vrije Univ Amsterdam, Med Ctr, EMGO, Dept Med Humanities, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Deventer Hospital; Radboud University Nijmegen; Vrije Universiteit Amsterdam	de Jonge, A (corresponding author), AVAG, Dept Midwifery Sci, Amsterdam, Netherlands.	ank.dejonge@vumc.nl	de Jonge, Ank/F-6475-2013; Dillen, J./L-4275-2015	Mannien, Judith/0000-0003-1698-9979	ZonMw	ZonMw(Netherlands Organization for Health Research and Development)	This study was funded with a career grant (VENI) from ZonMw. The funder had no role in any aspect of the study.	Amelink-Verburg MP, 2008, BJOG-INT J OBSTET GY, V115, P570, DOI 10.1111/j.1471-0528.2007.01580.x; [Anonymous], 2003, FIN REP MAT CAR COMM; Bedwell C, 2011, SEX REPROD HEALTHC, V2, P71, DOI 10.1016/j.srhc.2010.12.001; Blix E, 2012, SEX REPROD HEALTHC, V3, P147, DOI 10.1016/j.srhc.2012.10.001; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Christiaens W, 2013, MIDWIFERY, V29, pE1, DOI 10.1016/j.midw.2012.08.010; Davis D, 2011, BIRTH-ISS PERINAT C, V38, P111, DOI 10.1111/j.1523-536X.2010.00458.x; de Jonge A, 2009, BJOG-INT J OBSTET GY, V116, P1177, DOI 10.1111/j.1471-0528.2009.02175.x; Declercq E, 2008, BIRTH-ISS PERINAT C, V35, P16, DOI 10.1111/j.1523-536X.2007.00207.x; Declercq E, 2007, OBSTET GYNECOL, V109, P669, DOI 10.1097/01.AOG.0000255668.20639.40; Fitzpatrick KE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001184; Hutton EK, 2009, BIRTH-ISS PERINAT C, V36, P180, DOI 10.1111/j.1523-536X.2009.00322.x; Janssen PA, 2009, CAN MED ASSOC J, V181, P377, DOI 10.1503/cmaj.081869; Kramer MS, 2011, J OBSTET GYNAECOL CA, V33, P810, DOI 10.1016/S1701-2163(16)34984-2; Lindgren HE, 2008, ACTA OBSTET GYN SCAN, V87, P751, DOI 10.1080/00016340802199903; Meray N, 2007, J CLIN EPIDEMIOL, V60, P883, DOI 10.1016/j.jclinepi.2006.11.021; Offerhaus P, 2012, OBSTET GYNECOL, V119, P387, DOI 10.1097/AOG.0b013e318244bec6; Olsen O, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000352.pub2; Ravelli ACJ, 2011, BJOG-INT J OBSTET GY, V118, P457, DOI 10.1111/j.1471-0528.2010.02816.x; *STICHT PER REG NE, 2008, PER CAR NETH 2006; Stichting Perinatale Registratie Nederland, 2013, PER CAR NETH 2010; Stichting Perinatale Registratie Nederland, 2008, PER CAR NETH 2005; Stichting Perinatale Registratie Nederland, 2007, PER CAR NETH 2004; van der Kooy J, 2011, OBSTET GYNECOL, V118, P1037, DOI 10.1097/AOG.0b013e3182319737; van Dillen J, 2010, BJOG-INT J OBSTET GY, V117, P416, DOI 10.1111/j.1471-0528.2009.02480.x; van Dillen J, 2010, ACTA OBSTET GYN SCAN, V89, P1460, DOI 10.3109/00016349.2010.519018; ten Haken TV, 2012, MIDWIFERY, V28, P609, DOI 10.1016/j.midw.2012.07.010; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x; Zwart JJ, 2011, EUR J PUBLIC HEALTH, V21, P229, DOI 10.1093/eurpub/ckq046	29	51	56	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2013	346								f3263	10.1136/bmj.f3263	http://dx.doi.org/10.1136/bmj.f3263			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	166WQ	23766482	Green Published, hybrid			2022-12-28	WOS:000320590800020
J	Itkin, M; Heinig, U; Tzfadia, O; Bhide, AJ; Shinde, B; Cardenas, PD; Bocobza, SE; Unger, T; Malitsky, S; Finkers, R; Tikunov, Y; Bovy, A; Chikate, Y; Singh, P; Rogachev, I; Beekwilder, J; Giri, AP; Aharoni, A				Itkin, M.; Heinig, U.; Tzfadia, O.; Bhide, A. J.; Shinde, B.; Cardenas, P. D.; Bocobza, S. E.; Unger, T.; Malitsky, S.; Finkers, R.; Tikunov, Y.; Bovy, A.; Chikate, Y.; Singh, P.; Rogachev, I.; Beekwilder, J.; Giri, A. P.; Aharoni, A.			Biosynthesis of Antinutritional Alkaloids in Solanaceous Crops Is Mediated by Clustered Genes	SCIENCE			English	Article							GLYCOALKALOIDS; POTATO; PLANT; METABOLITES; PATHWAYS; SAPONINS; TOMATO	Steroidal glycoalkaloids (SGAs) such as alpha-solanine found in solanaceous food plants-as, for example, potato-are antinutritional factors for humans. Comparative coexpression analysis between tomato and potato coupled with chemical profiling revealed an array of 10 genes that partake in SGA biosynthesis. We discovered that six of them exist as a cluster on chromosome 7, whereas an additional two are adjacent in a duplicated genomic region on chromosome 12. Following systematic functional analysis, we suggest a revised SGA biosynthetic pathway starting from cholesterol up to the tetrasaccharide moiety linked to the tomato SGA aglycone. Silencing GLYCOALKALOID METABOLISM 4 prevented accumulation of SGAs in potato tubers and tomato fruit. This may provide a means for removal of unsafe, antinutritional substances present in these widely used food crops.	[Itkin, M.; Heinig, U.; Tzfadia, O.; Bhide, A. J.; Shinde, B.; Cardenas, P. D.; Bocobza, S. E.; Malitsky, S.; Chikate, Y.; Singh, P.; Rogachev, I.; Giri, A. P.; Aharoni, A.] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Bhide, A. J.; Shinde, B.; Chikate, Y.; Singh, P.; Giri, A. P.] CSIR, Natl Chem Lab, Div Biochem Sci, Plant Mol Biol Unit, Pune 411008, Maharashtra, India; Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel; [Unger, T.] Weizmann Inst Sci, Israel Struct Prote Ctr, IL-76100 Rehovot, Israel; [Finkers, R.; Tikunov, Y.; Bovy, A.; Beekwilder, J.] Univ Wageningen & Res Ctr, NL-6700 AA Wageningen, Netherlands	Weizmann Institute of Science; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Hebrew University of Jerusalem; Weizmann Institute of Science; Wageningen University & Research	Aharoni, A (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	asaph.aharoni@weizmann.ac.il	Beekwilder, Jules/A-6802-2011; Malitsky, Sergey/ABC-2545-2020; Finkers, Richard/G-1706-2010; Itkin, Maxim/ABB-9183-2020; Itkin, Maxim/AFU-5181-2022; aharoni, asaph/W-6670-2019; Tikunov, Yury/M-4748-2017; Cardenas, Pablo D./HGE-9392-2022	Beekwilder, Jules/0000-0003-3238-4427; Malitsky, Sergey/0000-0003-4619-7219; Finkers, Richard/0000-0002-4368-8058; Itkin, Maxim/0000-0003-1348-2814; Tikunov, Yury/0000-0001-5417-5066; Cardenas, Pablo D./0000-0002-4141-2410; Shinde, Balkrishna A/0000-0002-7806-5424; Tzfadia, Oren/0000-0002-7096-8063; Bovy, Arnaud/0000-0003-2643-7377	European Research Council (SAMIT-FP7 program); European Union [FP7-KBBE-2009-3-245121-ATHENA]; Volkswagen Foundation, Hannover, Germany [AZ: I/82 754]; Council of Scientific and Industrial Research (India); University Grants Commission (India)	European Research Council (SAMIT-FP7 program); European Union(European Commission); Volkswagen Foundation, Hannover, Germany(Volkswagen); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (India)(University Grants Commission, India)	We thank A. Tishbee and R. Kramer for operating the UPLC-qTOF-MS instrument and the European Research Council (SAMIT-FP7 program) for supporting the work in the A. A. laboratory. A. A. is the incumbent of the Peter J. Cohn Professorial Chair. J. B. was supported by the European Union 7th Frame Anthocyanin and Polyphenol Bioactives for Health Enhancement through Nutritional Advancement (ATHENA) Project (FP7-KBBE-2009-3-245121-ATHENA). U. H. was partially supported by fellowship AZ: I/82 754, Volkswagen Foundation, Hannover, Germany. We thank the Council of Scientific and Industrial Research (India) for support to A. P. G. (Raman Research Fellowship), A. J. B., Y.C., and P. S. (Research Fellowship) and the University Grants Commission (India) for supporting B. S. We also thank D. R. Nelson for assistance with CYP450 gene classification and R. Last for critically reading the manuscript. A. A. and M. I. are inventors on publication number WO2012095843 A1, submitted by Yeda Research and Development Co. Ltd, which covers the use of the GAME4 gene for generating low-alkaloid fruit and tubers.	[Anonymous], 2012, FDA Poisonous Plant Database, Patent No. [20120159676 A1, 20120519676]; Desfosses M., 1820, J PHARM, V6, P374; Dolan LC, 2010, TOXINS, V2, P2289, DOI 10.3390/toxins2092289; Dowd PF, 2011, J CHEM ECOL, V37, P443, DOI 10.1007/s10886-011-9950-3; Eich E., 2008, SOLANACEAE AND CONVO; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Friedman M, 2006, J AGR FOOD CHEM, V54, P8655, DOI 10.1021/jf061471t; Itkin M, 2011, PLANT CELL, V23, P4507, DOI 10.1105/tpc.111.088732; Kliebenstein DJ, 2012, CURR OPIN PLANT BIOL, V15, P415, DOI 10.1016/j.pbi.2012.05.005; McCue KF, 2005, PLANT SCI, V168, P267, DOI 10.1016/j.plantsci.2004.08.006; Narayanan NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021996; Osbourn A, 2010, PLANT PHYSIOL, V154, P531, DOI 10.1104/pp.110.161315; RODDICK JG, 1989, PHYTOCHEMISTRY, V28, P2631, DOI 10.1016/S0031-9422(00)98055-5; Sanford LL, 1998, AM J POTATO RES, V75, P167, DOI 10.1007/BF02853568; Sparg SG, 2004, J ETHNOPHARMACOL, V94, P219, DOI 10.1016/j.jep.2004.05.016; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yamanaka T, 2009, J AGR FOOD CHEM, V57, P3786, DOI 10.1021/jf900017n	18	322	340	15	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					175	179		10.1126/science.1240230	http://dx.doi.org/10.1126/science.1240230			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23788733				2022-12-28	WOS:000321965300043
J	Ma, J; Bai, L; Wang, MD				Ma, Jie; Bai, Lu; Wang, Michelle D.			Transcription Under Torsion	SCIENCE			English	Article							SINGLE-MOLECULE ANALYSIS; COLI RNA-POLYMERASE; UPSTREAM DNA; BACKTRACKING; ELONGATION; TEMPLATE; TOPOISOMERASE; SUPERCOILS; PROMOTER; STRESS	In cells, RNA polymerase (RNAP) must transcribe supercoiled DNA, whose torsional state is constantly changing, but how RNAP deals with DNA supercoiling remains elusive. We report direct measurements of individual Escherichia coli RNAPs as they transcribed supercoiled DNA. We found that a resisting torque slowed RNAP and increased its pause frequency and duration. RNAP was able to generate 11 +/- 4 piconewton-nanometers (mean +/- standard deviation) of torque before stalling, an amount sufficient to melt DNA of arbitrary sequence and establish RNAP as a more potent torsional motor than previously known. A stalled RNAP was able to resume transcription upon torque relaxation, and transcribing RNAP was resilient to transient torque fluctuations. These results provide a quantitative framework for understanding how dynamic modification of DNA supercoiling regulates transcription.	[Ma, Jie; Wang, Michelle D.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Ma, Jie; Wang, Michelle D.] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14853 USA; [Bai, Lu] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16801 USA; [Bai, Lu] Penn State Univ, Dept Phys, University Pk, PA 16801 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wang, MD (corresponding author), Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA.	mwang@physics.cornell.edu			NIH [GM059849]; NSF [MCB-0820293]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059849] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Wang lab for critical reading of the manuscript. We especially thank R. M. Fulbright for purification of the RNAP and S. Forth, Y. Yang, M. Y. Sheinin, J. T. Inman, and R. A. Forties for assistance with single-molecule assays, data acquisition, data analysis, and figure preparation. We wish to acknowledge support from an NIH grant (GM059849 to M.D.W) and an NSF grant (MCB-0820293 to M.D.W).	Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bai L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068103; Bai L, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/12/P12007; Deufel C, 2007, NAT METHODS, V4, P223, DOI 10.1038/nmeth1013; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Forth S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.148301; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Gore J, 2006, NATURE, V439, P100, DOI 10.1038/nature04319; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Kouzine F, 2004, NAT STRUCT MOL BIOL, V11, P1092, DOI 10.1038/nsmb848; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; KOWALSKI D, 1989, EMBO J, V8, P4335, DOI 10.1002/j.1460-2075.1989.tb08620.x; La Porta A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190801; Lavelle C, 2007, BIOCHIMIE, V89, P516, DOI 10.1016/j.biochi.2006.09.019; Levchenko V, 2005, BIOCHEMISTRY-US, V44, P5357, DOI 10.1021/bi047786o; LILLEY DMJ, 1991, MOL MICROBIOL, V5, P779, DOI 10.1111/j.1365-2958.1991.tb00749.x; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Matsumoto K, 2004, J CELL SCI, V117, P3797, DOI 10.1242/jcs.01225; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Sheinin MY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.108102; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8	28	183	184	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1580	1583		10.1126/science.1235441	http://dx.doi.org/10.1126/science.1235441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812716	Green Accepted			2022-12-28	WOS:000321007000044
J	Rao, N; Crail, S				Rao, Nitesh; Crail, Susan			Metastatic Calcification and Long-Term Hemodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rao, Nitesh; Crail, Susan] Royal Adelaide Hosp, Adelaide, SA 5000, Australia	Royal Adelaide Hospital	Rao, N (corresponding author), Royal Adelaide Hosp, Adelaide, SA 5000, Australia.	niteshnrao@yahoo.co.uk							0	3	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2415	2415		10.1056/NEJMicm1202544	http://dx.doi.org/10.1056/NEJMicm1202544			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782180				2022-12-28	WOS:000320601700011
J	Heijstek, MW; Kamphuis, S; Armbrust, W; Swart, J; Gorter, S; de Vries, LD; Smits, GP; van Gageldonk, PG; Berbers, GAM; Wulffraat, NM				Heijstek, Marloes W.; Kamphuis, Sylvia; Armbrust, Wineke; Swart, Joost; Gorter, Simone; de Vries, Lara D.; Smits, Gaby P.; van Gageldonk, Pieter G.; Berbers, Guy A. M.; Wulffraat, Nico M.			Effects of the Live Attenuated Measles-Mumps-Rubella Booster Vaccination on Disease Activity in Patients With Juvenile Idiopathic Arthritis A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RHEUMATOID-ARTHRITIS; VIRUS INFECTION; ACTIVITY SCORE; METHOTREXATE; IMMUNOGENICITY; REVACCINATION; IMMUNOASSAY; PROTECTION; ANTIBODIES; REMISSION	Importance The immunogenicity and the effects of live attenuated measles-mumpsrubella (MMR) vaccination on disease activity in patients with juvenile idiopathic arthritis (JIA) are matters of concern, especially in patients treated with immunocompromising therapies. Objectives To assess whether MMR booster vaccination affects disease activity and to describe MMR booster immunogenicity in patients with JIA. Design, Setting, and Participants Randomized, multicenter, open-label clinical equivalence trial including 137 patients with JIA aged 4 to 9 years who were recruited from 5 academic hospitals in the Netherlands between May 2008 and July 2011. Intervention Patients were randomly assigned to receive MMR booster vaccination (n=68) or no vaccination (control group; n=69). Among patients taking biologics, these treatments were discontinued at 5 times their half-lives prior to vaccination. Main Outcomes and Measures Disease activity as measured by the Juvenile Arthritis Disease Activity Score (JADAS-27), ranging from 0 (no activity) to 57 (high activity). Disease activity in the year following randomization was compared between revaccinated patients and controls using a linear mixed model. A difference in JADAS-27 of 2.0 was the equivalence margin. Primary immunogenicity outcomes were seroprotection rates and MMR-specific antibody concentrations at 3 and 12 months. Results Of 137 randomized patients, 131 were analyzed in the modified intention-to-treat analysis, including 60 using methotrexate and 15 using biologics. Disease activity during complete follow-up did not differ between 63 revaccinated patients (JADAS-27, 2.8; 95% CI, 2.1-3.5) and 68 controls (JADAS-27, 2.4; 95% CI, 1.7-3.1), with a difference of 0.4 (95% CI, -0.5 to 1.2), within the equivalence margin of 2.0. At 12 months, seroprotection rates were higher in revaccinated patients vs controls (measles, 100% vs 92%[95% CI, 84%-99%]; mumps, 97%[95% CI, 95%-100%] vs 81% [95% CI, 72%-93%]; and rubella, 100% vs 94% [95% CI, 86%-100%], respectively), as were antibody concentrations against measles (1.63 vs 0.78 IU/mL; P=.03), mumps (168 vs 104 RU/mL; P=.03), and rubella (69 vs 45 IU/mL; P=.01). Methotrexate and biologics did not affect humoral responses, but low patient numbers precluded definite conclusions. Conclusion and Relevance Among children with JIA who had undergone primary immunization, MMR booster vaccination compared with no booster did not result in worse JIA disease activity and was immunogenic. Larger studies are needed to assess MMR effects in patients using biologic agents.	[Heijstek, Marloes W.; Swart, Joost; de Vries, Lara D.; Wulffraat, Nico M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol, NL-3508 AB Utrecht, Netherlands; [Kamphuis, Sylvia] Sophia Childrens Univ Hosp, Erasmus Med Ctr Rotterdam, Dept Pediat Rheumatol, Rotterdam, Netherlands; [Armbrust, Wineke] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Rheumatol, Groningen, Netherlands; [Swart, Joost] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Pediat, Amsterdam, Netherlands; [Gorter, Simone] Maastricht Univ, Med Ctr, CAPHRI Res Inst Maastricht, Dept Internal Med,Div Rheumatol, Maastricht, Netherlands; [Smits, Gaby P.; van Gageldonk, Pieter G.; Berbers, Guy A. M.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, Ctr Infect Dis Control Netherlands, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Groningen; Vrije Universiteit Amsterdam; Maastricht University; Netherlands National Institute for Public Health & the Environment	Heijstek, MW (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol, Room KC03-063-0,POB 85090, NL-3508 AB Utrecht, Netherlands.	m.w.heijstek@umcutrecht.nl	Wulffraat, Nico M/AAE-8929-2020; Kamphuis, Sylvia/AAJ-8195-2020; Swart, Joost/AFF-8988-2022	Wulffraat, Nico M/0000-0001-9548-5562; van Gageldonk, Pieter/0000-0003-2753-9674	Dutch Arthritis Association [07-02-403]	Dutch Arthritis Association	The Dutch Arthritis Association (project 07-02-403) funded this study.	Andrews N, 2000, EPIDEMIOL INFECT, V125, P127, DOI 10.1017/S0950268899004173; Beukelman T, 2012, ARTHRITIS RHEUM-US, V64, P2773, DOI 10.1002/art.34458; Borte S, 2009, RHEUMATOLOGY, V48, P144, DOI 10.1093/rheumatology/ken436; CHANTLER JK, 1985, NEW ENGL J MED, V313, P1117, DOI 10.1056/NEJM198510313131803; Consolaro A, 2012, ARTHRITIS RHEUM-US, V64, P2366, DOI 10.1002/art.34373; Consolaro A, 2009, ARTHRIT RHEUM-ARTHR, V61, P658, DOI 10.1002/art.24516; Frenkel LM, 1996, CLIN INFECT DIS, V22, P287, DOI 10.1093/clinids/22.2.287; Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202; Heijstek MW, 2011, ANN RHEUM DIS, V70, P1704, DOI 10.1136/ard.2011.150193; Heijstek MW, 2007, ANN RHEUM DIS, V66, P1384, DOI 10.1136/ard.2006.063586; Korematsu S, 2009, VACCINE, V27, P5041, DOI 10.1016/j.vaccine.2009.06.052; Lovell DJ, 2008, NEW ENGL J MED, V359, P810, DOI 10.1056/NEJMoa0706290; Pebody RG, 2002, VACCINE, V20, P1134, DOI 10.1016/S0264-410X(01)00435-2; Petty RE, 2004, J RHEUMATOL, V31, P390; Pileggi GS, 2010, ARTHRIT CARE RES, V62, P1034, DOI 10.1002/acr.20183; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Ray P, 1997, JAMA-J AM MED ASSOC, V278, P551, DOI 10.1001/jama.278.7.551; Roush SW, 2008, MANUAL SURVEILLANCE; Rumke H C, 2004, Ned Tijdschr Geneeskd, V148, P356; Salvana EMT, 2009, CLIN MICROBIOL REV, V22, P274, DOI 10.1128/CMR.00040-08; Scheinberg M, 2010, ARTHRIT CARE RES, V62, P896, DOI 10.1002/acr.20045; Smits GP, 2012, CLIN VACCINE IMMUNOL, V19, P396, DOI 10.1128/CVI.05537-11; Thakur A, 2012, VACCINE, V30, P4907, DOI 10.1016/j.vaccine.2012.05.049; The British Society for Rheumatology, 2002, VACC IMM PERS GUID P	25	65	70	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2449	2456		10.1001/jama.2013.6768	http://dx.doi.org/10.1001/jama.2013.6768			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23780457	Bronze			2022-12-28	WOS:000320505100025
J	Cook, JA; McCulloch, P; Blazeby, JM; Beard, DJ; Marinac-Dabic, D; Sedrakyan, A				Cook, Jonathan A.; McCulloch, Peter; Blazeby, Jane M.; Beard, David J.; Marinac-Dabic, Danica; Sedrakyan, Art		IDEAL Grp	IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ABDOMINAL-AORTIC-ANEURYSM; OPEN REPAIR; SURGERY; HERNIA; KNEE	The complexity of surgical procedures oft en poses challenges for conducting a rigorous and comprehensive evaluation. This paper considers the final two IDEAL stages of surgical innovation. Surgical randomised controlled trials are oft en challenging to undertake and require careful consideration of the intervention definition, who should deliver it, and the impact of surgeon and patient preferences. In the long term study stage, better monitoring of surgical procedures is needed, along with improved surveillance of devices.	[Cook, Jonathan A.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [McCulloch, Peter] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Blazeby, Jane M.] Univ Bristol, Sch Social & Community Med, Surg Res Ctr, Bristol BS8 1TH, Avon, England; [Beard, David J.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX1 2JD, England; [Beard, David J.] Natl Inst Hlth Res, Oxford Musculoskeletal Biomed Res Unit, Oxford, England; [Marinac-Dabic, Danica] US FDA, Div Epidemiol, Off Surveillance & Biometr, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA; [Sedrakyan, Art] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA; [Sedrakyan, Art] New York Presbyterian Hosp, New York, NY USA	University of Aberdeen; University of Oxford; University of Bristol; University of Oxford; US Food & Drug Administration (FDA); Cornell University; NewYork-Presbyterian Hospital	Cook, JA (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland.	j.a.cook@abdn.ac.uk	Cook, Jonathan/D-3648-2015; Groves, Trish/A-9119-2009	Cook, Jonathan/0000-0002-4156-6989; Groves, Trish/0000-0001-7915-6419; Marinac-Dabic, Danica/0000-0002-1824-0104; Lyratzopoulos, Georgios/0000-0002-2873-7421; McCulloch, Peter/0000-0002-3210-8273	National Institute for Health Research's Health Technology Assessment programme; Johnson Johnson; Medtronic; Zimmer; Medical Research Council [G1002292]; Medical Research Council ConDuCT Hub for Trials Methodology Research; US Food and Drug Administration [HHSF22321110172C]; MRC [G1002292, G0800800] Funding Source: UKRI; Medical Research Council [G0800800] Funding Source: researchfish; National Institute for Health Research [06/301/233] Funding Source: researchfish	National Institute for Health Research's Health Technology Assessment programme; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Medtronic(Medtronic); Zimmer; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council ConDuCT Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US Food and Drug Administration; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	PM received funding from the National Institute for Health Research's Health Technology Assessment programme, Johnson & Johnson, Medtronic, and Zimmer (all unrestricted grants) for the IDEAL workshop in December 2010. JAC holds a Medical Research Council Methodology Fellowship (G1002292). JMB is supported in part by the Medical Research Council ConDuCT Hub for Trials Methodology Research. AS is supported in part by the US Food and Drug Administration contract for MDEpiNet Science and Infrastructure Centre (HHSF22321110172C).	Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Baum M, 1999, LANCET S1, V353, pS6; Bhandari M, 2008, J BONE JOINT SURG AM, V90A, P2567, DOI 10.2106/JBJS.G.01694; Biau DJ, 2009, CLIN ORTHOP RELAT R, V467, P298, DOI 10.1007/s11999-008-0575-y; BONENKAMP JJ, 1995, LANCET, V345, P745, DOI 10.1016/S0140-6736(95)90637-1; Brown GA, 2009, J ARTHROPLASTY, V24, P77, DOI 10.1016/j.arth.2009.06.002; CHALLAH S, 1986, BRIT MED J, V292, P877, DOI 10.1136/bmj.292.6524.877; Cook Jonathan A, 2004, Clin Trials, V1, P421, DOI 10.1191/1740774504cn042oa; Cook JA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-9; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Cuthbertson BH, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-41; Devereaux PJ, 2005, BMJ-BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88; Diener MK, 2011, LANCET, V377, P1514, DOI 10.1016/S0140-6736(11)60237-7; Dreyer NA, 2009, JAMA-J AM MED ASSOC, V302, P790, DOI 10.1001/jama.2009.1092; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Ergina PL, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3011; Fairbank J, 2005, BMJ-BRIT MED J, V330, P1233, DOI 10.1136/bmj.38441.620417.8F; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Health Industries, 2010, MEDICAL DEVICE INDUS; Healthcare Cost and Utilization Project, 2013, OVERVIEW OF THE NATI; Hunter KF, 2007, COCHRANE DB SYST REV, V2; Kuppermann M, 2004, JAMA-J AM MED ASSOC, V291, P1447, DOI 10.1001/jama.291.12.1447; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; McCulloch P, 2009, J ROY SOC MED, V102, P51, DOI 10.1258/jrsm.2008.080308; Meakins JL, 2002, AM J SURG, V183, P399, DOI 10.1016/S0002-9610(02)00825-5; Mills N, 2011, J CLIN EPIDEMIOL, V64, P1127, DOI 10.1016/j.jclinepi.2010.12.017; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; O'Dwyer P, 1999, LANCET, V354, P185; Peterson ED, 2003, J AM COLL CARDIOL, V42, P1611, DOI 10.1016/j.jacc.2003.07.003; POLLOCK AV, 1993, BRIT J SURG, V80, P964, DOI 10.1002/bjs.1800800807; Powell R, 2009, HEALTH EXPECT, V12, P149, DOI 10.1111/j.1369-7625.2009.00538.x; Price AJ, 2003, J BONE JOINT SURG BR, V85B, P62, DOI 10.1302/0301-620X.85B1.13233; Sedrakyan A, 2010, MED CARE, V48, pS121, DOI 10.1097/MLR.0b013e3181d991c4; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Tornqvist B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6457; University of Alabama at Birmingham School of Medicine, 2013, INTERAGENCY REGISTRY; US Food and Drug Administration, 2012, MEDSUN MEDICAL PRODU; US Food and Drug Administration, 2013, MEDWATCH THE FDA SAF; Ziebland S, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-4	40	91	96	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2013	346								f2820	10.1136/bmj.f2820	http://dx.doi.org/10.1136/bmj.f2820			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171PQ	23778425	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000320941900001
J	Fletcher, RH				Fletcher, Robert H.			Automated reminders and increasing intense support increased uptake of colorectal cancer screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTERVENTIONS		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Fletcher, RH (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Lasser KE, 2011, ARCH INTERN MED, V171, P906, DOI 10.1001/archinternmed.2011.201; Sabatino SA, 2012, AM J PREV MED, V43, P97, DOI 10.1016/j.amepre.2012.04.009	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12							JC8	10.7326/0003-4819-158-12-201306180-02008	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778932				2022-12-28	WOS:000320645000007
J	Legido-Quigley, H; Otero, L; la Parra, D; Alvarez-Dardet, C; Martin-Moreno, JM; McKee, M				Legido-Quigley, Helena; Otero, Laura; la Parra, Daniel; Alvarez-Dardet, Carlos; Martin-Moreno, Jose M.; McKee, Martin			Will austerity cuts dismantle the Spanish healthcare system?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY-OF-CARE; HOSPITAL OWNERSHIP; EFFICIENCY; CHARGES; EUROPE; CRISIS; SPAIN		[Legido-Quigley, Helena; McKee, Martin] London Sch Hyg & Trop Med, London, England; [Otero, Laura] Univ Lleida, Fac Nursing, Lleida, Spain; [la Parra, Daniel] Univ Alicante, Dept Sociol 2, Alicante, Spain; [Alvarez-Dardet, Carlos] Univ Alicante, CIBER Epidemiol & Salud Publ CIBERESP, Alicante, Spain; [Martin-Moreno, Jose M.] Univ Valencia, Dept Prevent Med & Publ Hlth, E-46003 Valencia, Spain; [Martin-Moreno, Jose M.] Univ Valencia, Clin Univ Hosp, E-46003 Valencia, Spain	University of London; London School of Hygiene & Tropical Medicine; Universitat de Lleida; Universitat d'Alacant; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat d'Alacant; University of Valencia; University of Valencia	Legido-Quigley, H (corresponding author), London Sch Hyg & Trop Med, London, England.	Helena.Legido-Quigley@lshtm.ac.uk	La Parra-Casado, Daniel/ABB-4220-2021; Martin-Moreno, Jose M./S-7733-2016; McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; La Parra-Casado, Daniel/I-5481-2016	La Parra-Casado, Daniel/0000-0002-9096-3972; Martin-Moreno, Jose M./0000-0002-8648-5541; McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; La Parra-Casado, Daniel/0000-0002-9096-3972; Alvarez-Dardet, Carlos/0000-0003-3530-7451				Abril G., 2012, PAIS; Agencia d'Informacio Avaluacio i Qualitat en Salut, 2012, INF SAL CAT 2011 HLT; Amnesty International Doctors in the World Red Acoge, 2012, REF SAN PUED COST VI; [Anonymous], WORLD EC OUTL DAT; Balsells Ferran, 2012, PAIS; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Casino G, 2012, LANCET, V379, P1777, DOI 10.1016/S0140-6736(12)60745-4; CIS, 2012, BAR SEPT; CIS, 2012, BAR DIC; Eggleston K, 2008, HEALTH ECON, V17, P1345, DOI 10.1002/hec.1333; El Mundo, 2012, SANIDAD TENDRA RECOR; Eldebat.cat, 2012, NOV RED BRUT PRESS S; Elorza A, 2012, PAIS; European Commission, 2013, EUR EC FOR AUT 2012; Federacion de Asociaciones para la Defensa de la Sanidad Publica, 2012, INF REC SAN COM AUT; Gallardo A., 2012, PERIODICO       0623; Rada AG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6466; Garcia Vega M. G, 2013, PAIS; Garcia-Armesto Sandra, 2010, Health Syst Transit, V12, P1; Garcia-Rada A., 2012, PAIS; Gemmill MC, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-12; Gene-Badia J, 2012, HEALTH POLICY, V106, P23, DOI 10.1016/j.healthpol.2012.02.001; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Health Information Institute, 2011, BAR SAL; Instituto Nacional de Estadistica, 2013, ENC POBL ACT EPA PRI; International Monetary Fund, 2012, WORLD EC OUTL; Kentikelenis A, 2011, LANCET, V378, P1457, DOI 10.1016/S0140-6736(11)61556-0; Klein N., 2007, SHOCK DOCTRINE RISE; Kondilis E, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-234; La Vanguardia, 2013, VANGUARDIA      0430; Martin-Moreno JM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1170; McKee M, 2006, B WORLD HEALTH ORGAN, V84, P890; McKee M, 2012, CLIN MED, V12, P346, DOI 10.7861/clinmedicine.12-4-346; Metges de Catalunya, 2012, PRESS SAL CONF ADV M; Montagu D., 2011, PRIVATE VERSUS PUBLI; Navarro V, 2012, GAC SANIT, V26, P174, DOI 10.1016/j.gaceta.2011.12.004; Newhouse JP, 1993, FREE ALL LESSONS RAN; OECD (Organisation for Economic Cooperation and Development), 2013, SOV BORR OUTL 2013; Perez Pons M, 2012, PAIS; Prensa ND, 2012, ENC COND VID AN 2012; Quercioli C, 2013, J EPIDEMIOL COMMUN H, V67, P132, DOI 10.1136/jech-2011-200640; RINCON R., 2012, PAIS; SESPAS, 2012, POS SESPAS POL PRIV; SEVILLANO EG, 2012, PAIS; Spanish Government, 2013, PROGR NAC REF; Spanish Ministry of Health, GAST PUBL; Suicide, 2012, HLTH GLANC EUR 2012, P28; Thomson S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3759; Tiemann O, 2012, HEALTH POLICY, V104, P163, DOI 10.1016/j.healthpol.2011.11.010; Trivedi AN, 2010, NEW ENGL J MED, V362, P320, DOI 10.1056/NEJMsa0904533	50	116	119	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2013	346								f2363	10.1136/bmj.f2363	http://dx.doi.org/10.1136/bmj.f2363			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	166WQ	23766463	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000320590800015
J	Marschall, J; Carpenter, CR; Fowler, S; Trautner, BW				Marschall, Jonas; Carpenter, Christopher R.; Fowler, Susan; Trautner, Barbara W.		CDC Prevention Epicenters Program	Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOUBLE-BLIND; PREVENTION; LONG; COMPLICATIONS; BACTERIURIA; SURGERY; REDUCE; WOMEN	Objective To determine whether antibiotic prophylaxis at the time of removal of a urinary catheter reduces the risk of subsequent symptomatic urinary tract infection. Design Systematic review and meta-analysis of studies published before November 2012 identified through PubMed, Embase, Scopus, and the Cochrane Library; conference abstracts for 2006-12 were also reviewed. Inclusion criteria Studies were included if they examined antibiotic prophylaxis administered to prevent symptomatic urinary tract infection after removal of a short term (<= 14 days) urinary catheter. Results Seven controlled studies had symptomatic urinary tract infection after catheter removal as an endpoint; six were randomized controlled trials (five published; one in abstract form) and one was a non-randomized controlled intervention study. Five of these seven studies were in surgical patients. Studies were heterogeneous in the type and duration of antimicrobial prophylaxis and the period of observation. Overall, antibiotic prophylaxis was associated with benefit to the patient, with an absolute reduction in risk of urinary tract infection of 5.8% between intervention and control groups. The risk ratio was 0.45 (95% confidence interval 0.28 to 0.72). The number needed to treat to prevent one urinary tract infection was 17 (12 to 30). Conclusions Patients admitted to hospital who undergo short term urinary catheterization might benefit from antimicrobial prophylaxis when the catheter is removed as they experience fewer subsequent urinary tract infections. Potential disadvantages of more widespread antimicrobial prophylaxis (side effects and cost of antibiotics, development of antimicrobial resistance) might be mitigated by the identification of which patients are most likely to benefit from this approach.	[Marschall, Jonas] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; [Marschall, Jonas] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland; [Marschall, Jonas] Univ Bern, CH-3010 Bern, Switzerland; [Carpenter, Christopher R.] Washington Univ, Sch Med, Div Emergency Med, Emergency Care Res Sect, St Louis, MO 63110 USA; [Fowler, Susan] Washington Univ, Bernard Becker Med Lib, St Louis, MO 63110 USA; [Trautner, Barbara W.] Michael E DeBakey VA Med Ctr, Houston VA Hlth Serv Res & Dev Ctr Excellence, Houston, TX USA; [Trautner, Barbara W.] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA	Washington University (WUSTL); University of Bern; University Hospital of Bern; University of Bern; Washington University (WUSTL); Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine	Marschall, J (corresponding author), Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA.	jmarscha@dom.wustl.edu	Marschall, Jonas/AAF-6425-2019; Carpenter, Christopher R./E-3720-2013	Marschall, Jonas/0000-0002-0052-3210; Carpenter, Christopher R./0000-0002-2603-7157	VA Career Development Award from rehabilitation research and development [B4623]; VA HSRD IIR [09-104]; NIDDK [R21 092293]; Building Interdisciplinary Research Careers in Women's Health (BIRCWH) award through the NIH NCATS [5K12HD001459-13]; CDC Prevention Epicenters Program [U54 CK000162]; Barnes-Jewish Hospital Patient Safety and Quality Fellowship Program; Barnes-Jewish Hospital Foundation; Washington University's Institute for Clinical and Translational Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450, UL1TR000448] Funding Source: NIH RePORTER	VA Career Development Award from rehabilitation research and development; VA HSRD IIR; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Building Interdisciplinary Research Careers in Women's Health (BIRCWH) award through the NIH NCATS; CDC Prevention Epicenters Program(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Barnes-Jewish Hospital Patient Safety and Quality Fellowship Program; Barnes-Jewish Hospital Foundation; Washington University's Institute for Clinical and Translational Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. BWT was funded during the time of manuscript preparation by a VA Career Development Award from rehabilitation research and development (B4623), by VA HSR&D IIR 09-104, and NIDDK R21 092293. BWT's work is also partially supported by the resources and facilities at the Houston VA Health Services Research and Development Center of Excellence (HFP90-020) at the Michael E DeBakey VA Medical Center. JM received support from the Building Interdisciplinary Research Careers in Women's Health (BIRCWH) award through the NIH NCATS, a career development award (5K12HD001459-13). He is also the section leader for a subproject of the CDC Prevention Epicenters Program grant (U54 CK000162; PI Fraser). In addition, JM is funded by the Barnes-Jewish Hospital Patient Safety and Quality Fellowship Program and by a research grant from the Barnes-Jewish Hospital Foundation and Washington University's Institute for Clinical and Translational Science.	Bakken JS, 2004, SCAND J INFECT DIS, V36, P85, DOI 10.1080/00365540410019039; Banks JA, 2012, UROL ONCOL; Brandenburg A, 2006, J HOSP INFECT, V64, pS108; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CONN IG, 1988, J HOSP INFECT, V11, P373, DOI 10.1016/0195-6701(88)90091-6; Cullen IM, 2012, BJU INT, V109, P1198, DOI 10.1111/j.1464-410X.2011.10528.x; Cutter CS, 2011, CAN J SURG, V54, P206, DOI 10.1503/cjs.009911; DUCLOS JM, 1992, AM J SURG, V164, pS21, DOI 10.1016/S0002-9610(06)80053-X; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2001, SYSTEMATIC REV HLTH; Fakih MG, 2012, ARCH INTERN MED, V172, P255, DOI 10.1001/archinternmed.2011.627; File TM, 2011, CLIN INFECT DIS, V53, pS15, DOI 10.1093/cid/cir364; FOX BC, 1990, AM J MED, V89, P255, DOI 10.1016/0002-9343(90)90337-D; Gould CV, 2009, CDC HICPAC GUIDELINE; GRABE M, 1984, SCAND J UROL NEPHROL, V18, P193, DOI 10.3109/00365598409180183; HARDING GKM, 1991, ANN INTERN MED, V114, P713, DOI 10.7326/0003-4819-114-9-713; Higgins JP, 2006, FORMULATING PROBLEM; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Leuck AM, 2012, J UROLOGY, V187, P1662, DOI 10.1016/j.juro.2011.12.113; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lo Evelyn, 2008, Infect Control Hosp Epidemiol, V29 Suppl 1, pS41, DOI 10.1086/591066; Pfefferkorn U, 2009, ANN SURG, V249, P573, DOI 10.1097/SLA.0b013e31819a0315; Pinochet R, 2010, UROL INT, V85, P415, DOI 10.1159/000321094; RAZ R, 1994, INFECTION, V22, P347, DOI 10.1007/BF01715544; Rogers RG, 2004, AM J OBSTET GYNECOL, V191, P182, DOI 10.1016/j.ajog.2004.03.088; Saint S, 1999, ARCH INTERN MED, V159, P800, DOI 10.1001/archinte.159.8.800; Stewardson AJ, 2011, CURR OPIN PHARMACOL, V11, P446, DOI 10.1016/j.coph.2011.06.011; SZE EHM, 1989, J GYNECOL SURG, V5, P171, DOI 10.1089/gyn.1989.5.171; Trautner BW, 2012, NAT REV UROL, V9, P85, DOI 10.1038/nrurol.2011.192; van Hees BC, 2011, CLIN MICROBIOL INFEC, V17, P1091, DOI 10.1111/j.1469-0691.2010.03447.x; VANDERWALL E, 1992, LANCET, V339, P946; WARREN JW, 1987, J INFECT DIS, V155, P1151, DOI 10.1093/infdis/155.6.1151; Wazait HD, 2004, J HOSP INFECT, V58, P297, DOI 10.1016/j.jhin.2004.06.012; Wazait HD, 2004, BJU INT, V94, P1048, DOI 10.1111/j.1464-410X.2004.05102.x; Wennberg DE, 1998, ANN INTERN MED, V128, P866, DOI 10.7326/0003-4819-128-10-199805150-00012; Wolf JS, 2008, J UROLOGY, V179, P1379, DOI [10.1016/j.juro.2008.01.068, 10.1016/S0022-5347(08)62119-9]	37	60	62	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2013	346								f3147	10.1136/bmj.f3147	http://dx.doi.org/10.1136/bmj.f3147			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VQ	23757735	hybrid, Green Published			2022-12-28	WOS:000320587600025
J	Smith, MEB; Totten, A; Hickam, DH; Fu, RW; Wasson, N; Rahman, B; Motu'apuaka, M; Saha, S				Smith, M. E. Beth; Totten, Annette; Hickam, David H.; Fu, Rongwei; Ngoc Wasson; Rahman, Basmah; Motu'apuaka, Makalapua; Saha, Somnath			Pressure Ulcer Treatment Strategies A Systematic Comparative Effectiveness Review	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; SPINAL-CORD-INJURY; III DECUBITUS ULCERS; GROWTH FACTOR-BB; AIR-FLUIDIZED THERAPY; LEVEL LASER THERAPY; CLINICAL-TRIAL; ELDERLY-PATIENTS; STAGE-II; HYDROCOLLOID DRESSINGS	Background: Pressure ulcers affect as many as 3 million Americans and are major sources of morbidity, mortality, and health care costs. Purpose: To summarize evidence comparing the effectiveness and safety of treatment strategies for adults with pressure ulcers. Data Sources: MEDLINE, EMBASE, CINAHL, Evidence-Based Medicine Reviews, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, and Health Technology Assessment Database for English-or foreign-language studies; reference lists; gray literature; and individual product packets from manufacturers (January 1985 to October 2012). Study Selection: Randomized trials and comparative observational studies of treatments for pressure ulcers in adults and noncomparative intervention series (n > 50) for surgical interventions and evaluation of harms. Data Extraction: Data were extracted and evaluated for accuracy of the extraction, quality of included studies, and strength of evidence. Data Synthesis: 174 studies met inclusion criteria and 92 evaluated complete wound healing. In comparison with standard care, placebo, or sham interventions, moderate-strength evidence showed that air-fluidized beds (5 studies [n = 908]; high consistency), protein-containing nutritional supplements (12 studies [n = 562]; high consistency), radiant heat dressings (4 studies [n = 160]; moderate consistency), and electrical stimulation (9 studies [n = 397]; moderate consistency) improved healing of pressure ulcers. Low-strength evidence showed that alternating-pressure surfaces, hydrocolloid dressings, platelet-derived growth factor, and light therapy improved healing of pressure ulcers. The evidence about harms was limited. Limitation: Applicability of results is limited by study quality, heterogeneity in methods and outcomes, and inadequate duration to assess complete wound healing. Conclusion: Moderate-strength evidence shows that healing of pressure ulcers in adults is improved with the use of air-fluidized beds, protein supplementation, radiant heat dressings, and electrical stimulation.	Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Portland, OR 97239 USA; Portland VA Med Ctr, Portland, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Smith, MEB (corresponding author), Oregon Hlth & Sci Univ, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.	smithbet@ohsu.edu	Totten, Annette/P-7909-2019	Totten, Annette/0000-0002-9100-8678; Rahman, Basmah/0000-0002-3576-2086; Hickman, Heather/0000-0003-4168-4894	AHRQ [290-2007-10057-I]; U.S. Department of Veterans Affairs; Agency for Healthcare Research and Quality	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By AHRQ (contract 290-2007-10057-I, Task Order 8). Dr. Saha is supported by the U.S. Department of Veterans Affairs.; Primary Funding Source: Agency for Healthcare Research and Quality.	Adegoke B O, 2001, Afr J Med Med Sci, V30, P195; Adunsky A, 2005, ARCH GERONTOL GERIAT, V41, P261, DOI 10.1016/j.archger.2005.04.004; Agency for Healthcare Research and Quality, 2011, METH GUID EFF COMP E; Ahmad E T, 2008, Ann Burns Fire Disasters, V21, P124; ALLMAN RM, 1987, ANN INTERN MED, V107, P641, DOI 10.7326/0003-4819-107-5-641; ALM A, 1989, ACTA DERM-VENEREOL, P1; Alvarez OM, 2000, WOUNDS, V12, P15; Aziz Z, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002930.pub4; Bader D, 2010, J TISSUE VIABILITY, V19, P2, DOI 10.1016/j.jtv.2009.11.010; Baker Lucinda L., 1996, Wound Repair and Regeneration, V4, P21, DOI 10.1046/j.1524-475X.1996.40106.x; Bale S, 1998, J Wound Care, V7, P327; Bale S, 1997, J Wound Care, V6, P463, DOI 10.12968/jowc.1997.6.10.463; Banks V, 1994, J Wound Care, V3, P132; Banks V, 1994, J Wound Care, V3, P175; Barnes Peyton Jr, 2007, Tex Med, V103, P65; Belmin J, 2002, J AM GERIATR SOC, V50, P269, DOI 10.1046/j.1532-5415.2002.50058.x; Benati G, 2001, ARCH GERONTOL GERIAT, P43, DOI 10.1016/S0167-4943(01)00120-0; Bergstrom N, 1994, PRESSURE ULCER TREAT; Bito S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000371; BRESLOW RA, 1993, J AM GERIATR SOC, V41, P357, DOI 10.1111/j.1532-5415.1993.tb06940.x; Brewer S, 2010, J WOUND CARE, V19, P311, DOI 10.12968/jowc.2010.19.7.48905; BROD M, 1990, ARCH DERMATOL, V126, P969, DOI 10.1001/archderm.126.7.969; Brown-Etris Marie, 2008, Adv Skin Wound Care, V21, P169, DOI 10.1097/01.ASW.0000305429.01413.f8; Burgos A, 2000, CLIN DRUG INVEST, V19, P399, DOI 10.2165/00044011-200019060-00002; Burke DT, 1998, AM J PHYS MED REHAB, V77, P394, DOI 10.1097/00002060-199809000-00006; Caley~ L, 1994, P 9 ANN CLIN S PRESS, P1; Cereda E, 2009, J AM GERIATR SOC, V57, P1395, DOI 10.1111/j.1532-5415.2009.02351.x; Chang K W, 1998, Med J Malaysia, V53, P428; Chernoff RS, 1990, J AM DIET ASSOC, V90, pA; Clark M, 1998, 7 EUR C ADV WOUND MA, P122; Colin D, 1996, J Wound Care, V5, P444; Colwell J C, 1993, Decubitus, V6, P28; Comorosan S, 1993, Rom J Physiol, V30, P41; Cullum N, 2001, Health Technol Assess, V5, P1; Danon D, 1997, EXP GERONTOL, V32, P633, DOI 10.1016/S0531-5565(97)00094-6; Darkovich S L, 1990, Ostomy Wound Manage, V29, P47; Day A, 1993, Decubitus, V6, P32; Dehlin O, 2003, AGING CLIN EXP RES, V15, P259; Dehlin O, 2007, AGING CLIN EXP RES, V19, P478; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desneves KJ, 2005, CLIN NUTR, V24, P979, DOI 10.1016/j.clnu.2005.06.011; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Durovic A, 2008, VOJNOSANIT PREGL, V65, P906; Evans D, 2000, J Wound Care, V9, P181; Felzani G, 2011, ADV THER, V28, P439, DOI 10.1007/s12325-011-0016-2; FERRELL BA, 1993, JAMA-J AM MED ASSOC, V269, P494, DOI 10.1001/jama.269.4.494; Ford CN, 2002, ANN PLAS SURG, V49, P55, DOI 10.1097/00000637-200207000-00009; Foster RD, 1997, BRIT J PLAST SURG, V50, P374, DOI 10.1016/S0007-1226(97)90548-8; Foster RD, 1997, ARCH SURG-CHICAGO, V132, P868; Gardner SE, 1999, WOUND REPAIR REGEN, V7, P495, DOI 10.1046/j.1524-475X.1999.00495.x; Gentzkow GD, 1991, WOUNDS, V3, P158; GORSE GJ, 1987, ARCH DERMATOL, V123, P766, DOI 10.1001/archderm.123.6.766; Graumlich JF, 2003, J AM GERIATR SOC, V51, P147, DOI 10.1046/j.1532-5415.2003.51051.x; Graves N, 2005, INFECT CONT HOSP EP, V26, P293, DOI 10.1086/502542; GRIFFIN JW, 1991, PHYS THER, V71, P433, DOI 10.1093/ptj/71.6.433; Groen H W, 1999, J Wound Care, V8, P333; Gunes UY, 2007, J WOUND OSTOMY CONT, V34, P184, DOI 10.1097/01.WON.0000264833.11108.35; Gupta A, 2009, NEUROL INDIA, V57, P622, DOI 10.4103/0028-3886.57820; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirshberg J, 2001, Adv Skin Wound Care, V14, P91, DOI 10.1097/00129334-200103000-00013; Ho CH, 2012, PHYS THER, V92, P38, DOI 10.2522/ptj.20100349; Hollisaz Mohammad Taghi, 2004, BMC Dermatol, V4, P18; HONDE C, 1994, J AM GERIATR SOC, V42, P1180, DOI 10.1111/j.1532-5415.1994.tb06985.x; Houghton PE, 2010, ARCH PHYS MED REHAB, V91, P669, DOI 10.1016/j.apmr.2009.12.026; Houston S, 2001, J AM GERIATR SOC, V49, P1130, DOI 10.1046/j.1532-5415.2001.49225.x; Hsu YC, 2000, AM J CHINESE MED, V28, P391, DOI 10.1142/S0192415X00000465; Iordanou Pangiota, 2002, Int J Nurs Pract, V8, P49, DOI 10.1046/j.1440-172x.2002.00338.x; Izutsu T, 1998, TOHOKU J EXP MED, V184, P153, DOI 10.1620/tjem.184.153; Jackson B S, 1988, J Enterostomal Ther, V15, P220; Juri H, 1986, J NEUROLOGICAL ORTHO, V7, P29; Kaya A Z, 2005, J Wound Care, V14, P42; Keogh A, 2001, J Wound Care, V10, P15; Kierney PC, 1998, PLAST RECONSTR SURG, V102, P765, DOI 10.1097/00006534-199809030-00022; Kim You Chul, 1996, Yonsei Medical Journal, V37, P181; KLOTH LC, 1988, PHYS THER, V68, P503, DOI 10.1093/ptj/68.4.503; Kloth Luther C, 2002, Adv Skin Wound Care, V15, P270, DOI 10.1097/00129334-200211000-00008; Kraft M R, 1993, Decubitus, V6, P42; Kraft MR, 1993, DECUBITUS, V6, P48; Kraft MR, 1993, DECUBITUS, V6, P46; Kuflik A, 2001, Ostomy Wound Manage, V47, P52; Kurzuk-Howard G, 1985, West J Nurs Res, V7, P58, DOI 10.1177/0092055X8500700106; Land L, 2000, J Tissue Viability, V10, P6; Landi F, 2003, ANN INTERN MED, V139, P635, DOI 10.7326/0003-4819-139-8-200310210-00006; Lee S Kwon, 2006, Adv Skin Wound Care, V19, P92, DOI 10.1097/00129334-200603000-00011; Leigh B, 2012, J WOUND CARE, V21, P150, DOI 10.12968/jowc.2012.21.3.150; Lucas C, 2003, LASER MED SCI, V18, P72, DOI 10.1007/s10103-003-0259-5; Lucas C, 2000, LASER MED SCI, V15, P94, DOI 10.1007/s101030050054; Lyder CH, 2003, JAMA-J AM MED ASSOC, V289, P223, DOI 10.1001/jama.289.2.223; Makhsous M, 2009, ADV SKIN WOUND CARE, V22, P514, DOI 10.1097/01.ASW.0000305495.77649.ee; Malbrain M, 2010, J TISSUE VIABILITY, V19, P7, DOI 10.1016/j.jtv.2009.12.001; Matzen S, 1999, SCAND J PLAST RECONS, V33, P13, DOI 10.1080/02844319950159578; Maume Sylive, 2003, Ostomy Wound Manage, V49, P44; McDiarmid T, 1985, PHYSIOTHERAPY, V71, P66; McGaughey H, 2009, PHYS THER REV, V14, P132, DOI 10.1179/174328809X435231; McInnes E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001735.pub3; Meaume S, 2009, J NUTR HEALTH AGING, V13, P623, DOI 10.1007/s12603-009-0173-z; Zeron HM, 2007, INT J DERMATOL, V46, P314, DOI 10.1111/j.1365-4632.2007.03181.x; Motta G, 1999, Ostomy Wound Manage, V45, P44; Motta G, 1999, OSTOMY WOUND MANAG, V45, P44; Motta G, 1999, OSTOMY WOUND MANAG, V46, P48; Mulder GD, 1994, J GERIATRIC DERMATOL, V2, P87; Mulder Gerit D., 1993, Wound Repair and Regeneration, V1, P213, DOI 10.1046/j.1524-475X.1993.10406.x; Muller E, 2001, PHARMACOECONOMICS, V19, P1209; Munro B H, 1989, Geriatr Nurs, V10, P190; MUSTOE TA, 1994, ARCH SURG-CHICAGO, V129, P213; Myers S A, 1990, Decubitus, V3, P16; Narayanan S, 2005, J WOUND OSTOMY CONT, V32, P163, DOI 10.1097/00152192-200505000-00004; Neill KM, 1989, WOUNDS, V1, P173; Nisi Giuseppe, 2005, Chir Ital, V57, P465; Nixon J, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10220; NUSSBAUM EL, 1994, PHYS THER, V74, P812, DOI 10.1093/ptj/74.9.812; NUSSBAUM EL, 1994, PHYS THER, V74, P825, DOI 10.1093/ptj/74.9.825; Ochs RF, 2005, OSTOMY WOUND MANAG, V51, P38; Ohura T, 2011, WOUND REPAIR REGEN, V19, P330, DOI 10.1111/j.1524-475X.2011.00691.x; Ozdemir F, 2011, BALK MED J, V28, P274, DOI 10.5174/tutfd.2010.03601.2; Parnell LKS, 2005, OSTOMY WOUND MANAG, V51, P50; Payne WG, 2001, AM J SURG, V181, P81, DOI 10.1016/S0002-9610(00)00536-5; Payne WG, 2004, J APPL RES HIGH EDUC, V4, P12; Payne WG, 2009, OSTOMY WOUND MANAG, V55, P50; Price P, 2000, J Wound Care, V9, P201; Reddy M, 2008, JAMA-J AM MED ASSOC, V300, P2647, DOI 10.1001/jama.2008.778; Rees RS, 1999, WOUND REPAIR REGEN, V7, P141, DOI 10.1046/j.1524-475X.1999.00141.x; Rhodes RS, 2001, ANN PHARMACOTHER, V35, P675; ROBSON MC, 1992, ANN PLAS SURG, V29, P193, DOI 10.1097/00000637-199209000-00001; ROBSON MC, 1992, LANCET, V339, P23, DOI 10.1016/0140-6736(92)90143-Q; Russell L, 2003, Br J Nurs, V12, P256; Russell L, 2000, J Wound Care, V9, P52; Russell L, 2000, Br J Nurs, V9, P2270; Russell L, 2003, BRIT J NURSING, V12, P256; Saha S, 2013, AHRQ PUBLICATION; SALZBERG CA, 1995, WOUNDS, V7, P11; Sayag J., 1996, J WOUND CARE, V5, P357, DOI 10.12968/jowc.1996.5.8.357; Scevola S, 2010, INT WOUND J, V7, P184, DOI 10.1111/j.1742-481X.2010.00671.x; Schryvers OI, 2000, ARCH PHYS MED REHAB, V81, P1556, DOI 10.1053/apmr.2000.17828; Schubert V, 2001, PHOTODERMATOL PHOTO, V17, P32, DOI 10.1034/j.1600-0781.2001.017001032.x; SEBERN MD, 1986, ARCH PHYS MED REHAB, V67, P726, DOI 10.1016/0003-9993(86)90004-3; Seeley J, 1999, Ostomy Wound Manage, V45, P39; Seeley J, 1999, OSTOMY WOUND MANAG, V45, P46; Sherman RA, 2002, WOUND REPAIR REGEN, V10, P208, DOI 10.1046/j.1524-475X.2002.10403.x; Sipponen A, 2008, BRIT J DERMATOL, V158, P1055, DOI 10.1111/j.1365-2133.2008.08461.x; Small N, 2002, Curationis, V25, P74; STRAUSS MJ, 1991, J FAM PRACTICE, V33, P52; Taly AB, 2004, ARCH PHYS MED REHAB, V85, P1657, DOI 10.1016/j.apmr.2004.03.028; terRiet G, 1995, J CLIN EPIDEMIOL, V48, P1453, DOI 10.1016/0895-4356(95)00053-4; TERRIET G, 1995, BMJ-BRIT MED J, V310, P1040, DOI 10.1136/bmj.310.6986.1040; Thomas D R, 1998, Adv Wound Care, V11, P273; Thomas DR, 2006, J AM MED DIR ASSOC, V7, P46, DOI 10.1016/j.jamda.2005.10.004; Thomas S, 1997, J Wound Care, V6, P383; US Preventive Services Task Force, 2008, AHRQ PUBLICATION, V08-05124-EF-3; Valente SA, 2012, KUWAIT MED J, V44, P40; van Anholt RD, 2010, NUTRITION, V26, P867, DOI 10.1016/j.nut.2010.05.009; Viamontes L, 2003, OSTOMY WOUND MANAG, V49, P58; Viamontes L, 2003, OSTOMY WOUND MANAG, V49, P56; Viamontes Louis, 2003, Ostomy Wound Manage, V49, P48; Wang Shou-yu, 2010, Orthop Surg, V2, P201, DOI 10.1111/j.1757-7861.2010.00087.x; Wanner MB, 2003, SCAND J PLAST RECONS, V37, P28; Warner D J, 1992, Decubitus, V5, P52; Warner DJ, 1992, DECUBITUS, V5, P62; Warner DJ, 1992, DECUBITUS, V5, P58; Whitney J D, 2001, J Wound Ostomy Continence Nurs, V28, P244, DOI 10.1067/mjw.2001.117564; Winter A, 1990, Nurs Times, V86, P59; WOOD JM, 1993, ARCH DERMATOL, V129, P999, DOI 10.1001/archderm.129.8.999; XAKELLIS GC, 1992, ARCH PHYS MED REHAB, V73, P463; Yamamoto T, 2009, WOUNDS, V21, P153; Yamamoto Y, 1997, PLAST RECONSTR SURG, V100, P1212, DOI 10.1097/00006534-199710000-00021; Zuloff-Shani A, 2010, ARCH GERONTOL GERIAT, V51, P268, DOI 10.1016/j.archger.2009.11.015	167	78	89	2	40	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 2	2013	159	1					39	+		10.7326/0003-4819-159-1-201307020-00007	http://dx.doi.org/10.7326/0003-4819-159-1-201307020-00007			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179JJ	23817703				2022-12-28	WOS:000321516200005
J	Fidock, DA				Fidock, David A.			Eliminating Malaria	SCIENCE			English	Editorial Material							RESISTANT PLASMODIUM-FALCIPARUM; ARTEMISININ RESISTANCE; WESTERN CAMBODIA; CLEARANCE		[Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA	Columbia University; Columbia University	Fidock, DA (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	df2260@columbia.edu		Fidock, David/0000-0001-6753-8938	NIAID NIH HHS [R01 AI079709, R01 AI050234, R37 AI050234] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079709, R01AI050234] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Boiteux S, 2013, GENETICS, V193, P1025, DOI 10.1534/genetics.112.145219; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Cheng Q, 2012, INT J PARASITOL-DRUG, V2, P249, DOI 10.1016/j.ijpddr.2012.01.001; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gold B, 2012, P NATL ACAD SCI USA, V109, P16004, DOI 10.1073/pnas.1214188109; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Vaughan AM, 2012, J CLIN INVEST, V122, P3618, DOI 10.1172/JCI62684; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Witkowski B, 2013, ANTIMICROB AGENTS CH, V57, P914, DOI 10.1128/AAC.01868-12	16	15	15	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1531	1533		10.1126/science.1240539	http://dx.doi.org/10.1126/science.1240539			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172ME	23812705	Green Accepted			2022-12-28	WOS:000321007000025
J	Labonte, R				Labonte, Ronald			Health activism in a globalising era: lessons past for efforts future	LANCET			English	Editorial Material									Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Labonte, R (corresponding author), Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada.	rlabonte@uottawa.ca	Labonte, Ronald/G-4229-2011					Olesen Thomas., 2011, POWER TRANSNATIONAL; People's Health Movement, 2000, PEOPL CHART HLTH; REITAN R, 2007, GLOBAL ACTIVISM	3	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 22	2013	381	9884					2158	2159		10.1016/S0140-6736(13)61429-4	http://dx.doi.org/10.1016/S0140-6736(13)61429-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KH	23802277				2022-12-28	WOS:000320925600017
J	Alexander, EK; Chan-Smutko, G; Saksena, MA; Popa, I				Alexander, Erik K.; Chan-Smutko, Gayun; Saksena, Mansi A.; Popa, Ion			Case 19-2013: A 35-Year-Old Woman with Recurrent Goiter and Ductal Carcinoma of the Breast	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THYROID-NODULES; RADIATION; CANCER		[Alexander, Erik K.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Chan-Smutko, Gayun] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Saksena, Mansi A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Popa, Ion] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Alexander, Erik K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Saksena, Mansi A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Popa, Ion] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Alexander, EK (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.							Allanson JE, 2009, AM J MED GENET A, V149A, P6, DOI 10.1002/ajmg.a.32612; Bahn RS, 2011, J CLIN ENDOCR METAB, V96, P1202, DOI 10.1210/jc.2010-2583; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Dellinger R. P., 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; Guth S, 2009, EUR J CLIN INVEST, V39, P699, DOI 10.1111/j.1365-2362.2009.02162.x; Harb WJ, 2009, HEAD NECK-J SCI SPEC, V31, P1511, DOI 10.1002/hed.21156; Jornayvaz FR, 2008, CLIN EXP DERMATOL, V33, P151, DOI 10.1111/j.1365-2230.2007.02602.x; Laury AR, 2011, THYROID, V21, P135, DOI 10.1089/thy.2010.0226; MAZZAFERRI EL, 1993, NEW ENGL J MED, V328, P553; Mihailescu DV, 2008, J CLIN ENDOCR METAB, V93, P2188, DOI 10.1210/jc.2008-0055; Pacini F, 2010, CLIN ONCOL-UK, V22, P475, DOI 10.1016/j.clon.2010.05.002; Sinnott B, 2010, ENDOCR REV, V31, P756, DOI 10.1210/er.2010-0003; Smith JR, 2011, J CLIN ENDOCR METAB, V96, P34, DOI 10.1210/jc.2010-1315; Tan MH, 2011, AM J HUM GENET, V88, P42, DOI 10.1016/j.ajhg.2010.11.013; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011	16	1	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2416	2424		10.1056/NEJMcpc1209273	http://dx.doi.org/10.1056/NEJMcpc1209273			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782181				2022-12-28	WOS:000320601700013
J	Hirsch, C				Hirsch, Calvin			Review: Case management does not reduce unplanned hospital admissions compared with usual care in older persons	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED-TRIAL; PROGRAM		Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.			Purdy, Sarah/0000-0002-3445-986X	National Institute for Health Research [PB-PG-1208-18013] Funding Source: researchfish; Department of Health [PB-PG-1208-18013] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Dunagan WC, 2005, J CARD FAIL, V11, P358, DOI 10.1016/j.cardfail.2004.12.004; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Wier L., 2006, HEALTHCARE COST UTIL	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12							JC13	10.7326/0003-4819-158-12-201306180-02013	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778925				2022-12-28	WOS:000320645000012
J	Lewin, SR				Lewin, Sharon R.			A cure for HIV: where we've been, and where we're headed	LANCET			English	Editorial Material									[Lewin, Sharon R.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Monash Univ, Ctr Biomed Res, Burnet Inst, Melbourne, Vic 3004, Australia	Florey Institute of Neuroscience & Mental Health; Burnet Institute; Monash University	Lewin, SR (corresponding author), Alfred Hosp, Dept Infect Dis, Melbourne, Vic 3004, Australia.	sharon.lewin@monash.edu	Lewin, Sharon/Z-3297-2019	Lewin, Sharon Ruth/0000-0002-0330-8241	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096109, R56AI095073] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI096109, R56 AI095073] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Elliott J., 2013, 20 C RETR OPP INF MA; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Persaud D., 2013, 20 C RETR OPP INF MA; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; UN, 2012, UNAIDS GLOB REP 2012	9	11	11	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 15	2013	381	9883					2057	2058		10.1016/S0140-6736(13)61180-0	http://dx.doi.org/10.1016/S0140-6736(13)61180-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KA	23769215	Green Accepted			2022-12-28	WOS:000320924800004
J	Etter, JF				Etter, Jean-Francois			Should electronic cigarettes be as freely available as tobacco? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEPENDENCE		Univ Geneva, Fac Med, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland	University of Geneva	Etter, JF (corresponding author), Univ Geneva, Fac Med, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland.	Jean-Francois.Etter@unige.ch		ETTER, Jean-Francois/0000-0002-1426-3157				Etter JF, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015487; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; European Union, 2012, PROP DIR EUR PARL CO; Goniewicz M. L, 2013, TOB CONTROL; Harris JE, 2004, BMJ-BRIT MED J, V328, P72, DOI 10.1136/bmj.37936.585382.44; Hughes JR, 2004, NICOTINE TOB RES, V6, P79, DOI 10.1080/14622200310001656894; HUGHES JR, 1989, BIOMED PHARMACOTHER, V43, P11, DOI 10.1016/0753-3322(89)90185-6; Koch W., 2012, US TODAY; Sparks I., 2013, DAILY MAIL	9	50	50	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2013	346								f3845	10.1136/bmj.f3845	http://dx.doi.org/10.1136/bmj.f3845			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	166XQ	23771039				2022-12-28	WOS:000320593900011
J	Barbui, C; Bighelli, I				Barbui, Corrado; Bighelli, Irene			Regulatory science in Europe: the case of schizophrenia trials	LANCET			English	Editorial Material							QUALITY		[Barbui, Corrado; Bighelli, Irene] Univ Verona, Dept Publ Hlth & Community Med, WHO Collaborating Ctr Res & Training Mental Hlth, Sect Psychiat, I-37134 Verona, Italy	University of Verona	Barbui, C (corresponding author), Univ Verona, Dept Publ Hlth & Community Med, WHO Collaborating Ctr Res & Training Mental Hlth, Sect Psychiat, I-37134 Verona, Italy.	corrado.barbui@univr.it	Bighelli, Irene/I-1118-2019	Bighelli, Irene/0000-0002-5661-5149				[Anonymous], 2012, GUID CLIN INV MED PR; Barbui C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2291; Bighelli I, 2012, EPIDEMIOL PSYCH SCI, V21, P245, DOI 10.1017/S2045796012000170; Chalmers I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f105; Garattini S, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1025; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Miyar J, 2013, SCHIZOPHRENIA BULL, V39, P226, DOI 10.1093/schbul/sbr140; Mulla SM, 2012, JAMA-J AM MED ASSOC, V308, P2605, DOI 10.1001/2012.jama.11235; O'Connor AB, 2010, JAMA-J AM MED ASSOC, V303, P979, DOI 10.1001/jama.2010.257; Psaty BM, 2012, JAMA-J AM MED ASSOC, V307, P2491, DOI 10.1001/jama.2012.5545; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]	11	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1234	1235		10.1016/S0140-6736(13)60255-X	http://dx.doi.org/10.1016/S0140-6736(13)60255-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235XP	23791471				2022-12-28	WOS:000325756400010
J	Rignot, E; Jacobs, S; Mouginot, J; Scheuchl, B				Rignot, E.; Jacobs, S.; Mouginot, J.; Scheuchl, B.			Ice-Shelf Melting Around Antarctica	SCIENCE			English	Article							PINE ISLAND GLACIER; MASS-BALANCE; SHEET; CIRCULATION; THICKNESS; CAVITY	We compare the volume flux divergence of Antarctic ice shelves in 2007 and 2008 with 1979 to 2010 surface accumulation and 2003 to 2008 thinning to determine their rates of melting and mass balance. Basal melt of 1325 +/- 235 gigatons per year (Gt/year) exceeds a calving flux of 1089 +/- 139 Gt/year, making ice-shelf melting the largest ablation process in Antarctica. The giant cold-cavity Ross, Filchner, and Ronne ice shelves covering two-thirds of the total ice-shelf area account for only 15% of net melting. Half of the meltwater comes from 10 small, warm-cavity Southeast Pacific ice shelves occupying 8% of the area. A similar high melt/area ratio is found for six East Antarctic ice shelves, implying undocumented strong ocean thermal forcing on their deep grounding lines.	[Rignot, E.; Mouginot, J.; Scheuchl, B.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Rignot, E.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Jacobs, S.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of California System; University of California Irvine; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Columbia University	Rignot, E (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	erignot@uci.edu	Rignot, Eric/A-4560-2014; Mouginot, Jeremie/G-7045-2015	Rignot, Eric/0000-0002-3366-0481; Mouginot, Jeremie/0000-0001-9155-5455; Scheuchl, Bernd/0000-0001-5947-7709	NASA's Cryospheric Science Program; NASA's Operation IceBridge (OIB); National Science Foundation; National Oceanic and Atmospheric Administration	NASA's Cryospheric Science Program(National Aeronautics & Space Administration (NASA)); NASA's Operation IceBridge (OIB); National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	We thank three anonymous reviewers for their constructive criticism of the manuscript. This work was performed at the University of California, Irvine, and at the Jet Propulsion Laboratory, California Institute of Technology, under grants from NASA's Cryospheric Science Program and Operation IceBridge (OIB) and at the Lamont-Doherty Earth Observatory of Columbia University under grants from the National Science Foundation and the National Oceanic and Atmospheric Administration.	Allen C, 2010, ICEBRIDGE MCORDS L2; Barkov N. I., 1985, ICE SHELVES ANTARCTI; Blankenship D.D., 2012, ICEBRIDGE HICARS 2 L; Cuffey K., 2010, PHYS GLACIERS; Foldvik A, 2001, J GEOPHYS RES-OCEANS, V106, P4463, DOI 10.1029/2000JC000217; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Griggs JA, 2011, J GLACIOL, V57, P485, DOI 10.3189/002214311796905659; Grosfeld K, 1998, ANTARCT RES SER, V75, P319; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; Hellmer HH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019506; Holland P. R., 2010, GEOPHYS RES LETT, V115; Holland PR, 2008, J CLIMATE, V21, P2558, DOI 10.1175/2007JCLI1909.1; Holland PR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038162; Hooke R.L., 2005, PRINCIPLES GLACIER M; Horgan HJ, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006192; JACOBS SS, 1992, J GLACIOL, V38, P375, DOI 10.3189/S0022143000002252; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; JENKINS A, 1991, J GEOPHYS RES-OCEANS, V96, P791, DOI 10.1029/90JC01952; Jenkins A, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004449; Joughin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016941; Lenaerts JTM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016145; Makinson K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046462; NESHYBA S, 1980, J PHYS OCEANOGR, V10, P1681, DOI 10.1175/1520-0485(1980)010<1681:OTEOAI>2.0.CO;2; Padman L, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007301; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047109; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Schodlok MP, 2012, ANN GLACIOL, V53, P156, DOI 10.3189/2012AoG60A073; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Swithinbank C., 1988, SATELLITE IMAGE ATLA; Timmermann R, 2012, ANN GLACIOL, V53, P303, DOI 10.3189/2012AoG60A156; Wen JH, 2010, J GLACIOL, V56, P81, DOI 10.3189/002214310791190820; Williams GD, 2011, DEEP-SEA RES PT II, V58, P1194, DOI 10.1016/j.dsr2.2010.10.035	35	746	763	14	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					266	270		10.1126/science.1235798	http://dx.doi.org/10.1126/science.1235798			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23765278	Green Submitted			2022-12-28	WOS:000321959300040
J	Meibom, S; Torres, G; Fressin, F; Latham, DW; Rowe, JF; Ciardi, DR; Bryson, ST; Rogers, LA; Henze, CE; Janes, K; Barnes, SA; Marcy, GW; Isaacson, H; Fischer, DA; Howell, SB; Horch, EP; Jenkins, JM; Schuler, SC; Crepp, J				Meibom, Soren; Torres, Guillermo; Fressin, Francois; Latham, David W.; Rowe, Jason F.; Ciardi, David R.; Bryson, Steven T.; Rogers, Leslie A.; Henze, Christopher E.; Janes, Kenneth; Barnes, Sydney A.; Marcy, Geoffrey W.; Isaacson, Howard; Fischer, Debra A.; Howell, Steve B.; Horch, Elliott P.; Jenkins, Jon M.; Schuler, Simon C.; Crepp, Justin			The same frequency of planets inside and outside open clusters of stars	NATURE			English	Article							INTERMEDIATE-MASS STARS; KEPLER; SYSTEMS; ISOCHRONES; DYNAMICS	Most stars and their planets form in open clusters. Over 95 per cent of such clusters have stellar densities too low (less than a hundred stars per cubic parsec) to withstand internal and external dynamical stresses and fall apart within a few hundred million years(1). Older open clusters have survived by virtue of being richer and denser in stars (1,000 to 10,000 per cubic parsec) when they formed. Such clusters represent a stellar environment very different from the birthplace of the Sun and other planet-hosting field stars. So far more than 800 planets have been found around Sun-like stars in the field(2). The field planets are usually the size of Neptune or smaller(3-5). In contrast, only four planets have been found orbiting stars in open clusters(6-8), all with masses similar to or greater than that of Jupiter. Here we report observations of the transits of two Sun-like stars by planets smaller than Neptune in the billion-year-old open cluster NGC6811. This demonstrates that small planets can form and survive in a dense cluster environment, and implies that the frequency and properties of planets in open clusters are consistent with those of planets around field stars in the Galaxy.	[Meibom, Soren; Torres, Guillermo; Fressin, Francois; Latham, David W.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Rowe, Jason F.; Bryson, Steven T.; Henze, Christopher E.; Howell, Steve B.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Ciardi, David R.] CALTECH, NASA, Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Rogers, Leslie A.] CALTECH, Pasadena, CA 91125 USA; [Janes, Kenneth] Boston Univ, Boston, MA 02215 USA; [Barnes, Sydney A.] Leibniz Inst Astrophys, D-14467 Potsdam, Germany; [Barnes, Sydney A.] Space Sci Inst, Boulder, CO 80301 USA; [Marcy, Geoffrey W.; Isaacson, Howard] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Fischer, Debra A.] Yale Univ, New Haven, CT 06520 USA; [Horch, Elliott P.] So Connecticut State Univ, New Haven, CT 06515 USA; [Jenkins, Jon M.] NASA, SETI Inst, Ames Res Ctr, Moffett Field, CA 94035 USA; [Schuler, Simon C.] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Crepp, Justin] Univ Notre Dame, Notre Dame, IN 46556 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); California Institute of Technology; Boston University; Leibniz Institut fur Astrophysik Potsdam (AIP); University of California System; University of California Berkeley; Yale University; Connecticut State University System; Southern Connecticut State University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Optical Astronomy Observatory; University of Notre Dame	Meibom, S (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	smeibom@cfa.harvard.edu	Fischer, Debra A/C-1639-2014; Marcy, Geoff/AAC-6050-2019	Fischer, Debra A/0000-0003-2221-0861; Schuler, Simon/0000-0001-7203-8014; Rowe, Jason/0000-0002-5904-1865; Ciardi, David/0000-0002-5741-3047; Latham, David/0000-0001-9911-7388; Rogers, Leslie/0000-0003-0638-3455	NASA's Science Mission Directorate; NASA [NNX09AH18A, HF-51313.01-A, NAS 5-26555]; Kepler mission via NASA Cooperative Agreement [NCC2-1390]; NASA's Kepler Participating Scientist Program [NNX12AC75G]; Space Telescope Science Institute	NASA's Science Mission Directorate; NASA(National Aeronautics & Space Administration (NASA)); Kepler mission via NASA Cooperative Agreement; NASA's Kepler Participating Scientist Program; Space Telescope Science Institute(Space Telescope Science Institute)	Kepler was competitively selected as the tenth Discovery mission. Funding for this mission is provided by NASA's Science Mission Directorate. S. M. acknowledges support through NASA grant NNX09AH18A (The Kepler Cluster Study) and from the Kepler mission via NASA Cooperative Agreement NCC2-1390. G. T. acknowledges support through NASA's Kepler Participating Scientist Program grant NNX12AC75G. L. A. R. acknowledges NASA support through Hubble Fellowship grant HF-51313.01-A awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS 5-26555.	Adams FC, 2006, ASTROPHYS J, V641, P504, DOI 10.1086/500393; Bonnell IA, 2001, MON NOT R ASTRON SOC, V322, P859, DOI 10.1046/j.1365-8711.2001.04171.x; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Fregeau JM, 2006, ASTROPHYS J, V640, P1086, DOI 10.1086/500111; Fressin F, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/81; Gautier TN, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/15; Girardi L, 2000, ASTRON ASTROPHYS SUP, V141, P371, DOI 10.1051/aas:2000126; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Howard AW, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/15; Janes K, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/1/7; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL87, DOI 10.1088/2041-8205/713/2/L87; Kroupa P., 2008, ASTRON SOC PACIF C S, V390, P303; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Malmberg D, 2007, MON NOT R ASTRON SOC, V378, P1207, DOI 10.1111/j.1365-2966.2007.11885.x; Mayor M., ASTRON ASTROPH UNPUB; Meibom S., 2011, B AM ASTRON SOC, V43; Meibom S, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/1/L9; Pace G, 2008, ASTRON ASTROPHYS, V489, P403, DOI 10.1051/0004-6361:200809969; Sato B, 2007, ASTROPHYS J, V661, P527, DOI 10.1086/513503; Scally A, 2001, MON NOT R ASTRON SOC, V325, P449, DOI 10.1046/j.1365-8711.2001.04274.x; Smith KW, 2001, MON NOT R ASTRON SOC, V322, pL1, DOI 10.1046/j.1365-8711.2001.04321.x; Spurzem R, 2009, ASTROPHYS J, V697, P458, DOI 10.1088/0004-637X/697/1/458; van Saders JL, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/63; Weiss LM, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/14; Yi S, 2001, ASTROPHYS J SUPPL S, V136, P417, DOI 10.1086/321795	27	82	82	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					55	58		10.1038/nature12279	http://dx.doi.org/10.1038/nature12279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23803764	Green Submitted, Green Accepted			2022-12-28	WOS:000321285600031
J	Shima, T; Hu, SW; Luo, G; Kang, XH; Luo, Y; Hou, ZM				Shima, Takanori; Hu, Shaowei; Luo, Gen; Kang, Xiaohui; Luo, Yi; Hou, Zhaomin			Dinitrogen Cleavage and Hydrogenation by a Trinuclear Titanium Polyhydride Complex	SCIENCE			English	Article							BIOLOGICAL NITROGEN-FIXATION; SIDE-ON; CATALYTIC-REDUCTION; END-ON; AMMONIA; CHEMISTRY; MOLYBDENUM; NITRIDE; N-2; COORDINATION	Both the Haber-Bosch and biological ammonia syntheses are thought to rely on the cooperation of multiple metals in breaking the strong N=N triple bond and forming an N-H bond. This has spurred investigations of the reactivity of molecular multimetallic hydrides with dinitrogen. We report here the reaction of a trinuclear titanium polyhydride complex with dinitrogen, which induces dinitrogen cleavage and partial hydrogenation at ambient temperature and pressure. By H-1 and N-15 nuclear magnetic resonance, x-ray crystallographic, and computational studies of some key reaction steps and products, we have determined that the dinitrogen (N-2) reduction proceeds sequentially through scission of a N-2 molecule bonded to three Ti atoms in a mu-eta(1):eta(2):eta(2)-end-on-side-on fashion to give a mu(2)-N/mu(3\)-N dinitrido species, followed by intramolecular hydrogen migration from Ti to the mu(2)-N nitrido unit.	[Shima, Takanori; Hu, Shaowei; Hou, Zhaomin] RIKEN Ctr Sustainable Resource Sci, Adv Catalysis Res Grp, Wako, Saitama 3510198, Japan; [Shima, Takanori; Hu, Shaowei; Kang, Xiaohui; Hou, Zhaomin] RIKEN, Organometall Chem Lab, Wako, Saitama 3510198, Japan; [Luo, Gen; Kang, Xiaohui; Luo, Yi; Hou, Zhaomin] Dalian Univ Technol, State Key Lab Fine Chem, Dalian 116024, Peoples R China; [Luo, Gen; Kang, Xiaohui; Luo, Yi; Hou, Zhaomin] Dalian Univ Technol, Sch Pharmaceut Sci & Technol, Dalian 116024, Peoples R China	RIKEN; RIKEN; Dalian University of Technology; Dalian University of Technology	Hou, ZM (corresponding author), RIKEN Ctr Sustainable Resource Sci, Adv Catalysis Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	houz@riken.jp	Hu, Shaowei/C-7982-2017; Shima, Takanori/C-8166-2017; Luo, Gen/C-8149-2017; Luo, Yi/B-3277-2013; Hou, Zhaomin/I-5981-2014	Shima, Takanori/0000-0003-1813-0439; Luo, Gen/0000-0002-5297-6756; Luo, Yi/0000-0001-6390-8639; Hou, Zhaomin/0000-0003-2841-5120; Hu, Shaowei/0000-0002-7209-438X	Japan Society for the Promotion of Science [21750068, 21225004]; RIKEN; National Natural Science Foundation of China [21028001, 21174023]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a Grant-in-Aid for Young Scientists (B) (no. 21750068) and a Grant-in-Aid for Scientific Research (S) (no. 21225004) from the Japan Society for the Promotion of Science, an Incentive Research Grant from RIKEN, and grants from the National Natural Science Foundation of China (nos. 21028001 and 21174023). We gratefully appreciate access to the RIKEN Integrated Cluster of Clusters and the Network and Information Center of Dalian University of Technology for computational resources. Metrical parameters for the structures of compounds 2 to 6 are available free of charge from the Cambridge Crystallographic Data Centre under reference nos. CCDC-937384 to 937388. Correspondence on DFT calculations should be sent to Y.L. (luoyi@dlut.edu.cn). Z.H., T. S., and S. H. conceived and designed the experiments. S. H. carried out most of the experiments. T. S. carried out the x-ray analyses and part of the experiments. G. L., X. K., and Y.L. performed the DFT calculations. Z.H., T. S., and S. H. analyzed the data and co-wrote the manuscript. Z.H. directed the project.	Akagi F, 2007, ANGEW CHEM INT EDIT, V46, P8778, DOI 10.1002/anie.200703336; Arashiba K, 2011, NAT CHEM, V3, P120, DOI 10.1038/NCHEM.906; Avenier P, 2007, SCIENCE, V317, P1056, DOI 10.1126/science.1143078; Ballmann J, 2010, CHEM COMMUN, V46, P1013, DOI 10.1039/b922853e; BAZHENOVA TA, 1995, COORDIN CHEM REV, V144, P69, DOI 10.1016/0010-8545(95)01139-G; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Caselli A, 2000, J AM CHEM SOC, V122, P3652, DOI 10.1021/ja9943288; CHATT J, 1978, CHEM REV, V78, P589, DOI 10.1021/cr60316a001; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; Ertl G, 2008, ANGEW CHEM INT EDIT, V47, P3524, DOI 10.1002/anie.200800480; Evans WJ, 2004, J AM CHEM SOC, V126, P14574, DOI 10.1021/ja046047s; Fryzuk MD, 1998, J AM CHEM SOC, V120, P11024, DOI 10.1021/ja982377z; Fryzuk MD, 1997, SCIENCE, V275, P1445, DOI 10.1126/science.275.5305.1445; HIDAI M, 1995, CHEM REV, V95, P1115, DOI 10.1021/cr00036a008; Honkala K, 2005, SCIENCE, V307, P555, DOI 10.1126/science.1106435; Hou ZM, 2007, EUR J INORG CHEM, P2535, DOI 10.1002/ejic.200700085; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; Hu SW, 2013, ORGANOMETALLICS, V32, P2145, DOI 10.1021/om400012a; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; LAPLAZA CE, 1995, SCIENCE, V268, P861, DOI 10.1126/science.268.5212.861; MacKay BA, 2004, CHEM REV, V104, P385, DOI 10.1021/cr020610c; Matsuo T, 2003, ORGANOMETALLICS, V22, P5379, DOI 10.1021/om034147l; Mori M, 2004, J ORGANOMET CHEM, V689, P4210, DOI 10.1016/j.jorganchem.2004.05.053; Nikiforov GB, 2009, ANGEW CHEM INT EDIT, V48, P7415, DOI 10.1002/anie.200903648; Nishiura M, 2011, CHEM-EUR J, V17, P5033, DOI 10.1002/chem.201002998; Nishiura M, 2010, NAT CHEM, V2, P257, DOI 10.1038/nchem.595; Pool JA, 2004, NATURE, V427, P527, DOI 10.1038/nature02274; Rodriguez MM, 2011, SCIENCE, V334, P780, DOI 10.1126/science.1211906; ROESKY HW, 1989, ANGEW CHEM INT EDIT, V28, P754, DOI 10.1002/anie.198907541; Schlogl R, 2003, ANGEW CHEM INT EDIT, V42, P2004, DOI 10.1002/anie.200301553; Schrock RR, 2008, ANGEW CHEM INT EDIT, V47, P5512, DOI 10.1002/anie.200705246; Semproni SP, 2012, ORGANOMETALLICS, V31, P3672, DOI 10.1021/om300156z; Semproni SP, 2011, J AM CHEM SOC, V133, P10406, DOI 10.1021/ja2042595; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; Yandulov DV, 2003, SCIENCE, V301, P76, DOI 10.1126/science.1085326	36	251	256	11	483	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1549	1552		10.1126/science.1238663	http://dx.doi.org/10.1126/science.1238663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812710				2022-12-28	WOS:000321007000035
J	Mandavilli, A				Mandavilli, Apoorva			Leukaemia	NATURE			English	Editorial Material																			0	3	4	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					S1	S1		10.1038/498S1a	http://dx.doi.org/10.1038/498S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171LH	23803941	Bronze			2022-12-28	WOS:000320929400001
J	Qiu, J				Qiu, Jane			CLIMATOLOGY Monsoon Melee	SCIENCE			English	News Item																			0	18	23	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1400	1401		10.1126/science.340.6139.1400	http://dx.doi.org/10.1126/science.340.6139.1400			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23788780				2022-12-28	WOS:000320647000017
J	Belden, WJ; Dunlap, JC				Belden, William J.; Dunlap, Jay C.			Aging Well with a Little Wine and a Good Clock	CELL			English	Editorial Material							CIRCADIAN CLOCK		[Belden, William J.] Rutgers State Univ, Dept Anim Sci, New Brunswick, NJ 08904 USA; [Dunlap, Jay C.] Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH 03755 USA	Rutgers State University New Brunswick; Dartmouth College	Dunlap, JC (corresponding author), Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH 03755 USA.	jay.c.dunlap@dartmouth.edu	Dunlap, Jay/L-6232-2013	Dunlap, Jay/0000-0003-1577-0457	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034985, P01GM068087, R01GM083336] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM083336, R01 GM034985, P01 GM068087, R01 GM101378] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; PITTENDR.CS, 1972, P NATL ACAD SCI USA, V69, P1537, DOI 10.1073/pnas.69.6.1537; PITTENDRIGH CS, 1974, SCIENCE, V186, P548, DOI 10.1126/science.186.4163.548; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957	11	6	6	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1421	1422		10.1016/j.cell.2013.05.055	http://dx.doi.org/10.1016/j.cell.2013.05.055			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791169	Green Accepted, Bronze			2022-12-28	WOS:000320722000007
J	King, B; Trimarchi, T; Reavie, L; Xu, LY; Mullenders, J; Ntziachristos, P; Aranda-Orgilles, B; Perez-Garcia, A; Shi, JW; Vakoc, C; Sandy, P; Shen, SS; Ferrando, A; Aifantis, I				King, Bryan; Trimarchi, Thomas; Reavie, Linsey; Xu, Luyao; Mullenders, Jasper; Ntziachristos, Panagiotis; Aranda-Orgilles, Beatriz; Perez-Garcia, Arianne; Shi, Junwei; Vakoc, Christopher; Sandy, Peter; Shen, Steven S.; Ferrando, Adolfo; Aifantis, Iannis			The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability	CELL			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GAMMA-SECRETASE INHIBITORS; EMBRYONIC STEM-CELLS; C-MYC; TUMOR-SUPPRESSOR; GENE-EXPRESSION; TRANSCRIPTIONAL NETWORK; MOLECULAR PATHOGENESIS; BET BROMODOMAINS; T-ALL	Sequencing efforts led to the identification of somatic mutations that could affect the self-renewal and differentiation of cancer-initiating cells. One such recurrent mutation targets the binding pocket of the ubiquitin ligase Fbxw7. Missense FBXW7 mutations are prevalent in various tumors, including T cell acute lymphoblastic leukemia (T-ALL). To study the effects of such lesions, we generated animals carrying regulatable Fbxw7 mutant alleles. Here, we show that these mutations specifically bolster cancer-initiating cell activity in collaboration with Notch1 oncogenes but spare normal hematopoietic stem cell function. We were also able to show that FBXW7 mutations specifically affect the ubiquitylation and half-life of c-Myc protein, a key T-ALL oncogene. Using animals carrying c-Myc fusion alleles, we connected Fbxw7 function to c-Myc abundance and correlated c-Myc expression to leukemia-initiating activity. Finally, we demonstrated that small-molecule-mediated suppression of MYC activity leads to T-ALL remission, suggesting an effective therapeutic strategy.	[King, Bryan; Trimarchi, Thomas; Reavie, Linsey; Mullenders, Jasper; Ntziachristos, Panagiotis; Aranda-Orgilles, Beatriz; Shen, Steven S.; Aifantis, Iannis] NYU Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [King, Bryan; Trimarchi, Thomas; Reavie, Linsey; Mullenders, Jasper; Ntziachristos, Panagiotis; Aranda-Orgilles, Beatriz; Shen, Steven S.; Aifantis, Iannis] NYU Sch Med, NYU Canc Inst, New York, NY 10016 USA; [Aifantis, Iannis] NYU Sch Med, Dept Pathol, New York, NY 10016 USA; [Shen, Steven S.] NYU Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Reavie, Linsey] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Xu, Luyao; Perez-Garcia, Arianne; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Shi, Junwei; Vakoc, Christopher] Cold Spring Harbor, Cold Spring Harbor Lab, New York, NY 11224 USA; [Sandy, Peter] Constellat Pharmaceut, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; IRCCS European Institute of Oncology (IEO); Columbia University; Cold Spring Harbor Laboratory	Aifantis, I (corresponding author), NYU Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	iannis.aifantis@nyumc.org	Ntziachristos, Panagiotis/CAG-2071-2022; xu, Luyao/F-2381-2015; Mullenders, Jasper/J-2398-2015	Mullenders, Jasper/0000-0003-3737-6901; Shen, Steven/0000-0001-7725-1260; Vakoc, Christopher/0000-0002-1158-7180	NIH/NCI [P30 CA016087-30]; NYU Cancer Institute Center [5P30CA16087-31]; NIH [1RO1CA133379, 1RO1CA105129, 1RO1CA149655, 5RO1CA173636, 1RO1GM088847]; William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society [6340-11, 6373-13]; Chemotherapy Foundation; V Foundation for Cancer Research; St. Baldrick's Foundation; NYU CMB Training Program; Ruth L. Kirschstein F31 Award; Marie Curie Actions Fellowship; NWO Rubicon; Dutch Cancer Society; Jose Carreras Leukemia Foundation [FIJC-12/EDTHOMAS]; NATIONAL CANCER INSTITUTE [R01CA133379, P30CA016087, R01CA105129, R01CA174793, R01CA149655, R01CA173636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088847] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYU Cancer Institute Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Chemotherapy Foundation; V Foundation for Cancer Research; St. Baldrick's Foundation; NYU CMB Training Program; Ruth L. Kirschstein F31 Award; Marie Curie Actions Fellowship; NWO Rubicon(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); Jose Carreras Leukemia Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Constellation Pharmaceuticals for providing CPI203; W. Pear, P. Premsrirut, J. Aster, J. Silva, M. Kelliher, and A. Klinakis for sharing materials; the NYU Genome Technology Center (supported in part by an NIH/NCI P30 CA016087-30 grant); L. Deriano and J. Chaumeil for mFISH analysis; the NYU Flow Cytometry facility for cell sorting; and the NYU Histology Core and Transgenic Mouse Core (NYU Cancer Institute Center grant 5P30CA16087-31). I.A. was supported by the NIH (1RO1CA133379, 1RO1CA105129, 1RO1CA149655, 5RO1CA173636, and 1RO1GM088847). I.A. was also supported by the William Lawrence and Blanche Hughes Foundation, the Leukemia & Lymphoma Society (TRP#6340-11 and LLS#6373-13), the Chemotherapy Foundation, the V Foundation for Cancer Research, and the St. Baldrick's Foundation. B.K. was supported by the NYU CMB Training Program. L.R. is supported by a Ruth L. Kirschstein F31 Award and a Marie Curie Actions Fellowship. J.M. is supported by NWO Rubicon and the Dutch Cancer Society. B.A.-O. is supported by the Jose Carreras Leukemia Foundation (FIJC-12/EDTHOMAS). I.A. is a Howard Hughes Medical Institute Early Career Scientist. I.A. and B.K. designed experiments and wrote the manuscript. B.K. performed most of the experiments. L.R. generated Eef1a1-targeted ESCs. L.X., A.P.-G., and A.F. assisted with in vivo and primary human T-ALL drug studies. P.S. assisted with inhibitor production and provided advice for use. C.V., J.S., and J. M. performed BRD4 knockdown experiments. B.A.-O. performed ubiquitylation assays. P.N., T.T., and S.S.S. performed and analyzed RNA-seq and ChIP-seq experiments. P.S. is an employee of Constellation Pharmaceuticals.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Armstrong F, 2009, BLOOD, V113, P1730, DOI 10.1182/blood-2008-02-138172; Aster JC, 1997, J BIOL CHEM, V272, P11336; Buchstaller J, 2012, CANCER CELL, V21, P240, DOI 10.1016/j.ccr.2011.12.027; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Davis H, 2011, J PATHOL, V224, P180, DOI 10.1002/path.2874; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Ferrando AA, 2003, SEMIN HEMATOL, V40, P274, DOI 10.1016/S0037-1963(03)00195-1; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Francis R, 2007, GENE DEV, V21, P1064, DOI 10.1101/gad.1522807; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Grim JE, 2012, MOL CELL BIOL, V32, P2160, DOI 10.1128/MCB.00305-12; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee MS, 2004, INT IMMUNOL, V16, P1109, DOI 10.1093/intimm/dxh112; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	53	223	230	1	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1552	1566		10.1016/j.cell.2013.05.041	http://dx.doi.org/10.1016/j.cell.2013.05.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791182	Green Accepted, Bronze			2022-12-28	WOS:000320722000022
J	Shah, P; Ding, Y; Niemczyk, M; Kudla, G; Plotkin, JB				Shah, Premal; Ding, Yang; Niemczyk, Malwina; Kudla, Grzegorz; Plotkin, Joshua B.			Rate-Limiting Steps in Yeast Protein Translation	CELL			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; CODON USAGE; TRANSFER-RNA; SECONDARY STRUCTURE; BINDING-SITES; IN-VIVO; EFFICIENCY; BIAS; TRANSCRIPTION	Deep sequencing now provides detailed snapshots of ribosome occupancy on mRNAs. We leverage these data to parameterize a computational model of translation, keeping track of every ribosome, tRNA, and mRNA molecule in a yeast cell. We determine the parameter regimes in which fast initiation or high codon bias in a transgene increases protein yield and infer the initiation rates of endogenous Saccharomyces cerevisiae genes, which vary by several orders of magnitude and correlate with 5' mRNA folding energies. Our model recapitulates the previously reported 5'-to-3' ramp of decreasing ribosome densities, although our analysis shows that this ramp is caused by rapid initiation of short genes rather than slow codons at the start of transcripts. We conclude that protein production in healthy yeast cells is typically limited by the availability of free ribosomes, whereas protein production under periods of stress can sometimes be rescued by reducing initiation or elongation rates.	[Shah, Premal; Ding, Yang; Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Niemczyk, Malwina; Kudla, Grzegorz] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH3 9LP, Midlothian, Scotland	University of Pennsylvania; University of Edinburgh	Plotkin, JB (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jplotkin@sas.upenn.edu	Taylor, Graham/A-4027-2012	Shah, Premal/0000-0002-8424-4218; Kudla, Grzegorz/0000-0002-7924-2744; Prater, Malwina/0000-0002-8202-5345	Burroughs Wellcome Fund; David and Lucile Packard Foundation; James S. McDonnell Foundation; Alfred P. Sloan Foundation; Foundational Questions in Evolutionary Biology Fund [RFP-12-16]; U.S. Department of the Interior [D12AP00025]; Wellcome Trust [077248]; Darwin Trust of Edinburgh	Burroughs Wellcome Fund(Burroughs Wellcome Fund); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Foundational Questions in Evolutionary Biology Fund; U.S. Department of the Interior; Wellcome Trust(Wellcome TrustEuropean Commission); Darwin Trust of Edinburgh	We thank M.A. Gilchrist, S.S. Yadavalli, and S. Jagannathan. J.B.P. acknowledges support from the Burroughs Wellcome Fund, the David and Lucile Packard Foundation, the James S. McDonnell Foundation, the Alfred P. Sloan Foundation, the Foundational Questions in Evolutionary Biology Fund (RFP-12-16), and grant D12AP00025 from the U.S. Department of the Interior. M.N. and G.K. were supported by The Wellcome Trust grant 077248 to David Tollervey and also thank the Tollervey lab. M.N. was supported by the Darwin Trust of Edinburgh.	ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Brackley CA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002203; BULMER M, 1991, GENETICS, V129, P897; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chu D, 2012, NUCLEIC ACIDS RES, V40, P10098, DOI 10.1093/nar/gks825; Chu D, 2011, NUCLEIC ACIDS RES, V39, P6705, DOI 10.1093/nar/gkr300; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Ding Y, 2012, GENOME BIOL EVOL, V4, P1046, DOI 10.1093/gbe/evs082; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gilchrist MA, 2006, J THEOR BIOL, V239, P417, DOI 10.1016/j.jtbi.2005.08.007; Gilchrist MA, 2007, MOL BIOL EVOL, V24, P2362, DOI 10.1093/molbev/msm169; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; Hinnebusch AG, 2012, COLD SPRING HARB PER, V4; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hurowitz EH, 2004, GENOME BIOL, V5; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lin ZG, 2012, MOL BIOL EVOL, V29, P81, DOI 10.1093/molbev/msr143; Mitarai N, 2008, J MOL BIOL, V382, P236, DOI 10.1016/j.jmb.2008.06.068; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Politz JCR, 2003, MOL BIOL CELL, V14, P4805, DOI 10.1091/mbc.E03-06-0395; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Reuveni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002127; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; Shah P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001128; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Siwiak M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000865; Tanguay RL, 1996, MOL CELL BIOL, V16, P146; Tuller T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r110; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; von der Haar T, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-87; WALDRON C, 1975, J BACTERIOL, V122, P855, DOI 10.1128/JB.122.3.855-865.1975; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Werner A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq808; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	58	286	290	1	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1589	1601		10.1016/j.cell.2013.05.049	http://dx.doi.org/10.1016/j.cell.2013.05.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791185	hybrid, Green Published			2022-12-28	WOS:000320722000025
J	Sun, S; Del Rosario, BC; Szanto, A; Ogawa, Y; Jeon, Y; Lee, JT				Sun, Sha; Del Rosario, Brian C.; Szanto, Attila; Ogawa, Yuya; Jeon, Yesu; Lee, Jeannie T.			Jpx RNA Activates Xist by Evicting CTCF	CELL			English	Article							X-CHROMOSOME INACTIVATION; EMBRYONIC STEM-CELLS; DOSAGE COMPENSATION; SEX DETERMINATION; MOUSE; TSIX; GENE; TRANSCRIPTION; SWITCH; BINDING	In mammals, dosage compensation between XX and XY individuals occurs through X chromosome inactivation (XCI). The noncoding Xist RNA is expressed and initiates XCI only when more than one X chromosome is present. Current models invoke a dependency on the X-to-autosome ratio (X:A), but molecular factors remain poorly defined. Here, we demonstrate that molecular titration between an X-encoded RNA and an autosomally encoded protein dictates Xist induction. In pre-XCI cells, CTCF protein represses Xist transcription. At the onset of XCI, Jpx RNA is upregulated, binds CTCF, and extricates CTCF from one Xist allele. We demonstrate that CTCF is an RNA-binding protein and is titrated away from the Xist promoter by Jpx RNA. Thus, Jpx activates Xist by evicting CTCF. The functional antagonism via molecular titration reveals a role for long noncoding RNA in epigenetic regulation.	[Sun, Sha; Del Rosario, Brian C.; Szanto, Attila; Ogawa, Yuya; Jeon, Yesu; Lee, Jeannie T.] Howard Hughes Med Inst, Boston, MA 02114 USA; [Sun, Sha; Del Rosario, Brian C.; Szanto, Attila; Ogawa, Yuya; Jeon, Yesu; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Sun, Sha; Del Rosario, Brian C.; Szanto, Attila; Ogawa, Yuya; Jeon, Yesu; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu	Szanto, Attila/B-2198-2012		National Institutes of Health [RO1-GM58839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058839, R01GM058839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to R. Jaenisch for the gift of F1-2.1 ES cells and G. Daley for Ainv15. We thank S. Pinter for sharing unpublished data, J. Ahn for sharing ChIP primers, B. Payer and D. Lessing for critically reading the manuscript, and all lab members for engaging discussions. This work is supported by a grant from the National Institutes of Health (RO1-GM58839 to J.T.L.). J.T.L. is an Investigator of the Howard Hughes Medical Institute.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Barakat TS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002001; BARBASH DA, 1995, GENETICS, V141, P1451; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BROWN SW, 1973, P NATL ACAD SCI USA, V70, P195, DOI 10.1073/pnas.70.1.195; Chow JC, 2003, GENOMICS, V82, P309, DOI 10.1016/S0888-7543(03)00170-8; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Cifuentes-Rojas C, 2011, P NATL ACAD SCI USA, V108, P73, DOI 10.1073/pnas.1013021107; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Essien K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r131; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Gartler SM, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-41; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Johnston CM, 2002, GENOMICS, V80, P236, DOI 10.1006/geno.2002.6819; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; LYON MF, 1971, NATURE-NEW BIOL, V232, P229, DOI 10.1038/newbio232229a0; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Navarro P, 2006, GENE DEV, V20, P2787, DOI 10.1101/gad.389006; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; OHNO S, 1969, ANNU REV GENET, V3, P495, DOI 10.1146/annurev.ge.03.120169.002431; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Ptashne M, 2011, NAT CHEM BIOL, V7, P484, DOI 10.1038/nchembio.611; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Sado T, 2001, DEVELOPMENT, V128, P1275; Salz HK, 2010, FLY, V4, P60, DOI 10.4161/fly.4.1.11277; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Spencer RJ, 2011, GENETICS, V189, P441, DOI 10.1534/genetics.111.132662; Starmer J, 2009, DEVELOPMENT, V136, P1, DOI 10.1242/dev.025908; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803; Yao HJ, 2010, GENE DEV, V24, P2543, DOI 10.1101/gad.1967810; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	53	221	227	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1537	1551		10.1016/j.cell.2013.05.028	http://dx.doi.org/10.1016/j.cell.2013.05.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791181	Green Accepted, Bronze			2022-12-28	WOS:000320722000021
J	Van de Perre, P; Tylleskar, T; Delfraissy, JF; Nagot, N				Van de Perre, Philippe; Tylleskar, Thorkild; Delfraissy, Jean-Francois; Nagot, Nicolas			How evidence based are public health policies for prevention of mother to child transmission of HIV?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTED MOTHERS; CONTROLLED-TRIAL; DOSE NEVIRAPINE; PROPHYLAXIS; DIARRHEA; ZIDOVUDINE; MORTALITY; INFANTS; BORN		[Van de Perre, Philippe; Nagot, Nicolas] INSERM, Infect HIV & Agents Mucocutaneous Tropism Pathoge, F-34394 Montpellier, France; [Van de Perre, Philippe; Nagot, Nicolas] Univ Montpellier I, F-34090 Montpellier, France; [Van de Perre, Philippe; Nagot, Nicolas] CHU Montpellier, Dept Bacteriol Virol, F-34295 Montpellier, France; [Van de Perre, Philippe; Nagot, Nicolas] CHU Montpellier, Dept Med Informat, F-34295 Montpellier, France; [Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, N-5020 Bergen, Norway; [Delfraissy, Jean-Francois] Agence Natl Rech Sida & Hepatites Virales, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Bergen	Van de Perre, P (corresponding author), INSERM, Infect HIV & Agents Mucocutaneous Tropism Pathoge, F-34394 Montpellier, France.	p-van_de_perre@chu-montpellier.fr	Nagot, Nicolas/I-9467-2014; Tylleskär, Thorkild/S-5529-2017; Van de Perre, Philippe/B-9692-2008	Tylleskär, Thorkild/0000-0003-4801-4324; Van de Perre, Philippe/0000-0002-3912-0427; Nagot, Nicolas/0000-0002-3493-2821				Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P1; [Anonymous], 2006, HIV INFANT FEEDING N; Arvelo W, 2010, INT J INFECT DIS, V14, pE1002, DOI 10.1016/j.ijid.2010.06.014; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chi BH, 2012, JAIDS-J ACQ IMM DEF, V60, pS78, DOI 10.1097/QAI.0b013e31825f3284; Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; Fawzy A, 2011, J INFECT DIS, V203, P1222, DOI 10.1093/infdis/jir019; Fogel J, 2011, CLIN INFECT DIS, V52, P1069, DOI 10.1093/cid/cir008; Kuhn L, 2010, CLIN INFECT DIS, V50, P437, DOI 10.1086/649886; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Lidstrom J., 2010, 17 C RETR OPP INF SA; Luo C., 2012, 19 INT AIDS C WASH D; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mofenson LM, 2000, LANCET, V355, P2237, DOI 10.1016/S0140-6736(00)02415-6; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Nagot N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-246; National Institutes of Health IMPAACT Trial Network, 2010, P1077 NIH IMPAACT TR, P1077; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; TZIPORI S, 1980, AUST VET J, V56, P274, DOI 10.1111/j.1751-0813.1980.tb05723.x; UNFPA/UNICEF/WHO/UNAIDS Interagency Task Team on Mother-to-Child Transmission of HIV, 2001, NEW DAT PREV MOTH TO; Unicef, 2012, OPT B B KEY CONS COU; WHO, 2012, US ANT DRUGS TREAT P; WHO, 2010, GUID HIV INF FEED 21; *WHO, 2004, ANT DRUGS PREV MOTH; World Health Organization, 1994, REC M PREV MOTH TO I; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zeh C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000430	31	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2013	346								f3763	10.1136/bmj.f3763	http://dx.doi.org/10.1136/bmj.f3763			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171QP	23788455				2022-12-28	WOS:000320944400005
J	Choopanya, K; Martin, M; Suntharasamai, P; Sangkum, U; Mock, PA; Leethochawalit, M; Chiamwongpaet, S; Kitisin, P; Natrujirote, P; Kittimunkong, S; Chuachoowong, R; Gvetadze, RJ; McNicholl, JM; Paxton, LA; Curlin, ME; Hendrix, CW; Vanichseni, S				Choopanya, Kachit; Martin, Michael; Suntharasamai, Pravan; Sangkum, Udomsak; Mock, Philip A.; Leethochawalit, Manoj; Chiamwongpaet, Sithisat; Kitisin, Praphan; Natrujirote, Pitinan; Kittimunkong, Somyot; Chuachoowong, Rutt; Gvetadze, Roman J.; McNicholl, Janet M.; Paxton, Lynn A.; Curlin, Marcel E.; Hendrix, Craig W.; Vanichseni, Suphak		Bangkok Tenofovir Study Grp	Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DISOPROXIL FUMARATE; PREEXPOSURE PROPHYLAXIS; RENAL SAFETY; PREVENTION; TRANSMISSION; MACAQUES; VACCINE	Background Antiretroviral pre-exposure prophylaxis reduces sexual transmission of HIV. We assessed whether daily oral use of tenofovir disoproxil fumarate (tenofovir), an antiretroviral, can reduce HIV transmission in injecting drug users. Methods In this randomised, double-blind, placebo-controlled trial, we enrolled volunteers from 17 drug-treatment clinics in Bangkok, Thailand. Participants were eligible if they were aged 20-60 years, were HIV-negative, and reported injecting drugs during the previous year. We randomly assigned participants (1: 1; blocks of four) to either tenofovir or placebo using a computer-generated randomisation sequence. Participants chose either daily directly observed treatment or monthly visits and could switch at monthly visits. Participants received monthly HIV testing and individualised risk-reduction and adherence counselling, blood safety assessments every 3 months, and were offered condoms and methadone treatment. The primary efficacy endpoint was HIV infection, analysed by modified intention-to-treat analysis. This trial is registered with ClinicalTrials.gov, number NCT00119106. Findings Between June 9, 2005, and July 22, 2010, we enrolled 2413 participants, assigning 1204 to tenofovir and 1209 to placebo. Two participants had HIV at enrolment and 50 became infected during follow-up: 17 in the tenofovir group (an incidence of 0.35 per 100 person-years) and 33 in the placebo group (0.68 per 100 person-years), indicating a 48.9% reduction in HIV incidence (95% CI 9.6-72.2; p=0.01). The occurrence of serious adverse events was much the same between the two groups (p=0.35). Nausea was more common in participants in the tenofovir group than in the placebo group (p=0.002). Interpretation In this study, daily oral tenofovir reduced the risk of HIV infection in people who inject drugs. Pre-exposure prophylaxis with tenofovir can now be considered for use as part of an HIV prevention package for people who inject drugs.	[Choopanya, Kachit; Suntharasamai, Pravan; Sangkum, Udomsak; Vanichseni, Suphak] Bangkok Tenofovir Study Grp, Bangkok, Thailand; [Martin, Michael; Mock, Philip A.; Chuachoowong, Rutt; McNicholl, Janet M.; Curlin, Marcel E.] Thailand Minist Publ Health, US CDC Collaborat, Nonthaburi, Thailand; [Martin, Michael; Gvetadze, Roman J.; McNicholl, Janet M.; Paxton, Lynn A.; Curlin, Marcel E.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Leethochawalit, Manoj; Chiamwongpaet, Sithisat; Kitisin, Praphan; Natrujirote, Pitinan] Bangkok Metropolitan Adm, Bangkok, Thailand; [Kittimunkong, Somyot] Thailand Minist Publ Hlth, Nonthaburi, Thailand; [Hendrix, Craig W.] Johns Hopkins Univ, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand; Johns Hopkins University	Martin, M (corresponding author), Minist Publ Hlth, DDC 7 Bldg,4th Floor,Soi 4, Nonthaburi 11000, Thailand.	Znd9@cdc.gov	Hendrix, Craig W/G-4182-2014	Hendrix, Craig W/0000-0002-5696-8665; Cherdtrakulkiat, Thitima/0000-0001-5006-6145	US Centers for Disease Control and Prevention; Bangkok Metropolitan Administration; Gilead Sciences	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bangkok Metropolitan Administration; Gilead Sciences(Gilead Sciences)	US Centers for Disease Control and Prevention and the Bangkok Metropolitan Administration.; CWH reports receiving grant support from Gilead Sciences. All other authors declare that they have no conflicts of interest.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; [Anonymous], 2012, TRUVADA APPROVED RED; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bureau of Policy and Strategy Ministry of Public Health, INT STAT CLASS DIS 1; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Gallant JE, 2008, AIDS, V22, P2155, DOI 10.1097/QAD.0b013e3283112b8e; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; KONINGS E, 1995, AIDS, V9, P375, DOI 10.1097/00002030-199509040-00009; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Marrazzo J, 20 C RETR OPP INF 20; Martin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025127; Martin M, 2010, INT J DRUG POLICY, V21, P296, DOI 10.1016/j.drugpo.2009.12.002; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Patel P, 2012, J CLIN VIROL, V54, P42, DOI 10.1016/j.jcv.2012.01.022; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Smith PF, 2004, PHARMACOTHERAPY, V24, P970, DOI 10.1592/phco.24.11.970.36141; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Sungkanuparph S, 2010, ASIAN BIOMED, V4, P515, DOI 10.2478/abm-2010-0066; Thailand Ministry of Public Health and the National AIDS Prevention and Alleviation Committee, UNGASS COUNTR PROGR; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; UNAIDS, AIDSINFO WORLD OV; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011; World Health Organization, HIV AIDS INJ DRUG US	34	950	975	2	69	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 15	2013	381	9883					2083	2090		10.1016/S0140-6736(13)61127-7	http://dx.doi.org/10.1016/S0140-6736(13)61127-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KA	23769234				2022-12-28	WOS:000320924800030
J	Inomata, H; Shibata, T; Haraguchi, T; Sasai, Y				Inomata, Hidehiko; Shibata, Tatsuo; Haraguchi, Tomoko; Sasai, Yoshiki			Scaling of Dorsal-Ventral Patterning by Embryo Size-Dependent Degradation of Spemann's Organizer Signals	CELL			English	Article							BMP MORPHOGEN GRADIENTS; XENOPUS EMBRYOS; CHORDIN; INHIBITION; INVARIANCE; DEPLETION; MESODERM; CLEAVAGE; BINDING; PROTEIN	Spemann's organizer plays a key role in dorsal-ventral (DV) patterning in the amphibian embryo by secreting diffusible proteins such as Chordin, an antagonist to ventralizing bone morphogenetic proteins (BMPs). The DV patterning is so robust that an amphibian embryo with its ventral half surgically removed can develop into a smaller but proportionally patterned larva. Here, we show that this robust patterning depends on facilitated Chordin degradation and requires the expression of the Chordin-proteinase inhibitor Sizzled on the opposite side. Sizzled, which is stable and diffuses widely along the DV axis, stabilizes Chordin and expands its distribution in the ventral direction. This expanded Chordin distribution, in turn, limits BMP-dependent Sizzled production, forming an axis-wide feedback loop for shaping Chordin's activity. Using bisection assays, we demonstrate that Chordin degradation is dynamically controlled by embryo-size-coupled Sizzled accumulation. We propose a scaling model that enables the DV pattern to adjust proportionally to embryonic axis size.	[Inomata, Hidehiko; Haraguchi, Tomoko; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Shibata, Tatsuo] RIKEN, Ctr Dev Biol, Phys Biol Lab, Kobe, Hyogo 6500047, Japan; [Inomata, Hidehiko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO Progr, Kawaguchi, Saitama 3320012, Japan	RIKEN; RIKEN; Japan Science & Technology Agency (JST)	Inomata, H (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	hideino@cdb.riken.jp; yoshikisasai@cdb.riken.jp	Inomata, Hidehiko/N-7390-2015; Shibata, Tatsuo/A-8119-2012	Shibata, Tatsuo/0000-0002-9294-9998	MEXT (Ministry of Education, Culture, Sports, Science, and Technology) Program; PRESTO Program of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25111736] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science, and Technology) Program; PRESTO Program of the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Yoshihiro Morishita, Masatoshi Ohgushi, and Mototsugu Eiraku for invaluable comments and discussion on this study. This study was supported by grants-in-aid from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) Program (Y.S., H.I., and T.S.) and the PRESTO Program of the Japan Science and Technology Agency.	Aramaki T, 2010, DEV CELL, V19, P547, DOI 10.1016/j.devcel.2010.09.001; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Ben-Zvi D, 2011, CURR OPIN GENET DEV, V21, P704, DOI 10.1016/j.gde.2011.07.011; Chen HM, 2008, METHOD CELL BIOL, V89, P3, DOI 10.1016/S0091-679X(08)00601-8; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; COOKE J, 1975, J EMBRYOL EXP MORPH, V33, P147; COOKE J, 1973, J EMBRYOL EXP MORPH, V30, P49; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Francois P, 2009, NATURE, V461, pE1, DOI 10.1038/nature08305; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hecht I, 2009, P NATL ACAD SCI USA, V106, P1710, DOI 10.1073/pnas.0807655106; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kimelman D, 2005, CELL, V123, P982, DOI 10.1016/j.cell.2005.11.028; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Marom K, 1999, MECH DEVELOP, V87, P33, DOI 10.1016/S0925-4773(99)00137-9; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; O'Connor MB, 2006, DEVELOPMENT, V133, P183; OTHMER HG, 1980, P NATL ACAD SCI-BIOL, V77, P4180, DOI 10.1073/pnas.77.7.4180; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Peluso CE, 2011, DEV CELL, V21, P375, DOI 10.1016/j.devcel.2011.06.025; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Spemann H, 1918, W ROUX ARCH ENTWMECH, V43, P448, DOI [10.1007/BF02267308, DOI 10.1007/BF02267308]; SPEMANN H, 1924, WILHELM ROUX ARCH EN, V100, P599; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Umulis DM, 2009, J R SOC INTERFACE, V6, P1179, DOI [10.1098/rsif.2008.0015, 10.1098/rsif.2009.0015]	38	82	85	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1296	1311		10.1016/j.cell.2013.05.004	http://dx.doi.org/10.1016/j.cell.2013.05.004			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746842	Bronze			2022-12-28	WOS:000319979200014
J	Wang, F; Ekiert, DC; Ahmad, I; Yu, WL; Zhang, Y; Bazirgan, O; Torkamani, A; Raudsepp, T; Mwangi, W; Criscitiello, MF; Wilson, IA; Schultz, PG; Smider, VV				Wang, Feng; Ekiert, Damian C.; Ahmad, Insha; Yu, Wenli; Zhang, Yong; Bazirgan, Omar; Torkamani, Ali; Raudsepp, Terje; Mwangi, Waithaka; Criscitiello, Michael F.; Wilson, Ian A.; Schultz, Peter G.; Smider, Vaughn V.			Reshaping Antibody Diversity	CELL			English	Article							EXCEPTIONALLY LONG CDR3H; V-H FAMILY; CRYSTAL-STRUCTURE; BOVINE; AFFINITY; REGION; PROTEINS; ANTIGEN; CATTLE; DOMAIN	Some species mount a robust antibody response despite having limited genome-encoded combinatorial diversity potential. Cows are unusual in having exceptionally long CDR H3 loops and few V regions, but the mechanism for creating diversity is not understood. Deep sequencing reveals that ultralong CDR H3s contain a remarkable complexity of cysteines, suggesting that disulfide-bonded minidomains may arise during repertoire development. Indeed, crystal structures of two cow antibodies reveal that these CDR H3s form a very unusual architecture composed of a beta strand "stalk'' that supports a structurally diverse, disulfide-bonded "knob'' domain. Diversity arises from somatic hypermutation of an ultralong DH with a severe codon bias toward mutation to cysteine. These unusual antibodies can be elicited to recognize defined antigens through the knob domain. Thus, the bovine immune system produces an antibody repertoire composed of ultralong CDR H3s that fold into a diversity of minidomains generated through combinations of somatically generated disulfides.	[Wang, Feng; Zhang, Yong; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Ekiert, Damian C.; Yu, Wenli; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Ahmad, Insha; Smider, Vaughn V.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Torkamani, Ali] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Bazirgan, Omar; Smider, Vaughn V.] Fabrus Inc, La Jolla, CA 92037 USA; [Raudsepp, Terje] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Mwangi, Waithaka; Criscitiello, Michael F.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Wilson, IA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	wilson@scripps.edu; vvsmider@scripps.edu		Ekiert, Damian/0000-0002-2570-0404; Smider, Vaughn/0000-0003-3488-6383	American Cancer Society [ACS RSG-09-1601]; National Institutes of Health [R01GM062159, R01 AI084817]; Skaggs Institute for Chemical Biology; Scripps Translational Sciences Institute Clinical Translational Science Award [UL1 RR025774-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062159] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; Scripps Translational Sciences Institute Clinical Translational Science Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Richard Lerner, Michael McHeyzer-Williams, Jeffery Kelly, and Michael Weiss for helpful discussions and Cory Bentley, Evan Holmes, James Graziano, Miguel de los Rios, and Jocelyn Bray for technical support. This work was supported by American Cancer Society Grant ACS RSG-09-1601 (to V.V.S.), National Institutes of Health Grants R01GM062159 (to P.G.S.) and R01 AI084817 (to I.A.W.), the Skaggs Institute for Chemical Biology (to P.G.S. and I.A.W.), and the Scripps Translational Sciences Institute Clinical Translational Science Award UL1 RR025774-03 (to A.T.). This is manuscript number 21869 of The Scripps Research Institute. V.V.S. and O.B. have equity interests in Fabrus, Inc. Please contact I.A.W. for structural information and V.V.S. for other inquiries.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agapov EV, 2004, J VIROL, V78, P2414, DOI 10.1128/JVI.78.5.2414-2425.2004; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Almagro JC, 2012, J MOL RECOGNIT, V25, P125, DOI 10.1002/jmr.1168; Berens SJ, 1997, INT IMMUNOL, V9, P189, DOI 10.1093/intimm/9.1.189; CAI L, 1995, GENOMICS, V29, P413, DOI 10.1006/geno.1995.9986; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gracy J, 2011, CURR PHARM DESIGN, V17, P4337, DOI 10.2174/138161211798999339; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; Hosseini A, 2004, INT IMMUNOL, V16, P843, DOI 10.1093/intimm/dxh085; Kato L, 2012, J IMMUNOL, V188, P3559, DOI 10.4049/jimmunol.1102397; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Koti M, 2008, DEV BIOLOGICALS, V132, P307, DOI 10.1159/000317176; Koti M, 2010, MOL IMMUNOL, V47, P2119, DOI 10.1016/j.molimm.2010.02.014; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lopez O, 1998, IMMUNOL REV, V162, P55, DOI 10.1111/j.1600-065X.1998.tb01429.x; Mao HY, 2010, NAT BIOTECHNOL, V28, P1195, DOI 10.1038/nbt.1694; Mariat D, 2001, CYTOGENET CELL GENET, V92, P144, DOI 10.1159/000056886; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moore SJ, 2012, METHOD ENZYMOL, V503, P223, DOI 10.1016/B978-0-12-396962-0.00009-4; Njongmeta LM, 2012, VACCINE, V30, P1624, DOI 10.1016/j.vaccine.2011.12.110; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Parng CL, 1996, J IMMUNOL, V157, P5478; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Raudsepp Terje, 2008, V422, P31, DOI 10.1007/978-1-59745-581-7_3; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Saini SS, 2003, INT IMMUNOL, V15, P845, DOI 10.1093/intimm/dxg083; Saini SS, 1999, EUR J IMMUNOL, V29, P2420, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2420::AID-IMMU2420&gt;3.0.CO;2-A; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; Sinclair MC, 1997, J IMMUNOL, V159, P3883; Smider V, 1997, Semin Immunol, V9, P189, DOI 10.1006/smim.1997.0070; Smith JJ, 2011, P NATL ACAD SCI USA, V108, P10478, DOI 10.1073/pnas.1103501108; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Thomson CA, 2008, EMBO J, V27, P2592, DOI 10.1038/emboj.2008.179; Wang F, 2013, P NATL ACAD SCI USA, V110, P4261, DOI 10.1073/pnas.1301810110; Zhao YF, 2006, DEV COMP IMMUNOL, V30, P175, DOI 10.1016/j.dci.2005.06.012	47	137	151	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1379	1393		10.1016/j.cell.2013.04.049	http://dx.doi.org/10.1016/j.cell.2013.04.049			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746848	Green Accepted, Bronze			2022-12-28	WOS:000319979200020
J	Reale, F; Orlando, S; Testa, P; Peres, G; Landi, E; Schrijver, CJ				Reale, Fabio; Orlando, Salvatore; Testa, Paola; Peres, Giovanni; Landi, Enrico; Schrijver, Carolus J.			Bright Hot Impacts by Erupted Fragments Falling Back on the Sun: A Template for Stellar Accretion	SCIENCE			English	Article							T-TAURI STARS; X-RAY SPECTROSCOPY; DISK ACCRETION; EMISSION; SHOCKS; PLASMA; HYDRAE	Impacts of falling fragments observed after the eruption of a filament in a solar flare on 7 June 2011 are similar to those inferred for accretion flows on young stellar objects. As imaged in the ultraviolet (UV)-extreme UV range by the Atmospheric Imaging Assembly onboard the Solar Dynamics Observatory, many impacts of dark, dense matter display uncommonly intense, compact brightenings. High-resolution hydrodynamic simulations show that such bright spots, with plasma temperatures increasing from similar to 10(4) to similar to 10(6) kelvin, occur when high-density plasma (>>10(10) particles per cubic centimeter) hits the solar surface at several hundred kilometers per second, producing high-energy emission as in stellar accretion. The high-energy emission comes from the original fragment material and is heavily absorbed by optically thick plasma, possibly explaining the lower mass accretion rates inferred from x-rays relative to UV-optical-near infrared observations of young stars.	[Reale, Fabio; Peres, Giovanni] Univ Palermo, Dipartimento Fis & Chim, I-90134 Palermo, Italy; [Reale, Fabio; Orlando, Salvatore; Peres, Giovanni] Osserv Astron Palermo, Ist Nazl Astrofis INAF, I-90134 Palermo, Italy; [Testa, Paola] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Landi, Enrico] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Schrijver, Carolus J.] Lockheed Martin Adv Technol Ctr, Palo Alto, CA 94304 USA	University of Palermo; Istituto Nazionale Astrofisica (INAF); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Michigan System; University of Michigan; Lockheed Martin	Reale, F (corresponding author), Univ Palermo, Dipartimento Fis & Chim, Piazza Parlamento 1, I-90134 Palermo, Italy.	reale@astropa.unipa.it	Landi, Enrico/H-4493-2011	Reale, Fabio/0000-0002-1820-4824; Schrijver, Carolus/0000-0002-6010-8182; Orlando, Salvatore/0000-0003-2836-540X; PERES, Giovanni/0000-0002-6033-8180	Italian Ministero dell'Universita e Ricerca; Agenzia Spaziale Italiana [I/023/09/0]; Lockheed-Martin [SP02H1701R]; NASA [NNG04EA00C, NNX11AC20G, NNX10AQ58G]; NSF [AGS-1154443]; INAF; U.S. Department of Energy; CINECA [HP10CEG9MW]; INAF/Osservatorio Astronomico di Palermo	Italian Ministero dell'Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); Lockheed-Martin; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); INAF(Istituto Nazionale Astrofisica (INAF)); U.S. Department of Energy(United States Department of Energy (DOE)); CINECA(CINECA, Italy); INAF/Osservatorio Astronomico di Palermo	We thank B. De Pontieu for help and suggestions. F. R., G. P., and S.O. acknowledge support from Italian Ministero dell'Universita e Ricerca and Agenzia Spaziale Italiana, contract I/023/09/0. P. T. was supported by contract SP02H1701R from Lockheed-Martin to the Smithsonian Astrophysical Observatory. P. T. and C.J.S. are supported by NASA contract NNG04EA00C for the SDO AIA. E. L. is supported by NASA grants NNX11AC20G and NNX10AQ58G and NSF grant AGS-1154443. S.O. acknowledges partial support from the INAF. The software used in this work was, in part, developed by the U.S. Department of Energy-supported Advanced Simulation and Computing/Alliance Center for Astrophysical Thermonuclear Flashes at the University of Chicago. We acknowledge the CINECA Award HP10CEG9MW and INAF/Osservatorio Astronomico di Palermo for high-performance computing resources and support. SDO data were supplied courtesy of the SDO/HMI and SDO/AIA consortia. SDO is the first mission to be launched for NASA's Living With a Star Program. See the supplementary materials for details on the data, data analysis, and modeling.	Argiroffi C, 2007, ASTRON ASTROPHYS, V465, pL5, DOI 10.1051/0004-6361:20067016; BERTOUT C, 1988, ASTROPHYS J, V330, P350, DOI 10.1086/166476; Brickhouse NS, 2010, ASTROPHYS J, V710, P1835, DOI 10.1088/0004-637X/710/2/1835; Brueckner GE, 1995, SOL PHYS, V162, P357, DOI 10.1007/BF00733434; Calvet N, 1998, ASTROPHYS J, V509, P802, DOI 10.1086/306527; Cheng X, 2012, ASTROPHYS J LETT, V745, DOI 10.1088/2041-8205/745/1/L5; Curran RL, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015522; Donati JF, 2008, MON NOT R ASTRON SOC, V386, P1234, DOI 10.1111/j.1365-2966.2008.13111.x; Drake JJ, 2005, ESA SP PUBL, V560, P519; Dupree AK, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/73; Gunther HM, 2007, ASTRON ASTROPHYS, V466, P1111, DOI 10.1051/0004-6361:20065669; Gullbring E, 1998, ASTROPHYS J, V492, P323, DOI 10.1086/305032; Hartmann L., 1998, CAMBRIDGE ASTROPHYSI; Innes DE, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118530; Kastner JH, 2002, ASTROPHYS J, V567, P434, DOI 10.1086/338419; KONIGL A, 1991, ASTROPHYS J, V370, pL39, DOI 10.1086/185972; Lemen JR, 2012, SOL PHYS, V275, P17, DOI 10.1007/s11207-011-9776-8; LYNDENBELL D, 1974, MON NOT R ASTRON SOC, V168, P603, DOI 10.1093/mnras/168.3.603; Muzerolle J, 2000, ASTROPHYS J, V535, pL47, DOI 10.1086/312691; Natta A, 2006, ASTRON ASTROPHYS, V452, P245, DOI 10.1051/0004-6361:20054706; Orlando S, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913565; Pesnell WD, 2012, SOL PHYS, V275, P3, DOI 10.1007/s11207-011-9841-3; Sacco GG, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201014950; Telleschi A, 2007, ASTRON ASTROPHYS, V468, P443, DOI 10.1051/0004-6361:20066193; Wulser JP, 2004, P SOC PHOTO-OPT INS, V5171, P111, DOI 10.1117/12.506877	26	40	40	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					251	253		10.1126/science.1235692	http://dx.doi.org/10.1126/science.1235692			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23788734	Green Published			2022-12-28	WOS:000321959300035
J	Stone, EC; Cummings, AC; McDonald, FB; Heikkila, BC; Lal, N; Webber, WR				Stone, E. C.; Cummings, A. C.; McDonald, F. B.; Heikkila, B. C.; Lal, N.; Webber, W. R.			Voyager 1 Observes Low-Energy Galactic Cosmic Rays in a Region Depleted of Heliospheric Ions	SCIENCE			English	Article							HELIOPAUSE; SPECTRUM; MODULATION	On 25 August 2012, Voyager 1 was at 122 astronomical units when the steady intensity of low-energy ions it had observed for the previous 6 years suddenly dropped for a third time and soon completely disappeared as the ions streamed away into interstellar space. Although the magnetic field observations indicate that Voyager 1 remained inside the heliosphere, the intensity of cosmic ray nuclei from outside the heliosphere abruptly increased. We report the spectra of galactic cosmic rays down to similar to 3 x 10(6) electron volts per nucleon, revealing H and He energy spectra with broad peaks from 10 x 10(6) to 40 x 10(6) electron volts per nucleon and an increasing galactic cosmic-ray electron intensity down to similar to 10 x 10(6) electron volts.	[Stone, E. C.; Cummings, A. C.] CALTECH, Pasadena, CA 91125 USA; [McDonald, F. B.] Univ Maryland, College Pk, MD 20742 USA; [Heikkila, B. C.; Lal, N.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Webber, W. R.] New Mexico State Univ, Las Cruces, NM 88003 USA	California Institute of Technology; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; New Mexico State University	Stone, EC (corresponding author), CALTECH, Pasadena, CA 91125 USA.	ecs@srl.caltech.edu			NASA [NNN12A012]	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by NASA (NNN12A012). This paper is dedicated to the memory of Frank McDonald, whose leadership in the cosmic-ray investigation on Voyager began in 1972. His contributions continued until the day of his passing, just after Voyager 1 durably entered the depletion region and fulfilled his vision of observing low-energy galactic cosmic rays from the local interstellar medium. This paper benefited substantially from discussions during meetings of the International Team on the Physics of the Heliopause at the International Space Science Institute in Bern, Switzerland.	Burlaga LF, 2013, SCIENCE, V341, P147, DOI 10.1126/science.1235451; Cummings AC, 2002, ASTROPHYS J, V578, P194, DOI 10.1086/342427; Fisk LA, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/127; George JS, 2009, ASTROPHYS J, V698, P1666, DOI 10.1088/0004-637X/698/2/1666; Herbst K, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/17; IP WH, 1985, ASTRON ASTROPHYS, V149, P7; Jokipii JR, 2001, COSPAR COLL, V11, P513; Krimigis SM, 2013, SCIENCE, V341, P144, DOI 10.1126/science.1235721; Langner U. W, 2001, P 27 INT COSM RAY C, V10, P3992; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; McComas DJ, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/19; Moskalenko IV, 2002, ASTROPHYS J, V565, P280, DOI 10.1086/324402; Scherer K, 2008, ASTROPHYS J LETT, V680, pL105, DOI 10.1086/589969; Scherer K, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/128; SIMPSON JA, 1983, ANNU REV NUCL PART S, V33, P323, DOI 10.1146/annurev.ns.33.120183.001543; STONE EC, 1977, SPACE SCI REV, V21, P355, DOI 10.1007/BF00211546; Strauss RD, 2013, ASTROPHYS J LETT, V765, DOI 10.1088/2041-8205/765/1/L18; Strong AW, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201116828; Webber WR, 2013, GEOPHYS RES LETT, V40, P1665, DOI 10.1002/grl.50383; Webber WR, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013386; Webber WR, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013689	21	383	385	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					150	153		10.1126/science.1236408	http://dx.doi.org/10.1126/science.1236408			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23811227				2022-12-28	WOS:000321965300036
J	Wing, R; Bolin, P; Brancati, FL; Bray, GA; Clark, JM; Coday, M; Crow, RS; Curtis, JM; Egan, CM; Espeland, MA; Evans, M; Foreyt, JP; Ghazarian, S; Gregg, EW; Harrison, B; Hazuda, HP; Hill, JO; Horton, ES; Hubbard, V; Jakicic, JM; Jeffery, RW; Johnson, KC; Kahn, SE; Kitabchi, AE; Knowler, WC; Lewis, CE; Maschak-Carey, BJ; Montez, MG; Murillo, A; Nathan, DM; Patricio, J; Peters, A; Pi-Sunyer, X; Pownall, H; Reboussin, D; Regensteiner, JG; Rickman, AD; Ryan, DH; Safford, M; Wadden, TA; Wagenknecht, LE; West, DS; Williamson, DF; Yanovski, SZ				Wing, Rena; Bolin, Paula; Brancati, Frederick L.; Bray, George A.; Clark, Jeanne M.; Coday, Mace; Crow, Richard S.; Curtis, Jeffrey M.; Egan, Caitlin M.; Espeland, Mark A.; Evans, Mary; Foreyt, John P.; Ghazarian, Siran; Gregg, Edward W.; Harrison, Barbara; Hazuda, Helen P.; Hill, James O.; Horton, Edward S.; Hubbard, Van S.; Jakicic, John M.; Jeffery, Robert W.; Johnson, Karen C.; Kahn, Steven E.; Kitabchi, Abbas E.; Knowler, William C.; Lewis, Cora E.; Maschak-Carey, Barbara J.; Montez, Maria G.; Murillo, Anne; Nathan, David M.; Patricio, Jennifer; Peters, Anne; Pi-Sunyer, Xavier; Pownall, Henry; Reboussin, David; Regensteiner, Judith G.; Rickman, Amy D.; Ryan, Donna H.; Safford, Monika; Wadden, Thomas A.; Wagenknecht, Lynne E.; West, Delia S.; Williamson, David F.; Yanovski, Susan Z.		Look AHEAD Res Grp	Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEIGHT-LOSS; OBESE ADULTS; MORTALITY; INDIVIDUALS; PREVENTION; MELLITUS; HEALTH; DIET	Background Weight loss is recommended for overweight or obese patients with type 2 diabetes on the basis of short-term studies, but long-term effects on cardiovascular disease remain unknown. We examined whether an intensive lifestyle intervention for weight loss would decrease cardiovascular morbidity and mortality among such patients. Methods In 16 study centers in the United States, we randomly assigned 5145 overweight or obese patients with type 2 diabetes to participate in an intensive lifestyle intervention that promoted weight loss through decreased caloric intake and increased physical activity (intervention group) or to receive diabetes support and education (control group). The primary outcome was a composite of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for angina during a maximum follow-up of 13.5 years. Results The trial was stopped early on the basis of a futility analysis when the median follow- up was 9.6 years. Weight loss was greater in the intervention group than in the control group throughout the study (8.6% vs. 0.7% at 1 year; 6.0% vs. 3.5% at study end). The intensive lifestyle intervention also produced greater reductions in glycated hemoglobin and greater initial improvements in fitness and all cardiovascular risk factors, except for low-density-lipoprotein cholesterol levels. The primary outcome occurred in 403 patients in the intervention group and in 418 in the control group (1.83 and 1.92 events per 100 person-years, respectively; hazard ratio in the intervention group, 0.95; 95% confidence interval, 0.83 to 1.09; P = 0.51). Conclusions An intensive lifestyle intervention focusing on weight loss did not reduce the rate of cardiovascular events in overweight or obese adults with type 2 diabetes.	[Wing, Rena; Curtis, Jeffrey M.] Brown Univ, Warren Alpert Med Sch, Weight Control & Diabet Res Ctr, Providence, RI 02903 USA; [Bolin, Paula; Evans, Mary; Harrison, Barbara; Hubbard, Van S.] NIDDK, NIH, Bethesda, MD 20892 USA; [Brancati, Frederick L.; Clark, Jeanne M.] Johns Hopkins Sch Med, Baltimore, MD USA; [Bray, George A.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Coday, Mace; Johnson, Karen C.; Kitabchi, Abbas E.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Crow, Richard S.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Curtis, Jeffrey M.] NIDDK, NIH, Phoenix, AZ USA; [Egan, Caitlin M.] Miriam Hosp, Providence, RI 02906 USA; [Espeland, Mark A.] Wake Forest Univ, Dept Biostat Sci, Sch Med, Winston Salem, NC 27109 USA; [Foreyt, John P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Ghazarian, Siran; Peters, Anne] Roybal Comprehens Hlth Ctr, Los Angeles, CA USA; [Gregg, Edward W.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Hazuda, Helen P.; Montez, Maria G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Clin Epidemiol, San Antonio, TX 78229 USA; [Hill, James O.] Univ Colorado, Hlth Sci Ctr, Ctr Human Nutr, Aurora, CO USA; [Horton, Edward S.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Jakicic, John M.] Univ Pittsburgh, Dept Hlth & Phys Act, Pittsburgh, PA USA; [Jeffery, Robert W.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Kahn, Steven E.; Murillo, Anne] Univ Washington, Dept Med, Seattle, WA USA; [Knowler, William C.] NIDDK, NIH, Southwest Amer Indian Ctr, Phoenix, AZ USA; [Lewis, Cora E.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Maschak-Carey, Barbara J.] Univ Penn, Weight & Eating Disorder Program, Philadelphia, PA 19104 USA; [Nathan, David M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Patricio, Jennifer] St Lukes Roosevelt Hosp, Dept Med, New York, NY 10025 USA; [Pi-Sunyer, Xavier] St Lukes Roosevelt Hosp, Dept Med, New York, NY 10025 USA; [Pownall, Henry] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Reboussin, David] Wake Forest Univ, Sch Med, Dept Biostat Sci, Winston Salem, NC 27109 USA; [Regensteiner, Judith G.] Univ Colorado, Hlth Sci Ctr, Ctr Womens Hlth Res, Aurora, CO USA; [Rickman, Amy D.] Univ Pittsburgh, Dept Hlth & Phys Act, Pittsburgh, PA USA; [Ryan, Donna H.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Safford, Monika] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Wadden, Thomas A.] Univ Penn, Weight & Eating Disorder Program, Philadelphia, PA 19104 USA; [Wagenknecht, Lynne E.] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27109 USA; [West, Delia S.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Hlth Behav & Hlth Educ, Little Rock, AR 72205 USA; [Williamson, David F.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Yanovski, Susan Z.] NIDDK, NIH, Bethesda, MD USA	Brown University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; Johns Hopkins Medicine; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Tennessee System; University of Tennessee Health Science Center; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Lifespan Health Rhode Island; Miriam Hospital; Wake Forest University; Baylor College of Medicine; Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Health San Antonio; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Joslin Diabetes Center, Inc.; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital; Mount Sinai St. Luke's; Mount Sinai West; Mount Sinai St. Luke's; Mount Sinai West; Baylor College of Medicine; Wake Forest University; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Pennsylvania Medicine; Wake Forest University; University of Arkansas System; University of Arkansas Medical Sciences; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wing, R (corresponding author), Brown Univ, Warren Alpert Med Sch, Weight Control & Diabet Res Ctr, 196 Richmond St, Providence, RI 02903 USA.	rwing@lifespan.org	Clark, Jeanne/AGG-8199-2022; West, Delia Smith/GWV-5839-2022; Soliman, Elsayed Z/AAD-7135-2020	Clark, Jeanne/0000-0003-1194-0092; West, Delia Smith/0000-0002-4375-2785; Soliman, Elsayed Z/0000-0001-5632-8150; Hill, James/0000-0003-4690-2264; Kahn, Steven/0000-0001-7307-9002; Gregg, Edward/0000-0003-2381-6822; Pownall, Henry/0000-0001-8412-506X; Ryan, Donna/0000-0001-8374-2277; Peters, Anne/0000-0003-0520-0776	National Institutes of Health (NIH); Department of Health and Human Services agencies; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK57136, DK57149, DK56990, DK57177, DK57171, DK57151, DK57182, DK57131, DK57002, DK57078, DK57154, DK57178, DK57219, DK57008, DK57135, DK56992]; Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; National Center on Minority Health and Health Disparities; NIH Office of Research on Women's Health; Centers for Disease Control and Prevention; Johns Hopkins Medical Institutions Bayview General Clinical Research Center [M01RR02719]; Massachusetts General Hospital Mallinckrodt General Clinical Research Center; Massachusetts Institute of Technology General Clinical Research Center [M01RR01066]; University of Colorado Health Sciences Center General Clinical Research Center [M01RR00051]; Clinical Nutrition Research Unit [P30 DK48520]; University of Tennessee at Memphis General Clinical Research Center [M01RR0021140]; University of Pittsburgh General Clinical Research Center [M01RR000056]; Clinical Translational Research Center; Clinical and Translational Science Award [UL1 RR 024153]; NIH [DK 046204]; VA Puget Sound Health Care System Medical Research Service, Department of Veterans Affairs; Frederic C. Bartter General Clinical Research Center [M01RR01346]; FedEx; Health Management Resources; Johnson Johnson; Nestle HealthCare Nutrition; Hoffmann-La Roche; Abbott Nutrition; Unilever North America; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000056, M01RR000051, M01RR001346, M01RR001066, M01RR002719, UL1RR024153] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK057078, U01DK057135, U01DK057154, P30DK017047, U01DK057131, U01DK056990, U01DK057149, U01DK056992, U01DK057136, U01DK057178, U01DK057171, U01DK057008, P30DK048520, U01DK057219, U01DK057182, U01DK057151, U01DK057177, ZIADK075077, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services agencies; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIH Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Johns Hopkins Medical Institutions Bayview General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Massachusetts General Hospital Mallinckrodt General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Massachusetts Institute of Technology General Clinical Research Center; University of Colorado Health Sciences Center General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical Nutrition Research Unit; University of Tennessee at Memphis General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Pittsburgh General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical Translational Research Center; Clinical and Translational Science Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Puget Sound Health Care System Medical Research Service, Department of Veterans Affairs; Frederic C. Bartter General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); FedEx; Health Management Resources; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Nestle HealthCare Nutrition(Nestle SA); Hoffmann-La Roche(Hoffmann-La Roche); Abbott Nutrition(Abbott Laboratories); Unilever North America(Unilever); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the National Institutes of Health (NIH) and other Department of Health and Human Services agencies through cooperative agreements with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK57136, DK57149, DK56990, DK57177, DK57171, DK57151, DK57182, DK57131, DK57002, DK57078, DK57154, DK57178, DK57219, DK57008, DK57135, and DK56992). Additional funding was provided by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; the National Heart, Lung, and Blood Institute; the National Institute of Nursing Research; the National Center on Minority Health and Health Disparities; the NIH Office of Research on Women's Health; and the Centers for Disease Control and Prevention. The Indian Health Service (IHS) provided personnel, medical oversight, and use of facilities. Additional support was provided by the Johns Hopkins Medical Institutions Bayview General Clinical Research Center (M01RR02719); the Massachusetts General Hospital Mallinckrodt General Clinical Research Center and the Massachusetts Institute of Technology General Clinical Research Center (M01RR01066); the University of Colorado Health Sciences Center General Clinical Research Center (M01RR00051) and Clinical Nutrition Research Unit (P30 DK48520); the University of Tennessee at Memphis General Clinical Research Center (M01RR0021140); the University of Pittsburgh General Clinical Research Center(M01RR000056) and Clinical Translational Research Center (funded by a Clinical and Translational Science Award [UL1 RR 024153] and an NIH grant [DK 046204]); the VA Puget Sound Health Care System Medical Research Service, Department of Veterans Affairs; and the Frederic C. Bartter General Clinical Research Center (M01RR01346); and by FedEx, Health Management Resources, Johnson & Johnson, Nestle HealthCare Nutrition, Hoffmann-La Roche, Abbott Nutrition, and Unilever North America.	Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; [Anonymous], 2013, CLIN PRACT REC; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Brancati FL, 2012, CLIN TRIALS, V9, P113, DOI 10.1177/1740774511432726; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Faulconbridge LF, 2012, OBESITY, V20, P783, DOI 10.1038/oby.2011.315; Foster GD, 2009, ARCH INTERN MED, V169, P1619, DOI 10.1001/archinternmed.2009.266; Foy CG, 2011, OBESITY, V19, P83, DOI 10.1038/oby.2010.120; Gregg EW, 2012, JAMA-J AM MED ASSOC, V308, P2489, DOI 10.1001/jama.2012.67929; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; ing R. R., 2004, HDB OBESITY CLIN APP, V2nd, P147; Look Ahead Research Group, 2006, Diab Vasc Dis Res, V3, P202, DOI 10.3132/dvdr.2006.031; Phelan S, 2012, J UROLOGY, V187, P939, DOI 10.1016/j.juro.2011.10.139; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rejeski WJ, 2012, NEW ENGL J MED, V366, P1209, DOI 10.1056/NEJMoa1110294; Romeo S, 2012, DIABETES CARE, V35, P2613, DOI 10.2337/dc12-0193; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wadden TA, 2007, OBESITY, V15, P1339; Wadden TA, 2006, OBESITY, V14, P737; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453; Williamson DF, 1998, EXP CLIN ENDOCR DIAB, V106, P14, DOI 10.1055/s-0029-1212031; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499; Williamson DA, 2009, ARCH INTERN MED, V169, P163, DOI 10.1001/archinternmed.2008.544	26	1611	1643	15	257	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					145	154		10.1056/NEJMoa1212914	http://dx.doi.org/10.1056/NEJMoa1212914			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180BH	23796131	Green Accepted			2022-12-28	WOS:000321567300010
J	Byrd, JC; Furman, RR; Coutre, SE; Flinn, IW; Burger, JA; Blum, KA; Grant, B; Sharman, JP; Coleman, M; Wierda, WG; Jones, JA; Zhao, WQ; Heerema, NA; Johnson, AJ; Sukbuntherng, J; Chang, BY; Clow, F; Hedrick, E; Buggy, JJ; James, DF; O'Brien, S				Byrd, John C.; Furman, Richard R.; Coutre, Steven E.; Flinn, Ian W.; Burger, Jan A.; Blum, Kristie A.; Grant, Barbara; Sharman, Jeff P.; Coleman, Morton; Wierda, William G.; Jones, Jeffrey A.; Zhao, Weiqiang; Heerema, Nyla A.; Johnson, Amy J.; Sukbuntherng, Juthamas; Chang, Betty Y.; Clow, Fong; Hedrick, Eric; Buggy, Joseph J.; James, Danelle F.; O'Brien, Susan			Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRUTONS TYROSINE KINASE; B-CELL MALIGNANCIES; ANTIGEN RECEPTOR; SURVIVAL SIGNALS; KAPPA-B; FLUDARABINE; INHIBITOR; ACTIVATION; PCI-32765; RITUXIMAB	BACKGROUND The treatment of relapsed chronic lymphocytic leukemia (CLL) has resulted in few durable remissions. Bruton's tyrosine kinase (BTK), an essential component of B-cell-receptor signaling, mediates interactions with the tumor microenvironment and promotes the survival and proliferation of CLL cells. METHODS We conducted a phase 1b-2 multicenter study to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of ibrutinib (PCI-32765), a first-in-class, oral covalent inhibitor of BTK designed for treatment of B-cell cancers, in patients with relapsed or refractory CLL or small lymphocytic lymphoma. A total of 85 patients, the majority of whom were considered to have high-risk disease, received ibrutinib orally once daily; 51 received 420 mg, and 34 received 840 mg. RESULTS Toxic effects were predominantly grade 1 or 2 and included transient diarrhea, fatigue, and upper respiratory tract infection; thus, patients could receive extended treatment with minimal hematologic toxic effects. The overall response rate was the same in the group that received 420 mg and the group that received 840 mg (71%), and an additional 20% and 15% of patients in the respective groups had a partial response with lymphocytosis. The response was independent of clinical and genomic risk factors present before treatment, including advanced-stage disease, the number of previous therapies, and the 17p13.1 deletion. At 26 months, the estimated progression-free survival rate was 75% and the rate of overall survival was 83%. CONCLUSIONS Ibrutinib was associated with a high frequency of durable remissions in patients with relapsed or refractory CLL and small lymphocytic lymphoma, including patients with high-risk genetic lesions.	[Byrd, John C.; Blum, Kristie A.; Jones, Jeffrey A.; Johnson, Amy J.] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA; [Zhao, Weiqiang; Heerema, Nyla A.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Furman, Richard R.; Coleman, Morton] Weill Cornell Med Coll, Dept Med, Div Hematol, New York, NY USA; [Coutre, Steven E.] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Coutre, Steven E.] Stanford Univ, Sch Med, Stanford Canc Ctr, Stanford, CA 94305 USA; [Sukbuntherng, Juthamas; Chang, Betty Y.; Clow, Fong; Hedrick, Eric; Buggy, Joseph J.; James, Danelle F.] Pharmacyclics, Sunnyvale, CA USA; [Flinn, Ian W.] Sarah Cannon Res Inst, Nashville, TN USA; [Burger, Jan A.; Wierda, William G.; O'Brien, Susan] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Grant, Barbara] Univ Vermont, Vermont Canc Ctr, Burlington, VT 05405 USA; [Sharman, Jeff P.] Willamette Valley Canc Inst & Res Ctr, Springfield, OR USA; [Sharman, Jeff P.] US Oncol Res, Springfield, OR USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cornell University; Stanford University; Stanford Cancer Institute; Stanford University; Pharmacyclics; Sarah Cannon Research Institute; University of Texas System; UTMD Anderson Cancer Center; University of Vermont; US Oncology Network	Byrd, JC (corresponding author), Ohio State Univ, Div Hematol, B305 Starling Loving Hall,320 W 10th Ave, Columbus, OH 43210 USA.	john.byrd@osumc.edu	Jones, Jeffrey A/E-9827-2013; Jones, Jeffrey A/E-3321-2011; Zhao, Weiqiang/E-4368-2011; Blum, Kristie/E-2768-2011	Coutre, Steven/0000-0001-8420-5748; Flinn, Ian/0000-0001-6724-290X	Pharmacyclics; Janssen; Leukemia and Lymphoma Society; D. Warren Brown Foundation; Harry T. Mangurian, Jr., Foundation; National Institutes of Health [P50 CA140158, P01 CA095426]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA177292, P01CA095426, P30CA016058, K12CA133250, P50CA140158, P01CA081534] Funding Source: NIH RePORTER	Pharmacyclics; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); D. Warren Brown Foundation; Harry T. Mangurian, Jr., Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Pharmacyclics and others; ClinicalTrials.gov number, NCT01105247.; Supported by Pharmacyclics, Janssen, and grants from the Leukemia and Lymphoma Society, the D. Warren Brown Foundation, Mr. and Mrs. Michael Thomas, the Harry T. Mangurian, Jr., Foundation, and the National Institutes of Health (P50 CA140158 and P01 CA095426).	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Bernal A, 2001, BLOOD, V98, P3050, DOI 10.1182/blood.V98.10.3050; Burger JA, 2011, HEMATOL-AM SOC HEMAT, P96, DOI 10.1182/asheducation-2011.1.96; Byrd JC, 2005, BLOOD, V105, P49, DOI 10.1182/blood-2004-03-0796; Byrd JC, 2006, J CLIN ONCOL, V24, P437, DOI 10.1200/JCO.2005.03.1021; Chen LG, 2002, BLOOD, V100, P4609, DOI 10.1182/blood-2002-06-1683; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cheson BD, 2012, J CLIN ONCOL, V30, P2820, DOI 10.1200/JCO.2012.43.3748; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Craxton A, 1999, J BIOL CHEM, V274, P30644, DOI 10.1074/jbc.274.43.30644; Dal-Bo M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-76; Gobessi S, 2007, BLOOD, V109, P2032, DOI 10.1182/blood-2006-03-011759; Gribben JG, 2011, J CLIN ONCOL, V29, P544, DOI 10.1200/JCO.2010.32.3865; Hallek, 2008, BLOOD, V112, P5259; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hallek M, 2012, BLOOD; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2012, BLOOD, V119, P5059, DOI 10.1182/blood-2012-04-413096; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Herman SEM, 2010, BLOOD, V116, P2078, DOI 10.1182/blood-2010-02-271171; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Jaffe ES, 2008, BLOOD, V112, P4384, DOI 10.1182/blood-2008-07-077982; Keating MJ, 2002, BLOOD, V99, P3554, DOI 10.1182/blood.V99.10.3554; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Perkins JG, 2002, CANCER-AM CANCER SOC, V94, P2033, DOI 10.1002/cncr.0680; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; Petro JB, 2001, J BIOL CHEM, V276, P1715, DOI 10.1074/jbc.M009137200; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Ringshausen I, 2002, BLOOD, V100, P3741, DOI 10.1182/blood-2002-02-0539; Sanchez-Aguilera A, 2010, LEUKEMIA, V24, P97, DOI 10.1038/leu.2009.217; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; Tam CS, 2008, BLOOD, V112, P975, DOI 10.1182/blood-2008-02-140582; Tomlinson M G, 2001, BMC Immunol, V2, P4, DOI 10.1186/1471-2172-2-4; Wierda WG, 2010, J CLIN ONCOL, V28, P1749, DOI 10.1200/JCO.2009.25.3187	39	1662	1739	8	265	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					32	42		10.1056/NEJMoa1215637	http://dx.doi.org/10.1056/NEJMoa1215637			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175WE	23782158	Green Accepted, Bronze			2022-12-28	WOS:000321263500008
J	Flood, TF; Iguchi, S; Gorczyca, M; White, B; Ito, K; Yoshihara, M				Flood, Thomas F.; Iguchi, Shinya; Gorczyca, Michael; White, Benjamin; Ito, Kei; Yoshihara, Motojiro			A single pair of interneurons commands the Drosophila feeding motor program	NATURE			English	Article							NEURONAL-SYNAPTOBREVIN; EXPRESSION; BEHAVIOR; REVEALS; RELEASE; PROTEIN; BRAIN; CELLS; GAL4	Many feeding behaviours are the result of stereotyped, organized sequences of motor patterns. These patterns have been the subject of neuroethological studies(1,2), such as electrophysiological characterization of neurons governing prey capture in toads(1,3). However, technical limitations have prevented detailed study of the functional role of these neurons, a common problem for vertebrate organisms. Complexities involved in studies of whole-animal behaviour can be resolved in Drosophila, in which remote activation of brain cells by genetic means(4) enables us to examine the nervous system in freely moving animals to identify neurons that govern a specific behaviour, and then to repeatedly target and manipulate these neurons to characterize their function. Here we show neurons that generate the feeding motor program in Drosophila. We carried out an unbiased screen using remote neuronal activation and identified a critical pair of brain cells that induces the entire feeding sequence when activated. These 'feeding neurons' (here abbreviated to Fdg neurons for brevity) are also essential for normal feeding as their suppression or ablation eliminates sugar-induced feeding behaviour. Activation of a single Fdg neuron induces asymmetric feeding behaviour and ablation of a single Fdg neuron distorts the sugar-induced feeding behaviour to become asymmetric, indicating the direct role of these neurons in shaping motor-program execution. Furthermore, recording neuronal activity and calcium imaging simultaneously during feeding behaviour(5) reveals that the Fdg neurons respond to food presentation, but only in starved flies. Our results demonstrate that Fdg neurons operate firmly within the sensorimotor watershed, downstream of sensory and metabolic cues and at the top of the feeding motor hierarchy, to execute the decision to feed.	[Flood, Thomas F.; Iguchi, Shinya; Gorczyca, Michael; Yoshihara, Motojiro] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [White, Benjamin] NIMH, Mol Biol Lab, Bethesda, MD 20892 USA; [Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Tokyo	Yoshihara, M (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	Motojiro.Yoshihara@umassmed.edu			National Institute of Mental Health [MH85958]; Worcester Foundation; National Institute of Mental Health Intramural Research Program; Japan Society for the Promotion of Science/National Science Foundation; Japan Science and Technology Agency CREST grant; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002800, R01MH085958] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Worcester Foundation; National Institute of Mental Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Japan Society for the Promotion of Science/National Science Foundation(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency CREST grant(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Waddell for discussions, fly stocks and reading of the manuscript; T. Lee for discussions and fly stocks; A. Sakurai for reading of the manuscript; S. Reppert for support; M. Alkema and T. Ip for discussions; members of the NP consortium for NP lines; T. Awasaki., C. Kao, V. Budnik, P. Garrity, M. Freeman, M. Rosbash, Y.-N. Jan, L. Luo, S. Sigrist, K. Scott, T. Tanimura, L. Looger, M. Ramaswami and K. Gajewski for fly stocks; K. Ikeda, T. Tanimura and H. Ishimoto for technical advices; A. Taylor and R. Seeham for technical help; and N. Yoshihara for material information. This work was supported by National Institute of Mental Health Grant MH85958, and the Worcester Foundation (to M.Y.), the National Institute of Mental Health Intramural Research Program(B. W.), the summer program of the Japan Society for the Promotion of Science/National Science Foundation (to T. F. F.), and a Japan Science and Technology Agency CREST grant (to K.I.).	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Dethier VG, 1976, HUNGRY FLY; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Ewert JP, 1997, TRENDS NEUROSCI, V20, P332; Ferris GF, 1950, BIOL DROSOPHILA, P368; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Gajewski KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010713; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; HAGIWARA S, 1978, J PHYSIOL-LONDON, V279, P167, DOI 10.1113/jphysiol.1978.sp012338; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leiss F, 2009, DEV NEUROBIOL, V69, P221, DOI 10.1002/dneu.20699; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Manzo A, 2012, P NATL ACAD SCI USA, V109, P6307, DOI 10.1073/pnas.1120305109; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; MATSUSHIMA T, 1989, J COMP PHYSIOL A, V166, P7; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miller A., 1950, BIOL DROSOPHILA, P420; Miyazaki T, 2010, J COMP NEUROL, V518, P4147, DOI 10.1002/cne.22433; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Peabody NC, 2009, J NEUROSCI, V29, P3343, DOI 10.1523/JNEUROSCI.4241-08.2009; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shiraiwa Takashi, 2007, J Vis Exp, P193, DOI 10.3791/193; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tinbergen N, 1989, STUDY INSTINCT; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; WIERSMA CAG, 1964, COMP BIOCHEM PHYSIOL, V12, P509, DOI 10.1016/0010-406X(64)90153-7; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yoshihara M, 1997, J NEUROSCI, V17, P8408; Yoshihara M, 1999, J NEUROSCI, V19, P2432; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Yoshihara M., 2000, DROS INFORM SERV, V83, P199; Yoshihara M, 2012, JOVE-J VIS EXP, DOI 10.3791/3625; Zar JH., 1999, BIOSTAT ANAL, V663rd	46	83	83	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					83	+		10.1038/nature12208	http://dx.doi.org/10.1038/nature12208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23748445	Green Accepted			2022-12-28	WOS:000321285600038
J	Park, SH; Kukushkin, Y; Gupta, R; Chen, T; Konagai, A; Hipp, MS; Hayer-Hartl, M; Hartl, FU				Park, Sae-Hun; Kukushkin, Yury; Gupta, Rajat; Chen, Taotao; Konagai, Ayano; Hipp, Mark S.; Hayer-Hartl, Manajit; Hartl, F. Ulrich			PolyQ Proteins Interfere with Nuclear Degradation of Cytosolic Proteins by Sequestering the Sis1p Chaperone	CELL			English	Article							UBIQUITIN-PROTEASOME SYSTEM; SPINOCEREBELLAR ATAXIA TYPE-3; QUALITY-CONTROL; MOLECULAR CHAPERONES; POLYGLUTAMINE EXPANSION; AGGREGATION; YEAST; TOXICITY; DISEASE; STRESS	Dysfunction of protein quality control contributes to the cellular pathology of polyglutamine (polyQ) expansion diseases and other neurodegenerative disorders associated with aggregate deposition. Here we analyzed how polyQ aggregation interferes with the clearance of misfolded proteins by the ubiquitin-proteasome system (UPS). We show in a yeast model that polyQ-expanded proteins inhibit the UPS-mediated degradation of misfolded cytosolic carboxypeptidase Y* fused to green fluorescent protein (GFP) (CG*) without blocking ubiquitylation or proteasome function. Quantitative proteomic analysis reveals that the polyQ aggregates sequester the low-abundant and essential Hsp40 chaperone Sis1p. Overexpression of Sis1p restores CG* degradation. Surprisingly, we find that Sis1p, and its homolog DnaJB1 in mammalian cells, mediates the delivery of misfolded proteins into the nucleus for proteasomal degradation. Sis1p shuttles between cytosol and nucleus, and its cellular level limits the capacity of this quality control pathway. Upon depletion of Sis1p by polyQ aggregation, misfolded proteins are barred from entering the nucleus and form cytoplasmic inclusions.	[Park, Sae-Hun; Kukushkin, Yury; Gupta, Rajat; Chen, Taotao; Konagai, Ayano; Hipp, Mark S.; Hayer-Hartl, Manajit; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82159 Martinsried, Germany	Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82159 Martinsried, Germany.	uhartl@biochem.mpg.de	Hipp, Mark/AAA-4238-2022; Hayer-Hartl, Manajit/V-8078-2017; Hartl, F. Ulrich/Y-8206-2019	Hayer-Hartl, Manajit/0000-0001-8213-6742; Park, Sae-Hun/0000-0002-8277-0732; Hipp, Mark/0000-0002-0497-3016; gupta, rajat/0000-0002-9743-1995	Deutsche Forschungsgemeinschaft [SFB 596]; Human Frontier Science Program [HFSP RGP0048/2011]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program)	We thank J. Buchner, E.A. Craig, D. Cyr, C. Enenkel, S. Jentsch, W.K. Huh, R.R. Kopito, A. Varshavsky, and D. Wolf for reagents. R.M. Vabulas, A. Woerner, and S.A. Broadley constructed the plasmids pUb-GFP, pNES-LG*, pNLS-LG*, and p20Q and p96Q, respectively. Support by the Deutsche Forschungsgemeinschaft (SFB 596) and the Human Frontier Science Program (HFSP RGP0048/2011) is acknowledged.	Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Chai YH, 1999, J NEUROSCI, V19, P10338; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2010, CURR OPIN STRUC BIOL, V20, P23, DOI 10.1016/j.sbi.2009.11.001; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hines JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001309; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Juretschke J, 2010, BIOCHEM BIOPH RES CO, V397, P447, DOI 10.1016/j.bbrc.2010.05.123; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Seidel K, 2012, NEUROPATH APPL NEURO, V38, P548, DOI 10.1111/j.1365-2990.2011.01220.x; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Summers DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052099; Summers DW, 2009, PRION, V3, P59, DOI 10.4161/pri.3.2.9062; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Yan W, 1999, MOL CELL BIOL, V19, P7751; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zijlstra MP, 2010, EUR J NEUROSCI, V32, P760, DOI 10.1111/j.1460-9568.2010.07352.x	45	246	248	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					134	145		10.1016/j.cell.2013.06.003	http://dx.doi.org/10.1016/j.cell.2013.06.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23791384	Bronze			2022-12-28	WOS:000321327900015
J	Sessums, LL; Jackson, JL				Sessums, Laura L.; Jackson, Jeffrey L.			Care of Returning Military Personnel	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; SUBSTANCE USE DISORDERS; MENTAL-HEALTH; PRIMARY-CARE; IRAQI FREEDOM; MILITARY; VETERANS; DEPRESSION; DEPLOYMENT; DIARRHEA						Jackson, Jeffrey/AAA-3519-2019	Jackson, Jeffrey/0000-0002-9820-5834				[Anonymous], 2011, WAR PREVENTING SUICI; Aronson NE, 2006, CLIN INFECT DIS, V43, P1045, DOI 10.1086/507539; Bagalman E, 2011, MENTAL DISORDERS OEF; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brown DW, 2010, J GEN INTERN MED, V25, P147, DOI 10.1007/s11606-009-1160-0; Bryan CJ, 2013, J AFFECT DISORDERS, V144, P148, DOI 10.1016/j.jad.2012.06.030; Cohen SP, 2010, LANCET, V375, P301, DOI 10.1016/S0140-6736(09)61797-9; Connor BA, 2005, CLIN INFECT DIS, V41, pS577, DOI 10.1086/432956; Eidelson R, 2011, AM PSYCHOL, V66, P643, DOI 10.1037/a0025272; ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971; Fischer H., 2010, US MILITARY CASUALTY; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Granado NS, 2009, HYPERTENSION, V54, P966, DOI 10.1161/HYPERTENSIONAHA.109.132555; Hawkins EJ, 2012, MIL MED, V177, P29, DOI 10.7205/MILMED-D-12-00125; Hermann BA, 2012, MIL MED, V177, P1; Institute for Clinical Systems Improvement, 2019, PAIN ASS NON TREATM; Jackson JL, 2007, PSYCHOSOM MED, V69, P270, DOI 10.1097/PSY.0b013e3180314b59; Jackson JL, 1999, MIL MED, V164, P112, DOI 10.1093/milmed/164.2.112; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jakupcak M, 2010, ADDICT BEHAV, V35, P840, DOI 10.1016/j.addbeh.2010.03.023; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kung S, 2012, MAYO CLIN PROC, V87, P890, DOI 10.1016/j.mayocp.2012.05.015; Leland Anne, 2010, AM WAR MILITARY OPER; Lester P. B., 2011, COMPREHENSIVE SOLDIE; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; Martin M, 2009, J TRAUMA, V66, pS51, DOI 10.1097/TA.0b013e31819d86ad; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; MULROW CD, 1995, ANN INTERN MED, V122, P913, DOI 10.7326/0003-4819-122-12-199506150-00004; *NAT RES COUNC, 2012, TREATM POSTTR STRESS; National Research Council, 2012, SUBST US DIS US ARM; National Research Council, 2008, GULF WAR AND HLTH, V7; National Research Council, 2011, LONG TERM HLTH CONS; National Research Council, 2006, NOIS MIL SERV IMPL H; *OFF PUBL HLTH VET, 2011, AN VA HLTH CARE UT O; *PRE DEPT HLTH ASS, 2007, DEF TECHN INF CTR; Putnam SD, 2006, J TRAVEL MED, V13, P92, DOI 10.1111/j.1708-8305.2006.00020.x; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Smith B, 2008, AM J PREV MED, V35, P539, DOI 10.1016/j.amepre.2008.07.009; Smith SL, 2013, J BEHAV HEALTH SER R, V40, P242, DOI 10.1007/s11414-012-9302-2; Smith TC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-340; US Department of Veterans Affairs and US Department of Defense, 2009, VA DOD CLIN PRACT GU; *US DEPT DEF, 2011, ACT DUT MIL PERS STR; *US DEPT DEF, 2012, DEM 2011 PROF MIL CO; *US DEPT DEF, 2011, DEP DEF INSTR NUMB 6; *US DEPT DEF, 2010, DEP DEF INSTR NUMB 6; *US NAVY, 2012, MAN MED MENT MANM NA; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Warner CH, 2011, AM J PSYCHIAT, V168, P378, DOI 10.1176/appi.ajp.2010.10091303; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Wisco BE, 2012, MIL MED, V177, P7, DOI 10.7205/MILMED-D-12-00111; Zoroya G, 2010, US TODAY	54	4	4	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 2	2013	159	1					ITC1	ITC14		10.7326/0003-4819-159-1-201307020-01001	http://dx.doi.org/10.7326/0003-4819-159-1-201307020-01001			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NP	23817720				2022-12-28	WOS:000209756000002
J	Rawlins, M				Rawlins, Michael			NICE times: a valedictory dispatch	LANCET			English	Editorial Material									Natl Inst Hlth & Clin Excellence, London SW1A 2BU, England	National Institute for Health & Care Excellence	Rawlins, M (corresponding author), Natl Inst Hlth & Clin Excellence, London SW1A 2BU, England.	michael.rawlins@nice.org.uk						[Anonymous], 2013, LANCET, V381, P268; Parris Matthew, 2011, PARTING SHOTS; Rawlins MD, 2013, CLIN MED, V13, P13, DOI 10.7861/clinmedicine.13-1-13	3	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 29	2013	381	9885					2225	2227		10.1016/S0140-6736(13)61250-7	http://dx.doi.org/10.1016/S0140-6736(13)61250-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173SU	23809547				2022-12-28	WOS:000321100300004
J	Pedaste, M; de Jong, T; Sarapuu, T; Piksoot, J; van Joolingen, WR; Giemza, A				Pedaste, Margus; de Jong, Ton; Sarapuu, Tago; Piksoeoet, Jaanika; van Joolingen, Wouter R.; Giemza, Adam			Investigating Ecosystems as a Blended Learning Experience	SCIENCE			English	Editorial Material									[Pedaste, Margus; Sarapuu, Tago; Piksoeoet, Jaanika] Univ Tartu, EE-50103 Tartu, Estonia; [de Jong, Ton; van Joolingen, Wouter R.] Univ Twente, NL-7500 AE Enschede, Netherlands; [Giemza, Adam] Univ Duisburg Essen, D-47048 Duisburg, Germany	University of Tartu; University of Twente; University of Duisburg Essen	Pedaste, M (corresponding author), Univ Tartu, EE-50103 Tartu, Estonia.	margus.pedaste@ut.ee	van Joolingen, Wouter/AAD-8970-2019; Pedaste, Margus/H-3139-2012	van Joolingen, Wouter/0000-0002-4271-2861; Pedaste, Margus/0000-0002-5087-9637; Piksoot, Jaanika/0000-0002-0420-5850				de Jong T, 2012, ETR&D-EDUC TECH RES, V60, P883, DOI 10.1007/s11423-012-9258-1; de Jong T, 2010, BRIT J EDUC TECHNOL, V41, P909, DOI 10.1111/j.1467-8535.2010.01121.x	2	8	8	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1537	1538		10.1126/science.1229908	http://dx.doi.org/10.1126/science.1229908			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172ME	23812708				2022-12-28	WOS:000321007000029
J	van der Meer, JWM; Netea, MG				van der Meer, Jos W. M.; Netea, Mihai G.			A Salty Taste to Autoimmunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6525 ED Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van der Meer, JWM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6525 ED Nijmegen, Netherlands.		Netea, Mihai/N-5155-2014; van der Meer, Jos W.M./C-8521-2013	van der Meer, Jos W.M./0000-0001-5120-3690				Charalambous MP, 2008, SURG INFECT, V9, P67, DOI 10.1089/sur.2005.069; delaSierra A, 1996, CLIN SCI, V91, P155, DOI 10.1042/cs0910155; Kleinewietfeld M, 2013, NATURE; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Wu C, 2013, NATURE	5	39	39	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2520	2521		10.1056/NEJMcibr1303292	http://dx.doi.org/10.1056/NEJMcibr1303292			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23802520				2022-12-28	WOS:000320926900017
J	McMurdo, M				McMurdo, Marion			Clinical research must include more older people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEART-FAILURE; TRIALS; GUIDELINES; EXCLUSION; DISEASES		Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland	University of Dundee	McMurdo, M (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland.	m.e.t.mcmurdo@dundee.ac.uk						Age UK, 2013, IMPR LAT LIF UND OLD; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Cherubini A, 2011, ARCH INTERN MED, V171, P550, DOI 10.1001/archinternmed.2011.31; Fitzsimmons PR, 2012, PARKINSONISM RELAT D, V18, P585, DOI 10.1016/j.parkreldis.2012.03.003; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; McMurdo MET, 2011, AGE AGEING, V40, P659, DOI 10.1093/ageing/afr115; National Institute for Health Research Clinical Research Coordinating Centre, 2010, EQ CLIN RES INCL OLD; Taylor JS, 2012, J AM GERIATR SOC, V60, P413, DOI 10.1111/j.1532-5415.2011.03847.x; Wang OJ, 2009, EUR J HEART FAIL, V11, P1021, DOI 10.1093/eurjhf/hfp137; WENGER NK, 1993, INCLUSION ELDERLY IN	12	7	7	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2013	346								f3899	10.1136/bmj.f3899	http://dx.doi.org/10.1136/bmj.f3899			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171RC	23794156				2022-12-28	WOS:000320945700002
J	Drake, T; Rustom, J; Davies, M				Drake, Tamsin; Rustom, Jane; Davies, Melissa			Phimosis in childhood	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Drake, Tamsin; Davies, Melissa] Salisbury Dist Hosp, Salisbury, Wilts, England; [Rustom, Jane; Davies, Melissa] New St Surg, Salisbury, England	Salisbury District Hospital	Drake, T (corresponding author), Salisbury Dist Hosp, Salisbury, Wilts, England.	tamsindrake@hotmail.com							0	3	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2013	346								f3678	10.1136/bmj.f3678	http://dx.doi.org/10.1136/bmj.f3678			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171QP	23788454				2022-12-28	WOS:000320944400004
J	O'Neill, D				O'Neill, Desmond			Should patients with dementia who wander be electronically tagged? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ETHICS; PEOPLE; CARE		Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland.	doneill@tcd.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				Algase DL, 2007, AGING MENT HEALTH, V11, P686, DOI 10.1080/13607860701366434; Cahill S., 2007, T D, V19, P55, DOI [10.3233/TAD-2007-192-302, DOI 10.3233/TAD-2007-192-302]; Chodosh J, 2007, J AM GERIATR SOC, V55, P1260, DOI 10.1111/j.1532-5415.2007.01249.x; Hughes JC, 2002, J ROY SOC MED, V95, P242, DOI 10.1258/jrsm.95.5.242; Kitwood T., 1997, DEMENTIA RECONSIDERE; Landau R, 2010, INT PSYCHOGERIATR, V22, P1301, DOI 10.1017/S1041610210001316; Niemeijer AR, 2010, INT PSYCHOGERIATR, V22, P1129, DOI 10.1017/S1041610210000037; O'Neill D, 1997, IRISH J PSYCHOL MED, V14, P121, DOI 10.1017/S079096670000330X; O'Neill DJ, 2003, BRIT MED J, V326, P281; ONeil M.E., 2011, SYSTEMATIC EVIDENCE; Petonito G, 2013, GERONTOLOGIST, V53, P17, DOI 10.1093/geront/gns060; Robinson L, 2007, HEALTH RISK SOC, V9, P389, DOI 10.1080/13698570701612774; Silverstein N., 2002, DEMENTIA WANDERING B; Padilla DV, 2013, INT PSYCHOGERIATR, V25, P500, DOI 10.1017/S1041610212001810	14	10	10	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2013	346								f3606	10.1136/bmj.f3606	http://dx.doi.org/10.1136/bmj.f3606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171QP	23794097				2022-12-28	WOS:000320944400003
J	Smalley, DE; Smithwick, QYJ; Bove, VM; Barabas, J; Jolly, S				Smalley, D. E.; Smithwick, Q. Y. J.; Bove, V. M., Jr.; Barabas, J.; Jolly, S.			Anisotropic leaky-mode modulator for holographic video displays	NATURE			English	Article							WAVE	Every holographic video display is built on a spatial light modulator, which directs light by diffraction to form points in three-dimensional space. The modulators currently used for holographic video displays are challenging to use for several reasons: they have relatively low bandwidth, high cost, low diffraction angle, poor scalability, and the presence of quantization noise, unwanted diffractive orders and zero-order light. Here we present modulators for holographic video displays based on anisotropic leaky-mode couplers, which have the potential to address all of these challenges. These modulators can be fabricated simply, monolithically and at low cost. Additionally, these modulators are capable of new functionalities, such as wavelength division multiplexing for colour display. We demonstrate three enabling properties of particular interest-polarization rotation, enlarged angular diffraction, and frequency domain colour filtering-and suggest that this technology can be used as a platform for low-cost, high-performance holographic video displays.	[Smalley, D. E.; Smithwick, Q. Y. J.; Bove, V. M., Jr.; Barabas, J.; Jolly, S.] MIT, Media Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Smalley, DE (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	desmalley@gmail.com			NVIDIA	NVIDIA	This work was supported by consortium funding at the MIT Media Lab and by Intel Corp. Graphics hardware was provided by NVIDIA. D. E. S. thanks the MIT Nanostructures Laboratory for use of its facilities, E. Pearson for discussion, and D. Novy for assistance with GPU coding.	Barabas J., 2009, P SPIE PRACTICAL HOL, VXXIII; Bove V., 2005, P SPIE STEREOSC DISP, VXII; Chen GL, 2007, OPT EXPRESS, V15, P8851, DOI 10.1364/OE.15.008851; Do NT, 1999, ULTRASON, P613, DOI 10.1109/ULTSYM.1999.849474; Haussier R., 2008, P SPIE STEREOSC DISP, VXIX; Ito K, 1998, JPN J APPL PHYS 1, V37, P4858, DOI 10.1143/JJAP.37.4858; JACKEL JL, 1982, APPL PHYS LETT, V41, P607, DOI 10.1063/1.93615; Kreis T, 2001, OPT ENG, V40, P926, DOI 10.1117/1.1367346; Lee HW, 1938, NATURE, V142, P59, DOI 10.1038/142059a0; Matteo AR, 2000, IEEE T ULTRASON FERR, V47, P16, DOI 10.1109/58.818745; OHMACHI Y, 1977, IEEE J QUANTUM ELECT, V13, P43, DOI 10.1109/JQE.1977.1069276; ONURAL L, 1991, ULTRASON, P543, DOI 10.1109/ULTSYM.1991.234222; Pearson E., 2001, THESIS MIT; PROKLOV VV, 1992, ULTRASON, P173, DOI 10.1109/ULTSYM.1992.276041; Rust U., 1992, OSA TECHNICAL DIGEST, V10; SATO K, 2006, P SPIE PRACTICAL HOL, V20, P6136; Smalley D, 2013, J PHYS CONF SER, V415, DOI 10.1088/1742-6596/415/1/012055; Smithwick QYJ, 2010, PROC SPIE, V7619, DOI 10.1117/12.840526; SOHLER W, 1989, THIN SOLID FILMS, V175, P191, DOI 10.1016/0040-6090(89)90827-4; STHILAIRE P, 1992, J OPT SOC AM A, V9, P1969, DOI 10.1364/JOSAA.9.001969	20	153	174	3	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					313	+		10.1038/nature12217	http://dx.doi.org/10.1038/nature12217			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23783627				2022-12-28	WOS:000320592900030
J	Kullgren, JT; Duey, KA; Werner, RM				Kullgren, Jeffrey T.; Duey, Katia A.; Werner, Rachel M.			A Census of State Health Care Price Transparency Websites	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kullgren, Jeffrey T.] Vet Affairs Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, Ann Arbor, MI 48105 USA; [Duey, Katia A.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Werner, Rachel M.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Kullgren, JT (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, Ann Arbor, MI 48105 USA.	jkullgre@med.umich.edu		Werner, Rachel/0000-0003-3435-4221				[Anonymous], KAISER HEALTH NEWS; Hibbard JH, 2008, ANN INTERN MED, V148, P160, DOI 10.7326/0003-4819-148-2-200801150-00011; Martinez ME, 2012, HEALTH INSURANCE COV; Mehrotra A, 2012, HEALTH AFFAIR, V31, P843, DOI 10.1377/hlthaff.2011.1181; National Conference of State Legislatures, STATE AND FEDERAL AC; Sinaiko AD, 2011, NEW ENGL J MED, V364, P891, DOI 10.1056/NEJMp1100041	6	31	31	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2437	2438		10.1001/jama.2013.6557	http://dx.doi.org/10.1001/jama.2013.6557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23780454	Bronze			2022-12-28	WOS:000320505100019
J	Bartsch, P; Swenson, ER				Baertsch, Peter; Swenson, Erik R.			Acute High-Altitude Illnesses	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MOUNTAIN-SICKNESS; PULMONARY-EDEMA; EXERCISE PERFORMANCE; NORMOBARIC HYPOXIA; CONTROLLED-TRIAL; DOUBLE-BLIND; PREVENTION; ASCENT; ACETAZOLAMIDE; PROPHYLAXIS	A 45-year-old healthy man wishes to climb Mount Kilimanjaro (5895 m) in a 5-day period, starting at 1800 m. The results of a recent exercise stress test were normal; he runs 10 km 4 or 5 times per week and finished a marathon in less than 4 hours last year. He wants to know how he can prevent becoming ill at high altitude and whether training or sleeping under normobaric hypoxic conditions in the weeks before the ascent would be helpful. What would you advise?	[Baertsch, Peter] Univ Clin, Dept Internal Med, Div Sports Med 7, D-69120 Heidelberg, Germany; [Swenson, Erik R.] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Dept Med, Seattle, WA 98195 USA	Ruprecht Karls University Heidelberg; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Bartsch, P (corresponding author), Univ Clin, Dept Internal Med, Div Sports Med 7, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	peter.bartsch@med.uni-heidelberg.de	Canoui-Poitrine, Florence/R-4474-2018	Canoui-Poitrine, Florence/0000-0001-9970-6051	Merck Sharp Dohme; Bayer HealthCare; Linde Group	Merck Sharp Dohme(Merck & Company); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Linde Group	Dr. Bartsch reports receiving lecture fees from Merck Sharp & Dohme and Bayer HealthCare and payment to his institution for meeting expenses from the Linde Group. No other potential conflict of interest relevant to this article was reported.	BARTSCH P, 1990, J WILDERNESS MED, V1, P162, DOI 10.1580/0953-9859-1.3.162; Bartsch P, 2001, LUNG BIOL HEALTH DIS, V161, P731; Bartsch P, 2002, LANCET, V360, P571, DOI 10.1016/S0140-6736(02)09723-4; BARTSCH P, 1991, NEW ENGL J MED, V325, P1284, DOI 10.1056/NEJM199110313251805; BARTSCH P, 1993, BRIT MED J, V306, P1098, DOI 10.1136/bmj.306.6885.1098; Basnyat B, 2003, HIGH ALT MED BIOL, V4, P45, DOI 10.1089/152702903321488979; Beidleman BA, 2009, HIGH ALT MED BIOL, V10, P253, DOI 10.1089/ham.2009.1004; BROOME JR, 1994, AVIAT SPACE ENVIR MD, V65, P19; Burtscher M, 1998, BRIT MED J, V316, P1057; Burtscher M, 2004, HIGH ALT MED BIOL, V5, P335, DOI 10.1089/ham.2004.5.335; Dehnert C, 2005, EUR RESPIR J, V25, P545, DOI 10.1183/09031936.05.00070404; ELLSWORTH AJ, 1987, AM J MED, V83, P1024, DOI 10.1016/0002-9343(87)90937-5; FERRAZZINI G, 1987, BRIT MED J, V294, P1380, DOI 10.1136/bmj.294.6584.1380; Fulco CS, 2011, AM J PHYSIOL-REG I, V300, pR428, DOI 10.1152/ajpregu.00633.2010; Fulco CS, 1998, AVIAT SPACE ENVIR MD, V69, P793; Gertsch JH, 2012, WILD ENVIRON MED, V23, P307, DOI 10.1016/j.wem.2012.08.001; Grunig E, 2009, CIRCULATION, V119, P1747, DOI 10.1161/CIRCULATIONAHA.108.800938; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; HONIGMAN B, 1993, ANN INTERN MED, V118, P587, DOI 10.7326/0003-4819-118-8-199304150-00003; Hultgren HN, 1996, WESTERN J MED, V164, P222; Imray C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4943; Kallenberg K, 2008, J CEREBR BLOOD F MET, V28, P1635, DOI 10.1038/jcbfm.2008.55; Kayser B, 2008, HIGH ALT MED BIOL, V9, P15, DOI 10.1089/ham.2007.1037; Lipman GS, 2012, ANN EMERG MED, V59, P484, DOI 10.1016/j.annemergmed.2012.01.019; Low EV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6779; Luks AM, 2007, EUR RESPIR J, V29, P770, DOI 10.1183/09031936.00052606; Luks AM, 2012, HIGH ALT MED BIOL, V13, P147, DOI 10.1089/ham.2012.1055; Luks AM, 2010, WILD ENVIRON MED, V21, P146, DOI 10.1016/j.wem.2010.03.002; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; Maggiorini M, 2001, CIRCULATION, V103, P2078; Maggiorini M, 2006, ANN INTERN MED, V145, P497, DOI 10.7326/0003-4819-145-7-200610030-00007; MILLEDGE JS, 1991, EUR RESPIR J, V4, P1000; MONTGOMERY AB, 1989, JAMA-J AM MED ASSOC, V261, P734, DOI 10.1001/jama.261.5.734; Muza SR, 2010, HIGH ALT MED BIOL, V11, P87, DOI 10.1089/ham.2010.1006; OELZ O, 1989, LANCET, V2, P1241; RICHALET J-P, 1988, Science and Sports, V3, P89, DOI 10.1016/S0765-1597(88)80002-9; Richalet JP, 2012, AM J RESP CRIT CARE, V185, P192, DOI 10.1164/rccm.201108-1396OC; Rimoldi SF, 2010, PROG CARDIOVASC DIS, V52, P512, DOI 10.1016/j.pcad.2010.03.005; Sartori C, 2002, NEW ENGL J MED, V346, P1631, DOI 10.1056/NEJMoa013183; Schneider M, 2002, MED SCI SPORT EXER, V34, P1886, DOI 10.1097/00005768-200212000-00005; Schommer K, 2010, HIGH ALT MED BIOL, V11, P19, DOI 10.1089/ham.2009.1019; SINGH I, 1965, LANCET, V1, P229; SINGH I, 1969, NEW ENGL J MED, V280, P175, DOI 10.1056/NEJM196901232800402; Swenson ER, 2002, JAMA-J AM MED ASSOC, V287, P2228, DOI 10.1001/jama.287.17.2228; van Patot MCT, 2008, HIGH ALT MED BIOL, V9, P289, DOI 10.1089/ham.2008.1029; Wille M, 2012, SCAND J MED SCI SPOR, V22, pe79, DOI 10.1111/j.1600-0838.2012.01499.x; Wu TY, 2007, WORLD J GASTROENTERO, V13, P774, DOI 10.3748/wjg.v13.i5.774; Wu TY, 2006, HIGH ALT MED BIOL, V7, P275, DOI 10.1089/ham.2006.7.275	50	258	283	15	103	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2294	2302		10.1056/NEJMcp1214870	http://dx.doi.org/10.1056/NEJMcp1214870			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YN	23758234				2022-12-28	WOS:000320230500005
J	Lee, W; Kim, K; Jeong, W; Zotti, LA; Pauly, F; Cuevas, JC; Reddy, P				Lee, Woochul; Kim, Kyeongtae; Jeong, Wonho; Angela Zotti, Linda; Pauly, Fabian; Carlos Cuevas, Juan; Reddy, Pramod			Heat dissipation in atomic-scale junctions	NATURE			English	Article							SINGLE-MOLECULE JUNCTIONS; CONDUCTANCE; THERMOPOWER; THERMOELECTRICITY; DEPENDENCE; CONTACT; FLOW	Atomic and single-molecule junctions represent the ultimate limit to the miniaturization of electrical circuits(1). They are also ideal platforms for testing quantum transport theories that are required to describe charge and energy transfer in novel functional nano-metre-scale devices. Recent work has successfully probed electric and thermoelectric phenomena(2-8) in atomic-scale junctions. However, heat dissipation and transport in atomic-scale devices remain poorly characterized owing to experimental challenges. Here we use custom-fabricated scanning probes with integrated nanoscale thermocouples to investigate heat dissipation in the electrodes of single-molecule ('molecular') junctions. We find that if the junctions have transmission characteristics that are strongly energy dependent, this heat dissipation is asymmetric-that is, unequal between the electrodes-and also dependent on both the bias polarity and the identity of the majority charge carriers (electrons versus holes). In contrast, junctions consisting of only a few gold atoms ('atomic junctions') whose transmission characteristics show weak energy dependence do not exhibit appreciable asymmetry. Our results unambiguously relate the electronic transmission characteristics of atomic-scale junctions to their heat dissipation properties, establishing a framework for understanding heat dissipation in a range of mesoscopic systems where transport is elastic-that is, without exchange of energy in the contact region. We anticipate that the techniques established here will enable the study of Peltier effects at the atomic scale, a field that has been barely explored experimentally despite interesting theoretical predictions(9-11). Furthermore, the experimental advances described here are also expected to enable the study of heat transport in atomic and molecular junctions-an important and challenging scientific and technological goal that has remained elusive(12,13).	[Lee, Woochul; Kim, Kyeongtae; Jeong, Wonho; Reddy, Pramod] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Angela Zotti, Linda; Carlos Cuevas, Juan] Univ Autonoma Madrid, Dept Fis Teor Mat Condensada, E-28049 Madrid, Spain; [Angela Zotti, Linda; Carlos Cuevas, Juan] Univ Autonoma Madrid, Condensed Matter Phys Ctr IFIMAC, E-28049 Madrid, Spain; [Pauly, Fabian] Univ Konstanz, Dept Phys, D-78457 Constance, Germany; [Reddy, Pramod] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Autonomous University of Madrid; Autonomous University of Madrid; University of Konstanz; University of Michigan System; University of Michigan	Reddy, P (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	juancarlos.cuevas@uam.es; pramodr@umich.edu	Lee, Woochul/B-8753-2013; Cuevas, Juan Carlos/B-7813-2012; Cuevas, Juan Carlos/P-2258-2019; Zotti, Linda Angela/E-3242-2014; Lee, Woochul/GMW-8587-2022; Pauly, Fabian/I-8965-2012	Lee, Woochul/0000-0002-0911-961X; Cuevas, Juan Carlos/0000-0001-7421-0682; Zotti, Linda Angela/0000-0002-5292-6759; Lee, Woochul/0000-0002-0911-961X; Pauly, Fabian/0000-0001-8017-2379; Kim, Kyongtae/0000-0003-4360-0148	US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0004871]; National Science Foundation [CBET 0844902]; Center for Solar and Thermal Energy conversion, an Energy Frontier Research Center; US Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0000957]; Spanish MICINN [FIS2010-21883]; Carl Zeiss Stiftung; DFG [SFB 767]; Baden-Wurttemberg Stiftung	US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Center for Solar and Thermal Energy conversion, an Energy Frontier Research Center; US Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carl Zeiss Stiftung; DFG(German Research Foundation (DFG)); Baden-Wurttemberg Stiftung	P.R. acknowledges support from the US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award no. DE-SC0004871 (nanofabrication of novel scanning probes), from the National Science Foundation under award no. CBET 0844902 (instrumentation for real-time control) and from the Center for Solar and Thermal Energy conversion, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Basic Energy Sciences under award no. DE-SC0000957 (development of a scanning probe microscope). L.A.Z. acknowledges financial support from the Spanish MICINN through grant no. FIS2010-21883. F. P. acknowledges funding through the Carl Zeiss Stiftung, the DFG SFB 767, and the Baden-Wurttemberg Stiftung. P. R. thanks E. Meyhofer for discussions and comments. P. R. and J.C.C. thank A. Nitzan for discussions. J.C.C. is grateful for the hospitality provided by the Institute for Advanced Studies of the Hebrew University of Jerusalem, where part of this work was carried out.	Agrait N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.216803; BRANDBYGE M, 1995, PHYS REV B, V52, P8499, DOI 10.1103/PhysRevB.52.8499; Cuevas J. C., 2010, MOL ELECT; Datta S., 1997, ELECT TRANSPORT MESO; Dubi Y, 2011, REV MOD PHYS, V83, P131, DOI 10.1103/RevModPhys.83.131; Galperin M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.115427; Huang ZF, 2007, NAT NANOTECHNOL, V2, P698, DOI 10.1038/nnano.2007.345; Ioffe Z, 2008, NAT NANOTECHNOL, V3, P727, DOI 10.1038/nnano.2008.304; Karlstrom O, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.113415; Kiguchi M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2392816; Kim Y, 2011, NANO LETT, V11, P3734, DOI 10.1021/nl201777m; Lee W, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/48/485703; Lepri S, 2003, PHYS REP, V377, P1, DOI 10.1016/S0370-1573(02)00558-6; Li NB, 2012, REV MOD PHYS, V84, P1045, DOI 10.1103/RevModPhys.84.1045; Ludoph B, 1999, PHYS REV B, V59, P12290, DOI 10.1103/PhysRevB.59.12290; Malen JA, 2009, NANO LETT, V9, P1164, DOI 10.1021/nl803814f; Nielsen SK, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.066804; Paulsson M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.241403; Pauly F, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125019; Reddy P, 2007, SCIENCE, V315, P1568, DOI 10.1126/science.1137149; Scheer E, 1998, NATURE, V394, P154, DOI 10.1038/28112; SIVAN U, 1986, PHYS REV B, V33, P551, DOI 10.1103/PhysRevB.33.551; Song H, 2009, NATURE, V462, P1039, DOI 10.1038/nature08639; Tsutsui M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00217; Venkataraman L, 2006, NANO LETT, V6, P458, DOI 10.1021/nl052373+; Venkataraman L, 2006, NATURE, V442, P904, DOI 10.1038/nature05037; Ward DR, 2011, NAT NANOTECHNOL, V6, P33, DOI 10.1038/NNANO.2010.240; Widawsky JR, 2012, NANO LETT, V12, P354, DOI 10.1021/nl203634m; Xu BQ, 2003, SCIENCE, V301, P1221, DOI 10.1126/science.1087481; Xue YQ, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.085403	30	194	194	6	344	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					209	+		10.1038/nature12183	http://dx.doi.org/10.1038/nature12183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23765496	Green Submitted			2022-12-28	WOS:000320283400043
J	Moore, W				Moore, Wendy			Ether frolics	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2013	346								f3861	10.1136/bmj.f3861	http://dx.doi.org/10.1136/bmj.f3861			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WQ	23766494				2022-12-28	WOS:000320590800002
J	Rice, SA; Swale, VJ; Haque, R; Rustin, MHA				Rice, S. A.; Swale, Victoria J.; Haque, Rubaiyat; Rustin, Malcolm H. A.			Erythroderma in the emergency department	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRESS SYNDROME; DRUG; COUGH		[Rice, S. A.; Swale, Victoria J.; Rustin, Malcolm H. A.] Royal Free Hosp, Dept Dermatol, London NW3 2QG, England; [Haque, Rubaiyat] Guys Hosp, Dept Allergy, London SE1 9RT, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Guy's & St Thomas' NHS Foundation Trust	Rice, SA (corresponding author), Royal Free Hosp, Dept Dermatol, London NW3 2QG, England.	shantini@doctors.net.uk		Swale, Victoria/0000-0002-1017-9249				Ardern-Jones MR, 2011, BRIT J CLIN PHARMACO, V71, P672, DOI 10.1111/j.1365-2125.2010.03703.x; Cacoub P, 2011, AM J MED, V124, P588, DOI 10.1016/j.amjmed.2011.01.017; Cantu C, 2003, STROKE, V34, P1667, DOI 10.1161/01.STR.0000075293.45936.FA; Descamps V, 2001, ARCH DERMATOL, V137, P301; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Friedmann PS, 2010, CURR OPIN ALLERGY CL, V10, P291, DOI 10.1097/ACI.0b013e32833aa54d; Kardaun SH, 2007, BRIT J DERMATOL, V156, P609, DOI 10.1111/j.1365-2133.2006.07704.x; Manini AF, 2005, ANN EMERG MED, V45, P213, DOI 10.1016/j.annemergmed.2004.07.003; Nagge JJ, 2005, ARCH DERMATOL, V141, P907, DOI 10.1001/archderm.141.7.907; Rimsza ME, 2008, PEDIATRICS, V122, pE318, DOI 10.1542/peds.2007-3813; ROCHINA A, 1995, J INVEST ALLERG CLIN, V5, P235; Sullivan JR, 2001, ARCH DERMATOL, V137, P357; Tennis P, 1997, NEUROLOGY, V49, P542, DOI 10.1212/WNL.49.2.542; WOLKENSTEIN P, 1995, DRUG SAFETY, V13, P56, DOI 10.2165/00002018-199513010-00007	14	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2013	346								f3613	10.1136/bmj.f3613	http://dx.doi.org/10.1136/bmj.f3613			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WQ	23766491				2022-12-28	WOS:000320590800003
J	Wilson, AM; Lowe, JC; Roskilly, K; Hudson, PE; Golabek, KA; McNutt, JW				Wilson, A. M.; Lowe, J. C.; Roskilly, K.; Hudson, P. E.; Golabek, K. A.; McNutt, J. W.			Locomotion dynamics of hunting in wild cheetahs	NATURE			English	Article							ACINONYX-JUBATUS; FUNCTIONAL-ANATOMY; RUNNING SPEED; LIMITATIONS; ECOLOGY; GPS	Although the cheetah is recognised as the fastest land animal, little is known about other aspects of its notable athleticism, particularly when hunting in the wild. Here we describe and use a new tracking collar of our own design, containing a combination of Global Positioning System (GPS) and inertial measurement units, to capture the locomotor dynamics and outcome of 367 predominantly hunting runs of five wild cheetahs in Botswana. A remarkable top speed of 25.9 ms(-1) (58 m.p.h. or 93 km h(-1)) was recorded, but most cheetah hunts involved only moderate speeds. We recorded some of the highest measured values for lateral and forward acceleration, deceleration and body-mass-specific power for any terrestrial mammal. To our knowledge, this is the first detailed locomotor information on the hunting dynamics of a large cursorial predator in its natural habitat.	[Wilson, A. M.; Lowe, J. C.; Roskilly, K.; Hudson, P. E.] Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; [Golabek, K. A.; McNutt, J. W.] Botswana Predator Conservat Trust, Maun, Botswana	University of London; University of London Royal Veterinary College	Wilson, AM (corresponding author), Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England.	awilson@rvc.ac.uk		Wilson, Alan/0000-0001-9914-3455	EPSRC [EP/H013016/1]; BBSRC [BB/J018007/1]; DARPA M3 Program [W91CRB-11-C-0048]; Boston Dynamics; Biotechnology and Biological Sciences Research Council [BB/J018007/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H013016/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DARPA M3 Program; Boston Dynamics; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. Amos and M. Dickson for fabricating collars, and F. Broekhuis, R. Furrer and N. Jordan for working with us in the study area; P. Apps for many discussions; T. Hubel and A. Wills for helping to collect and analyse validation data; P. Apps, J. Usherwood and A. Wilson for comments on the manuscript; and the EPSRC (EP/H013016/1), BBSRC (BB/J018007/1) and DARPA M3 Program (W91CRB-11-C-0048, with Boston Dynamics) for funding. This work was approved by RVC Ethics & Welfare Committee and was carried out under a Botswana Government Research Permit held by J. W. M. and Botswana Veterinary Registration held by A.M.W.	Bissett C, 2007, J ZOOL, V271, P310, DOI 10.1111/j.1469-7998.2006.00217.x; Broekhuis F., 2013, J ANIM ECOL; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Caro T., 1994, CHEETAHS SERENGETI P; CAVAGNA GA, 1971, J PHYSIOL-LONDON, V217, P709, DOI 10.1113/jphysiol.1971.sp009595; Chang YH, 2007, J EXP BIOL, V210, P971, DOI 10.1242/jeb.02728; Curtin NA, 2005, P ROY SOC B-BIOL SCI, V272, P581, DOI 10.1098/rspb.2004.2982; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Eaton R. L., 1973, CHEETAH BIOL ECOLOGY; GREENE PR, 1985, J BIOMECH ENG-T ASME, V107, P96, DOI 10.1115/1.3138542; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; HOtleferaaei M., 1961, Journal of Mammalogy, V42, P84; HOWLAND HC, 1974, J THEOR BIOL, V47, P333, DOI 10.1016/0022-5193(74)90202-1; Hudson PE, 2012, J EXP BIOL, V215, P2425, DOI 10.1242/jeb.066720; Hudson PE, 2011, J ANAT, V218, P375, DOI 10.1111/j.1469-7580.2011.01344.x; Hudson PE, 2011, J ANAT, V218, P363, DOI 10.1111/j.1469-7580.2010.01310.x; Ka1man R., 1960, J BASIC ENG-T ASME, V82, P34, DOI DOI 10.1115/1.3662552; Mills MGL, 2004, WILDLIFE BIOL, V10, P177, DOI 10.2981/wlb.2004.024; RAUCH HE, 1965, AIAA J, V3, P1445, DOI 10.2514/3.3166; Russell AP, 2001, J ZOOL, V254, P67, DOI 10.1017/S0952836901000565; SCHALLER G B, 1968, East African Wildlife Journal, V6, P95; Self ZT, 2012, J APPL PHYSIOL, V113, P602, DOI 10.1152/japplphysiol.00560.2011; Sharp NCC, 1997, J ZOOL, V241, P493, DOI 10.1111/j.1469-7998.1997.tb04840.x; Spence AJ, 2012, BIOL LETTERS, V8, P678, DOI 10.1098/rsbl.2011.1120; Tan HL, 2008, J BIOMECH, V41, P1398, DOI 10.1016/j.jbiomech.2008.02.021; Tan HL, 2011, P ROY SOC B-BIOL SCI, V278, P2105, DOI 10.1098/rspb.2010.2395; Titterton D. H., 2004, STRAPDOWN INERTIAL N, V207; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; Usherwood JR, 2006, BIOL LETTERS, V2, P47, DOI 10.1098/rsbl.2005.0399; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a; West T. G., 2013, J EXP BIOL; Williams SB, 2009, BIOL LETTERS, V5, P610, DOI 10.1098/rsbl.2009.0360	32	214	216	11	334	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					185	+		10.1038/nature12295	http://dx.doi.org/10.1038/nature12295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23765495				2022-12-28	WOS:000320283400038
J	Genther, DJ; Frick, KD; Chen, D; Betz, J; Lin, FR				Genther, Dane J.; Frick, Kevin D.; Chen, David; Betz, Joshua; Lin, Frank R.			Association of Hearing Loss With Hospitalization and Burden of Disease in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Genther, Dane J.; Chen, David; Lin, Frank R.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Frick, Kevin D.] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Betz, Joshua] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Genther, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	flin1@jhmi.edu		Genther, Dane/0000-0002-7925-012X; Frick, Kevin/0000-0002-0178-5319; Betz, Joshua/0000-0003-4488-9799	NIDCD NIH HHS [K23 DC011279, T32 DC000027, T32DC000027-24, 1K23DC011279] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000027, K23DC011279] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Viljanen A, 2009, J AM GERIATR SOC, V57, P2282, DOI 10.1111/j.1532-5415.2009.02553.x; WHO, PREV DEAFN HEAR IMP	6	105	114	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2322	2324		10.1001/jama.2013.5912	http://dx.doi.org/10.1001/jama.2013.5912			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161EV	23757078	Bronze, Green Accepted			2022-12-28	WOS:000320176000017
J	Bodnar, MS; Spector, DL				Bodnar, Megan S.; Spector, David L.			Chromatin Meets Its Organizers	CELL			English	Editorial Material							DROSOPHILA GENOME; TRANSCRIPTION; PRINCIPLES; LANDSCAPE; MEDIATOR; DOMAINS	Chromatin organization and gene-gene interactions are critical components of carrying out developmental programs. Phillips-Cremins et al. identify a series of unexpected architectural proteins that work in a combinatorial manner to functionally organize chromatin in a cell-type-specific manner at the submegabase-length scale.	[Bodnar, Megan S.; Spector, David L.] Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Spector, DL (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	spector@cshl.edu		Hogan, Megan/0000-0003-4752-3872	NCI NIH HHS [5P01CA013106] Funding Source: Medline; NEI NIH HHS [EY 18244] Funding Source: Medline; NIGMS NIH HHS [R01 GM042694] Funding Source: Medline; PHS HHS [42694] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042694] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035	9	3	3	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1187	1189		10.1016/j.cell.2013.05.030	http://dx.doi.org/10.1016/j.cell.2013.05.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746835	Bronze			2022-12-28	WOS:000319979200004
J	Liang, JJ; Fenstad, ER				Liang, Jackson J.; Fenstad, Eric R.			Twiddler's syndrome	LANCET			English	Editorial Material									[Liang, Jackson J.] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA; [Fenstad, Eric R.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Liang, JJ (corresponding author), Mayo Clin, 200 1st St Southwest, Rochester, MN 55905 USA.	liang.jackson@mayo.edu		Liang, Jackson/0000-0001-8608-8899					0	6	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					E47	E47		10.1016/S0140-6736(13)61419-1	http://dx.doi.org/10.1016/S0140-6736(13)61419-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269EI	23791473				2022-12-28	WOS:000328223700003
J	Mitsui, J; Matsukawa, T; Ishiura, H; Fukuda, Y; Ichikawa, Y; Date, H; Ahsan, B; Nakahara, Y; Momose, Y; Takahashi, Y; Iwata, A; Goto, J; Yamamoto, Y; Komata, M; Shirahige, K; Hara, K; Kakita, A; Yamada, M; Takahashi, H; Onodera, O; Nishizawa, M; Takashima, H; Kuwano, R; Watanabe, H; Ito, M; Sobue, G; Soma, H; Yabe, I; Sasaki, H; Aoki, M; Ishikawa, K; Mizusawa, H; Kanai, K; Hattori, T; Kuwabara, S; Arai, K; Koyano, S; Kuroiwa, Y; Hasegawa, K; Yuasa, T; Yasui, K; Nakashima, K; Ito, H; Izumi, Y; Kaji, R; Kato, T; Kusunoki, S; Osaki, Y; Horiuchi, M; Kondo, T; Murayama, S; Hattori, N; Yamamoto, M; Murata, M; Satake, W; Toda, T; Durr, A; Brice, A; Filla, A; Klockgether, T; Wullner, U; Nicholson, G; Gilman, S; Shults, CW; Tanner, CM; Kukull, WA; Lee, VMY; Masliah, E; Low, PA; Sandroni, P; Trojanowski, JQ; Ozelius, L; Foroud, T; Tsuji, S				Mitsui, Jun; Matsukawa, Takashi; Ishiura, Hiroyuki; Fukuda, Yoko; Ichikawa, Yaeko; Date, Hidetoshi; Ahsan, Budrul; Nakahara, Yasuo; Momose, Yoshio; Takahashi, Yuji; Iwata, Atsushi; Goto, Jun; Yamamoto, Yorihiro; Komata, Makiko; Shirahige, Katsuhiko; Hara, Kenju; Kakita, Akiyoshi; Yamada, Mitsunori; Takahashi, Hitoshi; Onodera, Osamu; Nishizawa, Masatoyo; Takashima, Hiroshi; Kuwano, Ryozo; Watanabe, Hirohisa; Ito, Mizuki; Sobue, Gen; Soma, Hiroyuki; Yabe, Ichiro; Sasaki, Hidenao; Aoki, Masashi; Ishikawa, Kinya; Mizusawa, Hidehiro; Kanai, Kazuaki; Hattori, Takamichi; Kuwabara, Satoshi; Arai, Kimihito; Koyano, Shigeru; Kuroiwa, Yoshiyuki; Hasegawa, Kazuko; Yuasa, Tatsuhiko; Yasui, Kenichi; Nakashima, Kenji; Ito, Hijiri; Izumi, Yuishin; Kaji, Ryuji; Kato, Takeo; Kusunoki, Susumu; Osaki, Yasushi; Horiuchi, Masahiro; Kondo, Tomoyoshi; Murayama, Shigeo; Hattori, Nobutaka; Yamamoto, Mitsutoshi; Murata, Miho; Satake, Wataru; Toda, Tatsushi; Duerr, Alexandra; Brice, Alexis; Filla, Alessandro; Klockgether, Thomas; Wuellner, Ullrich; Nicholson, Garth; Gilman, Sid; Shults, Clifford W.; Tanner, Caroline M.; Kukull, Walter A.; Lee, Virginia M. -Y.; Masliah, Eliezer; Low, Phillip A.; Sandroni, Paola; Trojanowski, John Q.; Ozelius, Laurie; Foroud, Tatiana; Tsuji, Shoji		Multiple-Syst Atrophy Res Collabor	Mutations in COQ2 in Familial and Sporadic Multiple-System Atrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLIAL CYTOPLASMIC INCLUSIONS; TRANSGENIC MOUSE MODEL; ALPHA-SYNUCLEIN; OLIVOPONTOCEREBELLAR ATROPHY; PARKINSONS-DISEASE; OXIDATIVE STRESS; SKELETAL-MUSCLE; IMMUNOREACTIVITY; DEGENERATION; VARIANTS	Background Multiple-system atrophy is an intractable neurodegenerative disease characterized by autonomic failure in addition to various combinations of parkinsonism, cerebellar ataxia, and pyramidal dysfunction. Although multiple-system atrophy is widely considered to be a nongenetic disorder, we previously identified multiplex families with this disease, which indicates the involvement of genetic components. Methods In combination with linkage analysis, we performed whole-genome sequencing of a sample obtained from a member of a multiplex family in whom multiple-system atrophy had been diagnosed on autopsy. We also performed mutational analysis of samples from members of five other multiplex families and from a Japanese series (363 patients and two sets of controls, one of 520 persons and one of 2383 persons), a European series (223 patients and 315 controls), and a North American series (172 patients and 294 controls). On the basis of these analyses, we used a yeast complementation assay and measured enzyme activity of parahydroxybenzoate-polyprenyl transferase. This enzyme is encoded by the gene COQ2 and is essential for the biosynthesis of coenzyme Q(10). Levels of coenzyme Q(10) in lymphoblastoid cells and brain tissue were measured on high-performance liquid chromatography. Results We identified a homozygous mutation (M78V-V343A/M78V-V343A) and compound heterozygous mutations (R337X/V343A) in COQ2 in two multiplex families. Furthermore, we found that a common variant (V343A) and multiple rare variants in COQ2, all of which are functionally impaired, are associated with sporadic multiple-system atrophy. The V343A variant was exclusively observed in the Japanese population. Conclusions Functionally impaired variants of COQ2 were associated with an increased risk of multiple-system atrophy in multiplex families and patients with sporadic disease, providing evidence of a role of impaired COQ2 activities in the pathogenesis of this disease. (Funded by the Japan Society for the Promotion of Science and others.) Multiple-system atrophy is a rare neurodegenerative disease characterized by autonomic failure. Mutations affecting an enzyme essential for the synthesis of coenzyme Q10 confer susceptibility to the disease in some persons.	[Mitsui, Jun; Matsukawa, Takashi; Ishiura, Hiroyuki; Fukuda, Yoko; Ichikawa, Yaeko; Date, Hidetoshi; Ahsan, Budrul; Nakahara, Yasuo; Momose, Yoshio; Takahashi, Yuji; Iwata, Atsushi; Goto, Jun] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1138655, Japan; [Fukuda, Yoko] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Yamamoto, Yorihiro] Tokyo Univ Technol, Sch Biosci & Biotechnol, Tokyo, Japan; [Komata, Makiko; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Ctr Epigenet Dis, Tokyo 1138655, Japan; [Hara, Kenju; Onodera, Osamu; Nishizawa, Masatoyo] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; [Kakita, Akiyoshi; Yamada, Mitsunori; Takahashi, Hitoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan; [Takashima, Hiroshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, Kagoshima 890, Japan; [Kuwano, Ryozo] Niigata Univ, Brain Res Inst, Ctr Bioresources, Dept Mol Genet, Niigata, Japan; [Watanabe, Hirohisa; Ito, Mizuki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan; [Soma, Hiroyuki; Yabe, Ichiro; Sasaki, Hidenao] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan; [Aoki, Masashi] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Ishikawa, Kinya; Mizusawa, Hidehiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Neurol & Neurol Sci, Tokyo, Japan; [Kanai, Kazuaki; Hattori, Takamichi; Kuwabara, Satoshi] Chiba Univ, Sch Med, Dept Neurol, Chiba 280, Japan; [Arai, Kimihito] Chiba East Hosp, Natl Hosp Org, Div Neurol, Chiba, Japan; [Koyano, Shigeru] Yokohama City Univ, Grad Sch Med, Dept Clin Neurol & Stroke Med, Yokohama, Kanagawa 232, Japan; [Kuroiwa, Yoshiyuki] Teikyo Univ, Sch Med, Univ Hosp, Dept Neurol, Kawasaki, Kanagawa, Japan; [Hasegawa, Kazuko] Sagamihara Natl Hosp, Natl Hosp Org, Div Neurol, Sagamihara, Kanagawa, Japan; [Yuasa, Tatsuhiko] Kamagaya Gen Hosp, Kamagaya Chiba Med Ctr Intractable Neurol Dis, Dept Neurol, Chiba, Japan; [Yasui, Kenichi; Nakashima, Kenji] Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neurol, Yonago, Tottori 683, Japan; [Ito, Hijiri] Mifukai Vihara Hananosato Hosp, Dept Neurol, Hiroshima, Japan; [Izumi, Yuishin; Kaji, Ryuji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Clin Neurosci, Tokushima 770, Japan; [Kato, Takeo] Yamagata Univ, Fac Med, Dept Neurol, Yamagata 990, Japan; [Kato, Takeo] Yamagata Univ, Fac Med, Dept Hematol, Yamagata 990, Japan; [Kato, Takeo] Yamagata Univ, Fac Med, Dept Metab, Yamagata 990, Japan; [Kato, Takeo] Yamagata Univ, Fac Med, Dept Endocrinol, Yamagata 990, Japan; [Kato, Takeo] Yamagata Univ, Fac Med, Dept Diabetol, Yamagata 990, Japan; [Kusunoki, Susumu] Kinki Univ, Sch Med, Dept Neurol, Osaka 589, Japan; [Osaki, Yasushi] Kochi Med Sch, Dept Geriatr Cardiol & Neurol, Nankoku, Kochi, Japan; [Horiuchi, Masahiro] St Marianna Univ, Sch Med, Dept Internal Med, Div Neurol, Kawasaki, Kanagawa, Japan; [Kondo, Tomoyoshi] Wakayama Med Univ, Dept Neurol, Wakayama, Japan; [Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Tokyo 173, Japan; [Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Brain Bank Aging Res, Tokyo 173, Japan; [Murayama, Shigeo] Inst Gerontol, Tokyo, Japan; [Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan; [Yamamoto, Mitsutoshi] Kagawa Prefectural Cent Hosp, Dept Neurol, Takamatsu, Kagawa, Japan; [Murata, Miho] Natl Ctr Hosp Neurol & Psychiat, Dept Neurol, Tokyo, Japan; [Satake, Wataru; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 657, Japan; [Duerr, Alexandra; Brice, Alexis] CRICM, INSERM, UMR S975, F-75013 Paris, France; [Duerr, Alexandra; Brice, Alexis] Univ Paris 06, UPMC, UMR S975, F-75013 Paris, France; [Duerr, Alexandra; Brice, Alexis] CNRS, UMR 7225, F-75013 Paris, France; [Duerr, Alexandra; Brice, Alexis] Hop La Pitie Salpetriere, Dept Genet & Cytogenet, F-75013 Paris, France; [Filla, Alessandro] Univ Naples Federico II, Dept Neurol Sci, Naples, Italy; [Klockgether, Thomas; Wuellner, Ullrich] Univ Bonn, Dept Neurol, Bonn, Germany; [Klockgether, Thomas; Wuellner, Ullrich] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Nicholson, Garth] Univ Sydney, Australian & New Zealand Army Corps ANZAC Res Ins, Concord Hosp, Sydney, NSW 2006, Australia; [Gilman, Sid] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Shults, Clifford W.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Tanner, Caroline M.] Parkinsons Inst, Sunnyvale, CA USA; [Kukull, Walter A.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Lee, Virginia M. -Y.; Trojanowski, John Q.] Univ Penn, Perelman Sch Med, Udall Parkinsons Res Ctr, Inst Aging,Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Lee, Virginia M. -Y.; Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Low, Phillip A.; Sandroni, Paola] Mayo Clin, Dept Neurol, Rochester, MN USA; [Ozelius, Laurie] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Foroud, Tatiana] Indiana Univ Sch Med, Indiana Alcohol Res Ctr, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Tsuji, Shoji] Univ Tokyo, Dept Neurol, Grad Sch Med, Tokyo 1138655, Japan; [Tsuji, Shoji] Univ Tokyo, Med Genome Ctr, Tokyo 1138655, Japan	University of Tokyo; Max Planck Society; Tokyo University of Technology; University of Tokyo; Niigata University; Niigata University; Kagoshima University; Niigata University; Nagoya University; Hokkaido University; Tohoku University; Tokyo Medical & Dental University (TMDU); Chiba University; Yokohama City University; Teikyo University; Tottori University; Tokushima University; Yamagata University; Yamagata University; Yamagata University; Yamagata University; Yamagata University; Kindai University (Kinki University); Kochi University; Saint Marianna University; Wakayama Medical University; Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; Juntendo University; National Center for Neurology & Psychiatry - Japan; Kobe University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Naples Federico II; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego; Mayo Clinic; Icahn School of Medicine at Mount Sinai; Indiana University System; Indiana University Bloomington; University of Tokyo; University of Tokyo	Tsuji, S (corresponding author), Univ Tokyo, Dept Neurol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tsuji@m.u-tokyo.ac.jp	Iwata, Atsushi/A-9598-2013; Brice, Alexis/A-2170-2009; Onodera, Osamu/K-7327-2013; Research Institute, ANZAC/CAE-9030-2022; Iwata, Atsushi/AAH-8924-2019; Wüllner, Ullrich/R-6790-2019; brice, alexis/AAE-8275-2019; Yabe, Ichiro/AAU-2495-2020; Hattori, Nobutaka/ACR-0069-2022; Braithwaite, Adam/R-4099-2016	Iwata, Atsushi/0000-0001-7308-5314; Onodera, Osamu/0000-0003-3354-5472; Iwata, Atsushi/0000-0001-7308-5314; brice, alexis/0000-0002-0941-3990; Yabe, Ichiro/0000-0002-1734-7997; Braithwaite, Adam/0000-0003-3228-2172; Nicholson, Garth/0000-0001-9694-066X; Kukull, Walter/0000-0001-8761-9014; Fukuda-Yuzawa, Yoko/0000-0002-9887-9820; Watanabe, Hirohisa/0000-0001-8553-8536; Toda, Tatsushi/0000-0002-0717-1123; Shirahige, Katsuhiko/0000-0002-7862-1144	Japan Society for the Promotion of Science (KAKENHI) [22129001, 22129002]; Ministry of Health, Labor, and Welfare of Japan [H23-Jitsuyoka [Nanbyo]-Ippan-004]; Japanese Ministry of Education, Culture, Sports, Science, and Technology; French Agency for Research [ANR-09-MNPS-032-01/R09148DS]; Programme Hospitalier de Recherche Clinique [AOM03059/R05129DD]; Deutsche Forschungsgemeinschaft [184-6]; Deutsche Parkinson Vereinigung; Grants-in-Aid for Scientific Research [25670420, 25713015] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); French Agency for Research(French National Research Agency (ANR)); Programme Hospitalier de Recherche Clinique; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Parkinson Vereinigung; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported in part by grants from the Japan Society for the Promotion of Science (KAKENHI) (22129001 and 22129002, to Dr. Tsuji); the Ministry of Health, Labor, and Welfare of Japan (H23-Jitsuyoka [Nanbyo]-Ippan-004, to Dr. Tsuji); the Japanese Ministry of Education, Culture, Sports, Science, and Technology; the French Agency for Research (ANR-09-MNPS-032-01/R09148DS, to Drs. Durr and Brice); Programme Hospitalier de Recherche Clinique (AOM03059/R05129DD, to Drs. Durr and Brice); Deutsche Forschungsgemeinschaft (Wu 184-6, to Dr. Wullner); and Deutsche Parkinson Vereinigung (to Dr. Wullner).	Al-Chalabi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007114; Arima K, 1998, ACTA NEUROPATHOL, V96, P439, DOI 10.1007/s004010050917; BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8; Buron MI, 2006, ANAL BIOCHEM, V353, P15, DOI 10.1016/j.ab.2006.03.029; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Ferrante KL, 2005, NEUROLOGY, V65, P1834, DOI 10.1212/01.wnl.0000187070.35365.d7; Fukuda Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-121; Geser F, 2005, J NEURAL TRANSM, V112, P1677, DOI 10.1007/s00702-005-0328-y; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; GRAHAM JG, 1969, J NEUROL NEUROSUR PS, V32, P28, DOI 10.1136/jnnp.32.1.28; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Hara K, 2007, ARCH NEUROL-CHICAGO, V64, P545, DOI 10.1001/archneur.64.4.545; Hohler AD, 2012, J CLIN NEUROSCI, V19, P479, DOI 10.1016/j.jocn.2011.06.018; Hyson HC, 2010, MOVEMENT DISORD, V25, P1924, DOI 10.1002/mds.22408; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; Martinelli P, 1996, ADV NEUROL, V69, P271; May S, 2007, MOVEMENT DISORD, V22, P2371, DOI 10.1002/mds.21734; NAKAZATO Y, 1990, J NEUROPATH EXP NEUR, V49, P521, DOI 10.1097/00005072-199009000-00007; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Sasaki H, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-24; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; SCHOLZ SW, 2010, ANN NEUROL, V67, P277; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stefanova N, 2005, AM J PATHOL, V166, P869, DOI 10.1016/S0002-9440(10)62307-3; Stefanova N, 2012, NEUROTOX RES, V21, P393, DOI 10.1007/s12640-011-9294-3; Tsuji S, 2008, CEREBELLUM, V7, P189, DOI 10.1007/s12311-008-0028-x; Tsuji S, 2010, HUM MOL GENET, V19, pR65, DOI 10.1093/hmg/ddq162; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Ubhi K, 2010, NEUROREPORT, V21, P457, DOI 10.1097/WNR.0b013e328338ba6b; Ubhi K, 2009, J NEUROSCI RES, V87, P2728, DOI 10.1002/jnr.22089; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; Wullner U, 2009, J NEUROL NEUROSUR PS, V80, P449, DOI 10.1136/jnnp.2008.158949; Yamashita S, 1997, ANAL BIOCHEM, V250, P66, DOI 10.1006/abio.1997.2187; Yamashita T, 2000, J NEUROL SCI, V175, P107, DOI 10.1016/S0022-510X(00)00296-3	37	219	222	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	2013	369	3					233	244		10.1056/NEJMoa1212115	http://dx.doi.org/10.1056/NEJMoa1212115			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DQ	23758206				2022-12-28	WOS:000321945800009
J	Orentlicher, D				Orentlicher, David			The FDA's Graphic Tobacco Warnings and the First Amendment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Orentlicher, David] Indiana Univ, Hall Ctr Law & Hlth, Robert H McKinney Sch Law, Indianapolis, IN 46204 USA; [Orentlicher, David] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Orentlicher, D (corresponding author), Indiana Univ, Hall Ctr Law & Hlth, Robert H McKinney Sch Law, Indianapolis, IN 46204 USA.							Orentlicher D, 2011, AM J LAW MED, V37, P299, DOI 10.1177/009885881103700205	1	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	2013	369	3					204	206		10.1056/NEJMp1304513	http://dx.doi.org/10.1056/NEJMp1304513			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	185DQ	23803137				2022-12-28	WOS:000321945800003
J	Horton, R; Lo, S				Horton, Richard; Lo, Selina			Turkey's democratic transition to universal health coverage	LANCET			English	Editorial Material									[Horton, Richard; Lo, Selina] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Atun R, 2013, LANCET	1	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 6	2013	382	9886					3	3		10.1016/S0140-6736(13)61181-2	http://dx.doi.org/10.1016/S0140-6736(13)61181-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177AD	23810017				2022-12-28	WOS:000321347000004
J	Rodnina, MV				Rodnina, Marina V.			Translocation in Action	SCIENCE			English	Editorial Material							TRANSFER-RNA MOVEMENT; GTP HYDROLYSIS; RIBOSOME		Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Rodnina, Marina V./AAD-4667-2019	Rodnina, Marina V./0000-0003-0105-3879				Cunha CE, 2013, TRANSLATION, V1, DOI 10.4161/trla.24315; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086	14	2	2	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1534	1535		10.1126/science.1240090	http://dx.doi.org/10.1126/science.1240090			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812707	Green Published			2022-12-28	WOS:000321007000027
J	Leonhardt, U				Leonhardt, Ulf			APPLIED PHYSICS Cloaking of heat	NATURE			English	Editorial Material									[Leonhardt, Ulf] S China Normal Univ, Ctr Opt & Electromagnet Res, Guangzhou, Guangdong, Peoples R China; [Leonhardt, Ulf] Weizmann Inst Sci, IL-76100 Rehovot, Israel	South China Normal University; Weizmann Institute of Science	Leonhardt, U (corresponding author), S China Normal Univ, Ctr Opt & Electromagnet Res, Guangzhou, Guangdong, Peoples R China.	ulf.leonhardt@weizmann.ac.il						Brule S., 2013, PREPRINT; Farhat M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.134501; Guenneau S, 2012, OPT EXPRESS, V20, P8207, DOI 10.1364/OE.20.008207; Leonhardt U, 2010, GEOMETRY LIGHT SCI I; Ma Y. G., 2013, PREPRINT; Schittny R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.195901; Service RF, 2010, SCIENCE, V330, P1622, DOI 10.1126/science.330.6011.1622; Smerlak M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023019; Stenger N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.014301; Zhang S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.024301	10	36	38	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					440	441		10.1038/498440a	http://dx.doi.org/10.1038/498440a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803838				2022-12-28	WOS:000320929400038
J	Spence, D				Spence, Des			Saying no to chemotherapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2013	346								f4023	10.1136/bmj.f4023	http://dx.doi.org/10.1136/bmj.f4023			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171RC	23794158				2022-12-28	WOS:000320945700005
J	Malmersjo, S; Meyer, T				Malmersjoe, Seth; Meyer, Tobias			Inside-Out Connections: The ER Meets the Plasma Membrane	CELL			English	Editorial Material							ENDOPLASMIC RETICULUM; PROTEINS; STIM		[Malmersjoe, Seth; Meyer, Tobias] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Meyer, T (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	tobias1@stanford.edu	Malmersjö, Seth/D-2454-2010	Malmersjö, Seth/0000-0002-1519-8916; Meyer, Tobias/0000-0003-4339-3804	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030179, R01GM030179] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM030179, GM030179, R37 GM030179] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carrasco S, 2011, ANNU REV BIOCHEM, V80, P973, DOI 10.1146/annurev-biochem-061609-165311; Lewis RS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003970; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; Walsh CM, 2010, BIOCHEM J, V425, P159, DOI 10.1042/BJ20090884	9	5	5	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1423	1424		10.1016/j.cell.2013.05.054	http://dx.doi.org/10.1016/j.cell.2013.05.054			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791170	Green Accepted, Bronze			2022-12-28	WOS:000320722000008
J	McShane, R				McShane, Rupert			Should patients with dementia who wander be electronically tagged? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRACKING; PEOPLE; FEASIBILITY; CAREGIVERS; GPS		Oxford Hlth NHS Fdn Trust, Oxford, England		McShane, R (corresponding author), Oxford Hlth NHS Fdn Trust, Oxford, England.	Rupert.McShane@oxfordhealth.nhs.uk						Ginns D, NEIGHBOURHOOD RETURN; Koester RJ, 1998, RESP 98 NASAR P; Landau R, 2009, BRIT J SOC WORK, V39, P670, DOI 10.1093/bjsw/bcp037; Landau R, 2012, INT PSYCHOGERIATR, V24, P358, DOI 10.1017/S1041610211001888; McShane R, 1998, INT J GERIATR PSYCH, V13, P556, DOI 10.1002/(SICI)1099-1166(199808)13:8<556::AID-GPS834>3.0.CO;2-6; McShane R, 1998, Int Psychogeriatr, V10, P253, DOI 10.1017/S1041610298005365; Pot AM, 2012, AGING MENT HEALTH, V16, P127, DOI 10.1080/13607863.2011.596810; Robinson L, 2007, HEALTH RISK SOC, V9, P389, DOI 10.1080/13698570701612774; Rowe MA, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-28; Scarmeas N, 2007, ARCH NEUROL-CHICAGO, V64, P1755, DOI 10.1001/archneur.64.12.1755; White EB, 2010, BRIT J OCCUP THER, V73, P152, DOI 10.4276/030802210X12706313443901	11	8	8	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2013	346								f3603	10.1136/bmj.f3603	http://dx.doi.org/10.1136/bmj.f3603			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171QP	23788491				2022-12-28	WOS:000320944400002
J	Satoh, D; Arber, S				Satoh, Daisuke; Arber, Silvia			Carving Axon Arbors to Fit: Master Directs One Kinase at a Time	CELL			English	Editorial Material							SAD KINASES; PATHWAY; LKB1		[Satoh, Daisuke; Arber, Silvia] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Satoh, Daisuke; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research	Arber, S (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	silvia.arber@unibas.ch		Satoh, Daisuke/0000-0002-4039-1670; Arber, Silvia/0000-0002-6261-250X				Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Courchet J, 2013, CELL, V153, P1510, DOI 10.1016/j.cell.2013.05.021; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Gibson DA, 2011, DEVELOPMENT, V138, P183, DOI 10.1242/dev.046441; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lilley BN, 2013, NEURON, V79, P39, DOI 10.1016/j.neuron.2013.05.017; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Ori-McKenney KM, 2012, NEURON, V76, P921, DOI 10.1016/j.neuron.2012.10.008; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010	11	0	0	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1425	1426		10.1016/j.cell.2013.05.047	http://dx.doi.org/10.1016/j.cell.2013.05.047			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791171	Bronze			2022-12-28	WOS:000320722000009
J	Tharakaraman, K; Jayaraman, A; Raman, R; Viswanathan, K; Stebbins, NW; Johnson, D; Shriver, Z; Sasisekharan, V; Sasisekharan, R				Tharakaraman, Kannan; Jayaraman, Akila; Raman, Rahul; Viswanathan, Karthik; Stebbins, Nathan W.; Johnson, David; Shriver, Zachary; Sasisekharan, V.; Sasisekharan, Ram			Glycan Receptor Binding of the Influenza A Virus H7N9 Hemagglutinin	CELL			English	Article							RESPIRATORY-TRACT; TRANSMISSION; HA; PATHOGENESIS; ADAPTATION; SITES	The advent of H7N9 in early 2013 is of concern for a number of reasons, including its capability to infect humans, the lack of clarity in the etiology of infection, and because the human population does not have pre-existing immunity to the H7 subtype. Earlier sequence analyses of H7N9 hemagglutinin (HA) point to amino acid changes that predicted human receptor binding and impinge on the antigenic characteristics of the HA. Here, we report that the H7N9 HA shows limited binding to human receptors; however, should a single amino acid mutation occur, this would result in structural changes within the receptor binding site that allow for extensive binding to human receptors present in the upper respiratory tract. Furthermore, a subset of the H7N9 HA sequences demarcating coevolving amino acids appears to be in the antigenic regions of H7, which, in turn, could impact effectiveness of the current WHO-recommended prepandemic H7 vaccines.	[Tharakaraman, Kannan; Jayaraman, Akila; Raman, Rahul; Viswanathan, Karthik; Stebbins, Nathan W.; Johnson, David; Shriver, Zachary; Sasisekharan, V.; Sasisekharan, Ram] MIT, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Infect Dis Interdisciplinary Res Grp, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART)	Sasisekharan, R (corresponding author), MIT, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Infect Dis Interdisciplinary Res Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health [R37 GM057073-13]; National-Research-Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073, R01GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National-Research-Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by National Institutes of Health (R37 GM057073-13) and the National-Research-Foundation-supported interdisciplinary research group in Infectious Diseases of SMART (Singapore-MIT Alliance for Research and Technology).	Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jayaraman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027517; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Kwon TY, 2011, VET MICROBIOL, V153, P393, DOI 10.1016/j.vetmic.2011.06.011; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Li WF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-183; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu D., 2013, LANCET; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mansfield KG, 2007, AM J PATHOL, V171, P1089, DOI 10.2353/ajpath.2007.070695; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Soundararajan V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00200; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059550, 10.1371/journal.pone.0049597]; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Tharakaraman K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01822; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768	28	120	127	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1486	1493		10.1016/j.cell.2013.05.034	http://dx.doi.org/10.1016/j.cell.2013.05.034			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23746830	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000320722000017
J	Coca, S				Coca, Steven			Adding Na/K citrate to standard hydration reduced CIN in patients having coronary angiography	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PREVENTION		Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Coca, S (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.		Coca, Steven/L-7801-2019	Coca, Steven/0000-0002-0928-9168				Cairns JA, 2010, CAN J CARDIOL, V26, P353, DOI 10.1016/S0828-282X(10)70408-6; Chertow GM, 2006, CLIN J AM SOC NEPHRO, V1, P1124, DOI 10.2215/CJN.01200406; Zoungas S, 2009, ANN INTERN MED, V151, P631, DOI 10.7326/0003-4819-151-9-200911030-00008	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12							JC9	10.7326/0003-4819-158-12-201306180-02009	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778933				2022-12-28	WOS:000320645000008
J	Myburgh, J				Myburgh, John			Review: Hydroxyethyl starch increases mortality and acute kidney injury in critically ill patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FLUID RESUSCITATION; METAANALYSIS		Univ New S Wales, St George Clin Sch, George Inst Global Hlth, Sydney, NSW, Australia	George Institute for Global Health; University of New South Wales Sydney; University of Sydney	Myburgh, J (corresponding author), Univ New S Wales, St George Clin Sch, George Inst Global Hlth, Sydney, NSW, Australia.			Zarychanski, Ryan/0000-0001-9455-6138				Gattas DJ, 2013, INTENS CARE MED, V39, P558, DOI 10.1007/s00134-013-2840-0; Haase N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f839; Myburgh J, 2013, INTENS CARE MED, V39, P998, DOI 10.1007/s00134-013-2890-3; Patel A, 2013, INTENS CARE MED, V39, P811, DOI 10.1007/s00134-013-2863-6	4	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12							JC4	10.7326/0003-4819-158-12-201306180-02004	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778928				2022-12-28	WOS:000320645000003
J	Shetty, P				Shetty, Priya			Adeeba Kamarulzaman: fighting HIV/AIDS in Malaysia	LANCET			English	Biographical-Item																		KAMARULZAMAN A, PUBLICATION LIST	1	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 15	2013	381	9883					2073	2073		10.1016/S0140-6736(13)61231-3	http://dx.doi.org/10.1016/S0140-6736(13)61231-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KA	23769222				2022-12-28	WOS:000320924800015
J	Hamm, JM; Hess, O				Hamm, Joachim M.; Hess, Ortwin			Two Two-Dimensional Materials Are Better than One	SCIENCE			English	Editorial Material							GRAPHENE; OPTICS		[Hamm, Joachim M.; Hess, Ortwin] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Dept Phys, London SW7 2AZ, England	Imperial College London	Hamm, JM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Dept Phys, Prince Consort Rd, London SW7 2AZ, England.	j.hamm@imperial.ac.uk; o.hess@imperial.ac.uk	Hess, Ortwin/O-1345-2019	Hess, Ortwin/0000-0002-6024-0677				Britnell L, 2013, SCIENCE, V340, P1311, DOI 10.1126/science.1235547; Davies P. M. Z., 2013, ARXIV13052839; Geim AK, 2007, PHYS TODAY, V60, P35, DOI 10.1063/1.2774096; Hess O, 2012, NAT MATER, V11, P573, DOI [10.1038/nmat3356, 10.1038/NMAT3356]; Hess O, 2008, NATURE, V455, P299, DOI 10.1038/455299a; Hess O, 2013, SCIENCE, V339, P654, DOI 10.1126/science.1231254; Kildishev AV, 2013, SCIENCE, V339, DOI 10.1126/science.1232009; Lee SH, 2012, NAT MATER, V11, P936, DOI [10.1038/NMAT3433, 10.1038/nmat3433]; Pendry JB, 2012, SCIENCE, V337, P549, DOI 10.1126/science.1220600; Yin XB, 2013, SCIENCE, V339, P1405, DOI 10.1126/science.1231758; Yu NF, 2012, NANO LETT, V12, P6328, DOI 10.1021/nl303445u	11	64	65	3	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1298	1299		10.1126/science.1239501	http://dx.doi.org/10.1126/science.1239501			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766321				2022-12-28	WOS:000320320200032
J	Anderson, GF; Willink, A; Osborn, R				Anderson, Gerard F.; Willink, Amber; Osborn, Robin			Reevaluating "Made in America"- Two Cost-Containment Ideas from Abroad	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Anderson, Gerard F.; Willink, Amber] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Osborn, Robin] Commonwealth Fund, Int Program Hlth Policy & Innovat, New York, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Commonwealth Fund	Anderson, GF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA.							Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; [Anonymous], 2011, HLTH GLANC 2011 OECD, DOI DOI 10.1787/HEALTH_; Ikegami N, 2012, HEALTH AFFAIR, V31, P1049, DOI 10.1377/hlthaff.2011.1037; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Woolf SH, 2013, US HLTH INT PERSPECT	5	5	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2247	2249		10.1056/NEJMp1302140	http://dx.doi.org/10.1056/NEJMp1302140			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YN	23758231				2022-12-28	WOS:000320230500014
J	Civaner, M				Civaner, Murat			PERSONAL VIEW Protests in Turkey, state violence, and how doctors are helping: it's about much more than a park	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Uludag Univ, Sch Med, Dept Med Eth, Bursa, Turkey	Uludag University	Civaner, M (corresponding author), Uludag Univ, Sch Med, Dept Med Eth, Bursa, Turkey.	mcivaner@gmail.com						Amnesty International, 2013, TURKEY AMNESTY INT C; [Anonymous], CHAP; [Anonymous], 2013, RADIKAL         0603; [Anonymous], 2013, BANU GUVEN      0605; Turkish Medical Association, 2013, HLTH STAT DEM	5	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2013	346								f3789	10.1136/bmj.f3789	http://dx.doi.org/10.1136/bmj.f3789			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VQ	23757756				2022-12-28	WOS:000320587600001
J	Akyuz, N; Altman, RB; Blanchard, SC; Boudker, O				Akyuz, Nurunisa; Altman, Roger B.; Blanchard, Scott C.; Boudker, Olga			Transport dynamics in a glutamate transporter homologue	NATURE			English	Article							TRANSLOCATION; SUBSTRATE; RIBOSOME; KINETICS; BINDING	Glutamate transporters are integral membrane proteins that catalyse neurotransmitter uptake from the synaptic cleft into the cytoplasm of glial cells and neurons(1). Their mechanism of action involves transitions between extracellular (outward)-facing and intracellular (inward)-facing conformations, whereby substrate binding sites become accessible to either side of the membrane(2). This process has been proposed to entail transmembrane movements of three discrete transport domains within a trimeric scaffold(3). Using single-molecule fluorescence resonance energy transfer (smFRET) imaging(4), we have directly observed large-scale transport domain movements in a bacterial homologue of glutamate transporters. We find that individual transport domains alternate between periods of quiescence and periods of rapid transitions, reminiscent of bursting patterns first recorded in single ion channels using patch-clamp methods(5,6). We propose that the switch to the dynamic mode in glutamate transporters is due to separation of the transport domain from the trimeric scaffold, which precedes domain movements across the bilayer. This spontaneous dislodging of the substrate-loaded transport domain is approximately 100-fold slower than subsequent transmembrane movements and may be rate determining in the transport cycle.	[Akyuz, Nurunisa; Altman, Roger B.; Blanchard, Scott C.; Boudker, Olga] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10064 USA	Cornell University	Blanchard, SC (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10064 USA.	scb2005@med.cornell.edu; olb2003@med.cornell.edu	Blanchard, Scott C./A-5804-2009	Blanchard, Scott C./0000-0003-2717-9365; Akyuz, Nurunisa/0000-0002-6340-1915	National Institute of Health [5U54GM087519, R01NS064357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064357] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank D. S. Terry for his help with the design of smFRET experiments and discussions; Z. Zhou for the synthesis of cyanine fluorophores; E. Georgieva for initial biochemical characterization of the single-cysteine mutants; G. Verdon, A. Accardi and N. Reyes for helpful discussions and comments on the manuscript. The work was supported in part by the National Institute of Health grants 5U54GM087519 and R01NS064357.	Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Blanchard SC, 2009, CURR OPIN STRUC BIOL, V19, P103, DOI 10.1016/j.sbi.2009.01.002; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; CULLCANDY SG, 1982, NATURE, V295, P410, DOI 10.1038/295410a0; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Liu SX, 2007, P NATL ACAD SCI USA, V104, P12634, DOI 10.1073/pnas.0610597104; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Motulsky H, 2004, FITTING MODELS BIOL, P256; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Otis TS, 2000, J NEUROSCI, V20, P2749; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Stolzenberg S, 2012, J PHYS CHEM B, V116, P5372, DOI 10.1021/jp301726s; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	35	124	124	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					114	+		10.1038/nature12265	http://dx.doi.org/10.1038/nature12265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	23792560	Green Accepted			2022-12-28	WOS:000325106000042
J	Fradet-Turcotte, A; Canny, MD; Escribano-Diaz, C; Orthwein, A; Leung, CCY; Huang, H; Landry, MC; Kitevski-LeBlanc, J; Noordermeer, SM; Sicheri, F; Durocher, D				Fradet-Turcotte, Amelie; Canny, Marella D.; Escribano-Diaz, Cristina; Orthwein, Alexandre; Leung, Charles C. Y.; Huang, Hao; Landry, Marie-Claude; Kitevski-LeBlanc, Julianne; Noordermeer, Sylvie M.; Sicheri, Frank; Durocher, Daniel			53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark	NATURE			English	Article							DOUBLE-STRAND BREAKS; CLASS-SWITCH RECOMBINATION; DEPENDENT RESPONSE; FISSION YEAST; SITES; RECRUITMENT; METHYLATION; CHROMATIN; RESECTION; CRB2	53BP1 (also called TP53BP1) is a chromatin-associated factor that promotes immunoglobulin class switching and DNA double-strand-break (DSB) repair by non-homologous end joining. To accomplish its function in DNA repair, 53BP1 accumulates at DSB sites downstream of the RNF168 ubiquitin ligase. How ubiquitin recruits 53BP1 to break sites remains unknown as its relocalization involves recognition of histone H4 Lys 20 (H4K20) methylation by its Tudor domain. Here we elucidate how vertebrate 53BP1 is recruited to the chromatin that flanks DSB sites. We show that 53BP1 recognizes mononucleosomes containing dimethylated H4K20 (H4K20me2) and H2A ubiquitinated on Lys 15 (H2AK15ub), the latter being a product of RNF168 action on chromatin. 53BP1 binds to nucleosomes minimally as a dimer using its previously characterized methyl-lysine-binding Tudor domain and a carboxy-terminal extension, termed the ubiquitination-dependent recruitment (UDR) motif, which interacts with the epitope formed by H2AK15ub and its surrounding residues on the H2A tail. 53BP1 is therefore a bivalent histone modification reader that recognizes a histone 'code' produced by DSB signalling.	[Fradet-Turcotte, Amelie; Canny, Marella D.; Escribano-Diaz, Cristina; Orthwein, Alexandre; Leung, Charles C. Y.; Huang, Hao; Landry, Marie-Claude; Noordermeer, Sylvie M.; Sicheri, Frank; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Kitevski-LeBlanc, Julianne; Sicheri, Frank; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Kitevski-LeBlanc, Julianne; Sicheri, Frank] Univ Toronto, Dept Biochem, Toronto, ON M5S 3E1, Canada; [Kitevski-LeBlanc, Julianne] Univ Toronto, Dept Chem, Toronto, ON M5S 3E1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto	Durocher, D (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	durocher@lunenfeld.ca	Noordermeer, Sylvie M/F-3517-2012; Noordermeer, Sylvie M/T-8095-2017; Durocher, Daniel/A-7733-2010; Sicheri, Frank/F-8856-2013; Fradet-Turcotte, Amelie/G-5790-2017	Noordermeer, Sylvie M/0000-0003-2737-9690; Noordermeer, Sylvie M/0000-0003-2737-9690; Durocher, Daniel/0000-0003-3863-8635; Fradet-Turcotte, Amelie/0000-0002-5431-8650; Orthwein, Alexandre/0000-0002-7350-3413	CIHR; Leukemia and Lymphoma Society; CIHR [MOP84297]; Ontario Research Fund [GL2-01-010]	CIHR(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund	We are grateful to R. Szilard, J. Cote and S. Panier for critically reading the manuscript; to L.-L. Du, A. Nussenzweig, Y. Tong and C. Arrowsmith for plasmids; to M. Cook and A. Rosebrock for centrifugal elutriation; and to B. Sauriol for help with FRAP data analysis. A.F.-T. and A.O. both receive post-doctoral fellowships from the CIHR; C.E.-D. is an Ontario Post-doctoral Fellow; J. K.-L. receives a post-doctoral fellowship from the Leukemia and Lymphoma Society; and C. C. Y. L. and M.-C. L. are post-doctoral fellows of the Canadian Breast Cancer Foundation(Ontario Division). D. D. is the Thomas Kierans Chair in Mechanisms of Cancer Development and a Canada Research Chair (Tier 1) in the Molecular Mechanisms of Genome Integrity. Work in the D. D. laboratory was supported by CIHR grant MOP84297 and grant GL2-01-010 from the Ontario Research Fund.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Nakamura TM, 2005, MOL CELL BIOL, V25, P10721, DOI 10.1128/MCB.25.24.10721-10730.2005; Panier S, 2012, MOL CELL, V47, P383, DOI 10.1016/j.molcel.2012.05.045; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; WANG AC, 1995, J BIOMOL NMR, V5, P376; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Wu LP, 2013, MOL CELL, V49, P1108, DOI 10.1016/j.molcel.2013.01.033; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	40	458	477	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2013	499	7456					50	+		10.1038/nature12318	http://dx.doi.org/10.1038/nature12318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23760478	Green Accepted			2022-12-28	WOS:000321285600030
J	Nielsen, S; Yuzenkova, Y; Zenkin, N				Nielsen, Soren; Yuzenkova, Yulia; Zenkin, Nikolay			Mechanism of Eukaryotic RNA Polymerase III Transcription Termination	SCIENCE			English	Article							STRUCTURAL BASIS; ACTIVE-CENTER; DNA HYBRID; ELONGATION	Gene expression in organisms involves many factors and is tightly controlled. Although much is known about the initial phase of transcription by RNA polymerase III (Pol III), the enzyme that synthesizes the majority of RNA molecules in eukaryotic cells, termination is poorly understood. Here, we show that the extensive structure of Pol III-synthesized transcripts dictates the release of elongation complexes at the end of genes. The poly-T termination signal, which does not cause termination in itself, causes catalytic inactivation and backtracking of Pol III, thus committing the enzyme to termination and transporting it to the nearest RNA secondary structure, which facilitates Pol III release. Similarity between termination mechanisms of Pol III and bacterial RNA polymerase suggests that hairpin-dependent termination may date back to the common ancestor of multisubunit RNA polymerases.	[Nielsen, Soren; Yuzenkova, Yulia; Zenkin, Nikolay] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England	Newcastle University - UK	Zenkin, N (corresponding author), Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Baddiley Clark Bldg,Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	n.zenkin@ncl.ac.uk		Zenkin, Nikolay/0000-0003-2212-9545; yuzenkova, yulia/0000-0003-4036-9235	UK Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council under the SysMO initiative; European Research Council [ERC-2007-StG 202994-MTP]; BBSRC [BB/J006378/1, BB/F013558/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J006378/1, BB/F013558/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council under the SysMO initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is dedicated to the memory of Denis Izyumov. We thank J. Roberts, E. Nudler, P. E. Geiduschek, and J. Brown for critical reading of the paper; G. Kassavetis, R. van Nues, H. Murray, N. Proudfoot, and P. Braglia for experimental advice; and J. Chong for help with Archaea. This work was supported by the UK Biotechnology and Biological Sciences Research Council, the Biotechnology and Biological Sciences Research Council under the SysMO initiative, and the European Research Council [grant ERC-2007-StG 202994-MTP]. Data are available in the supplementary materials.	BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; Braglia P, 2005, J BIOL CHEM, V280, P19551, DOI 10.1074/jbc.M412238200; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; Orioli A, 2012, GENE, V493, P185, DOI 10.1016/j.gene.2011.06.015; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Santangelo TJ, 2009, J BACTERIOL, V191, P7102, DOI 10.1128/JB.00982-09; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; WHITEHALL SK, 1994, J BIOL CHEM, V269, P2299; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zenkin N, 2006, NATURE, V439, P617, DOI 10.1038/nature04337; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	21	89	93	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1577	1580		10.1126/science.1237934	http://dx.doi.org/10.1126/science.1237934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812715	Green Submitted, Green Accepted			2022-12-28	WOS:000321007000043
J	Carmichael, M				Carmichael, Mary			DRUG SAFETY Double jeopardy	NATURE			English	Editorial Material							CHILDHOOD											Blanco JG, 2012, J CLIN ONCOL, V30, P1415, DOI 10.1200/JCO.2011.34.8987; Diller L, 2011, NEW ENGL J MED, V365, P1417, DOI 10.1056/NEJMcp1103645; Mulrooney DA, 2008, CANCER-AM CANCER SOC, V112, P2071, DOI 10.1002/cncr.23405; Sacco G, 2009, VASC PHARMACOL, V50, P166, DOI 10.1016/j.vph.2009.01.001; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	5	6	6	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					S14	S15		10.1038/498S14a	http://dx.doi.org/10.1038/498S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803944	Bronze			2022-12-28	WOS:000320929400008
J	Chen, L; Xin, FJ; Wang, J; Hu, JC; Zhang, YY; Wan, S; Cao, LS; Lu, C; Li, P; Yan, SF; Neumann, D; Schlattner, U; Xia, B; Wang, ZX; Wu, JW				Chen, Lei; Xin, Feng-Jiao; Wang, Jue; Hu, Jicheng; Zhang, Yuan-Yuan; Wan, Shuo; Cao, Lu-Sha; Lu, Chang; Li, Peng; Yan, S. Frank; Neumann, Dietbert; Schlattner, Uwe; Xia, Bin; Wang, Zhi-Xin; Wu, Jia-Wei			Conserved regulatory elements in AMPK	NATURE			English	Letter							ACTIVATED PROTEIN-KINASE; STRUCTURAL INSIGHT; ADP; SUBUNITS; SENSOR		[Chen, Lei; Xin, Feng-Jiao; Wang, Jue; Zhang, Yuan-Yuan; Cao, Lu-Sha; Lu, Chang; Li, Peng; Wang, Zhi-Xin; Wu, Jia-Wei] Tsinghua Univ, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Chen, Lei; Xin, Feng-Jiao; Wang, Jue; Zhang, Yuan-Yuan; Cao, Lu-Sha; Lu, Chang; Li, Peng; Wang, Zhi-Xin; Wu, Jia-Wei] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Hu, Jicheng; Wan, Shuo; Xia, Bin] Peking Univ, Coll Life Sci, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Hu, Jicheng; Wan, Shuo; Xia, Bin] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Yan, S. Frank] Roche Pharma Res & Early Dev China, Mol Design & Biostruct, Shanghai 201203, Peoples R China; [Neumann, Dietbert] Maastricht Univ, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Schlattner, Uwe] INSERM, U1055, F-38041 Grenoble 9, France; [Schlattner, Uwe] Univ Grenoble 1, Lab Fundamental & Appl Bioenerget, F-38041 Grenoble 9, France	Tsinghua University; Tsinghua University; Peking University; Peking University; Maastricht University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Chen, L (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	jiaweiwu@mail.tsinghua.edu.cn	Lu, Chang/AAL-3229-2021; wang, zhixin/GZH-2500-2022; Schlattner, Uwe/D-1267-2009	Lu, Chang/0000-0002-3272-0120; Schlattner, Uwe/0000-0003-1159-5911; Cao, Lusha/0000-0002-6157-6893; Neumann, Dietbert/0000-0002-4316-684X				Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Chen L, 2012, NAT STRUCT MOL BIOL, V19, P716, DOI 10.1038/nsmb.2319; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932	14	70	72	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					E8	E9		10.1038/nature12189	http://dx.doi.org/10.1038/nature12189			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23765502				2022-12-28	WOS:000320283400003
J	Skjerven, HO; Hunderi, JOG; Brugmann-Pieper, SK; Brun, AC; Engen, H; Eskedal, L; Haavaldsen, M; Kvenshagen, B; Lunde, J; Rolfsjord, LB; Siva, C; Vikin, T; Mowinckel, P; Carlsen, KH; Carlsen, KCL				Skjerven, Havard Ove; Hunderi, Jon Olav Gjengsto; Brugmann-Pieper, Sabine Kristin; Brun, Anne Charlotte; Engen, Hanne; Eskedal, Leif; Haavaldsen, Marius; Kvenshagen, Bente; Lunde, Jon; Rolfsjord, Leif Bjarte; Siva, Christian; Vikin, Truls; Mowinckel, Petter; Carlsen, Kai-Hakon; Carlsen, Karin C. Lodrup			Racemic Adrenaline and Inhalation Strategies in Acute Bronchiolitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYNCYTIAL-VIRUS BRONCHIOLITIS; CONTROLLED-TRIAL; NEBULIZED ADRENALINE; INFANTS; EPINEPHRINE; CHILDREN; HOSPITALIZATIONS; MULTICENTER; SALBUTAMOL; ALBUTEROL	BACKGROUND Acute bronchiolitis in infants frequently results in hospitalization, but there is no established consensus on inhalation therapy - either the type of medication or the frequency of administration - that may be of value. We aimed to assess the effectiveness of inhaled racemic adrenaline as compared with inhaled saline and the strategy for frequency of inhalation (on demand vs. fixed schedule) in infants hospitalized with acute bronchiolitis. METHODS In this eight-center, randomized, double-blind trial with a 2-by-2 factorial design, we compared inhaled racemic adrenaline with inhaled saline and on-demand inhalation with fixed-schedule inhalation (up to every 2 hours) in infants (<12 months of age) with moderate-to-severe acute bronchiolitis. An overall clinical score of 4 or higher (on a scale of 0 to 10, with higher scores indicating more severe illness) was required for study inclusion. Any use of oxygen therapy, nasogastric-tube feeding, or ventilatory support was recorded. The primary outcome was the length of the hospital stay, with analyses conducted according to the intention-to-treat principle. RESULTS The mean age of the 404 infants included in the study was 4.2 months, and 59.4% were boys. Length of stay, use of oxygen supplementation, nasogastric-tube feeding, ventilatory support, and relative improvement in the clinical score from baseline (preinhalation) were similar in the infants treated with inhaled racemic adrenaline and those treated with inhaled saline (P>0.1 for all comparisons). On-demand inhalation, as compared with fixed-schedule inhalation, was associated with a significantly shorter estimated mean length of stay - 47.6 hours (95% confidence interval [CI], 30.6 to 64.6) versus 61.3 hours (95% CI, 45.4 to 77.2; P = 0.01) - as well as less use of oxygen supplementation (in 38.3% of infants vs. 48.7%, P = 0.04), less use of ventilatory support (in 4.0% vs. 10.8%, P = 0.01), and fewer inhalation treatments (12.0 vs. 17.0, P<0.001). CONCLUSIONS In the treatment of acute bronchiolitis in infants, inhaled racemic adrenaline is not more effective than inhaled saline. However, the strategy of inhalation on demand appears to be superior to that of inhalation on a fixed schedule. (Funded by Medicines for Children; ClinicalTrials.gov number, NCT00817466; EudraCT number, 2009-012667-34.)	[Skjerven, Havard Ove; Hunderi, Jon Olav Gjengsto; Mowinckel, Petter; Carlsen, Kai-Hakon; Carlsen, Karin C. Lodrup] Univ Oslo, Oslo Univ Hosp, Dept Pediat, Oslo, Norway; [Skjerven, Havard Ove; Carlsen, Kai-Hakon; Carlsen, Karin C. Lodrup] Univ Oslo, Inst Clin Med, Oslo, Norway; [Hunderi, Jon Olav Gjengsto; Haavaldsen, Marius; Kvenshagen, Bente; Lunde, Jon] Ostfold Hosp Trust, Dept Pediat, Fredrikstad, Ostfold, Norway; [Brugmann-Pieper, Sabine Kristin] Vestre Viken Hosp Trust, Dept Pediat, Drammen, Buskerud, Norway; [Brun, Anne Charlotte; Siva, Christian] Vestfold Hosp Trust, Dept Pediat, Tonsberg, Vestfold, Norway; [Engen, Hanne] Telemark Hosp Trust, Dept Pediat, Skien, Telemark, Norway; [Eskedal, Leif] Sorlandet Hosp Trust, Dept Pediat, Kristiansand, Vest Agder, Norway; [Rolfsjord, Leif Bjarte] Innlandet Hosp Trust, Dept Pediat, Elverum, Hedmark, Norway; [Vikin, Truls] Innlandet Hosp Trust, Dept Pediat, Lillehammer, Oppland, Norway	University of Oslo; University of Oslo; Telemark Hospital Trust; Innlandet Hospital Trust; Innlandet Hospital Trust	Skjerven, HO (corresponding author), Oslo Univ Hosp, Dept Pediat, Postboks 4956 Nydalen, N-0424 Oslo, Norway.	h.o.skjerven@medisin.uio.no			Medicines for Children	Medicines for Children	Supported by Medicines for Children, a publicly funded body administered by Haukeland University Hospital.	Bacharier LB, 2008, ALLERGY, V63, P630, DOI 10.1111/j.1398-9995.2008.01739.x; Bacharier LB, 2008, ALLERGY, V63, P5, DOI 10.1111/j.1398-9995.2007.01586.x; Baumer JH, 2007, ARCH DIS CHILDHOOD-E, V92, pEP149, DOI 10.1136/adc.2007.126524; Carlsen KCL, 2000, RESP MED, V94, P709, DOI 10.1053/rmed.2000.0807; Carlsen KH, 2007, AKUTT BRONKIOLITT VE, P198; COURT SDM, 1973, POSTGRAD MED J, V49, P771, DOI 10.1136/pgmj.49.577.771; Donlan M, 2011, PEDIATR PULM, V46, P736, DOI 10.1002/ppul.21483; Hariprakash S, 2003, PEDIATR ALLERGY IMMU, V14, P134, DOI 10.1034/j.1399-3038.2003.00014.x; Hartling L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003123.pub3; Kimpen JLL, 1997, PEDIATR INFECT DIS J, V16, P479, DOI 10.1097/00006454-199705000-00004; KRISTJANSSON S, 1993, ARCH DIS CHILD, V69, P650, DOI 10.1136/adc.69.6.650; Langley Joanne M, 2005, BMC Pediatr, V5, P7, DOI 10.1186/1471-2431-5-7; LAW BJ, 1993, PEDIATR INFECT DIS J, V12, P659, DOI 10.1097/00006454-199308000-00007; Leader S, 2002, PEDIATR INFECT DIS J, V21, P629, DOI 10.1097/00006454-200207000-00005; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Mansbach JM, 2008, ACAD EMERG MED, V15, P111, DOI 10.1111/j.1553-2712.2007.00034.x; MENON K, 1995, J PEDIATR-US, V126, P1004, DOI 10.1016/S0022-3476(95)70234-2; MURDOCH DR, 1984, ARCH DIS CHILD, V59, P957, DOI 10.1136/adc.59.10.957; NEWCOMB RW, 1989, AM J DIS CHILD, V143, P481, DOI 10.1001/archpedi.1989.02150160111022; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Patel H, 2002, J PEDIATR-US, V141, P818, DOI 10.1067/mpd.2002.129844; REIJONEN T, 1995, ARCH PEDIAT ADOL MED, V149, P686, DOI 10.1001/archpedi.1995.02170190096017; SANCHEZ I, 1993, J PEDIATR-US, V122, P145, DOI 10.1016/S0022-3476(05)83508-5; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; Wainwright C, 2003, NEW ENGL J MED, V349, P27, DOI 10.1056/NEJMoa022226; WENNERGREN G, 1986, ACTA PAEDIATR SCAND, V75, P465, DOI 10.1111/j.1651-2227.1986.tb10231.x; WOHL MEB, 1978, AM REV RESPIR DIS, V118, P759, DOI 10.1164/arrd.1978.118.4.759	29	83	89	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2286	2293		10.1056/NEJMoa1301839	http://dx.doi.org/10.1056/NEJMoa1301839			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YN	23758233	Green Published			2022-12-28	WOS:000320230500004
J	Ralph, LJ; McCoy, SI; Hallett, T; Padian, N				Ralph, Lauren J.; McCoy, Sandra I.; Hallett, Timothy; Padian, Nancy			Next steps for research on hormonal contraception and HIV	LANCET			English	Editorial Material							FEASIBILITY; ACQUISITION; RISK		[Ralph, Lauren J.; McCoy, Sandra I.; Padian, Nancy] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94704 USA; [Hallett, Timothy] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	University of California System; University of California Berkeley; Imperial College London	Ralph, LJ (corresponding author), Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94704 USA.	lauren.ralph@berkeley.edu		Hallett, Timothy/0000-0002-9681-0424	NIMH NIH HHS [K01 MH094246] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH094246] Funding Source: NIH RePORTER; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Blanchard K, 2011, CONTRACEPTION, V83, P556, DOI 10.1016/j.contraception.2010.10.018; Butler AR, 2013, AIDS, V27, P105, DOI 10.1097/QAD.0b013e32835a5a52; Feldblum PJ, 2005, CONTRACEPTION, V72, P187, DOI 10.1016/j.contraception.2005.03.006; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hernan MA, 2012, CLIN TRIALS, V9, P48, DOI 10.1177/1740774511420743; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Hubacher D, 2008, CONTRACEPTION, V77, P366, DOI 10.1016/j.contraception.2008.01.006; Jain AK, 2012, CONTRACEPTION, V86, P645, DOI 10.1016/j.contraception.2012.03.008; Morrison CS, 2012, LANCET INFECT DIS, V12, P2, DOI 10.1016/S1473-3099(11)70254-7; Polis CB, 2012, XIX INTERNATIONAL AI; Pollack AE, 2007, REPORT PREPARED FOR; Singh S, 2009, ADDING IT UP THE COS; Smith J, 2013, 20TH CONFERENCE ON R, P114; Stringer EM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.031; Toh S., 2008, INT J BIOSTAT, DOI [10.2202/1557-4679.1117, DOI 10.2202/1557-4679.1117]; United Nations, 1994, UNITED NATIONS INTER; World Health Organization, 2012, HORMONAL CONTRACEPTI	17	19	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1467	1469		10.1016/S0140-6736(13)61420-8	http://dx.doi.org/10.1016/S0140-6736(13)61420-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247MR	23810224				2022-12-28	WOS:000326622500008
J	Hellstrom, A; Smith, LEH; Dammann, O				Hellstrom, Ann; Smith, Lois E. H.; Dammann, Olaf			Retinopathy of prematurity	LANCET			English	Article							GROWTH-FACTOR-I; OXYGEN-INDUCED RETINOPATHY; EXTREMELY PRETERM INFANTS; FOR-GESTATIONAL-AGE; POSTNATAL WEIGHT-GAIN; STANFORD-UNIVERSITY NETWORK; SCREENING ALGORITHM WINROP; TERM VISUAL OUTCOMES; BIRTH-WEIGHT; THRESHOLD RETINOPATHY	The immature retinas of preterm neonates are susceptible to insults that disrupt neurovascular growth, leading to retinopathy of prematurity. Suppression of growth factors due to hyperoxia and loss of the maternal-fetal interaction result in an arrest of retinal vascularisation (phase 1). Subsequently, the increasingly metabolically active, yet poorly vascularised, retina becomes hypoxic, stimulating growth factor-induced vasoproliferation (phase 2), which can cause retinal detachment. In very premature infants, controlled oxygen administration reduces but does not eliminate retinopathy of prematurity. Identification and control of factors that contribute to development of retinopathy of prematurity is essential to prevent progression to severe sight-threatening disease and to limit comorbidities with which the disease shares modifiable risk factors. Strategies to prevent retinopathy of prematurity will depend on optimisation of oxygen saturation, nutrition, and normalisation of concentrations of essential factors such as insulin-like growth factor 1 and omega-3 polyunsaturated fatty acids, as well as curbing of the effects of infection and inflammation to promote normal growth and limit suppression of neurovascular development.	[Hellstrom, Ann] Univ Gothenburg, Dept Ophthalmol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Smith, Lois E. H.] Boston Childrens Hosp, Dept Ophthalmol, Boston, MA USA; [Smith, Lois E. H.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Dammann, Olaf] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Dammann, Olaf] Floating Hosp Children, Tufts Med Ctr, Boston, MA USA; [Dammann, Olaf] Hannover Med Sch, Dept Gynaecol & Obstet, Perinatal Neuroepidemiol Unit, Hannover, Germany	University of Gothenburg; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Department of Public Health; Tufts University; Floating Hospital For Children; Tufts Medical Center; Hannover Medical School	Dammann, O (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, 136 Harrison Ave, Boston, MA 02111 USA.	olaf.dammann@tufts.edu		Hellstrom, Ann/0000-0002-9259-1244	Swedish Medical Research Council [2011-2432]; Swedish Government [ALFGB-137491]; VINNOVA [2009-00221]; Research to Prevent Blindness Senior Investigator Award; US National Institutes of Health [NEI EY017017, NEI EY022275, NIH P01 HD18655]; Lowy Medical Foundation; US National Eye Institute [EY021820]; US National Institute of Neurological Disorders and Stroke (ELGAN) [NS040069]; European Union [NEUROBID 241778, NEO-CIRC 282533]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021820, R01EY022275, R01EY017017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS040069] Funding Source: NIH RePORTER	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Government; VINNOVA(Vinnova); Research to Prevent Blindness Senior Investigator Award(Research to Prevent Blindness (RPB)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lowy Medical Foundation; US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institute of Neurological Disorders and Stroke (ELGAN); European Union(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	AH received support from the Swedish Medical Research Council (2011-2432), a Swedish Government grant (ALFGB-137491), and VINNOVA (2009-00221). LEHS received support from a Research to Prevent Blindness Senior Investigator Award, US National Institutes of Health grants (NEI EY017017, NEI EY022275, NIH P01 HD18655), and from the Lowy Medical Foundation. OD was supported by a grant from the US National Eye Institute (EY021820), a cooperative agreement with the US National Institute of Neurological Disorders and Stroke (ELGAN, NS040069), and by grants from the European Union (NEUROBID 241778, NEO-CIRC 282533). The authors thank Anna-Lena Hard for her contribution to researching the clinical data for the Seminar.	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Allegaert K, 2004, BRIT J OPHTHALMOL, V88, P239, DOI 10.1136/bjo.2003.027474; Allegaert K, 2003, J AAPOS, V7, P34, DOI 10.1016/S1091-8531(02)42015-0; Anderson Christina G, 2004, J Perinatol, V24, P164, DOI 10.1038/sj.jp.7211067; ASHTON N, 1954, BRIT J OPHTHALMOL, V38, P385, DOI 10.1136/bjo.38.7.385; Askie LM, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-6; Askie LM, 2003, NEW ENGL J MED, V349, P959, DOI 10.1056/NEJMoa023080; Austeng D, 2011, ARCH OPHTHALMOL-CHIC, V129, P167, DOI 10.1001/archophthalmol.2010.346; Austeng D, 2010, ACTA PAEDIATR, V99, P978, DOI 10.1111/j.1651-2227.2010.01846.x; Austeng D, 2009, ARCH OPHTHALMOL-CHIC, V127, P1315, DOI 10.1001/archophthalmol.2009.244; Aydemir O, 2011, EYE, V25, P725, DOI 10.1038/eye.2011.29; Bardin C, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.2.e4; Binenbaum G, 2011, PEDIATRICS, V127, pE607, DOI 10.1542/peds.2010-2240; Blanco CL, 2006, J PERINATOL, V26, P737, DOI 10.1038/sj.jp.7211594; BOLTON DPG, 1974, LANCET, V1, P445; Brooks SE, 1999, PEDIATRICS, V104, P514, DOI 10.1542/peds.104.3.514; CAMPBELL K, 1951, Med J Aust, V2, P48; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Castillo A, 2011, ACTA PAEDIATR, V100, P188, DOI 10.1111/j.1651-2227.2010.02001.x; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Chen J, 2012, INVEST OPHTH VIS SCI, V53, P2968, DOI 10.1167/iovs.12-9691; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; Chen MH, 2011, NEONATOLOGY, V99, P125, DOI 10.1159/000312821; Chen ML, 2011, INVEST OPHTH VIS SCI, V52, P7052, DOI 10.1167/iovs.11-7380; Chen ML, 2010, PEDIATRICS, V125, pE1483, DOI 10.1542/peds.2009-2218; Chen TC, 2010, INVEST OPHTH VIS SCI, V51, P6140, DOI 10.1167/iovs.10-5234; Chow LC, 2003, PEDIATRICS, V111, P339, DOI 10.1542/peds.111.2.339; Coleman RJ, 2008, PEDIATR RES, V64, P50, DOI 10.1203/PDR.0b013e31817307ac; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Zepeda-Romero LC, 2012, ARCH OPHTHALMOL-CHIC, V130, P720, DOI 10.1001/archophthalmol.2012.215; COOKE RWI, 1993, EUR J PEDIATR, V152, P833, DOI 10.1007/BF02073381; Crawford MA, 2003, LIPIDS, V38, P303, DOI 10.1007/s11745-003-1065-1; CUNNINGHAM S, 1995, LANCET, V346, P1464, DOI 10.1016/S0140-6736(95)92475-2; Dammann O, 2010, ACTA PAEDIATR, V99, P975, DOI 10.1111/j.1651-2227.2010.01836.x; Dammann O, 2009, EARLY HUM DEV, V85, P325, DOI 10.1016/j.earlhumdev.2008.12.010; Darlow BA, 2005, PEDIATRICS, V115, P990, DOI 10.1542/peds.2004-1309; Darlow BA, 2013, ARCH DIS CHILD-FETAL, V98, pF170, DOI 10.1136/archdischild-2011-301148; Darlow BA, 2012, BMC NURS, V11, DOI 10.1186/1472-6955-11-3; Demendi C, 2012, EUR J OBSTET GYN R B, V160, P40, DOI 10.1016/j.ejogrb.2011.10.005; Dhaliwal CA, 2009, ARCH DIS CHILD-FETAL, V94, pF193, DOI 10.1136/adc.2008.143552; Di Fiore JM, 2010, J PEDIATR-US, V157, P69, DOI 10.1016/j.jpeds.2010.01.046; Eckert GU, 2012, EYE, V26, P400, DOI 10.1038/eye.2011.334; Elsas FJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P417; Elsas FJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1110; Ertl T, 2006, BIOL NEONATE, V89, P56, DOI 10.1159/000088199; Farooqi A, 2011, PEDIATRICS, V127, pE1247, DOI 10.1542/peds.2010-0806; Fielder AR, 2005, ARCH OPHTHALMOL-CHIC, V123, P392, DOI 10.1001/archopht.123.3.392; Fierson WM, 2013, PEDIATRICS, V131, P189, DOI 10.1542/peds.2012-2996; Filippi L, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-83; Fledelius HC, 2000, ACTA OPHTHALMOL SCAN, V78, P359, DOI 10.1034/j.1600-0420.2000.078003359.x; Fluckiger S, 2011, KLIN MONATSBL AUGENH, V228, P306, DOI 10.1055/s-0031-1273217; Fortes JB, 2009, J PEDIAT-BRAZIL, V85, P48, DOI 10.2223/JPED.1870; Fortes JB, 2009, GRAEF ARCH CLIN EXP, V247, P831, DOI 10.1007/s00417-008-1012-3; Fryklund L, US Patent, Patent No. 6034059; Fulton AB, 2009, PROG RETIN EYE RES, V28, P452, DOI 10.1016/j.preteyeres.2009.06.003; Garg Ruchira, 2003, J Perinatol, V23, P186, DOI 10.1038/sj.jp.7210879; GARNER A, 1984, PEDIATRICS, V74, P127; Giannantonio C, 2012, J MATERN-FETAL NEO M, V25, P471, DOI 10.3109/14767058.2011.587056; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Good WV, 2001, OPHTHALMOLOGY, V108, P1013, DOI 10.1016/S0161-6420(01)00540-1; Gunn DJ, 2012, CLIN EXP OPHTHALMOL, V40, P93, DOI 10.1111/j.1442-9071.2011.02724.x; GYLLENSTEN L J, 1955, Br J Ophthalmol, V39, P409, DOI 10.1136/bjo.39.7.409; Haines L, 2005, ARCH DIS CHILD-FETAL, V90, P240, DOI 10.1136/adc.2004.057570; Haines L, 2002, EYE, V16, P33, DOI 10.1038/sj.eye.6700030; Hameed B, 2004, PEDIATRICS, V113, P1653, DOI 10.1542/peds.113.6.1653; Hansen RM, 2010, DOC OPHTHALMOL, V121, P29, DOI 10.1007/s10633-010-9228-z; Hansen-Pupp I, 2011, J CLIN ENDOCR METAB, V96, P1129, DOI 10.1210/jc.2010-2440; Hansen-Pupp I, 2011, PEDIATR RES, V69, P448, DOI 10.1203/PDR.0b013e3182115000; Hard AL, 2011, ACTA PAEDIATR, V100, P1523, DOI 10.1111/j.1651-2227.2011.02445.x; Hard AL, 2011, ACTA PAEDIATR, V100, P1063, DOI 10.1111/j.1651-2227.2011.02330.x; Hard AL, 2010, ARCH OPHTHALMOL-CHIC, V128, P1432, DOI 10.1001/archophthalmol.2010.255; Harder BC, 2011, J OCUL PHARMACOL TH, V27, P623, DOI 10.1089/jop.2011.0060; Hardy RJ, 2003, ARCH OPHTHALMOL-CHIC, V121, P1697, DOI 10.1001/archopht.121.12.1697; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Heidary G, 2009, SEMIN OPHTHALMOL, V24, P77, DOI 10.1080/08820530902800314; Hellstrom A, 2002, J CLIN ENDOCR METAB, V87, P3413, DOI 10.1210/jc.87.7.3413; Hellstrom A, 2001, P NATL ACAD SCI USA, V98, P5804, DOI 10.1073/pnas.101113998; Hellstrom A, 2003, PEDIATRICS, V112, P1016, DOI 10.1542/peds.112.5.1016; Hellstrom A, 2009, PEDIATRICS, V123, pE638, DOI 10.1542/peds.2008-2697; Holmstrom GE, 2012, ARCH OPHTHALMOL-CHIC, V130, P1418, DOI 10.1001/archophthalmol.2012.2357; Howlett A, 2012, COCHRANE DB SYST REV, V3; Husain SM, 2013, J PEDIATR-US, V163, P67, DOI 10.1016/j.jpeds.2012.12.038; Kaempf JW, 2011, J PERINATOL, V31, P251, DOI 10.1038/jp.2010.152; Kleberg A, 2008, PEDIATRICS, V121, pE1267, DOI 10.1542/peds.2006-2510; Lad EM, 2008, BRIT J OPHTHALMOL, V92, P320, DOI 10.1136/bjo.2007.126201; Lad EM, 2009, AM J OPHTHALMOL, V148, P451, DOI 10.1016/j.ajo.2009.04.018; Larnkjaer A, 2012, CURR OPIN CLIN NUTR, V15, P285, DOI 10.1097/MCO.0b013e328351c472; LASSARRE C, 1991, PEDIATR RES, V29, P219, DOI 10.1203/00006450-199103000-00001; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lee J, 2012, SEMIN FETAL NEONAT M, V17, P26, DOI 10.1016/j.siny.2011.08.007; Leviton A, 2010, ACTA PAEDIATR, V99, P1795, DOI 10.1111/j.1651-2227.2010.01973.x; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; LINEHAM JD, 1986, EARLY HUM DEV, V13, P37, DOI 10.1016/0378-3782(86)90096-4; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; Lofqvist C, 2006, PEDIATRICS, V117, P1930, DOI 10.1542/peds.2005-1926; Lofqvist C, 2009, PEDIATR RES, V65, P574, DOI 10.1203/PDR.0b013e31819d9e8c; Lofqvist C, 2006, ARCH OPHTHALMOL-CHIC, V124, P1711, DOI 10.1001/archopht.124.12.1711; Loqvist C, 2009, ARCH OPHTHALMOL-CHIC, V127, P622, DOI 10.1001/archophthalmol.2009.69; Lundqvist P, 2009, ACTA PAEDIATR, V98, P648, DOI 10.1111/j.1651-2227.2008.01155.x; Manzoni P, 2006, J PERINATOL, V26, P23, DOI 10.1038/sj.jp.7211420; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Mataftsi A, 2011, EARLY HUM DEV, V87, P683, DOI 10.1016/j.earlhumdev.2011.05.009; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Mittal M, 1998, PEDIATRICS, V101, P654, DOI 10.1542/peds.101.4.654; Msall ME, 2004, PEDIATRICS, V113, P790, DOI 10.1542/peds.113.4.790; Murakami Y, 2010, ACTA OPHTHALMOL, V88, P317, DOI 10.1111/j.1755-3768.2009.01715.x; NICOLAIDES KH, 1989, AM J OBSTET GYNECOL, V161, P996, DOI 10.1016/0002-9378(89)90770-9; PALMER EA, 1988, ARCH OPHTHALMOL-CHIC, V106, P471; Palmer EA, 2005, ARCH OPHTHALMOL-CHIC, V123, P311; PALMER EA, 1991, OPHTHALMOLOGY, V98, P1628; Parad RB, 2012, NEONATOLOGY, V102, P139, DOI 10.1159/000336639; PATZ A, 1952, AM J OPHTHALMOL, V35, P1248, DOI 10.1016/0002-9394(52)91140-9; Pawlik D, 2011, PEDIATRICS, V127, P223, DOI 10.1542/peds.2010-2427; PENN JS, 1994, PEDIATR RES, V36, P724, DOI 10.1203/00006450-199412000-00007; PENN JS, 1995, INVEST OPHTH VIS SCI, V36, P2063; PENN JS, 1993, INVEST OPHTH VIS SCI, V34, P576; Perez-Munuzuri A, 2010, ACTA PAEDIATR, V99, P519, DOI 10.1111/j.1651-2227.2009.01677.x; Phelps DL, 2000, PEDIATRICS, V105, P295; Phelps DL, 2001, COCHRANE DB SYST REV, V1; Pierce EA, 1996, ARCH OPHTHALMOL-CHIC, V114, P1219, DOI 10.1001/archopht.1996.01100140419009; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Qiu XM, 2012, AM J PERINAT, V29, P87, DOI 10.1055/s-0031-1295647; Quinn GE, 2004, ARCH OPHTHALMOL-CHIC, V122, P1659; Quinn GE, 2011, ARCH OPHTHALMOL-CHIC, V129, P840; Raghuveer TS, 2011, NEONATOLOGY, V100, P116, DOI 10.1159/000322848; Raju TNK, 1997, J PEDIATR-US, V131, P844, DOI 10.1016/S0022-3476(97)70031-3; REECE EA, 1994, OBSTET GYNECOL, V84, P88; Regev RH, 2003, J PEDIATR-US, V143, P186, DOI 10.1067/S0022-3476(03)00181-1; Repka MX, 2011, ARCH OPHTHALMOL-CHIC, V129, P1175, DOI 10.1001/archophthalmol.2011.229; Repka MX, 2002, MENT RETARD DEV D R, V8, P249, DOI 10.1002/mrdd.10045; Rivera JC, 2011, NEONATOLOGY, V100, P343, DOI 10.1159/000330174; SAITO Y, 1993, GRAEF ARCH CLIN EXP, V231, P151, DOI 10.1007/BF00920938; Salcone EM, 2010, SEMIN OPHTHALMOL, V25, P214, DOI 10.3109/08820538.2010.523671; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; Shah DN, 2011, BRIT J OPHTHALMOL, V95, P1442, DOI 10.1136/bjo.2010.185363; Shah PK, 2012, ARCH DIS CHILD-FETAL, V97, pF371, DOI 10.1136/fetalneonatal-2011-301121; Shastry BS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-69; Silva RA, 2011, OPHTHAL SURG LAS IM, V42, P1, DOI 10.3928/15428877-20100929-08; Silverman W. A., 1980, RETROLENTAL FIBROPLA; Singh R, 2012, BRIT J OPHTHALMOL, V96, P1395, DOI 10.1136/bjophthalmol-2011-301353; Slidsborg C, 2012, ARCH OPHTHALMOL-CHIC, V130, P1410, DOI 10.1001/archophthalmol.2012.1393; Slidsborg C, 2012, BRIT J OPHTHALMOL, V96, P549, DOI 10.1136/bjophthalmol-2011-300573; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Smith LEH, 1997, SCIENCE, V276, P1706, DOI 10.1126/science.276.5319.1706; Smith LEH, 2008, INVEST OPHTH VIS SCI, V49, P5177, DOI 10.1167/iovs.08-2584; Sood BG, 2010, PEDIATR RES, V67, P394, DOI 10.1203/PDR.0b013e3181d01a36; Stenson B, 2011, NEW ENGL J MED, V364, P1680, DOI 10.1056/NEJMc1101319; Sun SC, 2002, PEDIATR RES, V51, p350A; Tan SZ, 2012, ARCH DIS CHILD-FETAL, V97, pF310, DOI 10.1136/fetalneonatal-2011-301464; Tin W, 2001, ARCH DIS CHILD-FETAL, V84, pF106, DOI 10.1136/fn.84.2.F106; Tolsma KW, 2011, ARCH OPHTHALMOL-CHIC, V129, P1555, DOI 10.1001/archophthalmol.2011.319; Tommiska V, 2007, PEDIATRICS, V119, P29, DOI 10.1542/peds.2006-1472; Vander Veen DK, 2011, J AAPOS, V15, P536, DOI 10.1016/j.jaapos.2011.07.017; Wallace DK, 2000, J AAPOS, V4, P343, DOI 10.1067/mpa.2000.110342; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; Weber C, 2005, WIEN KLIN WOCHENSCHR, V117, P740, DOI 10.1007/s00508-005-0468-y; WILSON A, 1992, J ROY SOC MED, V85, P1; Wilson DC, 1997, ARCH DIS CHILD-FETAL, V77, pF4, DOI 10.1136/fn.77.1.F4; Wittenberg LA, 2012, J PEDIAT OPHTH STRAB, V49, P11, DOI 10.3928/01913913-20110222-01; Wu C, 2012, ARCH OPHTHALMOL-CHIC, V130, P992, DOI 10.1001/archophthalmol.2012.243; Wu C, 2010, ARCH OPHTHALMOL-CHIC, V128, P443, DOI 10.1001/archophthalmol.2010.31; Yang CS, 2010, EYE, V24, P14, DOI 10.1038/eye.2009.63; York Jackie R, 2004, J Perinatol, V24, P82, DOI 10.1038/sj.jp.7211040; Zepeda-Romero LC, 2011, EYE, V25, P1337, DOI 10.1038/eye.2011.170; Zin AA, 2010, PEDIATRICS, V126, pE410, DOI 10.1542/peds.2010-0090	171	487	515	6	93	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2013	382	9902					1445	1457		10.1016/S0140-6736(13)60178-6	http://dx.doi.org/10.1016/S0140-6736(13)60178-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242JW	23782686	Green Accepted, Green Submitted			2022-12-28	WOS:000326237500029
J	Stockl, H; Devries, K; Rotstein, A; Abrahams, N; Campbell, J; Watts, C; Moreno, CG				Stoeckl, Heidi; Devries, Karen; Rotstein, Alexandra; Abrahams, Naeemah; Campbell, Jacquelyn; Watts, Charlotte; Moreno, Claudia Garcia			The global prevalence of intimate partner homicide: a systematic review	LANCET			English	Review							VIOLENCE; CHICAGO; MURDER; KILLS	Background Homicide is an important cause of premature mortality globally, but evidence for the magnitude of homicides by intimate partners is scarce and hampered by the large amount of missing information about the victim-off ender relationship. The objective of the study was to estimate global and regional prevalence of intimate partner homicide. Methods A systematic search of five databases (Medline, Global Health, Embase, Social Policy, and Web of Science) yielded 2167 abstracts, and resulted in the inclusion of 118 full-text articles with 1122 estimates of the prevalence of intimate partner homicide after double-blind screening. All studies were included that reported the number or proportion of women or men who were murdered by an intimate partner in a country, province, or town, using an inclusive definition of an intimate partner. Additionally, a survey of official sources of 169 countries provided a further 53 estimates. We selected one estimate per country-year using a quality assessment decision algorithm. The median prevalence of intimate partner homicide was calculated by country and region overall, and for women and men separately. Findings Data were obtained for 66 countries. Overall 13.5% (IQR 9.2-18.2) of homicides were committed by an intimate partner, and this proportion was six times higher for female homicides than for male homicides (38.6%, 30.8-45.3, vs 6.3%, 3.1-6.3). Median percentages for all (male and female) and female intimate partner homicide were highest in high-income countries (all, 14.9%, 9.2-18.2; female homicide, 41.2%, 30.8-44.5) and in southeast Asia (18.8%, 11.3-18.8; 58.8%, 58.8-58.8). Adjustments to account for unknown victim-off ender relationships generally increased the prevalence, suggesting that results presented are conservative. Interpretation At least one in seven homicides globally and more than a third of female homicides are perpetrated by an intimate partner. Such violence commonly represents the culmination of a long history of abuse. Strategies to reduce homicide risk include increased investment in intimate partner violence prevention, risk assessments at different points of care, support for women experiencing intimate partner violence, and control of gun ownership for people with a history of violence. Improvements in country-level data collection and monitoring systems are also essential, because data availability and quality varied strongly across regions.	[Stoeckl, Heidi; Devries, Karen; Watts, Charlotte] Univ London London Sch Hyg & Trop Med, Social & Math Epidemiol Grp, Dept Global Hlth & Dev, London WC1H 9SH, England; [Rotstein, Alexandra] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada; [Abrahams, Naeemah] South African Med Res Council, Gender & Hlth Res Unit, Cape Town, South Africa; [Campbell, Jacquelyn] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA; [Moreno, Claudia Garcia] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; McMaster University; South African Medical Research Council; Johns Hopkins University; World Health Organization	Stockl, H (corresponding author), Univ London London Sch Hyg & Trop Med, Social & Math Epidemiol Grp, Dept Global Hlth & Dev, London WC1H 9SH, England.	heidi.stoeckl@lshtm.ac.uk	Moreno, Claudia/GRJ-1036-2022; Devries, Karen/K-1083-2016; Abrahams, Naeemah/AAF-1144-2020	Devries, Karen/0000-0001-8935-2181; Abrahams, Naeemah/0000-0002-6138-6256; Stockl, Heidi/0000-0002-0907-8483	WHO; Sigrid Rausing Trust; UK Economic and Social Research Council; Economic and Social Research Council [ES/I003045/1] Funding Source: researchfish; ESRC [ES/I003045/1] Funding Source: UKRI	WHO(World Health Organization); Sigrid Rausing Trust; UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	WHO, Sigrid Rausing Trust, and the UK Economic and Social Research Council.	Abrahams N, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001412; Block CR, 2012, HOMICIDE STUD, V16, P404, DOI 10.1177/1088767912461142; BLOCK CR, 1995, CRIME DELINQUENCY, V41, P496, DOI 10.1177/0011128795041004008; Campbell JC, 2007, TRAUMA VIOLENCE ABUS, V8, P246, DOI 10.1177/1524838007303505; Campbell JC, 2001, CLINICAL ASSESSMENT OF DANGEROUSNESS, P136; Cooper A., 2011, HOMICIDE TRENDS US 1; Dador J, 2008, FERMINICIDIO MONITOR; Dobash RP, 2012, VIOLENCE AGAINST WOM, V18, P662, DOI 10.1177/1077801212453984; GARTNER R, 1991, LAW SOC REV, V25, P287, DOI 10.2307/3053800; GARTNER R, 1990, SOC FORCES, V69, P351, DOI 10.2307/2579663; Geneva Declaration Secretariat, 2011, GLOB BURD ARM VIOL 2; Hilton NZ, 2008, LAW HUMAN BEHAV, V32, P150, DOI 10.1007/s10979-007-9088-6; Johnston H., 2003, HOMICIDE STUD, V7, P58, DOI DOI 10.1177/1088767902239243; Kaplan T, 1998, FAM PROCESS, V37, P479, DOI 10.1111/j.1545-5300.1998.00479.x; Kropp P. R., 2005, PROACTIVE RESOLUTION; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Lewandowski LA, 2004, J FAM VIOLENCE, V19, P211, DOI 10.1023/B:JOFV.0000032631.36582.23; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Murphy CM, 2010, PARTN ABUSE, V1, P26, DOI 10.1891/1946-6560.1.1.26; Paulozzi L J, 2001, MMWR CDC Surveill Summ, V50, P1; Regoeczi WC, 2003, J QUANT CRIMINOL, V19, P155, DOI 10.1023/A:1023002220545; RIEDEL M, 1998, HOMICIDE STUDIES, V0002; Sanmartin J., 2010, 3 INFORM INT VIOLENC; Sanmartin J., 2003, INFORM INT 2003 VIOL; Sanmartin J, 2007, 2 INFORM INT VIOLENC; Smith K, 2011, FIREARM OFFENCES I S, V2; The World Bank, COUNTR LEND GROUPS; UN Office on Drugs and Crime, 2011, GLOB STUD HOM 2011; Vigdor ER, 2006, EVALUATION REV, V30, P313, DOI 10.1177/0193841X06287307; Wilson M, 1993, Violence Vict, V8, P3; WILSON MI, 1992, CRIMINOLOGY, V30, P189, DOI 10.1111/j.1745-9125.1992.tb01102.x; Zahn M.A., 1999, HOMICIDE SOURCEBOOK	33	454	469	8	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2013	382	9895					859	865		10.1016/S0140-6736(13)61030-2	http://dx.doi.org/10.1016/S0140-6736(13)61030-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215WE	23791474	Bronze, Green Accepted			2022-12-28	WOS:000324240700027
J	Xiong, XL; Martin, SR; Haire, LF; Wharton, SA; Daniels, RS; Bennett, MS; McCauley, JW; Collins, PJ; Walker, PA; Skehel, JJ; Gamblin, SJ				Xiong, Xiaoli; Martin, Stephen R.; Haire, Lesley F.; Wharton, Stephen A.; Daniels, Rodney S.; Bennett, Michael S.; McCauley, John W.; Collins, Patrick J.; Walker, Philip A.; Skehel, John J.; Gamblin, Steven J.			Receptor binding by an H7N9 influenza virus from humans	NATURE			English	Article							HUMAN INFECTION; A VIRUSES; HEMAGGLUTININ; TRANSMISSION; FUSION; H9N2; PATHOGENICITY; CELL	Of the 132 people known to have been infected with H7N9 influenza viruses in China, 37 died, and many were severely ill(1). Infection seems to have involved contact with infected poultry(2,3). We have examined the receptor-binding properties of this H7N9 virus and compared them with those of an avian H7N3 virus. We find that the human H7 virus has significantly higher affinity for alpha-2, 6-linked sialic acid analogues ('human receptor') than avian H7 while retaining the strong binding to alpha-2,3-linked sialic acid analogues ('avian receptor') characteristic of avian viruses. The human H7 virus does not, therefore, have the preference for human versus avian receptors characteristic of pandemic viruses. X-ray crystallography of the receptor-binding protein, haemagglutinin (HA), in complex with receptor analogues indicates that both human and avian receptors adopt different conformations when bound to human H7 HA than they do when bound to avian H7 HA. Human receptor bound to human H7 HA exits the binding site in a different direction to that seen in complexes formed by HAs from pandemic viruses(4,5) and from an aerosol-transmissible H5 mutant(6). The human-receptor-binding properties of human H7 probably arise from the introduction of two bulky hydrophobic residues by the substitutions Gln226Leu and Gly186Val. The former is shared with the 1957 H2 and 1968 H3 pandemic viruses and with the aerosol-transmissible H5 mutant. We conclude that the human H7 virus has acquired some of the receptor-binding characteristics that are typical of pandemic viruses, but its retained preference for avian receptor may restrict its further evolution towards a virus that could transmit efficiently between humans, perhaps by binding to avian-receptor-rich mucins in the human respiratory tract(7) rather than to cellular receptors.	[Xiong, Xiaoli; Martin, Stephen R.; Haire, Lesley F.; Collins, Patrick J.; Walker, Philip A.; Skehel, John J.; Gamblin, Steven J.] Ridgeway, Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England; [Wharton, Stephen A.; Daniels, Rodney S.; Bennett, Michael S.; McCauley, John W.] Ridgeway, Natl Inst Med Res, MRC, WHO Collaborating Ctr Reference & Res Influenza, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Gamblin, SJ (corresponding author), Ridgeway, Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	skeheljj@nimr.mrc.ac.uk; sgambli@nimr.mrc.ac.uk		Gamblin, Steve/0000-0001-5331-639X; Xiong, Xiaoli/0000-0002-4632-9122	Medical Research Council [U117584222, U117570592, U117585868, U117512723]; Medical Research Council [MC_U117584222, MC_U117585868] Funding Source: researchfish; MRC [MC_U117584222, MC_U117585868] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge Y. Shu for sharing information and samples on recent H7N9 virus infections. We are grateful to staff at the Diamond Light Source Synchrotron for assistance and beamline access under proposal 7707 and the staff of the NIMR Large Scale laboratory. This work was funded by the Medical Research Council through programmes U117584222, U117570592, U117585868 and U117512723.	Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garten W, 1999, TRENDS MICROBIOL, V7, P99, DOI 10.1016/S0966-842X(99)01460-2; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; RUIGROK RWH, 1986, VIROLOGY, V155, P484, DOI 10.1016/0042-6822(86)90210-2; Russell RJ, 2006, GLYCOCONJUGATE J, V23, P85, DOI 10.1007/s10719-006-5440-1; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1971, VIROLOGY, V44, P396, DOI 10.1016/0042-6822(71)90270-4; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; World Health Organization, 2013, 8 WHO, V15, P45; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787	29	237	254	0	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					496	+		10.1038/nature12372	http://dx.doi.org/10.1038/nature12372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23787694				2022-12-28	WOS:000322157900044
J	Gellad, WF; Donohue, JM; Zhao, XH; Mor, MK; Thorpe, CT; Smith, J; Good, CB; Fine, MJ; Morden, NE				Gellad, Walid F.; Donohue, Julie M.; Zhao, Xinhua; Mor, Maria K.; Thorpe, Carolyn T.; Smith, Jeremy; Good, Chester B.; Fine, Michael J.; Morden, Nancy E.			Brand-Name Prescription Drug Use Among Veterans Affairs and Medicare Part D Patients With Diabetes A National Cohort Comparison	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE-SYSTEM; QUALITY-OF-CARE; GEOGRAPHIC-VARIATION; OLDER-ADULTS; COST; PRICES; IMPLEMENTATION; HYPERTENSION; MEDICATIONS; PHYSICIANS	Background: Medicare Part D and the U.S. Department of Veterans Affairs (VA) use different approaches to manage prescription drug benefits, with implications for spending. Medicare relies on private plans with distinct formularies, whereas the VA administers its own benefit using a national formulary. Objective: To compare overall and regional rates of brand-name drug use among older adults with diabetes in Medicare and the VA. Design: Retrospective cohort. Setting: Medicare and the VA, 2008. Patients: 1 061 095 Medicare Part D beneficiaries and 510 485 veterans aged 65 years or older with diabetes. Measurements: Percentage of patients taking oral hypoglycemics, statins, and angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) who filled brand-name drug prescriptions and percentage of patients taking long-acting insulins who filled analogue prescriptions. Sociodemographic-and health status-adjusted hospital referral region (HRR) brand-name drug use was compared, and changes in spending were calculated if use of brand-name drugs in 1 system mirrored the other. Results: Brand-name drug use in Medicare was 2 to 3 times that in the VA: 35.3% versus 12.7% for oral hypoglycemics, 50.7% versus 18.2% for statins, 42.5% versus 20.8% for ACE inhibitors or ARBs, and 75.1% versus 27.0% for insulin analogues. Adjusted HRR-level brand-name statin use ranged (from the 5th to 95th percentiles) from 41.0% to 58.3% in Medicare and 6.2% to 38.2% in the VA. For each drug group, the 95th-percentile HRR in the VA had lower brand-name drug use than the 5th-percentile HRR in Medicare. Medicare spending in this population would have been $1.4 billion less if brand-name drug use matched that of the VA. Limitation: This analysis cannot fully describe the factors underlying differences in brand-name drug use. Conclusion: Medicare beneficiaries with diabetes use 2 to 3 times more brand-name drugs than a comparable group within the VA, at substantial excess cost.	Univ Pittsburgh, RAND Corp, Vet Affairs Pittsburgh Healthcare Syst, Grad Sch Publ Hlth,Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA; Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA; [Smith, Jeremy; Morden, Nancy E.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; US Dept Vet Affairs, Pharm Benefits Management Serv, Hines, IL USA; Geisel Sch Med Dartmouth, Hanover, NH USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College; US Department of Veterans Affairs; Dartmouth College	Gellad, WF (corresponding author), Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, 7180 Highland Dr, Pittsburgh, PA 15206 USA.	walid.gellad@va.gov	Good, Chester B/K-2818-2019	Good, Chester B/0000-0003-4388-4558; Donohue, Julie/0000-0003-2418-6017	U.S. Department of Veterans Affairs; National Institutes of Health; Robert Wood Johnson Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS017695] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG035030, P01AG019783] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Primary Funding Source: U.S. Department of Veterans Affairs, National Institutes of Health, and Robert Wood Johnson Foundation.	Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; [Anonymous], 2011, TREATMENT GUIDELINES, V9, P47; Antos JR, 2012, NEW ENGL J MED, V367, P954, DOI 10.1056/NEJMsb1207996; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Barnett ML, 2012, MED CARE, V50, P152, DOI 10.1097/MLR.0b013e31822dcef7; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Choudhry NK, 2010, NEW ENGL J MED, V363, P1885, DOI 10.1056/NEJMp1006189; Congressional Budget Office, 2010, EFF US GEN DRUGS MED; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Donohue JM, 2012, NEW ENGL J MED, V366, P530, DOI 10.1056/NEJMsa1104816; Donohue JM, 2011, AM J GERIAT PSYCHIAT, V19, P989, DOI 10.1097/JGP.0b013e3182051a9b; Donohue JM, 2010, AM HEART J, V160, P159, DOI 10.1016/j.ahj.2010.04.023; Emanuel E, 2012, NEW ENGL J MED, V367, P949, DOI 10.1056/NEJMsb1205901; Frakt AB, 2012, HEALTH ECON, V21, P485, DOI 10.1002/hec.1733; Frank RG, 2008, HEALTH AFFAIR, V27, P33, DOI 10.1377/hlthaff.27.1.33; Gabow P, 2012, JAMA-J AM MED ASSOC, V308, P239, DOI 10.1001/jama.2012.7081; Gellad W, 2012, ARCH INTERN MED, V172, P1608, DOI 10.1001/archinternmed.2012.4482; Gellad WF, 2008, J GEN INTERN MED, V23, P1435, DOI 10.1007/s11606-008-0689-7; Gellad WF, 2010, AM J MANAG CARE, V16, P741; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Green JB, 2013, JAMA INTERN MED, V173, P229, DOI 10.1001/jamainternmed.2013.1529; Hargrave E, 2010, MEANINGFUL QUALITY D; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3; Huskamp HA, 2003, HEALTH AFFAIR, V22, P149, DOI 10.1377/hlthaff.22.3.149; Jacobson GA, 2007, PHARM COSTS COMP DEP; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Kronick R, 2012, HEALTH AFFAIR, V31, P948, DOI 10.1377/hlthaff.2009.1065; Laine C, 2012, ANN INTERN MED, V156, P162, DOI 10.7326/0003-4819-156-2-201201170-00016; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; Matchar DB, 2008, ANN INTERN MED, V148, P16, DOI 10.7326/0003-4819-148-1-200801010-00189; Miller DR, 2004, DIABETES CARE, V27, pB10, DOI 10.2337/diacare.27.suppl_2.B10; Polinski JM, 2011, J AM GERIATR SOC, V59, P1922, DOI 10.1111/j.1532-5415.2011.03537.x; Polinski JM, 2010, J AM GERIATR SOC, V58, P1764, DOI 10.1111/j.1532-5415.2010.03025.x; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Smith CD, 2012, ANN INTERN MED, V157, P284, DOI 10.7326/0003-4819-157-4-201208210-00496; The Henry J. Kaiser Family Foundation, 2009, MED PRESCR DRUG BEN; The Henry J. Kaiser Family Foundation, 2011, AN MED PRESCR DRUG P; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575; U.S. Department of Health and Human Services Office of the Inspector General, 2011, HIGH REB BRAND NAM D; US Census Bureau, AM FACTFINDER; Wilt TJ, 2012, ARCH INTERN MED, V172, P1610, DOI 10.1001/2013.jamainternmed.203; Young BA, 2008, AM J MANAG CARE, V14, P15; Zhang YT, 2012, ARCH INTERN MED, V172, P1465, DOI 10.1001/archinternmed.2012.3717; Zhang YT, 2012, J GEN INTERN MED, V27, P1251, DOI 10.1007/s11606-012-1993-9; Zhang YT, 2011, HEALTH SERV RES, V46, P185, DOI 10.1111/j.1475-6773.2010.01183.x; Zhang YT, 2010, NEW ENGL J MED, V363, P1985, DOI 10.1056/NEJMp1010220	49	30	30	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					105	W39		10.7326/0003-4819-159-2-201307160-00664	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00664			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187IX	23752663	Green Accepted			2022-12-28	WOS:000322112000016
J	Guttman, M; Russell, P; Ingolia, NT; Weissman, JS; Lander, ES				Guttman, Mitchell; Russell, Pamela; Ingolia, Nicholas T.; Weissman, Jonathan S.; Lander, Eric S.			Ribosome Profiling Provides Evidence that Large Noncoding RNAs Do Not Encode Proteins	CELL			English	Article							TRANSLATION INITIATION; NUCLEOTIDE RESOLUTION; HUMAN-CELLS; GENOME; GENE; REVEALS; MECHANISM; LINCRNAS; EXPRESSION; PRINCIPLES	Large noncoding RNAs are emerging as an important component in cellular regulation. Considerable evidence indicates that these transcripts act directly as functional RNAs rather than through an encoded protein product. However, a recent study of ribosome occupancy reported that many large intergenic ncRNAs (lincRNAs) are bound by ribosomes, raising the possibility that they are translated into proteins. Here, we show that classical noncoding RNAs and 50 UTRs show the same ribosome occupancy as lincRNAs, demonstrating that ribosome occupancy alone is not sufficient to classify transcripts as coding or noncoding. Instead, we define a metric based on the known property of translation whereby translating ribosomes are released upon encountering a bona fide stop codon. We show that this metric accurately discriminates between protein-coding transcripts and all classes of known noncoding transcripts, including lincRNAs. Taken together, these results argue that the large majority of lincRNAs do not function through encoded proteins.	[Guttman, Mitchell; Russell, Pamela; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Guttman, Mitchell; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ingolia, Nicholas T.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Carnegie Institution for Science; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Guttman, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mguttman@caltech.edu; lander@broadinstitute.org		Weissman, Jonathan/0000-0003-2445-670X; Russell, Pamela/0000-0003-2997-6392	NIH Director's Early Independence Award [DP5OD012190]; NHGRI [U54HG003067]; Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012190] Funding Source: NIH RePORTER	NIH Director's Early Independence Award; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Manuel Garber and John Rinn for helpful discussions and thoughtful comments on the manuscript, Moran Cabili and Jesse Engreitz for critical reading and suggestions on the manuscript, Alex Shishkin for generating the non-polyA-selected RNA-seq libraries, Shari Grossman for help with population-level dN/dS calculations, and Leslie Gaffney for assistance with figures. This work was funded by an NIH Director's Early Independence Award (DP5OD012190 to M.G.), NHGRI (U54HG003067 to E.S.L.), and funds from the Broad Institute of MIT and Harvard.	Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; GEBALLE AP, 1994, TRENDS BIOCHEM SCI, V19, P159, DOI 10.1016/0968-0004(94)90277-1; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kin T, 2007, NUCLEIC ACIDS RES, V35, pD145, DOI 10.1093/nar/gkl837; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Starck SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003460; STARK BC, 1978, P NATL ACAD SCI USA, V75, P3717, DOI 10.1073/pnas.75.8.3717; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018	33	513	527	3	80	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					240	251		10.1016/j.cell.2013.06.009	http://dx.doi.org/10.1016/j.cell.2013.06.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23810193	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000321327900023
J	Goldfine, AB; Fonseca, V; Jablonski, KA; Chen, YDI; Tipton, L; Staten, MA; Shoelson, SE				Goldfine, Allison B.; Fonseca, Vivian; Jablonski, Kathleen A.; Chen, Yii-Der Ida; Tipton, Laura; Staten, Myrlene A.; Shoelson, Steven E.		Targeting Inflammation Using Salsa	Salicylate (Salsalate) in Patients With Type 2 Diabetes A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; HEAT-SHOCK RESPONSE; BLOOD-CELL COUNT; SODIUM-SALICYLATE; INSULIN-RESISTANCE; NONACETYLATED SALICYLATE; ALPHA PHOSPHORYLATION; ASPIRIN; INHIBITION	Background: Short-duration studies show that salsalate improves glycemia in type 2 diabetes mellitus (T2DM). Objective: To assess 1-year efficacy and safety of salsalate in T2DM. Design: Placebo-controlled, parallel trial; computerized randomization and centralized allocation, with patients, providers, and researchers blinded to assignment. (ClinicalTrials.gov: NCT00799643) Setting: 3 private practices and 18 academic centers in the United States. Patients: Persons aged 18 to 75 years with fasting glucose levels of 12.5 mmol/L or less (<= 225 mg/dL) and hemoglobin A(1c) (HbA(1c)) levels of 7.0% to 9.5% who were treated for diabetes. Intervention: 286 participants were randomly assigned (between January 2009 and July 2011) to 48 weeks of placebo (n = 140) or salsalate, 3.5 g/d (n = 146), in addition to current therapies, and 283 participants were analyzed (placebo, n = 137; salsalate, n = 146). Measurements: Change in hemoglobin A(1c) level (primary outcome) and safety and efficacy measures. Results: The mean HbA(1c) level over 48 weeks was 0.37% lower in the salsalate group than in the placebo group (95% CI, -0.53% to -0.21%; P < 0.001). Glycemia improved despite more reductions in concomitant diabetes medications in salsalate recipients than in placebo recipients. Lower circulating leukocyte, neutrophil, and lymphocyte counts show the anti-inflammatory effects of salsalate. Adiponectin and hematocrit levels increased more and fasting glucose, uric acid, and triglyceride levels decreased with salsalate, but weight and low-density lipoprotein cholesterol levels also increased. Urinary albumin levels increased but reversed on discontinuation; estimated glomerular filtration rates were unchanged. Limitation: Trial duration and number of patients studied were insufficient to determine long-term risk-benefit of salsalate in T2DM. Conclusion: Salsalate improves glycemia in patients with T2DM and decreases inflammatory mediators. Continued evaluation of mixed cardiorenal signals is warranted.	[Shoelson, Steven E.] Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Tulane Univ, New Orleans, LA 70118 USA; George Washington Univ, Rockville, MD USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Natl Inst Diabet & Digest & Kidney Dis, Washington, DC USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Tulane University; George Washington University; Cedars Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Shoelson, SE (corresponding author), Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	steven.shoelson@joslin.harvard.edu	Buse, John Bernard/J-9742-2019	Buse, John Bernard/0000-0002-9723-3876; Goldfine, Allison/0000-0002-0345-1048	National Institutes of Health [U01 DK74556, P50 HL83813, P30 DK03836]; National Institutes of Health (General Clinical Research Center); National Institutes of Health (Clinical and Translational Science Award); Tullis-Tulane Chair; Helen and Morton Adler Chair; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090792, U01DK074556, P30DK063491, P30DK036836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (General Clinical Research Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (Clinical and Translational Science Award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tullis-Tulane Chair; Helen and Morton Adler Chair; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant Support: By National Institutes of Health (U01 DK74556, P50 HL83813, P30 DK03836, and General Clinical Research Center and Clinical and Translational Science Award at several sites) and the Tullis-Tulane (Dr. Fonseca) and Helen and Morton Adler (Dr. Shoelson) Chairs. Caraco Pharmaceutical Laboratories (Detroit, Michigan) supplied the salsalate and placebo, LifeScan (Milpitas, California) supplied the home glucose-monitoring kits, and Mercodia (Uppsala, Sweden) supplied the insulin assay kits.	Aceves M, 2004, J IMMUNOL, V173, P5721, DOI 10.4049/jimmunol.173.9.5721; Alpert D, 2000, J BIOL CHEM, V275, P10925, DOI 10.1074/jbc.275.15.10925; Amini M, 2011, ACTA DIABETOL; Baichwal VR, 1997, CURR BIOL, V7, pR94, DOI 10.1016/S0960-9822(06)00046-7; Broadbent WH, 1876, LANCET, V107, P530; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; EDMAR D, 1971, ACTA RADIOL DIAGN, V11, P57, DOI 10.1177/028418517101100107; ESTES D, 1980, ARTHRITIS RHEUM-US, V23, P1303, DOI 10.1002/art.1780231113; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; FRANTZ B, 1995, SCIENCE, V270, P2017, DOI 10.1126/science.270.5244.2017; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P1275, DOI 10.1056/NEJM197406062902302; Gallwitz B, 2012, LANCET, V380, P475, DOI 10.1016/S0140-6736(12)60691-6; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gillum RF, 2005, ANN EPIDEMIOL, V15, P266, DOI 10.1016/j.annepidem.2004.08.009; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; HINES WJW, 1964, NATURE, V201, P192, DOI 10.1038/201192a0; Jack DB, 1997, LANCET, V350, P437, DOI 10.1016/S0140-6736(97)07087-6; JURIVICH DA, 1992, SCIENCE, V255, P1243, DOI 10.1126/science.1546322; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Koska J, 2009, DIABETOLOGIA, V52, P385, DOI 10.1007/s00125-008-1239-x; Kullo IJ, 2002, AM J CARDIOL, V89, P1441, DOI 10.1016/S0002-9149(02)02366-4; Lafrance JP, 2009, PHARMACOEPIDEM DR S, V18, P923, DOI 10.1002/pds.1798; LANZA F, 1989, J RHEUMATOL, V16, P1570; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; MacLagan TJ, 1876, LANCET, V107, p[342, 383]; Mann CC, 1991, ASPIRIN WARS MONEY M; MORRIS HG, 1985, THER DRUG MONIT, V7, P435, DOI 10.1097/00007691-198512000-00012; Nixon M, 2012, DIABETES, V61, P790, DOI 10.2337/db11-0931; Pierce JW, 1996, J IMMUNOL, V156, P3961; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; ROTH S, 1990, SEMIN ARTHRITIS RHEU, V19, P11; RYAN J, 1986, Arthritis and Rheumatism, V29, pS103; SCHEIMAN JM, 1990, SEMIN ARTHRITIS RHEU, V20, P121, DOI 10.1016/0049-0172(90)90025-B; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; SMITH MJH, 1964, NATURE, V202, P96, DOI 10.1038/202096a0; Stevenson MA, 1999, J IMMUNOL, V163, P5608; SWEENEY JD, 1991, THROMB RES, V61, P23, DOI 10.1016/0049-3848(91)90165-S; Sweeney JD, 1988, BLOOD S, V72, p311A; Vis M, 2005, J RHEUMATOL, V32, P252; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	53	163	176	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 2	2013	159	1					1	+		10.7326/0003-4819-159-1-201307020-00003	http://dx.doi.org/10.7326/0003-4819-159-1-201307020-00003			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179JJ	23817699	Green Accepted			2022-12-28	WOS:000321516200001
J	Nesbit, MA; Hannan, FM; Howles, SA; Babinsky, VN; Head, RA; Cranston, T; Rust, N; Hobbs, MR; Heath, H; Thakker, RV				Nesbit, M. Andrew; Hannan, Fadil M.; Howles, Sarah A.; Babinsky, Valerie N.; Head, Rosie A.; Cranston, Treena; Rust, Nigel; Hobbs, Maurine R.; Heath, Hunter, III; Thakker, Rajesh V.			Mutations Affecting G-Protein Subunit alpha(11) in Hypercalcemia and Hypocalcemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CALCIUM-SENSING RECEPTOR; FAMILIAL BENIGN HYPERCALCEMIA; GENETIC-LINKAGE ANALYSIS; HYPOCALCIURIC HYPERCALCEMIA; CA2+-SENSING RECEPTOR; COUPLED RECEPTORS; UVEAL MELANOMA; HYPERPARATHYROIDISM; G(Q); ACTIVATION	BACKGROUND Familial hypocalciuric hypercalcemia is a genetically heterogeneous disorder with three variants: types 1, 2, and 3. Type 1 is due to loss-of-function mutations of the calcium-sensing receptor, a guanine nucleotide-binding protein (G-protein)-coupled receptor that signals through the G-protein subunit alpha(11) (G alpha(11)). Type 3 is associated with adaptor-related protein complex 2, sigma 1 subunit (AP2S1) mutations, which result in altered calcium-sensing receptor endocytosis. We hypothesized that type 2 is due to mutations effecting G alpha(11) loss of function, since G alpha(11) is involved in calcium-sensing receptor signaling, and its gene (GNA11) and the type 2 locus are colocalized on chromosome 19p13.3. We also postulated that mutations effecting G alpha(11) gain of function, like the mutations effecting calcium-sensing receptor gain of function that cause autosomal dominant hypocalcemia type 1, may lead to hypocalcemia. METHODS We performed GNA11 mutational analysis in a kindred with familial hypocalciuric hypercalcemia type 2 and in nine unrelated patients with familial hypocalciuric hypercalcemia who did not have mutations in the gene encoding the calcium-sensing receptor (CASR) or AP2S1. We also performed this analysis in eight unrelated patients with hypocalcemia who did not have CASR mutations. In addition, we studied the effects of GNA11 mutations on G alpha(11) protein structure and calcium-sensing receptor signaling in human embryonic kidney 293 (HEK293) cells. RESULTS The kindred with familial hypocalciuric hypercalcemia type 2 had an in-frame deletion of a conserved G alpha(11) isoleucine (Ile200del), and one of the nine unrelated patients with familial hypocalciuric hypercalcemia had a missense GNA11 mutation (Leu135Gln). Missense GNA11 mutations (Arg181Gln and Phe341Leu) were detected in two unrelated patients with hypocalcemia; they were therefore identified as having autosomal dominant hypocalcemia type 2. All four GNA11 mutations predicted disrupted protein structures, and assessment on the basis of in vitro expression showed that familial hypocalciuric hypercalcemia type 2-associated mutations decreased the sensitivity of cells expressing calcium-sensing receptors to changes in extracellular calcium concentrations, whereas autosomal dominant hypocalcemia type 2-associated mutations increased cell sensitivity. CONCLUSIONS G alpha(11) mutants with loss of function cause familial hypocalciuric hypercalcemia type 2, and G alpha(11) mutants with gain of function cause a clinical disorder designated as autosomal dominant hypocalcemia type 2.	[Nesbit, M. Andrew; Hannan, Fadil M.; Howles, Sarah A.; Babinsky, Valerie N.; Head, Rosie A.; Thakker, Rajesh V.] Univ Oxford, Nuffield Dept Clin Med, Acad Endocrine Unit, Oxford OX3 7LJ, England; [Rust, Nigel] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX3 7LJ, England; [Cranston, Treena] Churchill Hosp, Oxford Mol Genet Lab, Oxford OX3 7LJ, England; [Hobbs, Maurine R.] Univ Utah, Core Res Facil, Salt Lake City, UT USA; [Heath, Hunter, III] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	University of Oxford; University of Oxford; University of Oxford; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University Bloomington	Thakker, RV (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Acad Endocrine Unit, S Parks Rd, Oxford OX3 7LJ, England.	rajesh.thakker@ndm.ox.ac.uk		Howles, Sarah/0000-0001-6342-0895; Thakker, Rajesh/0000-0002-1438-3220; Hannan, Fadil/0000-0002-2975-5170	United Kingdom Medical Research Council [G9825289, G1000467]; National Institute for Health Research Oxford Biomedical Research Centre Programme; European Commission Seventh Framework Programme [FP7-264663]; National Institutes of Health [DK-38855, DK-44292]; Medical Research Council [G9825289, G1000467] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038855, R03DK044292] Funding Source: NIH RePORTER; MRC [G9825289, G1000467] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); European Commission Seventh Framework Programme(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the United Kingdom Medical Research Council and others.; Supported by grants from the United Kingdom Medical Research Council (G9825289 and G1000467, to Drs. Nesbit, Hannan, and Thakker), the National Institute for Health Research Oxford Biomedical Research Centre Programme (to Drs. Nesbit and Thakker), the European Commission Seventh Framework Programme (FP7-264663, to Ms. Babinsky), and the National Institutes of Health (DK-38855 and DK-44292, to Dr. Heath). Dr. Howles is a Wellcome Trust Clinical Research Training Fellow.	[Anonymous], 2007, MACPYMOL PYMOL BAS M; Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; Christensen SE, 2008, EUR J ENDOCRINOL, V159, P719, DOI 10.1530/EJE-08-0440; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; Hannan FM, 2012, HUM MOL GENET, V21, P2768, DOI 10.1093/hmg/dds105; HEATH H, 1992, J CLIN ENDOCR METAB, V75, P846, DOI 10.1210/jc.75.3.846; HEATH H, 1993, AM J HUM GENET, V53, P193; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAW WM, 1985, ANN INTERN MED, V102, P511, DOI 10.7326/0003-4819-102-4-511; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Raue F, 2011, CLIN ENDOCRINOL, V75, P760, DOI 10.1111/j.1365-2265.2011.04142.x; Reed AAC, 2010, AM J PHYSIOL-RENAL, V298, pF365, DOI 10.1152/ajprenal.00038.2009; Schubbert S, 2007, MOL CELL BIOL, V27, P7765, DOI 10.1128/MCB.00965-07; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Thakker RV, 2004, CELL CALCIUM, V35, P275, DOI 10.1016/j.ceca.2003.10.010; Thomas Tarita O., 2001, Molecular Cell Biology Research Communications, V4, P282, DOI 10.1006/mcbr.2001.0293; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; VARRAULT A, 1995, ENDOCRINOLOGY, V136, P4390, DOI 10.1210/en.136.10.4390; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wettschureck N, 2007, MOL ENDOCRINOL, V21, P274, DOI 10.1210/me.2006-0110; Yamamoto M, 2000, J CLIN ENDOCR METAB, V85, P4583, DOI 10.1210/jc.85.12.4583	37	232	246	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2476	2486		10.1056/NEJMoa1300253	http://dx.doi.org/10.1056/NEJMoa1300253			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23802516	Green Accepted			2022-12-28	WOS:000320926900008
J	Ellis, O				Ellis, Oliver			Suicidal memes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												oli.ellis@googlemail.com						Global Polio Eradication Initiative, 2010, INF COUNTR; Khowaja AR, 2012, B WORLD HEALTH ORGAN, V90, P822, DOI 10.2471/BLT.12.106260; Lewis H., 2013, GUARDIAN; Samaritans, 2011, LEV INQ CULT PRACT E	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2013	346								f4039	10.1136/bmj.f4039	http://dx.doi.org/10.1136/bmj.f4039			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171RC	23794277				2022-12-28	WOS:000320945700009
J	Beer, KD; Orellana, MV; Baliga, NS				Beer, Karlyn D.; Orellana, Monica V.; Baliga, Nitin S.			Modeling the Evolution of C-4 Photosynthesis	CELL			English	Editorial Material									[Beer, Karlyn D.; Orellana, Monica V.; Baliga, Nitin S.] Inst Syst Biol, Seattle, WA 98109 USA; [Orellana, Monica V.] Univ Washington, Polar Sci Ctr, Seattle, WA 98105 USA; [Beer, Karlyn D.; Baliga, Nitin S.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Baliga, NS (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	nbaliga@systemsbiology.org		Orellana, Monica/0000-0001-5990-9380; baliga, nitin/0000-0001-9157-5974	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM076547] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Heckmann D, 2013, CELL, V153, P1579, DOI 10.1016/j.cell.2013.04.058; Lindsey HA, 2013, NATURE, V494, P463, DOI 10.1038/nature11879; Raven JA, 2008, PHILOS T R SOC B, V363, P2641, DOI 10.1098/rstb.2008.0020; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; [No title captured]	8	3	4	1	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1427	1429		10.1016/j.cell.2013.05.058	http://dx.doi.org/10.1016/j.cell.2013.05.058			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791172	Green Accepted, Bronze			2022-12-28	WOS:000320722000010
J	Macilwain, C				Macilwain, Colin			Sharing information is preferable to patenting	NATURE			English	Editorial Material												cfmworldview@gmail.com						2004, NATURE, V431, P494	1	3	3	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					273	273		10.1038/498273a	http://dx.doi.org/10.1038/498273a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166XI	23783592	Bronze			2022-12-28	WOS:000320592900004
J	Malani, AN; Vandenberg, DM; Singal, B; Kasotakis, M; Koch, S; Moudgal, V; Jagarlamudi, R; Neelakanta, A; Otto, MH; Halasyamani, L; Kaakaji, R; Kauffman, CA				Malani, Anurag N.; Vandenberg, David M.; Singal, Bonita; Kasotakis, Michael; Koch, Spencer; Moudgal, Varsha; Jagarlamudi, Rajasekhar; Neelakanta, Anupama; Otto, Michael H.; Halasyamani, Lakshmi; Kaakaji, Rami; Kauffman, Carol A.			Magnetic Resonance Imaging Screening to Identify Spinal and Paraspinal Infections Associated With Injections of Contaminated Methylprednisolone Acetate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; FUNGAL; OUTBREAK	Importance Injection of contaminated methylprednisolone has resulted in an unprecedented nationwide outbreak of Exserohilum rostratum fungal infections, manifested initially as meningitis and/or basilar stroke. Insidious onset of spinal or paraspinal infection at the injection site has been increasingly reported and is occurring months after receipt of injection with the contaminated drug. The clinical findings are often subtle and similar to those that led the patient to undergo the methylprednisolone injection. Objective To determine if patients who had not presented for medical care but who had received contaminated methylprednisolone developed spinal or paraspinal infection at the injection site using contrast-enhanced magnetic resonance imaging (MRI) screening. Design, Setting, and Participants There were 172 patients who had received an injection of contaminated methylprednisolone from a highly contaminated lot (No. 06292012@26) at a pain facility but had not presented for medical care related to adverse effects after the injection. Screening MRI was performed between November 9, 2012, and April 30, 2013. Main Outcomes and Measures Number of persons identified with previously undiagnosed spinal or paraspinal infection. Results Of the 172 patients screened, MRI was abnormal in 36 (21%), showing epidural or paraspinal abscess or phlegmon, arachnoiditis, spinal osteomyelitis or diskitis, or moderate to severe epidural, paraspinal, or intradural enhancement. Of the 115 patients asked about new or worsening back or neck pain, lower extremity weakness, or radiculopathy symptoms, 35 (30%) had at least 1 symptom. Thirty-five of the 36 patients with abnormal MRIs met the Centers for Disease Control and Prevention (CDC) case definition for probable (17 patients) or confirmed (18 patients) fungal spinal or paraspinal infection. All 35 patients were treated with antifungal agents (voriconazole, with or without liposomal amphotericin B), and 24 required surgical debridement. At the time of surgery, 17 of 24 patients (71%), including 5 patients who denied having symptoms, had laboratory evidence of fungal infection. Conclusions and Relevance Among patients who underwent screening MRI to look for infection at the site of injection of contaminated methylprednisolone, 21% had an abnormal MRI, and all but one met CDC criteria for probable or confirmed fungal spinal or paraspinal infection. Screening MRI led to identification of patients who had minimal or no symptoms of spinal or paraspinal infection and allowed early initiation of medical and surgical treatment.	[Malani, Anurag N.; Moudgal, Varsha; Jagarlamudi, Rajasekhar; Neelakanta, Anupama; Otto, Michael H.] St Joseph Mercy Hosp, Infect Dis Sect, Ann Arbor, MI 48104 USA; [Malani, Anurag N.; Vandenberg, David M.; Moudgal, Varsha; Jagarlamudi, Rajasekhar; Neelakanta, Anupama; Otto, Michael H.; Halasyamani, Lakshmi] St Joseph Mercy Hosp, Dept Internal Med, Ann Arbor, MI 48104 USA; [Singal, Bonita] St Joseph Mercy Hosp, Dept Clin Res, Ann Arbor, MI 48104 USA; [Kasotakis, Michael; Koch, Spencer; Kaakaji, Rami] St Joseph Mercy Hosp, Dept Radiol, Ann Arbor, MI 48104 USA; [Kauffman, Carol A.] Univ Michigan, Sch Med, Div Infect Dis, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA	Saint Joseph Mercy Health System (SJMHS); Saint Joseph Mercy Health System (SJMHS); Saint Joseph Mercy Health System (SJMHS); Saint Joseph Mercy Health System (SJMHS); University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Malani, AN (corresponding author), St Joseph Mercy Hosp, 5333 McAuley Dr,Ste 3106, Ypsilanti, MI 48197 USA.	malania@trinity-health.org						Centers for Disease Control and Prevention, EM PREP RESP; Centers for Disease Control and Prevention, MULT FUNG MEN OUTBR; Kainer Marion, 2012, Morbidity and Mortality Weekly Report, V61, P839; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; Kerkering TM, 2013, ANN INTERN MED, V158, P154, DOI 10.7326/0003-4819-158-3-201302050-00568; Pettit AC, 2012, NEW ENGL J MED, V367, P2119, DOI 10.1056/NEJMoa1212292; Smith RM, NEW ENGL J MED, DOI [10.1056/NEJMoa1213978, DOI 10.1056/NEJMOA1213978]	7	23	24	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2465	2472		10.1001/jama.2013.6293	http://dx.doi.org/10.1001/jama.2013.6293			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23780459	Bronze			2022-12-28	WOS:000320505100027
J	Ergina, PL; Barkun, JS; McCulloch, P; Cook, JA; Altman, DG				Ergina, Patrick L.; Barkun, Jeffrey S.; McCulloch, Peter; Cook, Jonathan A.; Altman, Douglas G.		IDEAL Grp	IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; AORTIC DISSECTION IRAD; TIME-SERIES ANALYSIS; INTERNATIONAL REGISTRY; RADICAL PROSTATECTOMY; CLINICAL-RESEARCH; LEARNING-CURVE; SURGERY; CHOLECYSTECTOMY; TRANSPLANTATION	The IDEAL framework describes the stages of evaluation for surgical innovations. This paper considers the role of observational studies in the exploration and assessment stages. At the exploration stage, the surgical intervention is usually more widely used, and observational studies should collect prospective data from multiple surgeons, deal with factors such as case mix and learning, and prepare for a definitive evaluation at the next stage of assessment. Although a randomised controlled trial is preferable, a high quality observational study would be acceptable if a randomised trial is not feasible or, on rare occasions, deemed unnecessary.	[Ergina, Patrick L.] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Cardiothorac Surg, Montreal, PQ H3A 1A1, Canada; [Ergina, Patrick L.] Univ Oxford, Oxford Int Programme Evidence Based Hlth Care, Oxford, England; [Barkun, Jeffrey S.] McGill Univ, Dept Surg, Montreal, PQ H3A 1A1, Canada; [McCulloch, Peter] Univ Oxford, Nuffield Dept Surg Sci, Oxford OX1 2JD, England; [Cook, Jonathan A.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England	McGill University; Royal Victoria Hospital; University of Oxford; McGill University; University of Oxford; University of Aberdeen; University of Oxford	Ergina, PL (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Cardiothorac Surg, Montreal, PQ H3A 1A1, Canada.	patrick.ergina@muhc.mcgill.ca	Groves, Trish/A-9119-2009; Cook, Jonathan/D-3648-2015	Groves, Trish/0000-0001-7915-6419; Cook, Jonathan/0000-0002-4156-6989; Lyratzopoulos, Georgios/0000-0002-2873-7421; McCulloch, Peter/0000-0002-3210-8273	National Institute for Health Research's Health Technology Assessment programme; Johnson Johnson; Medtronic; Zimmer; Medical Research Council [G1002292]; Medical Research Council [G0800800] Funding Source: researchfish; National Institute for Health Research [06/301/233] Funding Source: researchfish; MRC [G1002292, G0800800] Funding Source: UKRI	National Institute for Health Research's Health Technology Assessment programme; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Medtronic(Medtronic); Zimmer; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The IDEAL group meeting in December 2010 was funded by the National Institute for Health Research's Health Technology Assessment programme, Johnson & Johnson, Medtronic and Zimmer (all unrestricted grants). JAC holds a Medical Research Council Methodology Fellowship (G1002292)	Arnold DM, 2009, CRIT CARE MED, V37, pS69, DOI 10.1097/CCM.0b013e3181920e33; ATTWOOD SEA, 1992, ANN ROY COLL SURG, V74, P397; Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Black N, 2008, TRANSPLANTATION, V86, P28, DOI 10.1097/TP.0b013e31817d9766; Buxton MJ, 1987, EC APPRAISAL HLTH TE, P103; Cook Jonathan A, 2004, Clin Trials, V1, P421, DOI 10.1191/1740774504cn042oa; Cook JA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2820; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; Deeks J J, 2003, Health Technol Assess, V7, piii; Degiuli M, 2004, BRIT J CANCER, V90, P1727, DOI 10.1038/sj.bjc.6601761; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Hall BL, 2009, AM J SURG, V198, pS56, DOI 10.1016/j.amjsurg.2009.07.026; Heinze G, 2011, EUR HEART J, V32, P1704, DOI 10.1093/eurheartj/ehr031; Hu JC, 2009, JAMA-J AM MED ASSOC, V302, P1557, DOI 10.1001/jama.2009.1451; HULTGREN HN, 1977, AM J CARDIOL, V39, P734, DOI 10.1016/S0002-9149(77)80137-9; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Johnson ML, 2009, VALUE HEALTH, V12, P1062, DOI 10.1111/j.1524-4733.2009.00602.x; Lilford RJ, 2000, BRIT MED J, V320, P43, DOI 10.1136/bmj.320.7226.43; Maciejewski ML, 2011, JAMA-J AM MED ASSOC, V305, P2419, DOI 10.1001/jama.2011.817; Marshall G, 1998, MED CARE, V36, P348, DOI 10.1097/00005650-199803000-00011; Matowe LK, 2003, ANN PHARMACOTHER, V37, P1110, DOI 10.1345/aph.1A109; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; McCulloch P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3012; McCulloch P, 2009, J ROY SOC MED, V102, P51, DOI 10.1258/jrsm.2008.080308; Miller DC, 2006, JAMA-J AM MED ASSOC, V295, P2480, DOI 10.1001/jama.295.21.2480; Nicholl J, 2007, J EPIDEMIOL COMMUN H, V61, P1010, DOI 10.1136/jech.2007.061747; Novick RJ, 2003, ANN THORAC SURG, V76, P749, DOI 10.1016/S0003-4975(03)00680-5; Rawlins M, 2008, LANCET, V372, P2152, DOI 10.1016/S0140-6736(08)61930-3; Robbins RC, 1999, J THORAC CARDIOV SUR, V117, P939, DOI 10.1016/S0022-5223(99)70375-2; Rutledge R, 1996, J AM COLL SURGEONS, V183, P31; Shikata S, 2006, ANN SURG, V244, P668, DOI 10.1097/01.sla.0000225356.04304.bc; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; STARZL TE, 1981, NEW ENGL J MED, V305, P266, DOI 10.1056/NEJM198107303050507; Sun Peter, 2012, J Med Econ, V15, P8, DOI 10.3111/13696998.2011.626097; Tsai TT, 2009, EUR J VASC ENDOVASC, V37, P149, DOI 10.1016/j.ejvs.2008.11.032; Vickers AJ, 2009, LANCET ONCOL, V10, P475, DOI 10.1016/S1470-2045(09)70079-8; Wilson CB, 2006, BMJ-BRIT MED J, V332, P112, DOI 10.1136/bmj.332.7533.112	40	112	117	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2013	346								f3011	10.1136/bmj.f3011	http://dx.doi.org/10.1136/bmj.f3011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171PQ	23778426	hybrid, Green Published			2022-12-28	WOS:000320941900002
J	Boyd, MA; Kumarasamy, N; Moore, CL; Nwizu, C; Losso, MH; Mohapi, L; Martin, A; Kerr, S; Sohn, AH; Teppler, H; Van de Steen, O; Molina, JM; Emery, S; Cooper, DA				Boyd, M. A.; Kumarasamy, N.; Moore, C. L.; Nwizu, C.; Losso, M. H.; Mohapi, L.; Martin, A.; Kerr, S.; Sohn, A. H.; Teppler, H.; Van de Steen, O.; Molina, J-M; Emery, S.; Cooper, D. A.		SECOND-LINE Study Grp	Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study	LANCET			English	Article							LOPINAVIR/RITONAVIR MONOTHERAPY; ANTIRETROVIRAL THERAPY; CLINICAL-TRIALS; ZIDOVUDINE; EFFICACY; NAIVE; LAMIVUDINE; EFAVIRENZ	Background Uncertainty exists about the best treatment for people with HIV-1 who have virological failure with first-line combination antiretroviral therapy of a non-nucleoside analogue (NNRTI) plus two nucleoside or nucleotide analogue reverse transcriptase inhibitors (NtRTI). We compared a second-line regimen combining two new classes of drug with a WHO-recommended regimen. Methods We did this 96-week, phase 3b/4, randomised, open-label non-inferiority trial at 37 sites worldwide. Adults with HIV-1 who had confirmed virological failure (plasma viral load >500 copies per mL) after 24 weeks or more of first-line treatment were randomly assigned (1:1) to receive ritonavir-boosted lopinavir plus two or three NtRTIs (control group) or ritonavir-boosted lopinavir plus raltegravir (raltegravir group). The randomisation sequence was computer generated with block randomisation (block size four). Neither participants nor investigators were masked to allocation. The primary endpoint was the proportion of participants with plasma viral load less than 200 copies per mL at 48 weeks in the modified intention-to-treat population, with a non-inferiority margin of 12%. This study is registered with ClinicalTrials.gov, number NCT00931463. Findings We enrolled 558 patients, of whom 541 (271 in the control group, 270 in the raltegravir group) were included in the primary analysis. At 48 weeks, 219 (81%) patients in the control group compared with 223 (83%) in the raltegravir group met the primary endpoint (difference 1.8%, 95% CI -4.7 to 8.3), fulfilling the criterion for non-inferiority. 993 adverse events occurred in 271 participants in the control group versus 895 in 270 participants in the raltegravir group, the most common being gastrointestinal. Interpretation The raltegravir regimen was no less efficacious than the standard of care and was safe and well tolerated. This simple NtRTI-free treatment strategy might extend the successful public health approach to management of HIV by providing simple, easy to administer, effective, safe, and tolerable second-line combination antiretroviral therapy.					Kerr, Stephen/J-6126-2012; Emery, Sean/J-3825-2017; Emery, Sean/O-9122-2019; Kumarasasmy, Nagalingeswaran/AAB-7348-2021	Kerr, Stephen/0000-0002-1919-4525; Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Boyd, Mark/0000-0002-6848-3307; Espinosa, Nuria/0000-0003-2249-2352; Moore, Cecilia/0000-0002-5438-6143	University of New South Wales; Merck; AbbVie; Foundation for AIDS Research; Boehringer Ingelheim; Bristol Myers Squibb; Gilead Sciences; Janssen Pharmaceuticals; Abbott; Merck Research Laboratories; Pfizer; ViiV Healthcare	University of New South Wales; Merck(Merck & Company); AbbVie(AbbVie); Foundation for AIDS Research; Boehringer Ingelheim(Boehringer Ingelheim); Bristol Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbott(Abbott Laboratories); Merck Research Laboratories(Merck & Company); Pfizer(Pfizer); ViiV Healthcare	University of New South Wales, Merck, AbbVie, the Foundation for AIDS Research.; MB has received research grant support and honoraria for serving on advisory boards and educational presentations from AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, and Merck. CN has served as a speaker and received honoraria from AbbVie. ML has received research grants and unrestricted educational grants from Abbott and Merck in the past 10 years. LM received travel assistance to a conference from Pfizer Pharmaceutical in 2008. OvdS is an employee of AbbVie and holds stock in the company. HT is an employee of Merck Sharp and Dohme and owns stock and holds stock options in the company. J-MM has participated in advisory boards on antiretroviral drugs organised by Merck, Bristol-Myers Squibb, AbbVie, Gilead Sciences, and Janssen Pharmaceuticals. SE has received research grant support from Abbvie, Gilead Sciences, Merck Research Laboratories, Pfizer, and ViiV Healthcare. The other authors declare that they have no conflicts of interest.	Bartlett JA, 2012, AIDS, V26, P1345, DOI 10.1097/QAD.0b013e328353b066; Boyd M, 2009, LANCET, V374, P185, DOI 10.1016/S0140-6736(09)61313-1; Bunupuradah T, 2012, ANTIVIR THER, V17, P1351, DOI 10.3851/IMP2443; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Galarraga O, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000279712.32051.29; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P11; Humphreys EH, 2010, COCHRANE DB SYST REV, V6; Humphreys EH, 2007, COCHRANE DB SYST REV, V4; Huttner AC, 2007, AIDS, V21, P939, DOI 10.1097/QAD.0b013e3280f00fd6; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lifson AR, 2010, HIV CLIN TRIALS, V11, P205, DOI 10.1310/hct1104-205; Reynes J, 2011, HIV CLIN TRIALS, V12, P255, DOI 10.1310/hct1205-255; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Ruxrungtham K, 2008, HIV MED, V9, P883, DOI 10.1111/j.1468-1293.2008.00644.x; Schneider K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054435; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; Tsoukas C, 2013, 20 C RETR OPP INF AT; UNAIDS, 2012, 2012 WORLD AIDS DAY; WHO, ANT THER HIV INF AD	21	126	129	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 15	2013	381	9883					2091	2099						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KA	23769235				2022-12-28	WOS:000320924800031
J	Bagcchi, S				Bagcchi, Sanjeet			Improving cancer care in rural India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drsanjitbagchi@gmail.com						[Anonymous], 2010, NATIONAL CANCER GRID; Bhaumik S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2858; Indian Space Research Organisation, TELEMEDICINE; Kambli R., 2013, EXPRESS HEALTHCARE; Marpakwar P., 2013, TIMES OF INDIA	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2013	346								f3826	10.1136/bmj.f3826	http://dx.doi.org/10.1136/bmj.f3826			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166XQ	23771224				2022-12-28	WOS:000320593900012
J	Lau, JYW; Barkun, A; Fan, DM; Kuipers, EJ; Yang, YS; Chan, FKL				Lau, James Y. W.; Barkun, Alan; Fan, Dai-ming; Kuipers, Ernst J.; Yang, Yun-sheng; Chan, Francis K. L.			Challenges in the management of acute peptic ulcer bleeding	LANCET			English	Review							TRANSCATHETER ARTERIAL EMBOLIZATION; UPPER GASTROINTESTINAL HEMORRHAGE; PROTON PUMP INHIBITORS; HELICOBACTER-PYLORI ERADICATION; EXPERT CONSENSUS DOCUMENT; ENDOSCOPIC TREATMENT; TIME-TRENDS; HIGH-RISK; ANTIPLATELET THERAPY; CLINICAL-OUTCOMES	Acute upper gastrointestinal bleeding is a common medical emergency worldwide, a major cause of which are bleeding peptic ulcers. Endoscopic treatment and acid suppression with proton-pump inhibitors are cornerstones in the management of the disease, and both treatments have been shown to reduce mortality. The role of emergency surgery continues to diminish. In specialised centres, radiological intervention is increasingly used in patients with severe and recurrent bleeding who do not respond to endoscopic treatment. Despite these advances, mortality from the disorder has remained at around 10%. The disease often occurs in elderly patients with frequent comorbidities who use antiplatelet agents, non-steroidal anti-inflammatory drugs, and anticoagulants. The management of such patients, especially those at high cardiothrombotic risk who are on anticoagulants, is a challenge for clinicians. We summarise the published scientific literature about the management of patients with bleeding peptic ulcers, identify directions for future clinical research, and suggest how mortality can be reduced.	[Lau, James Y. W.; Chan, Francis K. L.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Barkun, Alan] McGill Univ, Div Gastroenterol, Quebec City, PQ, Canada; [Barkun, Alan] McGill Univ, Ctr Hlth, Quebec City, PQ, Canada; [Fan, Dai-ming] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Peoples R China; [Kuipers, Ernst J.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Yang, Yun-sheng] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol & Hepatol, Beijing, Peoples R China	Chinese University of Hong Kong; McGill University; McGill University; Air Force Military Medical University; Erasmus University Rotterdam; Erasmus MC; Chinese People's Liberation Army General Hospital	Lau, JYW (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.	laujyw@surgery.cuhk.edu.hk	Kuipers, Ernst J/H-3293-2019; Lau, James Y. W./O-2612-2016; Chan, Francis K. L./F-4851-2010	Kuipers, Ernst J/0000-0002-0633-3098; Lau, James Y. W./0000-0003-0122-4068; Chan, Francis K. L./0000-0001-7388-2436				Abraham NS, 2010, AM J GASTROENTEROL, V105, P2533, DOI 10.1038/ajg.2010.445; Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Andriulli A, 2008, AM J GASTROENTEROL, V103, P3011, DOI 10.1111/j.1572-0241.2008.02149.x; Ang D, 2012, EUR J GASTROEN HEPAT, V24, P929, DOI 10.1097/MEG.0b013e32835463bc; [Anonymous], 2011, LANCET, V377, P1048, DOI 10.1016/S0140-6736(11)60419-4; Baradarian R, 2004, AM J GASTROENTEROL, V99, P619, DOI 10.1111/j.1572-0241.2004.04073.x; Barkun A, 2004, AM J GASTROENTEROL, V99, P1238, DOI 10.1111/j.1572-0241.2004.30272.x; Barkun AN, 2010, GASTROINTEST ENDOSC, V72, P1138, DOI 10.1016/j.gie.2010.08.011; Barkun AN, 2010, ANN INTERN MED, V152, P101, DOI 10.7326/0003-4819-152-2-201001190-00009; Barkun AN, 2009, GASTROINTEST ENDOSC, V69, P786, DOI 10.1016/j.gie.2008.05.031; Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Bjorkman DJ, 2004, GASTROINTEST ENDOSC, V60, P1, DOI 10.1016/S0016-5107(04)01287-8; Blatchford O, 2000, LANCET, V356, P1318, DOI 10.1016/S0140-6736(00)02816-6; Bleau BL, 2002, GASTROINTEST ENDOSC, V56, P1, DOI 10.1067/mge.2002.125365; Calvet X, 2004, GASTROENTEROLOGY, V126, P441, DOI 10.1053/j.gastro.2003.11.006; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Chan WH, 2011, BRIT J SURG, V98, P640, DOI 10.1002/bjs.7420; COOK DJ, 1992, GASTROENTEROLOGY, V102, P139, DOI 10.1016/0016-5085(92)91793-4; Dong WG, 2004, WORLD J GASTROENTERO, V10, P3377, DOI 10.3748/wjg.v10.i22.3377; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; El Ouali S, 2012, GASTROINTEST ENDOSC, V76, P283, DOI 10.1016/j.gie.2012.04.441; Elmunzer BJ, 2008, AM J GASTROENTEROL, V103, P2625, DOI 10.1111/j.1572-0241.2008.02070.x; Eriksson LG, 2008, J VASC INTERV RADIOL, V19, P1413, DOI 10.1016/j.jvir.2008.06.019; Gisbert JP, 2004, ALIMENT PHARM THER, V19, P617, DOI 10.1111/j.1365-2036.2004.01898.x; Gluud LL, 2012, COCHRANE DB SYST REV, V18; Hawkey GM, 2001, GUT, V49, P372, DOI 10.1136/gut.49.3.372; Hearnshaw SA, 2010, ALIMENT PHARM THER, V32, P215, DOI 10.1111/j.1365-2036.2010.04348.x; Hearnshaw SA, 2011, GUT, V60, P1327, DOI 10.1136/gut.2010.228437; Ho CW, 2013, ALIMENT PHARM THER, V37, P819, DOI 10.1111/apt.12259; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; ISRCTN Register, TRANSF GASTR BLEED T; Jairath V, 2012, BRIT J SURG, V99, P1672, DOI 10.1002/bjs.8932; Jairath V, 2013, TRANSFUSION, V53, P1069, DOI 10.1111/j.1537-2995.2012.03849.x; Jensen DM, 2002, GASTROENTEROLOGY, V123, P407, DOI 10.1053/gast.2002.34782; Kahi CJ, 2005, GASTROENTEROLOGY, V129, P855, DOI 10.1053/j.gastro.2005.06.070; Kang JY, 2006, ALIMENT PHARM THERAP, V24, P65, DOI 10.1111/j.1365-2036.2006.02960.x; Laine L, 2012, AM J GASTROENTEROL, V107, P1190, DOI 10.1038/ajg.2012.168; Laine L, 2009, CLIN GASTROENTEROL H, V7, P33, DOI 10.1016/j.cgh.2008.08.016; Lanas A, 2006, GUT, V55, P1731, DOI 10.1136/gut.2005.080754; Lanas A, 2013, SCAND J GASTROENTERO, V48, P285, DOI 10.3109/00365521.2012.758764; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Larssen L, 2008, SCAND J GASTROENTERO, V43, P217, DOI 10.1080/00365520701676443; Lau JY, 2011, DIGESTION, V84, P102, DOI 10.1159/000323958; Lau JYW, 1999, NEW ENGL J MED, V340, P751, DOI 10.1056/NEJM199903113401002; Lee JG, 1999, GASTROINTEST ENDOSC, V50, P755, DOI 10.1016/S0016-5107(99)70154-9; Leontiadis GI, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002094.pub3; Li ZS, 2010, AM J GASTROENTEROL, V105, P2570, DOI 10.1038/ajg.2010.324; Lin HJ, 1996, J CLIN GASTROENTEROL, V22, P267, DOI 10.1097/00004836-199606000-00005; Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696; Liu N, 2012, J GASTROEN HEPATOL, V27, P1473, DOI 10.1111/j.1440-1746.2012.07191.x; Loffroy R, 2009, WORLD J GASTROENTERO, V15, P5889, DOI 10.3748/wjg.15.5889; Loperfido S, 2009, GASTROINTEST ENDOSC, V70, P212, DOI 10.1016/j.gie.2008.10.051; Marlu R, 2012, THROMB HAEMOSTASIS, V108, P217, DOI 10.1160/TH12-03-0179; Marmo R, 2003, GASTROINTEST ENDOSC, V57, P62, DOI 10.1067/mge.2003.48; Marmo R, 2008, AM J GASTROENTEROL, V103, P1639, DOI 10.1111/j.1572-0241.2008.01865.x; Marmo R, 2007, AM J GASTROENTEROL, V102, P279, DOI 10.1111/j.1572-0241.2006.01023.x; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; Nikolsky E, 2009, J AM COLL CARDIOL, V54, P1293, DOI 10.1016/j.jacc.2009.07.019; Ohmann C, 2005, SCAND J GASTROENTERO, V40, P914, DOI 10.1080/00365520510015809; Ripoll C, 2004, J VASC INTERV RADIOL, V15, P447; ROCKALL TA, 1995, BRIT MED J, V311, P222, DOI 10.1136/bmj.311.6999.222; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Sadic J, 2009, ALIMENT PHARM THER, V30, P392, DOI 10.1111/j.1365-2036.2009.04058.x; Saltzman JR, 2011, GASTROINTEST ENDOSC, V74, P1215, DOI 10.1016/j.gie.2011.06.024; Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678; Spiegel BMR, 2001, ARCH INTERN MED, V161, P1393, DOI 10.1001/archinte.161.11.1393; Sreedharan A, 2010, COCHRANE DB SYST REV, V7; Srygley FD, 2012, JAMA-J AM MED ASSOC, V307, P1072, DOI 10.1001/jama.2012.253; Stanley AJ, 2011, ALIMENT PHARM THER, V34, P470, DOI 10.1111/j.1365-2036.2011.04747.x; Sung JJY, 2011, ENDOSCOPY, V43, P291, DOI 10.1055/s-0030-1256311; Sung JJY, 2007, GUT, V56, P1364, DOI 10.1136/gut.2007.123976; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; Sung JJY, 2009, ANN INTERN MED, V150, P455, DOI 10.7326/0003-4819-150-7-200904070-00105; van Leerdam ME, 2003, AM J GASTROENTEROL, V98, P1494, DOI 10.1016/S0002-9270(03)00299-5; van Soest EM, 2011, GUT, V60, P1650, DOI 10.1136/gut.2011.239848; Venclauskas L, 2010, SCAND J GASTROENTERO, V45, P299, DOI 10.3109/00365520903486109; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Wang CH, 2010, ARCH INTERN MED, V170, P751, DOI 10.1001/archinternmed.2010.100; Wang Kai-juan, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P443; Wang YR, 2010, ANN SURG, V251, P51, DOI 10.1097/SLA.0b013e3181b975b8; Witt D.M., 2012, ARCH INTERN MED, P1; Wolf AT, 2007, AM J GASTROENTEROL, V102, P290, DOI 10.1111/j.1572-0241.2006.00969.x; Wong GLH, 2009, GASTROENTEROLOGY, V137, P525, DOI 10.1053/j.gastro.2009.05.006; Wong TCL, 2011, GASTROINTEST ENDOSC, V73, P900, DOI 10.1016/j.gie.2010.11.024; Wu CY, 2009, CLIN GASTROENTEROL H, V7, P427, DOI 10.1016/j.cgh.2008.12.029; Xinghua L, 1996, CHIN J DIG, V16, P152	88	133	141	2	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 8	2013	381	9882					2033	2043		10.1016/S0140-6736(13)60596-6	http://dx.doi.org/10.1016/S0140-6736(13)60596-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171JY	23746903				2022-12-28	WOS:000320924400032
J	Assiri, A; McGeer, A; Perl, TM; Price, CS; Al Rabeeah, AA; Cummings, DAT; Alabdullatif, ZN; Assad, M; Almulhim, A; Makhdoom, H; Madani, H; Alhakeem, R; Al-Tawfiq, JA; Cotten, M; Watson, SJ; Kellam, P; Zumla, AI; Memish, ZA				Assiri, Abdullah; McGeer, Allison; Perl, Trish M.; Price, Connie S.; Al Rabeeah, Abdullah A.; Cummings, Derek A. T.; Alabdullatif, Zaki N.; Assad, Maher; Almulhim, Abdulmohsen; Makhdoom, Hatem; Madani, Hossam; Alhakeem, Rafat; Al-Tawfiq, Jaffar A.; Cotten, Matthew; Watson, Simon J.; Kellam, Paul; Zumla, Alimuddin I.; Memish, Ziad A.		KSA MERS-CoV Invest Team	Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFECTIONS; SARS	Background In September 2012, the World Health Organization reported the first cases of pneumonia caused by the novel Middle East respiratory syndrome coronavirus (MERS-CoV). We describe a cluster of health care-acquired MERS-CoV infections. Methods Medical records were reviewed for clinical and demographic information and determination of potential contacts and exposures. Case patients and contacts were interviewed. The incubation period and serial interval (the time between the successive onset of symptoms in a chain of transmission) were estimated. Viral RNA was sequenced. Results Between April 1 and May 23, 2013, a total of 23 cases of MERS-CoV infection were reported in the eastern province of Saudi Arabia. Symptoms included fever in 20 patients (87%), cough in 20 (87%), shortness of breath in 11 (48%), and gastrointestinal symptoms in 8 (35%); 20 patients (87%) presented with abnormal chest radiographs. As of June 12, a total of 15 patients (65%) had died, 6 (26%) had recovered, and 2 (9%) remained hospitalized. The median incubation period was 5.2 days (95% confidence interval [CI], 1.9 to 14.7), and the serial interval was 7.6 days (95% CI, 2.5 to 23.1). A total of 21 of the 23 cases were acquired by person-to-person transmission in hemodialysis units, intensive care units, or in-patient units in three different health care facilities. Sequencing data from four isolates revealed a single monophyletic clade. Among 217 household contacts and more than 200 health care worker contacts whom we identified, MERS-CoV infection developed in 5 family members (3 with laboratory-confirmed cases) and in 2 health care workers (both with laboratory-confirmed cases). Conclusions Person-to-person transmission of MERS-CoV can occur in health care settings and may be associated with considerable morbidity. Surveillance and infection-control measures are critical to a global public health response.	[Assiri, Abdullah; Al Rabeeah, Abdullah A.; Alabdullatif, Zaki N.; Assad, Maher; Almulhim, Abdulmohsen; Makhdoom, Hatem; Madani, Hossam; Alhakeem, Rafat; Zumla, Alimuddin I.; Memish, Ziad A.] Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh 11176, Saudi Arabia; [Memish, Ziad A.] Al Faisal Univ, Riyadh, Saudi Arabia; [Al-Tawfiq, Jaffar A.] Saudi Aramco Med Serv Org, Dhahran, Saudi Arabia; [McGeer, Allison] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [McGeer, Allison] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Perl, Trish M.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Perl, Trish M.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Perl, Trish M.; Cummings, Derek A. T.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Price, Connie S.] Univ Colorado Denver, Denver, CO USA; [Cotten, Matthew; Watson, Simon J.; Kellam, Paul] Wellcome Trust Sanger Inst, Hinxton, England; [Kellam, Paul; Zumla, Alimuddin I.] UCL, London WC1E 6BT, England; [Zumla, Alimuddin I.] Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England	Alfaisal University; Saudi Aramco; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Wellcome Trust Sanger Institute; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Memish, ZA (corresponding author), Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh 11176, Saudi Arabia.	zmemish@yahoo.com	ZUMLA, Alimuddin/ABA-8208-2020; Assiri, Abdullah M./GQP-2239-2022; McGeer, Allison/AAB-6885-2020; assiri, abdullah/AAF-5665-2021; Memish, Ziad Ahmed/AEJ-9424-2022; mcgeer, allison/H-7747-2014	ZUMLA, Alimuddin/0000-0002-5111-5735; McGeer, Allison/0000-0001-5647-6137; assiri, abdullah/0000-0002-5605-2876; Memish, Ziad Ahmed/0000-0002-5099-0714; mcgeer, allison/0000-0001-5647-6137; Kellam, Paul/0000-0003-3166-4734; Cotten, Matthew/0000-0002-3361-3351	NIGMS NIH HHS [U01 GM070708, U54 GM088491] Funding Source: Medline; Wellcome Trust [093724] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070708, U54GM088491] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; [Anonymous], 2013, SEVERE RESP DIS UNKN; [Anonymous], NOV COR INF UPD 12 M; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Buchholz U, 2013, EUROSURVEILLANCE, V18, P6; Centers for Disease Control and Prevention, 2013, COR MIDDL E RESP SYN; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057; Drosten C, PRELIMINARY SEQUENCE; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P6212, DOI 10.1073/pnas.0400762101; Hijawi B, 2013, E MEDITERR HEALTH J, V19, pS12; Kwok KO, 2007, P R SOC B, V274, P611, DOI 10.1098/rspb.2006.0026; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI [10.1016/j.gastro.2003.08.001, 10.1053/S0016-5085(03)01215-0]; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; McDonald LC, 2004, EMERG INFECT DIS, V10, P777, DOI 10.3201/eid1005.030791; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Rambaut A., NOVEL HUMAN BETACORO; Reich NG, 2009, STAT MED, V28, P2769, DOI 10.1002/sim.3659; Rha B, 2013, MMWR-MORBID MORTAL W, V62, P194; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Tahir M, 2013, EUROSURVEILLANCE, V18, P4; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Wang SX, 2006, EPIDEMIOL INFECT, V134, P786, DOI 10.1017/S095026880500556X; Wong SSY, 2008, J ANTIMICROB CHEMOTH, V62, P437, DOI 10.1093/jac/dkn243; World Health Organization, INT SURV REC HUM INF; World Health Organization Regional Office for the Eastern Mediterranean, 2012, WEEKLY EPIDEMIOLOGIC, V5; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	32	839	884	0	198	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					407	416		10.1056/NEJMoa1306742	http://dx.doi.org/10.1056/NEJMoa1306742			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193GQ	23782161	Green Accepted, Bronze			2022-12-28	WOS:000322547400007
J	Fernandez, IS; Ng, CL; Kelley, AC; Wu, GW; Yu, YT; Ramakrishnan, V				Fernandez, Israel S.; Chyan Leong Ng; Kelley, Ann C.; Wu, Guowei; Yu, Yi-Tao; Ramakrishnan, V.			Unusual base pairing during the decoding of a stop codon by the ribosome	NATURE			English	Article							TRANSFER-RNA; MECHANISM; PSEUDOURIDINE; REFINEMENT; TU	During normal translation, the binding of a release factor to one of the three stop codons (UGA, UAA or UAG) results in the termination of protein synthesis. However, modification of the initial uridine to a pseudouridine (Psi) allows efficient recognition and readthrough of these stop codons by a transfer RNA(tRNA), although it requires the formation of two normally forbidden purine-purine base pairs(1). Here we determined the crystal structure at 3.1 angstrom resolution of the 30S ribosomal subunit in complex with the anticodon stem loop of tRNA(Ser) bound to the Psi AG stop codon in the A site. The Psi A base pair at the first position is accompanied by the formation of purine-purine base pairs at the second and third positions of the codon, which show an unusual Watson-Crick/Hoogsteen geometry. The structure shows a previously unsuspected ability of the ribosomal decoding centre to accommodate non-canonical base pairs.	[Fernandez, Israel S.; Chyan Leong Ng; Kelley, Ann C.; Ramakrishnan, V.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Wu, Guowei; Yu, Yi-Tao] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	MRC Laboratory Molecular Biology; University of Rochester	Ramakrishnan, V (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	YiTao_Yu@URMC.Rochester.edu; ramak@mrc-lmb.cam.ac.uk	Ng, Chyan Leong/E-9689-2014; Ng, Chyan Leong/ABB-1385-2021	Ng, Chyan Leong/0000-0001-8590-7418; Ramakrishnan, V/0000-0002-4699-2194; Fernandez, Israel/0000-0001-7218-1603	UK Medical Research Council [U105184332]; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; National Institutes of Health [GM104077]; University of Rochester CTSA from the National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000042]; Fundacion Ramon Areces; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039559] Funding Source: NIH RePORTER; Medical Research Council [MC_U105184332] Funding Source: researchfish; MRC [MC_U105184332] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester CTSA from the National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Fundacion Ramon Areces; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Hall and G. Winter for help and advice with data collection at beamline I04, Diamond Light Source; T. Tomizaki at beamline X06SA for help with data collection at the Swiss Light Source; and A. McCarthy at beamline ID14-4, ESRF, where screening and initial data collection were done. We thank M. Hartlein for the gift of an overproducing tRNA<SUP>Ser</SUP> clone, M. Torrent for advice on yeast tRNA abundance, and G. Murshudov for advice and help with data analysis and refinement. V.R. was supported by the UK Medical Research Council (grant U105184332), a Programme Grant and Senior Investigator Award from the Wellcome Trust, the Agouron Institute and the Louis-Jeantet Foundation. Y.-T.Y. was supported by a grant from the National Institutes of Health (GM104077), and by the University of Rochester CTSA award (UL1TR000042) from the National Center for Advancing Translational Sciences of the National Institutes of Health. I.S.F. was supported by a postdoctoral fellowship from the Fundacion Ramon Areces.	BOREL F, 1993, FEBS LETT, V324, P162, DOI 10.1016/0014-5793(93)81385-D; Davis DR, 1998, J BIOMOL STRUCT DYN, V15, P1121, DOI 10.1080/07391102.1998.10509006; DeLano W., 2006, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Huang C, 2012, NAT PROTOC, V7, P789, DOI 10.1038/nprot.2012.029; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nikolova EN, 2011, NATURE, V470, P498, DOI 10.1038/nature09775; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Tomita K, 1999, NUCLEIC ACIDS RES, V27, P1683, DOI 10.1093/nar/27.7.1683; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yarian CS, 1999, NUCLEIC ACIDS RES, V27, P3543, DOI 10.1093/nar/27.17.3543	20	111	118	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					107	U136		10.1038/nature12302	http://dx.doi.org/10.1038/nature12302			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23812587	Green Accepted			2022-12-28	WOS:000322514800038
J	Atun, R; Aydin, S; Chakraborty, S; Sumer, S; Aran, M; Gurol, I; Nazlioglu, S; Ozgulcu, S; Aydogan, U; Ayar, B; Dilmen, U; Akdag, R				Atun, Rifat; Aydin, Sabahattin; Chakraborty, Sarbani; Sumer, Safir; Aran, Meltem; Guerol, Ipek; Nazlioglu, Serpil; Ozgulcu, Senay; Aydogan, Ulger; Ayar, Banu; Dilmen, Ugur; Akdag, Recep			Universal health coverage in Turkey: enhancement of equity	LANCET			English	Article								Turkey has successfully introduced health system changes and provided its citizens with the right to health to achieve universal health coverage, which helped to address inequities in financing, health service access, and health outcomes. We trace the trajectory of health system reforms in Turkey, with a particular emphasis on 2003-13, which coincides with the Health Transformation Program (HTP). The HTP rapidly expanded health insurance coverage and access to health-care services for all citizens, especially the poorest population groups, to achieve universal health coverage. We analyse the contextual drivers that shaped the transformations in the health system, explore the design and implementation of the HTP, identify the factors that enabled its success, and investigate its effects. Our findings suggest that the HTP was instrumental in achieving universal health coverage to enhance equity substantially, and led to quantifiable and beneficial effects on all health system goals, with an improved level and distribution of health, greater fairness in financing with better financial protection, and notably increased user satisfaction. After the HTP, five health insurance schemes were consolidated to create a unified General Health Insurance scheme with harmonised and expanded benefits. Insurance coverage for the poorest population groups in Turkey increased from 2.4 million people in 2003, to 10.2 million in 2011. Health service access increased across the country-in particular, access and use of key maternal and child health services improved to help to greatly reduce the maternal mortality ratio, and under-5, infant, and neonatal mortality, especially in socioeconomically disadvantaged groups. Several factors helped to achieve universal health coverage and improve outcomes. These factors include economic growth, political stability, a comprehensive transformation strategy led by a transformation team, rapid policy translation, flexible implementation with continuous learning, and simultaneous improvements in the health system, on both the demand side (increased health insurance coverage, expanded benefits, and reduced cost-sharing) and the supply side (expansion of infrastructure, health human resources, and health services).	[Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Atun, Rifat] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Aydin, Sabahattin; Chakraborty, Sarbani; Sumer, Safir] Medipol Univ, Istanbul, Turkey; [Aran, Meltem] Dev Analyt, Istanbul, Turkey; [Guerol, Ipek] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Nazlioglu, Serpil; Ozgulcu, Senay; Aydogan, Ulger; Ayar, Banu; Dilmen, Ugur] Republ Turkey Minist Hlth, Gen Directorate Hlth Res, Ankara, Turkey; [Akdag, Recep] Grand Assembly Republ Turkey, Ankara, Turkey	Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Istanbul Medipol University; University of London; London School of Hygiene & Tropical Medicine; Ministry of Health - Turkey; Grand National Assembly of Turkey	Atun, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London SW7 2AZ, England.	r.atun@imperial.ac.uk	culha, ülger aydoğan/C-9404-2015; Atun, Rifat/AAH-5537-2021	Aydin, Sabahattin/0000-0001-6374-817X; Aydogan Culha, Ulger/0000-0002-5899-172X; Atun, Rifat/0000-0002-1531-5983; Gurol-Urganci, Ipek/0000-0002-6517-3485	World Bank	World Bank(The World Bank India)	RiA has acted as an adviser and a consultant to the Ministry of Health of the Republic of Turkey, including in the Health Transformation Program, and has undertaken consulting assignments in Turkey for the Ministry of Health of Turkey, WHO, and the World Bank. ReA was the Minister of Health of Turkey from 2002 to 2012. SA was the Undersecretary of the Ministry of Health of Turkey from 2002 to 2009. SC works for the World Bank and was involved in the World Bank-funded Health Transition Project in Turkey. SC is on a secondment to Medipol University. SS, MA, IG, and SN have undertaken analytical consulting assignments for the Minstry of Health of Turkey. SO, UA, BA, and UD are employed at the General Directorate of Health Research, The Republic of Turkey Ministry of Health.		0	207	207	3	57	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 6	2013	382	9886					65	99		10.1016/S0140-6736(13)61051-X	http://dx.doi.org/10.1016/S0140-6736(13)61051-X			35	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177AD	23810020				2022-12-28	WOS:000321347000030
J	Fan, P; Manoli, DS; Ahmed, OM; Chen, Y; Agarwal, N; Kwong, S; Cai, AG; Neitz, J; Renslo, A; Baker, BS; Shah, NM				Fan, Pu; Manoli, Devanand S.; Ahmed, Osama M.; Chen, Yi; Agarwal, Neha; Kwong, Sara; Cai, Allen G.; Neitz, Jeffrey; Renslo, Adam; Baker, Bruce S.; Shah, Nirao M.			Genetic and Neural Mechanisms that Inhibit Drosophila from Mating with Other Species	CELL			English	Article							MALE COURTSHIP BEHAVIOR; CANDIDATE TASTE RECEPTORS; MALE SEXUAL-BEHAVIOR; CUTICULAR HYDROCARBONS; REPRODUCTIVE ISOLATION; PHEROMONE RECEPTOR; INCIPIENT SPECIATION; CHEMOSENSORY SYSTEM; MOLECULAR-BASIS; MELANOGASTER	Genetically hard-wired neural mechanisms must enforce behavioral reproductive isolation because interspecies courtship is rare even in sexually naive animals of most species. We find that the chemoreceptor Gr32a inhibits male D. melanogaster from courting diverse fruit fly species. Gr32a recognizes nonvolatile aversive cues present on these reproductively dead-end targets, and activity of Gr32a neurons is necessary and sufficient to inhibit interspecies courtship. Male-specific Fruitless (Fru(M)), a master regulator of courtship, also inhibits interspecies courtship. Gr32a and Fru(M) are not coexpressed, but Fru(M) neurons contact Gr32a neurons, suggesting that these genes influence a shared neural circuit that inhibits interspecies courtship. Gr32a and Fru(M) also suppress within-species intermale courtship, but we show that distinct mechanisms preclude sexual displays toward conspecific males and other species. Although this chemosensory pathway does not inhibit interspecies mating in D. melanogaster females, similar mechanisms appear to inhibit this behavior in many other male drosophilids.	[Fan, Pu] Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Life Sci, State Key Lab Biomembrane & Membrane Biol, Beijing 100871, Peoples R China; [Fan, Pu; Manoli, Devanand S.; Agarwal, Neha; Kwong, Sara; Cai, Allen G.; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Manoli, Devanand S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Shah, Nirao M.] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94158 USA; [Ahmed, Osama M.; Shah, Nirao M.] Univ Calif San Francisco, Neurosci Program, San Francisco, CA 94158 USA; [Neitz, Jeffrey; Renslo, Adam] Univ Calif San Francisco, Dept Pharmaceut Chem, Small Mol Discovery Ctr, San Francisco, CA 94158 USA; [Chen, Yi] Univ Calif Los Angeles, Dept Biol Chem, HHMI, Los Angeles, CA 90095 USA; [Baker, Bruce S.] HHMI, Ashbum, VA 20147 USA	Peking University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute	Shah, NM (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	nms@ucsf.edu		Ahmed, Osama/0000-0003-3539-3150; Renslo, Adam/0000-0002-1240-2846; Manoli, Devanand/0000-0002-7238-2330	China Scholarship Council; NARSAD; Program for Breakthrough Biomedical Research; NSF graduate fellowship; Burroughs Wellcome Fund; Ellison Medical Foundation; McKnight Foundation for Neuroscience; Sloan Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060482] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); NARSAD(NARSAD); Program for Breakthrough Biomedical Research; NSF graduate fellowship(National Science Foundation (NSF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ellison Medical Foundation(Lawrence Ellison Foundation); McKnight Foundation for Neuroscience; Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to S.L. Zipursky for discussions and sharing GRASP reagents and data and to G. Meissner, A. Nern, B. Pfeiffer, and G. Rubin from JFRC for reagents and advice on GRASP studies. We thank S. Barondes, Y. Rao, and K. Yamamoto for support; C. Bargmann, E. Kandel, and Z. Knight for discussions; R. Axel, T. Clandinin, Y. Jan, D. Julius, S. Lomvardas, K. Scott, and Shah lab members for comments on the manuscript; the laboratories of J. Carlson, T. Clandinin, A. Dahanukar, G. Davis, U. Heberlein, L. Jan, and Y. Jan for sharing fly reagents or equipment; and the UCSF Nikon Imaging Center for providing critical imaging resources. This work was supported by China Scholarship Council (P.F.), NARSAD and Program for Breakthrough Biomedical Research (D.S.M. and N.M.S.), NSF graduate fellowship (O.M.A.), Career Awards in Biomedical Sciences from the Burroughs Wellcome Fund, Ellison Medical Foundation, McKnight Foundation for Neuroscience, and Sloan Foundation (N.M.S.).	Acebes A, 2003, J EXP BIOL, V206, P3095, DOI 10.1242/jeb.00522; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; Barbash DA, 2010, GENETICS, V186, P1, DOI 10.1534/genetics.110.121459; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; BLAIR WF, 1964, Q REV BIOL, V39, P333, DOI 10.1086/404323; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Dahanukar A, 2011, FLY, V5, P58, DOI 10.4161/fly.5.1.13794; Darwin C., 1860, ORIGIN SPECIES MEANS; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; DETHIER VG, 1948, PHYSIOL REV, V28, P220, DOI 10.1152/physrev.1948.28.2.220; Dewan A, 2013, NATURE, V497, P486, DOI 10.1038/nature12114; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dobzhansky T, 1937, AM NAT, V71, P404, DOI 10.1086/280726; Dobzhansky T, 1944, P NATL ACAD SCI USA, V30, P238, DOI 10.1073/pnas.30.9.238; Dukas R, 2004, BEHAV ECOL, V15, P695, DOI 10.1093/beheco/arh068; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Ejima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003246; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; FRINGS H, 1949, AM MIDL NAT, V41, P602, DOI 10.2307/2421776; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; GILL KULBIR S., 1963, AMER ZOOL, V3, P507; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Grillet M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00224; Grosjean Y, 2008, NAT NEUROSCI, V11, P54, DOI 10.1038/nn2019; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; HALL JC, 1978, BEHAV GENET, V8, P125, DOI 10.1007/BF01066870; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566; Higgie M, 2000, SCIENCE, V290, P519, DOI 10.1126/science.290.5491.519; Hollocher H, 1997, GENETICS, V147, P1191; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; JULIUS D, 1983, CELL, V32, P839, DOI 10.1016/0092-8674(83)90070-3; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Knight D, 2011, MOL NEUROBIOL, V44, P426, DOI 10.1007/s12035-011-8213-1; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Kowalski S, 2004, CAN J ZOOL, V82, P1258, DOI 10.1139/Z04-102; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Laturney Meghan, 2012, Int J Evol Biol, V2012, P328392, DOI 10.1155/2012/328392; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Lin HP, 2005, P NATL ACAD SCI USA, V102, P12831, DOI 10.1073/pnas.0506420102; Lu BK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002587; MANNING A., 1959, ANIMAL BEHAVIOR, V7, P60, DOI 10.1016/0003-3472(59)90031-4; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; MAYR E, 1988, BIOL PHILOS, V3, P431, DOI 10.1007/BF00647963; MAYR E, 1945, P NATL ACAD SCI USA, V31, P75, DOI 10.1073/pnas.31.2.75; MCCULLOUGH J, 1979, J BACTERIOL, V138, P146, DOI 10.1128/JB.138.1.146-154.1979; McGrath PT, 2011, NATURE, V477, P321, DOI 10.1038/nature10378; Meissner GW, 2011, GENETICS, V189, P195, DOI 10.1534/genetics.111.129940; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Moehring AJ, 2006, GENETICS, V173, P215, DOI 10.1534/genetics.105.052993; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Nanda P, 2012, J BIOSCIENCES, V37, P359, DOI 10.1007/s12038-012-9193-7; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Orr HA, 2004, CURR OPIN GENET DEV, V14, P675, DOI 10.1016/j.gde.2004.08.009; Ovid, 2009, METAMORPHOSES; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Park JH, 2011, MOL CELLS, V32, P375, DOI 10.1007/s10059-011-0128-1; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; ROBERTSON HM, 1983, EXPERIENTIA, V39, P333, DOI 10.1007/BF01955335; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Siwicki KK, 2009, CURR OPIN NEUROBIOL, V19, P200, DOI 10.1016/j.conb.2009.04.001; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Spieth H.T., 1952, B AMNH, V99; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; SPIETH HT, 1949, EVOLUTION, V3, P67, DOI 10.2307/2405453; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Sturtevant AH, 1920, GENETICS, V5, P488; Tauber E, 2003, CURR BIOL, V13, P140, DOI 10.1016/S0960-9822(03)00004-6; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Toda H, 2012, CELL REP, V1, P599, DOI 10.1016/j.celrep.2012.05.007; TOMPKINS L, 1982, BEHAV GENET, V12, P295, DOI 10.1007/BF01067849; TOMPKINS L, 1980, J INSECT PHYSIOL, V26, P689, DOI 10.1016/0022-1910(80)90042-6; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Watanabe K, 2011, BEHAV GENET, V41, P746, DOI 10.1007/s10519-011-9461-6; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WHEELER DA, 1991, SCIENCE, V251, P1082, DOI 10.1126/science.1900131; Wisotsky Z, 2011, NAT NEUROSCI, V14, P1534, DOI 10.1038/nn.2944; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Yamaguchi S, 2011, FLY, V5, P333, DOI 10.4161/fly.5.4.16419; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	115	99	100	1	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					89	102		10.1016/j.cell.2013.06.008	http://dx.doi.org/10.1016/j.cell.2013.06.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23810192	Bronze, Green Accepted			2022-12-28	WOS:000321327900012
J	Turner, M				Turner, Marian			ANIMAL BEHAVIOUR Brain food	NATURE			English	Editorial Material																			0	0	0	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					446	446		10.1038/498446a	http://dx.doi.org/10.1038/498446a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803842	Bronze			2022-12-28	WOS:000320929400042
J	Decker, SL; Kostova, D; Kenney, GM; Long, SK				Decker, Sandra L.; Kostova, Deliana; Kenney, Genevieve M.; Long, Sharon K.			Health Status, Risk Factors, and Medical Conditions Among Persons Enrolled in Medicaid vs Uninsured Low-Income Adults Potentially Eligible for Medicaid Under the Affordable Care Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVENTION	Importance Under the Affordable Care Act (ACA), states can extend Medicaid eligibility to nearly all adults with income no more than 138% of the federal poverty level. Uncertainty exists regarding the scope of medical services required for new enrollees. Objective To document the health care needs and health risks of uninsured adults who could gain Medicaid coverage under the ACA. These data will help physicians, other clinicians, and state Medicaid programs prepare for the possible expansions. Design, Setting, and Patients Data from the National Health and Nutrition Examination Survey 2007-2010 were used to analyze health conditions among a nationally representative sample of 1042 uninsured adults aged 19 through 64 years with income no more than 138% of the federal poverty level, compared with 471 low-income adults currently enrolled in Medicaid. Main Outcomes and Measures Prevalence and control of diabetes, hypertension, and hypercholesterolemia based on examinations and laboratory tests, measures of self-reported health status including medical conditions, and risk factors such as measured obesity status. Results Compared with those already enrolled in Medicaid, uninsured adults were less likely to be obese and sedentary and less likely to report a physical, mental, or emotional limitation. They also were less likely to have several chronic conditions. For example, 30.1% (95% CI, 26.8%-33.4%) of uninsured adults had hypertension, hypercholesterolemia, or diabetes compared with 38.6% (95% CI, 32.0%-45.3%) of those enrolled in Medicaid (P=.02). However, if they had these conditions, uninsured adults were less likely to be aware of them and less likely to have them controlled. For example, 80.1% (95% CI, 75.2%-85.1%) of the uninsured adults with at least 1 of these 3 conditions had at least 1 uncontrolled condition, compared with 63.4% (95% CI, 53.7%-73.1%) of adults enrolled in Medicaid. Conclusion and Relevance Compared with adults currently enrolled in Medicaid, uninsured low-income adults potentially eligible to enroll in Medicaid under the ACA had a lower prevalence of many chronic conditions. A substantial proportion of currently uninsured adults with chronic conditions did not have good disease control; projections based on sample weighting suggest this may represent 3.5 million persons (95% CI, 2.9 million-4.2 million). These adults may need initial intensive medical care following Medicaid enrollment.	[Decker, Sandra L.] Ctr Dis Control & Prevent, Hyattsville, MD 20782 USA; [Kostova, Deliana] Ctr Dis Control & Prevent, Atlanta, GA USA; [Kenney, Genevieve M.; Long, Sharon K.] Urban Inst, Washington, DC 20037 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Urban Institute	Decker, SL (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA.	sdecker@cdc.gov						Allen H, 2010, HEALTH AFFAIR, V29, P1498, DOI 10.1377/hlthaff.2010.0191; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], 2011, STAT VERS 12 COMP PR; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Decker SL., 2007, REV ECON HOUSEHOLD, V5, P95; Holahan J. L., 2010, HLTH STATUS NEW MEDI; Kenney G, 2012, OPTING MEDICAID EXPA; Kenney GM, 2012, INQUIRY-J HEALTH CAR, V49, P231, DOI 10.5034/inquiryjrnl_49.03.08; Kenney GM, 2012, OPTING OUT MEDICAID; Ku L, 2011, NEW ENGL J MED, V364, P493, DOI 10.1056/NEJMp1011623; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Qureshi AI, 2004, STROKE, V35, P2346, DOI 10.1161/01.STR.0000141417.66620.09; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Somers SA, 2010, COVERING LOW INCOME; Sommers BD, 2011, NEW ENGL J MED, V365, P100, DOI 10.1056/NEJMp1104948; Sommers BD, 2010, NEW ENGL J MED, V363, P2085, DOI 10.1056/NEJMp1010866; Substance Abuse and Mental Health Service Administration (SAMHSA) Center for Integrated Health Solutions, PAT HLTH QUEST PHQ 9	20	94	94	0	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2579	2586		10.1001/jama.2013.7106	http://dx.doi.org/10.1001/jama.2013.7106			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23793267	Bronze			2022-12-28	WOS:000320848100028
J	Noble, B				Noble, Bill			PERSONAL VIEW Legalising assisted dying puts vulnerable patients at risk and doctors must speak up	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIE		Univ Sheffield, Acad Unit Support Care, Sheffield S11 9NE, S Yorkshire, England	University of Sheffield	Noble, B (corresponding author), Univ Sheffield, Acad Unit Support Care, Sheffield S11 9NE, S Yorkshire, England.	bill.noble@sheffield.ac.uk						Godlee F, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4075; Heath I, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3755; McPherson A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2827; McPherson T, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4007; Tallis R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4115	5	7	7	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2013	346								f4062	10.1136/bmj.f4062	http://dx.doi.org/10.1136/bmj.f4062			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QL	23804182				2022-12-28	WOS:000321246200011
J	Sidibe, M; Buse, K				Sidibe, Michel; Buse, Kent			AIDS governance: best practices for a post-2015 world	LANCET			English	Editorial Material							HEALTH		[Sidibe, Michel; Buse, Kent] Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland	UNAIDS	Buse, K (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland.	busek@unaids.org	Buse, Kent/AAK-6688-2020	Buse, Kent/0000-0002-5485-0110				[Anonymous], 2012, LANCET, V380, P1881; [Anonymous], 2013, LANCET; Canfin P, 2013, LANCET, V381, P1885, DOI 10.1016/S0140-6736(13)60952-6; Carlsson G, 2012, LANCET, V380, P1533, DOI 10.1016/S0140-6736(12)61809-1; High-Level Panel of Eminent Persons on the Post-2015 Development Agenda, 2013, NEW GLOB PARTN ER PO; Horton R., 2012, AIDS MOVEMENT CREATE; Peersman G, 2009, JAIDS-J ACQ IMM DEF, V52, pS97, DOI 10.1097/QAI.0b013e3181baee06; Sidibe M., 2010, GLOBAL HLTH GOVERNAN, V4, P1; Task Team for the Global Thematic Consultation on Health, 2013, HLTH POST2015 AG REP; Tyler TomR., 2003, TRUST GOVERNANCE, P269; UNAIDS, 2012, UNAIDS GLOB REP GLOB	11	12	12	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 22	2013	381	9884					2147	2149		10.1016/S0140-6736(13)61413-0	http://dx.doi.org/10.1016/S0140-6736(13)61413-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KH	23791333				2022-12-28	WOS:000320925600011
J	Saver, JL; Fonarow, GC; Smith, EE; Reeves, MJ; Grau-Sepulveda, MV; Pan, WQ; Olson, DM; Hernandez, AF; Peterson, ED; Schwamm, LH				Saver, Jeffrey L.; Fonarow, Gregg C.; Smith, Eric E.; Reeves, Mathew J.; Grau-Sepulveda, Maria V.; Pan, Wenqin; Olson, DaiWai M.; Hernandez, Adrian F.; Peterson, Eric D.; Schwamm, Lee H.			Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUIDELINES-STROKE; MEDICARE BENEFICIARIES; CARE; THROMBOLYSIS; ASSOCIATION; IMPROVEMENT; ALTEPLASE; QUALITY; SYSTEMS; DELAYS	Importance Randomized clinical trials suggest the benefit of intravenous tissue-type plasminogen activator (tPA) in acute ischemic stroke is time dependent. However, modest sample sizes have limited characterization of the extent to which onset to treatment (OTT) time influences outcome; and the generalizability of findings to clinical practice is uncertain. Objective To evaluate the degree to which OTT time is associated with outcome among patients with acute ischemic stroke treated with intraveneous tPA. Design, Setting, and Patients Data were analyzed from 58 353 patients with acute ischemic stroke treated with tPA within 4.5 hours of symptom onset in 1395 hospitals participating in the Get With The Guidelines-Stroke Program, April 2003 to March 2012. Main Outcomes and Measures Relationship between OTT time and in-hospital mortality, symptomatic intracranial hemorrhage, ambulatory status at discharge, and discharge destination. Results Among the 58 353 tPA-treated patients, median age was 72 years, 50.3% were women, median OTT time was 144 minutes (interquartile range, 115-170), 9.3% (5404) had OTT time of 0 to 90 minutes, 77.2% (45 029) had OTT time of 91 to 180 minutes, and 13.6% (7920) had OTT time of 181 to 270 minutes. Median pretreatment National Institutes of Health Stroke Scale documented in 87.7% of patients was 11 (interquartile range, 6-17). Patient factors most strongly associated with shorter OTT included greater stroke severity (odds ratio [ OR], 2.8; 95% CI, 2.5-3.1 per 5-point increase), arrival by ambulance (OR, 5.9; 95% CI, 4.5-7.3), and arrival during regular hours (OR, 4.6; 95% CI, 3.8-5.4). Overall, there were 5142 (8.8%) in-hospital deaths, 2873 (4.9%) patients had intracranial hemorrhage, 19 491 (33.4%) patients achieved independent ambulation at hospital discharge, and 22 541 (38.6%) patients were discharged to home. Faster OTT, in 15-minute increments, was associated with reduced in-hospital mortality (OR, 0.96; 95% CI, 0.95-0.98; P < .001), reduced symptomatic intracranial hemorrhage (OR, 0.96; 95% CI, 0.95-0.98; P < .001), increased achievement of independent ambulation at discharge (OR, 1.04; 95% CI, 1.03-1.05; P < .001), and increased discharge to home (OR, 1.03; 95% CI, 1.02-1.04; P < .001). Conclusions and Relevance In a registry representing US clinical practice, earlier thrombolytic treatment was associated with reduced mortality and symptomatic intracranial hemorrhage, and higher rates of independent ambulation at discharge and discharge to home following acute ischemic stroke. These findings support intensive efforts to accelerate hospital presentation and thrombolytic treatment in patients with stroke.	[Saver, Jeffrey L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA; [Smith, Eric E.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Smith, Eric E.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Reeves, Mathew J.] Michigan State Univ, Dept Epidemiol, E Lansing, MI 48824 USA; [Grau-Sepulveda, Maria V.; Pan, Wenqin; Olson, DaiWai M.; Hernandez, Adrian F.; Peterson, Eric D.] Duke Clin Res Ctr, Durham, NC USA; [Schwamm, Lee H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Calgary; University of Calgary; Michigan State University; Duke University; Harvard University; Massachusetts General Hospital	Saver, JL (corresponding author), Univ Calif Los Angeles, Comprehens Stroke Ctr, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	jsaver@mednet.ucla.edu	Olson, DaiWai/I-5932-2019; Hernandez, Adrian F/A-7818-2016; Smith, Eric E/C-5443-2012; Fonarow, Gregg C/D-5988-2014; Peterson, Eric David/ABF-5033-2021	Olson, DaiWai/0000-0002-9280-078X; Hernandez, Adrian F/0000-0003-3387-9616; Smith, Eric E/0000-0003-3956-1668; Fonarow, Gregg C/0000-0002-3192-8093; Schwamm, Lee/0000-0003-0592-9145; Saver, Jeffrey/0000-0001-9141-2251	Boehringer-Ingelheim; Merck; Bristol-Myers Squib/Sanofi Pharmaceutical Partnership; AHA Pharmaceutical Roundtable	Boehringer-Ingelheim(Boehringer Ingelheim); Merck(Merck & Company); Bristol-Myers Squib/Sanofi Pharmaceutical Partnership; AHA Pharmaceutical Roundtable(American Heart Association)	The GWTG-Stroke Program is provided by the AHA/American Stroke Association. The GWTG-Stroke Program is currently supported in part by a charitable contribution from Janssen Pharmaceutical Companies of Johnson & Johnson. The GWTG-Stroke Program has been funded in the past through support from Boehringer-Ingelheim, Merck, Bristol-Myers Squib/Sanofi Pharmaceutical Partnership, and the AHA Pharmaceutical Roundtable.	Acker JE, 2007, STROKE, V38, P3097, DOI 10.1161/STROKEAHA.107.186094; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Boden-Albala B, 2010, CONTEMP CLIN TRIALS, V31, P235, DOI 10.1016/j.cct.2010.02.003; Brott T, 1997, STROKE, V28, P1530, DOI 10.1161/01.STR.28.8.1530; Fonarow GC, 2012, J AM HEART ASSOC, V1, P42, DOI 10.1161/JAHA.111.000034; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Hodgson C, 2007, STROKE, V38, P2115, DOI 10.1161/STROKEAHA.107.484071; Kohrmann M, 2011, INT J STROKE, V6, P493, DOI 10.1111/j.1747-4949.2011.00585.x; LaBresh KA, 2008, ARCH INTERN MED, V168, P411, DOI 10.1001/archinternmed.2007.101; Lansberg MG, 2009, STROKE, V40, P2079, DOI 10.1161/STROKEAHA.108.540708; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lin CB, 2012, CIRC-CARDIOVASC QUAL, V5, P514, DOI 10.1161/CIRCOUTCOMES.112.965210; Mazya M, 2012, STROKE, V43, P1524, DOI 10.1161/STROKEAHA.111.644815; Meng XJ, 2004, ANN NEUROL, V55, P207, DOI 10.1002/ana.10803; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Morgenstern LB, 2007, STROKE, V38, P2972, DOI 10.1161/STROKEAHA.107.490078; Ovbiagele B, 2010, CEREBROVASC DIS, V29, P50, DOI 10.1159/000255974; Reeves MJ, 2012, STROKE, V43, P44, DOI 10.1161/STROKEAHA.111.626978; Robinson TG, 2013, EMERG MED J, V30, P467, DOI 10.1136/emermed-2012-201471; Saposnik G, 2005, NEUROLOGY, V65, P1169, DOI 10.1212/01.wnl.0000180687.75907.4b; Saver JL, 2009, STROKE, V40, P2433, DOI 10.1161/STROKEAHA.108.543561; Saver JL, 2010, LANCET, V375, P1667, DOI 10.1016/S0140-6736(10)60634-4; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Schwamm LH, 2005, STROKE, V36, P690, DOI 10.1161/01.STR.0000158165.42884.4F; Sobesky J, 2007, CEREBROVASC DIS, V24, P56, DOI 10.1159/000103117; Strbian D, 2010, STROKE, V41, P712, DOI 10.1161/STROKEAHA.109.571976; Tveiten A, 2009, EMERG MED J, V26, P324, DOI 10.1136/emj.2008.063610; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Xian Y, 2012, AM HEART J, V163, P392, DOI 10.1016/j.ahj.2011.12.012; Zhang QH, 2013, STROKE, V44	31	534	553	4	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2480	2488		10.1001/jama.2013.6959	http://dx.doi.org/10.1001/jama.2013.6959			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23780461	Bronze			2022-12-28	WOS:000320505100029
J	Arie, S				Arie, Sophie			Has austerity brought Europe to the brink of a health disaster?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophiearie@fmail.co.uk						Arie S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2740; Dalli, 2012, EURACTIV        0612; De Vogli R, 2013, J EPIDEMIOL COMMUN H, V67, DOI 10.1136/jech-2012-201607; Henley J., 2013, GUARDIAN; Hunter N, 2013, IRISH HLTH      0307; Lewis G, 1998, BMJ-BRIT MED J, V317, P1283, DOI 10.1136/bmj.317.7168.1283; Stuckler D., 2013, BODY EC AUSTERITY KI; Thomson S, 2013, HLTH HLTH SYSTEMS EC; Vlachadis N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1061	9	4	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2013	346								f3773	10.1136/bmj.f3773	http://dx.doi.org/10.1136/bmj.f3773			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171PQ	23778577				2022-12-28	WOS:000320941900005
J	Friberg, P; Wall, S; Blomstedt, Y; Beaglehole, R; Bonita, R; Stordalen, G; Byass, P				Friberg, Peter; Wall, Stig; Blomstedt, Yulia; Beaglehole, Robert; Bonita, Ruth; Stordalen, Gunhild; Byass, Peter			Public and global engagement with global health	LANCET			English	Editorial Material									[Friberg, Peter] Swedish Soc Med, Stockholm, Sweden; [Friberg, Peter] Sahlgrens Univ Hosp, Dept Mol & Clin Med, Gothenburg, Sweden; [Wall, Stig; Blomstedt, Yulia; Byass, Peter] Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res, SE-90187 Umea, Sweden; [Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Stordalen, Gunhild] Stordalen Fdn, Oslo, Norway	Sahlgrenska University Hospital; Umea University; University of Auckland	Byass, P (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res, SE-90187 Umea, Sweden.	peter.byass@epiph.umu.se		Byass, Peter/0000-0001-5474-4361				Byass P, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20671; Byass P, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20903; Horton R, 2013, LANCET, V381, P1260, DOI 10.1016/S0140-6736(13)60807-7	3	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 15	2013	381	9883					2066	2066		10.1016/S0140-6736(13)61206-4	http://dx.doi.org/10.1016/S0140-6736(13)61206-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KA	23769219				2022-12-28	WOS:000320924800009
J	Natarajan, C; Inoguchi, N; Weber, RE; Fago, A; Moriyama, H; Storz, JF				Natarajan, Chandrasekhar; Inoguchi, Noriko; Weber, Roy E.; Fago, Angela; Moriyama, Hideaki; Storz, Jay F.			Epistasis Among Adaptive Mutations in Deer Mouse Hemoglobin	SCIENCE			English	Article							GLOBIN GENES; EVOLUTION; ADAPTATION; PROTEIN; MICE; POLYMORPHISMS; SELECTION; INSIGHTS; PATHS	Epistatic interactions between mutant sites in the same protein can exert a strong influence on pathways of molecular evolution. We performed protein engineering experiments that revealed pervasive epistasis among segregating amino acid variants that contribute to adaptive functional variation in deer mouse hemoglobin (Hb). Amino acid mutations increased or decreased Hb-O-2 affinity depending on the allelic state of other sites. Structural analysis revealed that epistasis for Hb-O-2 affinity and allosteric regulatory control is attributable to indirect interactions between structurally remote sites. The prevalence of sign epistasis for fitness-related biochemical phenotypes has important implications for the evolutionary dynamics of protein polymorphism in natural populations.	[Natarajan, Chandrasekhar; Inoguchi, Noriko; Moriyama, Hideaki; Storz, Jay F.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Weber, Roy E.; Fago, Angela] Aarhus Univ, Dept Biosci, DK-8000 Aarhus, Denmark	University of Nebraska System; University of Nebraska Lincoln; Aarhus University	Storz, JF (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	jstorz2@unl.edu	Natarajan, Chandrasekhar/D-3144-2012; Natarajan, Chandrasekar/ABG-5195-2020; Fago, Angela/J-5946-2013	Natarajan, Chandrasekhar/0000-0002-4841-0426; Fago, Angela/0000-0001-7315-2628	NIH-National Heart, Lung, and Blood Institute [R01 HL087216, HL087216-S1]; NSF [DEB-0614342, IOS-0949931]; Faculty of Science and Technology, Aarhus University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087216] Funding Source: NIH RePORTER	NIH-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NSF(National Science Foundation (NSF)); Faculty of Science and Technology, Aarhus University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by grants from the NIH-National Heart, Lung, and Blood Institute (R01 HL087216 and HL087216-S1), the NSF (DEB-0614342 and IOS-0949931), and the Faculty of Science and Technology, Aarhus University. We thank S. Kachman for statistical advice, A. Bang for assistance in the lab, and M. Harms, S. Smith, and two reviewers for helpful comments. All experimental data are tabulated in the main text and in the supplementary materials.	Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; CHAPPELL MA, 1988, EVOLUTION, V42, P681, DOI 10.1111/j.1558-5646.1988.tb02486.x; CHAPPELL MA, 1984, P NATL ACAD SCI-BIOL, V81, P5484, DOI 10.1073/pnas.81.17.5484; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Inoguchi N, 2013, ACTA CRYSTALLOGR F, V69, P393, DOI 10.1107/S1744309113005708; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Lunzer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001162; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Rokyta DR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002075; Salverda MLM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001321; Storz JF, 2008, GENETICS, V180, P367, DOI 10.1534/genetics.108.088732; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Storz JF, 2007, J MAMMAL, V88, P24, DOI 10.1644/06-MAMM-S-199R1.1; Storz JF, 2012, GENETICS, V190, P203, DOI 10.1534/genetics.111.134494; Storz JF, 2010, J EXP BIOL, V213, P2565, DOI 10.1242/jeb.042598; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165	24	137	141	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1324	1327		10.1126/science.1236862	http://dx.doi.org/10.1126/science.1236862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766324	Green Published, Green Accepted			2022-12-28	WOS:000320320200043
J	Camaschella, C				Camaschella, Clara			Treating Iron Overload	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BETA-THALASSEMIA; MOUSE MODEL; HEMOCHROMATOSIS; MICE		[Camaschella, Clara] Univ Vita Salute San Raffaele, Milan, Italy; [Camaschella, Clara] Ist Sci San Raffaele, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Camaschella, C (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.		Camaschella, Clara/A-3289-2015; Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899				Finberg KE, 2011, BLOOD, V117, P4590, DOI 10.1182/blood-2010-10-315507; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Nai A, 2012, BLOOD, V119, P5021, DOI 10.1182/blood-2012-01-401885; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Schmidt PJ, 2013, BLOOD, V121, P1200, DOI 10.1182/blood-2012-09-453977	5	27	29	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2325	2327		10.1056/NEJMcibr1304338	http://dx.doi.org/10.1056/NEJMcibr1304338			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YN	23758239				2022-12-28	WOS:000320230500012
J	Lam, HM; Remais, J; Fung, MC; Xu, LQ; Sun, SSM				Lam, Hon-Ming; Remais, Justin; Fung, Ming-Chiu; Xu, Liqing; Sun, Samuel Sai-Ming			Food supply and food safety issues in China	LANCET			English	Review							NUTRITION TRANSITION; HEALTH; WATER; OUTBREAK; CADMIUM; CROPS; RICE	Food supply and food safety are major global public health issues, and are particularly important in heavily populated countries such as China. Rapid industrialisation and modernisation in China are having profound effects on food supply and food safety. In this Review, we identified important factors limiting agricultural production in China, including conversion of agricultural land to other uses, freshwater deficits, and soil quality issues. Additionally, increased demand for some agricultural products is examined, particularly those needed to satisfy the increased consumption of animal products in the Chinese diet, which threatens to drive production towards crops used as animal feed. Major sources of food poisoning in China include pathogenic microorganisms, toxic animals and plants entering the food supply, and chemical contamination. Meanwhile, two growing food safety issues are illegal additives and contamination of the food supply by toxic industrial waste. China's connections to global agricultural markets are also having important effects on food supply and food safety within the country. Although the Chinese Government has shown determination to reform laws, establish monitoring systems, and strengthen food safety regulation, weak links in implementation remain.	[Lam, Hon-Ming; Fung, Ming-Chiu; Sun, Samuel Sai-Ming] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Lam, Hon-Ming; Fung, Ming-Chiu; Sun, Samuel Sai-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Remais, Justin] Emory Univ, Dept Environm Hlth, Atlanta, GA 30322 USA; [Xu, Liqing] Jiangnan Univ, Sch Business, Wuxi, Jiangsu, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Emory University; Jiangnan University	Sun, SSM (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	ssun@cuhk.edu.hk	Remais, Justin/V-3207-2019; Lam, Hon-Ming/A-9866-2008	Remais, Justin/0000-0002-0223-4615; Lam, Hon-Ming/0000-0002-6673-8740	Hong Kong University Grants Committee Area of Excellence [AoE-B-07/09]; Hong Kong Research Grants Council Collaborative Research Fund [CUHK3/CRF/11G]; Lee Hysan Foundation; US National Institute of Allergy and Infectious Diseases [K01AI091864]; US National Institutes of Health; National Science Foundation's Ecology of Infectious Disease Program [0622743]; Emory University's Global Health Institute Faculty Distinction Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI091864] Funding Source: NIH RePORTER	Hong Kong University Grants Committee Area of Excellence; Hong Kong Research Grants Council Collaborative Research Fund(Hong Kong Research Grants Council); Lee Hysan Foundation; US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation's Ecology of Infectious Disease Program; Emory University's Global Health Institute Faculty Distinction Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Fuk-Ling Wong and Hongmei Wang for collecting related scientific literature and preparing the figures, and Stephen Ng for critically reading this manuscript. This Review is supported by the Hong Kong University Grants Committee Area of Excellence scheme: Plant and Agricultural Biotechnology Project (AoE-B-07/09 to SS-MS and H-ML), the Hong Kong Research Grants Council Collaborative Research Fund (CUHK3/CRF/11G to H-ML), and funding from the Lee Hysan Foundation (to H-ML and SS-MS). JR is supported by the US National Institute of Allergy and Infectious Diseases (K01AI091864), by the US National Institutes of Health and National Science Foundation's Ecology of Infectious Disease Program (0622743), and by Emory University's Global Health Institute Faculty Distinction Fund.	[Anonymous], 2012, THE ECONOMIST; [Anonymous], 2011, SIXTY NATIONWIDE DIT; Ben WW, 2008, J CHROMATOGR A, V1202, P173, DOI 10.1016/j.chroma.2008.07.014; Bernard A, 2008, INDIAN J MED RES, V128, P557; Brown L.R., 1995, WHO WILL FEED CHINA; Brugha R, 1999, EPIDEMIOL INFECT, V122, P145, DOI 10.1017/S0950268898001885; Bureau of Veterinary Medicine, 2010, ANIMAL HEALTH IN CHI; Campbell, 2016, THE CHINA STUDY; Carlton EJ, 2012, B WORLD HEALTH ORGAN, V90, P578, DOI 10.2471/BLT.11.098343; Chang YF, 2012, FORENSIC SCI INT, V220, pE5, DOI 10.1016/j.forsciint.2012.01.032; Chinese Ministry of Agriculture, 2010, GUIDELINE FOR SAFETY; Chinese Ministry of Agriculture, 2006, GUIDELINE FOR SAFETY; Chinese Ministry of Health, 2012 REPORT OF NATIO; Codex Alimentarius Commission, 1997, CODEX ALIMENTARIUS F; De Waal CS, 2005, GLOBAL AND LOCAL FOO; Dennis Tao Yang, 2008, Agroalim, V14, P13; Department of Population Statistics National Bureau of Statistics of China, 1988, COMPILATION OF POPUL; EconomyWatch, 2010, ECONOMY WATCH; Emerson C, AQUACULTURE IMPACTS; Fang Y, 2011, BEIJING AGRIC, V36, P80; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gale H. F., 2009, CHINA IS USING MORE; General Office of the State Council, 2012, NATIONAL PLAN FOR TH; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Gong P, 2011, NATURE, V473, P284, DOI 10.1038/473284e; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Guan N, 2009, NEW ENGL J MED, V360, P1067, DOI 10.1056/NEJMoa0809550; HALLIDAY ML, 1991, J INFECT DIS, V164, P852, DOI 10.1093/infdis/164.5.852; Hoffmann S, 2010, FOOD SAFETY POLICY A; Jin L., 2001, WATER POLICY, V3, P215, DOI [DOI 10.1016/S1366-7017(01)00015-0, 10.1016/S1366-7017(01)00015-0]; KANTHA SS, 1990, PROG FOOD NUTR SCI, V14, P93; Keiser J, 2009, CLIN MICROBIOL REV, V22, P466, DOI 10.1128/CMR.00012-09; Kim SA, 2013, MK BUSINESS NEWS; Kwok J, 2006, SUDAN DYES IN FOOD F; Li J., 2009, HYBRID RICE TECHNOLO; Li Xiaowei, 2012, Wei Sheng Yan Jiu, V41, P379; Liu X., 2011, CHINESE J FOOD HYGIE, V23, P132; Ma GS, 2008, PUBLIC HEALTH NUTR, V11, P632, DOI 10.1017/S1368980007001085; Ma MT, 2012, THE BEIJING NEWS, pB05; Mayer JE, 2008, CURR OPIN PLANT BIOL, V11, P166, DOI 10.1016/j.pbi.2008.01.007; Ministry of Agriculture, 2009, CHINA AGRICULTURE YE, P365; Ministry of Industry and Information Technology Ministry of Agriculture Ministry of Commerce Ministry of Health State Administration for Industry and Commerce General Administration of Quality Supervision Inspection and Quarantine, 2011, LOCK UP OF RACTOPAMI; Ministry of Water Resources of the People's Republic of China, 2008, 2007 2008 ANNUAL REP; National Development and Reform Commission and the Ministry of Industry and Information Technology, 2011, DEVELOPMENT PLAN FOR; Nisha AR, 2008, VET WORLD, V1, P375; Niu S, 2011, REUTERS; NUBE M, 2006, STAFF WORKING PAPER; Office of the South-to-North Water Diversion Project Commission, SOUTH TO NORTH WATER; Office of the United Nations Resident Coordinator in China, 2008, UNITED NATIONS IN CH; Ouyang H.Y., 2011, INSIGHT CHINA, V7, P50; PENG XZ, 1987, POPUL DEV REV, V13, P639, DOI 10.2307/1973026; Popkin BM, 2008, HEALTH AFFAIR, V27, P1064, DOI 10.1377/hlthaff.27.4.1064; Shi YL, 2006, LAND RESOURCES MAP O; Soderstrom A, 2008, FOODBORNE PATHOG DIS, V5, P339, DOI 10.1089/fpd.2007.0065; Song H, 2011, J PUBLIC ADMIN, V2, P30; Song X, 2011, CHINA ECONOMIC WEEKL; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Stone R, 2008, SCIENCE, V321, P1279, DOI 10.1126/science.321.5894.1279; Umali-Deininger D, 2006, 26TH CONFERENCE OF T; UN Food and Agricultural Organization, 1997, FAO ENVIRONMENT AND; UN Food and Agricultural Organization, STATISTICS; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD POPULATION PRO; US Centers for Disease Control and Prevention, 2011, INVESTIGATION UPDATE; US Centers for Disease Control and Prevention, CDC ESTIMATES OF FOO; US Central Intelligence Agency, THE WORLD FACTBOOK P; Van den Berg MM, 2007, AGR SYST, V94, P841, DOI 10.1016/j.agsy.2006.11.010; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Whitehead AJ, 1995, FOOD SAFETY THROUGH; WHO, 2007, WHO FACT SHEET FOOD; Wu YN, 2013, J EPIDEMIOL COMMUN H, V67, P478, DOI 10.1136/jech-2012-201767; [谢文彪 Xie Wenbiao], 2008, [生态环境, Ecology and Environment], V17, P206; Xu J, 2011, CHINA DAILY, P5; Xu L, 2011, REPORT ON CHINA FOOD; zccw.info, CIVILIAN DATABASE FO; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x; Zhang JF, 2010, LANCET, V375, P1110, DOI 10.1016/S0140-6736(10)60062-1; Zhang Liang-yun, 2009, Huanjing Kexue, V30, P2792; Zhang WenJun, 2011, Proceedings of the International Academy of Ecology and Environmental Sciences, V1, P125; [甄燕红 ZHEN Yanhong], 2008, [安全与环境学报, Journal of Safety and Environment], V8, P119; ZOU C, 2008, MICRONUTRIENT DEFICI	80	245	252	62	359	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 8	2013	381	9882					2044	2053		10.1016/S0140-6736(13)60776-X	http://dx.doi.org/10.1016/S0140-6736(13)60776-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171JY	23746904	Green Accepted			2022-12-28	WOS:000320924400033
J	Prince, MJ				Prince, Martin J.			Dementia in China: east-west collaboration bears fruit	LANCET			English	Editorial Material							PREVALENCE; CARE		Kings Coll London, Inst Psychiat, London SE5 8AF, England	University of London; King's College London	Prince, MJ (corresponding author), Kings Coll London, Inst Psychiat, London SE5 8AF, England.	martin.prince@kcl.ac.uk	Prince, Martin J/A-9170-2010	Prince, Martin J/0000-0003-1379-7146				Alzheimer's Disease International, 2009, WORLD ALZHEIMER REPO; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Dong MJ, 2007, AGE AGEING, V36, P619, DOI 10.1093/ageing/afm128; Liu ZR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-394; Loef M, 2012, OBESITY SILVER SPRIN, V21, pE51; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Wagstaff A, 2007, 4150 WORLD BANK; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Xinhua, 2012, XINHUA          1229; Xu QW, 2011, INT SOC WORK, V54, P374, DOI 10.1177/0020872810396260; Zhan Heying J, 2006, J Aging Soc Policy, V18, P85, DOI 10.1300/J031v18n02_06	11	6	7	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 8	2013	381	9882					1967	1968		10.1016/S0140-6736(13)60770-9	http://dx.doi.org/10.1016/S0140-6736(13)60770-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171JY	23746886				2022-12-28	WOS:000320924400008
J	Appleby, J				Appleby, John			Are accident and emergency attendances increasing?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Appleby J., 2013, SLIDESHOW PRESSURES; Department of Health, TOTAL TIME SPENT IN; NHS England, 2013, A E WAITING TIMES AN; NHS England, WEEKLY TIME SERIES A; NHS England, 2013, NHS SUPPORT PLAN LAU; Skidmore C., 2013, DAILY MAIL; Steventon A, 2011, J HEALTH SERV RES PO, V16, P90, DOI 10.1258/jhsrp.2010.010097	7	4	4	2	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 7	2013	346								f3677	10.1136/bmj.f3677	http://dx.doi.org/10.1136/bmj.f3677			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YM	23747970				2022-12-28	WOS:000320230400007
J	Hirschfield, GM; Karlsen, TH; Lindor, KD; Adams, DH				Hirschfield, Gideon M.; Karlsen, Tom H.; Lindor, Keith D.; Adams, David H.			Primary sclerosing cholangitis	LANCET			English	Article							DOSE URSODEOXYCHOLIC ACID; GENOME-WIDE ASSOCIATION; PRIMARY BILIARY-CIRRHOSIS; ULCERATIVE-COLITIS; LIVER-TRANSPLANTATION; COLORECTAL NEOPLASIA; RISK-FACTORS; BILE-DUCTS; NORURSODEOXYCHOLIC ACID; AUTOIMMUNE HEPATITIS	Primary sclerosing cholangitis is the classic hepatobiliary manifestation of infl ammatory bowel disease and is generally chronic and progressive. Patients frequently present with asymptomatic, anicteric cholestasis, but many develop progressive biliary strictures with time, leading to recurrent cholangitis, biliary cirrhosis, and end-stage liver disease. Medical treatment does not slow the progression of disease, and many patients need liver transplantation, after which recurrent disease is a risk. The increased incidence of hepatobiliary cancer, which is not related to the underlying severity of biliary fi brosis, is of particular concern. Risk of colorectal cancer is also increased in patients with coexistent infl ammatory bowel disease. Mechanistic insights have arisen from studies of secondary sclerosing cholangitis, in which a similar clinical profi le is associated with a specifi c cause, and genomic studies have elucidated potential disease-initiating pathways in the primary form. The close association between infl ammatory bowel disease and primary sclerosing cholangitis underscores the need to further understand the role of environmental factors in generation of lymphocytes that are postulated to be retargeted, deleteriously, to the biliary tree. Treatment of primary sclerosing cholangitis is confi ned to supportive measures, but advances in pathobiology suggest that new stratifi ed approaches will soon be available.	[Hirschfield, Gideon M.; Adams, David H.] Univ Birmingham, Liver Res Ctr, Natl Inst Hlth Res, Biomed Res Unit, Birmingham B15 2TT, W Midlands, England; [Karlsen, Tom H.] Univ Oslo, Rikshosp,Oslo Univ Hosp, Norwegian Primary Sclerosing Cholangitis Res Ctr, Dept Transplantat Med,Div Canc Med Surg & Transpl, N-0027 Oslo, Norway; [Karlsen, Tom H.] Univ Bergen, Dept Clin Med, Fac Med & Dent, Bergen, Norway; [Lindor, Keith D.] Arizona State Univ, Phoenix, AZ USA	University of Birmingham; University of Oslo; National Hospital Norway; University of Bergen; Arizona State University; Arizona State University-Downtown Phoenix	Hirschfield, GM (corresponding author), Univ Birmingham, Liver Res Ctr, Natl Inst Hlth Res, Biomed Res Unit, Birmingham B15 2TT, W Midlands, England.	g.hirschfield@bham.ac.uk	Gross, Wolfgang Ludwig WG/C-8733-2011; Lukas, Milan/J-6382-2017; Hirschfield, Gideon M/M-2143-2015	Lukas, Milan/0000-0002-1463-3840; Hirschfield, Gideon M/0000-0002-6736-2255; ADAMS, David/0000-0001-6776-0336	MRC [G0400496, G0700301, G0300101] Funding Source: UKRI; National Institute for Health Research [NF-SI-0512-10080] Funding Source: researchfish; Medical Research Council [G0400496, G0700301, G0300101] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdalian R, 2008, HEPATOLOGY, V47, P949, DOI 10.1002/hep.22073; Al Mamari S, 2013, J HEPATOL, V58, P329, DOI 10.1016/j.jhep.2012.10.013; Al-Harthy N, 2010, HEPATOLOGY, V52, P562, DOI 10.1002/hep.23683; Alabraba E, 2009, LIVER TRANSPLANT, V15, P330, DOI 10.1002/lt.21679; Alemi F, 2013, J CLIN INVEST, V123, P1513, DOI 10.1172/JCI64551; Aljiffry M, 2011, HPB, V13, P79, DOI 10.1111/j.1477-2574.2010.00268.x; Alswat K, 2012, AM J GASTROENTEROL, V107, P56, DOI 10.1038/ajg.2011.375; Angulo P, 2000, AM J GASTROENTEROL, V95, P2333; Angulo P, 2011, GASTROENTEROLOGY, V140, P180, DOI 10.1053/j.gastro.2010.10.014; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Aspinall AI, 2010, HEPATOLOGY, V51, P2030, DOI 10.1002/hep.23591; Baghdasaryan A, 2011, HEPATOLOGY, V54, P1303, DOI 10.1002/hep.24537; Bangarulingam SY, 2009, AM J GASTROENTEROL, V104, P855, DOI 10.1038/ajg.2008.161; Bergquist A, 1998, HEPATOLOGY, V27, P311, DOI 10.1002/hep.510270201; BEUERS U, 1992, HEPATOLOGY, V16, P707, DOI 10.1002/hep.1840160315; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Bjornsson E, 2002, GUT, V51, P731, DOI 10.1136/gut.51.5.731; Bjornsson E, 2008, GASTROENTEROLOGY, V134, P975, DOI 10.1053/j.gastro.2008.01.042; Bjornsson E, 2011, AM J THER, V18, P198, DOI 10.1097/MJT.0b013e3181c9dac6; Boberg KM, 2006, J HEPATOL, V45, P568, DOI 10.1016/j.jhep.2006.05.010; Boberg KM, 2011, J HEPATOL, V54, P374, DOI 10.1016/j.jhep.2010.09.002; Boberg KM, 2002, SCAND J GASTROENTERO, V37, P1205, DOI 10.1080/003655202760373434; Boner AL, 2007, INT J IMMUNOPATH PH, V20, P847, DOI 10.1177/039463200702000423; Boonstra K, 2012, INFLAMM BOWEL DIS, V18, P2270, DOI 10.1002/ibd.22938; Boonstra K, 2012, J HEPATOL, V56, P1181, DOI 10.1016/j.jhep.2011.10.025; Borchers AT, 2009, SEMIN IMMUNOPATHOL, V31, P309, DOI 10.1007/s00281-009-0167-2; Broome U, 1996, GUT, V38, P610, DOI 10.1136/gut.38.4.610; BROOME U, 1995, HEPATOLOGY, V22, P1404, DOI 10.1016/0270-9139(95)90144-2; Buckles DC, 2002, AM J GASTROENTEROL, V97, P1138; Burak K, 2004, AM J GASTROENTEROL, V99, P523, DOI 10.1111/j.1572-0241.2004.04067.x; Chapman MH, 2012, EUR J GASTROEN HEPAT, V24, P1051, DOI 10.1097/MEG.0b013e3283554bbf; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; Chapman RW, 2009, HEPATOLOGY, V50, P671, DOI 10.1002/hep.23174; Charatcharoenwitthaya P, 2008, HEPATOLOGY, V48, P1106, DOI 10.1002/hep.22441; CHAZOUILLERES O, 1990, J HEPATOL, V11, P120, DOI 10.1016/0168-8278(90)90281-U; Choi ER, 2011, J GASTROEN HEPATOL, V26, P1804, DOI 10.1111/j.1440-1746.2011.06804.x; Claessen MMH, 2009, J HEPATOL, V50, P158, DOI 10.1016/j.jhep.2008.08.013; Dave M, 2010, RADIOLOGY, V256, P387, DOI 10.1148/radiol.10091953; Davies YK, 2008, J PEDIATR GASTR NUTR, V47, P61, DOI 10.1097/MPG.0b013e31816fee95; de Valle MB, 2012, CLIN GASTROENTEROL H, V10, DOI 10.1016/j.cgh.2012.01.025; de Valle MB, 2012, LIVER INT, V32, P441, DOI 10.1111/j.1478-3231.2011.02614.x; Denk GU, 2010, HEPATOLOGY, V52, P1758, DOI 10.1002/hep.23911; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Eaton JE, 2012, AM J GASTROENTEROL, V107, P431, DOI 10.1038/ajg.2011.361; Eaton JE, 2011, AM J GASTROENTEROL, V106, P1638, DOI 10.1038/ajg.2011.156; Eksteen B, 2004, J EXP MED, V200, P1511, DOI 10.1084/jem.20041035; Eksteen B, 2006, J IMMUNOL, V177, P593, DOI 10.4049/jimmunol.177.1.593; Ellinghaus D, 2013, HEPATOLOGY, V58, P1074, DOI 10.1002/hep.25977; Engler S, 2003, GUT, V52, P688, DOI 10.1136/gut.52.5.688; Etzel JP, 2008, GASTROINTEST ENDOSC, V67, P643, DOI 10.1016/j.gie.2007.07.042; Fan XY, 2012, CLIN IMMUNOL, V143, P152, DOI 10.1016/j.clim.2012.01.014; Farkkila M, 2004, HEPATOLOGY, V40, P1379, DOI 10.1002/hep.20457; Fickert P, 2006, GASTROENTEROLOGY, V130, P465, DOI 10.1053/j.gastro.2005.10.018; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Folseraas T, 2012, J HEPATOL, V57, P366, DOI 10.1016/j.jhep.2012.03.031; Fritcher EGB, 2009, GASTROENTEROLOGY, V136, P2180, DOI 10.1053/j.gastro.2009.02.040; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Grant AJ, 2002, LANCET, V359, P150, DOI 10.1016/S0140-6736(02)07374-9; Grant AJ, 2002, AM J PATHOL, V160, P1445, DOI 10.1016/S0002-9440(10)62570-9; Grant AJ, 2001, HEPATOLOGY, V33, P1065, DOI 10.1053/jhep.2001.24231; Gregorio GV, 2001, HEPATOLOGY, V33, P544, DOI 10.1053/jhep.2001.22131; Halilbasic E, 2009, HEPATOLOGY, V49, P1972, DOI 10.1002/hep.22891; Halliday JS, 2012, J CROHNS COLITIS, V6, P174, DOI 10.1016/j.crohns.2011.07.015; Hohenester S, 2012, HEPATOLOGY, V55, P173, DOI 10.1002/hep.24691; Hommes DW, 2008, J CLIN GASTROENTEROL, V42, P522, DOI 10.1097/MCG.0b013e3181662426; Hov JR, 2011, HEPATOLOGY, V53, P1967, DOI 10.1002/hep.24299; Hov JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012403; Imam MH, 2011, ALIMENT PHARM THER, V34, P1185, DOI 10.1111/j.1365-2036.2011.04863.x; Janse M, 2011, HEPATOLOGY, V53, P1977, DOI 10.1002/hep.24307; Jess T, 2012, GASTROENTEROLOGY, V143, P375, DOI 10.1053/j.gastro.2012.04.016; Jonker JW, 2012, J STEROID BIOCHEM, V130, P147, DOI 10.1016/j.jsbmb.2011.06.012; Jorgensen KK, 2013, CLIN GASTROENTEROL H, V11, P517, DOI 10.1016/j.cgh.2012.12.027; Jorgensen KK, 2012, SCAND J GASTROENTERO, V47, P1021, DOI 10.3109/00365521.2012.685754; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kalaitzakis E, 2012, EUR J GASTROEN HEPAT, V24, P656, DOI 10.1097/MEG.0b013e3283526fa1; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Karaahmet F, 2012, ALIMENT PHARM THER, V35, P490, DOI 10.1111/j.1365-2036.2011.04974.x; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Kaya M, 2001, AM J GASTROENTEROL, V96, P1059; Kremer AE, 2012, HEPATOLOGY, V56, P1391, DOI 10.1002/hep.25748; Lankisch TO, 2011, HEPATOLOGY, V53, P875, DOI 10.1002/hep.24103; Levy MJ, 2008, AM J GASTROENTEROL, V103, P1263, DOI 10.1111/j.1572-0241.2007.01776.x; Lewin M, 2009, HEPATOLOGY, V50, P528, DOI 10.1002/hep.23024; Liaskou E, 2011, HEPATOLOGY, V53, P661, DOI 10.1002/hep.24085; Lindkvist B, 2010, HEPATOLOGY, V52, P571, DOI 10.1002/hep.23678; Lindor KD, 1997, NEW ENGL J MED, V336, P691, DOI 10.1056/NEJM199703063361003; Lindor KD, 2009, HEPATOLOGY, V50, P808, DOI 10.1002/hep.23082; Lindstrom L, 2012, ALIMENT PHARM THER, V35, P451, DOI 10.1111/j.1365-2036.2011.04966.x; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Luna LEM, 2006, GASTROENTEROLOGY, V131, P1064, DOI 10.1053/j.gastro.2006.08.021; MACCARTY RL, 1983, RADIOLOGY, V149, P39, DOI 10.1148/radiology.149.1.6412283; Marelli L, 2011, GUT, V60, P1224, DOI 10.1136/gut.2010.235408; Marsh RD, 2012, J SURG ONCOL, V106, P339, DOI 10.1002/jso.23027; Marsh RD, 2012, J SURG ONCOL, V106, P332, DOI 10.1002/jso.23028; Martin CR, 2012, ALIMENT PHARM THER, V35, P255, DOI 10.1111/j.1365-2036.2011.04926.x; Martin CR, 2012, AM J PHYSIOL-GASTR L, V303, pG474, DOI 10.1152/ajpgi.00055.2012; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Mendes FD, 2006, AM J GASTROENTEROL, V101, P2070, DOI 10.1111/j.1572-0241.2006.00772.x; Metzger J, 2013, GUT, V62, P122, DOI 10.1136/gutjnl-2012-302047; Miles A, 2008, AM J PHYSIOL-GASTR L, V294, pG1257, DOI 10.1152/ajpgi.00266.2007; Mitchell SA, 2001, GASTROENTEROLOGY, V121, P900, DOI 10.1053/gast.2001.27965; Modica S, 2012, GASTROENTEROLOGY, V142, P355, DOI 10.1053/j.gastro.2011.10.028; Mohamadnejad M, 2011, GASTROINTEST ENDOSC, V73, P71, DOI 10.1016/j.gie.2010.08.050; Molodecky NA, 2011, HEPATOLOGY, V53, P1590, DOI 10.1002/hep.24247; Murad SD, 2012, GASTROENTEROLOGY, V143, P88, DOI 10.1053/j.gastro.2012.04.008; Navaneethan U, 2012, CLIN GASTROENTEROL H, V10, P540, DOI 10.1016/j.cgh.2012.01.006; Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730; Ngu JH, 2012, HEPATOLOGY, V55, P522, DOI 10.1002/hep.24743; O'Toole A, 2012, CLIN GASTROENTEROL H, V10, P439, DOI 10.1016/j.cgh.2011.11.010; OBRIEN CB, 1991, HEPATOLOGY, V14, P838, DOI 10.1002/hep.1840140516; Olsson R, 2005, GASTROENTEROLOGY, V129, P1464, DOI 10.1053/j.gastro.2005.08.017; OLSSON R, 1991, GASTROENTEROLOGY, V100, P1319; Pardi DS, 2003, GASTROENTEROLOGY, V124, P889, DOI 10.1053/gast.2003.50156; Penna C, 1996, GUT, V38, P234, DOI 10.1136/gut.38.2.234; Pohl J, 2006, EUR J GASTROEN HEPAT, V18, P69, DOI 10.1097/00042737-200601000-00012; Portmann B, 2012, HISTOPATHOLOGY, V60, P236, DOI 10.1111/j.1365-2559.2011.03853.x; RABINOVITZ M, 1990, HEPATOLOGY, V12, P747, DOI 10.1002/hep.1840120421; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Razumilava N, 2011, HEPATOLOGY, V54, P1842, DOI 10.1002/hep.24570; Rudolph G, 2007, EUR J GASTROEN HEPAT, V19, P487, DOI 10.1097/MEG.0b013e3281108068; Rudolph G, 2009, J HEPATOL, V51, P149, DOI 10.1016/j.jhep.2009.01.023; Sah RP, 2010, GASTROENTEROLOGY, V139, P140, DOI 10.1053/j.gastro.2010.03.054; Said K, 2008, J HEPATOL, V48, P598, DOI 10.1016/j.jhep.2007.11.019; Schramm C, 1999, ANN INTERN MED, V131, P943, DOI 10.7326/0003-4819-131-12-199912210-00006; SCHRUMPF E, 1980, SCAND J GASTROENTERO, V15, P689, DOI 10.3109/00365528009181516; Silveira MG, 2009, AM J GASTROENTEROL, V104, P83, DOI 10.1038/ajg.2008.14; Sinakos E, 2011, CLIN GASTROENTEROL H, V9, P434, DOI 10.1016/j.cgh.2011.02.007; Sinakos E, 2010, HEPATOLOGY, V52, P197, DOI 10.1002/hep.23631; Soetikno RM, 2002, GASTROINTEST ENDOSC, V56, P48, DOI 10.1067/mge.2002.125367; Stiehl A, 2002, J HEPATOL, V36, P151, DOI 10.1016/S0168-8278(01)00251-3; Strazzabosco M, 2008, ANAT REC, V291, P653, DOI 10.1002/ar.20664; Syal G, 2012, AM J PHYSIOL-GASTR L, V303, pG1077, DOI 10.1152/ajpgi.00227.2012; Talwalkar JA, 2007, LIVER INT, V27, P451, DOI 10.1111/j.1478-3231.2007.01441.x; Terg Ruben, 2008, Acta Gastroenterologica Latinoamericana, V38, P26; Terjung B, 2010, GUT, V59, P808, DOI 10.1136/gut.2008.157818; Tischendorf JJW, 2007, AM J GASTROENTEROL, V102, P107, DOI 10.1111/j.1572-0241.2006.00872.x; Torres J, 2011, ALIMENT PHARM THER, V34, P497, DOI 10.1111/j.1365-2036.2011.04753.x; Treeprasertsuk S, 2010, HEPATOLOGY, V51, P1302, DOI 10.1002/hep.23432; Triantos CK, 2011, ALIMENT PHARM THER, V34, P901, DOI 10.1111/j.1365-2036.2011.04822.x; van Hoogstraten HJF, 2000, AM J GASTROENTEROL, V95, P2015, DOI 10.1016/S0002-9270(00)01059-5; Woo K, 2010, HEPATOLOGY, V52, P1819, DOI 10.1002/hep.23883	141	354	366	8	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1587	1599		10.1016/S0140-6736(13)60096-3	http://dx.doi.org/10.1016/S0140-6736(13)60096-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247NE	23810223				2022-12-28	WOS:000326623900030
J	Hegarty, K				Hegarty, Kelsey			Can fracture clinics respond to domestic violence?	LANCET			English	Editorial Material							INTIMATE PARTNER VIOLENCE; RANDOMIZED CONTROLLED-TRIAL; WOMEN; HEALTH; PREVALENCE; AUSTRALIA		Gen Practice & Primary Hlth Care Acad Ctr, Carlton, Vic 3053, Australia		Hegarty, K (corresponding author), Gen Practice & Primary Hlth Care Acad Ctr, Carlton, Vic 3053, Australia.	k.hegarty@unimelb.edu.au		Hegarty, Kelsey/0000-0002-7532-5147				Feder G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13160; Feder G, 2011, LANCET, V378, P1788, DOI 10.1016/S0140-6736(11)61179-3; Hegarty K, 2000, MED J AUSTRALIA, V173, P363, DOI 10.5694/j.1326-5377.2000.tb125688.x; Hegarty K., 2006, INTIMATE PARTNER ABU, P19; Hegarty K, 2013, LANCET, V382, P249, DOI 10.1016/S0140-6736(13)60052-5; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Nelson HD, 2012, ANN INTERN MED, V156, P796, DOI 10.7326/0003-4819-156-11-201206050-00447; Pirotta M, 2002, AUST NZ J PUBL HEAL, V26, P152, DOI 10.1111/j.1467-842X.2002.tb00909.x; PRAISE Investigators, 2013, LANCET; Rees S, 2011, JAMA-J AM MED ASSOC, V306, P513, DOI 10.1001/jama.2011.1098; Sprague S, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-23; Stayton CD, 2005, TRAUMA VIOLENCE ABUS, V6, P271, DOI 10.1177/1524838005277439; Taft A, 2013, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD007007.PUB2; Vos T, 2006, B WORLD HEALTH ORGAN, V84, P739, DOI 10.2471/BLT.06.030411	14	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2013	382	9895					838	839		10.1016/S0140-6736(13)60818-1	http://dx.doi.org/10.1016/S0140-6736(13)60818-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215WE	23768758				2022-12-28	WOS:000324240700007
J	Simon, MS; Weiss, D; Gulick, RM				Simon, Matthew S.; Weiss, Don; Gulick, Roy M.			Invasive Meningococcal Disease in Men Who Have Sex With Men	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NEISSERIA-MENINGITIDIS		Weill Cornell Med Coll, New York, NY 10065 USA; New York City Dept Hlth & Mental Hyg, New York, NY USA	Cornell University; New York City Department of Health & Mental Hygiene	Simon, MS (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, 402 East 67th St, New York, NY 10065 USA.	mss9008@med.cornell.edu			Clinical and Translational Science Center at Weill Cornell Medical College [UL1 TR000457]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER	Clinical and Translational Science Center at Weill Cornell Medical College; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Grant Support: In part by grant UL1 TR000457 from the Clinical and Translational Science Center at Weill Cornell Medical College.	Brooks R, 2006, CLIN INFECT DIS, V43, P49, DOI 10.1086/504804; Cohen C, 2010, AIDS, V24, P1351, DOI 10.1097/QAD.0b013e32833a2520; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; JANDA WM, 1980, JAMA-J AM MED ASSOC, V244, P2060, DOI 10.1001/jama.244.18.2060; Lujan-Zilbermann J, 2012, J PEDIATR-US, V161, P676, DOI 10.1016/j.jpeds.2012.04.005; Neal KR, 2000, BRIT MED J, V320, P846, DOI 10.1136/bmj.320.7238.846; Schmink S, 2007, J CLIN MICROBIOL, V45, P3768, DOI 10.1128/JCM.01190-07; STEPHENS DS, 1995, ANN INTERN MED, V123, P937, DOI 10.7326/0003-4819-123-12-199512150-00007; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Zucker JR, 2013, 2012 ALERT 5 UPDATE	10	29	29	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					300	+		10.7326/0003-4819-159-4-201308200-00674	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00674			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	23778867	Green Accepted			2022-12-28	WOS:000323421700022
J	Black, ME				Black, Mary E.			International health is a misnomer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2013	347								f4167	10.1136/bmj.f4167	http://dx.doi.org/10.1136/bmj.f4167			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180CL	23819965				2022-12-28	WOS:000321570400006
J	Iqbal, F; Beggs, AD; Holt, T; Bowley, DM				Iqbal, Fareed; Beggs, Andrew D.; Holt, Tim; Bowley, Douglas M.			A pain in the bottom	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Iqbal, Fareed; Beggs, Andrew D.] Univ Birmingham, Acad Dept Surg, Birmingham B15 2TT, W Midlands, England; [Holt, Tim] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Bowley, Douglas M.] Heart England NHS Fdn Trust, Dept Surg, Birmingham B9 5SS, W Midlands, England	University of Birmingham; University of Oxford; Heart of England NHS Foundation Trust	Iqbal, F (corresponding author), Univ Birmingham, Acad Dept Surg, Birmingham B15 2TT, W Midlands, England.	F.Iqbal@bham.ac.uk	Beggs, Andrew D/A-6912-2013	Beggs, Andrew D/0000-0003-0784-2967	Academy of Medical Sciences (AMS) [AMS-SGCL8-Beggs] Funding Source: researchfish; National Institute for Health Research [CL-2010-13-005] Funding Source: researchfish	Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))		Acheson AG, 2008, BRIT MED J, V336, P380, DOI 10.1136/bmj.39465.674745.80; Bharucha AE, 2008, GASTROENTEROL CLIN N, V37, P685, DOI 10.1016/j.gtc.2008.06.002; Cross KLR, 2008, COLORECTAL DIS, V10, P1, DOI 10.1111/j.1463-1318.2008.01681.x	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2013	347								f4192	10.1136/bmj.f4192	http://dx.doi.org/10.1136/bmj.f4192			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180CB	23818561				2022-12-28	WOS:000321569400005
J	Deweerdt, S				Deweerdt, Sarah			GENETICS Written in blood	NATURE			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; MUTATIONS											Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Vassiliou GS, 2011, NAT GENET, V43, P470, DOI 10.1038/ng.796; Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042	7	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					S4	S6		10.1038/498S4a	http://dx.doi.org/10.1038/498S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803948				2022-12-28	WOS:000320929400003
J	Stephenson, T				Stephenson, Terence			PERSONAL VIEW To boldly go from "computer says no" to an iNHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Acad Med Royal Coll, London EC1V 0DB, England		Stephenson, T (corresponding author), Acad Med Royal Coll, London EC1V 0DB, England.	t.stephenson@ucl.ac.uk		Stephenson, Terence/0000-0001-8871-7847				Academy of Medical Royal Colleges, 7 DAY CONS PRES CAR; [Anonymous], FIN REP; Department of Health, 2000, ORG MEM	3	4	4	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2013	346								f4028	10.1136/bmj.f4028	http://dx.doi.org/10.1136/bmj.f4028			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QH	23798722				2022-12-28	WOS:000321245800003
J	Rowley, JD				Rowley, Janet D.			A Story of Swapped Ends	SCIENCE			English	Editorial Material							CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOCYTIC-LEUKEMIA; QUINACRINE FLUORESCENCE; HUMAN CHROMOSOMES; TRANSLOCATION; GENE; ABL; BCR; LOCALIZATION		Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Rowley, JD (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jrowley@medicine.bsd.uchicago.edu						CASPERSS.T, 1970, EXP CELL RES, V60, P315, DOI 10.1016/0014-4827(70)90523-9; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HEISTERKAMP N, 1982, NATURE, V299, P747, DOI 10.1038/299747a0; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; NOWELL PC, 1960, SCIENCE, V132, P1497; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; ROWLEY JD, 1973, ANN GENET-PARIS, V16, P109; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SUMNER AT, 1971, NATURE-NEW BIOL, V232, P31, DOI 10.1038/newbio232031a0; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; WHANGPENG J, 1968, BLOOD, V32, P755, DOI 10.1182/blood.V32.5.755.755	17	12	12	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1412	1413		10.1126/science.1241318	http://dx.doi.org/10.1126/science.1241318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23788787				2022-12-28	WOS:000320647000027
J	Memtsoudis, SG; Besculides, MC; Mazumdar, M				Memtsoudis, Stavros G.; Besculides, Melanie C.; Mazumdar, Madhu			A Rude Awakening - The Perioperative Sleep Apnea Epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Memtsoudis, Stavros G.] Cornell Univ, Hosp Special Surg, Dept Anesthesiol, Princeton, NJ USA; [Mazumdar, Madhu] Cornell Univ, Div Biostatist & Epidemiol, Princeton, NJ USA	Cornell University; Cornell University	Memtsoudis, SG (corresponding author), Cornell Univ, Hosp Special Surg, Dept Anesthesiol, Princeton, NJ USA.							Amer Soc Anesthesiologists, 2006, ANESTHESIOLOGY, V104, P1081; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Kaw R, 2012, CHEST, V141, P436, DOI 10.1378/chest.11-0283; Memtsoudis S, 2011, ANESTH ANALG, V112, P113, DOI 10.1213/ANE.0b013e3182009abf; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	5	74	81	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2352	2353		10.1056/NEJMp1302941	http://dx.doi.org/10.1056/NEJMp1302941			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782177				2022-12-28	WOS:000320601700004
J	Jurkovic, D; Overton, C; Bender-Atik, R				Jurkovic, Davor; Overton, Caroline; Bender-Atik, Ruth			Diagnosis and management of first trimester miscarriage	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HUMAN CHORIONIC-GONADOTROPIN; MANUAL VACUUM ASPIRATION; EARLY-PREGNANCY; EXPECTANT MANAGEMENT; CONTROLLED-TRIAL; MISSED ABORTION; MEDICAL-MANAGEMENT; SURGICAL-MANAGEMENT; UNKNOWN LOCATION; RANDOMIZED-TRIAL		[Jurkovic, Davor] Univ Coll London Hosp, Dept Obstet & Gynaecol, London NW1 2BU, England; [Overton, Caroline] St Michaels Univ Hosp, Bristol, Avon, England; [Bender-Atik, Ruth] Miscarriage Assoc, Wakefield, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Jurkovic, D (corresponding author), Univ Coll London Hosp, Dept Obstet & Gynaecol, London NW1 2BU, England.	davor.jurkovic@uclh.nhs.uk						ALCAZAR JL, 1995, ULTRASOUND OBST GYN, V6, P126, DOI 10.1046/j.1469-0705.1995.06020126.x; Aleman A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003576.pub2; American College of Radiology, 1996, ACR APPR CRIT 1 TRIM; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Bagratee JS, 2004, HUM REPROD, V19, P266, DOI 10.1093/humrep/deh049; Baird DT, 2006, HUM REPROD UPDATE, V12, P193, DOI 10.1093/humupd/dmk003; Blohm F, 2005, BJOG-INT J OBSTET GY, V112, P1090, DOI 10.1111/j.1471-0528.2005.00632.x; CACCIATORE B, 1989, OBSTET GYNECOL, V73, P770; Chan YY, 2011, ULTRASOUND OBST GYN, V38, P371, DOI 10.1002/uog.10056; Chung K, 2011, FERTIL STERIL, V96, P659, DOI 10.1016/j.fertnstert.2011.06.017; Chung TKH, 1999, FERTIL STERIL, V71, P1054, DOI 10.1016/S0015-0282(99)00128-4; Condous G, 2006, BJOG-INT J OBSTET GY, V113, P521, DOI 10.1111/j.1471-0528.2006.00924.x; Cordina M, 2011, BJOG-INT J OBSTET GY, V118, P693, DOI 10.1111/j.1471-0528.2011.02893.x; Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; EGARTER C, 1995, ARCH GYNECOL OBSTET, V256, P29, DOI 10.1007/BF00634345; ELREFAEY H, 1992, BRIT MED J, V305, P1399, DOI 10.1136/bmj.305.6866.1399; Elson J, 2005, HUM REPROD, V20, P2330, DOI 10.1093/humrep/dei038; Empson M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002859.pub2; Gazvani R, 2004, EUR J OBSTET GYN R B, V112, P197, DOI 10.1016/S0301-2115(03)00320-8; Graziosi GCM, 2004, HUM REPROD, V19, P1894, DOI 10.1093/humrep/deh344; Gronlund A, 2002, ACTA OBSTET GYN SCAN, V81, P1060, DOI 10.1034/j.1600-0412.2002.811111.x; HAHLIN M, 1995, HUM REPROD, V10, P1223, DOI 10.1093/oxfordjournals.humrep.a136123; Harwood B, 2008, BJOG-INT J OBSTET GY, V115, P501, DOI 10.1111/j.1471-0528.2007.01632.x; HATELY W, 1995, ULTRASOUND OBST GYN, V5, P353, DOI 10.1046/j.1469-0705.1995.05050353.x; Health and Social Care Information Centre, HOSP EP STAT NHS MAT; Howie HJ, 1986, DEWHURSTS TXB OBSTET, P176; Irish Health Service Executive (HSE), 2011, NAT MISC MISD REV; Jeve Y, 2011, ULTRASOUND OBST GYN, V38, P489, DOI 10.1002/uog.10108; Kaandorp S, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858; Kovavisarach E, 2002, AUST NZ J OBSTET GYN, V42, P161, DOI 10.1111/j.0004-8666.2002.00161.x; Kulier R, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002855.PUB3; KURTZ AB, 1991, J ULTRAS MED, V10, P387; Lister MS, 2005, AM J OBSTET GYNECOL, V193, P1338, DOI 10.1016/j.ajog.2005.05.010; Love ER, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3967; LOWER AM, 1992, HUM REPROD, V7, P711, DOI 10.1093/oxfordjournals.humrep.a137723; Luise C, 2002, ULTRASOUND OBST GYN, V19, P580, DOI 10.1046/j.1469-0705.2002.00662.x; Maconochie N, 2007, BJOG-INT J OBSTET GY, V114, P170, DOI 10.1111/j.1471-0528.2006.01193.x; Milingos DS, 2009, BJOG-INT J OBSTET GY, V116, P1268, DOI 10.1111/j.1471-0528.2009.02223.x; Muffley PE, 2002, AM J OBSTET GYNECOL, V187, P321, DOI 10.1067/mob.2002.126205; National Institute for Health and Care Excellence, 2012, CG154 NAT I HLTH CAR; Negro R, 2011, BEST PRACT RES CL EN, V25, P927, DOI 10.1016/j.beem.2011.07.010; Ngoc NTN, 2004, INT J GYNECOL OBSTET, V87, P138, DOI 10.1016/j.ijgo.2004.07.015; NIELSEN S, 1995, LANCET, V345, P84, DOI 10.1016/S0140-6736(95)90060-8; OHNO M, 1991, OBSTET GYNECOL, V77, P394; PITTAWAY DE, 1985, AM J OBSTET GYNECOL, V152, P299, DOI 10.1016/S0002-9378(85)80215-5; Prendeville W., 1997, PROBLEMS EARLY PREGN, P1; Royal College of Obstetricians and Gynaecologists, 2006, MAN EARL PREGN LOSS; Royal College of Obstetricians and Gynecologists, 2011, INV TREATM COUPL REC; Rumbold A, 2011, COCHRANE DB SYST REV, V1; Sairam S, 2001, ULTRASOUND OBST GYN, V17, P506, DOI 10.1046/j.1469-0705.2001.00364.x; Saving Mothers' Lives, 2011, BJOG S1, V118, P81; Sawyew E, 2007, ULTRASOUND OBST GYN, V29, P205, DOI 10.1002/uog.3914; Shankar M, 2007, J OBSTET GYNAECOL, V27, P283, DOI 10.1080/01443610701213927; Shelley JM, 2005, AUST NZ J OBSTET GYN, V45, P122, DOI 10.1111/j.1479-828X.2005.00357.x; Shillito J, 1997, Br J Hosp Med, V58, P505; Skinner Juliet, 2003, J Obstet Gynaecol, V23, P228; Stockheim D, 2006, FERTIL STERIL, V86, P956, DOI 10.1016/j.fertnstert.2006.03.032; Tang OS, 2006, CURR OPIN OBSTET GYN, V18, P581, DOI 10.1097/GCO.0b013e32800feedb; Temple R, 2002, BRIT MED J, V325, P1275, DOI 10.1136/bmj.325.7375.1275; Trinder J, 2006, BMJ-BRIT MED J, V332, P1235, DOI 10.1136/bmj.38828.593125.55; Turner MJ, 2010, EUR J OBSTET GYN R B, V151, P168, DOI 10.1016/j.ejogrb.2010.04.021; van den Berg MMJ, 2012, BBA-MOL BASIS DIS, V1822, P1951, DOI 10.1016/j.bbadis.2012.07.001; Verhaegen J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6077; Wieringa-De Waard M, 2002, BRIT J GEN PRACT, V52, P825; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wood SL, 2002, OBSTET GYNECOL, V99, P563, DOI 10.1016/S0029-7844(01)01765-3	66	102	110	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2013	346								f3676	10.1136/bmj.f3676	http://dx.doi.org/10.1136/bmj.f3676			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171QB	23783355				2022-12-28	WOS:000320943000002
J	Jaar, BG				Jaar, Bernard G.			Ramipril improved walking times and QOL in peripheral artery disease and intermittent claudication	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Johns Hopkins Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Jaar, BG (corresponding author), Johns Hopkins Med Inst, Baltimore, MD 21205 USA.							Heran BS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003823.pub2; Hiatt WR, 2010, VASC MED, V15, P171, DOI 10.1177/1358863X09360579; Norgren L, 2007, INT ANGIOL, V26, P81; Sica DA, 2001, CURR OPIN NEPHROL HY, V10, P597, DOI 10.1097/00041552-200109000-00008	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12							JC7	10.7326/0003-4819-158-12-201306180-02007	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778931				2022-12-28	WOS:000320645000006
J	Zhu, YF; Qi, X; Cui, LB; Zhou, MH; Wang, H				Zhu, Yefei; Qi, Xian; Cui, Lunbiao; Zhou, Minghao; Wang, Hua			Human co-infection with novel avian influenza A H7N9 and influenza A H3N2 viruses in Jiangsu province, China	LANCET			English	Editorial Material									[Zhu, Yefei; Qi, Xian; Cui, Lunbiao; Zhou, Minghao; Wang, Hua] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention	Wang, H (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, 172 Jiangsu Rd, Nanjing 210009, Jiangsu, Peoples R China.	hua@jscdc.cn	cui, lunbiao/AAP-7931-2021; zhou, minghao/GZA-7244-2022	Zhu, Yefei/0000-0002-2625-2199				Chen Y, 2013, LANCET; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617	3	41	44	0	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 15	2013	381	9883					2134	2134		10.1016/S0140-6736(13)61135-6	http://dx.doi.org/10.1016/S0140-6736(13)61135-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KA	23769236				2022-12-28	WOS:000320924800036
J	Chapman, A; Wyndham, J				Chapman, Audrey; Wyndham, Jessica			A Human Right to Science	SCIENCE			English	Editorial Material									[Chapman, Audrey] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA; [Wyndham, Jessica] AAAS, Sci Responsibil Human Rights & Law Program, Washington, DC 20005 USA	University of Connecticut	Chapman, A (corresponding author), Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA.	achapman@uchc.edu						Chapman AR, 2009, J HUM RIGHTS, V8, P1, DOI 10.1080/14754830802701200; Claude RP, 2002, SCIENCE IN THE SERVI; CLAUDE RP, 2002, CORE OBLIGATIONS BUI, P247; Haugen HM, 2008, J HUM RIGHTS, V7, P224, DOI 10.1080/14754830802285931; Leshner AI, 2009, SCIENCE, V326, P1459, DOI 10.1126/science.1184624; Macklin R, 2004, DOUBLE STANDARDS MED; Muller A, 2010, HUM RIGHTS LAW REV, V10, P765, DOI 10.1093/hrlr/ngq033; Posner MH, 2012, SCIENCE, V337, P13, DOI 10.1126/science.1226099; Presidential Commission for the Study of Bioethical Issues, 2011, MORAL SCIENCE PROTEC; Shaheed F, 2012, AHRC2026; UN CESCR, 2001, EC12200115	11	13	13	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1291	1291		10.1126/science.1233319	http://dx.doi.org/10.1126/science.1233319			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766315				2022-12-28	WOS:000320320200026
J	Chapman, S				Chapman, Simon			Should electronic cigarettes be as freely available as tobacco cigarettes? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NICOTINE		Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009					Adkison SE, 2013, AM J PREV MED, V44, P207, DOI 10.1016/j.amepre.2012.10.018; Australian Bureau of Statistics, AUSTR HLTH SURV 1 RE; Chapman S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001342; Chen RJ, 2008, TOXICOL SCI, V104, P283, DOI 10.1093/toxsci/kfn086; Moore M, 2012, REYNOLDS AM CEO HOST; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Tobacco in Australia, FACTS ISS; Tverdal A, 2006, TOB CONTROL, V15, P472, DOI 10.1136/tc.2006.016246; Vassallo R, 2008, MOL IMMUNOL, V45, P3321, DOI 10.1016/j.molimm.2008.04.014; Zeidler R, 2007, APOPTOSIS, V12, P1927, DOI 10.1007/s10495-007-0102-8	10	48	49	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2013	346								f3840	10.1136/bmj.f3840	http://dx.doi.org/10.1136/bmj.f3840			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166XQ	23771038				2022-12-28	WOS:000320593900010
J	Famiglietti, JS; Rodell, M				Famiglietti, James S.; Rodell, Matthew			Water in the Balance	SCIENCE			English	Editorial Material							GROUNDWATER DEPLETION; GRACE; CYCLE		[Famiglietti, James S.] Univ Calif Irvine, UC Ctr Hydrol Modeling, Irvine, CA 92697 USA; [Famiglietti, James S.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Famiglietti, James S.] Univ Calif Irvine, Dept Civil & Environm Engn, Irvine, CA 92697 USA; [Rodell, Matthew] NASA, Hydrol Sci Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Famiglietti, JS (corresponding author), Univ Calif Irvine, UC Ctr Hydrol Modeling, Irvine, CA 92697 USA.	jfamigli@uci.edu	Rodell, Matthew/E-4946-2012; Famiglietti, James S/G-7383-2017	Rodell, Matthew/0000-0003-0106-7437; Famiglietti, James S/0000-0002-6053-5379				Blunden J, 2013, B AM METEOROL SOC, V94, pS1, DOI 10.1175/2013BAMSStateoftheClimate.1; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; Famiglietti J. S., 2012, FALL M 3 7 DEC; Houborg R, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011291; Ramillien G, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004331; Reager JT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040826; Scanlon BR, 2012, P NATL ACAD SCI USA, V109, P9320, DOI 10.1073/pnas.1200311109; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Swenson SC, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004628; Swenson S, 2009, J HYDROL, V370, P163, DOI 10.1016/j.jhydrol.2009.03.008; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Tiwari VM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039401; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Voss KA, 2013, WATER RESOUR RES, V49, P904, DOI 10.1002/wrcr.20078; Zaitchik BF, 2008, J HYDROMETEOROL, V9, P535, DOI 10.1175/2007JHM951.1	15	246	257	6	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1300	1301		10.1126/science.1236460	http://dx.doi.org/10.1126/science.1236460			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766323				2022-12-28	WOS:000320320200034
J	Dancer, SJ				Dancer, Stephanie J.			Put your ties back on: scruffy doctors damage our reputation and indicate a decline in hygiene	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTION-CONTROL; WASH		Hairmyres Hosp, E Kilbride G75 8RG, Lanark, Scotland	University Hospital Hairmyres	Dancer, SJ (corresponding author), Hairmyres Hosp, E Kilbride G75 8RG, Lanark, Scotland.	stephanie.dancer@lanarkshire.scot.nhs.uk		Dancer, Stephanie/0000-0002-8777-2614				[Anonymous], 2007, LANCET, V370, P1102; [Anonymous], 2008, BMA NEWS        0927; Burden M, 2011, J HOSP MED, V6, P177, DOI 10.1002/jhm.864; Cubitt J, 2010, B ROYAL COLL SURG EN, V92, P242; Dancer SJ, 2012, J HOSP INFECT, V80, P189, DOI 10.1016/j.jhin.2011.12.003; Dancer SJ, 2010, J HOSP INFECT, V74, P10, DOI 10.1016/j.jhin.2009.10.012; Dancer SJ, 2008, BMJ; Horlock A, 2012, DAILY MAIL; Magee TR, 2008, B ROYAL COLL SURG EN, V90, P126; Mann CM, 2006, J HOSP INFECT, V64, P366, DOI 10.1016/j.jhin.2006.06.030; Mooney H., 2008, NURSING TIMES; Price EH, 2008, J HOSP INFECT, V69, P89, DOI 10.1016/j.jhin.2008.01.009; Rehman SU, 2005, AM J MED, V118, P1279, DOI 10.1016/j.amjmed.2005.04.026; Steinlechner C, 2002, ANN R COLL SURG EN S, V84, P307; Wellcome Collection, 2011, DIRT FILTH REAL EV L; Whitby M, 2006, INFECT CONT HOSP EP, V27, P484, DOI 10.1086/503335	16	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2013	346								f3211	10.1136/bmj.f3211	http://dx.doi.org/10.1136/bmj.f3211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WQ	23766481				2022-12-28	WOS:000320590800016
J	Fei, HZ; Wiedenbeck, M; Yamazaki, D; Katsura, T				Fei, Hongzhan; Wiedenbeck, Michael; Yamazaki, Daisuke; Katsura, Tomoo			Small effect of water on upper-mantle rheology based on silicon self-diffusion coefficients	NATURE			English	Article							PLASTIC-DEFORMATION; O DIFFUSION; GRAIN-SIZE; OLIVINE; MELT; FORSTERITE; SYSTEM; PHASE	Water has been thought to affect the dynamical processes in the Earth's interior to a great extent. In particular, experimental deformation results(1-4) suggest that even only a few tens of parts per million of water by weight enhances the creep rates in olivine by orders of magnitude. However, those deformation studies have limitations, such as considering only a limited range of water concentrations and very high stresses, which might affect the results. Rock deformation can also be understood as an effect of silicon self-diffusion, because the creep rates of minerals at temperatures as high as those in the Earth's interior are limited by self-diffusion of the slowest species(5,6). Here we experimentally determine the silicon self-diffusion coefficient D-Si in forsterite at 8 GPa and 1,600 K to 1,800 K as a function of water content C-H2O from less than 1 to about 800 parts per million of water by weight, yielding the relationship, D-Si approximate to (C-H2O)(1/3). This exponent is strikingly lower than that obtained by deformation experiments (1.2; ref. 7). The high nominal creep rates in the deformation studies under wet conditions may be caused by excess grain boundary water. We conclude that the effect of water on upper-mantle rheology is very small. Hence, the smooth motion of the Earth's tectonic plates cannot be caused by mineral hydration in the asthenosphere. Also, water cannot cause the viscosity minimum zone in the upper mantle. And finally, the dominant mechanism responsible for hotspot immobility cannot be water content differences between their source and surrounding regions.	[Fei, Hongzhan; Katsura, Tomoo] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany; [Wiedenbeck, Michael] Helmholtz Ctr Potsdam, D-14473 Potsdam, Germany; [Yamazaki, Daisuke] Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan	University of Bayreuth; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Okayama University	Fei, HZ (corresponding author), Univ Bayreuth, Bayer Geoinst, POB 101251, D-95440 Bayreuth, Germany.	hongzhan.fei@uni-bayreuth.de	Katsura, Tomoo/ABC-1899-2021; Katsura, Tomoo/A-7483-2010; Fei, Hongzhan/C-9661-2014; Fei, Hongzhan/E-7560-2017; Fei, Hongzhan/ABA-8044-2021	Katsura, Tomoo/0000-0001-7857-5101; Katsura, Tomoo/0000-0001-7857-5101; Fei, Hongzhan/0000-0003-3143-7363; 	ENB (Elite Network Bavaria) programmes; Grants-in-Aid for Scientific Research [13F03327] Funding Source: KAKEN	ENB (Elite Network Bavaria) programmes; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Chakraborty and R. Dohmen at Ruhr-University of Bochum for thin-film deposition and discussions about experimental methods. We also thank A. Yoneda at Okayama University for providing the single crystal, H. Keppler for FT-IR measurement, A. Audetat for ICP-MS analysis, and T. Boffa-Ballaran for X-ray diffraction analysis. We acknowledge support from the ENB (Elite Network Bavaria) programmes.	ANDERSON DL, 1966, SCIENCE, V151, P321, DOI 10.1126/science.151.3708.321; Bell DR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000679; BELL DR, 1992, SCIENCE, V255, P1391, DOI 10.1126/science.255.5050.1391; Brodholt JP, 2000, J GEOPHYS RES-SOL EA, V105, P18977, DOI 10.1029/2000JB900057; Costa F, 2008, PHYS EARTH PLANET IN, V166, P11, DOI 10.1016/j.pepi.2007.10.006; Demouchy S, 2003, PHYS CHEM MINER, V30, P486, DOI 10.1007/s00269-003-0342-2; Dixon JE, 2002, NATURE, V420, P385, DOI 10.1038/nature01215; Dohmen R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015480; Dohmen R, 2002, EUR J MINERAL, V14, P1155, DOI 10.1127/0935-1221/2002/0014-1155; DURHAM WB, 1977, TECTONOPHYSICS, V40, pT15, DOI 10.1016/0040-1951(77)90063-4; Fei HZ, 2012, EARTH PLANET SC LETT, V345, P95, DOI 10.1016/j.epsl.2012.06.044; Frost H., 1982, DEFORMATION MECH MAP; Green D., 1967, CONTRIB MINERAL PETR, V15, P103, DOI [10.1007/BF00372052, DOI 10.1007/BF00372052]; Hirschmann MM, 2010, PHYS EARTH PLANET IN, V179, P60, DOI 10.1016/j.pepi.2009.12.003; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Hirth G., 2003, GEOPHYS MONOGR INSID, V138, P83, DOI DOI 10.1029/138GM06; HOULIER B, 1990, PHYS EARTH PLANET IN, V62, P329, DOI 10.1016/0031-9201(90)90177-Y; INOUE T, 1994, PHYS EARTH PLANET IN, V85, P237, DOI 10.1016/0031-9201(94)90116-3; Jung H, 2001, SCIENCE, V293, P1460, DOI 10.1126/science.1062235; Karato S, 1998, EARTH PLANET SC LETT, V157, P193, DOI 10.1016/S0012-821X(98)00034-X; KARATO SI, 1986, J GEOPHYS RES-SOLID, V91, P8151, DOI 10.1029/JB091iB08p08151; KARATO SI, 1984, TECTONOPHYSICS, V104, P155, DOI 10.1016/0040-1951(84)90108-2; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; Kohlstedt DL, 2006, REV MINERAL GEOCHEM, V62, P377, DOI 10.2138/rmg.2006.62.16; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; MCKENZIE DP, 1967, GEOPHYS J ROY ASTR S, V14, P297; Mei S, 2000, J GEOPHYS RES-SOL EA, V105, P21471, DOI 10.1029/2000JB900180; Mei S, 2002, EARTH PLANET SC LETT, V201, P491, DOI 10.1016/S0012-821X(02)00745-8; Mei S, 2000, J GEOPHYS RES-SOL EA, V105, P21457, DOI 10.1029/2000JB900179; Putirka KD, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000915; Raterron P, 2009, PHYS EARTH PLANET IN, V172, P74, DOI 10.1016/j.pepi.2008.07.026; Weertman J, 1999, MECHANICS AND MATERIALS, P451	34	117	122	0	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					213	+		10.1038/nature12193	http://dx.doi.org/10.1038/nature12193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23765497				2022-12-28	WOS:000320283400044
J	Silverman, E				Silverman, Ed			Pfizer versus Kaiser: insurers want their day in court	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Pharmalot, Millburn, NJ USA		Silverman, E (corresponding author), Pharmalot, Millburn, NJ USA.	pharmalot@gmail.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2013	346								f3738	10.1136/bmj.f3738	http://dx.doi.org/10.1136/bmj.f3738			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WH	23760967				2022-12-28	WOS:000320589800008
J	Wake, M; Lycett, K; Clifford, SA; Sabin, MA; Gunn, J; Gibbons, K; Hutton, C; McCallum, Z; Arnup, SJ; Wittert, G				Wake, Melissa; Lycett, Kate; Clifford, Susan A.; Sabin, Matthew A.; Gunn, Jane; Gibbons, Kay; Hutton, Cathy; McCallum, Zoe; Arnup, Sarah J.; Wittert, Gary			Shared care obesity management in 3-10 year old children: 12 month outcomes of HopSCOTCH randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILDHOOD OVERWEIGHT; HEALTH-CARE; RISK; INTERVENTIONS; ADIPOSITY; BARRIERS; PROGRAM	Objective To determine whether general practice surveillance for childhood obesity, followed by obesity management across primary and tertiary care settings using a shared care model, improves body mass index and related outcomes in obese children aged 3-10 years. Design Randomised controlled trial. Setting 22 family practices (35 participating general practitioners) and a tertiary weight management service (three paediatricians, two dietitians) in Melbourne, Australia. Participants Children aged 3-10 years with body mass index above the 95th centile recruited through their general practice between July 2009 and April 2010. Intervention Children were randomly allocated to one tertiary appointment followed by up to 11 general practice consultations over one year, supported by shared care, web based software (intervention) or "usual care" (control). Researchers collecting outcome measurements, but not participants, were blinded to group assignment. Main outcome measures Children's body mass index z score (primary outcome), body fat percentage, waist circumference, physical activity, quality of diet, health related quality of life, self esteem, and body dissatisfaction and parents' body mass index (all 15 months post-enrolment). Results 118 (60 intervention, 56 control) children were recruited and 107 (91%) were retained and analysed (56 intervention, 51 control). All retained intervention children attended the tertiary appointment and their general practitioner for at least one (mean 3.5 (SD 2.5, range 1-11)) weight management consultation. At outcome, children in the two trial arms had similar body mass index (adjusted mean difference -0.1 (95% confidence interval -0.7 to 0.5; P=0.7)) and body mass index z score (-0.05 (-0.14 to 0.03); P=0.2). Similarly, no evidence was found of benefit or harm on any secondary outcome. Outcomes varied widely in the combined cohort (mean change in body mass index z score -0.20 (SD 0.25, range -0.97-0.47); 26% of children resolved from obese to overweight and 2% to normal weight. Conclusions Although feasible, not harmful, and highly rated by both families and general practitioners, the shared care model of primary and tertiary care management did not lead to better body mass index or other outcomes for the intervention group compared with the control group. Improvements in body mass index in both groups highlight the value of untreated controls when determining efficacy.	[Wake, Melissa; Sabin, Matthew A.; Gibbons, Kay; McCallum, Zoe] Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Wake, Melissa; Lycett, Kate; Clifford, Susan A.; Sabin, Matthew A.; Gibbons, Kay; Arnup, Sarah J.] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Wake, Melissa; Lycett, Kate; Sabin, Matthew A.; McCallum, Zoe] Univ Melbourne, Parkville, Vic 3052, Australia; [Gunn, Jane; Hutton, Cathy] Univ Melbourne, Dept Gen Practice, Parkville, Vic 3052, Australia; [Wittert, Gary] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Adelaide	Wake, M (corresponding author), Royal Childrens Hosp, Ctr Community Child Hlth, Flemington Rd, Parkville, Vic 3052, Australia.	melissa.wake@rch.org.au	Lycett, Kate/AAN-6007-2020; Wake, Melissa/J-1396-2012; wittert, gary/AAE-2398-2019; Sabin, Matthew/B-3539-2012	Wake, Melissa/0000-0001-7501-9257; Sabin, Matthew/0000-0002-1828-7404; Clifford, Susan/0000-0002-2678-9439; Lycett, Kate/0000-0002-8988-4038; Gunn, Jane/0000-0001-8836-7525; Wittert, Gary/0000-0001-6818-6065; Gibbons, Kay/0000-0002-1428-3166; Arnup, Sarah/0000-0002-9497-1902	Australian National Health and Medical Research Council (NHMRC) [491212]; NHMRC [284556, 546405, 1012201]; Victorian Government	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	HopSCOTCH was funded by the Australian National Health and Medical Research Council (NHMRC Priority Driven Research Grant 491212). MW was part funded by NHMRC Population Health Career Development Grants 284556 and 546405 and MAS by NHMRC Professional Training Fellowship 1012201. Murdoch Childrens Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program.	Anderson SE, 2007, PSYCHOSOM MED, V69, P740, DOI 10.1097/PSY.0b013e31815580b4; Au N, 2012, HEALTH SERV RES, V47, P655, DOI 10.1111/j.1475-6773.2011.01326.x; Australian Bureau of Statistics, 2006, SOC IND AR SEIFA TEC; Australian Bureau of Statistics, 2007, NAT HLTH SURV SUMM R; Australian Bureau of Statistics, 2007, POP AG SEX AUSTR STA; Banks J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X616319; COLLINS ME, 1991, INT J EAT DISORDER, V10, P199, DOI 10.1002/1098-108X(199103)10:2&lt;199::AID-EAT2260100209&gt;3.0.CO;2-D; Cretikos MA, 2008, MED CARE, V46, P1163, DOI 10.1097/MLR.0b013e318179259a; Dettori H, 2009, AUST FAM PHYSICIAN, V38, P460; Gerner B, 2006, J PAEDIATR CHILD H, V42, P206, DOI 10.1111/j.1440-1754.2006.00831.x; Gerner B, 2010, MED EDUC, V44, P706, DOI 10.1111/j.1365-2923.2010.03686.x; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Gruen R L, 2004, Cochrane Database Syst Rev, pCD003798, DOI 10.1002/14651858.CD003798.pub2; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hughes AR, 2008, PEDIATRICS, V121, pE539, DOI 10.1542/peds.2007-1786; Hunt LP, 2007, ARCH DIS CHILD, V92, P399, DOI 10.1136/adc.2006.103986; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kuczmarski RJ., 2000, ADV DATA, P1; Madsen KA, 2011, ARCH PEDIAT ADOL MED, V165, P987, DOI 10.1001/archpediatrics.2011.127; McCallum Z, 2007, INT J OBESITY, V31, P630, DOI 10.1038/sj.ijo.0803509; Meriaux BG, 2008, INT J PEDIATR OBES, V3, P102, DOI 10.1080/17477160701789489; National Health Medical Research Council (Australia), 2003, CLIN PRACT GUID MAN; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001872.PUB2; Perera R, 2007, BRIT MED J, V334, P127, DOI 10.1136/bmj.39045.396817.68; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Reinehr T, 2004, ARCH DIS CHILD, V89, P419, DOI 10.1136/adc.2003.028803; Reinehr T, 2009, OBESITY, V17, P1196, DOI 10.1038/oby.2009.17; Richman RM, 1996, INT J OBESITY, V20, P413; Rocchini AP, 2011, NEW ENGL J MED, V365, P1927, DOI 10.1056/NEJMe1110898; Sabin MA, 2007, J EVAL CLIN PRACT, V13, P364, DOI 10.1111/j.1365-2753.2006.00706.x; Sargent GM, 2011, OBES REV, V12, pe219, DOI 10.1111/j.1467-789X.2010.00777.x; SCHAEFER F, 1994, PEDIATR RES, V35, P617, DOI 10.1203/00006450-199405000-00016; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Smith SM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004910.pub2; Taveras EM, 2011, ARCH PEDIAT ADOL MED, V165, P714, DOI 10.1001/archpediatrics.2011.44; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Wake M, 2013, ARCH DIS CHILD, V98, P3, DOI 10.1136/archdischild-2012-301659; Wake M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-39; Wake M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3308; Waters EB, 2000, MED J AUSTRALIA, V173, P68, DOI 10.5694/j.1326-5377.2000.tb139244.x; Whitlock EP, 2005, PEDIATRICS, V116, pE125, DOI 10.1542/peds.2005-0242	42	48	48	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2013	346								f3092	10.1136/bmj.f3092	http://dx.doi.org/10.1136/bmj.f3092			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VK	23751902	Green Published, hybrid			2022-12-28	WOS:000320586700003
J	Davies, M; Carter, P; Drake, L				Davies, Martin; Carter, Pam; Drake, Loreto			Spinal injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Carter, Pam] Univ Leicester, Dept Hlth Sci, Social Sci Appl Healthcare Improvement Res SAPPHI, Leicester LE1 6TP, Leics, England; [Drake, Loreto] Alsager Hlth Ctr, Stoke On Trent ST7 2LU, Staffs, England	University of Leicester	Carter, P (corresponding author), Univ Leicester, Dept Hlth Sci, Social Sci Appl Healthcare Improvement Res SAPPHI, Leicester LE1 6TP, Leics, England.	pc216@le.ac.uk						Cohen SP, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2718; Gibson JNA, 2005, SPINE, V30, P2312, DOI 10.1097/01.brs.0000182315.88558.9c	2	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 7	2013	346								f3374	10.1136/bmj.f3374	http://dx.doi.org/10.1136/bmj.f3374			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YM	23747969	Bronze			2022-12-28	WOS:000320230400004
J	Colak, D; Ji, SJ; Porse, BT; Jaffrey, SR				Colak, Dilek; Ji, Sheng-Jian; Porse, Bo T.; Jaffrey, Samie R.			Regulation of Axon Guidance by Compartmentalized Nonsense-Mediated mRNA Decay	CELL			English	Article							LOCAL PROTEIN-SYNTHESIS; COMMISSURAL AXONS; MAMMALIAN-CELLS; MIDLINE SWITCH; SPINAL-CORD; GROWTH CONE; IN-VIVO; TRANSLATION; EXPRESSION; SURVEILLANCE	Growth cones enable axons to navigate toward their targets by responding to extracellular signaling molecules. Growth-cone responses are mediated in part by the local translation of axonal messenger RNAs (mRNAs). However, the mechanisms that regulate local translation are poorly understood. Here we show that Robo3.2, a receptor for the Slit family of guidance cues, is synthesized locally within axons of commissural neurons. Robo3.2 translation is induced by floor-plate-derived signals as axons cross the spinal cord midline. Robo3.2 is also a predicted target of the nonsense-mediated mRNA decay (NMD) pathway. We find that NMD regulates Robo3.2 synthesis by inducing the degradation of Robo3.2 transcripts in axons that encounter the floor plate. Commissural neurons deficient in NMD proteins exhibit aberrant axonal trajectories after crossing the midline, consistent with misregulation of Robo3.2 expression. These data show that local translation is regulated by mRNA stability and that NMD acts locally to influence axonal pathfinding.	[Colak, Dilek; Ji, Sheng-Jian; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Porse, Bo T.] Univ Copenhagen, Fac Hlth Sci, Finsen Lab, Rigshosp, DK-2200 Copenhagen, Denmark; [Porse, Bo T.] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Porse, Bo T.] Univ Copenhagen, Fac Hlth Sci, Danish Stem Cell Ctr DanStem, DK-2200 Copenhagen, Denmark	Cornell University; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Jaffrey, SR (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA.	srj2003@med.cornell.edu	Ji, Sheng-Jian/H-6288-2013	Jaffrey, Samie/0000-0003-3615-6958; Porse, Bo/0000-0001-6043-0844	NIH [NS56306]; European Molecular Biology Organization (EMBO); Lundbeck Foundation [R5-2006-99] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Lykke-Andersen for generously providing the hUpf1 K498A construct and anti-Upf1 and anti-Upf2 antibodies, S. Blanchard and L. Wang for equipment and helpful suggestions regarding the polysome experiments, S. Kadison for advice on DiI labeling, and M. Tessier-Lavigne and Genentech for sharing Robo3.1- and Robo3.2-specific antibodies. We also thank members of the Jaffrey lab for helpful comments and suggestions. This work was supported by NIH grant NS56306 to S.R.J. and a European Molecular Biology Organization (EMBO) postdoctoral fellowship to D.C.	Black DL, 2008, NEURON, V58, P297, DOI 10.1016/j.neuron.2008.04.019; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Cohen MS, 2011, P NATL ACAD SCI USA, V108, P11246, DOI 10.1073/pnas.1012401108; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Evans TA, 2010, CURR BIOL, V20, P567, DOI 10.1016/j.cub.2010.02.021; Feng Y, 2010, PROTEIN CELL, V1, P237, DOI 10.1007/s13238-010-0021-2; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; HODGKIN J, 1989, GENETICS, V123, P301; Imondi R, 2001, DEVELOPMENT, V128, P4859; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kadison SR, 2004, J COMP NEUROL, V472, P411, DOI 10.1002/cne.20086; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; MAQUAT LE, 1981, CELL, V27, P543, DOI 10.1016/0092-8674(81)90396-2; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Moore Simon W, 2008, Curr Protoc Neurosci, VChapter 3, DOI [10.1002/0471142301.ns0320s43, 10.1002/0471142301.ns0320s45]; Nawabi H, 2010, GENE DEV, V24, P396, DOI 10.1101/gad.542510; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; PERRY VH, 1991, EUR J NEUROSCI, V3, P102, DOI 10.1111/j.1460-9568.1991.tb00815.x; Reeber SL, 2008, J NEUROSCI, V28, P8698, DOI 10.1523/JNEUROSCI.1479-08.2008; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; TENNYSON VM, 1970, J CELL BIOL, V44, P62, DOI 10.1083/jcb.44.1.62; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Weischenfeldt J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r35; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zheng S, 2012, NAT NEUROSCI, V15, P381, DOI 10.1038/nn.3026; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	46	134	136	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1252	1265		10.1016/j.cell.2013.04.056	http://dx.doi.org/10.1016/j.cell.2013.04.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746841	Green Accepted, Bronze			2022-12-28	WOS:000319979200011
J	Shi, T; Bunker, RD; Mattarocci, S; Ribeyre, C; Faty, M; Gut, H; Scrima, A; Rass, U; Rubin, SM; Shore, D; Thoma, NH				Shi, Tianlai; Bunker, Richard D.; Mattarocci, Stefano; Ribeyre, Cyril; Faty, Mahamadou; Gut, Heinz; Scrima, Andrea; Rass, Ulrich; Rubin, Seth M.; Shore, David; Thomae, Nicolas H.			Rif1 and Rif2 Shape Telomere Function and Architecture through Multivalent Rap1 Interactions	CELL			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERES; LENGTH REGULATION; YEAST; DNA; PROTEIN; BINDING; ANTICHECKPOINT; ASSOCIATION; PATHWAYS; COMPLEX	Yeast telomeres comprise irregular TG1-3 DNA repeats bound by the general transcription factor Rap1. Rif1 and Rif2, along with Rap1, form the telosome, a protective cap that inhibits telomerase, counteracts SIR-mediated transcriptional silencing, and prevents inadvertent recognition of telomeres as DNA double-strand breaks. We provide a molecular, biochemical, and functional dissection of the protein backbone at the core of the yeast telosome. The X-ray structures of Rif1 and Rif2 bound to the Rap1 C-terminal domain and that of the Rif1 C terminus are presented. Both Rif1 and Rif2 have separable and independent Rap1-binding epitopes, allowing Rap1 binding over large distances (42-110 angstrom). We identify tetramerization (Rif1) and polymerization (Rif2) modules that, in conjunction with the long-range binding, give rise to a higher-order architecture that interlinks Rap1 units. This molecular Velcro relies on Rif1 and Rif2 to recruit and stabilize Rap1 on telomeric arrays and is required for telomere homeostasis in vivo.	[Shi, Tianlai; Bunker, Richard D.; Faty, Mahamadou; Gut, Heinz; Scrima, Andrea; Rass, Ulrich; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Mattarocci, Stefano; Ribeyre, Cyril; Shore, David] NCCR Frontiers Genet Program, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Mattarocci, Stefano; Ribeyre, Cyril; Shore, David] Inst Genet & Genom Geneva iGE3, CH-1211 Geneva, Switzerland; [Rubin, Seth M.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	Friedrich Miescher Institute for Biomedical Research; University of Geneva; University of California System; University of California Santa Cruz	Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	nicolas.thoma@fmi.ch	Shore, David/F-6240-2015	Shore, David/0000-0002-9859-143X; Ribeyre, Cyril/0000-0002-5146-0977; Thoma, Nicolas/0000-0003-2685-906X; Rass, Ulrich/0000-0001-9275-9062; Bunker, Richard/0000-0001-8866-5290; Rubin, Seth/0000-0002-1670-4147	Swiss National Fund; Canton of Geneva; Novartis Research Foundation; European Research Council [ERC-2010-StG 260481-MoBa-CS]; AICR; Oncosuisse; Swiss National Science Foundation	Swiss National Fund(Swiss National Science Foundation (SNSF)); Canton of Geneva; Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); AICR; Oncosuisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank S. Gasser, J. Lingner, P. Baumann, M. Wellinger, P. Cejka, and D. Schubeler for discussion and J. Keusch and D. Hess from the Friedrich Miescher Institute for help and analysis. Crystallographic experiments described were performed with the X10SA beamline at Swiss Light Source, Paul Scherrer Institut, Villigen, Switzerland. D.S. received support from the Swiss National Fund and the Canton of Geneva. Work in the lab of N.H.T. is supported by the Novartis Research Foundation, the European Research Council (ERC-2010-StG 260481-MoBa-CS), AICR, and Oncosuisse. N.H.T. and A.S. received support from the Swiss National Science Foundation. R.D.B. and S.M. contributed equally to this work.	Anbalagan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002024; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Bonetti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014142; Borsi V, 2010, J MED CHEM, V53, P4285, DOI 10.1021/jm901723z; Chen Y, 2011, NAT STRUCT MOL BIOL, V18, P213, DOI 10.1038/nsmb.1974; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Feeser EA, 2008, J MOL BIOL, V380, P520, DOI 10.1016/j.jmb.2008.04.078; Gallardo F, 2011, MOL CELL, V44, P819, DOI 10.1016/j.molcel.2011.09.020; GILSON E, 1993, J MOL BIOL, V231, P293, DOI 10.1006/jmbi.1993.1283; GILSON E, 1994, NUCLEIC ACIDS RES, V22, P5310, DOI 10.1093/nar/22.24.5310; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Levy DL, 2004, MOL CELL BIOL, V24, P10857, DOI 10.1128/MCB.24.24.10857-10867.2004; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lisby M, 2004, CURR OPIN CELL BIOL, V16, P328, DOI 10.1016/j.ceb.2004.03.011; LONGTINE MS, 1989, CURR GENET, V16, P225, DOI 10.1007/BF00422108; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 2008, GENE DEV, V22, P1153, DOI 10.1101/gad.455108; Matot B, 2012, NUCLEIC ACIDS RES, V40, P3197, DOI 10.1093/nar/gkr1166; Michelson RJ, 2005, GENE DEV, V19, P2546, DOI 10.1101/gad.1293805; MILLER WG, 1968, BIOCHEMISTRY-US, V7, P3925, DOI 10.1021/bi00851a021; Ribeyre C, 2012, NAT STRUCT MOL BIOL, V19, P307, DOI 10.1038/nsmb.2225; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Vodenicharov MD, 2006, MOL CELL, V24, P127, DOI 10.1016/j.molcel.2006.07.035; Vodenicharov MD, 2010, EMBO J, V29, P3007, DOI 10.1038/emboj.2010.155; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Williams TL, 2010, J BIOL CHEM, V285, P35814, DOI 10.1074/jbc.M110.170167; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197	32	74	76	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1340	1353		10.1016/j.cell.2013.05.007	http://dx.doi.org/10.1016/j.cell.2013.05.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746845	Bronze			2022-12-28	WOS:000319979200017
J	Ma, DKK; Rothe, M; Zheng, S; Bhatla, N; Pender, CL; Menzel, R; Horvitz, HR				Ma, Dengke K.; Rothe, Michael; Zheng, Shu; Bhatla, Nikhil; Pender, Corinne L.; Menzel, Ralph; Horvitz, H. Robert			Cytochrome P450 Drives a HIF-Regulated Behavioral Response to Reoxygenation by C. elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; DISEASE; UPDATE; OMEGA-3-FATTY-ACIDS; EGL-9; ACID	Oxygen deprivation followed by reoxygenation causes pathological responses in many disorders, including ischemic stroke, heart attacks, and reperfusion injury. Key aspects of ischemia-reperfusion can be modeled by a Caenorhabditis elegans behavior, the O2-ON response, which is suppressed by hypoxic preconditioning or inactivation of the O-2-sensing HIF (hypoxia-inducible factor) hydroxylase EGL-9. From a genetic screen, we found that the cytochrome P450 oxygenase CYP-13A12 acts in response to the EGL-9-HIF-1 pathway to facilitate the O2-ON response. CYP-13A12 promotes oxidation of polyunsaturated fatty acids into eicosanoids, signaling molecules that can strongly affect inflammatory pain and ischemia-reperfusion injury responses in mammals. We propose that roles of the EGL-9-HIF-1 pathway and cytochrome P450 in controlling responses to reoxygenation after anoxia are evolutionarily conserved.	[Ma, Dengke K.; Zheng, Shu; Bhatla, Nikhil; Pender, Corinne L.; Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Dept Biol,McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Rothe, Michael] Lipidomix GmbH, D-13125 Berlin, Germany; [Menzel, Ralph] Humboldt Univ, Dept Biol, D-12437 Berlin, Germany	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Humboldt University of Berlin	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Dept Biol,McGovern Inst Brain Res, Cambridge, MA 02139 USA.	horvitz@mit.edu		Pender, Corinne/0000-0001-7092-3079	NIH [GM24663]; German Research Foundation [ME2056/3-1]; NSF; MIT Undergraduate Research Opportunities Program; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484, R37GM024663, R01GM024663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); MIT Undergraduate Research Opportunities Program; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Bargmann, A. Fire, A. Hart, Y. Iino, J. Powell-Coffman, and C. Rongo for reagents and the Caenorhabditis Genetics Center and the Million Mutation Project for strains. H. R. H. is an Investigator of the Howard Hughes Medical Institute. Supported by NIH grant GM24663 (H. R. H), German Research Foundation grant ME2056/3-1 (R. M.), a NSF Graduate Research Fellowship (N.B.), the MIT Undergraduate Research Opportunities Program (S.Z.), and a Helen Hay Whitney Foundation postdoctoral fellowship (D.K.M.).	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chapkin R. S., 2009, PROSTAGLANDINS LEUKO, V81, P187; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gerber M, 2012, BRIT J NUTR, V107, pS228, DOI 10.1017/S0007114512001614; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gotoh O, 1998, MOL BIOL EVOL, V15, P1447, DOI 10.1093/oxfordjournals.molbev.a025872; Gottlieb RA, 2003, ARCH BIOCHEM BIOPHYS, V420, P262, DOI 10.1016/j.abb.2003.07.004; Harder DR, 1996, CIRC RES, V79, P54, DOI 10.1161/01.RES.79.1.54; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kosel M, 2011, BIOCHEM J, V435, P689, DOI 10.1042/BJ20101942; Kulas J, 2008, ARCH BIOCHEM BIOPHYS, V472, P65, DOI 10.1016/j.abb.2008.02.002; Ma Dengke K, 2012, Front Biol (Beijing), V7, P246; Ma DK, 2012, NEURON, V73, P925, DOI 10.1016/j.neuron.2011.12.037; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Panigrahy D, 2010, CANCER METAST REV, V29, P723, DOI 10.1007/s10555-010-9264-x; Powell-Coffman JA, 2010, TRENDS ENDOCRIN MET, V21, P435, DOI 10.1016/j.tem.2010.02.006; Rappleye Chad A, 2003, BMC Dev Biol, V3, P8, DOI 10.1186/1471-213X-3-8; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza Gregg L, 2011, Biochim Biophys Acta, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Szefel J, 2011, Curr Mol Med, V11, P13, DOI 10.2174/156652411794474374; TRENT C, 1983, GENETICS, V104, P619; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018	30	24	29	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					554	558		10.1126/science.1235753	http://dx.doi.org/10.1126/science.1235753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23811225	Green Accepted, Green Submitted			2022-12-28	WOS:000322586700055
J	Chen, SS; Oldham, ML; Davidson, AL; Chen, J				Chen, Shanshuang; Oldham, Michael L.; Davidson, Amy L.; Chen, Jue			Carbon catabolite repression of the maltose transporter revealed by X-ray crystallography	NATURE			English	Article							GLUCOSE PHOSPHOTRANSFERASE SYSTEM; SIGNAL-TRANSDUCING PROTEIN; PHOSPHORYL TRANSFER COMPLEX; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; INDUCER EXCLUSION; ABC TRANSPORTER; REGULATORY PROTEIN; CRYSTAL-STRUCTURE; LACTOSE PERMEASE	Efficient carbon utilization is critical to the survival of microorganisms in competitive environments. To optimize energy usage, bacteria have developed an integrated control system to preferentially uptake carbohydrates that support rapid growth. The availability of a preferred carbon source, such as glucose, represses the synthesis and activities of proteins necessary for the transport and metabolism of secondary carbon sources. This regulatory phenomenon is defined as carbon catabolite repression(1). In enteric bacteria, the key player of carbon catabolite repression is a component of the glucose-specific phosphotransferase system, enzyme IIA (EIIA(Glc))(1,2). It is known that unphosphorylated EIIA(Glc) binds to and inhibits a variety of transporters when glucose is available(1,2). However, understanding the underlying molecular mechanism has been hindered by the complete absence of structures for any EIIA(Glc)-transporter complexes. Here we present the 3.9 angstrom crystal structure of Escherichia coli EIIA(Glc) in complex with the maltose transporter, an ATP-binding cassette (ABC) transporter. The structure shows that two EIIA(Glc) molecules bind to the cytoplasmic ATPase subunits, stabilizing the transporter in an inward-facing conformation and preventing the structural rearrangements necessary for ATP hydrolysis. We also show that the half-maximal inhibitory concentrations of the full-length EIIA(Glc) and an amino-terminal truncation mutant differ by 60-fold, consistent with the hypothesis that the amino-terminal region, disordered in the crystal structure, functions as a membrane anchor to increase the effective EIIA(Glc) concentration at the membrane(3,4). Together these data suggest a model of how the central regulatory protein EIIAGlc allosterically inhibits maltose uptake in E. coli.	[Chen, Shanshuang; Chen, Jue] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Oldham, Michael L.; Chen, Jue] Howard Hughes Med Inst, W Lafayette, IN 47907 USA; [Davidson, Amy L.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Howard Hughes Medical Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chen, J (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	chenjue@purdue.edu	Chen, Shanshuang/N-6665-2019	Chen, Shanshuang/0000-0003-2317-6589	National Institutes of Health [GM070515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM070515, R01GM070515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advance Photon Source GM/CA-CAT, NE-CAT and SBC for assistance with data collection. This work was supported by a National Institutes of Health grant (GM070515 to J.C. and A.L.D.).	Alvarez FJD, 2010, J AM CHEM SOC, V132, P9513, DOI 10.1021/ja104047c; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bluschke B, 2006, J BIOL CHEM, V281, P12833, DOI 10.1074/jbc.M512646200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; DEAN DA, 1990, J BIOL CHEM, V265, P21005; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; DORSCHUG M, 1984, EUR J BIOCHEM, V144, P113, DOI 10.1111/j.1432-1033.1984.tb08438.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; KUHNAU S, 1991, J BACTERIOL, V173, P2180; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEADOW ND, 1982, J BIOL CHEM, V257, P4526; Meadow ND, 2006, J BIOL CHEM, V281, P11450, DOI 10.1074/jbc.M507417200; MISKO TP, 1987, J BIOL CHEM, V262, P16261; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; OSUMI T, 1982, P NATL ACAD SCI-BIOL, V79, P1457, DOI 10.1073/pnas.79.5.1457; OSUMI T, 1982, ANN INST PASTEUR MIC, VA133, P269; PELTON JG, 1992, BIOCHEMISTRY-US, V31, P5215, DOI 10.1021/bi00137a017; ROSSMANN MG, 1990, ACTA CRYSTALLOGR A, V46, P73, DOI 10.1107/S0108767389009815; SAIER MH, 1983, J BACTERIOL, V155, P1351, DOI 10.1128/JB.155.3.1351-1357.1983; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; SCHOLTE BJ, 1981, J BACTERIOL, V148, P257, DOI 10.1128/JB.148.1.257-264.1981; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Stein A, 2002, EUR J BIOCHEM, V269, P4074, DOI 10.1046/j.1432-1033.2002.03099.x; Ujwal R, 2012, JOVE-J VIS EXP, DOI 10.3791/3383; VANDERVLAG J, 1994, J BACTERIOL, V176, P3518, DOI 10.1128/JB.176.12.3518-3526.1994; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Wang GS, 2003, PROTEIN SCI, V12, P1087, DOI 10.1110/ps.0301503; Wang GS, 2000, J BIOL CHEM, V275, P39811, DOI 10.1074/jbc.C000709200; WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382	41	63	65	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					364	U147		10.1038/nature12232	http://dx.doi.org/10.1038/nature12232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23770568	Green Accepted			2022-12-28	WOS:000321910700042
J	Hu, ZH; Yan, CY; Liu, PY; Huang, ZW; Ma, R; Zhang, CL; Wang, RY; Zhang, YT; Martinon, F; Miao, D; Deng, HT; Wang, JW; Chang, JB; Chai, JJ				Hu, Zehan; Yan, Chuangye; Liu, Peiyuan; Huang, Zhiwei; Ma, Rui; Zhang, Chenlu; Wang, Ruiyong; Zhang, Yueteng; Martinon, Fabio; Miao, Di; Deng, Haiteng; Wang, Jiawei; Chang, Junbiao; Chai, Jijie			Crystal Structure of NLRC4 Reveals Its Autoinhibition Mechanism	SCIENCE			English	Article							III SECRETION APPARATUS; CAENORHABDITIS-ELEGANS; INFLAMMASOME RECEPTORS; FLAGELLIN; ACTIVATION; APOPTOSOME; CASPASE-1; APAF-1; DEATH; IPAF	Nucleotide-binding and oligomerization domain-like receptor (NLR) proteins oligomerize into multiprotein complexes termed inflammasomes when activated. Their autoinhibition mechanism remains poorly defined. Here, we report the crystal structure of mouse NLRC4 in a closed form. The adenosine diphosphate-mediated interaction between the central nucleotide-binding domain (NBD) and the winged-helix domain (WHD) was critical for stabilizing the closed conformation of NLRC4. The helical domain HD2 repressively contacted a conserved and functionally important alpha-helix of the NBD. The C-terminal leucine-rich repeat (LRR) domain is positioned to sterically occlude one side of the NBD domain and consequently sequester NLRC4 in a monomeric state. Disruption of ADP-mediated NBD-WHD or NBD-HD2/NBD-LRR interactions resulted in constitutive activation of NLRC4. Together, our data reveal the NBD-organized cooperative autoinhibition mechanism of NLRC4 and provide insight into its activation.	[Hu, Zehan; Yan, Chuangye; Liu, Peiyuan; Ma, Rui; Zhang, Chenlu; Miao, Di; Deng, Haiteng; Wang, Jiawei; Chai, Jijie] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Hu, Zehan; Yan, Chuangye; Liu, Peiyuan; Ma, Rui; Zhang, Chenlu; Miao, Di; Deng, Haiteng; Wang, Jiawei; Chai, Jijie] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Hu, Zehan] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Hu, Zehan] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Huang, Zhiwei] Harbin Inst Technol, Sch Life Sci & Biotechnol, Harbin 150080, Peoples R China; [Wang, Ruiyong; Zhang, Yueteng; Chang, Junbiao] Zhengzhou Univ, Coll Chem & Mol Engn, Zhengzhou 450001, Peoples R China; [Martinon, Fabio] Univ Lausanne, Dept Biochem, CH-1066 Lausanne, Switzerland	Tsinghua University; Tsinghua University; National Institute of Biological Sciences, Beijing; Beijing Normal University; Harbin Institute of Technology; Zhengzhou University; University of Lausanne	Chai, JJ (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	chaijj@mail.tsinghua.edu.cn	Martinon, Fabio/A-5575-2009; Hu, Zehan/AAH-7139-2020; Wang, Jiawei/D-1144-2010; Yan, Chuangye/AAJ-5832-2021; Huang, Zhiwei/AAF-6846-2019; chang, junbiao/P-1095-2014; Hu, Zehan/AAU-4752-2021; Liu, Peiyuan/B-2824-2016; Ma, Rui/N-4436-2018	Martinon, Fabio/0000-0002-6969-822X; Wang, Jiawei/0000-0001-9893-8539; chang, junbiao/0000-0001-6236-1256; Hu, Zehan/0000-0002-4648-5301; Ma, Rui/0000-0003-0045-2157; Chai, Jijie/0000-0001-7591-3873; Zhang, Yueteng/0000-0002-6882-196X; Yan, Chuangye/0000-0001-9338-8048; Deng, Haiteng/0000-0001-9496-1280	National Outstanding Young Scholar Science Foundation of China [20101331722]; State Key Program of National Natural Science of China [31130063]	National Outstanding Young Scholar Science Foundation of China; State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	We thank P. Schulze-Lefert for critically reading the manuscript, F. Yu and J. He at Shanghai Synchrotron Radiation Facility BL17U1 for data collection, L. Yu for helpful suggestions on culturing 293T cells, G. He from Y. Yan's laboratory assistance with CD, and J. Yang from F. Shao's laboratory for suggestions on cell-based assays. The coordinates and structural factors for mNLRC4 Delta CARD have been deposited in the Protein Data Bank (PDB) with the accession code 4KXF. This research was funded by the National Outstanding Young Scholar Science Foundation of China (20101331722) and State Key Program of National Natural Science of China (31130063) to J. Chai.	Danot O, 2009, STRUCTURE, V17, P172, DOI 10.1016/j.str.2009.01.001; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Ng TM, 2013, CURR OPIN IMMUNOL, V25, P34, DOI 10.1016/j.coi.2012.11.009; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Yuan SJ, 2013, BIOCHEMISTRY-US, V52, P2319, DOI 10.1021/bi301721g; Yuan SJ, 2011, STRUCTURE, V19, P128, DOI 10.1016/j.str.2010.10.009; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	28	261	273	3	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					172	175		10.1126/science.1236381	http://dx.doi.org/10.1126/science.1236381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23765277				2022-12-28	WOS:000321965300042
J	Madison, K; Schmidt, H; Volpp, KG				Madison, Kristin; Schmidt, Harald; Volpp, Kevin G.			Smoking, Obesity, Health Insurance, and Health Incentives in the Affordable Care Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Madison, Kristin] Northeastern Univ, Sch Law, Boston, MA 02115 USA; [Madison, Kristin] Northeastern Univ, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Schmidt, Harald] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Philadelphia VA Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Volpp, Kevin G.] Univ Penn, Perelman Sch Med, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA	Northeastern University; Northeastern University; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Madison, K (corresponding author), Northeastern Univ, Sch Law, 400 Huntington Ave, Boston, MA 02115 USA.	k.madison@neu.edu		Volpp, Kevin/0000-0003-1423-4599				[Anonymous], 2011, FED REGISTER, V76, P67992; Blumenthal KJ, 2013, HEALTH AFFAIR, V32, P497, DOI 10.1377/hlthaff.2012.0431; Department of Health and Human Services, 2013, FED REG, V78, P13405; Department of the Treasury Department of Labor Department of Health and Human Services, 2013, FED REGISTER, V78, P33157; Internal Revenue Service Department of the Treasury; Employee Benefits Security Administration Department of Labor; Centers for Medicare & Medicaid Services Department of Health and Human Services, 2012, FED REG, V77, P70627; Volpp KG, 2011, NEW ENGL J MED, V365, P388, DOI 10.1056/NEJMp1105966	6	33	33	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					143	144		10.1001/jama.2013.7617	http://dx.doi.org/10.1001/jama.2013.7617			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23765171				2022-12-28	WOS:000321511500009
J	Farrell, L				Farrell, Liam			Private medicine's real manifesto	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2013	347								f4188	10.1136/bmj.f4188	http://dx.doi.org/10.1136/bmj.f4188			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180CB	23818560				2022-12-28	WOS:000321569400004
J	Garcia-Pichel, F; Loza, V; Marusenko, Y; Mateo, P; Potrafka, RM				Garcia-Pichel, Ferran; Loza, Virginia; Marusenko, Yevgeniy; Mateo, Pilar; Potrafka, Ruth M.			Temperature Drives the Continental-Scale Distribution of Key Microbes in Topsoil Communities	SCIENCE			English	Article							BIOLOGICAL SOIL CRUSTS; COLORADO PLATEAU; CYANOBACTERIA; DIVERSITY; BIOGEOGRAPHY; WATER	Global warming will likely force terrestrial plant and animal species to migrate toward cooler areas or sustain range losses; whether this is also true for microorganisms remains unknown. Through continental-scale compositional surveys of soil crust microbial communities across arid North America, we observed a latitudinal replacement in dominance between two key topsoil cyanobacteria that was driven largely by temperature. The responses to temperature of enrichment cultures and cultivated strains support this contention, with one cyanobacterium (Microcoleus vaginatus) being more psychrotolerant and less thermotolerant than the other (M. steenstrupii). In view of our data and regional climate predictions, the latter cyanobacterium may replace the former in much of the studied area within the next few decades, with unknown ecological consequences for soil fertility and erodibility.	[Garcia-Pichel, Ferran; Loza, Virginia; Marusenko, Yevgeniy; Mateo, Pilar; Potrafka, Ruth M.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Loza, Virginia; Mateo, Pilar] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain	Arizona State University; Arizona State University-Tempe; Autonomous University of Madrid	Garcia-Pichel, F (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	ferran@asu.edu	Marusenko, Yevgeniy/F-8304-2013	Marusenko, Yevgeniy/0000-0002-2399-7689	NSF; Division Of Environmental Biology [1235828] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant (NSF-Biodiversity Surveys and Inventories) to F. G.-P. P. M. acknowledges the support of Universidad Autonoma de Madrid for a sabbatical leave at Arizona State University. Data are available in the supplementary materials and at the Desert Soil Microbe Web page and database (http://garcia-pichel.lab.asu.edu/databases.html).	Bates ST, 2012, MYCOLOGIA, V104, P353, DOI 10.3852/11-232; BELNAP J, 1993, GREAT BASIN NAT, V53, P40; Belnap J, 1998, J ARID ENVIRON, V39, P133, DOI 10.1006/jare.1998.0388; Belnap J., 2001, BIOL SOIL CRUSTS STR, V150; Belnap J, 2006, HYDROL PROCESS, V20, P3159, DOI 10.1002/hyp.6325; BROCK TD, 1975, J PHYCOL, V11, P316; Budel B, 2001, ECOL STU AN, V150, P141; Chen LZ, 2003, J ARID ENVIRON, V55, P645, DOI 10.1016/S0140-1963(02)00292-6; Elbert W, 2012, NAT GEOSCI, V5, P459, DOI 10.1038/ngeo1486; Ellis AW, 2008, CLIM RES, V35, P227, DOI 10.3354/cr00727; Garcia-Pichel F, 2001, NATURE, V413, P380, DOI 10.1038/35096640; Garcia-Pichel F, 2001, APPL ENVIRON MICROB, V67, P1902, DOI 10.1128/AEM.67.4.1902-1910.2001; Garcia-Pichel F., 2002, ENCY ENV MICROBIOLOG, P1019; Garcia-Pichel F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007801; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Gundlapally SR, 2006, MICROB ECOL, V52, P345, DOI 10.1007/s00248-006-9011-6; Johnson SL, 2007, ENVIRON MICROBIOL, V9, P680, DOI 10.1111/j.1462-2920.2006.01187.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Nagy ML, 2005, FEMS MICROBIOL ECOL, V54, P233, DOI 10.1016/j.femsec.2005.03.011; Overpeck J, 2010, SCIENCE, V328, P1642, DOI 10.1126/science.1186591; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Reed SC, 2012, NAT CLIM CHANGE, V2, P752, DOI [10.1038/nclimate1596, 10.1038/NCLIMATE1596]; Seager R, 2010, P NATL ACAD SCI USA, V107, P21277, DOI 10.1073/pnas.0910856107; Smith SM, 2004, MICROB ECOL, V48, P200, DOI 10.1007/s00248-004-0254-9; Starkenburg SR, 2011, J BACTERIOL, V193, P4569, DOI 10.1128/JB.05138-11; Strauss SL, 2012, BIOGEOCHEMISTRY, V108, P171, DOI 10.1007/s10533-011-9587-x; Yeager CM, 2007, FEMS MICROBIOL ECOL, V60, P85, DOI 10.1111/j.1574-6941.2006.00265.x	28	186	195	10	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1574	1577		10.1126/science.1236404	http://dx.doi.org/10.1126/science.1236404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812714				2022-12-28	WOS:000321007000042
J	Xue, L; Li, HB; Brodsky, EE; Xu, ZQ; Kano, Y; Wang, H; Mori, JJ; Si, JL; Pei, JL; Zhang, W; Yang, G; Sun, ZM; Huang, Y				Xue, Lian; Li, Hai-Bing; Brodsky, Emily E.; Xu, Zhi-Qing; Kano, Yasuyuki; Wang, Huan; Mori, James J.; Si, Jia-Liang; Pei, Jun-Ling; Zhang, Wei; Yang, Guang; Sun, Zhi-Ming; Huang, Yao			Continuous Permeability Measurements Record Healing Inside the Wenchuan Earthquake Fault Zone	SCIENCE			English	Article							PRESSURE SOLUTION; FLUID; COMPACTION; CALIFORNIA	Permeability controls fluid flow in fault zones and is a proxy for rock damage after an earthquake. We used the tidal response of water level in a deep borehole to track permeability for 18 months in the damage zone of the causative fault of the 2008 moment magnitude 7.9 Wenchuan earthquake. The unusually high measured hydraulic diffusivity of 2.4 x 10(-2) square meters per second implies a major role for water circulation in the fault zone. For most of the observation period, the permeability decreased rapidly as the fault healed. The trend was interrupted by abrupt permeability increases attributable to shaking from remote earthquakes. These direct measurements of the fault zone reveal a process of punctuated recovery as healing and damage interact in the aftermath of a major earthquake.	[Xue, Lian; Brodsky, Emily E.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Xue, Lian; Li, Hai-Bing; Xu, Zhi-Qing; Wang, Huan; Si, Jia-Liang; Zhang, Wei; Yang, Guang] Chinese Acad Geol Sci, Inst Geol, State Key Lab Continental Tecton & Dynam, Beijing 100037, Peoples R China; [Kano, Yasuyuki; Mori, James J.] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan; [Pei, Jun-Ling; Sun, Zhi-Ming] Chinese Acad Geol Sci, Inst Geomech, Beijing 100081, Peoples R China; [Zhang, Wei] Shandong Prov Lunan Geoengn Explorat Inst, Yangzhou 272100, Shandong, Peoples R China; [Yang, Guang] Guangdong Zhuhai Engn Invest Inst, Zhuhai 519000, Peoples R China; [Huang, Yao] 6 Brigade Jiangsu Geol & Mineral Resources Bur, Lianyungang 222023, Jiangsu, Peoples R China	University of California System; University of California Santa Cruz; Chinese Academy of Geological Sciences; Kyoto University; Chinese Academy of Geological Sciences	Xue, L (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	lxue3@ucsc.edu	Brodsky, Emily/B-9139-2014	Brodsky, Emily/0000-0002-6855-6860; Kano, Yasuyuki/0000-0002-3809-698X	National Science and Technology Planning Project in China; NSF [EAR1220642]; Directorate For Geosciences [1220642] Funding Source: National Science Foundation	National Science and Technology Planning Project in China; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Supported by the National Science and Technology Planning Project in China (H.-B.L.) and NSF grant EAR1220642 (E. E. B.). Seismic data from the Chinese national network are archived and distributed by Incorporated Research Institutions for Seismology (IRIS) Data Management System.	Andrews DJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2002JB001942; Brenguier F, 2008, SCIENCE, V321, P1478, DOI 10.1126/science.1160943; Brodsky E. E., 2010, EOS T AGU, V91, P237, DOI [DOI 10.1029/2010E0270001, DOI 10.1029/2010EO270001]; Brudy M, 1999, INT J ROCK MECH MIN, V36, P191, DOI 10.1016/S0148-9062(98)00182-X; Caine JS, 1996, GEOLOGY, V24, P1025, DOI 10.1130/0091-7613(1996)024<1025:FZAAPS>2.3.CO;2; Doan ML, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026889; Elkhoury JE, 2006, NATURE, V441, P1135, DOI 10.1038/nature04798; Elkhoury JE, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007759; Freeze R. A., 1977, GROUNDWATER; Fulton PM, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007103; Gratier JP, 2011, OIL GAS SCI TECHNOL, V66, P491, DOI 10.2516/ogst/2010014; Gratier JP, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000380; HSIEH PA, 1987, WATER RESOUR RES, V23, P1824, DOI 10.1029/WR023i010p01824; HUBBERT MK, 1959, GEOL SOC AM BULL, V70, P115; Kitagawa Y, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014030; Li HB, 2013, TECTONOPHYSICS, V584, P23, DOI 10.1016/j.tecto.2012.08.021; Li Y., 2012, IMAGING MODELING ASS, V1, P151; Li YG, 1998, SCIENCE, V279, P217, DOI 10.1126/science.279.5348.217; Lockner D., 1999, P INT WORKSH NOJ FAU, P22; Manga M, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000382; Marone C., 2007, SEISMOGENIC ZONE SUB, P346; Rempel AW, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2006JB004314; Renard F, 2000, J STRUCT GEOL, V22, P1395, DOI 10.1016/S0191-8141(00)00064-X; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; Rukai Z., 2009, PETROL EXPLOR DEV, V36, P46; Savage HM, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007665; SIBSON RH, 1992, TECTONOPHYSICS, V211, P283, DOI 10.1016/0040-1951(92)90065-E; Xu ZQ, 2008, EPISODES, V31, P291, DOI 10.18814/epiiugs/2008/v31i3/002	28	174	201	6	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1555	1559		10.1126/science.1237237	http://dx.doi.org/10.1126/science.1237237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812711				2022-12-28	WOS:000321007000037
J	Baets, R				Baets, Roel			PHOTONICS An ultra-small silicon laser	NATURE			English	Editorial Material							RAMAN LASER		Univ Ghent, IMEC, Dept Informat Technol, Photon Res Grp, B-9000 Ghent, Belgium	Ghent University; IMEC	Baets, R (corresponding author), Univ Ghent, IMEC, Dept Informat Technol, Photon Res Grp, B-9000 Ghent, Belgium.	roel.baets@intec.ugent.be						Boyraz O, 2005, OPT EXPRESS, V13, P796, DOI 10.1364/OPEX.13.000796; Boyraz O, 2004, OPT EXPRESS, V12, P5269, DOI 10.1364/OPEX.12.005269; Rong HS, 2005, NATURE, V433, P725, DOI 10.1038/nature03346; Takahashi Y, 2013, NATURE, V498, P470, DOI 10.1038/nature12237; Takahashi Y, 2009, OPT EXPRESS, V17, P18093, DOI 10.1364/OE.17.018093	5	4	4	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					447	448		10.1038/498447a	http://dx.doi.org/10.1038/498447a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803844				2022-12-28	WOS:000320929400044
J	Goldfarb, DS				Goldfarb, David S.			Cocktail Party Nephrology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Goldfarb, David S.] New York Harbor VA Healthcare Syst, Nephrol Sect, New York, NY USA; [Goldfarb, David S.] NYU, Langone Med Ctr, New York, NY USA	New York University; NYU Langone Medical Center	Goldfarb, DS (corresponding author), New York Harbor VA Healthcare Syst, Nephrol Sect, New York, NY USA.	david.goldfarb@va.gov		Goldfarb, David/0000-0002-9215-1273					0	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2561	2562		10.1001/jama.2013.4927	http://dx.doi.org/10.1001/jama.2013.4927			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23800933				2022-12-28	WOS:000320848100025
J	Saltman, RB; Cahn, Z				Saltman, Richard B.; Cahn, Zachary			ESSAY Restructuring health systems for an era of prolonged austerity: an essay by Richard B Saltman and Zachary Cahn	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		[Saltman, Richard B.; Cahn, Zachary] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Saltman, RB (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	rsaltma@emory.edu						Alesina A, 2008, FUTURE EUROPE; Anell A, 2011, HEALTH ECON POLICY L, V6, P549, DOI 10.1017/S1744133110000216; [Anonymous], 2012, GOR ENKLAR SLUBETANK; [Anonymous], 10 COMMANDMENTS FISC; [Anonymous], 2013, FINANCIAL TIMES; Appleby J., 2013, SPENDING HLTH SOCIAL; BARR N, 1999, EC WELFARE STATE; Dalton Matthew, 2013, WALL STREET J; De Maeseneer J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652553; Genet N., 2013, HOME CARE EUROPE CUR; Heller P., 2005, UNDERSTANDING FISCAL; Jacques M., 2009, CHINA RULES WORLD EN; Jeurissen P, 2010, THESIS ERASMUS U; McKee M, 2012, CLIN MED, V12, P346, DOI 10.7861/clinmedicine.12-4-346; Ostrow D, 2012, WORKSH SWED FOR HLTH; Pierson P, 1996, WORLD POLIT, V48, P143, DOI 10.1353/wp.1996.0004; Pollin R., 2013, FINANCIAL TIMES; Reinhart C. M., 2012, DEBT OVERHANGS PRESE; Schmidt H, 2010, IMPROVING HLTH HLTH, P316; Thomson A, 2012, WALL STREET J; Thomson S, 2013, HLTH HLTH SYSTEMS EC; Tinghog G, 2010, HEALTH ECON POLICY L, V5, P201, DOI 10.1017/S174413310999017X; Walter M, 2013, WALL STREET J	23	18	18	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2013	346								f3972	10.1136/bmj.f3972	http://dx.doi.org/10.1136/bmj.f3972			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QH	23798721				2022-12-28	WOS:000321245800002
J	Flint, J; Munafo, M				Flint, Jonathan; Munafo, Marcus			Herit-Ability	SCIENCE			English	Editorial Material							HUMAN HEIGHT; ASSOCIATION; GENETICS; HERITABILITY; VARIANTS; DISEASE; COMMON; LOCI		[Flint, Jonathan; Munafo, Marcus] Univ Oxford, Oxford OX3 7BN, England	University of Oxford	Flint, J (corresponding author), Univ Oxford, Oxford OX3 7BN, England.	jf@well.ox.ac.uk	Munafo, Marcus/AAE-2306-2020	Munafo, Marcus/0000-0002-4049-993X; Flint, Jonathan/0000-0002-9427-4429	Wellcome Trust [090532] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Flint J, 2013, CURR OPIN NEUROBIOL, V23, P57, DOI 10.1016/j.conb.2012.07.005; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; GOLDBERGER AS, 1978, AM ECON REV, V68, P960; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McNeill A, 2013, J PSYCHOPHARMACOL, V27, P13, DOI 10.1177/0269881112458731; Munafo MR, 2009, MOL PSYCHIATR, V14, P119, DOI 10.1038/mp.2008.77; Munafo MR, 2012, JNCI-J NATL CANCER I, V104, P740, DOI 10.1093/jnci/djs191; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; TAUBMAN P, 1976, AM ECON REV, V66, P858; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	18	9	9	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1416	1417		10.1126/science.1240684	http://dx.doi.org/10.1126/science.1240684			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23788790				2022-12-28	WOS:000320647000030
J	Wienholtz, F; Beck, D; Blaum, K; Borgmann, C; Breitenfeldt, M; Cakirli, RB; George, S; Herfurth, F; Holt, JD; Kowalska, M; Kreim, S; Lunney, D; Manea, V; Menendez, J; Neidherr, D; Rosenbusch, M; Schweikhard, L; Schwenk, A; Simonis, J; Stanja, J; Wolf, RN; Zuber, K				Wienholtz, F.; Beck, D.; Blaum, K.; Borgmann, Ch.; Breitenfeldt, M.; Cakirli, R. B.; George, S.; Herfurth, F.; Holt, J. D.; Kowalska, M.; Kreim, S.; Lunney, D.; Manea, V.; Menendez, J.; Neidherr, D.; Rosenbusch, M.; Schweikhard, L.; Schwenk, A.; Simonis, J.; Stanja, J.; Wolf, R. N.; Zuber, K.			Masses of exotic calcium isotopes pin down nuclear forces	NATURE			English	Article							SHELL-MODEL; SPECTROMETRY; PHYSICS	The properties of exotic nuclei on the verge of existence play a fundamental part in our understanding of nuclear interactions(1). Exceedingly neutron-rich nuclei become sensitive to new aspects of nuclear forces(2). Calcium, with its doubly magic isotopes Ca-40 and Ca-48, is an ideal test for nuclear shell evolution, from the valley of stability to the limits of existence. With a closed proton shell, the calcium isotopes mark the frontier for calculations with three-nucleon forces from chiral effective field theory(3-6). Whereas predictions for the masses of Ca-51 and Ca-52 have been validated by direct measurements(4), it is an open question as to how nuclear masses evolve for heavier calcium isotopes. Here we report the mass determination of the exotic calcium isotopes Ca-53 and Ca-54, using the multi-reflection time-of-flight mass spectrometer(7) of ISOLTRAP at CERN. The measured masses unambiguously establish a prominent shell closure at neutron number N = 32, in excellent agreement with our theoretical calculations. These results increase our understanding of neutron-rich matter and pin down the subtle components of nuclear forces that are at the forefront of theoretical developments constrained by quantum chromodynamics(8).	[Wienholtz, F.; George, S.; Rosenbusch, M.; Schweikhard, L.; Wolf, R. N.] Ernst Moritz Arndt Univ Greifswald, Inst Phys, Felix Hausdorff Str 6, D-17489 Greifswald, Germany; [Beck, D.; Herfurth, F.; Neidherr, D.] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany; [Blaum, K.; Borgmann, Ch.; Cakirli, R. B.; Kreim, S.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Breitenfeldt, M.] Katholieke Univ Leuven, Inst Kern & Stralingsfys, B-3001 Heverlee, Belgium; [Cakirli, R. B.] Istanbul Univ, Dept Phys, TR-34134 Istanbul, Turkey; [Holt, J. D.; Menendez, J.; Schwenk, A.; Simonis, J.] Tech Univ Darmstadt, Inst Kernphys, D-64289 Darmstadt, Germany; [Holt, J. D.; Menendez, J.; Schwenk, A.; Simonis, J.] GSI Helmholtzzentrum Schwerionenforsch GmbH, ExtreMe Matter Inst EMMI, D-64291 Darmstadt, Germany; [Kowalska, M.; Kreim, S.] CERN, CH-1211 Geneva 23, Switzerland; [Lunney, D.; Manea, V.] Univ Paris Sud, CNRS, IN2P3, CSNSM, F-91405 Orsay, France; [Stanja, J.; Zuber, K.] Tech Univ Dresden, Inst Kern & Teilchenphys, D-01069 Dresden, Germany	Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Max Planck Society; KU Leuven; Istanbul University; Technical University of Darmstadt; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; European Organization for Nuclear Research (CERN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; Technische Universitat Dresden	Wienholtz, F (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Phys, Felix Hausdorff Str 6, D-17489 Greifswald, Germany.	wienholtz@physik.uni-greifswald.de	Schweikhard, Lutz/AAX-3044-2021; Cakirli, R.Burcu/AAF-1459-2020; Lunney, David/AAT-1922-2021; Schwenk, Achim/ABD-5857-2021; Menéndez, Javier/A-3533-2016; Wolf, Robert/D-9181-2012	Schwenk, Achim/0000-0001-8027-4076; Menéndez, Javier/0000-0002-1355-4147; Manea, Vladimir/0000-0003-2065-5517; Wolf, Robert/0000-0003-0748-7387; Holt, Jason/0000-0003-4833-7959	BMBF [06GF9102, 05P12HGCI1, 05P12HGFNE, 06DA70471, 06DD9054]; DFG [SFB 634, GE2183/2-1]; ERC [307986 STRONGINT]; EU through ENSAR [262010]; Helmholtz Alliance [HA216/EMMI]; French IN2P3; ISOLDE Collaboration; Max-Planck Society	BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); EU through ENSAR; Helmholtz Alliance; French IN2P3; ISOLDE Collaboration; Max-Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the BMBF (contracts 06GF9102, 05P12HGCI1, 05P12HGFNE, 06DA70471, 06DD9054), the DFG (grants SFB 634 and GE2183/2-1), the ERC (grant 307986 STRONGINT), the EU through ENSAR (grant 262010), the Helmholtz Alliance HA216/EMMI, the French IN2P3, the ISOLDE Collaboration and the Max-Planck Society. Computations were performedat the Julich Supercomputing Center.	Audi G, 2006, INT J MASS SPECTROM, V251, P85, DOI 10.1016/j.ijms.2006.01.048; Audi G, 2012, CHINESE PHYS C, V36, P1157, DOI 10.1088/1674-1137/36/12/001; Baumann T, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/3/036301; Blaum K, 2006, PHYS REP, V425, P1, DOI 10.1016/j.physrep.2005.10.011; Crawford HL, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.014311; Epelbaum E, 2009, REV MOD PHYS, V81, P1773, DOI 10.1103/RevModPhys.81.1773; Erler J, 2012, NATURE, V486, P509, DOI 10.1038/nature11188; Fedosseev VN, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3662206; Forssen C, 2013, PHYS SCRIPTA, VT152, DOI 10.1088/0031-8949/2013/T152/014022; Gade A, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.021302; Gallant AT, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.032506; Hagen G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.032502; Hagen G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.242501; Hammer HW, 2013, REV MOD PHYS, V85, P197, DOI 10.1103/RevModPhys.85.197; Holt JD, 2012, J PHYS G NUCL PARTIC, V39, DOI 10.1088/0954-3899/39/8/085111; Honma M, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.034335; HUCK A, 1985, PHYS REV C, V31, P2226, DOI 10.1103/PhysRevC.31.2226; Janssens RVF, 2009, NATURE, V459, P1069, DOI 10.1038/4591069a; Janssens RVF, 2002, PHYS LETT B, V546, P55, DOI 10.1016/S0370-2693(02)02682-5; Mantica PF, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.014313; Mukherjee M, 2008, EUR PHYS J A, V35, P1, DOI 10.1140/epja/i2007-10528-9; Otsuka T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.082502; Otsuka T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.032501; Poves A, 2001, NUCL PHYS A, V694, P157, DOI 10.1016/S0375-9474(01)00967-8; Roth R, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.052501; Sorlin O, 2008, PROG PART NUCL PHYS, V61, P602, DOI 10.1016/j.ppnp.2008.05.001; Wang M, 2012, CHINESE PHYS C, V36, P1603, DOI 10.1088/1674-1137/36/12/003; Warner D, 2004, NATURE, V430, P517, DOI 10.1038/430517a; Wolf RN, 2012, NUCL INSTRUM METH A, V686, P82, DOI 10.1016/j.nima.2012.05.067; WOLLNIK H, 1990, INT J MASS SPECTROM, V96, P267, DOI 10.1016/0168-1176(90)85127-N	30	333	350	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					346	349		10.1038/nature12226	http://dx.doi.org/10.1038/nature12226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23783629	Green Published			2022-12-28	WOS:000320592900036
J	Krogsboll, LT; Jorgensen, KJ; Gotzsche, PC				Krogsboll, Lasse T.; Jorgensen, Karsten Juhl; Gotzsche, Peter C.			General Health Checks in Adults for Reducing Morbidity and Mortality From Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Krogsboll, Lasse T.; Jorgensen, Karsten Juhl; Gotzsche, Peter C.] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Krogsboll, LT (corresponding author), Rigshosp, Dept 7811, Nord Cochrane Ctr, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	ltk@cochrane.dk		Jorgensen, Karsten/0000-0001-8554-0388				Boulware LE, 2007, ANN INTERN MED, V146, P289, DOI 10.7326/0003-4819-146-4-200702200-00008; COULTER A, 1995, BRIT MED J, V310, P1099; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Krogsboll LT, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009009.pub2; WOOD DA, 1994, BRIT MED J, V308, P313, DOI 10.1136/bmj.308.6924.313	5	30	30	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2489	2490		10.1001/jama.2013.5039	http://dx.doi.org/10.1001/jama.2013.5039			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23780462	Green Published			2022-12-28	WOS:000320505100030
J	Budenholzer, B				Budenholzer, Brian			Use of SSRIs during pregnancy was not associated with increased risk for stillbirth or neonatal mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									E Carolina Univ, Brody Sch Med, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Budenholzer, B (corresponding author), E Carolina Univ, Brody Sch Med, Greenville, NC 27858 USA.		Jimenez-Solem, Espen/B-4207-2012	Jimenez-Solem, Espen/0000-0002-3777-147X				ACOG Committee on Practice Bulletins--Obstetrics, 2008, Obstet Gynecol, V111, P1001, DOI 10.1097/AOG.0b013e31816fd910; Kallen BAJ, 2007, BIRTH DEFECTS RES A, V79, P301, DOI 10.1002/bdra.20327	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12							JC12	10.7326/0003-4819-158-12-201306180-02012	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778924				2022-12-28	WOS:000320645000011
J	Su, CY; Carlson, JR				Su, Chih-Ying; Carlson, John R.			Circuit Logic of Avoidance and Attraction	SCIENCE			English	Editorial Material							OLFACTORY CIRCUIT; GAIN-CONTROL; DROSOPHILA; BEHAVIOR; TASTE; INHIBITION; NEURONS		[Su, Chih-Ying; Carlson, John R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Su, CY (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004729, R01DC011697] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004729, R01 DC011697] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Ishimoto H, 2004, CELL MOL LIFE SCI, V61, P10, DOI 10.1007/s00018-003-3182-9; Lin HH, 2013, SCIENCE, V340, P1338, DOI 10.1126/science.1236693; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Zhang YLV, 2013, SCIENCE, V340, P1334, DOI 10.1126/science.1234133	13	6	6	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1295	1297		10.1126/science.1240139	http://dx.doi.org/10.1126/science.1240139			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766319				2022-12-28	WOS:000320320200030
J	Black, ME				Black, Mary E.			Life assurance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2013	346								f3722	10.1136/bmj.f3722	http://dx.doi.org/10.1136/bmj.f3722			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WH	23761190	Bronze			2022-12-28	WOS:000320589800005
J	van Oosten-Hawle, P; Porter, RS; Morimoto, RI				van Oosten-Hawle, Patricija; Porter, Robert S.; Morimoto, Richard I.			Regulation of Organismal Proteostasis by Transcellular Chaperone Signaling	CELL			English	Article							MYOSIN HEAVY-CHAIN; CAENORHABDITIS-ELEGANS; SHOCK FACTORS; HSP90; STRESS; EXPRESSION; LONGEVITY; IDENTIFICATION; ENDOCYTOSIS; EXOCYTOSIS	A major challenge for metazoans is to ensure that different tissues, each expressing distinctive proteomes, are nevertheless well protected at an organismal level from proteotoxic stress. We show that expression of endogenous metastable proteins in muscle cells, which rely on chaperones for proper folding, induces a systemic stress response throughout multiple tissues of C. elegans. Suppression of misfolding in muscle cells can be achieved not only by enhanced expression of HSP90 in muscle cells but as effectively by elevated expression of HSP90 in intestine or neuronal cells. This cell-nonautonomous control of HSP90 expression relies upon transcriptional feedback between somatic tissues that is regulated by the FoxA transcription factor PHA-4. This transcellular chaperone signaling response maintains organismal proteostasis when challenged by a local tissue imbalance in folding and provides the basis for organismal stress-sensing surveillance.	[van Oosten-Hawle, Patricija; Porter, Robert S.; Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Morimoto, RI (corresponding author), Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu	van Oosten-Hawle, Patricija/GVS-1791-2022	van Oosten-Hawle, Patricija/0000-0002-5713-6457	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Erwin-Schroedinger postdoctoral fellowship by the Austrian Science Fund (FWF) [J2895]; NIGMS [P50-GM081192]; National Institutes of Health (NIGMS, NIA, and NINDS); Ellison Medical Foundation; Daniel F. and Ada L. Rice Foundation; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026647, R37AG026647] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Erwin-Schroedinger postdoctoral fellowship by the Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIGMS, NIA, and NINDS); Ellison Medical Foundation(Lawrence Ellison Foundation); Daniel F. and Ada L. Rice Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Caenorhabditis Genetics Center (University of Minnesota) for strains used in this study, the BC C. elegans Gene Expression Consortium for strain BC10293, Dr. Daniel Czyz for the hsp70pr::mCherry reporter strain (AM722), Dr. P.W. Piper and Dr. S. Millson (University of Sheffield, UK) for providing yeast strains and plasmids, and Chris Low for advice on the graphical abstract. This work was funded by the Chicago Biomedical Consortium, with support from the Searle Funds at The Chicago Community Trust (a postdoctoral fellowship of the Institute for Genomics and Systems Biology), by an Erwin-Schroedinger postdoctoral fellowship by the Austrian Science Fund (FWF; J2895) to P.v.O.-H., by a NIGMS P50 grant (P50-GM081192), and by grants from the National Institutes of Health (NIGMS, NIA, and NINDS), the Ellison Medical Foundation, the Chicago Biomedical Consortium, and the Daniel F. and Ada L. Rice Foundation (to R.I.M.).	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Altun Z.F., 2009, WORMATLAS, DOI DOI 10.3908/W0RMATLAS.1.11; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Birnby DA, 2000, GENETICS, V155, P85; Burga A, 2012, FEBS J, V279, P3765, DOI 10.1111/j.1742-4658.2012.08810.x; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Fares H, 2001, GENETICS, V159, P133; Gaiser AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025485; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; GENGYOANDO K, 1991, J MOL BIOL, V219, P429, DOI 10.1016/0022-2836(91)90184-8; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Hammarlund M, 2008, J CELL BIOL, V180, P483, DOI 10.1083/jcb.200708018; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; MACLEOD AR, 1977, J MOL BIOL, V114, P133, DOI 10.1016/0022-2836(77)90287-X; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Richmond JE, 2002, CURR OPIN NEUROBIOL, V12, P499, DOI 10.1016/S0959-4388(02)00360-4; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Zhao C, 2002, EXP CELL RES, V275, P200, DOI 10.1006/excr.2002.5501; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	46	130	131	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1366	1378		10.1016/j.cell.2013.05.015	http://dx.doi.org/10.1016/j.cell.2013.05.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746847	Green Accepted, Bronze			2022-12-28	WOS:000319979200019
J	Talpalar, AE; Bouvier, J; Borgius, L; Fortin, G; Pierani, A; Kiehn, O				Talpalar, Adolfo E.; Bouvier, Julien; Borgius, Lotta; Fortin, Gilles; Pierani, Alessandra; Kiehn, Ole			Dual-mode operation of neuronal networks involved in left-right alternation	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; SPINAL-CORD; COMMISSURAL INTERNEURONS; LOCOMOTOR-ACTIVITY; MICE; IDENTIFICATION; COORDINATION; EXPRESSION; ZEBRAFISH; CIRCUITS	All forms of locomotion are repetitive motor activities that require coordinated bilateral activation of muscles. The executive elements of locomotor control are networks of spinal neurons that determine gait pattern through the sequential activation of motor-neuron pools on either side of the body axis(1-4). However, little is known about the constraints that link left-right coordination to locomotor speed. Recent advances have indicated that both excitatory and inhibitory commissural neurons may be involved in left-right coordination(5-7). But the neural underpinnings of this, and a possible causal link between these different groups of commissural neurons and left-right alternation, are lacking. Here we show, using intersectional mouse genetics, that ablation of a group of transcriptionally defined commissural neurons-the V0 population-leads to a quadrupedal hopping at all frequencies of locomotion. The selective ablation of inhibitory V0 neurons leads to a lack of left-right pattern at low frequencies, mixed coordination at medium frequencies, and alternation at high locomotor frequencies. When ablation is targeted to excitatory V0 neurons, left-right alternation is present at low frequencies, and hopping is restricted to medium and high locomotor frequencies. Therefore, the intrinsic logic of the central control of locomotion incorporates a modular organization, with two subgroups of V0 neurons required for the existence of left-right alternating modes at different speeds of locomotion. The two molecularly distinct sets of commissural neurons may constrain species-related naturally occurring frequency-dependent coordination and be involved in the evolution of different gaits.	[Talpalar, Adolfo E.; Bouvier, Julien; Borgius, Lotta; Kiehn, Ole] Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden; [Fortin, Gilles] CNRS, F-91198 Gif Sur Yvette, France; [Pierani, Alessandra] Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592, F-75205 Paris, France	Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Kiehn, O (corresponding author), Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden.	ole.kiehn@ki.se	kiehn, ole/AAB-1262-2019; kiehn, ole/AAT-7881-2021; Pierani, Alessandra/O-6136-2017; Talpalar, Adolfo/H-3996-2019; Bouvier, Julien/C-1018-2017	Pierani, Alessandra/0000-0002-4872-4791; Talpalar, Adolfo/0000-0001-9056-6021; Bouvier, Julien/0000-0002-1307-4426; Fortin, Gilles/0000-0002-2123-8603; Kiehn, Ole/0000-0002-5954-469X	Soderberg Foundation; Swedish Research Council; European Research Council	Soderberg Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Soderberg Foundation, Swedish Research Council and European Research Council. J.B. is an EMBO fellow. We thank H. U. Zeilhofer for donating the Hoxb8::Cre mouse strain, S. Karaz, A. C. Westerdahl and P. Low for extensive genotyping, L. Lundfald for participating in early experiments, N. Sleiers for participating in the in vivo experiments, and P. L. Ruffault for providing mouse tissue. We thank colleagues for discussing different aspects of our study.	Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399; Ausborn J, 2012, P NATL ACAD SCI USA, V109, pE3631, DOI 10.1073/pnas.1216256110; Berger J, 2004, GENESIS, V40, P195, DOI 10.1002/gene.20081; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Borgius L, 2010, MOL CELL NEUROSCI, V45, P245, DOI 10.1016/j.mcn.2010.06.016; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Butt SJB, 2003, NEURON, V38, P953, DOI 10.1016/S0896-6273(03)00353-2; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Crone SA, 2009, J NEUROSCI, V29, P7098, DOI 10.1523/JNEUROSCI.1206-09.2009; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Jankowska E, 2008, BRAIN RES REV, V57, P46, DOI 10.1016/j.brainresrev.2007.06.022; Jordan L. M., 1991, NEUROBIOLOGICAL BASI, P3; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Liu B, 2007, DEV DYNAM, V236, P829, DOI 10.1002/dvdy.21061; Mahan R.P., 1991, 16 US ARM RES I BEH; McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009; Mor Y, 2007, J NEUROPHYSIOL, V98, P2807, DOI 10.1152/jn.00740.2007; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; Restrepo CE, 2009, J COMP NEUROL, V517, P177, DOI 10.1002/cne.22144; Roberts A, 2008, BRAIN RES REV, V57, P22, DOI 10.1016/j.brainresrev.2007.06.015; Serradj N, 2009, BEHAV BRAIN RES, V201, P59, DOI 10.1016/j.bbr.2009.01.030; Skaggs K, 2011, DEVELOPMENT, V138, P3199, DOI 10.1242/dev.057281; Suster ML, 2009, DEV BIOL, V325, P422, DOI 10.1016/j.ydbio.2008.10.004; Talpalar AE, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00019; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Teissier A, 2010, J NEUROSCI, V30, P10563, DOI 10.1523/JNEUROSCI.0776-10.2010; Witschi R, 2010, GENESIS, V48, P596, DOI 10.1002/dvg.20656; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017; Zar JH, 1974, BIOSTATISTICAL ANAL; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027	39	195	196	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					85	U108		10.1038/nature12286	http://dx.doi.org/10.1038/nature12286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23812590				2022-12-28	WOS:000322514800033
J	Li, L; Dudin, YO; Kuzmich, A				Li, L.; Dudin, Y. O.; Kuzmich, A.			Entanglement between light and an optical atomic excitation	NATURE			English	Article							SINGLE-PHOTON; RYDBERG BLOCKADE; QUANTUM MEMORIES; GAS	The generation, distribution and control of entanglement across quantum networks is one of the main goals of quantum information science(1,2). In previous studies, hyperfine ground states of single atoms or atomic ensembles have been entangled with spontaneously emitted light(3-6). The probabilistic character of the spontaneous emission process leads to long entanglement generation times, limiting realized network implementations to just two nodes(7-10). The success probability for atom-photon entanglement protocols can be increased by confining a single atom in a high-finesse optical cavity(11,12). Alternatively, quantum networks with superior scaling properties could be achieved using entanglement between light fields and atoms in quantum superpositions of the ground and highly excited (Rydberg) electronic states(2,13,14). Here we report the generation of such entanglement. The dephasing of the optical atomic coherence is inhibited by state-insensitive confinement of both the ground and Rydberg states of an ultracold atomic gas in an optical lattice(15). Our results pave the way for functional, many-node quantum networks capable of deterministic quantum logic operations between long-lived atomic memories.	[Li, L.; Dudin, Y. O.; Kuzmich, A.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Kuzmich, A (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	alex.kuzmich@physics.gatech.edu	Li, Lin/K-5236-2013	Li, Lin/0000-0003-3795-0088	Atomic Physics Program; Quantum Memories MURI of the Air Force Office of Scientific Research; National Science Foundation	Atomic Physics Program; Quantum Memories MURI of the Air Force Office of Scientific Research; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Atomic Physics Program and the Quantum Memories MURI of the Air Force Office of Scientific Research and the National Science Foundation.	Acin A, 2007, NAT PHYS, V3, P256, DOI 10.1038/nphys549; Anderson SE, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.263001; Brion E, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.042324; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Dudin YO, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.031801; Dudin YO, 2012, NAT PHYS, V8, P790, DOI [10.1038/NPHYS2413, 10.1038/nphys2413]; Dudin YO, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.133602; Dudin YO, 2012, SCIENCE, V336, P887, DOI 10.1126/science.1217901; Eisaman MD, 2005, NATURE, V438, P837, DOI 10.1038/nature04327; Gaetan A, 2009, NAT PHYS, V5, P115, DOI 10.1038/NPHYS1183; Gallagher T. F., 1994, RYDBERG ATOMS; Hofmann J, 2012, SCIENCE, V337, P72, DOI 10.1126/science.1221856; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; Matsukevich DN, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030405; Matsukevich DN, 2004, SCIENCE, V306, P663, DOI 10.1126/science.1103346; Maxwell D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.103001; Mohapatra AK, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.113003; Monroe C, 2013, SCIENCE, V339, P1164, DOI 10.1126/science.1231298; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Saffman M, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.022347; Saffman M, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.065403; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Schauss P, 2012, NATURE, V491, P87, DOI 10.1038/nature11596; Simon J, 2007, NAT PHYS, V3, P765, DOI 10.1038/nphys726; Stute A, 2012, NATURE, V485, P482, DOI 10.1038/nature11120; TAN SM, 1991, PHYS REV LETT, V66, P252, DOI 10.1103/PhysRevLett.66.252; Urban E, 2009, NAT PHYS, V5, P110, DOI 10.1038/NPHYS1178; Volz J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030404; Zhao B, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.052329	31	142	143	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					466	469		10.1038/nature12227	http://dx.doi.org/10.1038/nature12227			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23783514				2022-12-28	WOS:000320929400048
J	Johnson, C; Koria, S; Fattah, D				Johnson, Chris; Koria, Shiv; Fattah, David			PICTURE QUIZ An unusual death in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							YERSINIA-PSEUDOTUBERCULOSIS; MYCOBACTERIUM-AVIUM; CROHNS-DISEASE; SARCOIDOSIS; TUBERCULOSIS; GRANULOMAS; INFECTION		[Johnson, Chris; Koria, Shiv; Fattah, David] Northampton Gen Hosp, Dept Histopathol, Northampton NN1 5BD, England		Johnson, C (corresponding author), Northampton Gen Hosp, Dept Histopathol, Northampton NN1 5BD, England.	christopher.johnson@uhl-tr.nhs.uk						Azzam HC, 2009, AM J MED SCI, V337, P218, DOI 10.1097/MAJ.0b013e31818457a3; BANATVALA JE, 1995, HIV PRACTICE PATHOLO; CHONG SKF, 1985, GUT, V26, P55, DOI 10.1136/gut.26.1.55; Collins C H, 1999, Commun Dis Public Health, V2, P161; Denoya P, 2011, COLORECTAL DIS, V13, P1142, DOI 10.1111/j.1463-1318.2010.02421.x; Dorries C, 1999, CORONER COURTS GUIDE; Dumot JA, 1998, AM J GASTROENTEROL, V93, P1949; ELMARAGHI NRH, 1979, AM J CLIN PATHOL, V71, P631; Farman J, 1997, ABDOM IMAGING, V22, P248, DOI 10.1007/s002619900182; Finkbeiner W, 2004, AUTOPSY PATHOLOGY MA, P104; Flavin RJ, 2007, J CLIN PATHOL, V60, P487, DOI 10.1136/jcp.2005.032276; Geevarghese S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6227; Health Protection Agency, TUB UK TUB UK 2012 R; *HLTH PROT AG, MIGR HLTH INF DIS NO; Naktin J, 1999, CLIN LAB MED, V19, P523; National Institute for Health and Clinical Excellence, 2011, TUB CLIN DIAGN MAN T, V117; Odze D, 2009, SURG PATHOLOGY GI TR, P63; Office for National Statistics, 2010, GUID DOC COMPL MED C; ROTH RI, 1985, DIGEST DIS SCI, V30, P497, DOI 10.1007/BF01318186; Royal College of Pathologists, GUID AUT PRACT APP 3; Vahid B, 2007, DIGEST DIS SCI, V52, P3316, DOI 10.1007/s10620-006-9448-y; Varinot J, 2012, INT J COLORECTAL DIS, V27, P1117, DOI 10.1007/s00384-011-1330-5; Word Health Organization, GLOB TUB REP 2012	23	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2013	346								f3667	10.1136/bmj.f3667	http://dx.doi.org/10.1136/bmj.f3667			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QL	23804256				2022-12-28	WOS:000321246200008
J	Holmes, D				Holmes, David			Profile Xuetao Cao: reforming medical research in China	LANCET			English	Biographical-Item																			0	2	2	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 8	2013	381	9882					1977	1977		10.1016/S0140-6736(13)61188-5	http://dx.doi.org/10.1016/S0140-6736(13)61188-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171JY	23746888	Bronze			2022-12-28	WOS:000320924400014
J	Wiener, R; Wolberger, C				Wiener, Reuven; Wolberger, Cynthia			A New DUB Makes Linear Ubiquitin a Party to Its Own Destruction	CELL			English	Editorial Material							INHIBITION; CHAINS; OTUB1	Linear ubiquitin (Ub) plays a role in nuclear factor kappa B signaling, but the deubiquitinating enzyme that disassembles these chains was unknown. In this issue of Cell, Keusekotten et al. identify a new enzyme that disassembles linear chains with the use of a mechanism that relies on Ub itself to help catalyze peptide bond cleavage.	[Wiener, Reuven] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, Hadassah Med Sch, IL-91120 Jerusalem, Israel; [Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Hebrew University of Jerusalem; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu		Wolberger, Cynthia/0000-0001-8578-2969				Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Rieser E, 2013, TRENDS BIOCHEM SCI, V38, P94, DOI 10.1016/j.tibs.2012.11.007; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911	10	1	1	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1189	1191		10.1016/j.cell.2013.05.018	http://dx.doi.org/10.1016/j.cell.2013.05.018			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746836	Bronze			2022-12-28	WOS:000319979200005
J	Heneghan, MA; Yeoman, AD; Verma, S; Smith, AD; Longhi, MS				Heneghan, Michael A.; Yeoman, Andrew D.; Verma, Sumita; Smith, Alastair D.; Longhi, Maria Serena			Autoimmune hepatitis	LANCET			English	Article							CHRONIC ACTIVE HEPATITIS; PRIMARY BILIARY-CIRRHOSIS; SOLUBLE LIVER ANTIGEN; REGULATORY T-CELLS; PRIMARY SCLEROSING CHOLANGITIS; MYCOPHENOLATE-MOFETIL; CORTICOSTEROID-THERAPY; OVERLAP SYNDROME; JAPANESE PATIENTS; CONTROLLED-TRIAL	Autoimmune hepatitis is a disease of the hepatic parenchyma that can present in acute or chronic forms. In common with many autoimmune diseases, autoimmune hepatitis is associated with non-organ-specific antibodies in the context of hepatic autoimmunity. This dichotomy has made definition of a unifying hypothesis in the pathophysiology of the disease difficult, although data from the past 8 years have drawn attention to the role of regulatory T cells. Several triggers have been identified, and the disease arises in genetically susceptible individuals. Clinical and biochemical remission is achievable in up to 85% of cases. For the remaining patients, alternative immunosuppression strategies are an option. Liver transplantation provides an excellent outcome for patients with acute liver failure or complications of end-stage liver disease, including hepatocellular carcinoma. Variant or overlapping syndromes are worthy of consideration when unexpected disease features arise.	[Heneghan, Michael A.; Yeoman, Andrew D.; Longhi, Maria Serena] Kings Coll Hosp NHS Fdn Trust, Inst Liver Studies, London SE5 9RS, England; [Verma, Sumita] Brighton & Sussex Med Sch, Dept Med, Brighton, E Sussex, England; [Smith, Alastair D.] Duke Univ, Med Ctr, Div Gastroenterol & Hepatol, Durham, NC USA	King's College Hospital NHS Foundation Trust; University of London; King's College London; University of Brighton; University of Sussex; Duke University	Heneghan, MA (corresponding author), Kings Coll Hosp NHS Fdn Trust, Inst Liver Studies, Denmark Hill, London SE5 9RS, England.	michael.heneghan@nhs.net		Verma, Sumita/0000-0001-7021-8409	Wellcome Trust; Kelly Group; Medical Research Council; MRC [G0902288] Funding Source: UKRI; Medical Research Council [G0902288, MR/J006742/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Kelly Group; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MAH is the recipient of research funding from the Wellcome Trust and The Kelly Group. MSL is the recipient of a Medical Research Council Clinician Scientist Fellowship. We thank Alberto Quaglia (King's College Hospital London, UK) for histological images.	Abdo AA, 2002, HEPATOLOGY, V36, P1393, DOI 10.1053/jhep.2002.37200; Agarwal K, 2000, HEPATOLOGY, V31, P49, DOI 10.1002/hep.510310110; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Al-Chalabi T, 2008, ALIMENT PHARM THER, V28, P209, DOI 10.1111/j.1365-2036.2008.03722.x; Al-Chalabi T, 2008, J HEPATOL, V48, P140, DOI 10.1016/j.jhep.2007.08.013; Al-Chalabi T, 2007, AM J GASTROENTEROL, V102, P1013, DOI 10.1111/j.1572-0241.2007.01147.x; Al-Chalabi T, 2006, J HEPATOL, V45, P575, DOI 10.1016/j.jhep.2006.04.007; Alla V, 2006, J CLIN GASTROENTEROL, V40, P757, DOI 10.1097/00004836-200609000-00018; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Alvarez F, 1999, J HEPATOL, V30, P222, DOI 10.1016/S0168-8278(99)80065-8; Angulo P, 2001, AM J GASTROENTEROL, V96, P3021; Ballot E, 2000, J HEPATOL, V33, P208, DOI 10.1016/S0168-8278(00)80361-X; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; BENARI Z, 1993, HEPATOLOGY, V18, P10, DOI 10.1016/0270-9139(93)90499-D; Berardi S, 2007, GUT, V56, P237, DOI 10.1136/gut.2006.092064; Bittencourt PL, 1999, AM J GASTROENTEROL, V94, P1906; Bittencourt PL, 2003, AM J GASTROENTEROL, V98, P1616, DOI 10.1016/S0002-9270(03)00307-1; Bjornsson E, 2010, HEPATOLOGY, V51, P2040, DOI 10.1002/hep.23588; Boberg KM, 2011, J HEPATOL, V54, P374, DOI 10.1016/j.jhep.2010.09.002; Boberg KM, 1998, SCAND J GASTROENTERO, V33, P99; Brunt EM, 2004, HUM PATHOL, V35, P509, DOI 10.1016/j.humpath.2003.10.017; Buchel E, 2002, AM J GASTROENTEROL, V97, P3160; Burak KW, 1998, J HEPATOL, V29, P990, DOI 10.1016/S0168-8278(98)80128-1; Chatur N, 2005, LIVER INT, V25, P723, DOI 10.1111/j.1478-3231.2005.01107.x; Chazouilleres O, 1998, HEPATOLOGY, V28, P296, DOI 10.1002/hep.510280203; Cholongitas E, 2006, TRANSPLANTATION, V81, P488, DOI 10.1097/01.tp.0000196716.07188.c4; COLOMBATO LA, 1994, GASTROENTEROLOGY, V107, P1839, DOI 10.1016/0016-5085(94)90829-X; COOK GC, 1971, Q J MED, V40, P159, DOI 10.1093/oxfordjournals.qjmed.a067264; Cookson S, 1999, HEPATOLOGY, V30, P851, DOI 10.1002/hep.510300412; Cotler SJ, 2001, J CLIN GASTROENTEROL, V32, P428, DOI 10.1097/00004836-200105000-00014; Csepregi A, 2006, WORLD J GASTROENTERO, V12, P1362, DOI 10.3748/wjg.v12.i9.1362; Cuarterolo M, 2006, J PEDIATR GASTR NUTR, V43, P635, DOI 10.1097/01.mpg.0000235975.75120.38; Czaja AJ, 2006, HEPATOLOGY, V43, P532, DOI 10.1002/hep.21074; Czaja AJ, 2005, J CLIN GASTROENTEROL, V39, P819, DOI 10.1097/01.mcg.0000177260.72692.e8; Czaja AJ, 2004, J HEPATOL, V40, P646, DOI 10.1016/j.jhep.2004.01.009; Czaja AJ, 1999, GASTROENTEROLOGY, V117, P645, DOI 10.1016/S0016-5085(99)70458-0; Czaja AJ, 2002, AM J GASTROENTEROL, V97, P2051; Czaja AJ, 2002, J HEPATOL, V37, P302, DOI 10.1016/S0168-8278(02)00182-4; CZAJA AJ, 1981, GASTROENTEROLOGY, V80, P687; CZAJA AJ, 1988, GASTROENTEROLOGY, V95, P448, DOI 10.1016/0016-5085(88)90503-3; Czaja AJ, 2001, HEPATOLOGY, V34, P659, DOI 10.1053/jhep.2001.27562; Czaja AJ, 1996, ANN INTERN MED, V125, P588, DOI 10.7326/0003-4819-125-7-199610010-00009; Czaja AJ, 1999, HEPATOLOGY, V30, P1381, DOI 10.1002/hep.510300603; Czaja AJ, 2000, GASTROENTEROLOGY, V119, P1312, DOI 10.1053/gast.2000.0010000001; Czaja AJ, 2008, HEPATOLOGY, V48, P1540, DOI 10.1002/hep.22513; Dalekos GN, 1999, J HEPATOL, V30, P366, DOI 10.1016/S0168-8278(99)80092-0; DANIELSSON A, 1994, ALIMENT PHARM THERAP, V8, P585; Debray D, 1999, J PEDIATR-US, V135, P111, DOI 10.1016/S0022-3476(99)70339-2; Djilali-Saiah I, 2006, J HEPATOL, V45, P844, DOI 10.1016/j.jhep.2006.07.034; DOHERTY DG, 1994, HEPATOLOGY, V19, P609, DOI 10.1002/hep.1840190311; Donaldson PT, 2004, GUT, V53, P599, DOI 10.1136/gut.2003.031732; Duchini A, 2000, AM J GASTROENTEROL, V95, P3238; Duclos-Vallee JC, 2003, GUT, V52, P893, DOI 10.1136/gut.52.6.893; DUCLOSVALLEE JC, 1995, DIGEST DIS SCI, V40, P1069, DOI 10.1007/BF02064201; Dufour JF, 1997, ANN INTERN MED, V127, P981, DOI 10.7326/0003-4819-127-11-199712010-00006; EUGENE C, 1980, NOUV PRESSE MED, V9, P1885; Fainboim L, 2001, HEPATOLOGY, V33, P1512, DOI 10.1053/jhep.2001.24562; FAINBOIM L, 1994, HUM IMMUNOL, V41, P146, DOI 10.1016/0198-8859(94)90008-6; Feld JJ, 2005, HEPATOLOGY, V42, P53, DOI 10.1002/hep.20732; Fernandes NF, 1999, AM J GASTROENTEROL, V94, P241; Ferri S, 2010, HEPATOLOGY, V52, P999, DOI 10.1002/hep.23792; Gautam M, 2006, LIVER TRANSPLANT, V12, P1813, DOI 10.1002/lt.20910; Gohlke F, 1996, J HEPATOL, V24, P699, DOI 10.1016/S0168-8278(96)80266-2; Goldenberg G, 2005, J DERMATOL TREAT, V16, P347, DOI 10.1080/09546630500424722; Gorham JD, 2001, J IMMUNOL, V166, P6413, DOI 10.4049/jimmunol.166.10.6413; Graziadei IW, 2003, LUPUS, V12, P409, DOI 10.1191/0961203303lu313cr; Gregorio GV, 2001, HEPATOLOGY, V33, P544, DOI 10.1053/jhep.2001.22131; Gregorio GV, 1997, HEPATOLOGY, V25, P541, DOI 10.1002/hep.510250308; Grunhage F, 2004, DIGESTION, V70, P187, DOI 10.1159/000082253; GUEGUEN M, 1988, J EXP MED, V168, P801, DOI 10.1084/jem.168.2.801; HEGARTY JE, 1983, HEPATOLOGY, V3, P685; Heneghan MA, 2006, EXPERT OPIN PHARMACO, V7, P145, DOI 10.1517/14656566.7.2.145; Heneghan MA, 2002, HEPATOLOGY, V35, P7, DOI 10.1053/jhep.2002.30991; Heneghan MA, 2001, HEPATOLOGY, V34, P464, DOI 10.1053/jhep.2001.26756; Heneghan MA, 2001, GUT, V48, P97, DOI 10.1136/gut.48.1.97; Heneghan MA, 2006, J HEPATOL, V45, P584, DOI 10.1016/j.jhep.2006.05.011; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Hennes EM, 2008, AM J GASTROENTEROL, V103, P3063, DOI 10.1111/j.1572-0241.2008.02180.x; Hilzenrat N, 1999, DIGEST DIS SCI, V44, P1950, DOI 10.1023/A:1026645629103; Hlivko JT, 2008, CLIN GASTROENTEROL H, V6, P1036, DOI 10.1016/j.cgh.2008.04.006; Hochman JA, 1998, PEDIATRICS, V101, P106, DOI 10.1542/peds.101.1.106; Hoeroldt B, 2011, GASTROENTEROLOGY, V140, P1980, DOI 10.1053/j.gastro.2011.02.065; Holdener M, 2008, J EXP MED, V205, P1409, DOI 10.1084/jem.20071859; HOMBERG JC, 1987, HEPATOLOGY, V7, P1333, DOI 10.1002/hep.1840070626; Hong YG, 1997, J CLIN GASTROENTEROL, V25, P376, DOI 10.1097/00004836-199707000-00020; Hurlburt KJ, 2002, AM J GASTROENTEROL, V97, P2402, DOI 10.1111/j.1572-0241.2002.06019.x; JOHNSON PJ, 1995, NEW ENGL J MED, V333, P958, DOI 10.1056/NEJM199510123331502; JOHNSON PJ, 1993, HEPATOLOGY, V18, P998, DOI 10.1002/hep.1840180435; Joshi S, 2002, HEPATOLOGY, V35, P409, DOI 10.1053/jhep.2002.30902; Kamiyama T, 1997, AM J GASTROENTEROL, V92, P703; Kanzler S, 1997, Z GASTROENTEROL, V35, P571; Kanzler S, 1999, J HEPATOL, V31, P635, DOI 10.1016/S0168-8278(99)80342-0; Kanzler S, 2001, J HEPATOL, V34, P354, DOI 10.1016/S0168-8278(00)00095-7; Kerkar N, 1998, LANCET, V351, P409, DOI 10.1016/S0140-6736(97)06478-7; Kerkar N, 2003, J IMMUNOL, V170, P1481, DOI 10.4049/jimmunol.170.3.1481; Kido M, 2008, GASTROENTEROLOGY, V135, P1333, DOI 10.1053/j.gastro.2008.06.042; KIRK AP, 1980, GUT, V21, P78, DOI 10.1136/gut.21.1.78; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kosar Y, 2001, EUR J GASTROEN HEPAT, V13, P737; Langley PG, 2002, J HEPATOL, V37, P441, DOI 10.1016/S0168-8278(02)00214-3; Lapierre P, 2004, HEPATOLOGY, V39, P1066, DOI 10.1002/hep.20109; LeCann P, 1997, SCAND J GASTROENTERO, V32, P387, DOI 10.3109/00365529709007689; Lim KN, 2001, AM J GASTROENTEROL, V96, P3390, DOI 10.1111/j.1572-0241.2001.05272.x; LOBOYEO A, 1990, HEPATOLOGY, V12, P224, DOI 10.1002/hep.1840120208; Lohse AW, 1998, HEPATOLOGY, V27, P1536, DOI 10.1002/hep.510270611; Lohse AW, 1999, HEPATOLOGY, V29, P1078, DOI 10.1002/hep.510290409; Longhi MS, 2011, HEPATOLOGY, V53, P536, DOI 10.1002/hep.24039; Longhi MS, 2009, HEPATOLOGY, V50, P130, DOI 10.1002/hep.22914; Longhi MS, 2005, J AUTOIMMUN, V25, P63, DOI 10.1016/j.jaut.2005.05.001; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Ma Y, 2002, HEPATOLOGY, V35, P658, DOI 10.1053/jhep.2002.32092; Malekzadeh R, 2001, DIGEST DIS SCI, V46, P1321, DOI 10.1023/A:1010683817344; MANNS M, 1987, LANCET, V1, P292; Manns MP, 2010, GASTROENTEROLOGY, V139, P1198, DOI 10.1053/j.gastro.2010.06.046; MANNS MP, 1989, J CLIN INVEST, V83, P1066, DOI 10.1172/JCI113949; MANNS MP, 1991, J CLIN INVEST, V88, P1370, DOI 10.1172/JCI115443; MANNS MP, 1993, INTERVIROLOGY, V35, P108, DOI 10.1159/000150301; McFarlane Ian G, 2002, Clin Liver Dis, V6, P605, DOI 10.1016/S1089-3261(02)00019-3; Mieli-Vergani G, 2004, J HEPATOL, V40, P3, DOI 10.1016/j.jhep.2003.10.022; Miyake Y, 2006, ALIMENT PHARM THER, V23, P1347, DOI 10.1111/j.1365-2036.2006.02894.x; Miyake Y, 2005, J HEPATOL, V43, P951, DOI 10.1016/j.jhep.2005.06.006; Montano-Loza AJ, 2008, AM J GASTROENTEROL, V103, P1944, DOI 10.1111/j.1572-0241.2008.01922.x; Montano-Loza AJ, 2007, AM J GASTROENTEROL, V102, P1005, DOI 10.1111/j.1572-0241.2007.01153.x; MURRAYLYON IM, 1973, LANCET, V1, P735; Nakamura K, 1998, J GASTROEN HEPATOL, V13, P490, DOI 10.1111/j.1440-1746.1998.tb00674.x; NEUBERGER J, 1984, TRANSPLANTATION, V37, P363, DOI 10.1097/00007890-198404000-00009; Poupon R, 2006, HEPATOLOGY, V44, P85, DOI 10.1002/hep.21229; Primo J, 2009, ACTA GASTRO-ENT BELG, V72, P402; Ramakrishna J, 2009, J CLIN GASTROENTEROL, V43, P787, DOI 10.1097/MCG.0b013e31818c8801; Richardson PD, 2000, J HEPATOL, V33, P371, DOI 10.1016/S0168-8278(00)80271-8; Roberts MS, 2004, LIVER TRANSPLANT, V10, P886, DOI 10.1002/lt.20137; Samuel D, 2004, CLIN GASTROENTEROL H, V2, P622, DOI 10.1016/S1542-3565(04)00245-9; Santos ES, 2006, LIVER INT, V26, P625, DOI 10.1111/j.1478-3231.2006.01262.x; Schramm C, 2006, AM J GASTROENTEROL, V101, P556, DOI 10.1111/j.1572-0241.2006.00479.x; Schramm C, 2001, AM J GASTROENTEROL, V96, P1587; SCHVARCZ R, 1993, J HEPATOL, V18, P15, DOI 10.1016/S0168-8278(05)80005-4; Sciveres M, 2004, ALIMENT PHARM THER, V19, P209, DOI 10.1046/j.1365-2036.2003.01754.x; SCULLY LJ, 1993, DIGEST DIS SCI, V38, P744, DOI 10.1007/BF01316809; SEKI T, 1992, GASTROENTEROLOGY, V103, P1041, DOI 10.1016/0016-5085(92)90041-V; SHERMAN KE, 1994, J HEPATOL, V21, P1040, DOI 10.1016/S0168-8278(05)80615-4; Sipe WEB, 2006, PEDIATR TRANSPLANT, V10, P525, DOI 10.1111/j.1399-3046.2006.00487.x; SOLOWAY RD, 1972, GASTROENTEROLOGY, V63, P820; STELLON AJ, 1988, HEPATOLOGY, V8, P781, DOI 10.1002/hep.1840080414; STELLON AJ, 1985, LANCET, V1, P668; STEVEN MM, 1979, Q J MED, V48, P519; Stravitz RT, 2011, HEPATOLOGY, V53, P517, DOI 10.1002/hep.24080; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; TREICHEL U, 1994, GASTROENTEROLOGY, V107, P799, DOI 10.1016/0016-5085(94)90129-5; VANTHIEL DH, 1995, AM J GASTROENTEROL, V90, P771; Vento S, 1997, LANCET, V350, P1298, DOI 10.1016/S0140-6736(05)62476-2; Vento S, 2004, AUTOIMMUN REV, V3, P61, DOI 10.1016/S1568-9972(03)00053-3; VENTO S, 1995, LANCET, V346, P608, DOI 10.1016/S0140-6736(95)91438-2; VENTO S, 1991, LANCET, V337, P1183, DOI 10.1016/0140-6736(91)92858-Y; Vento S, 1996, AM J GASTROENTEROL, V91, P2618; Vergani D, 2004, J HEPATOL, V41, P677, DOI 10.1016/j.jhep.2004.08.002; Verma S, 2006, J HEPATOL, V44, P819, DOI 10.1016/j.jhep.2005.11.050; Verma S, 2007, HEPATOLOGY, V46, P1828, DOI 10.1002/hep.21884; Vogel A, 2002, HEPATOLOGY, V35, P126, DOI 10.1053/jhep.2002.30084; Vogel A, 2001, HEPATOLOGY, V33, P1047, DOI 10.1053/jhep.2001.24031; WALDENSTROM J, 1950, DTSCH GES VERDAU STO, V15, P113, DOI DOI 10.1016/S0168-8278(02)00408-7; WATANABE Y, 1987, CLIN EXP IMMUNOL, V67, P105; WEN L, 1990, LANCET, V336, P1527, DOI 10.1016/0140-6736(90)93306-A; Werner M, 2009, J HEPATOL, V50, P388, DOI 10.1016/j.jhep.2008.08.022; Westbrook RH, 2012, J AUTOIMMUN, V38, pJ239, DOI 10.1016/j.jaut.2011.12.002; Wiegand J, 2005, LIVER INT, V25, P927, DOI 10.1111/j.1478-3231.2005.01122.x; Wies I, 2000, LANCET, V355, P1510, DOI 10.1016/S0140-6736(00)02166-8; Yamauchi K, 2004, HEPATOLOGY, V40, P687, DOI 10.1002/hep.20377; Yeoman AD, 2008, HEPATOLOGY, V48, P863, DOI 10.1002/hep.22432; Yeoman AD, 2009, HEPATOLOGY, V50, P538, DOI 10.1002/hep.23042; Yokosawa S, 2007, HEPATOLOGY, V45, P384, DOI 10.1002/hep.21518; Yoshizawa K, 2005, J HEPATOL, V42, P578, DOI 10.1016/j.jhep.2004.12.019; Zandieh I, 2008, CAN J GASTROENTEROL, V22, P388, DOI 10.1155/2008/509459; ZANGER UM, 1988, P NATL ACAD SCI USA, V85, P8256, DOI 10.1073/pnas.85.21.8256; Zolfino T, 2002, GUT, V50, P713, DOI 10.1136/gut.50.5.713	174	169	183	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2013	382	9902					1433	1444		10.1016/S0140-6736(12)62163-1	http://dx.doi.org/10.1016/S0140-6736(12)62163-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242JW	23768844				2022-12-28	WOS:000326237500028
J	Tusting, LS; Willey, B; Lucas, H; Thompson, J; Kafy, HT; Smith, R; Lindsay, SW				Tusting, Lucy S.; Willey, Barbara; Lucas, Henry; Thompson, John; Kafy, Hmooda T.; Smith, Richard; Lindsay, Steve W.			Socioeconomic development as an intervention against malaria: a systematic review and meta-analysis	LANCET			English	Review							CROSS-SECTIONAL SURVEY; RISK-FACTORS; YOUNG-CHILDREN; BURDEN; TANZANIA; ANEMIA; GHANA; AREA; TRANSMISSION; PARASITEMIA	Background Future progress in tackling malaria mortality will probably be hampered by the development of resistance to drugs and insecticides and by the contraction of aid budgets. Historically, control was often achieved without malaria-specific interventions. Our aim was to assess whether socioeconomic development can contribute to malaria control. Methods We did a systematic review and meta-analysis to assess whether the risk of malaria in children aged 0-15 years is associated with socioeconomic status. We searched Medline, Web of Science, Embase, the Cochrane Database of Systematic Reviews, the Campbell Library, the Centre for Reviews and Dissemination, Health Systems Evidence, and the Evidence for Policy and Practice Information and Co-ordinating Centre evidence library for studies published in English between Jan 1, 1980, and July 12, 2011, that measured socioeconomic status and parasitologically confirmed malaria or clinical malaria in children. Unadjusted and adjusted effect estimates were combined in fixed-effects and random-effects meta-analyses, with a subgroup analysis for different measures of socioeconomic status. We used funnel plots and Egger's linear regression to test for publication bias. Findings Of 4696 studies reviewed, 20 met the criteria for inclusion in the qualitative analysis, and 15 of these reported the necessary data for inclusion in the meta-analysis. The odds of malaria infection were higher in the poorest children than in the least poor children (unadjusted odds ratio [OR] 1.66, 95% CI 1.35-2.05, p<0.001, I-2 = 68%; adjusted OR 2.06, 1.42-2.97, p<0.001, I-2 = 63%), an effect that was consistent across subgroups. Interpretation Although we would not recommend discontinuation of existing malaria control efforts, we believe that increased investment in interventions to support socioeconomic development is warranted, since such interventions could prove highly effective and sustainable against malaria in the long term.	[Tusting, Lucy S.; Willey, Barbara; Smith, Richard] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Lucas, Henry; Thompson, John] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England; [Kafy, Hmooda T.] Fed Minist Hlth, Natl Malaria Control Programme, Khartoum, Sudan; [Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	University of London; London School of Hygiene & Tropical Medicine; University of Sussex; Durham University	Lindsay, SW (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	s.w.lindsay@durham.ac.uk		Smith, Richard/0000-0003-3837-6559; Tusting, Lucy/0000-0002-6897-8625; Lindsay, Steve/0000-0002-3461-9050	UK Department for International Development; ESRC [ES/I021620/1] Funding Source: UKRI; MRC [G0700837] Funding Source: UKRI; Economic and Social Research Council [ES/I021620/1] Funding Source: researchfish; Medical Research Council [G0700837] Funding Source: researchfish	UK Department for International Development; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Department for International Development.	Ahmed SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-173; Al-Taiar A, 2009, T ROY SOC TROP MED H, V103, P72, DOI 10.1016/j.trstmh.2008.09.010; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P177; Baragatti M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-13; Barat LM, 2004, AM J TROP MED HYG, V71, P174, DOI 10.4269/ajtmh.2004.71.174; Bruce-Chwatt LJ, 1980, RISE FALL MALARIA EU; Chuma JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-76; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Custodio E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-225; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gahutu JB, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-134; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; GARCIAMARTIN G, 1972, AM J TROP MED HYG, V21, P617, DOI 10.4269/ajtmh.1972.21.617; Garrett L, 2012, NATURE, V482, P7, DOI 10.1038/482007a; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Gingrich CD, 2011, SOC SCI MED, V73, P160, DOI 10.1016/j.socscimed.2011.04.028; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Jetten TH., 1994, ANOPHELISM MALARIA E; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Kidson C, 1998, Parassitologia, V40, P39; Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3; Klinkenberg E, 2006, TROP MED INT HEALTH, V11, P578, DOI 10.1111/j.1365-3156.2006.01609.x; KORAM KA, 1995, T ROY SOC TROP MED H, V89, P146, DOI 10.1016/0035-9203(95)90471-9; Krefis AC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-201; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Mandelbaum-Schmid J, 2004, B WORLD HEALTH ORGAN, V82, P554; Matovu F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-109; Matthys B, 2006, AM J TROP MED HYG, V75, P1223, DOI 10.4269/ajtmh.2006.75.1223; Modher D, 2009, PLOS MED, V6; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Onwujekwe O, 2010, TROP MED INT HEALTH, V15, P18, DOI 10.1111/j.1365-3156.2009.02418.x; Pullan RL, 2011, J INFECT DIS, V203, P406, DOI 10.1093/infdis/jiq063; Pullan RL, 2010, MALARIA J, V4, P9; Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Roll Back Malaria, 2010, ROLL BACK MAL MAL EN; Ronald LA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-105; Saaka Mahama, 2009, East Afr J Public Health, V6, P55; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sachs J.D., 2001, MACROECONOMICS HLTH; Sicuri E, 2012, HEALTH POLICY PLANN, V27, P339, DOI 10.1093/heapol/czr046; Sinden RE, 2007, B WORLD HEALTH ORGAN, V85, P894, DOI 10.2471/BLT.04.020735; Slutsker L, 1996, AM J TROP MED HYG, V55, P71, DOI 10.4269/ajtmh.1996.55.71; Somi MF, 2007, AM J TROP MED HYG, V77, P1020, DOI 10.4269/ajtmh.2007.77.1020; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; UNDP, MILL DEV GOAL 6 FOC; United Nations Development Programme (UNDP), INT HUM DEV IND; van den Berg H, 2012, WHO GUIDANCE POLICY; Villamor E, 2003, TROP MED INT HEALTH, V8, P1051, DOI 10.1046/j.1360-2276.2003.01134.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Winskill P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-98; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x; Yamamoto S, 2010, T ROY SOC TROP MED H, V104, P61, DOI 10.1016/j.trstmh.2009.07.003	62	121	123	2	51	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2013	382	9896					963	972		10.1016/S0140-6736(13)60851-X	http://dx.doi.org/10.1016/S0140-6736(13)60851-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VD	23790353	Green Accepted			2022-12-28	WOS:000324238000029
J	Halpern, SD				Halpern, Scott D.			Turning Wrong Into Right: The 2013 Lung Allocation Controversy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRANSPLANTATION; SINGLE		Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, 719 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	shalpern@exchange.upenn.edu			Greenwall Foundation Faculty Scholar Award in Bioethics	Greenwall Foundation Faculty Scholar Award in Bioethics	The author was supported by a Greenwall Foundation Faculty Scholar Award in Bioethics.	Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Halpern SD, 2008, NEW ENGL J MED, V358, P2832, DOI 10.1056/NEJMsb0800674; Halpern Scott D, 2013, Ann Am Thorac Soc, V10, P73, DOI 10.1513/AnnalsATS.201211-109OC; Munson JC, 2011, AM J RESP CRIT CARE, V184, P1282, DOI 10.1164/rccm.201104-0695OC; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Thabut G, 2009, ANN INTERN MED, V151, P767, DOI 10.7326/0003-4819-151-11-200912010-00004; Young MJ, 2012, CRIT CARE MED, V40, P261, DOI 10.1097/CCM.0b013e31822d750d	7	8	8	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2013	159	5					358	+		10.7326/0003-4819-159-5-201309030-00684	http://dx.doi.org/10.7326/0003-4819-159-5-201309030-00684			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215YA	23797998				2022-12-28	WOS:000324245900007
J	Blaschke, K; Ebata, KT; Karimi, MM; Zepeda-Martinez, JA; Goyal, P; Mahapatra, S; Tam, A; Laird, DJ; Hirst, M; Rao, A; Lorincz, MC; Ramalho-Santos, M				Blaschke, Kathryn; Ebata, Kevin T.; Karimi, Mohammad M.; Zepeda-Martinez, Jorge A.; Goyal, Preeti; Mahapatra, Sahasransu; Tam, Angela; Laird, Diana J.; Hirst, Martin; Rao, Anjana; Lorincz, Matthew C.; Ramalho-Santos, Miguel			Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells	NATURE			English	Article							GROUND-STATE; METHYLATION; 5-HYDROXYMETHYLCYTOSINE; DYNAMICS; GENES; PLURIPOTENCY; DIOXYGENASE; GENERATION; PARALLEL; TOOL	DNA methylation is a heritable epigenetic modification involved in gene silencing, imprinting, and the suppression of retrotransposons(1). Global DNA demethylation occurs in the early embryo and the germ line(2,3), and may be mediated by Tet (ten eleven translocation) enzymes(4-6), which convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC)(7). Tet enzymes have been studied extensively in mouse embryonic stem (ES) cells(8-12), which are generally cultured in the absence of vitamin C, a potential cofactor for Fe(II) 2-oxoglutarate dioxygenase enzymes such as Tet enzymes. Here we report that addition of vitamin C to mouse ES cells promotes Tet activity, leading to a rapid and global increase in 5hmC. This is followed by DNA demethylation of many gene promoters and upregulation of demethylated germline genes. Tet1 binding is enriched near the transcription start site of genes affected by vitamin C treatment. Importantly, vitamin C, but not other antioxidants, enhances the activity of recombinant Tet1 in a biochemical assay, and the vitamin-C-induced changes in 5hmC and 5mC are entirely suppressed in Tet1 and Tet2 double knockout ES cells. Vitamin C has a stronger effect on regions that gain methylation in cultured ES cells compared to blastocysts, and in vivo are methylated only after implantation. In contrast, imprinted regions and intracisternal A particle retroelements, which are resistant to demethylation in the early embryo(2,13), are resistant to vitamin-C-induced DNA demethylation. Collectively, the results of this study establish vitamin C as a direct regulator of Tet activity and DNA methylation fidelity in ES cells.	[Blaschke, Kathryn; Ebata, Kevin T.; Laird, Diana J.; Ramalho-Santos, Miguel] Univ Calif San Francisco, Dept Obstet & Gynecol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Blaschke, Kathryn; Ebata, Kevin T.; Laird, Diana J.; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Karimi, Mohammad M.; Goyal, Preeti; Lorincz, Matthew C.] Univ British Columbia, Dept Med Genet, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Karimi, Mohammad M.; Tam, Angela; Hirst, Martin] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Zepeda-Martinez, Jorge A.; Mahapatra, Sahasransu; Rao, Anjana] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Zepeda-Martinez, Jorge A.; Mahapatra, Sahasransu; Rao, Anjana] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Hirst, Martin] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of British Columbia; British Columbia Cancer Agency; La Jolla Institute for Immunology; University of British Columbia	Lorincz, MC (corresponding author), Univ British Columbia, Dept Med Genet, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada.	mlorincz@mail.ubc.ca; mrsantos@diabetes.ucsf.edu	Laird, Diana/Y-4387-2019; Hirst, Martin/B-7684-2016; Ramalho-Santos, Miguel/L-9092-2018	Ramalho-Santos, Miguel/0000-0003-0177-5556; Ebata, Kevin/0000-0001-7166-7513; Lorincz, Matthew/0000-0003-0885-0467; Karimi, Mohammad Mahdi/0000-0001-5017-1252	NSF; California Institute of Regenerative Medicine postdoctoral training grant [TG2-01153]; Michael Smith Foundation for Health Research; CIHR [92093]; NIH [HD065812, CA151535, DP2OD004698, OD012204]; California Institute of Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA151535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007420, DP2OD004698, R01OD012204] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); California Institute of Regenerative Medicine postdoctoral training grant; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors wish to acknowledge the epigenomics and sequencing groups at the Michael Smith Genome Sciences Centre, Canada, for performing 5mC DIP and 5hmC DIP Illumina sequencing, as well as for technical support. We thank C. -J. Lin for technical advice on isolation of blastocysts. We particularly thank M. M. Dawlaty and R. Jaenisch for the Tet1<SUP>-/-</SUP> and Tet1<SUP>-/-</SUP> Tet2<SUP>-/-</SUP> ES cells. We also wish to thank M. Okano for the Dnmt1<SUP>-/-</SUP> Dnmt3a<SUP>-/-</SUP> Dnmt3b<SUP>-/-</SUP> ES cells. We thank J. S. Song for statistical advice, as well as M. Conti, S. Lomvardas, J. Costello and members of the Ramalho-Santos laboratory for critical reading of the manuscript. K. B. is a recipient of an NSF pre-doctoral fellowship and K. T. E. is supported by a California Institute of Regenerative Medicine postdoctoral training grant (TG2-01153). M. M. K. is supported by a postdoctoral fellowship from the Michael Smith Foundation for Health Research. M. C. L. is supported by a CIHR New Investigator Award. This work was funded by a CIHR grant (92093) to M. C. L. and M. H., NIH grants HD065812 and CA151535, a grant from the California Institute of Regenerative Medicine to A. R., and an NIH New Innovator Award (DP2OD004698) and R01 (OD012204) to M.R.-S.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Younesy H, 2013, COMPUT GRAPH FORUM, V32, P91, DOI 10.1111/cgf.12096	42	563	583	7	225	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					222	+		10.1038/nature12362	http://dx.doi.org/10.1038/nature12362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23812591	Green Accepted, Green Submitted			2022-12-28	WOS:000322825500038
J	Hasuwa, H; Ueda, J; Ikawa, M; Okabe, M				Hasuwa, Hidetoshi; Ueda, Jun; Ikawa, Masahito; Okabe, Masaru			MiR-200b and miR-429 Function in Mouse Ovulation and Are Essential for Female Fertility	SCIENCE			English	Article							MICRORNAS; MICE; INFERTILITY; FAMILY; CELLS; ZEB1	Ovulation in the mouse and other mammals is controlled by hormones secreted by the hypothalamo-pituitary-ovarian axis. We describe anovulation and infertility in female mice lacking the microRNAs miR-200b and miR-429. Both miRNAs are strongly expressed in the pituitary gland, where they suppress expression of the transcriptional repressor ZEB1. Eliminating these miRNAs, in turn, inhibits luteinizing hormone (LH) synthesis by repressing transcription of its beta-subunit gene, which leads to lowered serum LH concentration, an impaired LH surge, and failure to ovulate. Our results reveal roles for miR-200b and miR-429, and their target the Zeb1 gene, in the regulation of mammalian reproduction. Thus, the hypothalamo-pituitary-ovarian axis was shown to require miR-200b and miR-429 to support ovulation.	[Hasuwa, Hidetoshi; Ueda, Jun; Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Osaka University	Okabe, M (corresponding author), Osaka Univ, Microbial Dis Res Inst, Yamadaoka 3-1, Suita, Osaka 5650871, Japan.	okabe@biken.osaka-u.ac.jp	ikawa, masahito/A-5315-2009; Hasuwa, Hidetoshi/B-1083-2009; Ueda, Jun/AAX-9704-2020; Ueda, Jun/G-1670-2010; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Ueda, Jun/0000-0002-9766-203X; Ueda, Jun/0000-0002-9766-203X; Okabe, Masaru/0000-0002-0803-9044	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science KAKENHI [20062008, 20700364, 18700397, 24115710]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the late N. B. Hecht for critical reading of the manuscript and Y. Esaki and Y. Maruyama for preparing the KO and TG mice. We also thank T. Miyazawa and T. Yoshida of Kyowa Hakko Kirin Co., Ltd. for analyzing the miRNA target predictions. This work was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Society for the Promotion of Science KAKENHI; grant numbers 20062008, 20700364, 18700397, and 24115710. The miR-DKO mice (RBRC05917) are available from RIKEN BioResource Center with a materials transfer agreement.	Alarid ET, 1996, DEVELOPMENT, V122, P3319; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Christian CA, 2005, P NATL ACAD SCI USA, V102, P15682, DOI 10.1073/pnas.0504270102; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kubosaki A, 2006, ENDOCRINOLOGY, V147, P811, DOI 10.1210/en.2005-0638; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	16	122	132	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					71	73		10.1126/science.1237999	http://dx.doi.org/10.1126/science.1237999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23765281				2022-12-28	WOS:000321291700050
J	Belnap, J				Belnap, Jayne			Some Like It Hot, Some Not	SCIENCE			English	Editorial Material							MICROBIAL BIOGEOGRAPHY		US Geol Survey, Moab, UT 84532 USA	United States Department of the Interior; United States Geological Survey	Belnap, J (corresponding author), US Geol Survey, 2290 South Resource Blvd, Moab, UT 84532 USA.	jayne_belnap@usgs.gov						Belnap J., 2003, ECOLOGICAL STUDIES S, V2nd; Belnap J, 2003, BIOL SOIL CRUSTS STR, P241, DOI DOI 10.1007/978-3-642-56475-8_; Collins SL, 2008, J ECOL, V96, P413, DOI 10.1111/j.1365-2745.2008.01362.x; Elbert W, 2012, NAT GEOSCI, V5, P459, DOI 10.1038/ngeo1486; Garcia-Pichel F, 2013, SCIENCE, V340, P1574, DOI 10.1126/science.1236404; Garcia-Pichel F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007801; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Marusenko Y., 2013, ECOL PROCESS, V2, P9, DOI DOI 10.1186/2192-1709-2-9; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pointing SB, 2012, NAT REV MICROBIOL, V10, P551, DOI 10.1038/nrmicro2831	11	10	10	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1533	1534		10.1126/science.1240318	http://dx.doi.org/10.1126/science.1240318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172ME	23812706				2022-12-28	WOS:000321007000026
J	Mac Low, MM				Mac Low, Mordecai-Mark			From Gas to Stars Over Cosmic Time	SCIENCE			English	Review							CO-H2 CONVERSION FACTOR; ISOLATED DISK GALAXIES; GAMMA-RAY BURST; MOLECULAR CLOUDS; NEARBY GALAXIES; FORMATION LAW; DARK-MATTER; HYDRODYNAMIC SIMULATIONS; FORMATION EFFICIENCY; INTERSTELLAR-MEDIUM	From the time the first stars formed over 13 billion years ago to the present, star formation has had an unexpectedly dynamic history. At first, the star-formation rate density increased dramatically, reaching a peak 10 billion years ago of more than 10 times the present-day value. Observations of the initial rise in star formation remain difficult, poorly constraining it. Theoretical modeling has trouble predicting this history because of the difficulty in following the feedback of energy from stellar radiation and supernova explosions into the gas from which further stars form. Observations from the ground and space with the next generation of instruments should reveal the full history of star formation in the universe, and simulations appear poised to accurately predict the observed history.	[Mac Low, Mordecai-Mark] Amer Museum Nat Hist, Dept Astrophys, New York, NY 10024 USA; [Mac Low, Mordecai-Mark] Heidelberg Univ, Zentrum Astrophys, Inst Theoret Astrophys, D-69121 Heidelberg, Germany	American Museum of Natural History (AMNH); Ruprecht Karls University Heidelberg	Mac Low, MM (corresponding author), Amer Museum Nat Hist, Dept Astrophys, 79th St & Cent Pk West, New York, NY 10024 USA.	mordecai@amnh.org	Low, Mordecai-Mark Mac/AAN-1967-2021	Low, Mordecai-Mark Mac/0000-0003-0064-4060	NSF [AST11-09395]; NASA Chandra Theory grant [TMO-11008X]; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 881]; Direct For Mathematical & Physical Scien [1109395] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA Chandra Theory grant; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	An early version of this review was presented at International Astronomical Union Symposium 292 (121). I have benefited over the past 15 years from discussions and collaborations on these topics with M. A. Avillez, B. G. Elmegreen, C. Federrath, S. C. O. Glover, F. Heitsch, A. S. Hill, M. R. Joung, R. S. Klessen, M. R. Krumholz, Yuexing Li, T. Peters, and E. Vazquez-Semadeni. I thank J. Beacom, C. Federrath, S. C. O. Glover, and J. C. Ibanez Mejia for useful comments on the manuscript and the anonymous referees for detailed and constructive reviews that improved this work. I was partially supported by NSF grant AST11-09395, NASA Chandra Theory grant TMO-11008X, and Deutsche Forschungsgemeinschaft (DFG) Sonderforschungsbereich 881-The Milky Way System.	Agertz O, 2009, MON NOT R ASTRON SOC, V397, pL64, DOI 10.1111/j.1745-3933.2009.00685.x; Balbus SA, 1998, REV MOD PHYS, V70, P1, DOI 10.1103/RevModPhys.70.1; Bigiel F, 2008, ASTRON J, V136, P2846, DOI 10.1088/0004-6256/136/6/2846; Bigiel F, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/2/L13; Boissier S, 2007, ASTROPHYS J SUPPL S, V173, P524, DOI 10.1086/516642; BOND JR, 1991, ASTROPHYS J, V379, P440, DOI 10.1086/170520; Bournaud F, 2010, MON NOT R ASTRON SOC, V409, P1088, DOI 10.1111/j.1365-2966.2010.17370.x; Bouwens RJ, 2012, ASTROPHYS J LETT, V752, DOI 10.1088/2041-8205/752/1/L5; Bouwens RJ, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/90; Bromm V, 2011, ANNU REV ASTRON ASTR, V49, P373, DOI 10.1146/annurev-astro-081710-102608; Buchhave LA, 2012, NATURE, V486, P375, DOI 10.1038/nature11121; Cen R, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/99; CEN RY, 1993, ASTROPHYS J, V417, P404, DOI 10.1086/173321; CHANDRASEKHAR S, 1951, PROC R SOC LON SER-A, V210, P26, DOI 10.1098/rspa.1951.0228; Christensen C, 2012, MON NOT R ASTRON SOC, V425, P3058, DOI 10.1111/j.1365-2966.2012.21628.x; Costa E, 1997, NATURE, V387, P783, DOI 10.1038/42885; Crosthwaite LP, 2007, ASTRON J, V134, P1827, DOI 10.1086/521645; Dale JE, 2007, MON NOT R ASTRON SOC, V377, P535, DOI 10.1111/j.1365-2966.2007.11515.x; DALGARNO A, 1972, ANNU REV ASTRON ASTR, V10, P375, DOI 10.1146/annurev.aa.10.090172.002111; Dawson JR, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/56; Dobbs CL, 2011, MON NOT R ASTRON SOC, V417, P1318, DOI 10.1111/j.1365-2966.2011.19346.x; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; ELMEGREEN BG, 1994, ASTROPHYS J, V435, pL121, DOI 10.1086/187609; ELMEGREEN BG, 1977, ASTROPHYS J, V214, P725, DOI 10.1086/155302; Elmegreen BG, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/10; Elmegreen DM, 2009, ASTROPHYS J, V701, P306, DOI 10.1088/0004-637X/701/1/306; European Southern Observatory, 2009, EXP VIEW UN SCI EUR; Fall SM, 2010, ASTROPHYS J LETT, V710, pL142, DOI 10.1088/2041-8205/710/2/L142; Federrath C, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/51; Federrath C, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/156; FIELD GB, 1965, ASTROPHYS J, V142, P531, DOI 10.1086/148317; Fryxell B, 2000, ASTROPHYS J SUPPL S, V131, P273, DOI 10.1086/317361; Gammie C. F., 1992, THESIS PRINCETON U P; Gao Y, 2004, ASTROPHYS J, V606, P271, DOI 10.1086/382999; Gardner JP, 2006, SPACE SCI REV, V123, P485, DOI 10.1007/s11214-006-8315-7; GEROLA H, 1978, ASTROPHYS J, V223, P129, DOI 10.1086/156243; Getman KV, 2012, MON NOT R ASTRON SOC, V426, P2917, DOI 10.1111/j.1365-2966.2012.21879.x; Glover SCO, 2011, MON NOT R ASTRON SOC, V412, P337, DOI 10.1111/j.1365-2966.2010.17907.x; Glover SCO, 2007, ASTROPHYS J, V659, P1317, DOI 10.1086/512227; Glover SCO, 2012, MON NOT R ASTRON SOC, V426, P377, DOI 10.1111/j.1365-2966.2012.21737.x; Glover SCO, 2012, MON NOT R ASTRON SOC, V421, P9, DOI 10.1111/j.1365-2966.2011.19648.x; Gnedin NY, 2010, ASTROPHYS J, V714, P287, DOI 10.1088/0004-637X/714/1/287; Goldbaum NJ, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/101; Governato F, 2012, MON NOT R ASTRON SOC, V422, P1231, DOI 10.1111/j.1365-2966.2012.20696.x; Heiderman A, 2010, ASTROPHYS J, V723, P1019, DOI 10.1088/0004-637X/723/2/1019; Hill AS, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/104; HOLLENBACH D, 1971, ASTROPHYS J, V163, P155, DOI 10.1086/150754; Hopkins AM, 2006, ASTROPHYS J, V651, P142, DOI 10.1086/506610; Hopkins PF, 2011, MON NOT R ASTRON SOC, V417, P950, DOI 10.1111/j.1365-2966.2011.19306.x; Hummels CB, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/140; Jarosik N, 2011, ASTROPHYS J SUPPL S, V192, P1, DOI 10.1088/0067-0049/192/2/14; Jeans JH, 1902, PHILOS T R SOC LOND, V199, P1, DOI 10.1098/rsta.1902.0012; Joung MR, 2009, ASTROPHYS J, V704, P137, DOI 10.1088/0004-637X/704/1/137; Karim A, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/61; Katz N, 1996, ASTROPHYS J SUPPL S, V105, P19, DOI 10.1086/192305; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Kennicutt RC, 2003, PUBL ASTRON SOC PAC, V115, P928, DOI 10.1086/376941; Kennicutt RC, 2007, ASTROPHYS J, V671, P333, DOI 10.1086/522300; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Keres D, 2009, MON NOT R ASTRON SOC, V396, P2332, DOI 10.1111/j.1365-2966.2009.14924.x; Kim CG, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/25; Kistler MD, 2009, ASTROPHYS J LETT, V705, pL104, DOI 10.1088/0004-637X/705/2/L104; Klessen RS, 2010, ASTRON ASTROPHYS, V520, DOI 10.1051/0004-6361/200913780; Klessen RS, 2000, ASTROPHYS J, V535, P887, DOI 10.1086/308891; Kravtsov AV, 1997, ASTROPHYS J SUPPL S, V111, P73, DOI 10.1086/313015; Krumholz MR, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/155; Krumholz MR, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/9; Krumholz MR, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/25; Krumholz MR, 2009, ASTROPHYS J, V699, P850, DOI 10.1088/0004-637X/699/1/850; Lada CJ, 2010, ASTROPHYS J, V724, P687, DOI 10.1088/0004-637X/724/1/687; Leroy AK, 2008, ASTRON J, V136, P2782, DOI 10.1088/0004-6256/136/6/2782; Li YX, 2005, ASTROPHYS J, V626, P823, DOI 10.1086/430205; Li YX, 2006, ASTROPHYS J, V639, P879, DOI 10.1086/499350; Lilly SJ, 1996, ASTROPHYS J, V460, pL1, DOI 10.1086/309975; Lynden-Bell D, 1965, MNRAS, V130, P97, DOI DOI 10.1093/MNRAS/130.2.97; Mac Low M.-M., 2013, MOL GAS DUST STAR FO, P3; Mac Low MM, 1999, ASTROPHYS J, V524, P169, DOI 10.1086/307784; Mac Low MM, 2004, REV MOD PHYS, V76, P125, DOI 10.1103/RevModPhys.76.125; MACLOW MM, 1989, ASTROPHYS J, V337, P141, DOI 10.1086/167094; Madau P, 1996, MON NOT R ASTRON SOC, V283, P1388, DOI 10.1093/mnras/283.4.1388; Moster BP, 2013, MON NOT R ASTRON SOC, V428, P3121, DOI 10.1093/mnras/sts261; Murray N, 2010, ASTROPHYS J, V709, P191, DOI 10.1088/0004-637X/709/1/191; Narayanan D, 2012, MON NOT R ASTRON SOC, V421, P3127, DOI 10.1111/j.1365-2966.2012.20536.x; Narayanan D, 2011, MON NOT R ASTRON SOC, V418, P664, DOI 10.1111/j.1365-2966.2011.19516.x; OShea B. W., 2004, LECT NOTES COMPUTATI, P341; Ostriker EC, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/41; Ostriker EC, 2010, ASTROPHYS J, V721, P975, DOI 10.1088/0004-637X/721/2/975; Padoan P, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/2/L27; Petric AO, 2007, ASTRON J, V134, P1952, DOI 10.1086/518558; Piontek RA, 2007, ASTROPHYS J, V663, P183, DOI 10.1086/518103; PRESS WH, 1974, ASTROPHYS J, V187, P425, DOI 10.1086/152650; Rafikov RR, 2001, MON NOT R ASTRON SOC, V323, P445, DOI 10.1046/j.1365-8711.2001.04201.x; Robertson BE, 2008, ASTROPHYS J, V680, P1083, DOI 10.1086/587796; Robertson BE, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/95; Romeo AB, 2011, MON NOT R ASTRON SOC, V416, P1191, DOI 10.1111/j.1365-2966.2011.19120.x; Rownd BK, 1999, ASTRON J, V118, P670, DOI 10.1086/300957; Safronov V.S., 1960, ANAP, V23, P979; Schaye J, 2004, ASTROPHYS J, V609, P667, DOI 10.1086/421232; Schruba A, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/2/37; Schuster KF, 2007, ASTRON ASTROPHYS, V461, P143, DOI 10.1051/0004-6361:20065579; Sellwood JA, 1999, ASTROPHYS J, V511, P660, DOI 10.1086/306728; Shetty R, 2013, MON NOT R ASTRON SOC, V430, P288, DOI 10.1093/mnras/sts617; Shetty R, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/2; Shetty R, 2011, MON NOT R ASTRON SOC, V412, P1686, DOI 10.1111/j.1365-2966.2010.18005.x; SMOOT GF, 1992, ASTROPHYS J, V396, pL1, DOI 10.1086/186504; Spergel DN, 2007, ASTROPHYS J SUPPL S, V170, P377, DOI 10.1086/513700; Springel V, 2010, MON NOT R ASTRON SOC, V401, P791, DOI 10.1111/j.1365-2966.2009.15715.x; Steidel CC, 1996, ASTROPHYS J, V462, pL17, DOI 10.1088/1538-4357/462/1/L17; SUTHERLAND RS, 1993, ASTROPHYS J SUPPL S, V88, P253, DOI 10.1086/191823; Tamburro D, 2009, ASTRON J, V137, P4424, DOI 10.1088/0004-6256/137/5/4424; Tasker EJ, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/11; TOMISAKA K, 1986, PUBL ASTRON SOC JPN, V38, P697; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; Trenti M, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/2/L39; Trenti M, 2010, ASTROPHYS J LETT, V714, pL202, DOI 10.1088/2041-8205/714/2/L202; Trenti M, 2012, ASTROPHYS J LETT, V749, DOI 10.1088/2041-8205/749/2/L38; Tyson JA, 2002, PROC SPIE, V4836, P10, DOI 10.1117/12.456772; Vazquez-Semadeni E, 2010, ASTROPHYS J, V715, P1302, DOI 10.1088/0004-637X/715/2/1302; Vogelsberger M, 2012, MON NOT R ASTRON SOC, V425, P3024, DOI 10.1111/j.1365-2966.2012.21590.x; VONWEIZSACKER CF, 1951, ASTROPHYS J, V114, P165, DOI 10.1086/145462; WANG BQ, 1994, ASTROPHYS J, V427, P759, DOI 10.1086/174182; Wong T, 2002, ASTROPHYS J, V569, P157, DOI 10.1086/339287; Wyder TK, 2009, ASTROPHYS J, V696, P1834, DOI 10.1088/0004-637X/696/2/1834	129	5	5	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1541	+	1229229	10.1126/science.1229229	http://dx.doi.org/10.1126/science.1229229			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812719	Green Submitted			2022-12-28	WOS:000321007000030
J	Egholm, DL; Knudsen, MF; Sandiford, M				Egholm, David L.; Knudsen, Mads F.; Sandiford, Mike			Lifespan of mountain ranges scaled by feedbacks between landsliding and erosion by rivers	NATURE			English	Article							SEDIMENT-FLUX; LANDSCAPE EVOLUTION; BEDROCK INCISION; ROCK-UPLIFT; BED-LOAD; MODEL; RATES; TOPOGRAPHY; HILLSLOPES; HIMALAYAS	An important challenge in geomorphology is the reconciliation of the high fluvial incision rates observed in tectonically active mountain ranges with the long-term preservation of significant mountain-range relief in ancient, tectonically inactive orogenic belts(1-3). River bedrock erosion and sediment transport are widely recognized to be the principal controls on the lifespan of mountain ranges. But the factors controlling the rate of erosion(4-8) and the reasons why they seem to vary significantly as a function of tectonic activity remain controversial. Here we use computational simulations to show that the key to understanding variations in the rate of erosion between tectonically active and inactive mountain ranges may relate to a bidirectional coupling between bedrock river incision and landslides. Whereas fluvial incision steepens surrounding hillslopes and increases landslide frequency(9), landsliding affects fluvial erosion rates in two fundamentally distinct ways. On the one hand, large landslides overwhelm the river transport capacity and cause upstream build up of sediment that protects the river bed from further erosion(9-11). On the other hand, in delivering abrasive agents to the streams(4-6), landslides help accelerate fluvial erosion. Our models illustrate how this coupling has fundamentally different implications for rates of fluvial incision in active and inactive mountain ranges. The coupling there-fore provides a plausible physical explanation for the preservation of significant mountain-range relief in old orogenic belts, up to several hundred million years after tectonic activity has effectively ceased.	[Egholm, David L.; Knudsen, Mads F.] Aarhus Univ, Dept Geosci, DK-8000 Aarhus C, Denmark; [Sandiford, Mike] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia	Aarhus University; University of Melbourne	Egholm, DL (corresponding author), Aarhus Univ, Dept Geosci, Hoegh Guldbergs Gade 2, DK-8000 Aarhus C, Denmark.	david@geo.au.dk	Sandiford, Mike/N-4453-2019; Faurschou Knudsen, Mads/H-4842-2012; Egholm, David/G-8227-2011; Sandiford, Mike/B-5020-2016	Sandiford, Mike/0000-0002-9757-745X; Sandiford, Mike/0000-0002-9757-745X; Faurschou Knudsen, Mads/0000-0001-5039-1773; Egholm, David Lundbek/0000-0003-4045-240X	Danish Council for Independent Research under the Sapere Aude programme; Carlsberg Foundation; Villum Foundation; ARC [DP110104098]; AISRF; Villum Fonden [00007263] Funding Source: researchfish	Danish Council for Independent Research under the Sapere Aude programme; Carlsberg Foundation(Carlsberg Foundation); Villum Foundation(Villum Fonden); ARC(Australian Research Council); AISRF(Australian GovernmentDepartment of Industry, Innovation and Science); Villum Fonden(Villum Fonden)	D. L. E. acknowledges funding from the Danish Council for Independent Research under the Sapere Aude programme. M. F. K. acknowledges funding from the Carlsberg Foundation and the Villum Foundation. M. S. acknowledges funding from ARC DP110104098 and AISRF.	Ahnert F., 1970, Z GEOMORPHOL S, V24, P11; ANDREWS DJ, 1987, J GEOPHYS RES-SOLID, V92, P12857, DOI 10.1029/JB092iB12p12857; Baldwin JA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000550; Braun J, 1997, BASIN RES, V9, P27, DOI 10.1046/j.1365-2117.1997.00030.x; Burbank DW, 2003, NATURE, V426, P652, DOI 10.1038/nature02187; Burbank DW, 1996, NATURE, V379, P505, DOI 10.1038/379505a0; Cowie PA, 2008, GEOLOGY, V36, P535, DOI 10.1130/G24681A.1; Crosta GB, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2005JF000455; Dadson SJ, 2003, NATURE, V426, P648, DOI 10.1038/nature02150; Densmore AL, 1998, J GEOPHYS RES-SOL EA, V103, P15203, DOI 10.1029/98JB00510; Gasparini NM, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000567; Hancock GS, 2002, GEOL SOC AM BULL, V114, P1131; Heimsath AM, 1997, NATURE, V388, P358, DOI 10.1038/41056; Hovius N, 2000, J GEOL, V108, P73, DOI 10.1086/314387; HOWARD AD, 1983, GEOL SOC AM BULL, V94, P739, DOI 10.1130/0016-7606(1983)94<739:CCIB>2.0.CO;2; HOWARD AD, 1994, WATER RESOUR RES, V30, P2261, DOI 10.1029/94WR00757; Jansen JD, 2011, GEOLOGY, V39, P543, DOI 10.1130/G32018.1; Kirby E, 2001, GEOLOGY, V29, P415, DOI 10.1130/0091-7613(2001)029<0415:QDRURV>2.0.CO;2; Korup O, 2010, GEOMORPHOLOGY, V120, P77, DOI 10.1016/j.geomorph.2009.09.017; Larsen IJ, 2012, NAT GEOSCI, V5, P468, DOI 10.1038/ngeo1479; Molnar P, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2005JF000433; Montgomery DR, 2002, EARTH PLANET SC LETT, V201, P481, DOI 10.1016/S0012-821X(02)00725-2; Ouimet WB, 2007, GEOL SOC AM BULL, V119, P1462, DOI 10.1130/B26136.1; PARKER G, 1985, WATER RESOUR RES, V21, P1361, DOI 10.1029/WR021i009p01361; Riebe CS, 2001, GEOLOGY, V29, P447, DOI 10.1130/0091-7613(2001)029<0447:MCCOER>2.0.CO;2; Roering JJ, 1999, WATER RESOUR RES, V35, P853, DOI 10.1029/1998WR900090; Scharf TE, 2013, GEOLOGY, V41, P331, DOI 10.1130/G33806.1; Seidl M.A., 1992, CATENA S, V23, P101, DOI DOI 10.1029/2007WR006219; Sklar LS, 2008, EARTH SURF PROC LAND, V33, P1129, DOI 10.1002/esp.1689; Sklar LS, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002496; Sklar LS, 2001, GEOLOGY, V29, P1087, DOI 10.1130/0091-7613(2001)029<1087:SARSCO>2.0.CO;2; Small EE, 1999, GEOMORPHOLOGY, V27, P131, DOI 10.1016/S0169-555X(98)00094-4; Stock JD, 2005, GEOL SOC AM BULL, V117, P174, DOI 10.1130/B25560.1; Tucker GE, 1996, BASIN RES, V8, P329, DOI 10.1046/j.1365-2117.1996.00238.x; Turcotte D. L., 1992, FRACTALS CHAOS GEOLO, P20; Turowski JM, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000697; von Blanckenburg F, 2004, J GEOPHYS RES-EARTH, V109, DOI 10.1029/2003JF000049; von Blanckenburg F, 2005, EARTH PLANET SC LETT, V237, P462, DOI 10.1016/j.epsl.2005.06.030; Whipple KX, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000044; Whipple KX, 2000, GEOL SOC AM BULL, V112, P490, DOI 10.1130/0016-7606(2000)112<0490:RIIBMA>2.3.CO;2; Whipple KX, 1999, NATURE, V401, P39, DOI 10.1038/43375; Wilcock PR, 1998, SCIENCE, V280, P410, DOI 10.1126/science.280.5362.410; Yanites BJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001933	43	100	106	6	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					475	+		10.1038/nature12218	http://dx.doi.org/10.1038/nature12218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803847				2022-12-28	WOS:000320929400050
J	Maddaluno, L; Rudini, N; Cuttano, R; Bravi, L; Giampietro, C; Corada, M; Ferrarini, L; Orsenigo, F; Papa, E; Boulday, G; Tournier-Lasserve, E; Chapon, F; Richichi, C; Retta, SF; Lampugnani, MG; Dejana, E				Maddaluno, Luigi; Rudini, Noemi; Cuttano, Roberto; Bravi, Luca; Giampietro, Costanza; Corada, Monica; Ferrarini, Luca; Orsenigo, Fabrizio; Papa, Eleanna; Boulday, Gwenola; Tournier-Lasserve, Elisabeth; Chapon, Francoise; Richichi, Cristina; Retta, Saverio Francesco; Lampugnani, Maria Grazia; Dejana, Elisabetta			EndMT contributes to the onset and progression of cerebral cavernous malformations	NATURE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BLOOD-BRAIN-BARRIER; GROWTH-FACTOR; VASCULAR INTEGRITY; SIGNALING PATHWAY; BETA-CATENIN; VE-CADHERIN; CANCER; CELLS; EXPRESSION	Cerebral cavernous malformation (CCM) is a vascular dysplasia, mainly localized within the brain and affecting up to 0.5% of the human population. CCM lesions are formed by enlarged and irregular blood vessels that often result in cerebral haemorrhages. CCM is caused by loss-of-function mutations in one of three genes, namely CCM1 (also known as KRIT1), CCM2 (OSM) and CCM3 (PDCD10), and occurs in both sporadic and familial forms(1). Recent studies(2-7) have investigated the cause of vascular dysplasia and fragility in CCM, but the in vivo functions of this ternary complex remain unclear(8). Postnatal deletion of any of the three Ccm genes in mouse endothelium results in a severe phenotype, characterized by multiple brain vascular malformations that are markedly similar to human CCM lesions(9). Endothelial-to-mesenchymal transition (EndMT) has been described in different pathologies, and it is defined as the acquisition of mesenchymal- and stem-cell-like characteristics by the endothelium(10-12). Here we show that endothelial-specific disruption of the Ccm1 gene in mice induces EndMT, which contributes to the development of vascular malformations. EndMT in CCM1-ablated endothelial cells is mediated by the upregulation of endogenous BMP6 that, in turn, activates the transforming growth factor-beta (TGF-beta) and bone morphogenetic protein (BMP) signalling pathway. Inhibitors of the TGF-beta and BMP pathway prevent EndMT both in vitro and in vivo and reduce the number and size of vascular lesions in CCM1-deficient mice. Thus, increased TGF-beta and BMP signalling, and the consequent EndMT of CCM1-null endothelial cells, are crucial events in the onset and progression of CCM disease. These studies offer novel therapeutic opportunities for this severe, and so far incurable, pathology.	[Maddaluno, Luigi; Rudini, Noemi; Cuttano, Roberto; Bravi, Luca; Giampietro, Costanza; Corada, Monica; Ferrarini, Luca; Orsenigo, Fabrizio; Papa, Eleanna; Lampugnani, Maria Grazia; Dejana, Elisabetta] IFOM Fdn, FIRC Inst Mol Oncol, I-20139 Milan, Italy; [Boulday, Gwenola; Tournier-Lasserve, Elisabeth] INSERM, UMR S740, F-75010 Paris, France; [Boulday, Gwenola; Tournier-Lasserve, Elisabeth] Univ Paris Diderot, Sorbonne Paris Cite, Genet Malad Vasc UMR S740, F-75010 Paris, France; [Tournier-Lasserve, Elisabeth] Grp Hosp St Louis Lariboisiere Fernand Widal, AP HP, F-75010 Paris, France; [Chapon, Francoise] CHU Caen, Dept Pathol, F-14032 Caen, France; [Richichi, Cristina] IEO European Inst Oncol, I-20139 Milan, Italy; [Retta, Saverio Francesco] Univ Turin, CCM Italia Dept Clin & Biol Sci, I-10043 Turin, Italy; [Lampugnani, Maria Grazia] Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy; [Dejana, Elisabetta] Univ Milan, Dept Biosci, I-20133 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie; IRCCS European Institute of Oncology (IEO); University of Turin; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan	Dejana, E (corresponding author), IFOM Fdn, FIRC Inst Mol Oncol, I-20139 Milan, Italy.	luigi.maddaluno@ifom.eu; elisabetta.dejana@ifom.eu	Dejana, Elisabetta/A-6274-2016; Cuttano, Roberto/AAT-4778-2021; Giampietro, Costanza/D-4643-2016; Cuttano, Roberto/B-5884-2017; Retta, Saverio Francesco/Q-4770-2019; Tournier-Lasserve, Elisabeth/N-7134-2017; Boulday, Gwenola/AAV-3768-2020	Giampietro, Costanza/0000-0001-5229-3835; Cuttano, Roberto/0000-0003-4150-2114; Retta, Saverio Francesco/0000-0001-9761-2959; Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; Boulday, Gwenola/0000-0002-5591-1659; Lampugnani, Maria Grazia/0000-0002-4802-7064; DEJANA, ELISABETTA/0000-0002-0007-0426; Orsenigo, Fabrizio/0000-0001-9135-8478; Corada, Monica/0000-0001-8220-0871	Fondation Leducq Transatlantic Network of Excellence; Associazione Italiana per la Ricerca sul Cancro (AIRC); 'Special Program Molecular Clinical Oncology 5x1000' to AIRC-Gruppo Italiano Malattie Mieloproliferative (AGIMM); European Community: European Research Council (ERC) [268870, ERC-2010-SdG]; EU [202213, 223098, ENDOSTEM-HEALTH-2009-241440, JUSTBRAIN-HEALTH-2009-241861]; CARIPLO Foundation	Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); 'Special Program Molecular Clinical Oncology 5x1000' to AIRC-Gruppo Italiano Malattie Mieloproliferative (AGIMM)(Fondazione AIRC per la ricerca sul cancro); European Community: European Research Council (ERC); EU(European Commission); CARIPLO Foundation(Fondazione Cariplo)	This work was supported by grants from: Fondation Leducq Transatlantic Network of Excellence, Associazione Italiana per la Ricerca sul Cancro (AIRC) and a 'Special Program Molecular Clinical Oncology 5x1000' to AIRC-Gruppo Italiano Malattie Mieloproliferative (AGIMM); the European Community: European Research Council (ERC grant 268870 call identifier ERC-2010-SdG) (EU Networks: EUSTROKE-contract-202213, OPTISTEM-contract-223098, ENDOSTEM-HEALTH-2009-241440, ENDOSTEM-HEALTH-2009-241440, JUSTBRAIN-HEALTH-2009-241861, ITN-VESSEL), and the CARIPLO Foundation. We are strongly indebted to R. Adams and D. A. Melton for sharing Cdh5(PAC)-CreERT2 and NotchIC mice, respectively. We are grateful to M. Forni and the Italian research network for Cerebral Cavernous Malformation (CCM Italia; http://www.ccmitalia.unito.it) for contributing to the study with important biological materials.	Ao A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041627; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boulday G, 2011, J EXP MED, V208, P1835, DOI 10.1084/jem.20110571; BUSSOLINO F, 1991, J IMMUNOL, V147, P2122; Chan AC, 2011, J CLIN INVEST, V121, P1871, DOI 10.1172/JCI44393; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Felici A, 2003, EMBO J, V22, P4465, DOI 10.1093/emboj/cdg428; Gauger KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-59; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Korff T, 1999, J CELL SCI, V112, P3249; Korpal M, 2010, EUR J CANCER, V46, P1232, DOI 10.1016/j.ejca.2010.02.040; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Li YJ, 2007, J AM SOC NEPHROL, V18, P449, DOI 10.1681/ASN.2006030236; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liebner S, 2011, INT J DEV BIOL, V55, P467, DOI 10.1387/ijdb.103224sl; Lopez D, 2009, ARCH BIOCHEM BIOPHYS, V482, P77, DOI 10.1016/j.abb.2008.11.016; Louvi A, 2011, P NATL ACAD SCI USA, V108, P3737, DOI 10.1073/pnas.1012617108; Mariotti A, 2007, EXPERT OPIN INV DRUG, V16, P451, DOI 10.1517/13543784.16.4.451; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Tanaka H, 2010, ONCOL REP, V24, P1637, DOI 10.3892/or_00001028; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vivien C, 2012, J BIOL CHEM, V287, P7427, DOI 10.1074/jbc.M111.324368; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Yuan QJ, 2011, PHARMAZIE, V66, P961, DOI 10.1691/ph.2011.1535; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	37	328	340	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					492	+		10.1038/nature12207	http://dx.doi.org/10.1038/nature12207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23748444				2022-12-28	WOS:000320929400054
J	Pyle, J; Harris, N				Pyle, John; Harris, Neil			Joe Farman (1930-2013)	NATURE			English	Biographical-Item									[Pyle, John; Harris, Neil] Univ Cambridge, Dept Chem, Cambridge CB2 1TN, England	University of Cambridge	Pyle, J (corresponding author), Univ Cambridge, Dept Chem, Cambridge CB2 1TN, England.	john.pyle@atm.ch.cam.ac.uk; neil.harris@ozone-sec.ch.cam.ac.uk		Harris, Neil/0000-0003-1256-3006	NERC [NE/G014655/1] Funding Source: UKRI; Natural Environment Research Council [ncas10009, NE/G014655/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		FARMAN J, PUBLICATION LIST	1	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					435	435		10.1038/498435a	http://dx.doi.org/10.1038/498435a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803837	Bronze			2022-12-28	WOS:000320929400035
J	Nishihara, R; Lochhead, P; Kuchiba, A; Jung, S; Yamauchi, M; Liao, XY; Imamura, Y; Qian, ZR; Morikawa, T; Wang, ML; Spiegelman, D; Cho, E; Giovannucci, E; Fuchs, CS; Chan, AT; Ogino, S				Nishihara, Reiko; Lochhead, Paul; Kuchiba, Aya; Jung, Seungyoun; Yamauchi, Mai; Liao, Xiaoyun; Imamura, Yu; Qian, Zhi Rong; Morikawa, Teppei; Wang, Molin; Spiegelman, Donna; Cho, Eunyoung; Giovannucci, Edward; Fuchs, Charles S.; Chan, Andrew T.; Ogino, Shuji			Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISLAND METHYLATOR PHENOTYPE; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; COLON-CANCER; MICROSATELLITE INSTABILITY; LINE-1 HYPOMETHYLATION; PIK3CA MUTATION; FAMILY-HISTORY; KRAS MUTATION; LIFE-STYLE; SURVIVAL	Importance Aspirin use reduces the risk of colorectal carcinoma. Experimental evidence implicates a role of RAF kinases in up-regulation of prostaglandin-endoperoxide synthase 2 (PTGS2, cyclooxygenase 2), suggesting that BRAF-mutant colonic cells might be less sensitive to the antitumor effects of aspirin than BRAF-wild-type neoplastic cells. Objective To examine whether the association of aspirin intake with colorectal cancer risk differs according to status of tumor BRAF oncogene mutation. Design and Setting We collected biennial questionnaire data on aspirin use and followed up participants in the Nurses' Health Study (from 1980) and the Health Professionals Follow-up Study (from 1986) until July 1, 2006, for cancer incidence and until January 1, 2012, for cancer mortality. Duplication-method Cox proportional cause-specific hazards regression for competing risks data was used to compute hazard ratios (HRs) for colorectal carcinoma incidence according to BRAF mutation status. Main Outcomes and Measures Incidence of colorectal cancer cases according to tumor BRAF mutation status. Results Among 127 865 individuals, with 3 165 985 person-years of follow-up, we identified 1226 incident rectal and colon cancers with available molecular data. Compared with nonuse, regular aspirin use was associated with lower BRAF-wild-type cancer risk (multivariable HR, 0.73; 95% CI, 0.64 to 0.83; age-adjusted incidence rate difference [RD], -9.7; 95% CI, -12.6 to -6.7 per 100 000 person-years). This association was observed irrespective of status of tumor PTGS2 expression or PIK3CA or KRAS mutation. In contrast, regular aspirin use was not associated with a lower risk of BRAF-mutated cancer (multivariable HR, 1.03; 95% CI, 0.76 to 1.38; age-adjusted, incidence RD, 0.7; 95% CI, -0.3 to 1.7 per 100 000 person-years: P for heterogeneity = .037, between BRAF-wild-type vs BRAF-mutated cancer risks). Compared with no aspirin use, aspirin use of more than 14 tablets per week was associated with a lower risk of BRAF-wild-type cancer (multivariable HR, 0.43; 95% CI, 0.25 to 0.75; age-adjusted incidence RD, -19.8; 95% CI, -26.3 to -13.3 per 100 000 person-years). The relationship between the number of aspirin tablets per week and colorectal cancer risk differed significantly by BRAF mutation status (P for heterogeneity = .005). Conclusions and Relevance Regular aspirin use was associated with lower risk of BRAF-wild-type colorectal cancer but not with BRAF-mutated cancer risk. These findings suggest that BRAF-mutant colon tumor cells may be less sensitive to the effect of aspirin. Given the modest absolute risk difference, further investigations are necessary to determine clinical implications of our findings.	[Nishihara, Reiko; Lochhead, Paul; Kuchiba, Aya; Yamauchi, Mai; Liao, Xiaoyun; Imamura, Yu; Qian, Zhi Rong; Morikawa, Teppei; Fuchs, Charles S.; Ogino, Shuji] Brigham & Womens Hosp, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Jung, Seungyoun; Wang, Molin; Spiegelman, Donna; Cho, Eunyoung; Giovannucci, Edward; Fuchs, Charles S.; Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Nishihara, Reiko; Kuchiba, Aya; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wang, Molin; Spiegelman, Donna; Giovannucci, Edward; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wang, Molin; Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lochhead, Paul] Univ Aberdeen, Gastrointestinal Res Grp, Inst Med Sci, Aberdeen, Scotland; [Morikawa, Teppei] Tokyo Univ Hosp, Dept Pathol, Tokyo 113, Japan; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Aberdeen; University of Tokyo; Harvard University; Massachusetts General Hospital	Chan, AT (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, 55 Fruit St, Boston, MA 02114 USA.	achan@partners.org; shuji_ogino@dfci.harvard.edu	Cho, Eunyoung/AAV-4469-2020; Chan, Andrew T/P-8293-2014	Cho, Eunyoung/0000-0001-6594-2582; Chan, Andrew T/0000-0001-7284-6767; Qian, Zhi rong/0000-0003-1633-4120; Ogino, Shuji/0000-0002-3909-2323	National Institutes of Health (NIH) [P01 CA87969, P01 CA55075, UM1 CA167552, P50 CA127003, R01 CA137178, K24 DK098311, R01 CA151993]; Bennett Family Fund for Targeted Therapies Research; National Colorectal Cancer Research Alliance; Harvard University; Chief Scientist Office [CAF/10/15] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA055075, P01CA087969, R01CA137178, P50CA127003, R01CA169141, UM1CA167552, R01CA151993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK098311, P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund for Targeted Therapies Research; National Colorectal Cancer Research Alliance; Harvard University; Chief Scientist Office; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants P01 CA87969 to Dr Hankinson; P01 CA55075 and UM1 CA167552 to Dr Willett; P50 CA127003 to Dr Fuchs.; R01 CA137178 and K24 DK098311 to Dr Chan; and R01 CA151993 to Dr Ogino from the National Institutes of Health (NIH); the Bennett Family Fund for Targeted Therapies Research; and the National Colorectal Cancer Research Alliance. Dr Lochhead is a Scottish Government Clinical Academic Fellow and was supported by a Harvard University Frank Knox Memorial Fellowship. Dr Chan is a Damon Runyon Clinical Investigator.	Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113; Buchanan DD, 2013, CANCER EPIDEM BIOMAR, V22, P917, DOI 10.1158/1055-9965.EPI-12-1211; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Burnett-Hartman AN, 2013, CANCER RES, V73, P2863, DOI 10.1158/0008-5472.CAN-12-3462; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Chang MS, 2009, PHARMACOL RES, V60, P247, DOI 10.1016/j.phrs.2009.03.015; Chia WK, 2012, NAT REV CLIN ONCOL, V9, P561, DOI 10.1038/nrclinonc.2012.137; Curtin K, 2011, NUTR CANCER, V63, P357, DOI 10.1080/01635581.2011.535965; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Funkhouser WK, 2012, J MOL DIAGN, V14, P91, DOI 10.1016/j.jmoldx.2011.11.001; Gavin PG, 2012, CLIN CANCER RES, V18, P6531, DOI 10.1158/1078-0432.CCR-12-0605; Gay LJ, 2012, J PATHOL, V228, P405, DOI 10.1002/path.4085; Hughes LAE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018571; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2013, JNCI-J NATL CANCER I, V105, P130, DOI 10.1093/jnci/djs482; Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/ERM.12.46, 10.1586/erm.12.46]; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Phipps AI, 2012, CANCER EPIDEM BIOMAR, V21, P1792, DOI 10.1158/1055-9965.EPI-12-0674; Popovici V, 2012, J CLIN ONCOL, V30, P1288, DOI 10.1200/JCO.2011.39.5814; Razzak AA, 2012, NUTR CANCER, V64, P899, DOI 10.1080/01635581.2012.714833; Rosty C, 2013, MODERN PATHOL, V26, P825, DOI 10.1038/modpathol.2012.240; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Shigaki H, 2012, ANN SURG ONCOL, V19, P4238, DOI 10.1245/s10434-012-2488-y; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang Dingzhi, 2011, Cancers (Basel), V3, P3894, DOI 10.3390/cancers3043894; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Zlobec I, 2011, J PATHOL, V225, P336, DOI 10.1002/path.2879	43	131	133	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2563	2571		10.1001/jama.2013.6599	http://dx.doi.org/10.1001/jama.2013.6599			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23800934	Bronze, Green Accepted			2022-12-28	WOS:000320848100026
J	Mushtaq, A				Mushtaq, Ammara			Anita Zaidi: promoting newborn and child health in Pakistan	LANCET			English	Biographical-Item																		ZAIDI A, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 22	2013	381	9884					2156	2156		10.1016/S0140-6736(13)61427-0	http://dx.doi.org/10.1016/S0140-6736(13)61427-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KH	23791335				2022-12-28	WOS:000320925600016
J	von Bartheld, MB; Dekkers, OM; Szlubowski, A; Eberhardt, R; Herth, FJ; in't Veen, JCCM; de Jong, YP; van der Heijden, EHFM; Tournoy, KG; Claussen, M; van den Blink, B; Shah, PL; Zoumot, Z; Clementsen, P; Porsbjerg, C; Mauad, T; Bernardi, FD; van Zwet, EW; Rabe, KF; Annema, JT				von Bartheld, Martin B.; Dekkers, Olaf M.; Szlubowski, Artur; Eberhardt, Ralf; Herth, Felix J.; in't Veen, Johannes C. C. M.; de Jong, Ynze P.; van der Heijden, Erik H. F. M.; Tournoy, Kurt G.; Claussen, Martin; van den Blink, Bernt; Shah, Pallav L.; Zoumot, Zaid; Clementsen, Paul; Porsbjerg, Celeste; Mauad, Thais; Bernardi, Fabiola D.; van Zwet, Erik W.; Rabe, Klaus F.; Annema, Jouke T.			Endosonography vs Conventional Bronchoscopy for the Diagnosis of Sarcoidosis The GRANULOMA Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRANSBRONCHIAL NEEDLE ASPIRATION; ENDOSCOPIC ULTRASOUND; EBUS-TBNA; STAGE-I; STANDARD; YIELD	Importance Tissue verification of noncaseating granulomas is recommended for the diagnosis of sarcoidosis. Bronchoscopy with transbronchial lung biopsies, the current diagnostic standard, has moderate sensitivity in assessing granulomas. Endosonography with intrathoracic nodal aspiration appears to be a promising diagnostic technique. Objective To evaluate the diagnostic yield of bronchoscopy vs endosonography in the diagnosis of stage I/II sarcoidosis. Design, Setting, and Patients Randomized clinical multicenter trial (14 centers in 6 countries) between March 2009 and November 2011 of 304 consecutive patients with suspected pulmonary sarcoidosis (stage I/II) in whom tissue confirmation of noncaseating granulomas was indicated. Interventions Either bronchoscopy with transbronchial and endobronchial lung biopsies or endosonography (esophageal or endobronchial ultrasonography) with aspiration of intrathoracic lymph nodes. All patients also underwent bronchoalveolar lavage. Main Outcomes and Measures The primary outcome was the diagnostic yield for detecting noncaseating granulomas in patients with a final diagnosis of sarcoidosis. The diagnosis was based on final clinical judgment by the treating physician, according to all available information (including findings from initial bronchoscopy or endosonography). Secondary outcomes were the complication rate in both groups and sensitivity and specificity of bronchoalveolar lavage in the diagnosis of sarcoidosis. Results A total of 149 patients were randomized to bronchoscopy and 155 to endosonography. Significantly more granulomas were detected at endosonography vs bronchoscopy (114 vs 72 patients; 74% vs 48%; P < .001). Diagnostic yield to detect granulomas for endosonography was 80%(95% CI, 73%-86%); for bronchoscopy, 53%(95% CI, 45%-61%) (P < .001). Two serious adverse events occurred in the bronchoscopy group and 1 in the endosonography group; all patients recovered completely. Sensitivity of the bronchoalveolar lavage for sarcoidosis based on CD4/CD8 ratio was54%(95% CI, 46%-62%) for flow cytometry and 24% (95% CI, 16%-34%) for cytospin analysis. Conclusion and Relevance Among patients with suspected stage I/II pulmonary sarcoidosis undergoing tissue confirmation, the use of endosonographic nodal aspiration compared with bronchoscopic biopsy resulted in greater diagnostic yield.	[von Bartheld, Martin B.; Rabe, Klaus F.; Annema, Jouke T.] Leiden Univ, Dept Pulmonol, Med Ctr, Leiden, Netherlands; [Dekkers, Olaf M.] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [van Zwet, Erik W.] Leiden Univ, Dept Med Stat, Med Ctr, NL-2300 RA Leiden, Netherlands; [Annema, Jouke T.] Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, NL-1100 DE Amsterdam, Netherlands; [Szlubowski, Artur] John Paul 2 Hosp, Endoscopy Unit, Krakow, Poland; [Szlubowski, Artur] Pulm Hosp Zakopane, Endoscopy Unit, Zakopane, Poland; [Eberhardt, Ralf; Herth, Felix J.] Thoraxclin Heidelberg, Dept Pneumonol, Heidelberg, Germany; [in't Veen, Johannes C. C. M.] St Franciscus Gasthuis, Dept Pulmonol, Rotterdam, Netherlands; [de Jong, Ynze P.] Rijnstate Hosp, Dept Pulmonol, Arnhem, Netherlands; [van der Heijden, Erik H. F. M.] Radboud Univ Nijmegen, Dept Pulmonol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Tournoy, Kurt G.] Ghent Univ Hosp, Dept Pulmonol, Ghent, Belgium; [Tournoy, Kurt G.] Onze Lieve Vrouw Hosp Aalst, Aalst, Belgium; [Claussen, Martin; Rabe, Klaus F.] Hosp Grosshansdorf, Dept Pneumonol, Grosshansdorf, Germany; [van den Blink, Bernt] Erasmus MC, Dept Pulmonol, Rotterdam, Netherlands; [Shah, Pallav L.; Zoumot, Zaid] Royal Brompton Hosp, Dept Resp Med, London SW3 6LY, England; [Clementsen, Paul; Porsbjerg, Celeste] Copenhagen Univ Hosp, Dept Chest Med, Gentofte, Denmark; [Mauad, Thais; Bernardi, Fabiola D.] Univ Sao Paulo, Dept Pathol, BR-05508 Sao Paulo, Brazil; [Bernardi, Fabiola D.] Med Sci Sch Santa Casa Sao Paulo, Sao Paulo, Brazil	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Franciscus Gasthuis; Rijnstate Hospital; Radboud University Nijmegen; Ghent University; Ghent University Hospital; Grosshansdorf Hospital; Erasmus University Rotterdam; Erasmus MC; Royal Brompton Hospital; University of Copenhagen; Universidade de Sao Paulo	Annema, JT (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, NL-1100 DE Amsterdam, Netherlands.	j.t.annema@amc.nl	Bernardi, Fabiola/D-8261-2014; Shah, Pallav L/AAB-2758-2019; Mauad, Thais/G-1254-2012; Rabe, Klaus F./AAW-6296-2021; van der Heijden, Erik H.F.M/D-3774-2009	Shah, Pallav L/0000-0002-9052-4638; Mauad, Thais/0000-0002-3354-1466; Rabe, Klaus F./0000-0002-7020-1401; van der Heijden, Erik H.F.M/0000-0003-3596-518X; Dekkers, Olaf/0000-0002-1333-7580; Porsbjerg, Celeste/0000-0003-4825-9436; Herth, Felix/0000-0002-7638-2506; Zoumot, Zaid/0000-0003-2533-6160; Clementsen, Paul Frost/0000-0001-6624-4620	Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands	Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands(Netherlands Government)	This study was partly funded by the Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands. Operation costs were borne by the respective study sites individually. No other funding from commercial sources was sought.	Agarwal R, 2012, RESP MED, V106, P883, DOI 10.1016/j.rmed.2012.02.014; Annema JT, 2005, EUR RESPIR J, V25, P405, DOI 10.1183/09031936.05.00098404; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Chee A, 2012, J BRONCHOL INTERN PU, V19, P24, DOI 10.1097/LBR.0b013e3182442925; Costabel U, 1999, EUR RESPIR J, V14, P735, DOI 10.1034/j.1399-3003.1999.14d02.x; Costabel U, 2008, CURR OPIN PULM MED, V14, P455, DOI 10.1097/MCP.0b013e3283056a61; Fritscher-Ravens A, 2011, ENDOSCOPY, V43, P955, DOI 10.1055/s-0031-1271110; Haslam PL, 1999, EUR RESPIR J, V14, P245, DOI 10.1034/j.1399-3003.1999.14b01.x; Heron M, 2008, CLIN IMMUNOL, V126, P338, DOI 10.1016/j.clim.2007.11.005; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Iannuzzi MC, 2011, JAMA-J AM MED ASSOC, V305, P391, DOI 10.1001/jama.2011.10; Iwashita T, 2008, ENDOSCOPY, V40, P400, DOI 10.1055/s-2007-995593; Kantrow SP, 1997, EUR RESPIR J, V10, P2716, DOI 10.1183/09031936.97.10122716; Navani N, 2011, RESPIROLOGY, V16, P467, DOI 10.1111/j.1440-1843.2011.01933.x; Oki M, 2012, J THORAC CARDIOV SUR, V143, P1324, DOI 10.1016/j.jtcvs.2012.01.040; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; Swigris JJ, 2011, AM J RESP CRIT CARE, V183, P1524, DOI 10.1164/rccm.201010-1679OC; Tournoy KG, 2010, EUR RESPIR J, V35, P1329, DOI 10.1183/09031936.00111509; Tournoy KG, 2009, LUNG CANCER, V63, P45, DOI 10.1016/j.lungcan.2008.04.004; Tremblay A, 2009, CHEST, V136, P340, DOI 10.1378/chest.08-2768; Trisolini R, 2004, SARCOIDOSIS VASC DIF, V21, P147; von Bartheld MB, 2010, ENDOSCOPY, V42, P213, DOI 10.1055/s-0029-1243890; von Bartheld M, 2012, GASTROINTEST ENDOSC, V75, P1104, DOI 10.1016/j.gie.2012.01.002; Wells AU, 2008, THORAX, V63, DOI 10.1136/thx.2008.101691	24	145	146	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2457	2464		10.1001/jama.2013.5823	http://dx.doi.org/10.1001/jama.2013.5823			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23780458	Bronze			2022-12-28	WOS:000320505100026
J	Gerber, JS; Prasad, PA; Fiks, AG; Localio, AR; Grundmeier, RW; Bell, LM; Wasserman, RC; Keren, R; Zaoutis, TE				Gerber, Jeffrey S.; Prasad, Priya A.; Fiks, Alexander G.; Localio, A. Russell; Grundmeier, Robert W.; Bell, Louis M.; Wasserman, Richard C.; Keren, Ron; Zaoutis, Theoklis E.			Effect of an Outpatient Antimicrobial Stewardship Intervention on Broad-Spectrum Antibiotic Prescribing by Primary Care Pediatricians A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-TRACT INFECTIONS; DISEASES-SOCIETY; CHILDREN; COMMUNITY; TRENDS; RATES; CALL	Importance Antimicrobial stewardship programs have been effective for inpatients, often through prescribing audit and feedback. However, most antimicrobial use occurs in outpatients with acute respiratory tract infections (ARTIs). Objective To evaluate the effect of an antimicrobial stewardship intervention on antibiotic prescribing for pediatric outpatients. Design Cluster randomized trial of outpatient antimicrobial stewardship comparing prescribing between intervention and control practices using a common electronic health record. After excluding children with chronic medical conditions, antibiotic allergies, and prior antibiotic use, we estimated prescribing rates for targeted ARTIs standardized for age, sex, race, and insurance from 20 months before the intervention to 12 months afterward (October 2008-June 2011). Setting and Participants A network of 25 pediatric primary care practices in Pennsylvania and New Jersey; 18 practices (162 clinicians) participated. Interventions One 1-hour on-site clinician education session (June 2010) followed by 1 year of personalized, quarterly audit and feedback of prescribing for bacterial and viral ARTIs or usual practice. Main Outcomes and Measures Rates of broad-spectrum (off-guideline) antibiotic prescribing for bacterial ARTIs and antibiotics for viral ARTIs for 1 year after the intervention. Results Broad-spectrum antibiotic prescribing decreased from 26.8% to 14.3% (absolute difference, 12.5%) among intervention practices vs from 28.4% to 22.6% (absolute difference, 5.8%) in controls (difference of differences [DOD], 6.7%; P=.01 for differences in trajectories). Off-guideline prescribing for children with pneumonia decreased from 15.7% to 4.2% among intervention practices compared with 17.1% to 16.3% in controls (DOD, 10.7%; P<.001) and for acute sinusitis from 38.9% to 18.8% in intervention practices and from 40.0% to 33.9% in controls (DOD, 14.0%; P=.12). Off-guideline prescribing was uncommon at baseline and changed little for streptococcal pharyngitis (intervention, from 4.4% to 3.4%; control, from 5.6% to 3.5%; DOD, -1.1%; P=.82) and for viral infections (intervention, from 7.9% to 7.7%; control, from 6.4% to 4.5%; DOD, -1.7%; P=.93). Conclusions and Relevance In this large pediatric primary care network, clinician education coupled with audit and feedback, compared with usual practice, improved adherence to prescribing guidelines for common bacterial ARTIs, and the intervention did not affect antibiotic prescribing for viral infections. Future studies should examine the drivers of these effects, as well as the generalizability, sustainability, and clinical outcomes of outpatient antimicrobial stewardship.	[Gerber, Jeffrey S.; Prasad, Priya A.; Bell, Louis M.; Zaoutis, Theoklis E.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Prasad, Priya A.; Fiks, Alexander G.; Grundmeier, Robert W.; Bell, Louis M.; Keren, Ron] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Gerber, Jeffrey S.; Fiks, Alexander G.; Localio, A. Russell; Bell, Louis M.; Keren, Ron; Zaoutis, Theoklis E.] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA; [Fiks, Alexander G.; Localio, A. Russell] Childrens Hosp Philadelphia, PolicyLab, Philadelphia, PA 19104 USA; [Grundmeier, Robert W.] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Gerber, Jeffrey S.; Fiks, Alexander G.; Grundmeier, Robert W.; Bell, Louis M.; Keren, Ron; Zaoutis, Theoklis E.] Perelman Sch Med, Dept Pediat, Philadelphia, PA USA; [Localio, A. Russell] Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA USA; [Localio, A. Russell; Keren, Ron; Zaoutis, Theoklis E.] Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA USA; [Wasserman, Richard C.] Univ Vermont, Coll Med, Dept Pediat, Burlington, VT 05405 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Vermont	Gerber, JS (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, 3535 Market St,Ste 1518, Philadelphia, PA 19104 USA.	gerberj@email.chop.edu	Gerber, Jeffrey/GYD-3567-2022; Wasserman, Richard/G-3775-2015	Gerber, Jeffrey/0000-0002-3076-3186; 	Agency for Healthcare Research and Quality [HHSA2900200710013]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was supported by Agency for Healthcare Research and Quality contract HHSA2900200710013.	Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Bartlett JG, 2011, CLIN INFECT DIS, V53, pS4, DOI 10.1093/cid/cir362; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Chai G, 2012, PEDIATRICS, V130, P23, DOI 10.1542/peds.2011-2879; Davison AC, 1997, BOOTSTRAP METHODS TH, DOI [10.1017/CBO9780511802843, DOI 10.2307/1271471]; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Feudtner C, 2000, PEDIATRICS, V106, P205; Finch RG, 2004, LANCET INFECT DIS, V4, P44, DOI 10.1016/S1473-3099(03)00860-0; Finkelstein JA, 2008, PEDIATRICS, V121, pE15, DOI 10.1542/peds.2007-0819; Finkelstein Jonathan A., 2001, Pediatrics, V108, P1, DOI 10.1542/peds.108.1.1; Fishman N, 2006, AM J MED, V119, pS62, DOI 10.1016/j.amjmed.2006.04.004; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Gerber JS, 2010, PEDIATRICS, V126, P1067, DOI 10.1542/peds.2010-1275; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Hersh AL, 2011, PEDIATRICS, V128, P1053, DOI 10.1542/peds.2011-1337; Korn EL., 1999, ANAL HLTH SURVEYS; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; McCaig LF, 2003, EMERG INFECT DIS, V9, P432; Nash DR, 2002, ARCH PEDIAT ADOL MED, V156, P1114, DOI 10.1001/archpedi.156.11.1114; Newland JG, 2010, PEDIATR INFECT DIS J, V29, P862, DOI 10.1097/INF.0b013e3181ef2507; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; Patel SJ, 2007, PEDIATR INFECT DIS J, V26, P531, DOI 10.1097/INF.0b013e3180593170; Pickering LK, 2009, RED BOOK 2009 REPORT; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719	26	265	267	0	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2345	2352		10.1001/jama.2013.6287	http://dx.doi.org/10.1001/jama.2013.6287			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161EV	23757082	Bronze			2022-12-28	WOS:000320176000024
J	Parker, MJ				Parker, Martyn J.			PERSONAL VIEW We need an alternative to the Liverpool care pathway for patients who might recover	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Peterborough & Stamford Hosp NHS Fdn Trust, Peterborough City Hosp, Dept Orthopaed, Peterborough PE3 9GZ, Cambs, England		Parker, MJ (corresponding author), Peterborough & Stamford Hosp NHS Fdn Trust, Peterborough City Hosp, Dept Orthopaed, Peterborough PE3 9GZ, Cambs, England.	Martyn.Parker@pbh-tr.nhs.uk						Chinthapalli K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1184; National Institute for Health and Care Excellence, 2011, GUID COMM END LIF CA; Royal Brompton and Harefield NHS Foundation Trust, QUAL ACC 2010 11	3	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2013	346								f3702	10.1136/bmj.f3702	http://dx.doi.org/10.1136/bmj.f3702			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VQ	23757741				2022-12-28	WOS:000320587600003
J	Galbraith, MD; Allen, MA; Bensard, CL; Wang, XX; Schwinn, MK; Qin, B; Long, HW; Daniels, DL; Hahn, WC; Dowell, RD; Espinosa, JM				Galbraith, Matthew D.; Allen, Mary A.; Bensard, Claire L.; Wang, Xiaoxing; Schwinn, Marie K.; Qin, Bo; Long, Henry W.; Daniels, Danette L.; Hahn, William C.; Dowell, Robin D.; Espinosa, Joaquin M.			HIF1A Employs CDK8-Mediator to Stimulate RNAPII Elongation in Response to Hypoxia	CELL			English	Article							BROMODOMAIN PROTEIN BRD4; POLYMERASE-II CTD; TRANSCRIPTION ELONGATION; P-TEFB; COMPLEX; CDK8; RECRUITMENT; COACTIVATOR; INITIATION; BINDING	The transcription factor HIF1A is a key mediator of the cellular response to hypoxia. Despite the importance of HIF1A in homeostasis and various pathologies, little is known about how it regulates RNA polymerase II (RNAPII). We report here that HIF1A employs a specific variant of the Mediator complex to stimulate RNAPII elongation. The Mediator-associated kinase CDK8, but not the paralog CDK19, is required for induction of many HIF1A target genes. HIF1A induces binding of CDK8-Mediator and the super elongation complex (SEC), containing AFF4 and CDK9, to alleviate RNAPII pausing. CDK8 is dispensable for HIF1A chromatin binding and histone acetylation, but it is essential for binding of SEC and RNAPII elongation. Global analysis of active RNAPII reveals that hypoxia-inducible genes are paused and active prior to their induction. Our results provide a mechanistic link between HIF1A and CDK8, two potent oncogenes, in the cellular response to hypoxia.	[Galbraith, Matthew D.; Allen, Mary A.; Bensard, Claire L.; Espinosa, Joaquin M.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Galbraith, Matthew D.; Allen, Mary A.; Bensard, Claire L.; Dowell, Robin D.; Espinosa, Joaquin M.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Allen, Mary A.; Dowell, Robin D.] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA; [Wang, Xiaoxing; Qin, Bo; Long, Henry W.; Hahn, William C.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Wang, Xiaoxing; Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Schwinn, Marie K.; Daniels, Danette L.] Promega Corp, Madison, WI 53711 USA; [Qin, Bo] Tongji Univ, Dept Bioinformat, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Promega Corporation; Tongji University	Espinosa, JM (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	joaquin.espinosa@colorado.edu	Allen, Mary/AAQ-2364-2021; Galbraith, Matthew D/I-3306-2019	Galbraith, Matthew D/0000-0003-0485-3927; DOWELL, ROBIN/0000-0001-7665-9985; Allen, Mary/0000-0001-7490-0165	NSF [MCB-0842974, MCB-1243522]; NIH [RO1CA117907, RO1CA140545]; Butcher Seed Grant; Boettcher Foundation's Webb-Waring Biomedical Research program; DoD Breast Cancer Postdoctoral Fellowship [W81XWH-10-1-0062, 2T15LM009451]; Direct For Biological Sciences [1627615] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA117907, R01CA140545] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Butcher Seed Grant; Boettcher Foundation's Webb-Waring Biomedical Research program; DoD Breast Cancer Postdoctoral Fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Shilatifard for AFF4 antibody, Dr. Taatjes and Dr. Lin for HeLa nuclear extracts and MED15 antibody, and Edward Head for helpful discussions. This work was supported primarily by NSF grants MCB-0842974 and MCB-1243522, and also by NIH RO1CA117907 grant (J.M.E.), a Butcher Seed Grant (J.M.E, R.D.D.), the Boettcher Foundation's Webb-Waring Biomedical Research program (R.D.D.), DoD Breast Cancer Postdoctoral Fellowship W81XWH-10-1-0062 (X.W.), 2T15LM009451 (M.A.A.), and NIH RO1CA140545 (W.C.H.). J.M.E. is an HHMI Early Career Scientist. W.C.H. is a consultant for Novartis. Promega Corporation is the commercial owner by assignment of patents of the HaloTag technology and its applications.	Adler AS, 2012, CANCER RES, V72, P2129, DOI 10.1158/0008-5472.CAN-11-3886; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Galbraith MD, 2010, TRANSCR-AUSTIN, V1, P4, DOI 10.4161/trns.1.1.12373; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Mukhopadhyay A, 2010, HUM GENET, V128, P281, DOI 10.1007/s00439-010-0848-x; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Westerling T, 2007, MOL CELL BIOL, V27, P6177, DOI 10.1128/MCB.01302-06; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	40	218	222	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1327	1339		10.1016/j.cell.2013.04.048	http://dx.doi.org/10.1016/j.cell.2013.04.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746844	Green Accepted, Bronze			2022-12-28	WOS:000319979200016
J	Perera, MA; Cavallari, LH; Limdi, NA; Gamazon, ER; Konkashbaev, A; Daneshjou, R; Pluzhnikov, A; Crawford, DC; Wang, JL; Liu, NJ; Tatonetti, N; Bourgeois, S; Takahashi, H; Bradford, Y; Burkley, BM; Desnick, RJ; Halperin, JL; Khalifa, SI; Langaee, TY; Lubitz, SA; Nutescu, EA; Oetjens, M; Shahin, MH; Patel, SR; Sagreiya, H; Tector, M; Weck, KE; Rieder, MJ; Scott, SA; Wu, AHB; Burmester, JK; Wadelius, M; Deloukas, P; Wagner, MJ; Mushiroda, T; Kubo, M; Roden, DM; Cox, NJ; Altman, RB; Klein, TE; Nakamura, Y; Johnson, JA				Perera, Minoli A.; Cavallari, Larisa H.; Limdi, Nita A.; Gamazon, Eric R.; Konkashbaev, Anuar; Daneshjou, Roxana; Pluzhnikov, Anna; Crawford, Dana C.; Wang, Jelai; Liu, Nianjun; Tatonetti, Nicholas; Bourgeois, Stephane; Takahashi, Harumi; Bradford, Yukiko; Burkley, Benjamin M.; Desnick, Robert J.; Halperin, Jonathan L.; Khalifa, Sherief I.; Langaee, Taimour Y.; Lubitz, Steven A.; Nutescu, Edith A.; Oetjens, Matthew; Shahin, Mohamed H.; Patel, Shitalben R.; Sagreiya, Hersh; Tector, Matthew; Weck, Karen E.; Rieder, Mark J.; Scott, Stuart A.; Wu, Alan H. B.; Burmester, James K.; Wadelius, Mia; Deloukas, Panos; Wagner, Michael J.; Mushiroda, Taisei; Kubo, Michiaki; Roden, Dan M.; Cox, Nancy J.; Altman, Russ B.; Klein, Teri E.; Nakamura, Yusuke; Johnson, Julie A.			Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study	LANCET			English	Article							EUROPEAN-AMERICANS; VKORC1; CYP2C9; ANTICOAGULATION; REQUIREMENTS; POLYMORPHISM; MAINTENANCE; HAPLOTYPES; GENOTYPE; PHARMACOGENETICS	Background VKORC1 and CYP2C9 are important contributors to warfarin dose variability, but explain less variability for individuals of African descent than for those of European or Asian descent. We aimed to identify additional variants contributing to warfarin dose requirements in African Americans. Methods We did a genome-wide association study of discovery and replication cohorts. Samples from African-American adults (aged >= 18 years) who were taking a stable maintenance dose of warfarin were obtained at International Warfarin Pharmacogenetics Consortium (IWPC) sites and the University of Alabama at Birmingham (Birmingham, AL, USA). Patients enrolled at IWPC sites but who were not used for discovery made up the independent replication cohort. All participants were genotyped. We did a stepwise conditional analysis, conditioning first for VKORC1 -1639G -> A, followed by the composite genotype of CYP2C9*2 and CYP2C9*3. We prespecified a genome-wide significance threshold of p<5x10(-8) in the discovery cohort and p<0.0038 in the replication cohort. Findings The discovery cohort contained 533 participants and the replication cohort 432 participants. After the prespecified conditioning in the discovery cohort, we identified an association between a novel single nucleotide polymorphism in the CYP2C cluster on chromosome 10 (rs12777823) and warfarin dose requirement that reached genome-wide significance (p=1.51x10(-8)). This association was confirmed in the replication cohort (p=5.04x10(-5)); analysis of the two cohorts together produced a p value of 4.5x10(-12). Individuals heterozygous for the rs12777823 A allele need a dose reduction of 6.92 mg/week and those homozygous 9.34 mg/week. Regression analysis showed that the inclusion of rs12777823 significantly improves warfarin dose variability explained by the IWPC dosing algorithm (21% relative improvement). Interpretation A novel CYP2C single nucleotide polymorphism exerts a clinically relevant effect on warfarin dose in African Americans, independent of CYP2C9*2 and CYP2C9*3. Incorporation of this variant into pharmacogenetic dosing algorithms could improve warfarin dose prediction in this population.	[Perera, Minoli A.; Gamazon, Eric R.; Konkashbaev, Anuar; Pluzhnikov, Anna; Cox, Nancy J.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Cavallari, Larisa H.; Nutescu, Edith A.; Patel, Shitalben R.] Univ Illinois, Dept Pharm Practice, Chicago, IL USA; [Limdi, Nita A.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Limdi, Nita A.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Wang, Jelai; Liu, Nianjun] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Daneshjou, Roxana; Tatonetti, Nicholas; Sagreiya, Hersh; Altman, Russ B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Klein, Teri E.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Crawford, Dana C.; Bradford, Yukiko; Oetjens, Matthew] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Bourgeois, Stephane; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Takahashi, Harumi] Meiji Pharmaceut Univ, Dept Biopharmaceut, Tokyo, Japan; [Burkley, Benjamin M.; Langaee, Taimour Y.; Shahin, Mohamed H.; Johnson, Julie A.] Univ Florida, Ctr Pharmacogen, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA; [Desnick, Robert J.; Scott, Stuart A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Halperin, Jonathan L.] Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY USA; [Khalifa, Sherief I.] Qatar Univ, Coll Pharm, Pharmaceut Sci Sect, Doha, Qatar; [Lubitz, Steven A.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; [Lubitz, Steven A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Tector, Matthew] Aurora St Lukes Med Ctr, Milwaukee, WI USA; [Weck, Karen E.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Weck, Karen E.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Wagner, Michael J.] Univ N Carolina, Sch Pharm, Chapel Hill, NC USA; [Rieder, Mark J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wu, Alan H. B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Burmester, James K.] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA; [Wadelius, Mia] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Mushiroda, Taisei; Kubo, Michiaki; Nakamura, Yusuke] RIKEN Ctr Genom Med, Yokohama, Kanagawa, Japan	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Stanford University; Stanford University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Wellcome Trust Sanger Institute; Meiji Pharmaceutical University; State University System of Florida; University of Florida; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Qatar University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Marshfield Clinic; Uppsala University; RIKEN	Johnson, JA (corresponding author), Univ Florida, Ctr Pharmacogen, Dept Pharmacotherapy & Translat Res, Box 100486, Gainesville, FL 32610 USA.	johnson@cop.ufl.edu	Crawford, Dana/O-5578-2019; Halperin, Jonathan/AAJ-4721-2020; Daneshjou, Roxana/ABE-7764-2021; Deloukas, Panos/B-2922-2013; Shahin, Mohamed/Q-2874-2019; Gamazon, Eric/I-6873-2018; Sagreiya, Hersh/Z-1641-2019; Perera, Minoli/AHD-3525-2022; Kubo, Michiaki/N-7947-2015; Mushiroda, Taisei/E-3022-2010; Wadelius, Mia/C-7740-2016; Roden, Dan/ABD-5412-2021	Crawford, Dana/0000-0002-6437-6248; Halperin, Jonathan/0000-0002-8318-5471; Deloukas, Panos/0000-0001-9251-070X; Gamazon, Eric/0000-0003-4204-8734; Wadelius, Mia/0000-0002-6368-2622; Khalifa, Sherief/0000-0003-3590-1397; Weck, Karen/0000-0002-8516-333X; Scott, Stuart/0000-0001-5720-1864; Tatonetti, Nicholas/0000-0002-2700-2597; Nutescu, Edith/0000-0002-2651-0020; Perera, Minoli/0000-0002-1146-2791; Klein, Teri/0000-0001-5527-6475; Patel, Shitalben/0000-0003-3710-0497	National Institutes of Health; American Heart Association; Howard Hughes Medical Institute; Wisconsin Network for Health Research; Wellcome Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000165, KL2TR000069, UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL112908, R01HL092173, R21HL106097, K23HL089808, U19HL065962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092618, U19GM061390, U01GM074492, U01GM061393, R01GM081488, R24GM061374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS045598] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wisconsin Network for Health Research; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	National Institutes of Health, American Heart Association, Howard Hughes Medical Institute, Wisconsin Network for Health Research, and the Wellcome Trust.	Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Cavallari LH, 2010, CLIN PHARMACOL THER, V87, P459, DOI 10.1038/clpt.2009.223; Cavallari LH, 2012, PHARMACOGENET GENOM, V22, P152, DOI 10.1097/FPC.0b013e32834f288f; Cha PC, 2010, HUM MOL GENET, V19, P4735, DOI 10.1093/hmg/ddq389; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; Ferder NS, 2010, J THROMB HAEMOST, V8, P95, DOI 10.1111/j.1538-7836.2009.03677.x; French B, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-108; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gamazon ER, 2012, AM J HUM GENET, V90, P1046, DOI 10.1016/j.ajhg.2012.04.023; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Limdi NA, 2008, PHARMACOGENOMICS, V9, P1445, DOI 10.2217/14622416.9.10.1445; Limdi NA, 2008, PHARMACOGENOMICS, V9, P511, DOI 10.2217/14622416.9.5.511; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Liu Y, 2012, CLIN PHARMACOL THER, V91, P660, DOI 10.1038/clpt.2011.269; Perera MA, 2011, CLIN PHARMACOL THER, V89, P408, DOI 10.1038/clpt.2010.322; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramirez AH, 2012, PHARMACOGENOMICS, V13, P407, DOI [10.2217/PGS.11.164, 10.2217/pgs.11.164]; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Schelleman H, 2010, BRIT J CLIN PHARMACO, V70, P393, DOI 10.1111/j.1365-2125.2010.03709.x; Shahin MHA, 2011, PHARMACOGENET GENOM, V21, P130, DOI 10.1097/FPC.0b013e3283436b86; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Takahashi H, 1998, CLIN PHARMACOL THER, V63, P519, DOI 10.1016/S0009-9236(98)90103-5; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309; The National Board of Health and Welfare, LAKEMEDELSSTATISTIK; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; van Schie RMF, 2009, PHARMACOGENOMICS, V10, P1687, DOI [10.2217/pgs.09.125, 10.2217/PGS.09.125]; Voora D, 2010, CLIN PHARMACOL THER, V87, P445, DOI 10.1038/clpt.2009.291	33	176	190	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2013	382	9894					790	796		10.1016/S0140-6736(13)60681-9	http://dx.doi.org/10.1016/S0140-6736(13)60681-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VP	23755828	Green Published, Green Accepted			2022-12-28	WOS:000324239200029
J	Agnelli, G; Buller, HR; Cohen, A; Curto, M; Gallus, AS; Johnson, M; Masiukiewicz, U; Pak, R; Thompson, J; Raskob, GE; Weitz, JI				Agnelli, Giancarlo; Buller, Harry R.; Cohen, Alexander; Curto, Madelyn; Gallus, Alexander S.; Johnson, Margot; Masiukiewicz, Urszula; Pak, Raphael; Thompson, John; Raskob, Gary E.; Weitz, Jeffrey I.		AMPLIFY Investigators	Oral Apixaban for the Treatment of Acute Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WARFARIN	Background Apixaban, an oral factor Xa inhibitor administered in fixed doses, may simplify the treatment of venous thromboembolism. Methods In this randomized, double-blind study, we compared apixaban (at a dose of 10 mg twice daily for 7 days, followed by 5 mg twice daily for 6 months) with conventional therapy (subcutaneous enoxaparin, followed by warfarin) in 5395 patients with acute venous thromboembolism. The primary efficacy outcome was recurrent symptomatic venous thromboembolism or death related to venous thromboembolism. The principal safety outcomes were major bleeding alone and major bleeding plus clinically relevant nonmajor bleeding. Results The primary efficacy outcome occurred in 59 of 2609 patients (2.3%) in the apixaban group, as compared with 71 of 2635 (2.7%) in the conventional-therapy group (relative risk, 0.84; 95% confidence interval [CI], 0.60 to 1.18; difference in risk [apixaban minus conventional therapy], -0.4 percentage points; 95% CI, -1.3 to 0.4). Apixaban was noninferior to conventional therapy (P<0.001) for predefined upper limits of the 95% confidence intervals for both relative risk (<1.80) and difference in risk (<3.5 percentage points). Major bleeding occurred in 0.6% of patients who received apixaban and in 1.8% of those who received conventional therapy (relative risk, 0.31; 95% CI, 0.17 to 0.55; P<0.001 for superiority). The composite outcome of major bleeding and clinically relevant nonmajor bleeding occurred in 4.3% of the patients in the apixaban group, as compared with 9.7% of those in the conventional-therapy group (relative risk, 0.44; 95% CI, 0.36 to 0.55; P<0.001). Rates of other adverse events were similar in the two groups. Conclusions A fixed-dose regimen of apixaban alone was noninferior to conventional therapy for the treatment of acute venous thromboembolism and was associated with significantly less bleeding (Funded by Pfizer and Bristol-Myers Squibb; ClinicalTrials.gov number, NCT00643201).	[Agnelli, Giancarlo] Univ Perugia, Internal & Cardiovasc Med Stroke Unit, I-06100 Perugia, Italy; [Buller, Harry R.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Cohen, Alexander] Kings Coll Hosp London, London, England; [Curto, Madelyn; Johnson, Margot; Masiukiewicz, Urszula; Pak, Raphael; Thompson, John] Pfizer Inc, Groton, CT 06340 USA; [Gallus, Alexander S.] Flinders Med Ctr, Dept Haematol, Adelaide, SA, Australia; [Gallus, Alexander S.] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Raskob, Gary E.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA; [Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Weitz, Jeffrey I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada	University of Perugia; University of Amsterdam; Academic Medical Center Amsterdam; King's College Hospital NHS Foundation Trust; King's College Hospital; Pfizer; Flinders Medical Centre; Flinders University South Australia; University of Oklahoma System; University of Oklahoma Health Sciences Center; McMaster University; McMaster University; McMaster University	Agnelli, G (corresponding author), Univ Perugia, Piazzale Menghini 1, I-06100 Perugia, Italy.	agnellig@unipg.it	Gurghean, Adriana/AAN-1243-2021; Weitz, Jeffrey/AAD-1929-2019; Holaj, Robert/D-4241-2017; Beyer-Westendorf, Jan/K-7569-2019; Szopiński, Piotr/X-6579-2018; Nishinari, Kenji/J-1655-2014; Schulman, Sam/I-7559-2019; Lodigiani, Corrado/AAW-1964-2020; Fijalkowska, Anna/V-3994-2018	Weitz, Jeffrey/0000-0002-1092-7550; Holaj, Robert/0000-0002-9488-9706; Beyer-Westendorf, Jan/0000-0002-6983-9993; Szopiński, Piotr/0000-0001-6001-0823; Nishinari, Kenji/0000-0002-8952-7874; Schulman, Sam/0000-0002-8512-9043; Lodigiani, Corrado/0000-0002-9152-9385; Fijalkowska, Anna/0000-0002-2225-9684; Lissauer, Matthew/0000-0002-6008-9778; Gallus, Alexander/0000-0001-7347-9989; Ritchie, Bruce/0000-0003-4754-1050; Harenberg, Job/0000-0003-4590-4225; Schjesvold, Fredrik/0000-0003-1096-0569; Marschang, Peter/0000-0002-8239-3447	Pfizer; Bristol-Myers Squibb	Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb)	Funded by Pfizer and Bristol-Myers Squibb; ClinicalTrials.gov number, NCT00643201	Adam SS, 2012, ANN INTERN MED, V157, P796, DOI 10.7326/0003-4819-157-10-201211200-00532; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Mehrotra DV, 2000, STAT MED, V19, P811, DOI 10.1002/(SICI)1097-0258(20000330)19:6<811::AID-SIM390>3.0.CO;2-Z; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598	12	1474	1536	4	138	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					799	808		10.1056/NEJMoa1302507	http://dx.doi.org/10.1056/NEJMoa1302507			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	208KB	23808982				2022-12-28	WOS:000323676100007
J	Bergenstal, RM; Klonoff, DC; Garg, SK; Bode, BW; Meredith, M; Slover, RH; Ahmann, AJ; Welsh, JB; Lee, SW; Kaufman, FR				Bergenstal, Richard M.; Klonoff, David C.; Garg, Satish K.; Bode, Bruce W.; Meredith, Melissa; Slover, Robert H.; Ahmann, Andrew J.; Welsh, John B.; Lee, Scott W.; Kaufman, Francine R.		ASPIRE In-Home Study Grp	Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SAMPLE-SIZE; SUSPENSION; THERAPY; DEAD	Background The threshold-suspend feature of sensor-augmented insulin pumps is designed to minimize the risk of hypoglycemia by interrupting insulin delivery at a preset sensor glucose value. We evaluated sensor-augmented insulin-pump therapy with and without the threshold-suspend feature in patients with nocturnal hypoglycemia. Methods We randomly assigned patients with type 1 diabetes and documented nocturnal hypoglycemia to receive sensor-augmented insulin-pump therapy with or without the threshold-suspend feature for 3 months. The primary safety outcome was the change in the glycated hemoglobin level. The primary efficacy outcome was the area under the curve (AUC) for nocturnal hypoglycemic events. Two-hour threshold-suspend events were analyzed with respect to subsequent sensor glucose values. Results A total of 247 patients were randomly assigned to receive sensor-augmented insulin-pump therapy with the threshold-suspend feature (threshold-suspend group, 121 patients) or standard sensor-augmented insulin-pump therapy (control group, 126 patients). The changes in glycated hemoglobin values were similar in the two groups. The mean AUC for nocturnal hypoglycemic events was 37.5% lower in the threshold-suspend group than in the control group (980 +/- 1200 mg per deciliter [54.4 +/- 66.6 mmol per liter]xminutes vs. 1568 +/- 1995 mg per deciliter [87.0 +/- 110.7 mmol per liter]xminutes, P<0.001). Nocturnal hypoglycemic events occurred 31.8% less frequently in the threshold-suspend group than in the control group (1.5 +/- 1.0 vs. 2.2 +/- 1.3 per patient-week, P<0.001). The percentages of nocturnal sensor glucose values of less than 50 mg per deciliter (2.8 mmol per liter), 50 to less than 60 mg per deciliter (3.3 mmol per liter), and 60 to less than 70 mg per deciliter (3.9 mmol per liter) were significantly reduced in the threshold-suspend group (P<0.001 for each range). After 1438 instances at night in which the pump was stopped for 2 hours, the mean sensor glucose value was 92.6 +/- 40.7 mg per deciliter (5.1 +/- 2.3 mmol per liter). Four patients (all in the control group) had a severe hypoglycemic event; no patients had diabetic ketoacidosis. Conclusions This study showed that over a 3-month period the use of sensor-augmented insulin-pump therapy with the threshold-suspend feature reduced nocturnal hypoglycemia, without increasing glycated hemoglobin values. (Funded by Medtronic MiniMed; ASPIRE ClinicalTrials.gov number, NCT01497938.)	[Bergenstal, Richard M.] Int Diabet Ctr Pk Nicollet, Minneapolis, MN 55416 USA; [Klonoff, David C.] Mills Peninsula Hlth Serv, Diabet Res Inst, San Mateo, CA USA; [Welsh, John B.; Lee, Scott W.; Kaufman, Francine R.] Medtronic, Northridge, CA USA; [Garg, Satish K.; Slover, Robert H.] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Bode, Bruce W.] Atlanta Diabet Associates, Atlanta, GA USA; [Meredith, Melissa] Univ Wisconsin, Dept Med, Madison, WI USA; [Ahmann, Andrew J.] Oregon Hlth & Sci Univ, Harold Schnitzer Diabet Hlth Ctr, Portland, OR 97201 USA	International Diabetes Center; Medtronic; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University	Bergenstal, RM (corresponding author), Int Diabet Ctr Pk Nicollet, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA.	richard.bergenstal@parknicollet.com	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285	Medtronic MiniMed	Medtronic MiniMed	Supported by Medtronic MiniMed.	Agrawal Pratik, 2011, J Diabetes Sci Technol, V5, P1137; Bailey TS, 2012, DIABETES, V61, pLB8; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Chen YHJ, 2004, STAT MED, V23, P1023, DOI 10.1002/sim.1688; Choudhary P, 2011, DIABETES CARE, V34, P2023, DOI 10.2337/dc10-2411; COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617; Cryer PE, 2005, DIABETES, V54, P3592, DOI 10.2337/diabetes.54.12.3592; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; Cryer PE, 2010, ENDOCRIN METAB CLIN, V39, P641, DOI 10.1016/j.ecl.2010.05.003; Danne T, 2011, DIABETES TECHNOL THE, V13, P1129, DOI 10.1089/dia.2011.0084; Garg S, 2012, DIABETES TECHNOL THE, V14, P205, DOI 10.1089/dia.2011.0292; Li G, 2002, BIOSTATISTICS, V3, P277, DOI 10.1093/biostatistics/3.2.277; Ly TT, 2012, DIABETES CARE, V35, P1462, DOI 10.2337/dc12-0052; Mehta CR, 2011, STAT MED, V30, P3267, DOI 10.1002/sim.4102; Peyrot M, 2013, DIABETIC MED, V30, P464, DOI 10.1111/dme.12079; Tanenberg RJ, 2010, ENDOCR PRACT, V16, P244, DOI 10.4158/EP09260.CR; TOWLER DA, 1993, DIABETES, V42, P1791, DOI 10.2337/diabetes.42.12.1791; Waheed N, 2013, PRACT DIABETES, V30, P33, DOI 10.1002/pdi.1737; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	19	415	419	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 18	2013	369	3					224	232		10.1056/NEJMoa1303576	http://dx.doi.org/10.1056/NEJMoa1303576			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185DQ	23789889				2022-12-28	WOS:000321945800008
J	Krimigis, SM; Decker, RB; Roelof, EC; Hill, ME; Armstrong, TP; Gloeckler, G; Hamilton, DC; Lanzerotti, LJ				Krimigis, S. M.; Decker, R. B.; Roelof, E. C.; Hill, M. E.; Armstrong, T. P.; Gloeckler, G.; Hamilton, D. C.; Lanzerotti, L. J.			Search for the Exit: Voyager 1 at Heliosphere's Border with the Galaxy	SCIENCE			English	Article							TERMINATION SHOCK; COSMIC-RAYS; SOLAR-WIND; TRANSITION REGION; HELIOSHEATH; FLOW; ACCELERATION; INTENSITY; DISTANCE; VELOCITY	We report measurements of energetic (>40 kiloelectron volts) charged particles on Voyager 1 from the interface region between the heliosheath, dominated by heated solar plasma, and the local interstellar medium, which is expected to contain cold nonsolar plasma and the galactic magnetic field. Particles of solar origin at Voyager 1, located at 18.5 billion kilometers (123 astronomical units) from the Sun, decreased by a factor of >10(3) on 25 August 2012, while those of galactic origin (cosmic rays) increased by 9.3% at the same time. Intensity changes appeared first for particles moving in the azimuthal direction and were followed by those moving in the radial and antiradial directions with respect to the solar radius vector. This unexpected heliospheric "depletion region" may form part of the interface between solar plasma and the galaxy.	[Krimigis, S. M.; Decker, R. B.; Roelof, E. C.; Hill, M. E.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Krimigis, S. M.] Acad Athens, Off Space Res & Technol, Athens 10679, Greece; [Armstrong, T. P.] Fundamental Technol LLC, Lawrence, KS 66046 USA; [Gloeckler, G.] Univ Michigan, Ann Arbor, MI 48109 USA; [Hamilton, D. C.] Univ Maryland, College Pk, MD 20742 USA; [Lanzerotti, L. J.] New Jersey Inst Technol, Newark, NJ 07102 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Academy of Athens; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland College Park; New Jersey Institute of Technology	Krimigis, SM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	tom.krimigis@jhuapl.edu	Roelof, Edmond/G-6654-2019; Krimigis, Stamatios/G-4591-2019; Hill, Matthew/H-4312-2016	Roelof, Edmond/0000-0002-2270-0652; Krimigis, Stamatios/0000-0003-2781-2386; Hill, Matthew/0000-0002-5674-4936; Hamilton, Douglas/0000-0001-6103-8019	NASA [NNN06AA01C]	NASA(National Aeronautics & Space Administration (NASA))	Work at the Johns Hopkins University Applied Physics Laboratory is supported by NASA contract NNN06AA01C and by subcontracts at the University of Maryland and Fundamental Technologies LLC. We thank J. Gunther, L. Brown, and S. Lasley for assistance in the data analyses efforts.	Burlaga LF, 2013, SCIENCE, V341, P147, DOI 10.1126/science.1235451; Compton AH, 1935, PHYS REV, V47, P0817, DOI 10.1103/PhysRev.47.817; DAVIS L, 1955, PHYS REV, V100, P1440, DOI 10.1103/PhysRev.100.1440; Decker RB, 2008, NATURE, V454, P67, DOI 10.1038/nature07030; Decker R. B., 2013, 12 ANN INT ASTR C MY; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; Decker RB, 2012, NATURE, V489, P124, DOI 10.1038/nature11441; Fermi E., 1949, PHYS REV, V75, P1169, DOI DOI 10.1103/PHYSREV.75.1169; Fisk L. A., 2011, AM GEOPH UN M SAN FR; Gurnett D. A., 2005, INTRO PLASMA PHYS; Izmodenov V. V., 2006, MODERN MULTICOMPONEN, P67; Kota J, 2012, AIP CONF PROC, V1436, P157, DOI 10.1063/1.4723603; Krimigis SM, 2003, NATURE, V426, P45, DOI 10.1038/nature02068; KRIMIGIS SM, 1977, SPACE SCI REV, V21, P329, DOI 10.1007/BF00211545; Krimigis SM, 2011, NATURE, V474, P359, DOI 10.1038/nature10115; LANZEROTTI LJ, 1995, GEOPHYS RES LETT, V22, P3353, DOI 10.1029/95GL03551; McComas DJ, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/19; McComas DJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025437; Opher M, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/80; PESSES ME, 1981, ASTROPHYS J, V246, pL85, DOI 10.1086/183559; Pogorelov NV, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L4; Stone EC, 2013, SCIENCE, V341, P150, DOI 10.1126/science.1236408; Washimi H, 2011, MON NOT R ASTRON SOC, V416, P1475, DOI 10.1111/j.1365-2966.2011.19144.x; Webber WR, 2013, GEOPHYS RES LETT, V40, P1665, DOI 10.1002/grl.50383; Webber WR, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013689; Zank GP, 1999, SPACE SCI REV, V89, P413, DOI 10.1023/A:1005155601277	26	162	162	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					144	147		10.1126/science.1235721	http://dx.doi.org/10.1126/science.1235721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23811223				2022-12-28	WOS:000321965300034
J	Annas, GJ; Crosby, SS; Glantz, LH				Annas, George J.; Crosby, Sondra S.; Glantz, Leonard H.			Guantanamo Bay: A Medical Ethics-free Zone?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUNGER STRIKES		[Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831; Crosby, Sondra/0000-0002-1672-5407; Glantz, Leonard/0000-0003-4591-2305				Annas GJ, 2006, NEW ENGL J MED, V355, P1377, DOI 10.1056/NEJMhle062316; Annas GJ., 2010, WORST CASE BIOETHICS; [Anonymous], 2013, REP CONST PROJ TASK; BEAM T, 2003, MILITARY MED ETHICS, V2; Crosby SS, 2007, JAMA-J AM MED ASSOC, V298, P563, DOI 10.1001/jama.298.5.563	5	22	23	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					101	103		10.1056/NEJMp1306065	http://dx.doi.org/10.1056/NEJMp1306065			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180BH	23758205				2022-12-28	WOS:000321567300003
J	Black, N				Black, Nicholas			Can England's NHS Survive?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England	University of London; London School of Hygiene & Tropical Medicine	Black, N (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England.							Black N, 2013, J HEALTH SERV RES PO, V18, P129, DOI 10.1177/1355819613489545; Francis R., 2013, REPORT OF THE MID ST; Nuffield Trust, 2013, RATING PROVIDERS FOR; Roberts A, 2012, DECADE AUSTERITY FUN; Shahian DM, 2010, NEW ENGL J MED, V363, P2530, DOI 10.1056/NEJMsa1006396	5	24	25	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					1	3		10.1056/NEJMp1305771	http://dx.doi.org/10.1056/NEJMp1305771			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175WE	23782160	Green Published			2022-12-28	WOS:000321263500002
J	Hempel, S				Hempel, Sandra			James Marsh and the poison panic	LANCET			English	Editorial Material											Hempel, S (corresponding author), 68 Palewell Pk, London SW14 8JH, England.	palewell@globalnet.co.uk						Forbes TR, 1985, SURGEONS AT THE BAIL; Hempel S., 2013, THE INHERITORS POWDE; Marsh James, 1836, EDINBURGH NEW PHIL J, V21, P229; Watson K., 2004, POISONED LIVES; Whorton J., 2010, THE ARSENIC CENTURY	5	0	0	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 29	2013	381	9885					2247	2248		10.1016/S0140-6736(13)61472-5	http://dx.doi.org/10.1016/S0140-6736(13)61472-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173SU	23819157				2022-12-28	WOS:000321100300016
J	Fryzuk, MD				Fryzuk, Michael D.			More Can Be Better in N-2 Activation	SCIENCE			English	Editorial Material							DINITROGEN		Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia	Fryzuk, MD (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	fryzuk@chem.ubc.ca	Fryzuk, Michael/B-7440-2015					Akagi F, 2007, ANGEW CHEM INT EDIT, V46, P8778, DOI 10.1002/anie.200703336; Ballmann J, 2010, CHEM COMMUN, V46, P1013, DOI 10.1039/b922853e; Fryzuk MD, 2013, CHEM COMMUN, V49, P4866, DOI 10.1039/c3cc42001a; Fryzuk MD, 2009, ACCOUNTS CHEM RES, V42, P127, DOI 10.1021/ar800061g; Hoffman BM, 2013, ACCOUNTS CHEM RES, V46, P587, DOI 10.1021/ar300267m; Peplow M., 2013, CHEM WORLD, P48; Shima T, 2013, SCIENCE, V340, P1549, DOI 10.1126/science.1238663	7	27	29	4	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1530	1531		10.1126/science.1240365	http://dx.doi.org/10.1126/science.1240365			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812704				2022-12-28	WOS:000321007000024
J	Chien, KR				Chien, Kenneth R.			REGENERATIVE BIOLOGY Heartbroken embryos heal	NATURE			English	Editorial Material							CELLS		[Chien, Kenneth R.] Karolinska Inst, Dept Cell & Mol Biol & Med, S-17177 Stockholm, Sweden; [Chien, Kenneth R.] Harvard Univ, Cambridge, MA 02138 USA	Karolinska Institutet; Harvard University	Chien, KR (corresponding author), Karolinska Inst, Dept Cell & Mol Biol & Med, S-17177 Stockholm, Sweden.	kenneth.chien@ki.se						Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Drenckhahn JD, 2008, DEV CELL, V15, P521, DOI 10.1016/j.devcel.2008.09.005; Fernandez E, 2001, DEV DYNAM, V221, P302, DOI 10.1002/dvdy.1139; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2012, ANNU REV CELL DEV BI, V28, P719, DOI 10.1146/annurev-cellbio-101011-155739; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Morgan T.H., 1901, REGENERATION; Mummery CL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000558; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stevens KN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010855; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhang RL, 2013, NATURE, V498, P497, DOI 10.1038/nature12322	18	1	1	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					439	440		10.1038/nature12262	http://dx.doi.org/10.1038/nature12262			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23783518				2022-12-28	WOS:000320929400037
J	Cipriani, A; Hawton, K; Stockton, S; Geddes, JR				Cipriani, Andrea; Hawton, Keith; Stockton, Sarah; Geddes, John R.			Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DELIBERATE SELF-HARM; MENTAL-DISORDERS; YOUNG-PEOPLE; RISK; BEHAVIOR; MORTALITY; THERAPY; DISEASE; BURDEN	Objective To assess whether lithium has a specific preventive effect for suicide and self harm in people with unipolar and bipolar mood disorders. Design Systematic review and meta-analysis. Data sources Medline, Embase, CINAHL, PsycINFO, CENTRAL, web based clinical trial registries, major textbooks, authors of important papers and other experts in the discipline, and websites of pharmaceutical companies that manufacture lithium or the comparator drugs (up to January 2013). Inclusion criteria Randomised controlled trials comparing lithium with placebo or active drugs in long term treatment for mood disorders. Review methods Two reviewers assessed studies for inclusion and risk of bias and extracted data. The main outcomes were the number of people who completed suicide, engaged in deliberate self harm, and died from any cause. Results 48 randomised controlled trials (6674 participants, 15 comparisons) were included. Lithium was more effective than placebo in reducing the number of suicides (odds ratio 0.13, 95% confidence interval 0.03 to 0.66) and deaths from any cause (0.38, 0.15 to 0.95). No clear benefits were observed for lithium compared with placebo in preventing deliberate self harm (0.60, 0.27 to 1.32). In unipolar depression, lithium was associated with a reduced risk of suicide (0.36, 0.13 to 0.98) and also the number of total deaths (0.13, 0.02 to 0.76) compared with placebo. When lithium was compared with each active individual treatment a statistically significant difference was found only with carbamazepine for deliberate self harm. Lithium tended to be generally better than the other active comparators, with small statistical variation between the results. Conclusions Lithium is an effective treatment for reducing the risk of suicide in people with mood disorders. Lithium may exert its antisuicidal effects by reducing relapse of mood disorder, but additional mechanisms should also be considered because there is some evidence that lithium decreases aggression and possibly impulsivity, which might be another mechanism mediating the antisuicidal effect.	[Cipriani, Andrea] Univ Verona, Sect Psychiat, Dept Publ Hlth & Community Med, I-37100 Verona, Italy; [Cipriani, Andrea; Hawton, Keith; Stockton, Sarah; Geddes, John R.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England	University of Verona; University of Oxford	Cipriani, A (corresponding author), Univ Verona, Sect Psychiat, Dept Publ Hlth & Community Med, I-37100 Verona, Italy.	andrea.cipriani@psych.ox.ac.uk	Geddes, John/B-8240-2011; Cipriani, Andrea/P-6944-2015	Geddes, John/0000-0002-5281-5960; Cipriani, Andrea/0000-0001-5179-8321	UK Medical Research Council; UK Economic and Social Research Council; National Institute for Health Research; Stanley Medical Research Institute; MRC [G0700477] Funding Source: UKRI; Medical Research Council [G0700477] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10053, NF-SI-0611-10150] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Stanley Medical Research Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; JRG currently receives research funding from the UK Medical Research Council, UK Economic and Social Research Council, the National Institute for Health Research, and the Stanley Medical Research Institute. He was expert witness for Dr Reddys Laboratories and is chief investigator on the Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in people with bipolar depression: a 2x2 factorial randomised trial (CEQUEL) to which GlaxoSmithKline have contributed and supplied investigational drugs; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	[Anonymous], 2001, NAT STRAT SUIC PREV; Baldessarini RJ, 2006, BIPOLAR DISORD, V8, P625, DOI 10.1111/j.1399-5618.2006.00344.x; Bondy B, 2006, MOL PSYCHIATR, V11, P336, DOI 10.1038/sj.mp.4001803; Cipriani A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003492.pub2; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Cipriani A, 2011, CLIN EVID; Currier D, 2008, PSYCHIAT CLIN N AM, V31, P247, DOI 10.1016/j.psc.2008.01.005; Department of Health, 2002, NAT SUIC PREV STRAT; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Ernst CL, 2004, HARVARD REV PSYCHIAT, V12, P14, DOI 10.1080/10673220490425924; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Geddes JR, 2004, AM J PSYCHIAT, V161, P217, DOI 10.1176/appi.ajp.161.2.217; Gonzalez-Pinto A, 2006, BIPOLAR DISORD, V8, P618, DOI 10.1111/j.1399-5618.2006.00368.x; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Guzzetta F, 2007, J CLIN PSYCHIAT, V68, P380, DOI 10.4088/JCP.v68n0304; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hawton K, 2003, PSYCHOL MED, V33, P987, DOI 10.1017/S0033291703007943; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kovacsics CE, 2009, ANNU REV PHARMACOL, V49, P175, DOI 10.1146/annurev.pharmtox.011008.145557; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Madge N, 2008, J CHILD PSYCHOL PSYC, V49, P667, DOI 10.1111/j.1469-7610.2008.01879.x; Malhi GS, 2011, CNS DRUGS, V25, P289, DOI 10.2165/11586970-000000000-00000; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; National Institute for Health and Clinical Excellence, 2011, SELF HARM LONG TERM, V133; National Institute of Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR, V90; Nordentoft M, 2011, ARCH GEN PSYCHIAT, V68, P1058, DOI 10.1001/archgenpsychiatry.2011.113; O'Donnell KC, 2007, NEUROSCI BIOBEHAV R, V31, P932, DOI 10.1016/j.neubiorev.2007.04.002; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Perlis RH, 2011, AM J PSYCHIAT, V168, P1009, DOI 10.1176/appi.ajp.2011.11081250; Saunders KEA, 2009, EPIDEMIOL PSICHIAT S, V18, P172, DOI 10.1017/S1121189X00000427; Simon GE, 2006, AM J PSYCHIAT, V163, P41, DOI 10.1176/appi.ajp.163.1.41; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Yerevanian BI, 2007, J AFFECT DISORDERS, V103, P5, DOI 10.1016/j.jad.2007.05.019	38	460	470	8	88	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2013	346								f3646	10.1136/bmj.f3646	http://dx.doi.org/10.1136/bmj.f3646			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179AA	23814104	hybrid, Green Published			2022-12-28	WOS:000321487300002
J	Maxted, PFL; Serenelli, AM; Miglio, A; Marsh, TR; Heber, U; Dhillon, VS; Littlefair, S; Copperwheat, C; Smalley, B; Breedt, E; Schaffenroth, V				Maxted, Pierre F. L.; Serenelli, Aldo M.; Miglio, Andrea; Marsh, Thomas R.; Heber, Ulrich; Dhillon, Vikram S.; Littlefair, Stuart; Copperwheat, Chris; Smalley, Barry; Breedt, Elme; Schaffenroth, Veronika			Multi-periodic pulsations of a stripped red-giant star in an eclipsing binary system	NATURE			English	Article							WHITE-DWARF COMPANION; HELIUM-RICH; EVOLUTION; CORE; DISCOVERY; AGES; COOL; HOT	Low-mass white-dwarf stars are the remnants of disrupted red-giant stars in binary millisecond pulsars(1) and other exotic binary star systems(2-4). Some low-mass white dwarfs cool rapidly, whereas others stay bright for millions of years because of stable fusion in thick surface hydrogen layers(5). This dichotomy is not well understood, so the potential use of low-mass white dwarfs as independent clocks with which to test the spin-down ages of pulsars(6,7) or as probes of the extreme environments in which low-mass white dwarfs form(8-10) cannot fully be exploited. Here we report precise mass and radius measurements for the precursor to a low-mass white dwarf. We find that only models in which this disrupted red-giant star has a thick hydrogen envelope can match the strong constraints provided by our data. Very cool low-mass white dwarfs must therefore have lost their thick hydrogen envelopes by irradiation from pulsar companions(11,12) or by episodes of unstable hydrogen fusion (shell flashes). We also find that this low-mass white-dwarf precursor is a type of pulsating star not hitherto seen. The observed pulsation frequencies are sensitive to internal processes that determine whether this star will undergo shell flashes.	[Maxted, Pierre F. L.; Smalley, Barry] Keele Univ, Astrophys Grp, Keele ST5 5BG, Staffs, England; [Serenelli, Aldo M.] Fac Ciencias, Inst Ciencias Espacio CSIC IEEC, Bellaterra 08193, Spain; [Miglio, Andrea] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Marsh, Thomas R.; Breedt, Elme] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Heber, Ulrich; Schaffenroth, Veronika] Univ Erlangen Nurnberg, Dr Karl Remeis Observ, D-96049 Bamberg, Germany; [Heber, Ulrich; Schaffenroth, Veronika] Univ Erlangen Nurnberg, ECAP, Astron Inst, D-96049 Bamberg, Germany; [Dhillon, Vikram S.; Littlefair, Stuart] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Copperwheat, Chris] Liverpool John Moores Univ, Astrophys Res Inst, Wirral CH41 1LD, Merseyside, England; [Schaffenroth, Veronika] Univ Innsbruck, Inst Astrophys & Particle Phys, A-6020 Innsbruck, Austria	Keele University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Birmingham; University of Warwick; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Sheffield; Liverpool John Moores University; University of Innsbruck	Maxted, PFL (corresponding author), Keele Univ, Astrophys Grp, Keele ST5 5BG, Staffs, England.	p.maxted@keele.ac.uk	Miglio, Andrea/M-5789-2018; Dhillon, Vikram/AAB-5180-2019; Serenelli, Aldo/F-2836-2017; miglio, andrea/O-9594-2019; Heber, Ulrich/W-3956-2019	Miglio, Andrea/0000-0001-5998-8533; Dhillon, Vikram/0000-0003-4236-9642; Serenelli, Aldo/0000-0001-6359-2769; miglio, andrea/0000-0001-5998-8533; Heber, Ulrich/0000-0001-7798-6769; Littlefair, Stuart/0000-0001-7221-855X; Schaffenroth, Veronika/0000-0001-6339-6768; Copperwheat, Christopher/0000-0001-7983-8698	Re-integration Grant [PIRG-GA-2009-247732]; MICINN grant [AYA2011-24704]; Deutsches Zentrum fur Luft- und Raumfahrt [50 OR 1110]; Erika-Giehrl-Stiftung; UK Science and Technology Facilities Council [ST/I001719/1]; STFC [ST/J001589/1, ST/I001719/1, ST/J000035/1, ST/G002355/1, ST/I005773/1, PP/D000955/1, PP/F000057/1, ST/K002783/1, ST/J001384/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001589/1, PP/F000057/1, ST/K002783/1, ST/J000035/1, ST/J001384/1, ST/I001719/1, ST/I005773/1, PP/D000955/1, ST/G002355/1] Funding Source: researchfish	Re-integration Grant; MICINN grant(Spanish Government); Deutsches Zentrum fur Luft- und Raumfahrt(Helmholtz AssociationGerman Aerospace Centre (DLR)); Erika-Giehrl-Stiftung; UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the ESO staff who obtained our UVES data for carefully scheduling the observations at the correct orbital phases. We thank A. Cherman and D. Kurtz for comments on a draft version of the paper. This work is based on observations collected at the ESO, Chile (program ID: 086.D-0194). A. M. S. is partially supported by a Re-integration Grant (PIRG-GA-2009-247732; FP7-People), and a MICINN grant (AYA2011-24704). V. S. acknowledges funding by the Deutsches Zentrum fur Luft- und Raumfahrt (grant 50 OR 1110) and by the Erika-Giehrl-Stiftung. T. R. M. acknowledges funding from the UK Science and Technology Facilities Council (ST/I001719/1).	Aerts C., 2010, ASTRON ASTROPHYS LIB; Althaus LG, 2001, MON NOT R ASTRON SOC, V323, P471, DOI 10.1046/j.1365-8711.2001.04227.x; Bassa CG, 2006, ASTRON ASTROPHYS, V450, P295, DOI 10.1051/0004-6361:20054316; Beck PG, 2012, NATURE, V481, P55, DOI 10.1038/nature10612; Biro IB, 2011, MON NOT R ASTRON SOC, V416, P1601, DOI 10.1111/j.1365-2966.2011.18400.x; Breton RP, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/108; Breton RP, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/115; Dhillon VS, 2007, MON NOT R ASTRON SOC, V378, P825, DOI 10.1111/j.1365-2966.2007.11881.x; Dotter A, 2008, ASTROPHYS J SUPPL S, V178, P89, DOI 10.1086/589654; Driebe T, 1998, ASTRON ASTROPHYS, V339, P123; Dupret MA, 2004, ASTRON ASTROPHYS, V414, pL17, DOI 10.1051/0004-6361:20031740; Dupret MA, 2004, ASTRON ASTROPHYS, V415, P251, DOI 10.1051/0004-6361:20034143; Ergma E, 2001, MON NOT R ASTRON SOC, V321, P71, DOI 10.1046/j.1365-8711.2001.04000.x; Espinoza CM, 2011, ASTROPHYS J LETT, V741, DOI 10.1088/2041-8205/741/1/L13; Gezari S, 2012, NATURE, V485, P217, DOI 10.1038/nature10990; Hermes JJ, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/42; IBEN I, 1986, ASTROPHYS J, V311, P742, DOI 10.1086/164812; Kilic M, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/3; Kiziltan B, 2010, ASTROPHYS J, V715, P335, DOI 10.1088/0004-637X/715/1/335; Knigge C, 2008, ASTROPHYS J, V683, P1006, DOI 10.1086/589987; Lorimer DR, 2008, LIVING REV RELATIV, V11, DOI 10.12942/lrr-2008-8; Maxted PFL, 2012, ASTR SOC P, V452, P137; Maxted PFL, 2011, MON NOT R ASTRON SOC, V418, P1156, DOI 10.1111/j.1365-2966.2011.19567.x; Nelson LA, 2004, ASTROPHYS J, V616, P1124, DOI 10.1086/421698; Noutsos A, 2013, MON NOT R ASTRON SOC, V430, P2281, DOI 10.1093/mnras/stt047; Strickler RR, 2009, ASTROPHYS J, V699, P40, DOI 10.1088/0004-637X/699/1/40; van Kerkwijk M. H., 2005, ASP C SER, V328, P357; WEBBINK RF, 1975, MON NOT R ASTRON SOC, V171, P555, DOI 10.1093/mnras/171.3.555	28	75	75	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					463	465		10.1038/nature12192	http://dx.doi.org/10.1038/nature12192			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803845	Green Submitted			2022-12-28	WOS:000320929400047
J	Wise, J				Wise, Jacqui			People in mental health crises are treated like criminals, says report	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2013, CRIMINAL USE POLICE	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2013	346								f4036	10.1136/bmj.f4036	http://dx.doi.org/10.1136/bmj.f4036			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171RC	23794275				2022-12-28	WOS:000320945700007
J	Ananthanarayanan, V; Schattat, M; Vogel, SK; Krull, A; Pavin, N; Tolic-Norrelykke, IM				Ananthanarayanan, Vaishnavi; Schattat, Martin; Vogel, Sven K.; Krull, Alexander; Pavin, Nenad; Tolic-Norrelykke, Iva M.			Dynein Motion Switches from Diffusive to Directed upon Cortical Anchoring	CELL			English	Article							SINGLE-MOLECULE ANALYSIS; CYTOPLASMIC DYNEIN; FISSION YEAST; CAENORHABDITIS-ELEGANS; MEIOTIC PROPHASE; NUCLEAR-MOVEMENT; TAIL DOMAIN; SPINDLE ORIENTATION; MYOSIN VA; IN-VIVO	Cytoplasmic dynein is a motor protein that exerts force on microtubules. To generate force for the movement of large organelles, dynein needs to be anchored, with the anchoring sites being typically located at the cell cortex. However, the mechanism by which dyneins target sites where they can generate large collective forces is unknown. Here, we directly observe single dyneins during meiotic nuclear oscillations in fission yeast and identify the steps of the dynein binding process: from the cytoplasm to the microtubule and from the microtubule to cortical anchors. We observed that dyneins on the microtubule move either in a diffusive or directed manner, with the switch from diffusion to directed movement occurring upon binding of dynein to cortical anchors. This dual behavior of dynein on the microtubule, together with the two steps of binding, enables dyneins to self-organize into a spatial pattern needed for them to generate large collective forces.	[Ananthanarayanan, Vaishnavi; Schattat, Martin; Vogel, Sven K.; Krull, Alexander; Pavin, Nenad; Tolic-Norrelykke, Iva M.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Pavin, Nenad] Univ Zagreb, Fac Sci, Dept Phys, Zagreb 10002, Croatia	Max Planck Society; University of Zagreb	Pavin, N (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	npavin@phy.hr; tolic@mpi-cbg.de	Tolić, Iva/F-1704-2014; Schattat, Martin/AAT-8247-2020; Pavin, Nenad/N-6376-2013; Ananthanarayanan, Vaishnavi/AAJ-7170-2020	Tolić, Iva/0000-0003-1305-7922; Schattat, Martin/0000-0002-1995-1960; Pavin, Nenad/0000-0002-4313-1081; Ananthanarayanan, Vaishnavi/0000-0003-2936-7853; Krull, Alexander/0000-0002-7778-7169; Vogel, Sven Kenjiro/0000-0003-2540-5947	Max Planck Society; German Research Foundation (DFG)	Max Planck Society(Max Planck Society); German Research Foundation (DFG)(German Research Foundation (DFG))	V.A. carried out all experiments and data analysis. M.S. established a protocol for fast imaging and obtained initial data. S.K.V. performed pilot experiments. A.K. developed the tracking software. I.M.T-N. and N.P. designed the project and wrote the paper with input from V.A. We thank G. Rodel, K. Bloom, K. Sawin, A. Yamashita, and the Yeast Genetic Resource Center for strains and plasmids; Dr. Jacob Kerssemakers and Dr. Marileen Dogterom for the STEPFINDER software; B. Schroth-Diez and D.J. White from the Light Microscopy Facility of MPI-CBG; P. Delivani, D. Ramunno-Johnson, and H. Weisse for technical help; I. Saric for the drawings; J. Howard, S.W. Grill, N. Maghelli, M. Neetz, M. Chacon, A. Klemm, D. Accardi, and I. Kalinina for discussions and comments on the manuscript; and the Max Planck Society and the German Research Foundation (DFG) for funding.	Abraham AV, 2009, OPT EXPRESS, V17, P23352, DOI 10.1364/OE.17.023352; Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Coelho M, 2013, INTEGR BIOL-UK, V5, P748, DOI 10.1039/c3ib40018b; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; ESHEL D, 1993, P NATL ACAD SCI USA, V90, P11172, DOI 10.1073/pnas.90.23.11172; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Friedman DS, 1999, NAT CELL BIOL, V1, P293, DOI 10.1038/13008; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; Hammond JW, 2010, J CELL BIOL, V189, P1013, DOI 10.1083/jcb.201001057; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Heil-Chapdelaine RA, 2000, J CELL BIOL, V151, P1337, DOI 10.1083/jcb.151.6.1337; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; JOHNSON KA, 1983, J CELL BIOL, V96, P669, DOI 10.1083/jcb.96.3.669; Kalinina I, 2013, NAT CELL BIOL, V15, P82, DOI 10.1038/ncb2640; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Kimura K, 2011, P NATL ACAD SCI USA, V108, P137, DOI 10.1073/pnas.1013275108; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; LI YY, 1993, P NATL ACAD SCI USA, V90, P10096, DOI 10.1073/pnas.90.21.10096; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Saito TT, 2006, J CELL BIOL, V173, P27, DOI 10.1083/jcb.200512129; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Trokter M, 2012, P NATL ACAD SCI USA, V109, P20895, DOI 10.1073/pnas.1210573110; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamamoto A, 2001, MOL BIOL CELL, V12, P3933, DOI 10.1091/mbc.12.12.3933; Yamashita A, 2006, GENETICS, V173, P1187, DOI 10.1534/genetics.105.050062; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	50	56	57	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1526	1536		10.1016/j.cell.2013.05.020	http://dx.doi.org/10.1016/j.cell.2013.05.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791180	Bronze			2022-12-28	WOS:000320722000020
J	Rembold, CM				Rembold, Christopher M.			Review: Vitamin and antioxidant supplements do not prevent adverse cardiovascular events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DISEASE		Univ Virginia, Charlottesville, VA 22903 USA	University of Virginia	Rembold, CM (corresponding author), Univ Virginia, Charlottesville, VA 22903 USA.		Rembold, Christopher/K-8359-2013	Rembold, Christopher/0000-0003-0819-7488				Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Rembold CM, 2007, ATHEROSCLEROSIS, V195, P1, DOI 10.1016/j.atherosclerosis.2006.09.009; Rembold CM, 1998, BMJ-BRIT MED J, V317, P307, DOI 10.1136/bmj.317.7154.307	5	5	5	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12							JC10	10.7326/0003-4819-158-12-201306180-02010	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778922				2022-12-28	WOS:000320645000009
J	Eriksson, UK; Fischer, G; Friemann, R; Enkavi, G; Tajkhorshid, E; Neutze, R				Eriksson, Urszula Kosinska; Fischer, Gerhard; Friemann, Rosmarie; Enkavi, Giray; Tajkhorshid, Emad; Neutze, Richard			Subangstrom Resolution X-Ray Structure Details Aquaporin-Water Interactions	SCIENCE			English	Article							CRYSTAL-STRUCTURE; PROTON EXCLUSION; CHANNEL; PERMEATION; MECHANISM; SELECTIVITY; TRANSPORT; DYNAMICS	Aquaporins are membrane channels that facilitate the flow of water across biological membranes. Two conserved regions are central for selective function: the dual asparagine-proline-alanine (NPA) aquaporin signature motif and the aromatic and arginine selectivity filter (SF). Here, we present the crystal structure of a yeast aquaporin at 0.88 angstrom resolution. We visualize the H-bond donor interactions of the NPA motif's asparagine residues to passing water molecules; observe a polarized water-water H-bond configuration within the channel; assign the tautomeric states of the SF histidine and arginine residues; and observe four SF water positions too closely spaced to be simultaneously occupied. Strongly correlated movements break the connectivity of SF waters to other water molecules within the channel and prevent proton transport via a Grotthuss mechanism.	[Eriksson, Urszula Kosinska; Fischer, Gerhard; Friemann, Rosmarie; Neutze, Richard] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden; [Enkavi, Giray; Tajkhorshid, Emad] Univ Illinois, Ctr Biophys & Computat Biol, Coll Med, Dept Biochem, Urbana, IL 61802 USA; [Enkavi, Giray; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61802 USA	University of Gothenburg; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Tajkhorshid, E (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Coll Med, Dept Biochem, Urbana, IL 61802 USA.	emad@life.illinois.edu; richard.neutze@chem.gu.se	Neutze, Richard/A-7573-2010; Tajkhorshid, Emad/AAN-8323-2021; Friemann, Rosmarie/C-1018-2008; Fischer, Gerhard/B-2900-2011	Neutze, Richard/0000-0003-0986-6153; Friemann, Rosmarie/0000-0002-5633-2894; Fischer, Gerhard/0000-0001-9861-1528; Tajkhorshid, Emad/0000-0001-8434-1010	European Union Integrated Project EDICT; Marie Curie Training Network Aqua(glycero)porins; Olle Engkvist Foundation; Swedish Research Council; NIH [R01-GM086749, U54-GM087519, P41-GM104601]; NSF supercomputing centers [MCA06N060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104601, U54GM087519, R01GM086749] Funding Source: NIH RePORTER	European Union Integrated Project EDICT; Marie Curie Training Network Aqua(glycero)porins; Olle Engkvist Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF supercomputing centers(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support is acknowledged from the European Union Integrated Project EDICT and the Marie Curie Training Network Aqua(glycero)porins, the Olle Engkvist Foundation, the Swedish Research Council, and NIH (grants R01-GM086749, U54-GM087519, and P41-GM104601). All simulations were performed using XSEDE resources at NSF supercomputing centers (grant MCA06N060). We thank staff of beamline ID29 of the ESRF for assistance during data collection and Karin Rodstrom for setting up crystallization plates at the ESRF in advance of data collection. The authors have made the following contributions: G. F., U. K. E., and R.N. conceived and designed the experiments; G. F. and U. K. E. performed the experiments; G. F., R. F., and U. K. E. analyzed the crystallographic data; G. E. and E. T. conceived and designed the MD simulations; and G. E. performed and analyzed the simulations. All authors contributed to writing the manuscript. Coordinates and structure factors have been deposited in the Protein Data Bank with accession number 3zoj.	Burykin A, 2003, BIOPHYS J, V85, P3696, DOI 10.1016/S0006-3495(03)74786-9; Chakrabarti N, 2004, STRUCTURE, V12, P65, DOI 10.1016/j.str.2003.11.017; de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003; de Groot BL, 2003, J MOL BIOL, V333, P279, DOI 10.1016/j.jmb.2003.08.003; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; de Grotthuss CJT, 2006, BBA-BIOENERGETICS, V1757, P871, DOI 10.1016/j.bbabio.2006.07.004; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Jensen MO, 2003, BIOPHYS J, V85, P2884, DOI 10.1016/S0006-3495(03)74711-0; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Lee JK, 2005, P NATL ACAD SCI USA, V102, P18932, DOI 10.1073/pnas.0509469102; Li H, 2011, J MOL BIOL, V407, P607, DOI 10.1016/j.jmb.2011.01.036; Marx D, 2006, CHEMPHYSCHEM, V7, P1848, DOI 10.1002/cphc.200600128; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Newby ZER, 2008, NAT STRUCT MOL BIOL, V15, P619, DOI 10.1038/nsmb.1431; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Wang Y, 2005, STRUCTURE, V13, P1107, DOI 10.1016/j.str.2005.05.005; Wree D, 2011, FEBS J, V278, P740, DOI 10.1111/j.1742-4658.2010.07993.x; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	26	142	144	3	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1346	1349		10.1126/science.1234306	http://dx.doi.org/10.1126/science.1234306			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766328	Green Accepted			2022-12-28	WOS:000320320200049
J	Jiang, F; Zhang, J; Shen, XM				Jiang, Fan; Zhang, Jun; Shen, Xiaoming			Towards evidence-based public health policy in China	LANCET			English	Editorial Material							TWITTER		[Jiang, Fan; Zhang, Jun; Shen, Xiaoming] Xinhua Hosp, Minist Educ, Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China; [Jiang, Fan; Shen, Xiaoming] Shanghai Childrens Med Ctr, Shanghai, Peoples R China; [Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, XM (corresponding author), Xinhua Hosp, Minist Educ, Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China.	xmshen@shsmu.edu.cn	Jiang, Fan/AHA-6297-2022; Jiang, Fan/AGX-9052-2022	Jiang, Fan/0000-0003-0634-101X				Gray JAM, 2004, BRIT MED J, V329, P988, DOI 10.1136/bmj.329.7473.988; Hines A, 2012, HEALTH PROMOT PRACT, V13, P733, DOI 10.1177/1524839912457682; Jacobs JA, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110324; Jiang F, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-33; King D, 2013, HEALTH POLICY, V110, P291, DOI 10.1016/j.healthpol.2013.02.005; Kotchen TA, 2011, HYPERTENSION, V58, P522, DOI 10.1161/HYPERTENSIONAHA.111.177766; Li Y, 2008, ZHONGGUO XUN ZHENG Y, V8, P945; Lomas J, 2009, MILBANK Q, V87, P903, DOI 10.1111/j.1468-0009.2009.00583.x; McKee M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d948; Orton L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021704; Pfeiffer J, 2013, ACAD MED, V88, P131, DOI 10.1097/ACM.0b013e318276bdf4; van Kammen J, 2006, B WORLD HEALTH ORGAN, V84, P608, DOI 10.2471/BLT.05.028308	12	14	18	2	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 8	2013	381	9882					1962	1964		10.1016/S0140-6736(13)61083-1	http://dx.doi.org/10.1016/S0140-6736(13)61083-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171JY	23746884				2022-12-28	WOS:000320924400006
J	Quental, TB; Marshall, CR				Quental, Tiago B.; Marshall, Charles R.			How the Red Queen Drives Terrestrial Mammals to Extinction	SCIENCE			English	Article							NORTH-AMERICAN MAMMALS; FOSSIL RECORD; COURT JESTER; DIVERSITY; DIVERSIFICATION; EVOLUTION; HISTORY	Most species disappear by the processes of background extinction, yet those processes are poorly understood. We analyzed the evolutionary dynamics of 19 Cenozoic terrestrial mammalian clades with rich fossil records that are now fully extinct or in diversity decline. We find their diversity loss was not just a consequence of "gamblers ruin" but resulted from the evolutionary loss to the Red Queen, a failure to keep pace with a deteriorating environment. Diversity loss is driven equally by both depressed origination rates and elevated extinction rates. Although we find diversity-dependent origination and extinction rates, the diversity of each clade only transiently equaled the implied equilibrium diversity. Thus, the processes that drove diversity loss in terrestrial mammal clades were fundamentally nonequilibrial and overwhelmed diversity-dependent processes.	[Quental, Tiago B.] Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil; [Marshall, Charles R.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA	Universidade de Sao Paulo; University of California System; University of California Berkeley	Quental, TB (corresponding author), Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil.	tbquental@usp.br; crmarshall@berkeley.edu	Quental, Tiago B/C-7077-2013		Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/04072-3]; USP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); USP	We thank all those who generated the mammal data as well as those who entered the data into the Paleobiology Database, especially J. Alroy, K. Behrensmeyer, A. Turner, M. Uhen, and M. Carrano. This is the Paleobiology Database publication number 178. We thank S. Finnegan, H. Morlon, and S. P. Quek for discussion. T. B. Q. thanks Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2012/04072-3) and USP for funding. All of the data are available from the Paleobiology Database (http://paleodb.org).	Alroy J, 1996, PALAEOGEOGR PALAEOCL, V127, P285, DOI 10.1016/S0031-0182(96)00100-9; Alroy John, 2009, P301; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; Bambach RK, 2004, PALEOBIOLOGY, V30, P522, DOI 10.1666/0094-8373(2004)030<0522:OEAMDO>2.0.CO;2; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; Benton MJ, 2007, PALAEONTOLOGY, V50, P23, DOI 10.1111/j.1475-4983.2006.00612.x; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Foote M, 2007, PALEOBIOLOGY, V33, P517, DOI 10.1666/06084.1; Gilinsky L., 1987, PALEOBIOLOGY, V13, P427; MAC ARTHUR ROBERT H., 1967; RAUP DM, 1973, J GEOL, V81, P525, DOI 10.1086/627905; RAUP DM, 1986, SCIENCE, V231, P1528, DOI 10.1126/science.11542058; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; STANLEY SM, 1981, PALEOBIOLOGY, V7, P115, DOI 10.1017/S0094837300003833; Stanley SM, 2008, PALEOBIOLOGY, V34, P1, DOI 10.1666/07026.1; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; Tolkien J. R. R., 2012, LORD RINGS; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x	19	83	84	2	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					290	292		10.1126/science.1239431	http://dx.doi.org/10.1126/science.1239431			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23788731				2022-12-28	WOS:000321959300047
J	Almada, AE; Wu, XB; Kriz, AJ; Burge, CB; Sharp, PA				Almada, Albert E.; Wu, Xuebing; Kriz, Andrea J.; Burge, Christopher B.; Sharp, Phillip A.			Promoter directionality is controlled by U1 snRNP and polyadenylation signals	NATURE			English	Article							PRE-MESSENGER-RNAS; DIVERGENT TRANSCRIPTION; UPSTREAM; CLEAVAGE; SEQUENCE; REVEALS; TERMINATION; DOWNSTREAM; EXOSOME	Transcription of the mammalian genome is pervasive, but productive transcription outside of protein-coding genes is limited by unknown mechanisms(1). In particular, although RNA polymerase II (RNAPII) initiates divergently from most active gene promoters, productive elongation occurs primarily in the sense-coding direction(2-4). Here we show in mouse embryonic stem cells that asymmetric sequence determinants flanking gene transcription start sites control promoter directionality by regulating promoter-proximal cleavage and polyadenylation. We find that upstream antisense RNAs are cleaved and polyadenylated at poly(A) sites (PASs) shortly after initiation. De novo motif analysis shows PAS signals and U1 small nuclear ribonucleoprotein (snRNP) recognition sites to be the most depleted and enriched sequences, respectively, in the sense direction relative to the upstream antisense direction. These U1 snRNP sites and PAS sites are progressively gained and lost, respectively, at the 5' end of coding genes during vertebrate evolution. Functional disruption of U1 snRNP activity results in a dramatic increase in promoter-proximal cleavage events in the sense direction with slight increases in the antisense direction. These data suggest that a U1-PAS axis characterized by low U1 snRNP recognition and a high density of PASs in the upstream antisense region reinforces promoter directionality by promoting early termination in upstream antisense regions, whereas proximal sense PAS signals are suppressed by U1 snRNP. We propose that the U1-PAS axis limits pervasive transcription throughout the genome.	[Almada, Albert E.; Wu, Xuebing; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Almada, Albert E.; Kriz, Andrea J.; Burge, Christopher B.; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wu, Xuebing; Burge, Christopher B.] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu	Wu, Xuebing/C-9152-2013; Burge, Christopher B./AAH-2177-2020	Wu, Xuebing/0000-0003-0369-5269; 	United States Public Health Service grants from the National Institutes of Health [RO1-GM34277, R01-CA133404]; National Cancer Institute [P30-CA14051]; Public Health Service research grant from the National Institute of General Medical Sciences [M-085319]; NATIONAL CANCER INSTITUTE [R01CA133404, P30CA014051, P01CA042063] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277, R01GM085319] Funding Source: NIH RePORTER	United States Public Health Service grants from the National Institutes of Health; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Public Health Service research grant from the National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the service to the MIT community of the late Sean Collier. We would like to thank N. Spies for generously sharing his optimized 3'-end sequencing protocol, C. Lin for providing computational assistance, M. Lindstrom for assistance on constructing Supplementary Figure 11, and S. Chen, A. Chiu, M. Jangi, Q. Liu, J. Wilusz and J. Zamudio for reading of the manuscript. We also thank the Core Facility in the Swanson Biotechnology Center at the David H. Koch Institute for Integrative Cancer Research at MIT for their assistance with high-throughput sequencing. This work was supported by United States Public Health Service grants RO1-GM34277 and R01-CA133404 from the National Institutes of Health (P. A. S.), partially by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute, and by a Public Health Service research grant (G<SUP>M</SUP>-085319) from the National Institute of General Medical Sciences (C. B. B.). X. W. is a Howard Hughes Medical Institute International Student Research fellow.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Andersen PK, 2012, GENE DEV, V26, P2169, DOI 10.1101/gad.189126.112; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; CONNELLY S, 1989, CELL, V57, P561, DOI 10.1016/0092-8674(89)90126-8; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; GIL A, 1987, CELL, V49, P399, DOI 10.1016/0092-8674(87)90292-3; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; MACDONALD CC, 1994, MOL CELL BIOL, V14, P6647, DOI 10.1128/MCB.14.10.6647; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Preker P, 2011, NUCLEIC ACIDS RES, V39, P7179, DOI 10.1093/nar/gkr370; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xie C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002942; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang L, 2013, BIOCHEM BIOPH RES CO, V430, P26, DOI 10.1016/j.bbrc.2012.11.052; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	34	274	279	4	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					360	U141		10.1038/nature12349	http://dx.doi.org/10.1038/nature12349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23792564	Green Submitted, Green Accepted			2022-12-28	WOS:000321910700041
J	Viboud, C; Simonsen, L				Viboud, Cecile; Simonsen, Lone			Timely estimates of influenza A H7N9 infection severity	LANCET			English	Editorial Material							H1N1 VIRUS		[Viboud, Cecile; Simonsen, Lone] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Simonsen, Lone] George Washington Univ, Dept Global Hlth, Sch Publ Hlth & Hlth Serv, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); George Washington University	Viboud, C (corresponding author), NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	viboudc@mail.nih.gov	Simonsen, Lone/K-4531-2014	Simonsen, Lone/0000-0003-1535-8526				Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; [Anonymous], 2013, LANCET; Bai T, 2013, NEW ENGL J MED, V368, P2339, DOI 10.1056/NEJMc1305865; Baker MG, 2009, EUROSURVEILLANCE, V14, P6; Cowling B, 2013, EUROSURVEILLANCE, V18, P19; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Fiebig L, 2011, EUROSURVEILLANCE, V16, P13; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007; Presanis AM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5408; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Sun XJ, 2013, J VIROL, V87, P8756, DOI 10.1128/JVI.00593-13; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; WHO, 2020, PAND INFL RISK MAN W; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Yu H, 2013, LANCET; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144	19	3	4	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					106	108		10.1016/S0140-6736(13)61447-6	http://dx.doi.org/10.1016/S0140-6736(13)61447-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187JY	23803486	Bronze, Green Published			2022-12-28	WOS:000322115300006
J	Bozinovic, N; Yue, Y; Ren, YX; Tur, M; Kristensen, P; Huang, H; Willner, AE; Ramachandran, S				Bozinovic, Nenad; Yue, Yang; Ren, Yongxiong; Tur, Moshe; Kristensen, Poul; Huang, Hao; Willner, Alan E.; Ramachandran, Siddharth			Terabit-Scale Orbital Angular Momentum Mode Division Multiplexing in Fibers	SCIENCE			English	Article							MULTIPATH INTERFERENCE; OPTICAL-FIBERS; LIGHT; TRANSMISSION	Internet data traffic capacity is rapidly reaching limits imposed by optical fiber nonlinear effects. Having almost exhausted available degrees of freedom to orthogonally multiplex data, the possibility is now being explored of using spatial modes of fibers to enhance data capacity. We demonstrate the viability of using the orbital angular momentum (OAM) of light to create orthogonal, spatially distinct streams of data-transmitting channels that are multiplexed in a single fiber. Over 1.1 kilometers of a specially designed optical fiber that minimizes mode coupling, we achieved 400-gigabits-per-second data transmission using four angular momentum modes at a single wavelength, and 1.6 terabits per second using two OAM modes over 10 wavelengths. These demonstrations suggest that OAM could provide an additional degree of freedom for data multiplexing in future fiber networks.	[Bozinovic, Nenad; Ramachandran, Siddharth] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Bozinovic, Nenad; Ramachandran, Siddharth] Boston Univ, Photon Ctr, Boston, MA 02215 USA; [Yue, Yang; Ren, Yongxiong; Huang, Hao; Willner, Alan E.] Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA; [Tur, Moshe] Tel Aviv Univ, Sch Elect Engn, IL-69978 Tel Aviv, Israel; [Kristensen, Poul] OFS Fitel, DK-2605 Brondby, Denmark	Boston University; Boston University; University of Southern California; Tel Aviv University; Furukawa Electric	Willner, AE (corresponding author), Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA.	willner@usc.edu; sidr@bu.edu	Ramachandran, Siddharth/AAC-4306-2020; Ramachandran, Siddharth/ABF-1647-2020; Ramachandran, Siddharth/G-5799-2012; Kristensen, Poul/GMW-8369-2022; Bozinovic, Nenad/O-1740-2013	Ramachandran, Siddharth/0000-0001-9356-6377; Ramachandran, Siddharth/0000-0001-9356-6377; 	Defense Advanced Research Projects Agency-InPho program; Chief Scientist Office of the Israeli Ministry of Industry, Trade and Labor within the "Tera Santa" consortium	Defense Advanced Research Projects Agency-InPho program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Chief Scientist Office of the Israeli Ministry of Industry, Trade and Labor within the "Tera Santa" consortium	We thank S. Golowich, P. Gregg, and P. Steinvurzel for insightful discussions and M. V. Pedersen for the numerical waveguide simulation tool. This work was funded by the Defense Advanced Research Projects Agency-InPho program. M. T. acknowledges support from the Chief Scientist Office of the Israeli Ministry of Industry, Trade and Labor within the "Tera Santa" consortium. All data related to the experiments described in this manuscript are recorded in laboratory notebooks of members in S.R.'s group, and all associated digital data are stored on networked computers at Boston University, whose contents are archived daily.	Andrews DL, 2008, STRUCTURED LIGHT AND ITS APPLICATIONS: AN INTRODUCTION TO PHASE-STRUCTURED BEAMS AND NANOSCALE OPTICAL FORCES, P1; Berkhout GCG, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.153601; Bozinovic N., 2013, EUR C EXH OPT COMM O; Bozinovic N., 2011, FRONTIERS OPTICS 201; Bozinovic N, 2012, OPT LETT, V37, P2451, DOI 10.1364/OL.37.002451; Carpenter J, 2012, J LIGHTWAVE TECHNOL, V30, P3946, DOI 10.1109/JLT.2012.2206562; Dashti PZ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.043604; Essiambre RJ, 2012, P IEEE, V100, P1035, DOI 10.1109/JPROC.2012.2182970; Gregg P., 2013, C LAS EL 2013 OSA; Groblacher S, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/5/075; MARCUSE D, 1984, APPL OPTICS, V23, P1082, DOI 10.1364/AO.23.001082; McGloin D, 1998, APPL OPTICS, V37, P469, DOI 10.1364/AO.37.000469; Ramachandran S, 2005, IEEE PHOTONIC TECH L, V17, P238, DOI 10.1109/LPT.2004.836902; Ramachandran S, 2003, IEEE PHOTONIC TECH L, V15, P1171, DOI 10.1109/LPT.2003.814880; Ramachandran S, 2009, OPT LETT, V34, P2525, DOI 10.1364/OL.34.002525; Richardson DJ, 2010, SCIENCE, V330, P327, DOI 10.1126/science.1191708; Ryf R, 2012, J LIGHTWAVE TECHNOL, V30, P521, DOI 10.1109/JLT.2011.2174336; Sakaguchi J, 2012, J LIGHTWAVE TECHNOL, V30, P658, DOI 10.1109/JLT.2011.2180509; Su TH, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.009396; Sunnerud H, 2002, J LIGHTWAVE TECHNOL, V20, P368, DOI 10.1109/50.988985; Wang J, 2012, NAT PHOTONICS, V6, P488, DOI [10.1038/nphoton.2012.138, 10.1038/NPHOTON.2012.138]; Wong GKL, 2012, SCIENCE, V337, P446, DOI 10.1126/science.1223824; Yue Y., 2013, C OPT FIB COMM OSA	23	1895	1958	48	619	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1545	1548		10.1126/science.1237861	http://dx.doi.org/10.1126/science.1237861			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812709				2022-12-28	WOS:000321007000034
J	Tourigny, DS; Fernandez, IS; Kelley, AC; Ramakrishnan, V				Tourigny, David S.; Fernandez, Israel S.; Kelley, Ann C.; Ramakrishnan, V.			Elongation Factor G Bound to the Ribosome in an Intermediate State of Translocation	SCIENCE			English	Article							TRANSFER-RNA BINDING; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; MESSENGER-RNA; HYBRID-STATE; BACTERIAL RIBOSOME; FACTOR TU; L1 STALK; EF-TU; ACTIVATION	A key step of translation by the ribosome is translocation, which involves the movement of messenger RNA (mRNA) and transfer RNA (tRNA) with respect to the ribosome. This allows a new round of protein chain elongation by placing the next mRNA codon in the A site of the 30S subunit. Translocation proceeds through an intermediate state in which the acceptor ends of the tRNAs have moved with respect to the 50S subunit but not the 30S subunit, to form hybrid states. The guanosine triphosphatase (GTPase) elongation factor G (EF-G) catalyzes the subsequent movement of mRNA and tRNA with respect to the 30S subunit. Here, we present a crystal structure at 3 angstrom resolution of the Thermus thermophilus ribosome with a tRNA in the hybrid P/E state bound to EF-G with a GTP analog. The structure provides insights into structural changes that facilitate translocation and suggests a common GTPase mechanism for EF-G and elongation factor Tu.	[Tourigny, David S.; Fernandez, Israel S.; Kelley, Ann C.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk		Fernandez, Israel/0000-0001-7218-1603; Ramakrishnan, V/0000-0002-4699-2194	UK Medical Research Council [U105184332]; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332, 1359296] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are indebted to P. R. Elliott and the beamline staff on IO4 at Diamond Light Source and ID14-4 at the European Synchrotron Radiation Facility for help and advice with data collection, and to R. M. Voorhees and C. Spahn for critical comments. This work was supported by grants to V. R. from the UK Medical Research Council (U105184332), a program grant and Senior Investigator Award from the Wellcome Trust, the Agouron Institute, and the Louis-Jeantet Foundation. Coordinates and structure factors have been deposited in the PDB with codes 4JUW and 4JUX.	Adamczyk AJ, 2011, P NATL ACAD SCI USA, V108, P9827, DOI 10.1073/pnas.1105714108; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Agirrezabala X, 2012, P NATL ACAD SCI USA, V109, P6094, DOI 10.1073/pnas.1201288109; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chen CL, 2011, MOL CELL, V42, P367, DOI 10.1016/j.molcel.2011.03.024; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; Czworkowski J, 1997, BIOCHEMISTRY-US, V36, P10327, DOI 10.1021/bi970610k; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; DeLano W., 2006, PYMOL MOL GRAPHICS S; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ermolenko DN, 2007, J MOL BIOL, V370, P530, DOI 10.1016/j.jmb.2007.04.042; Ermolenko DN, 2011, NAT STRUCT MOL BIOL, V18, P457, DOI 10.1038/nsmb.2011; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Guo ZJ, 2012, P NATL ACAD SCI USA, V109, P20391, DOI 10.1073/pnas.1218999109; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; INOUEYOKOSAWA N, 1974, J BIOL CHEM, V249, P4321; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Liljas A, 2011, SCIENCE, V333, P37, DOI 10.1126/science.1202472; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Martemyanov KA, 2000, J BIOL CHEM, V275, P35820, DOI 10.1074/jbc.M002656200; McCarthy AA, 2009, J SYNCHROTRON RADIAT, V16, P803, DOI 10.1107/S0909049509035377; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Munro JB, 2010, P NATL ACAD SCI USA, V107, P709, DOI 10.1073/pnas.0908597107; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shi XY, 2012, J MOL BIOL, V419, P125, DOI 10.1016/j.jmb.2012.03.016; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Voorhees RM, 2011, SCIENCE, V333, P37, DOI 10.1126/science.1202532; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275; Zhou J, 2012, RNA, V18, P230, DOI 10.1261/rna.031187.111	50	166	169	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1542	+	1235490	10.1126/science.1235490	http://dx.doi.org/10.1126/science.1235490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812720	Green Accepted			2022-12-28	WOS:000321007000031
J	Weidemuller, M				Weidemueller, Matthias			QUANTUM PHYSICS Spooky action gets collective	NATURE			English	Editorial Material							ATOMS; ENTANGLEMENT; PHOTONS; CAVITY; GAS		[Weidemueller, Matthias] Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; [Weidemueller, Matthias] Heidelberg Univ, Heidelberg Ctr Quantum Dynam, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Weidemuller, M (corresponding author), Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany.	weidemueller@uni-heidelberg.de	Weidemüller, Matthias/N-2232-2014	Weidemüller, Matthias/0000-0001-5639-5126				Comparat D, 2010, J OPT SOC AM B, V27, pA208, DOI 10.1364/JOSAB.27.00A208; Dudin YO, 2012, SCIENCE, V336, P887, DOI 10.1126/science.1217901; Hofmann CS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203601; Li L, 2013, NATURE, V498, P466, DOI 10.1038/nature12227; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Schauss P, 2012, NATURE, V491, P87, DOI 10.1038/nature11596; Stute A, 2012, NATURE, V485, P482, DOI 10.1038/nature11120	10	1	1	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					438	439		10.1038/nature12259	http://dx.doi.org/10.1038/nature12259			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23783516				2022-12-28	WOS:000320929400036
J	Willyard, C				Willyard, Cassandra			STEM CELLS Bad seeds	NATURE			English	Editorial Material							ACUTE MYELOID-LEUKEMIA											Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Jan M., 2012, SCI TRANSL MED, V4; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Saito Y, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004387; Uy GL, 2012, BLOOD, V119, P3917, DOI 10.1182/blood-2011-10-383406	5	6	6	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					S12	S13		10.1038/498S12a	http://dx.doi.org/10.1038/498S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803943	Bronze			2022-12-28	WOS:000320929400007
J	Zhang, RL; Han, PD; Yang, HB; Ouyang, KF; Lee, D; Lin, YF; Ocorr, K; Kang, GS; Chen, J; Stainier, DYR; Yelon, D; Chi, NC				Zhang, Ruilin; Han, Peidong; Yang, Hongbo; Ouyang, Kunfu; Lee, Derek; Lin, Yi-Fan; Ocorr, Karen; Kang, Guson; Chen, Ju; Stainier, Didier Y. R.; Yelon, Deborah; Chi, Neil C.			In vivo cardiac reprogramming contributes to zebrafish heart regeneration	NATURE			English	Article							CARDIOMYOCYTE; RENEWAL; DIFFERENTIATION; TRANSIENT; ABLATION; MYOCYTES; FIELD; TUBE	Despite current treatment regimens, heart failure remains the leading cause of morbidity and mortality in the developed world due to the limited capacity of adult mammalian ventricular cardiomyocytes to divide and replace ventricular myocardium lost from ischaemia-induced infarct(1,2). Hence there is great interest to identify potential cellular sources and strategies to generate new ventricular myocardium(3). Past studies have shown that fish and amphibians and early postnatal mammalian ventricular cardiomyocytes can proliferate to help regenerate injured ventricles(4-6); however, recent studies have suggested that additional endogenous cellular sources may contribute to this overall ventricular regeneration(3). Here we have developed, in the zebrafish (Danio rerio), a combination of fluorescent reporter transgenes, genetic fate-mapping strategies and a ventricle-specific genetic ablation system to discover that differentiated atrial cardiomyocytes can transdifferentiate into ventricular cardiomyocytes to contribute to zebrafish cardiac ventricular regeneration. Using in vivo time-lapse and confocal imaging, we monitored the dynamic cellular events during atrial-to-ventricular cardiomyocyte transdifferentiation to define intermediate cardiac reprogramming stages. We observed that Notch signalling becomes activated in the atrial endocardium following ventricular ablation, and discovered that inhibiting Notch signalling blocked the atrial-to-ventricular transdifferentiation and cardiac regeneration. Overall, these studies not only provide evidence for the plasticity of cardiac lineages during myocardial injury, but more importantly reveal an abundant new potential cardiac resident cellular source for cardiac ventricular regeneration.	[Zhang, Ruilin; Han, Peidong; Yang, Hongbo; Ouyang, Kunfu; Lee, Derek; Chen, Ju; Chi, Neil C.] Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Lin, Yi-Fan; Yelon, Deborah] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ocorr, Karen] Sanford Burnham Inst Med Res, Dev & Aging Program, La Jolla, CA 92037 USA; [Kang, Guson; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Chi, Neil C.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Francisco; University of California System; University of California San Diego	Chi, NC (corresponding author), Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA.	nchi@ucsd.edu	Chen, Ju/E-5579-2011; zhang, ruilin/J-5074-2013; ouyang, kunfu/B-3073-2011	zhang, ruilin/0000-0002-0358-8415; ouyang, kunfu/0000-0003-0292-375X; Zhang, Ruilin/0000-0002-6594-450X; Stainier, Didier/0000-0002-0382-0026	American Heart Association [0940041N, 11POST7090024, 12POST12050080]; Packard Foundation; National Institutes of Health (NIH) [HL54737]; NIH/NHLBI (NIH Heart, Lung, and Blood Institute); NIH [OD007464, HL104239]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069305] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108599, R01HL054737, R01HL104239, R01HL069594] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007464] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Packard Foundation(The David & Lucile Packard Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NHLBI (NIH Heart, Lung, and Blood Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Tedeschi, L. Pandolfo and A. Ayala for fish care; O. Huang, J. Kim, T. Kuo and J. Sun for experimental assistance; S. Tu and other laboratory members for comments on the manuscript; Q. Liu for anti-N-cadherin antibody; M. Lardelli, J. Lenis and W. Clements for plasmids; and N. Lawson for the Notch reporter line. This work was supported in part by grants from the American Heart Association to D.Y. (0940041N), R.Z. (11POST7090024) and H.Y. (12POST12050080); the Packard Foundation and the National Institutes of Health (NIH) (HL54737) to D.Y.R.S.; NIH/NHLBI (NIH Heart, Lung, and Blood Institute) to J. C.; and the NIH (OD007464, HL104239) to N.C.C.	Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; D'Amico L, 2007, CURR BIOL, V17, P252, DOI 10.1016/j.cub.2006.12.023; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Dong ZQ, 2011, JOVE-J VIS EXP, DOI 10.3791/2594; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; Genead R, 2010, STEM CELL RES, V4, P69, DOI 10.1016/j.scr.2009.10.001; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Hinits Y, 2012, DEV BIOL, V369, P199, DOI 10.1016/j.ydbio.2012.06.019; Huang W, 2009, DEV BIOL, V331, P237, DOI 10.1016/j.ydbio.2009.04.039; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kerstetter AE, 2004, DEV DYNAM, V230, P137, DOI 10.1002/dvdy.20021; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lin YF, 2012, DEV BIOL, V362, P242, DOI 10.1016/j.ydbio.2011.12.005; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; MCDONNELL TJ, 1984, CELL TISSUE RES, V235, P583; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; OBERPRILLER JO, 1987, AM J ANAT, V179, P285, DOI 10.1002/aja.1001790310; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; STAINIER DYR, 1992, DEV BIOL, V153, P91, DOI 10.1016/0012-1606(92)90094-W; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Wang YY, 2011, DEVELOPMENT, V138, P609, DOI 10.1242/dev.059097; Zhang RL, 2009, DEV DYNAM, V238, P1564, DOI 10.1002/dvdy.21929; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094	41	170	177	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					497	+		10.1038/nature12322	http://dx.doi.org/10.1038/nature12322			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23783515	Green Accepted			2022-12-28	WOS:000320929400055
J	Amunts, K; Lepage, C; Borgeat, L; Mohlberg, H; Dickscheid, T; Rousseau, ME; Bludau, S; Bazin, PL; Lewis, LB; Oros-Peusquens, AM; Shah, NJ; Lippert, T; Zilles, K; Evans, AC				Amunts, Katrin; Lepage, Claude; Borgeat, Louis; Mohlberg, Hartmut; Dickscheid, Timo; Rousseau, Marc-Etienne; Bludau, Sebastian; Bazin, Pierre-Louis; Lewis, Lindsay B.; Oros-Peusquens, Ana-Maria; Shah, Nadim J.; Lippert, Thomas; Zilles, Karl; Evans, Alan C.			BigBrain: An Ultrahigh-Resolution 3D Human Brain Model	SCIENCE			English	Article							HUMAN CEREBRAL-CORTEX; IN-VIVO; CORTICAL AREAS; PATTERNS; ATLASES; MRI; CYTOARCHITECTURE; SYSTEM; MONKEY; MAP	Reference brains are indispensable tools in human brain mapping, enabling integration of multimodal data into an anatomically realistic standard space. Available reference brains, however, are restricted to the macroscopic scale and do not provide information on the functionally important microscopic dimension. We created an ultrahigh-resolution three-dimensional (3D) model of a human brain at nearly cellular resolution of 20 micrometers, based on the reconstruction of 7404 histological sections. "BigBrain" is a free, publicly available tool that provides considerable neuroanatomical insight into the human brain, thereby allowing the extraction of microscopic data for modeling and simulation. BigBrain enables testing of hypotheses on optimal path lengths between interconnected cortical regions or on spatial organization of genetic patterning, redefining the traditional neuroanatomy maps such as those of Brodmann and von Economo.	[Amunts, Katrin; Mohlberg, Hartmut; Dickscheid, Timo; Bludau, Sebastian; Oros-Peusquens, Ana-Maria; Shah, Nadim J.; Zilles, Karl] Res Ctr Julich, Inst Neurosci & Med INM 1, INM 4, D-52425 Julich, Germany; [Amunts, Katrin; Mohlberg, Hartmut; Dickscheid, Timo; Bludau, Sebastian; Oros-Peusquens, Ana-Maria; Shah, Nadim J.; Zilles, Karl] Julich Aachen Res Alliance JARA, Julich, Germany; [Amunts, Katrin; Zilles, Karl] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Sect Struct Funct Brain Mapping, D-52074 Aachen, Germany; [Amunts, Katrin; Zilles, Karl] Univ Dusseldorf, C&O Vogt Inst Brain Res, D-40001 Dusseldorf, Germany; [Lepage, Claude; Rousseau, Marc-Etienne; Lewis, Lindsay B.; Evans, Alan C.] McGill Univ, Montreal Neurol Inst MNI, Montreal, PQ, Canada; [Borgeat, Louis] Natl Res Council Canada, Ottawa, ON, Canada; [Bazin, Pierre-Louis] Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany; [Lippert, Thomas] Res Ctr Julich, Julich Supercomp Ctr JSC, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; Heinrich Heine University Dusseldorf; McGill University; National Research Council Canada; Max Planck Society; Helmholtz Association; Research Center Julich	Amunts, K (corresponding author), Res Ctr Julich, Inst Neurosci & Med INM 1, INM 4, D-52425 Julich, Germany.	k.amunts@fz-juelich.de	Amunts, Katrin/I-3470-2013; Shah, N. Jon/H-5849-2013; Evans, Alan C/B-2373-2013; Dickscheid, Timo/AFK-2544-2022; Dickscheid, Timo/AAF-9819-2022; Zilles, Karl/J-9704-2013; Zilles, Karl/Y-3784-2019	Amunts, Katrin/0000-0001-5828-0867; Shah, N. Jon/0000-0002-8151-6169; Evans, Alan C/0000-0003-3841-6098; Dickscheid, Timo/0000-0002-9051-3701; Dickscheid, Timo/0000-0002-9051-3701; Zilles, Karl/0000-0001-9296-9959; Zilles, Karl/0000-0002-4705-4175; Oros-Peusquens, Ana-Maria/0000-0002-8536-8044; Rousseau, Marc-Etienne/0000-0001-6281-1691; Mohlberg, Hartmut/0000-0002-7040-3812; Bazin, Pierre-Louis/0000-0002-0141-5510; Bludau, Sebastian/0000-0001-6173-9050	Canada's Advanced Research and Innovation Network (CANARIE); Portfolio project "Supercomputing and Modeling for the Human Brain"; Helmholtz Association Germany; Human Brain Project, a European Union Flagship project	Canada's Advanced Research and Innovation Network (CANARIE); Portfolio project "Supercomputing and Modeling for the Human Brain"; Helmholtz Association Germany(Helmholtz Association); Human Brain Project, a European Union Flagship project	We acknowledge funding support from Canada's Advanced Research and Innovation Network (CANARIE; www.canarie.ca) for the software development of the CBRAIN portal. We also thank Compute Canada (www.computecanada.ca) for continued support through extensive access to the Compute Canada HPC grid. We thank P. Morosan and U. Pietrzyk for helpful discussion, as well as F. Kocaer and U. Blohm for technical assistance. We are particularly grateful to R. Adalat for his efforts in management and coordination on this collaboration. This work was supported by the Portfolio project "Supercomputing and Modeling for the Human Brain," funded by the Helmholtz Association Germany, and the Human Brain Project, a European Union Flagship project. The normalized BigBrain data are available at: http://bigbrain.cbrain.mcgill.ca (upon free subscription).	Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Amunts K, 2004, NEUROIMAGE, V22, P42, DOI 10.1016/j.neuroimage.2003.12.031; Armstrong E, 1991, CEREB CORTEX, V1, P426, DOI 10.1093/cercor/1.5.426; Augustinack JC, 2013, NEUROIMAGE, V64, P32, DOI 10.1016/j.neuroimage.2012.08.071; Axer Markus, 2011, Front Neuroinform, V5, P34, DOI 10.3389/fninf.2011.00034; Bludau S, 2014, NEUROIMAGE, V93, P260, DOI 10.1016/j.neuroimage.2013.05.052; Chen HB, 2013, CEREB CORTEX, V23, P1208, DOI 10.1093/cercor/bhs113; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Fatterpekar GM, 2002, AM J NEURORADIOL, V23, P1313; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Hilgetag CC, 2009, BRAIN STRUCT FUNCT, V213, P365, DOI 10.1007/s00429-009-0202-z; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Kasthuri N, 2007, NAT METHODS, V4, P307, DOI 10.1038/nmeth0407-307; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Lefevre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000749; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; LUPPINO G, 1991, J COMP NEUROL, V311, P463, DOI 10.1002/cne.903110403; MERKER B, 1983, J NEUROSCI METH, V9, P235, DOI 10.1016/0165-0270(83)90086-9; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Roland P E, 1994, Hum Brain Mapp, V1, P173, DOI 10.1002/hbm.460010303; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P458, DOI 10.1016/0166-2236(94)90131-7; Sanchez-Panchuelo RM, 2012, J MAGN RESON IMAGING, V35, P287, DOI 10.1002/jmri.22822; Schleicher A, 2009, J AUTISM DEV DISORD, V39, P1568, DOI 10.1007/s10803-009-0790-8; Shen EH, 2012, TRENDS NEUROSCI, V35, P711, DOI 10.1016/j.tins.2012.09.005; Talairach J., 1988, COPLANAR STEREOTAXIC; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Toro R, 2008, CEREB CORTEX, V18, P2352, DOI 10.1093/cercor/bhm261; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Walters NB, 2007, HUM BRAIN MAPP, V28, P1, DOI 10.1002/hbm.20267; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Zilles K, 2012, SCIENCE, V335, P1582, DOI 10.1126/science.1221366; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776; Zilles K, 2009, CURR OPIN NEUROL, V22, P331, DOI 10.1097/WCO.0b013e32832d95db	38	363	370	13	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1472	1475		10.1126/science.1235381	http://dx.doi.org/10.1126/science.1235381			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23788795	Green Published			2022-12-28	WOS:000320647000047
J	Bettencourt, LMA				Bettencourt, Luis M. A.			The Origins of Scaling in Cities	SCIENCE			English	Article							GROWTH; LIFE; CITY; LAW	Despite the increasing importance of cities in human societies, our ability to understand them scientifically and manage them in practice has remained limited. The greatest difficulties to any scientific approach to cities have resulted from their many interdependent facets, as social, economic, infrastructural, and spatial complex systems that exist in similar but changing forms over a huge range of scales. Here, I show how all cities may evolve according to a small set of basic principles that operate locally. A theoretical framework was developed to predict the average social, spatial, and infrastructural properties of cities as a set of scaling relations that apply to all urban systems. Confirmation of these predictions was observed for thousands of cities worldwide, from many urban systems at different levels of development. Measures of urban efficiency, capturing the balance between socioeconomic outputs and infrastructural costs, were shown to be independent of city size and might be a useful means to evaluate urban planning strategies.	Santa Fe Inst, Santa Fe, NM 87501 USA	The Santa Fe Institute	Bettencourt, LMA (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	bettencourt@santafe.edu	Bettencourt, Luis/R-9861-2019		Rockefeller Foundation; James S. McDonnell Foundation [220020195]; NSF [103522]; Bill and Melinda Gates Foundation [OPP1076282]; John Templeton Foundation [15705]; Bryan J. and June B. Zwan Foundation	Rockefeller Foundation; James S. McDonnell Foundation; NSF(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); John Templeton Foundation; Bryan J. and June B. Zwan Foundation	I thank J. Lobo, G. West, and H. Youn for discussions. This research was supported by grants from the Rockefeller Foundation, James S. McDonnell Foundation (grant 220020195), NSF (grant 103522), Bill and Melinda Gates Foundation (grant OPP1076282), John Templeton Foundation (grant 15705), and Bryan J. and June B. Zwan Foundation.	Alexander Christopher, 1965, ARCHIT FORUM, V122, P58; ANDERSON R M, 1991; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; Bacon E. N., 1976, DESIGN CITIES; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Dendrinos D. S., 1985, URBAN EVOLUTION STUD; DOWNS A, 1962, TRAFFIC QUART, V16, P393; Downs A., 1962, TRAFFIC Q, V16, P409; Duranton G, 2011, AM ECON REV, V101, P2616, DOI 10.1257/aer.101.6.2616; Fujita M., 1999, SPATIAL EC CITIES RE; Glaeser EL, 2009, J ECON LIT, V47, P983, DOI 10.1257/jel.47.4.983; Glaeser EL, 1999, J POLIT ECON, V107, pS225, DOI 10.1086/250109; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Jacobs J., 1969, EC CITIES; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Marshall A., 1920, PRINCIPLES EC; MILGRAM S, 1970, SCIENCE, V167, P1461, DOI 10.1126/science.167.3924.1461; Mumford Lewis, 1961, CITY HIST ITS ORIGIN, DOI DOI 10.1016/j.jaa.2011.06.005; NORDBECK S, 1971, GEOGR ANAL, VB 53, P54, DOI 10.2307/490887; Rodriguez-Iturbe I., 1997, FRACTAL RIVER BASINS; Samaniego H., 2008, J TRANSP LAND USE, V1, P21, DOI [DOI 10.5198/JTLU.V1I1.29, 10.5198/jtlu.v1i1.29]; Sassen S., 1991, GLOBAL CITY, DOI DOI 10.1515/9781400847488; Saunders Doug, 2010, ARRIVAL CITY; Schlapfer M., SCALING HUMAN INTERA; SVEIKAUSKAS L, 1975, Q J ECON, V89, P393, DOI 10.2307/1885259; Waters JS, 2010, AM NAT, V176, P501, DOI 10.1086/656266; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	32	653	668	38	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1438	1441		10.1126/science.1235823	http://dx.doi.org/10.1126/science.1235823			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	167QL	23788793				2022-12-28	WOS:000320647000038
J	Mochizuki, K; Matsumoto, M; Ohmine, I				Mochizuki, Kenji; Matsumoto, Masakazu; Ohmine, Iwao			Defect pair separation as the controlling step in homogeneous ice melting	NATURE			English	Article							MOLECULAR-DYNAMICS; HEXAGONAL ICE; WATER; NUCLEATION; GROWTH; TEMPERATURE; SIMULATIONS; STABILITY	On being heated, ice melts into liquid water. Although in practice this process tends to be heterogeneous, it can occur homogeneously inside bulk ice(1). The thermally induced homogeneous melting of solids is fairly well understood, and involves the formation and growth of melting nuclei(1-5). But in the case of water, resilient hydrogen bonds render ice melting more complex. We know that the first defects appearing during homogeneous ice melting are pairs of five-and seven-membered rings, which appear and disappear repeatedly and randomly in space and time in the crystalline ice structure(6-8). However, the accumulation of these defects to form an aggregate is nearly additive in energy, and results in a steep free energy increase that suppresses further growth. Here we report molecular dynamics simulations of homogeneous ice melting that identify as a crucial first step not the formation but rather the spatial separation of a defect pair. We find that once it is separated, the defect pair-either an interstitial (I) and a vacancy (V) defect pair (a Frenkel pair), or an L and a D defect pair (a Bjerrum pair)(9) - is entropically stabilized, or 'entangled'. In this state, defects with threefold hydrogen-bond coordination persist and grow, and thereby prepare the system for subsequent rapid melting.	[Mochizuki, Kenji] Grad Univ Adv Studies SOKENDAI, Sch Phys Sci, Okazaki, Aichi 4448585, Japan; [Matsumoto, Masakazu] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Ohmine, Iwao] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan	Graduate University for Advanced Studies - Japan; Okayama University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Mochizuki, K (corresponding author), Grad Univ Adv Studies SOKENDAI, Sch Phys Sci, Okazaki, Aichi 4448585, Japan.	kmochi@ims.ac.jp	Mochizuki, Kenji/L-6385-2018; MATSUMOTO, Masakazu/B-1495-2011	Mochizuki, Kenji/0000-0002-8947-9980; MATSUMOTO, Masakazu/0000-0002-6799-6813	Grants-in-Aid for Scientific Research [24550025] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abraham F.F, 1974, HOMOGENEOUS NUCL THE; Bernal JD, 1933, J CHEM PHYS, V1, P515, DOI 10.1063/1.1749327; BJERRUM N, 1952, SCIENCE, V115, P385, DOI 10.1126/science.115.2989.385; Cahn RW, 2001, NATURE, V413, P582, DOI 10.1038/35098169; Donadio D, 2005, J PHYS CHEM B, V109, P5421, DOI 10.1021/jp050690z; FECHT HJ, 1992, NATURE, V356, P133, DOI 10.1038/356133a0; Forsblom M, 2005, NAT MATER, V4, P388, DOI 10.1038/nmat1375; Frenkel D., 2000, UNDERSTANDING MOL SI; Grishina N, 2004, J CHEM PHYS, V120, P5217, DOI 10.1063/1.1647523; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Iglev H, 2006, NATURE, V439, P183, DOI 10.1038/nature04415; Jacobson LC, 2010, J AM CHEM SOC, V132, P11806, DOI 10.1021/ja1051445; Jacobson LC, 2009, J PHYS CHEM B, V113, P10298, DOI 10.1021/jp903439a; Jin ZH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.055703; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1985, MOL PHYS, V56, P1381, DOI 10.1080/00268978500103111; Matsumoto M, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2772627; Matsumoto M, 2002, NATURE, V416, P409, DOI 10.1038/416409a; McBride C, 2005, MOL PHYS, V103, P1, DOI 10.1080/00268970412331293820; Moore EB, 2011, NATURE, V479, P506, DOI 10.1038/nature10586; NOSE S, 1990, J PHYS-CONDENS MAT, V2, pSA115, DOI 10.1088/0953-8984/2/S/013; Petrenko VF, 1999, PHYS ICE; Tanaka H, 2002, J AM CHEM SOC, V124, P8085, DOI 10.1021/ja011927h; Vega C, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1862245; WALES DJ, 2004, ENERGY LANDSCAPES AP; Walsh MR, 2009, SCIENCE, V326, P1095, DOI 10.1126/science.1174010	26	43	43	0	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					350	354		10.1038/nature12190	http://dx.doi.org/10.1038/nature12190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23783630				2022-12-28	WOS:000320592900037
J	Iwig, JS; Kuriyan, J				Iwig, Jeffrey S.; Kuriyan, John			Fixing a Hole Where the Ras Gets In	CELL			English	Editorial Material							PDE-DELTA; GTPASES; ARL2-GTP	A clinically efficacious Ras inhibitor has eluded drug-discovery efforts for decades. In a paper in Nature, Zimmermann and et al. show that blocking a hole in PDE delta that normally engages the lipid tail of Ras disrupts downstream signaling, pointing to a potentially promising route to develop Ras inhibitors for cancer treatment.	[Iwig, Jeffrey S.; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Iwig, Jeffrey S.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Nancy V, 2002, J BIOL CHEM, V277, P15076, DOI 10.1074/jbc.M109983200; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	9	4	4	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1191	1193		10.1016/j.cell.2013.05.029	http://dx.doi.org/10.1016/j.cell.2013.05.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746837	Bronze			2022-12-28	WOS:000319979200006
J	Lopez-Otin, C; Blasco, MA; Partridge, L; Serrano, M; Kroemer, G				Lopez-Otin, Carlos; Blasco, Maria A.; Partridge, Linda; Serrano, Manuel; Kroemer, Guido			The Hallmarks of Aging	CELL			English	Review							DNA-DAMAGE-RESPONSE; NF-KAPPA-B; LIFE-SPAN EXTENSION; DETECTABLE CLONAL MOSAICISM; DEPENDENT GENE-EXPRESSION; C. ELEGANS; STEM-CELLS; CELLULAR SENESCENCE; OXIDATIVE STRESS; TELOMERE LENGTH	Aging is characterized by a progressive loss of physiological integrity, leading to impaired function and increased vulnerability to death. This deterioration is the primary risk factor for major human pathologies, including cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases. Aging research has experienced an unprecedented advance over recent years, particularly with the discovery that the rate of aging is controlled, at least to some extent, by genetic pathways and biochemical processes conserved in evolution. This Review enumerates nine tentative hallmarks that represent common denominators of aging in different organisms, with special emphasis on mammalian aging. These hallmarks are: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. A major challenge is to dissect the interconnectedness between the candidate hallmarks and their relative contributions to aging, with the final goal of identifying pharmaceutical targets to improve human health during aging, with minimal side effects.	[Lopez-Otin, Carlos] Univ Oviedo, Dept Bioquim & Biol Mol, Inst Univ Oncol IUOPA, Oviedo, Spain; [Blasco, Maria A.] Spanish Natl Canc Res Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid, Spain; [Partridge, Linda] Max Planck Inst Biol Ageing, Cologne, Germany; [Partridge, Linda] UCL, Inst Hlth Aging, Dept Genet Evolut & Environm, London, England; [Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Mol Oncol Program, Tumor Suppress Grp, Madrid, Spain; [Kroemer, Guido] U848, INSERM, Villejuif, France; [Kroemer, Guido] Inst Gustave Roussy, Metabol & Cell Biol Platforms, Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, Pole Biol, AP HP, Paris, France; [Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, Paris, France	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Centro Nacional de Investigaciones Oncologicas (CNIO); Max Planck Society; University of London; University College London; Centro Nacional de Investigaciones Oncologicas (CNIO); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Oncol Program, Tumor Suppress Grp, Madrid, Spain.	mserrano@cnio.es	Serrano, Manuel/H-2634-2015; KROEMER, Guido/B-4263-2013; López-Otín, Carlos/AAB-2106-2020; Kroemer, Guido/AAY-9859-2020; Blasco, Maria A./M-1694-2014; Partridge, Linda/E-7342-2015	Serrano, Manuel/0000-0001-7177-9312; KROEMER, Guido/0000-0002-9334-4405; López-Otín, Carlos/0000-0001-6964-1904; Blasco, Maria A./0000-0002-4211-233X; Partridge, Linda/0000-0001-9615-0094	Ministerio de Economia y Competitividad (MINECO); Instituto de Salud Carlos III (RTICC); European Union (ERC Advanced Grant); Regional Government of Madrid; Botin Foundation; Ramon Areces Foundation; AXA Foundation; Max Planck Society; ERC; Wellcome Trust (UK); FP7 Projects MARK-AGE; EuroBATS; Fundacion Lilly (Spain); Ligue Nationale contre le Cancer (Equipes labellisee); Agence Nationale pour la Recherche; AXA Foundation Chair for Longevity Research; Institut National du Cancer (INCa); Fondation de France; Canceropole Ile-de-France; Fondation Bettencourt- Schueller; LabEx ImmunoOncology; Paris Alliance of Cancer Research Institutes	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Instituto de Salud Carlos III (RTICC)(Instituto de Salud Carlos III); European Union (ERC Advanced Grant); Regional Government of Madrid; Botin Foundation; Ramon Areces Foundation; AXA Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC(European Research Council (ERC)European Commission); Wellcome Trust (UK)(Wellcome Trust); FP7 Projects MARK-AGE; EuroBATS; Fundacion Lilly (Spain); Ligue Nationale contre le Cancer (Equipes labellisee); Agence Nationale pour la Recherche(French National Research Agency (ANR)); AXA Foundation Chair for Longevity Research(AXA Research Fund); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation de France(Fondation de France); Canceropole Ile-de-France(Region Ile-de-France); Fondation Bettencourt- Schueller; LabEx ImmunoOncology; Paris Alliance of Cancer Research Institutes	We thank all members of our labs for their helpful comments on the manuscript and apologize for omission of relevant works due to space constraints. C.L.-O. is supported by grants from Ministerio de Economia y Competitividad (MINECO) and Instituto de Salud Carlos III (RTICC) and is an Investigator of the Botin Foundation. M.S. is funded by grants from the MINECO, European Union (ERC Advanced Grant), Regional Government of Madrid, Botin Foundation, Ramon Areces Foundation, and AXA Foundation. L.P. is supported by the Max Planck Society, the ERC, and the Wellcome Trust (UK). M.A.B. is funded by ERC Project TEL STEM CELL; FP7 Projects MARK-AGE; and EuroBATS, MINECO, Regional Government of Madrid, AXA Research Fund, Botin Foundation, and Fundacion Lilly (Spain). G.K. is supported by the Ligue Nationale contre le Cancer (Equipes labellisee), Agence Nationale pour la Recherche, AXA Foundation Chair for Longevity Research, European Commission (ERC Advanced Grant, ArtForce, ChemoRes), Fondation pour la Recherche Medicale (FRM), Institut National du Cancer (INCa), Fondation de France, Canceropole Ile-de-France, Fondation Bettencourt- Schueller, the LabEx ImmunoOncology, and the Paris Alliance of Cancer Research Institutes. All of the authors contributed equally to conceive and elaborate upon the ideas presented in this Review. All of the authors can be contacted for discussions or clarifications.	Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028; Anisimov VN, 2011, AGING-US, V3, P148, DOI 10.18632/aging.100273; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Armanios M, 2009, AM J HUM GENET, V85, P823, DOI 10.1016/j.ajhg.2009.10.028; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Begus-Nahrmann Y, 2009, NAT GENET, V41, P1138, DOI 10.1038/ng.426; de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965; Blagosklonny MV, 2011, CELL CYCLE, V10, P4217, DOI 10.4161/cc.10.24.18595; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Boonekamp JJ, 2013, AGING CELL, V12, P330, DOI 10.1111/acel.12050; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Cabanillas R, 2011, AM J MED GENET A, V155A, P2617, DOI 10.1002/ajmg.a.34249; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Calabrese V, 2011, MOL ASPECTS MED, V32, P279, DOI 10.1016/j.mam.2011.10.007; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Castello L, 2011, MECH AGEING DEV, V132, P305, DOI 10.1016/j.mad.2011.06.006; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chiang WC, 2012, CELL, V148, P322, DOI 10.1016/j.cell.2011.12.019; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2012, CELL CYCLE, V11, P2260, DOI 10.4161/cc.20437; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; de Magalhaes JP, 2012, PHARMACOL REV, V64, P88, DOI 10.1124/pr.110.004499; de Magalhaes JP, 2010, AGEING RES REV, V9, P315, DOI 10.1016/j.arr.2009.10.006; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Espada J, 2008, J CELL BIOL, V181, P27, DOI 10.1083/jcb.200801096; Faggioli F, 2012, HUM MOL GENET, V21, P5246, DOI 10.1093/hmg/dds375; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Foukas LC, 2013, EMBO MOL MED, V5, P563, DOI 10.1002/emmm.201201953; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Freije JMP, 2012, CURR OPIN CELL BIOL, V24, P757, DOI 10.1016/j.ceb.2012.08.009; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Fridell YWC, 2009, AGING-US, V1, P699, DOI 10.18632/aging.100067; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010; Gehrig SM, 2012, NATURE, V484, P394, DOI 10.1038/nature10980; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Gillum MP, 2011, DIABETES, V60, P3235, DOI 10.2337/db11-0616; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713; Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Gundry M, 2012, MUTAT RES-FUND MOL M, V729, P1, DOI [10.1016/j.mrfmmm.2011.10.001, 10.1016/mrfmmm.2011.10.001]; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Han S, 2012, TRENDS CELL BIOL, V22, P42, DOI 10.1016/j.tcb.2011.11.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARMAN D, 1965, J GERONTOL, V20, P151, DOI 10.1093/geronj/20.2.151; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Jin CY, 2011, CELL METAB, V14, P161, DOI 10.1016/j.cmet.2011.07.001; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Larson K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002473; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lavasani M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1611; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee JS, 2012, MECH AGEING DEV, V133, P467, DOI 10.1016/j.mad.2012.05.006; Lefebvre JS, 2012, AGING CELL, V11, P732, DOI 10.1111/j.1474-9726.2012.00836.x; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu G, 2011, EMBO J, V30, P2990, DOI 10.1038/emboj.2011.195; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Marino G, 2010, P NATL ACAD SCI USA, V107, P16268, DOI 10.1073/pnas.1002696107; Martin GM, 2011, FASEB J, V25, P3756, DOI 10.1096/fj.11-1102.ufm; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Matheu A, 2009, AGING CELL, V8, P152, DOI 10.1111/j.1474-9726.2009.00458.x; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107; Miller RA, 2012, J GERONTOL A-BIOL, V67, P495, DOI 10.1093/gerona/gls082; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Nicholas A, 2010, MECH AGEING DEV, V131, P445, DOI 10.1016/j.mad.2010.06.001; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; O'Rourke EJ, 2013, GENE DEV, V27, P429, DOI 10.1101/gad.205294.112; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Osorio FG, 2010, AGING CELL, V9, P947, DOI 10.1111/j.1474-9726.2010.00621.x; Ottaviani E, 2011, BIOGERONTOLOGY, V12, P599, DOI 10.1007/s10522-011-9352-5; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Perez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; Pollina EA, 2011, ONCOGENE, V30, P3105, DOI 10.1038/onc.2011.45; Pont AR, 2012, MOL CELL, V47, P5, DOI 10.1016/j.molcel.2012.04.019; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Raffaello A, 2011, BBA-MOL CELL RES, V1813, P260, DOI 10.1016/j.bbamcr.2010.10.007; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Renner O, 2009, CURR MOL MED, V9, P612, DOI 10.2174/156652409788488766; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Ruzankina Y, 2009, NAT GENET, V41, P1144, DOI 10.1038/ng.441; Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108; Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Sanchez-Roman I, 2012, BIOGERONTOLOGY, V13, P399, DOI 10.1007/s10522-012-9384-5; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; Sebastiani Paola, 2012, Frontiers in Genetics, V2, P90, DOI 10.3389/fgene.2011.00090; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Shen YD, 2012, SCIENCE, V338, P1472, DOI 10.1126/science.1228967; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x; Strong R, 2013, J GERONTOL A-BIOL, V68, P6, DOI 10.1093/gerona/gls070; Swindell WR, 2009, MECH AGEING DEV, V130, P393, DOI 10.1016/j.mad.2009.03.004; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Tomaru U, 2012, AM J PATHOL, V180, P963, DOI 10.1016/j.ajpath.2011.11.012; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tsurumi A, 2012, EPIGENETICS-US, V7, P680, DOI 10.4161/epi.20540; Ugalde AP, 2011, NUCLEUS-PHILA, V2, P549, DOI 10.4161/nucl.2.6.17986; van Ham TJ, 2010, CELL, V142, P601, DOI 10.1016/j.cell.2010.07.020; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vijg J., 2007, AGING GENOME DUAL RO; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Worman HJ, 2012, J PATHOL, V226, P316, DOI 10.1002/path.2999; Xie J, 2013, PHARMACOL RES, V67, P60, DOI 10.1016/j.phrs.2012.10.010; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yamaza H, 2010, AGING CELL, V9, P372, DOI 10.1111/j.1474-9726.2010.00563.x; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	296	7089	7305	223	1458	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1194	1217		10.1016/j.cell.2013.05.039	http://dx.doi.org/10.1016/j.cell.2013.05.039			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746838	Green Accepted, Bronze			2022-12-28	WOS:000319979200007
J	Iglehart, JK				Iglehart, John K.			The Residency Mismatch	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								<p id="p002">In response to concerns about a growing physician shortage, existing U.S. medical schools have expanded, new ones have been developed, and colleges of osteopathy have grown rapidly. But there are insufficient residency posts to accommodate all these medical graduates. <p id="p003">For generations, the supply of practicing physicians in the United States has swung from too small to too large and back again. In 2006, alarmed about a growing physician shortage, the Association of American Medical Colleges (AAMC) recommended that medical school enrollments be increased by 30% over the next decade. Now, entering classes are projected to reach 21,434 students by the 2016-2017 academic year, almost a 30% increase over 2002 (see table). Colleges of osteopathic medicine have been growing for the past 20 years, doubling in number from 15 to 30 and increasing enrollments from 6892 students in 1990 to ...										Bednash G. D., 2012, 2011 2012 ENROLLMENT; Iglehart JK, 2008, NEW ENGL J MED, V358, P1741, DOI 10.1056/NEJMhpr0800058; Jolly P, 2013, ACAD MED, V88, P468, DOI 10.1097/ACM.0b013e318285199d; National Resident Matching Program, 2013, RES DAT 2013 MAIN RE	4	45	45	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					297	299		10.1056/NEJMp1306445	http://dx.doi.org/10.1056/NEJMp1306445			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	188VJ	23782122				2022-12-28	WOS:000322223900002
J	Hay, AJ; Hayden, FG				Hay, Alan J.; Hayden, Frederick G.			Oseltamivir resistance during treatment of H7N9 infection	LANCET			English	Editorial Material							INFLUENZA-VIRUS; INHIBITORS; PATIENT; VARIANT		[Hay, Alan J.] MRC Natl Inst Med Res, Div Virol, London NW7 1AA, England; [Hayden, Frederick G.] Univ Virginia, Sch Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA	MRC National Institute for Medical Research; University of Virginia	Hay, AJ (corresponding author), MRC Natl Inst Med Res, Div Virol, Mill Hill, London NW7 1AA, England.	ahay@nimr.mrc.ac.uk						Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; Chan PKS, 2012, J INFECT DIS, V206, P1359, DOI 10.1093/infdis/jis509; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Hayden FG, 2013, INFLUENZA OTHER RESP, V7, P63, DOI 10.1111/irv.12045; Herlocher ML, 2002, ANTIVIR RES, V54, P99, DOI 10.1016/S0166-3542(01)00214-5; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Hui DS, 2013, ANTIVIR RES, V98, P410, DOI 10.1016/j.antiviral.2013.03.019; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Liu XH, 2013, EMERG MICROBES INFEC, V2, DOI [10.1038/emi2013.30, 10.1038/emi.2013.30]; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; South East Asia Infectious Disease Clinical Research Network, 2013, BMJ, V346, pf3039, DOI 10.1136/bmj.f3039; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; WHO, WHO GUID PHARM MAN P; Yang SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029652, 10.1371/journal.pone.0035836]; Yen HL, 2005, J INFECT DIS, V192, P665, DOI 10.1086/432008; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433	22	47	52	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2230	2232		10.1016/S0140-6736(13)61209-X	http://dx.doi.org/10.1016/S0140-6736(13)61209-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173SU	23809549				2022-12-28	WOS:000321100300007
J	Li, X; Erclik, T; Bertet, C; Chen, ZQ; Voutev, R; Venkatesh, S; Morante, J; Celik, A; Desplan, C				Li, Xin; Erclik, Ted; Bertet, Claire; Chen, Zhenqing; Voutev, Roumen; Venkatesh, Srinidhi; Morante, Javier; Celik, Arzu; Desplan, Claude			Temporal patterning of Drosophila medulla neuroblasts controls neural fates	NATURE			English	Article							NEURONAL SUBTYPE SPECIFICATION; CELL-DIVISION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; OPTIC LOBE; IDENTITY; LINEAGE; NOTCH; COMPETENCE; SPECIFY	In the Drosophila optic lobes, the medulla processes visual information coming from inner photoreceptors R7 and R8 and from lamina neurons. It contains approximately 40,000 neurons belonging to more than 70 different types. Here we describe how precise temporal patterning of neural progenitors generates these different neural types. Five transcription factors-Homothorax, Eyeless, Sloppy paired, Dichaete and Tailless-are sequentially expressed in a temporal cascade in each of the medulla neuroblasts as they age. Loss of Eyeless, Sloppy paired or Dichaete blocks further progression of the temporal sequence. We provide evidence that this temporal sequence in neuroblasts, together with Notch-dependent binary fate choice, controls the diversification of the neuronal progeny. Although a temporal sequence of transcription factors had been identified in Drosophila embryonic neuroblasts, our work illustrates the generality of this strategy, with different sequences of transcription factors being used in different contexts.	[Li, Xin; Erclik, Ted; Bertet, Claire; Chen, Zhenqing; Venkatesh, Srinidhi; Morante, Javier; Celik, Arzu; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA; [Voutev, Roumen] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA	New York University; Columbia University	Desplan, C (corresponding author), NYU, Dept Biol, 100 Washington Sq East, New York, NY 10003 USA.	cd38@nyu.edu	Morante, Javier/P-2976-2019; Fuss, ARZU Celik/AAD-2870-2020; Morante, Javier/E-3292-2014; Li, Xin/D-3421-2013	Morante, Javier/0000-0002-5594-0644; Fuss, ARZU Celik/0000-0001-9889-6957; Morante, Javier/0000-0002-5594-0644; Li, Xin/0000-0002-3428-3569; Chen, Zhenqing/0000-0002-9214-9480; Voutev, Roumen/0000-0003-0066-4731; Desplan, Claude/0000-0002-6914-1413	National Institutes of Health (NIH) [R01 Ey017916]; The Robert Leet and Clara Guthrie Patterson Trust Postdoctoral Fellowship; Canadian Institutes of Health Research (CIHR); EMBO [ALTF 680-2009]; HFSPO [LT000077/2010-L]; NIH [GM058575]; Leukemia and Lymphoma Society; NATIONAL EYE INSTITUTE [R01EY017916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058575] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Robert Leet and Clara Guthrie Patterson Trust Postdoctoral Fellowship; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); EMBO(European Molecular Biology Organization (EMBO)); HFSPO(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the fly community and the modENCODE team for gifts of antibodies and fly stocks. K. White, N. Negre, D. Vasiliauskas and R. Johnston contributed to screening the modENCODE antibodies. Special thanks to C.-H. Lee for sharing unpublished information and the OrtC1-gal4 line. We thank R. Mann for suggestions and reagents; and Desplan laboratory members for discussion and support, especially R. Johnston, D. Vasiliauskas and N. Neriec for critically reading the manuscript. This work was supported by National Institutes of Health (NIH) grant R01 Ey017916 to C. D.; The Robert Leet and Clara Guthrie Patterson Trust Postdoctoral Fellowship to X. L.; The Canadian Institutes of Health Research (CIHR) to T. E.; fellowships from EMBO (ALTF 680-2009) and HFSPO (LT000077/2010-L) to C. B.; NIH grant GM058575 and a Career Development fellowship from the Leukemia and Lymphoma Society to R. V.	Akiyama-Oda Y, 1999, DEVELOPMENT, V126, P1967; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110; Cleary MD, 2006, GENE DEV, V20, P429, DOI 10.1101/gad.1382206; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Colonques J, 2007, MECH DEVELOP, V124, P327, DOI 10.1016/j.mod.2007.01.004; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Egger B, 2010, DEVELOPMENT, V137, P2981, DOI 10.1242/dev.051250; Elliott J, 2008, NEURON, V60, P26, DOI 10.1016/j.neuron.2008.08.008; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hasegawa E, 2013, DEV BIOL, V377, P90, DOI 10.1016/j.ydbio.2013.02.012; Hasegawa E, 2011, DEVELOPMENT, V138, P983, DOI 10.1242/dev.058370; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jacob J, 2008, DEVELOPMENT, V135, P3481, DOI 10.1242/dev.016931; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Kao CF, 2012, NEURON, V73, P677, DOI 10.1016/j.neuron.2011.12.018; Kohwi M, 2013, CELL, V152, P97, DOI 10.1016/j.cell.2012.11.049; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Lee T, 1999, DEVELOPMENT, V126, P4065; Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morante J., 2011, COLD SPRING HARB PRO, V2011, P653; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Morante J, 2011, DEVELOPMENT, V138, P687, DOI 10.1242/dev.056069; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Ngo KT, 2010, DEV BIOL, V346, P284, DOI 10.1016/j.ydbio.2010.07.036; Novotny T, 2002, DEVELOPMENT, V129, P1027; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Reddy BVVG, 2010, DEVELOPMENT, V137, P2397, DOI 10.1242/dev.050013; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sato A, 2007, DEVELOPMENT, V134, P659, DOI 10.1242/dev.02786; Skeath JB, 1998, DEVELOPMENT, V125, P1857; Soustelle L, 2007, DEV DYNAM, V236, P2101, DOI 10.1002/dvdy.21232; Tran KD, 2008, DEVELOPMENT, V135, P3491, DOI 10.1242/dev.024349; Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749; Yasugi T, 2008, DEVELOPMENT, V135, P1471, DOI 10.1242/dev.019117; Yasugi T, 2010, DEVELOPMENT, V137, P3193, DOI 10.1242/dev.048058; Yu HH, 2009, NAT NEUROSCI, V12, P947, DOI 10.1038/nn.2345	48	166	167	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					456	+		10.1038/nature12319	http://dx.doi.org/10.1038/nature12319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23783517	Green Submitted, Green Accepted			2022-12-28	WOS:000320929400046
J	Sawyers, CL				Sawyers, Charles L.			PERSPECTIVE Combined forces	NATURE			English	Editorial Material							CHRONIC MYELOID-LEUKEMIA; MUTATIONS; IMATINIB		[Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.		Sawyers, Charles/G-5327-2016					Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Experts in Chronic Myeloid Leukemia, 2013, BLOOD, V121, P4439; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Marin D, 2012, J CLIN ONCOL, V30, P232, DOI 10.1200/JCO.2011.38.6565; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X	6	11	11	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					S7	S7		10.1038/498S7a	http://dx.doi.org/10.1038/498S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803949	Bronze			2022-12-28	WOS:000320929400004
J	Haider, BA; Olofin, I; Wang, ML; Spiegelman, D; Ezzati, M; Fawzi, WW				Haider, Batool A.; Olofin, Ibironke; Wang, Molin; Spiegelman, Donna; Ezzati, Majid; Fawzi, Wafaie W.		Nutr Impact Model Study Grp Anaemi	Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; LOW-DOSE IRON; MATERNAL HEMOGLOBIN; FOLIC-ACID; PRETERM DELIVERY; SERUM FERRITIN; PERINATAL-MORTALITY; NUTRITIONAL ANEMIA; PROSPECTIVE COHORT; RANDOMIZED-TRIAL	Objectives To summarise evidence on the associations of maternal anaemia and prenatal iron use with maternal haematological and adverse pregnancy outcomes; and to evaluate potential exposure-response relations of dose of iron, duration of use, and haemoglobin concentration in prenatal period with pregnancy outcomes. Design Systematic review and meta-analysis Data sources Searches of PubMed and Embase for studies published up to May 2012 and references of review articles. Study selection criteria Randomised trials of prenatal iron use and prospective cohort studies of prenatal anaemia; cross sectional and case-control studies were excluded. Results 48 randomised trials (17 793 women) and 44 cohort studies (1 851 682 women) were included. Iron use increased maternal mean haemoglobin concentration by 4.59 (95% confidence interval 3.72 to 5.46) g/L compared with controls and significantly reduced the risk of anaemia (relative risk 0.50, 0.42 to 0.59), iron deficiency (0.59, 0.46 to 0.79), iron deficiency anaemia (0.40, 0.26 to 0.60), and low birth weight (0.81, 0.71 to 0.93). The effect of iron on preterm birth was not significant (relative risk 0.84, 0.68 to 1.03). Analysis of cohort studies showed a significantly higher risk of low birth weight (adjusted odds ratio 1.29, 1.09 to 1.53) and preterm birth (1.21, 1.13 to 1.30) with anaemia in the first or second trimester. Exposure-response analysis indicated that for every 10 mg increase in iron dose/day, up to 66 mg/day, the relative risk of maternal anaemia was 0.88 (0.84 to 0.92) (P for linear trend<0.001). Birth weight increased by 15.1 (6.0 to 24.2) g (P for linear trend=0.005) and risk of low birth weight decreased by 3% (relative risk 0.97, 0.95 to 0.98) for every 10 mg increase in dose/day (P for linear trend<0.001). Duration of use was not significantly associated with the outcomes after adjustment for dose. Furthermore, for each 1 g/L increase in mean haemoglobin, birth weight increased by 14.0 (6.8 to 21.8) g (P for linear trend=0.002); however, mean haemoglobin was not associated with the risk of low birth weight and preterm birth. No evidence of a significant effect on duration of gestation, small for gestational age births, and birth length was noted. Conclusions Daily prenatal use of iron substantially improved birth weight in a linear dose-response fashion, probably leading to a reduction in risk of low birth weight. An improvement in prenatal mean haemoglobin concentration linearly increased birth weight.	[Haider, Batool A.; Olofin, Ibironke; Wang, Molin; Spiegelman, Donna; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Haider, Batool A.; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wang, Molin] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Wang, Molin; Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London SW7 2AZ, England; [Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health	Haider, BA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	bah201@mail.harvard.edu	Lucas, Maria Tamires Barroso/H-9587-2015		Bill and Melinda Gates Foundation; Saving Brains Program, Grand Challenges Canada [0073-03]; Medical Research Council [G0801056B] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Saving Brains Program, Grand Challenges Canada; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Nutrition Impact Model Study was funded by the Bill and Melinda Gates Foundation. Additional support came from the Saving Brains Program, Grand Challenges Canada Grant Number 0073-03. The funding sources had no role in the study design; in the collection, analysis, and interpretation of results; in the writing of the manuscript; or in the submission of the manuscript for publication. No author has any affiliation with the funding agency.	Agarwal D K, 1998, Indian Pediatr, V35, P733; Al Mamun A, 2006, PAEDIATR PERINAT EP, V20, P482, DOI 10.1111/j.1365-3016.2006.00752.x; Allen LH, 2001, J NUTR, V131, p581S, DOI 10.1093/jn/131.2.581S; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Andrews NC, 2000, ANNU REV GENOM HUM G, V1, P75, DOI 10.1146/annurev.genom.1.1.75; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], WORLD BANK LIST EC; [Anonymous], SPAT LIM MAL TRANSM; [Anonymous], IR DEF AN GUID PREV; [Anonymous], LANCET GLOB IN PRESS; [Anonymous], BR J OBSTET GYNAECOL; [Anonymous], IR FOL SUPPL STAND M; [Anonymous], ANN TROP MED PARASIT; [Anonymous], WHOMCHMSM92 DIV FAM; [Anonymous], IR DIET REF INT VIT; [Anonymous], MICR DEF IR DEF AN; Arbuckle T E, 1989, Paediatr Perinat Epidemiol, V3, P115, DOI 10.1111/j.1365-3016.1989.tb00503.x; AUNGTHANBATU, 1976, ISRAEL J MED SCI, V12, P1410; Banhidy F, 2011, NUTRITION, V27, P65, DOI 10.1016/j.nut.2009.12.005; BARTON DPJ, 1994, AM J OBSTET GYNECOL, V170, P896, DOI 10.1016/S0002-9378(94)70305-1; Bastin J, 2006, BRIT J HAEMATOL, V134, P532, DOI 10.1111/j.1365-2141.2006.06216.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BLOXAM DL, 1989, CLIN SCI, V76, P59, DOI 10.1042/cs0760059; Bondevik GT, 2001, ACTA OBSTET GYN SCAN, V80, P402, DOI 10.1034/j.1600-0412.2001.080005402.x; BRABIN BJ, 1990, ANN TROP MED PARASIT, V84, P11, DOI 10.1080/00034983.1990.11812429; BUTLER E B, 1968, Journal of Obstetrics and Gynaecology of the British Commonwealth, V75, P497; BUYTAERT G, 1983, EUR J OBSTET GYN R B, V15, P11, DOI 10.1016/0028-2243(83)90291-5; CANTLIE GSD, 1971, AM J CLIN NUTR, V24, P637; Chan KKL, 2009, BJOG-INT J OBSTET GY, V116, P789, DOI 10.1111/j.1471-0528.2008.02014.x; Chang SC, 2003, J NUTR, V133, P2348, DOI 10.1093/jn/133.7.2348; CHAROENLARP P, 1988, AM J CLIN NUTR, V47, P280, DOI 10.1093/ajcn/47.2.280; CHISHOLM M., 1966, Journal of Obstetrics and Gynaecology of the British Commonwealth, V73, P191; Christian P, 2003, BMJ-BRIT MED J, V326, P571, DOI 10.1136/bmj.326.7389.571; Cogswell ME, 2003, AM J CLIN NUTR, V78, P773, DOI 10.1093/ajcn/78.4.773; Conde-Agudelo A, 2000, ACTA OBSTET GYN SCAN, V79, P371, DOI 10.1034/j.1600-0412.2000.079005371.x; DAWSON EB, 1989, AM J CLIN NUTR, V50, P848, DOI 10.1093/ajcn/50.4.848; DEBENAZE C, 1989, REV EPIDEMIOL SANTE, V37, P109; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El Guindi W, 2004, J Gynecol Obstet Biol Reprod (Paris), V33, P506; Eskeland B, 1997, ACTA OBSTET GYN SCAN, V76, P822, DOI 10.3109/00016349709024359; Fareh O I, 2005, J Obstet Gynaecol, V25, P440, DOI 10.1080/01443610500160451; Feldman RE, 2011, MAGN RESON MED, V66, P1798, DOI 10.1002/mrm.22971; Feresu SA, 2004, INT J EPIDEMIOL, V33, P1194, DOI 10.1093/ije/dyh120; FINCH C, 1994, BLOOD, V84, P1697; FLEMING AF, 1986, ANN TROP MED PARASIT, V80, P211, DOI 10.1080/00034983.1986.11812006; FREIRE WB, 1989, AM J CLIN NUTR, V50, P1442, DOI 10.1093/ajcn/50.6.1442; Gambling L, 2009, AM J PHYSIOL-REG I, V296, pR1063, DOI 10.1152/ajpregu.90793.2008; Gonzales GF, 2009, AM J PHYSIOL-REG I, V297, pR1477, DOI 10.1152/ajpregu.00275.2009; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Hamalainen H, 2003, CLIN NUTR, V22, P271, DOI 10.1016/S0261-5614(02)00209-1; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Harvey LJ, 2007, AM J CLIN NUTR, V85, P131, DOI 10.1093/ajcn/85.1.131; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hoa P. Thuy, 2005, Food and Nutrition Bulletin, V26, P32; HOLLY RG, 1955, OBSTET GYNECOL, V5, P562; Hwang HS, 2010, J PERINAT MED, V38, P467, DOI [10.1515/JPM.2010.047, 10.1515/jpm.2010.047]; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P168, DOI 10.1111/j.1365-3016.2012.01312.x; Jehan I, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.012; KLEBANOFF MA, 1989, JAMA-J AM MED ASSOC, V262, P511, DOI 10.1001/jama.262.4.511; KNOTTNERUS JA, 1990, J CLIN EPIDEMIOL, V43, P461, DOI 10.1016/0895-4356(90)90134-B; Lao TT, 2002, OBSTET GYNECOL, V99, P807, DOI 10.1016/S0029-7844(02)01941-5; Lee HS, 2006, EUR J CLIN NUTR, V60, P1130, DOI 10.1038/sj.ejcn.1602429; Lee JI, 2005, AM J CLIN NUTR, V82, P843, DOI 10.1093/ajcn/82.4.843; Levy A, 2005, EUR J OBSTET GYN R B, V122, P182, DOI 10.1016/j.ejogrb.2005.02.015; Lipinski P, 2013, CELL MOL LIFE SCI, V70, P23, DOI 10.1007/s00018-012-1018-1; Little MP, 2005, AM J OBSTET GYNECOL, V193, P220, DOI 10.1016/j.ajog.2004.11.053; Liu X N, 1996, Biomed Environ Sci, V9, P341; Lone FW, 2004, TROP MED INT HEALTH, V9, P486, DOI 10.1111/j.1365-3156.2004.01222.x; Ma AG, 2010, BRIT J NUTR, V104, P1655, DOI 10.1017/S000711451000259X; Makrides M, 2003, AM J CLIN NUTR, V78, P145, DOI 10.1093/ajcn/78.1.145; Malhotra M, 2002, INT J GYNECOL OBSTET, V79, P93, DOI 10.1016/S0020-7292(02)00225-4; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marahatta R, 2007, Nepal Med Coll J, V9, P270; MAU G, 1977, J PERINAT MED, V5, P172, DOI 10.1515/jpme.1977.5.4.172; McArdle HJ, 2011, NUTR REV, V69, pS17, DOI 10.1111/j.1753-4887.2011.00428.x; McKenna D, 2003, CLIN LAB HAEMATOL, V25, P99, DOI 10.1046/j.1365-2257.2003.00501.x; Meier Paul R, 2003, Clin Med Res, V1, P29; MENENDEZ C, 1994, T ROY SOC TROP MED H, V88, P590, DOI 10.1016/0035-9203(94)90176-7; MILMAN N, 1991, DAN MED BULL, V38, P471; Milman N, 2005, ACTA OBSTET GYN SCAN, V84, P238, DOI 10.1111/j.0001-6349.2005.00610.x; Mola G, 1999, AUST NZ J OBSTET GYN, V39, P31, DOI 10.1111/j.1479-828X.1999.tb03439.x; MURPHY JF, 1986, LANCET, V1, P992; Nacher M, 2003, T ROY SOC TROP MED H, V97, P273, DOI 10.1016/S0035-9203(03)90140-4; Ndyomugyenyi R, 2000, ANN TROP MED PARASIT, V94, P759, DOI 10.1080/00034980020015189; NORDENVALL M, 1990, ACTA OBSTET GYN SCAN, V69, P127, DOI 10.3109/00016349009006157; OPPENHEIMER SJ, 1986, T ROY SOC TROP MED H, V80, P603, DOI 10.1016/0035-9203(86)90154-9; OPPENHEIMER SJ, 1986, T ROY SOC TROP MED H, V80, P818, DOI 10.1016/0035-9203(86)90393-7; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Pena-Rosas JP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub3; Preziosi P, 1997, AM J CLIN NUTR, V66, P1178, DOI 10.1093/ajcn/66.5.1178; PRITCHARD JA, 1958, SURG GYNECOL OBSTET, V106, P516; Puolakka J, 1980, Acta Obstet Gynecol Scand Suppl, V95, P43; Ren A, 2007, INT J GYNECOL OBSTET, V98, P124, DOI 10.1016/j.ijgo.2007.05.011; Rohlfs EM, 2011, CLIN CHEM, V57, P841, DOI 10.1373/clinchem.2010.159285; ROMSLO I, 1983, BRIT J OBSTET GYNAEC, V90, P101, DOI 10.1111/j.1471-0528.1983.tb08891.x; Rush D, 2000, AM J CLIN NUTR, V72, p212S, DOI 10.1093/ajcn/72.1.212S; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Scanlon KS, 2000, OBSTET GYNECOL, V96, P741, DOI 10.1016/S0029-7844(00)00982-0; Scholl TO, 2011, NUTR REV, V69, pS23, DOI 10.1111/j.1753-4887.2011.00429.x; SCHOLL TO, 1992, AM J CLIN NUTR, V55, P985, DOI 10.1093/ajcn/55.5.985; Shobeiri F, 2006, NUTR RES, V26, P209, DOI 10.1016/j.nutres.2006.05.008; Siega-Riz AM, 1998, AM J PERINAT, V15, P515, DOI 10.1055/s-2007-993976; Siega-Riz AM, 2006, AM J OBSTET GYNECOL, V194, P512, DOI 10.1016/j.ajog.2005.08.011; SIMMONS WK, 1993, AM J CLIN NUTR, V58, P622, DOI 10.1093/ajcn/58.5.622; Sloan NL, 2002, AM J PUBLIC HEALTH, V92, P288, DOI 10.2105/AJPH.92.2.288; SOOD SK, 1975, Q J MED, V44, P241; Steer PJ, 2000, AM J CLIN NUTR, V71, p1285S, DOI 10.1093/ajcn/71.5.1285s; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Stoltzfus RJ, 1998, GUIDELINES USE IRON; Stram DO, 1996, BIOMETRICS, V52, P536, DOI 10.2307/2532893; SUHARNO D, 1993, LANCET, V342, P1325, DOI 10.1016/0140-6736(93)92246-P; SVANBERG B, 1975, ACTA OBSTET GYN SCAN, P87; Tanumihardjo SA, 2002, J NUTR, V132, P1909, DOI 10.1093/jn/132.7.1909; TAYLOR DJ, 1982, BRIT J OBSTET GYNAEC, V89, P1011, DOI 10.1111/j.1471-0528.1982.tb04656.x; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Torlesse H, 2000, LANCET, V356, P1083, DOI 10.1016/S0140-6736(00)02738-0; Tura S, 1989, Recenti Prog Med, V80, P607; VANEIJK HG, 1978, CLIN CHIM ACTA, V83, P81, DOI 10.1016/0009-8981(78)90210-3; Vijayalaxmi KG, 2009, INDIAN J CLIN BIOCHE, V24, P269, DOI 10.1007/s12291-009-0051-9; von Tempelhoff GF, 2008, CLIN APPL THROMB-HEM, V14, P19, DOI 10.1177/1076029607304748; WALLENBURG HCS, 1984, J PERINAT MED, V12, P7, DOI 10.1515/jpme.1984.12.1.7; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864; Xiong X, 2000, AM J PERINAT, V17, P137, DOI 10.1055/s-2000-9508; Xiong X, 2003, INT J GYNECOL OBSTET, V83, P159, DOI [10.1016/S0020-7292(03)00214-5, 10.1016/s0020-7292(03)00214-5]; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S21; Zeng LX, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2001; Zhang QY, 2009, ANN EPIDEMIOL, V19, P793, DOI 10.1016/j.annepidem.2009.06.002; Zhou LM, 1998, AM J EPIDEMIOL, V148, P998; Zhou SJ, 2009, EUR J CLIN NUTR, V63, P183, DOI 10.1038/sj.ejcn.1602926; Zhou SJ, 2007, J PEDIATR-US, V151, P438, DOI 10.1016/j.jpeds.2007.06.001; Ziaei S, 2007, BJOG-INT J OBSTET GY, V114, P684, DOI 10.1111/j.1471-0528.2007.01325.x; Ziaei S, 2008, INT J GYNECOL OBSTET, V100, P133, DOI 10.1016/j.ijgo.2007.07.026	141	397	419	3	99	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2013	346								f3443	10.1136/bmj.f3443	http://dx.doi.org/10.1136/bmj.f3443			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171RC	23794316	Green Published, hybrid			2022-12-28	WOS:000320945700001
J	Weil, D; Graham, M; Fung, A				Weil, David; Graham, Mary; Fung, Archon			Targeting Transparency	SCIENCE			English	Editorial Material							INFORMATION DISCLOSURE; QUALITY		[Weil, David] Boston Univ, Sch Management, Boston, MA 02215 USA; [Graham, Mary; Fung, Archon] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA	Boston University; Harvard University	Weil, D (corresponding author), Boston Univ, Sch Management, Boston, MA 02215 USA.	davweil@bu.edu						[Anonymous], 2011, FED REG; Bennear LS, 2008, J ENVIRON ECON MANAG, V56, P117, DOI 10.1016/j.jeem.2008.03.002; Board O, 2009, J IND ECON, V57, P197, DOI 10.1111/j.1467-6451.2009.00369.x; Dranove D, 2003, J POLIT ECON, V111, P555, DOI 10.1086/374180; Dranove D, 2010, J ECON LIT, V48, P935, DOI 10.1257/jel.48.4.935; Fung A, 2007, FULL DISCLOSURE PERI; Gormely W., 1999, ORG REPORTS CARDS; Graham M., 2002, DEMOCRACY DISCLOSURE; Hamilton J.T., 2005, REGULATION REVELATIO; Ho DE, 2012, YALE LAW J, V122, P574; Jin GZ, 2003, Q J ECON, V118, P409, DOI 10.1162/003355303321675428; Stiglitz JE, 2000, Q J ECON, V115, P1441, DOI 10.1162/003355300555015; Sunstein CR, 1999, U PENN LAW REV, V147, P613, DOI 10.2307/3312719; Thaler RH., 2021, NUDGE FINAL EDITION; Tietenberg T, 1998, ENVIRON RESOUR ECON, V11, P587, DOI 10.1023/A:1008291411492; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Zeckhauser R., 1996, WISE CHOICES GAMES D; 2009, FED REG, V74, P4685	18	29	29	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1410	1411		10.1126/science.1233480	http://dx.doi.org/10.1126/science.1233480			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	167QL	23788786				2022-12-28	WOS:000320647000026
J	Nelder, C				Nelder, Chris			Positive energy	NATURE			English	Editorial Material												chris@getreallist.com						American Psychological Association Task Force on the Interface between Psychology and Global Climate Change, 2009, PSYCH GLOB CLIM CHAN; International Energy Agency, 2012, WORLD EN OUTL 2012; Kahan D, 2010, NATURE, V463, P296, DOI 10.1038/463296a; Littlefield SR, 2013, ENERG POLICY, V52, P779, DOI 10.1016/j.enpol.2012.10.040; U.S Energy Information Administration, 2013, TECHN REC SHAL OIL S; US Energy Information Administration, 2010, ANN EN OUTL RETR REV; Yergin Daniel, 2011, WALL STREET J	7	3	3	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					293	295		10.1038/498293a	http://dx.doi.org/10.1038/498293a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166XI	23783612				2022-12-28	WOS:000320592900013
J	[Anonymous]				[Anonymous]			During Turkish protests, medical personnel targeted	LANCET			English	Editorial Material																		Bihr J, 2011, MEDIA JUSTICE TURKEY; Kimmelman M, 2013, NY TIMES; Seymour R., 2013, GUARDIAN; Weaver A., 2010, GUARDIAN; Yavuz Hakan, 2009, SECULARISM MUSLIM DE	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 15	2013	381	9883					2067	2067						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KA	23769220				2022-12-28	WOS:000320924800010
J	Cole, AJ; Eskandar, E; Mela, T; Noebels, JL; Gonzalez, RG; McGuone, D				Cole, Andrew J.; Eskandar, Emad; Mela, Theofanie; Noebels, Jeffrey L.; Gonzalez, R. Gilberto; McGuone, Declan			Case 18-2013: A 32-Year-Old Woman with Recurrent Episodes of Altered Consciousness Oligoastrocytoma, WHO grade II of IV, associated with temporal-lobe seizures and ictal asystole (arrhythmogenic epilepsy)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-QT SYNDROME; BRADYCARDIA; IDENTIFICATION; LOBECTOMY; GENETICS; SYNCOPE; DEATH		[Cole, Andrew J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Eskandar, Emad] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Mela, Theofanie] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [McGuone, Declan] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Cole, Andrew J.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Eskandar, Emad] Harvard Univ, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; [Mela, Theofanie] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [McGuone, Declan] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Baylor College of Medicine	Cole, AJ (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.			Noebels, Jeffrey/0000-0002-2887-0839	Clarus Ventures; Concert Pharmaceuticals; Sage Pharmaceuticals; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090340, U01NS090405, P20NS076916] Funding Source: NIH RePORTER	Clarus Ventures; Concert Pharmaceuticals; Sage Pharmaceuticals; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Cole reports receiving consulting fees from Clarus Ventures, Concert Pharmaceuticals, and Sage Pharmaceuticals. Dr. Eskandar reports payment to his institution for a patent on a device for deep-brain stimulation for enhancing learning, motivation, and memory. No other potential conflict of interest relevant to this article was reported.	Baruscotti M, 2011, P NATL ACAD SCI USA, V108, P1705, DOI 10.1073/pnas.1010122108; Britton JW, 2006, EPILEPSIA, V47, P737, DOI 10.1111/j.1528-1167.2006.00509.x; Cerrone M, 2011, EUR HEART J, V32, P2109, DOI 10.1093/eurheartj/ehr082; DiFrancesco JC, 2011, J NEUROSCI, V31, P17327, DOI 10.1523/JNEUROSCI.3727-11.2011; Foldvary N, 2000, NEUROLOGY, V54, P630, DOI 10.1212/WNL.54.3.630; Glasscock E, 2010, J NEUROSCI, V30, P5167, DOI 10.1523/JNEUROSCI.5591-09.2010; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; Graebenitz S, 2011, BRAIN, V134, P2929, DOI 10.1093/brain/awr202; Johnson JN, 2009, NEUROLOGY, V72, P224, DOI 10.1212/01.wnl.0000335760.02995.ca; Jons C, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001551; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Kouakam C, 2009, ARCH CARDIOVASC DIS, V102, P397, DOI 10.1016/j.acvd.2009.02.014; Lanz M, 2011, SEIZURE-EUR J EPILEP, V20, P167, DOI 10.1016/j.seizure.2010.11.017; Liu JF, 2011, J AM COLL CARDIOL, V57, P941, DOI 10.1016/j.jacc.2010.10.025; Livolsi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015618; Lu JT, 2010, CURR OPIN CARDIOL, V25, P216, DOI 10.1097/HCO.0b013e32833846b3; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Montenegro RA, 2011, NEUROSCI LETT, V497, P32, DOI 10.1016/j.neulet.2011.04.019; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Rugg-Gunn FJ, 2004, LANCET, V364, P2212, DOI 10.1016/S0140-6736(04)17594-6; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Schmidt D, 2004, EPILEPSIA, V45, P179, DOI 10.1111/j.0013-9580.2004.37803.x; Schuele SU, 2007, NEUROLOGY, V69, P434, DOI 10.1212/01.wnl.0000266595.77885.7f; Schwartz PJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P868, DOI 10.1161/CIRCEP.111.962019; Sheldon R, 2003, EUROPACE, V5, P71, DOI 10.1053/eupc.2002.0284; Skinner JR, 2011, HEART RHYTHM, V8, P412, DOI 10.1016/j.hrthm.2010.11.016; Tinuper P, 2001, BRAIN, V124, P2361, DOI 10.1093/brain/124.12.2361; van der Sluijs BM, 2004, J NEURO-ONCOL, V67, P241, DOI 10.1023/B:NEON.0000021899.69560.e6; Wong JA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P120, DOI 10.1161/CIRCEP.109.907865; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408; Zuberi SM, 2011, NEUROLOGY, V76, P594, DOI 10.1212/WNL.0b013e31820c309b	32	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2304	2312		10.1056/NEJMcpc1215969	http://dx.doi.org/10.1056/NEJMcpc1215969			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YN	23758236				2022-12-28	WOS:000320230500008
J	Doshi, P; Dickersin, K; Healy, D; Vedula, SS; Jefferson, T				Doshi, Peter; Dickersin, Kay; Healy, David; Vedula, S. Swaroop; Jefferson, Tom			Restoring invisible and abandoned trials: a call for people to publish the findings	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEURAMINIDASE INHIBITOR ZANAMIVIR; PLACEBO-CONTROLLED TRIAL; OBSESSIVE-COMPULSIVE DISORDER; MAJOR DEPRESSIVE DISORDER; DOUBLE-BLIND; INHALED ZANAMIVIR; MYOCARDIAL-INFARCTION; ORAL OSELTAMIVIR; CLINICAL-TRIALS; INFLUENZA-A		[Doshi, Peter] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Baltimore, MD USA; [Dickersin, Kay] US Cochrane Ctr, Baltimore, MD USA; [Healy, David] Bangor Univ, Bangor, Gwynedd, Wales; [Vedula, S. Swaroop] Johns Hopkins Univ, Baltimore, MD USA; [Jefferson, Tom] Cochrane Collaborat, Rome, Italy	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Bangor University; Johns Hopkins University	Doshi, P (corresponding author), Reed Hall West,Room 201-C,1620 McElderry St, Baltimore, MD 21205 USA.	pdoshi@post.harvard.edu						Ambrozaitis Arvydas, 2005, J Am Med Dir Assoc, V6, P367, DOI 10.1016/j.jamda.2005.08.007; [Anonymous], 1995, STRUCT CONT CLIN STU; [Anonymous], OUTP EUR MED AG POL; [Anonymous], 2012, HMA EMA GUID DOC ID; Aronoff S, 2000, DIABETES CARE, V23, P1605, DOI 10.2337/diacare.23.11.1605; Backonja M, 1998, JAMA-J AM MED ASSOC, V280, P1831, DOI 10.1001/jama.280.21.1831; Baldwin D, 2006, J PSYCHOPHARMACOL, V20, P91, DOI 10.1177/0269881105056666; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Bauchner H, 2013, JAMA-J AM MED ASSOC, V309, P607, DOI 10.1001/jama.2013.58; Berard R, 2006, J CHILD ADOL PSYCHOP, V16, P59, DOI 10.1089/cap.2006.16.59; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Blumsohn A., 2006, AAAS PROFESSIONAL ET, V19, P1; Boulton G, 2011, LANCET, V377, P1633, DOI 10.1016/S0140-6736(11)60647-8; Braconnier A, 2003, J AM ACAD CHILD PSY, V42, P22, DOI 10.1097/00004583-200301000-00007; Calabrese JR, 2005, AM J PSYCHIAT, V162, P1351, DOI 10.1176/appi.ajp.162.7.1351; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Caraceni A, 2004, J CLIN ONCOL, V22, P2909, DOI 10.1200/jco.2004.08.141; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Coyne DW, 2012, KIDNEY INT, V82, P235, DOI 10.1038/ki.2012.76; Department of Energy, 2012, COMPR EP DAT RES; DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x; Doshi Peter, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-002496; Doshi P, 2013, JAMA INTERN MED, V173, P380, DOI 10.1001/jamainternmed.2013.3838; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Doshi P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7898; Dutkowski R, 2010, INT J ANTIMICROB AG, V35, P461, DOI 10.1016/j.ijantimicag.2009.12.023; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; Emslie GJ, 2006, J AM ACAD CHILD PSY, V45, P709, DOI 10.1097/01.chi.0000214189.73240.63; European Medicines Agency, 2010, EUR MED AG POL ACC D; European Medicines Agency, 2004, NOT GUID INCL APP CL; Ferguson JM, 2003, INT CLIN PSYCHOPHARM, V18, P9, DOI 10.1097/00004850-200301000-00002; Findling RL, 2006, NEUROPSYCHOPHARMACOL, V31, P1274, DOI 10.1038/sj.npp.1300960; Fong R, 2005, J CHILD ADOL PSYCHOP, V15, P856; Fromer M, 2001, ONCOLOGY TIMES, V23, P52; Fugh-Berman AJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000335; Geller DA, 2004, J AM ACAD CHILD PSY, V43, P1387, DOI 10.1097/01.chi.0000138356.29099.f1; Geller DA, 2003, J CHILD ADOL PSYCHOP, V13, pS19, DOI 10.1089/104454603322126313; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Gomez-Perez FJ, 2004, BRIT J DIABETES VASC, V4, P173; Gordh TE, 2008, PAIN, V138, P255, DOI 10.1016/j.pain.2007.12.011; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Gravenstein Stefan, 2005, J Am Med Dir Assoc, V6, P359, DOI 10.1016/j.jamda.2005.08.006; Groves T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c564; Hanson B, 2011, SCIENCE, V331, P649, DOI 10.1126/science.1203354; Hayden FG, 2000, ANTIVIR THER, V5, P205; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Healy D., 2012, PHARMAGEDDON; Hedrick JA, 2000, PEDIATR INFECT DIS J, V19, P410, DOI 10.1097/00006454-200005000-00005; Hendrick R, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7860; Hersch J, 1962, FINAL REPORT PROJECT; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Horton R, 1997, LANCET, V350, P5, DOI 10.1016/S0140-6736(05)66236-8; Hrynaszkiewicz Iain, 2010, BMJ, V340, pc181, DOI [10.1186/1745-6215-11-9, 10.1136/bmj.c181]; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Johnston SL, 2005, PEDIATR INFECT DIS J, V24, P225, DOI 10.1097/01.inf.0000154322.38267.ce; Jureidini JN, 2008, INT J RISK SAF MED, V29, P73, DOI DOI 10.3233/JRS-2008-0426; Kaiser L, 2000, CLIN INFECT DIS, V30, P587, DOI 10.1086/313696; Keck PE, 2009, J AFFECT DISORDERS, V112, P36, DOI 10.1016/j.jad.2008.05.014; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Korn D, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010001; LaForce C, 2007, CLIN THER, V29, P1579, DOI 10.1016/j.clinthera.2007.08.023; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Langworth S, 2006, J CLIN PSYCHOPHARM, V26, P121, DOI 10.1097/01.jcp.0000204138.20417.c3; Law MR, 2011, HEALTH AFFAIR, V30, P2338, DOI 10.1377/hlthaff.2011.0172; Li JS, 2008, CIRCULATION, V117, P553, DOI 10.1161/CIRCULATIONAHA.107.715821; Makela MJ, 2000, J INFECTION, V40, P42, DOI 10.1053/jinf.1999.0602; Mansi BA, 2012, MAYO CLIN PROC, V87, P424, DOI 10.1016/j.mayocp.2012.02.009; Massana J, 1999, INT CLIN PSYCHOPHARM, V14, P73, DOI 10.1097/00004850-199903000-00003; Mathew NT, 2001, HEADACHE, V41, P119, DOI 10.1046/j.1526-4610.2001.111006119.x; Matsumoto K, 1999, ANTIVIR THER, V4, P61; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Mello MM, 2005, NEW ENGL J MED, V352, P2202, DOI 10.1056/NEJMsa044115; Mirowski P, 2005, SOC STUD SCI, V35, P503, DOI 10.1177/0306312705052103; Monto AS, 1999, J ANTIMICROB CHEMOTH, V44, P23, DOI 10.1093/jac/44.suppl_2.23; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; Monto AS, 1999, J INFECT DIS, V180, P254, DOI 10.1086/314904; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Murphy KR, 2000, CLIN DRUG INVEST, V20, P337, DOI 10.2165/00044011-200020050-00005; National Heart Lung and Blood Institute, 2011, WOM HLTH IN; Newcomer JW, 2009, J CLIN PSYCHIAT, V70, P487, DOI 10.4088/JCP.08m04132; Newman M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6985; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Pande AC, 2000, BIPOLAR DISORD, V2, P249, DOI 10.1034/j.1399-5618.2000.20305.x; Pendleton C, 2011, WORLD NEUROSURGERY; Peng AW, 2000, J CLIN PHARMACOL, V40, P242, DOI 10.1177/00912700022008900; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Puhakka T, 2003, SCAND J INFECT DIS, V35, P52, DOI 10.1080/0036554021000026981; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Rumke HC, 2008, VACCINE, V26, P2378, DOI 10.1016/j.vaccine.2008.02.068; Sabatine MS, 2005, AM HEART J, V149, P227, DOI 10.1016/j.ahj.2004.11.006; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Schilling M, 1998, VACCINE, V16, P1771, DOI 10.1016/S0264-410X(98)00141-8; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Serpell MG, 2002, PAIN, V99, P557, DOI 10.1016/S0304-3959(02)00255-5; Silagy C, 1998, LANCET, V352, P1877, DOI 10.1016/S0140-6736(98)10190-3; Sismondo S, 2010, BIOETHICS, V24, P273, DOI 10.1111/j.1467-8519.2008.01702.x; SLADE J, 1995, JAMA-J AM MED ASSOC, V274, P225, DOI 10.1001/jama.274.3.225; Smith R, 1997, BRIT MED J, V315, P696, DOI 10.1136/bmj.315.7110.696; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; University of California, 2007, LEG TOB DOC LIB; Unlu M, 2010, MICH TELECOMM TECH L, V16, P511; Vedula SS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001378; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Versiani M, 2000, J CLIN PSYCHOPHARM, V20, P28, DOI 10.1097/00004714-200002000-00006; Vesikari T, 2010, PEDIATRICS, V126, pE762, DOI 10.1542/peds.2009-2628; Vieta E, 2006, J CLIN PSYCHIAT, V67, P473, DOI 10.4088/JCP.v67n0320; Wagner KD, 2004, ARCH GEN PSYCHIAT, V61, P1153, DOI 10.1001/archpsyc.61.11.1153; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	125	82	82	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2013	346								f2865	10.1136/bmj.f2865	http://dx.doi.org/10.1136/bmj.f2865			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	166WQ	23766480	Green Published, hybrid			2022-12-28	WOS:000320590800017
J	Cnattingius, S; Villamor, E; Johansson, S; Bonamy, AKE; Persson, M; Wikstrom, AK; Granath, F				Cnattingius, Sven; Villamor, Eduardo; Johansson, Stefan; Bonamy, Anna-Karin Edstedt; Persson, Martina; Wikstrom, Anna-Karin; Granath, Fredrik			Maternal Obesity and Risk of Preterm Delivery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; GESTATIONAL WEIGHT-GAIN; VISCERAL FAT; BIRTH; PREGNANCY; EPIDEMIOLOGY; ULTRASOUND; WOMEN; OVERWEIGHT; VALIDITY	Importance Preterm birth is a leading cause of infant mortality, morbidity, and long-term disability, and these risks increase with decreasing gestational age. Obesity increases the risk of preterm delivery, but the associations between overweight and obesity and subtypes of preterm delivery are not clear. Objective To study the associations between early pregnancy body mass index (BMI) and risk of preterm delivery by gestational age and by precursors of preterm delivery. Design, Setting, and Participants Population-based cohort study of women with live singleton births in Sweden from 1992 through 2010. Maternal and pregnancy characteristics were obtained from the nationwide Swedish Medical Birth Register. Main Outcomes and Measures Risks of preterm deliveries (extremely, 22-27 weeks; very, 28-31 weeks; and moderately, 32-36 weeks). These outcomes were further characterized as spontaneous (related to preterm contractions or preterm premature rupture of membranes) and medically indicated preterm delivery (cesarean delivery before onset of labor or induced onset of labor). Risk estimates were adjusted for maternal age, parity, smoking, education, height, mother's country of birth, and year of delivery. Results Among 1 599 551 deliveries with information on early pregnancy BMI, 3082 were extremely preterm, 6893 were very preterm, and 67 059 were moderately preterm. Risks of extremely, very, and moderately preterm deliveries increased with BMI and the overweight and obesity-related risks were highest for extremely preterm delivery. Among normal-weight women (BMI 18.5-<25), the rate of extremely preterm delivery was 0.17%. As compared with normal-weight women, rates (%) and adjusted odds ratios (ORs [95% CIs]) of extremely preterm delivery were as follows: BMI 25 to less than 30 (0.21%; OR, 1.26; 95% CI, 1.15-1.37), BMI 30 to less than 35 (0.27%; OR, 1.58; 95% CI, 1.39-1.79), BMI 35 to less than 40 (0.35%; OR, 2.01; 95% CI, 1.66-2.45), and BMI of 40 or greater (0.52%; OR, 2.99; 95% CI, 2.28-3.92). Risk of spontaneous extremely preterm delivery increased with BMI among obese women (BMI >= 30). Risks of medically indicated preterm deliveries increased with BMI among overweight and obese women. Conclusions and Relevance In Sweden, maternal overweight and obesity during pregnancy were associated with increased risks of preterm delivery, especially extremely preterm delivery. These associations should be assessed in other populations.	[Cnattingius, Sven; Johansson, Stefan; Bonamy, Anna-Karin Edstedt; Persson, Martina; Wikstrom, Anna-Karin; Granath, Fredrik] Karolinska Inst, Karolinska Univ Hosp, Clin Epidemiol Unit, Dept Med Solna, SE-17176 Stockholm, Sweden; [Persson, Martina] Karolinska Inst, Dept Clin Sci Intervent & Technol, SE-17176 Stockholm, Sweden; [Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Wikstrom, Anna-Karin] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Michigan System; University of Michigan; Uppsala University	Cnattingius, S (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Clin Epidemiol Unit, Dept Med Solna, T2, SE-17176 Stockholm, Sweden.	sven.cnattingius@ki.se	Persson, Martina/B-7667-2015; Bonamy, Anna-Karin E/B-7106-2012	Persson, Martina/0000-0003-2268-3159; Bonamy, Anna-Karin E/0000-0003-4552-9912; Johansson, Stefan/0000-0001-8832-6918	Karolinska Institutet	Karolinska Institutet(Karolinska Institutet)	The study was funded by grants from Karolinska Institutet (Distinguished Professor Award to Dr Cnattingius).	Aviram A, 2011, INT J GYNECOL OBSTET, V115, pS6, DOI 10.1016/S0020-7292(11)60004-0; Bartha JL, 2007, OBESITY, V15, P2233, DOI 10.1038/oby.2007.265; Behrman, PRETERM BIRTH CAUSES; Caughey AB, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.034; Dalenius K, 2012, PREGNANCY NUTR SURVE; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; HACK M, 1993, NEW ENGL J MED, V329, P1649, DOI 10.1056/NEJM199311253292210; Hedderson MM, 2010, OBSTET GYNECOL, V115, P597, DOI 10.1097/AOG.0b013e3181cfce4f; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Hutcheon JA, 2012, PAEDIATR PERINAT EP, V26, P109, DOI 10.1111/j.1365-3016.2011.01254.x; Jarvie E, 2010, CLIN SCI, V119, P123, DOI 10.1042/CS20090640; Khatibi A, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.002; Lucca A, 2010, CAD SAUDE PUBLICA, V26, P110, DOI 10.1590/S0102-311X2010000100012; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; NAEYE RL, 1990, AM J CLIN NUTR, V52, P273, DOI 10.1093/ajcn/52.2.273; Nohr EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008444; Nohr EA, 2007, PAEDIATR PERINAT EP, V21, P5, DOI 10.1111/j.1365-3016.2007.00762.x; Raisanen S, PLOS ONE, DOI [10.1371/journal.pone.0060660/PONE-D-13-04948, DOI 10.1371/JOURNAL.PONE.0060660/PONE-D-13-04948]; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; Salihu H, 2010, J MATERN-FETAL NEO M, V23, P1444, DOI 10.3109/14767051003678044; Sarris I, 2010, HUM REPROD, V25, P1895, DOI 10.1093/humrep/deq132; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; Soltani H, 2000, BRIT J NUTR, V84, P95, DOI 10.1017/S0007114500001276; The Swedish Centre for Epidemiology, SWED MED BIRTH REG S; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; Tucker J, 2004, BRIT MED J, V329, P675, DOI 10.1136/bmj.329.7467.675; United States Department of Health and Human Services ; Centers for Disease Control and Prevention; National Center for Health Statistics, LINK BIRTH INF DEATH; Wei SY, 2009, OBESITY, V17, P1070, DOI 10.1038/oby.2008.641; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; World Health Organization, GLOB DAT BOD MASS IN	38	412	424	3	82	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2362	2370		10.1001/jama.2013.6295	http://dx.doi.org/10.1001/jama.2013.6295			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161EV	23757084	Bronze			2022-12-28	WOS:000320176000026
J	Thomsen, M; Ingebrigtsen, TS; Marott, JL; Dahl, M; Lange, P; Vestbo, J; Nordestgaard, BG				Thomsen, Mette; Ingebrigtsen, Truls Sylvan; Marott, Jacob Louis; Dahl, Morten; Lange, Peter; Vestbo, Jorgen; Nordestgaard, Borge G.			Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISCHEMIC-HEART-DISEASE; C-REACTIVE PROTEIN; SYSTEMIC INFLAMMATION; COPD EXACERBATIONS; PLASMA-FIBRINOGEN; RISK; ASSOCIATION; POPULATION; PREDICTION; INFECTION	Importance Exacerbations of respiratory symptoms in chronic obstructive pulmonary disease (COPD) have profound and long-lasting adverse effects on patients. Objective To test the hypothesis that elevated levels of inflammatory biomarkers in individuals with stable COPD are associated with an increased risk of having exacerbations. Design, Setting, and Participants Prospective cohort study examining 61 650 participants with spirometry measurements from the Copenhagen City Heart Study (20012003) and the Copenhagen General Population Study (2003-2008). Of these, 6574 had COPD, defined as a ratio between forced expiratory volume in 1 second (FEV1) and forced vital capacity below 0.7. Main Outcomes and Measures Baseline levels of C-reactive protein (CRP) and fibrinogen and leukocyte count were measured in participants at a time when they were not experiencing symptoms of exacerbations. Exacerbations were recorded and defined as short-course treatment with oral corticosteroids alone or in combination with an antibiotic or as a hospital admission due to COPD. Levels of CRP and fibrinogen and leukocyte count were defined as high or low according to cut points of 3 mg/L, 14 mu mol/L, and 9 x 10(9)/L, respectively. Results During follow-up, 3083 exacerbations were recorded (mean, 0.5/participant). In the first year of follow-up, multivariable-adjusted odds ratios for having frequent exacerbations were 1.2 (95% CI, 0.7-2.2; 17 events/1000 person-years) for individuals with 1 high biomarker, 1.7 (95% CI, 0.9-3.2; 32 events/1000 person-years) for individuals with 2 high biomarkers, and 3.7 (95% CI, 1.9-7.4; 81 events/1000 person-years) for individuals with 3 high biomarkers compared with individuals who had no elevated biomarkers (9 events/1000 person-years; trend: P=2 x 10(-5)). Corresponding hazard ratios using maximum follow-up time were 1.4 (95% CI, 1.1-1.8), 1.6 (95% CI, 1.3-2.2), and 2.5 (95% CI, 1.8-3.4), respectively (trend: P=1 x 10(-8)). The addition of inflammatory biomarkers to a basic model including age, sex, FEV1 percent predicted, smoking, use of any inhaled medication, body mass index, history of previous exacerbations, and time since most recent prior exacerbation improved the C statistics from 0.71 to 0.73 (comparison: P=9 x 10(-5)). Relative risks were consistent in those with milder COPD, in those with no history of frequent exacerbations, and in the 2 studies separately. The highest 5-year absolute risks of having frequent exacerbations in those with 3 high biomarkers (vs no high biomarkers) were 62% (vs 24%) for those with Global Initiative for Chronic Obstructive Lung Disease (GOLD) grades C-D (n=558), 98% (vs 64%) in those with a history of frequent exacerbations (n=127), and 52% (vs 15%) for those with GOLD grades 3-4 (n=465). Conclusions and Relevance Simultaneously elevated levels of CRP and fibrinogen and leukocyte count in individuals with COPD were associated with increased risk of having exacerbations, even in those with milder COPD and in those without previous exacerbations. Further investigation is needed to determine the clinical value of these biomarkers for risk stratification.	[Thomsen, Mette; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Thomsen, Mette; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark; [Ingebrigtsen, Truls Sylvan; Marott, Jacob Louis; Lange, Peter; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark; [Dahl, Morten] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Lange, Peter] Copenhagen Univ Hosp, Hvidovre Hosp, Resp Sect, Hvidovre, Denmark; [Thomsen, Mette; Dahl, Morten; Lange, Peter; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Lange, Peter] Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark; [Ingebrigtsen, Truls Sylvan; Vestbo, Jorgen] Univ Southern Denmark, Odense Univ Hosp, Dept Resp Med, Odense, Denmark; [Vestbo, Jorgen] Univ Hosp South Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Resp Res Grp, Manchester, Lancs, England	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	boerge.nordestgaard@regionh.dk	Vestbo, Jorgen/Y-2912-2019; Dahl, Morten/F-4219-2014	Vestbo, Jorgen/0000-0001-6355-6362; Dahl, Morten/0000-0002-6686-312X; Nordestgaard, Borge/0000-0002-1954-7220	Herlev Hospital from Denmark; Copenhagen University Hospital from Denmark; Danish Heart Foundation from Denmark; Copenhagen County Foundation from Denmark; University of Copenhagen from Denmark	Herlev Hospital from Denmark; Copenhagen University Hospital from Denmark; Danish Heart Foundation from Denmark; Copenhagen County Foundation from Denmark; University of Copenhagen from Denmark	This work was supported by Herlev Hospital, Copenhagen University Hospital, the Danish Heart Foundation, the Copenhagen County Foundation, and the University of Copenhagen, all from Denmark.	Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; [Anonymous], 2010, INT CLASS DIS 2010; Cazzola M, 2012, EUR RESPIR J, V40, P724, DOI 10.1183/09031936.00213711; Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Dahl M, 2001, AM J RESP CRIT CARE, V164, P1008, DOI 10.1164/ajrccm.164.6.2010067; Dahl M, 2007, AM J RESP CRIT CARE, V175, P250, DOI 10.1164/rccm.200605-713OC; Dahl M, 2011, THORAX, V66, P197, DOI 10.1136/thx.2009.131193; Dentener MA, 2001, THORAX, V56, P721, DOI 10.1136/thorax.56.9.721; Dickens JA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-146; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Groenewegen KH, 2008, CHEST, V133, P350, DOI 10.1378/chest.07-1342; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hogg JC, 2001, AM J RESP CRIT CARE, V164, pS71, DOI 10.1164/ajrccm.164.supplement_2.2106063; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Juul K, 2004, ANN INTERN MED, V140, P330, DOI 10.7326/0003-4819-140-5-200403020-00008; Kessler R, 2006, CHEST, V130, P133, DOI 10.1378/chest.130.1.133; Lange P, 2012, AM J RESP CRIT CARE, V186, P975, DOI 10.1164/rccm.201207-1299OC; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Powrie DJ, 2007, EUR RESPIR J, V30, P472, DOI 10.1183/09031936.00023907; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; Thomsen RW, 2011, RESP MED, V105, P1063, DOI 10.1016/j.rmed.2011.01.012; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; WHO Collaborating Centre for Drug Statistics Methodology, ATC DDD IND 2013; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	39	267	280	1	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2353	2361		10.1001/jama.2013.5732	http://dx.doi.org/10.1001/jama.2013.5732			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161EV	23757083	Bronze, Green Published			2022-12-28	WOS:000320176000025
J	Cohen, D				Cohen, Deborah			DIABETES DRUGS Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALPHA CELL HYPERPLASIA; HYPERINSULINEMIC HYPOGLYCEMIA; RECEPTOR ACTIVATION; PEPTIDE-1 ANALOG; LIRAGLUTIDE; ENDOCRINE; RATS; HYPERGLUCAGONEMIA; GLUCOSE		BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; Bernstein Research, 2009, NOV LILL GLP 1S BYET; Bock T, 2003, APMIS, V111, P1117, DOI 10.1111/j.1600-0463.2003.apm1111207.x; Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Butler AE, 2013, DIABETES; Butler PC, 2013, DIABETES CARE; Campbell JE, 2013, CELL METAB; Cohen D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1808; Cummings BP, 2010, DIABETES, V59, P2653, DOI 10.2337/db09-1564; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gier B, 2012, DIABETES, V61, P1250, DOI 10.2337/db11-1109; Hirschler B, 2012, REUTERS; Institute for Safe Medication Practices, 2013, PERSP GLP 1 AG DIAB; Koehler JA, 2009, DIABETES, V58, P2148, DOI 10.2337/db09-0626; Matveyenko AV, 2009, DIABETES, V58, P1604, DOI 10.2337/db09-0058; Nauck MA:, 2013, DIABETES CARE; Nyborg NCB, 2012, DIABETES, V61, P1243, DOI 10.2337/db11-0936; Rabiee A, 2011, J SURG RES, V167, P199, DOI 10.1016/j.jss.2010.09.047; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; Service GJ, 2005, NEW ENGL J MED, V353, P249, DOI 10.1056/NEJMoa043690; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Stearns Bear, TYPE 2 DIAB OUR THOU; Tatarkiewicz K, 2013, DIABETES OBES METAB, V15, P417, DOI 10.1111/dom.12040; Vrang N, 2012, AM J PHYSIOL-ENDOC M, V303, pE253, DOI 10.1152/ajpendo.00182.2012; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021255; Zhou CQ, 2009, PANCREAS, V38, P941, DOI 10.1097/MPA.0b013e3181b2bb03	29	39	40	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2013	346								f3680	10.1136/bmj.f3680	http://dx.doi.org/10.1136/bmj.f3680			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VK	23748128				2022-12-28	WOS:000320586700013
J	Roukens, A; Vlasveld, T; Veelken, H; Kersting, S				Roukens, Anna; Vlasveld, Tom; Veelken, Hendrik; Kersting, Sabina			Vanishing ulnae: symmetrical diffuse large B-cell lymphoma	LANCET			English	Editorial Material									[Roukens, Anna; Vlasveld, Tom; Veelken, Hendrik; Kersting, Sabina] Leiden Univ, Med Ctr, Dept Hematol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Roukens, A (corresponding author), Leiden Univ, Med Ctr, Dept Hematol, POB 9600, NL-2300 RC Leiden, Netherlands.	a.h.e.roukens@lumc.nl		Veelken, Hendrik/0000-0002-9108-3125					0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					E40	E40		10.1016/S0140-6736(13)60144-0	http://dx.doi.org/10.1016/S0140-6736(13)60144-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269DX	23746923	Bronze			2022-12-28	WOS:000328222400005
J	Bayer, R; Johns, D; Colgrove, J				Bayer, Ronald; Johns, David; Colgrove, James			The FDA and Graphic Cigarette-Pack Warnings - Thwarted by the Courts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bayer, Ronald; Johns, David; Colgrove, James] Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA	Columbia University	Bayer, R (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA.							[Anonymous], 2013, NY TIMES; Azagba S, 2013, NICOTINE TOB RES, V15, P708, DOI 10.1093/ntr/nts194; Glantz S, 2013, FDA MADE RIGHT DECIS; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; HOLDER EH, 2013, COMMUNICATION	5	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	2013	369	3					206	208		10.1056/NEJMp1306205	http://dx.doi.org/10.1056/NEJMp1306205			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	185DQ	23803139	Bronze			2022-12-28	WOS:000321945800004
J	Bach, PB				Bach, Peter B.			Reforming the Payment System for Medical Oncology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER CARE		[Bach, Peter B.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, 1275 York Ave,POB 44, New York, NY 10021 USA.	bachp@mskcc.org						[Anonymous], 2013, COMMUNICATION, P2; Bach PB, 2011, HEALTH AFFAIR, V30, P500, DOI 10.1377/hlthaff.2010.0752; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Center for Medicare & Medicaid Services, COMP ACQ B; Conti RM, 2013, JAMA-J AM MED ASSOC, V309, P1995, DOI 10.1001/jama.2013.4156; Kohl Helmut, COMMUNICATION; Neubauer MA, 2010, J ONCOL PRACT, V6, P12, DOI 10.1200/JOP.091058; Newcomer LN, 2012, HEALTH AFFAIR, V31, P780, DOI 10.1377/hlthaff.2012.0002	8	14	14	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					261	262		10.1001/jama.2013.8127	http://dx.doi.org/10.1001/jama.2013.8127			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23817729				2022-12-28	WOS:000321835700009
J	Yoshimoto, S; Loo, TM; Atarashi, K; Kanda, H; Sato, S; Oyadomari, S; Iwakura, Y; Oshima, K; Morita, H; Hattori, M; Honda, K; Ishikawa, Y; Hara, E; Ohtani, N				Yoshimoto, Shin; Loo, Tze Mun; Atarashi, Koji; Kanda, Hiroaki; Sato, Seidai; Oyadomari, Seiichi; Iwakura, Yoichiro; Oshima, Kenshiro; Morita, Hidetoshi; Hattori, Masahisa; Honda, Kenya; Ishikawa, Yuichi; Hara, Eiji; Ohtani, Naoko			Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome	NATURE			English	Article							HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; MECHANISMS; CLOSTRIDIUM; EXPRESSION; ACID; INFLAMMATION; PHENOTYPE; BACTERIUM; STRESS	Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer(1). As the worldwide obesity epidemic has shown no signs of abating(2), better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer1,3, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP)(4,5) has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage(6). The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs)(7), which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer(8) or depleted of senescent HSCs, indicating that the DCA-SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis(3), indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.	[Yoshimoto, Shin; Loo, Tze Mun; Sato, Seidai; Hara, Eiji; Ohtani, Naoko] Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Koto Ku, Tokyo 1358550, Japan; [Yoshimoto, Shin; Loo, Tze Mun; Sato, Seidai; Honda, Kenya; Hara, Eiji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Loo, Tze Mun] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Atarashi, Koji; Honda, Kenya] RIKEN, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; [Atarashi, Koji; Ohtani, Naoko] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kanda, Hiroaki; Ishikawa, Yuichi] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Koto Ku, Tokyo 1358550, Japan; [Oyadomari, Seiichi] Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biol Sci, Noda, Chiba 2788510, Japan; [Oshima, Kenshiro; Hattori, Masahisa] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa 2298501, Japan	Japanese Foundation for Cancer Research; Japan Science & Technology Agency (JST); Tokyo University of Science; RIKEN; Japan Science & Technology Agency (JST); Japanese Foundation for Cancer Research; Tokushima University; Tokyo University of Science; University of Tokyo; Azabu University	Hara, E (corresponding author), Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Koto Ku, Tokyo 1358550, Japan.	eiji.hara@jfcr.or.jp	Honda, Kenya/N-5297-2015; Oyadomari, Seiichi/GZA-7072-2022; Atarashi, Koji/I-5363-2014; Oyadomari, Seiichi/GZA-7157-2022; Ohtani, Naoko/AAB-1891-2021; Iwakura, Yoichiro/E-5457-2011; Yoshimoto, Shin/ACD-1941-2022	Atarashi, Koji/0000-0001-5422-0736; Ohtani, Naoko/0000-0001-8934-0797; Iwakura, Yoichiro/0000-0002-9934-5775; Yoshimoto, Shin/0000-0001-8405-0301; Loo, Tze Mun/0000-0001-5725-1423	Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Ministry of Health, Labour and Welfare of Japan (MHLW); Uehara Memorial Foundation; Takeda Science Foundation; Japan Society for Promotion of Science (JSPS); Ajinomoto Scholarship Foundation; Grants-in-Aid for Scientific Research [24650625, 221S0001] Funding Source: KAKEN	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan (MHLW)(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ajinomoto Scholarship Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank M. Oshima for suggestions in antibiotics treatment and members of the Hara laboratory for discussion during the preparation of this manuscript. This work was supported by grants from Japan Science and Technology Agency (JST), Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Ministry of Health, Labour and Welfare of Japan (MHLW), Uehara Memorial Foundation and Takeda Science Foundation. S.Y. was partly supported by a postdoctoral fellowship from the Japan Society for Promotion of Science (JSPS). T. M. L. was partly supported by an international scholarship from the Ajinomoto Scholarship Foundation.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Beuers U, 2006, NAT CLIN PRACT GASTR, V3, P318, DOI 10.1038/ncpgasthep0521; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; KITAZAWA S, 1990, CARCINOGENESIS, V11, P1323, DOI 10.1093/carcin/11.8.1323; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Minamida K, 2006, BIOSCI BIOTECH BIOCH, V70, P332, DOI 10.1271/bbb.70.332; Muto A, 2012, J CHROMATOGR B, V900, P24, DOI 10.1016/j.jchromb.2012.05.023; Newell P, 2009, J HEPATOL, V51, P725, DOI 10.1016/j.jhep.2009.03.028; Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139; RAFTER JJ, 1987, AM J CLIN NUTR, V45, P559, DOI 10.1093/ajcn/45.3.559; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ridlon JM, 2012, J LIPID RES, V53, P66, DOI 10.1194/jlr.M020313; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097; Sekiya Y, 2011, J CELL PHYSIOL, V226, P2535, DOI 10.1002/jcp.22598; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Takuma Y, 2010, WORLD J GASTROENTERO, V16, P1436, DOI 10.3748/wjg.v16.i12.1436; Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105	39	1268	1357	9	425	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2013	499	7456					97	+		10.1038/nature12347	http://dx.doi.org/10.1038/nature12347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23803760				2022-12-28	WOS:000321285600041
J	Chou, R; Dana, T; Bougatsos, C; Blazina, I; Starmer, AJ; Reitel, K; Buckley, DI				Chou, Roger; Dana, Tracy; Bougatsos, Christina; Blazina, Ian; Starmer, Amy J.; Reitel, Katie; Buckley, David I.			Pressure Ulcer Risk Assessment and Prevention A Systematic Comparative Effectiveness Review	ANNALS OF INTERNAL MEDICINE			English	Review							AUSTRALIAN MEDICAL SHEEPSKIN; RELIEVING SUPPORT SURFACES; ASSESSMENT SCALES; CLINICAL-TRIAL; NUTRITIONAL SUPPLEMENTATION; ELDERLY-PATIENTS; AIR-MATTRESSES; SORES; CARE; QUALITY	Background: Pressure ulcers are associated with substantial health burdens but may be preventable. Purpose: To review the clinical utility of pressure ulcer risk assessment instruments and the comparative effectiveness of preventive interventions in persons at higher risk. Data Sources: MEDLINE (1946 through November 2012), CINAHL, the Cochrane Library, grant databases, clinical trial registries, and reference lists. Study Selection: Randomized trials and observational studies on effects of using risk assessment on clinical outcomes and randomized trials of preventive interventions on clinical outcomes. Data Extraction: Multiple investigators abstracted and checked study details and quality using predefined criteria. Data Synthesis: One good-quality trial found no evidence that use of a pressure ulcer risk assessment instrument, with or without a protocolized intervention strategy based on assessed risk, reduces risk for incident pressure ulcers compared with less standardized risk assessment based on nurses' clinical judgment. In higher-risk populations, 1 good-quality and 4 fair-quality randomized trials found that more advanced static support surfaces were associated with lower risk for pressure ulcers compared with standard mattresses (relative risk range, 0.20 to 0.60). Evidence on the effectiveness of low-air-loss and alternating-air mattresses was limited, with some trials showing no clear differences from advanced static support surfaces. Evidence on the effectiveness of nutritional supplementation, repositioning, and skin care interventions versus usual care was limited and had methodological shortcomings, precluding strong conclusions. Limitation: Only English-language articles were included, publication bias could not be formally assessed, and most studies had methodological shortcomings. Conclusion: More advanced static support surfaces are more effective than standard mattresses for preventing ulcers in higher-risk populations. The effectiveness of formal risk assessment instruments and associated intervention protocols compared with less standardized assessment methods and the effectiveness of other preventive interventions compared with usual care have not been clearly established.	[Chou, Roger; Dana, Tracy; Bougatsos, Christina; Blazina, Ian; Starmer, Amy J.; Reitel, Katie; Buckley, David I.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610; Blazina, Ian/0000-0003-0164-6674	AHRQ [290-2007-10057-I]; Agency for Healthcare Research and Quality	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Financial Support: By AHRQ (contract 290-2007-10057-I).; Primary Funding Source: Agency for Healthcare Research and Quality.	Agency for Healthcare Research and Quality, 2011, AHRQ PUBL, P11; ANDERSEN KE, 1983, ACTA DERM-VENEREOL, V63, P227; Ayello EA, 2008, EVIDENCE BASED GERIA, P403; Bale S, 1995, J WOUND CARE, V4, P465; BERGSTROM N, 1987, NURS RES, V36, P205, DOI 10.1097/00006199-198707000-00002; Bourdel-Marchasson I, 2000, NUTRITION, V16, P1, DOI 10.1016/S0899-9007(99)00227-0; Boyle M, 2001, Aust Crit Care, V14, P24, DOI 10.1016/S1036-7314(01)80019-9; Brienza D, 2010, J AM GERIATR SOC, V58, P2308, DOI 10.1111/j.1532-5415.2010.03168.x; Brindle CT, 2012, J WOUND OSTOMY CONT, V39, P133, DOI 10.1097/WON.0b013e318247cb82; Brown M M, 1981, J Gerontol Nurs, V7, P401; Cavicchioli A, 2007, J Wound Care, V16, P285; Chou R., 2013, PRESSURE ULCER RISK; Clark M, 2011, UNDERSTANDING SUPPOR, V2; Collier M E, 1996, J Wound Care, V5, P207; Conine T A, 1994, Int J Rehabil Res, V17, P123, DOI 10.1097/00004356-199406000-00003; Conine T A, 1990, Int J Rehabil Res, V13, P57, DOI 10.1097/00004356-199003000-00006; CONINE TA, 1993, OCCUP THER J RES, V13, P101, DOI 10.1177/153944929301300203; Cooper P, 2001, Br J Nurs, V10, ppassim; Cooper P, 2001, BR J NURS, V10, pS8; Cooper P, 2001, BR J NURS, V10, pS10; Cooper P J, 1998, J Wound Care, V7, P374; DAECHSEL D, 1985, ARCH PHYS MED REHAB, V66, P246, DOI 10.1016/0003-9993(85)90161-3; Declair V, 1997, Ostomy Wound Manage, V43, P48; Declair V., 1997, OSTOMY WOUND MANAG, V43, P54; Defloor T, 2005, J CLIN NURS, V14, P373, DOI 10.1111/j.1365-2702.2004.01058.x; Defloor T, 2005, INT J NURS STUD, V42, P37, DOI 10.1016/j.ijnurstu.2004.05.013; DELMI M, 1990, LANCET, V335, P1013, DOI 10.1016/0140-6736(90)91073-J; Demarre L, 2012, INT J NURS STUD, V49, P416, DOI 10.1016/j.ijnurstu.2011.10.007; Donnelly J, 2011, J WOUND CARE, V20, P309, DOI 10.12968/jowc.2011.20.7.309; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; EK AC, 1991, CLIN NUTR, V10, P245, DOI 10.1016/0261-5614(91)90002-T; European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel, 2009, PREV TREATM PRESS UL; Fader M, 2003, J CLIN NURS, V12, P374, DOI 10.1046/j.1365-2702.2003.00731.x; Fogerty MD, 2008, WOUND REPAIR REGEN, V16, P11, DOI 10.1111/j.1524-475X.2007.00327.x; Gebhardt K S, 1996, J Wound Care, V5, P116; Geyer M J, 2001, Adv Skin Wound Care, V14, P120, DOI 10.1097/00129334-200105000-00008; Gilcreast DM, 2005, J WOUND OSTOMY CONT, V32, P112, DOI 10.1097/00152192-200503000-00008; GOLDSTONE LA, 1982, J ADV NURS, V7, P545, DOI 10.1111/j.1365-2648.1982.tb00274.x; Gray D G, 2000, J Wound Care, V9, P29; Gray DG, 1994, J TISSUE VIABILITY, V4, P128, DOI DOI 10.1016/S0965-206X(14)80124-1; Gunningberg L, 2000, J Wound Care, V9, P455; Hampton S, 1999, Br J Nurs, V8, P990; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hartgrink HH, 1998, CLIN NUTR, V17, P287, DOI 10.1016/S0261-5614(98)80321-X; HOFMAN A, 1994, LANCET, V343, P568, DOI 10.1016/S0140-6736(94)91521-0; Houwing RH, 2003, CLIN NUTR, V22, P401, DOI 10.1016/S0261-5614(03)00039-6; Houwing R, 2008, WOUNDS, V20, P84; INMAN KJ, 1993, JAMA-J AM MED ASSOC, V269, P1139; Jesurum J, 1996, Crit Care Nurs Clin North Am, V8, P423; Jolley DJ, 2004, MED J AUSTRALIA, V180, P324, DOI 10.5694/j.1326-5377.2004.tb05966.x; KEMP MG, 1993, RES NURS HEALTH, V16, P89, DOI 10.1002/nur.4770160203; Keogh A, 2001, J Wound Care, V10, P15; Kim EK, 2009, AUST J ADV NURS, V26, P87; Krapfl LA, 2008, J WOUND OSTOMY CONT, V35, P571, DOI 10.1097/01.WON.0000341469.33567.61; Kuhn B A, 1992, Nurs Econ, V10, P353; Lazzara D J, 1991, Decubitus, V4, P42; Lazzara DJ, 1991, DECUBITUS, V4, P48; Lazzara DJD, 1991, DECUBITUS, V4, P46; Lim R, 1988, J Rehabil Res Dev, V25, P19; Lyder C, 2008, AHRQ PUBLICATION, V8, P1; Lyder CH, 2003, JAMA-J AM MED ASSOC, V289, P223, DOI 10.1001/jama.289.2.223; McGowan S, 2000, PRIMARY INTENTION, P127; McInnes E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001735.pub3; Mistiaen P, 2010, WOUND REPAIR REGEN, V18, P572, DOI 10.1111/j.1524-475X.2010.00629.x; Moore Z, 2011, J CLIN NURS, V20, P2633, DOI 10.1111/j.1365-2702.2011.03736.x; Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086; Nakagami G, 2007, J ADV NURS, V59, P520, DOI 10.1111/j.1365-2648.2007.04334.x; National Pressure Ulcer Advisory Panel, 2013, SUPP SURF STAND IN T; National Pressure Ulcer Advisory Panel, 1995, ADV WOUND CARE, V8, P32; Nixon J, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10220; Nixon J, 2006, BMJ-BRIT MED J, V332, P1413, DOI 10.1136/bmj.38849.478299.7C; Oot-Giromini B, 1989, Decubitus, V2, P54; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pang SM, 1998, NURS RES, V47, P147, DOI 10.1097/00006199-199805000-00005; Perneger TV, 2002, J CLIN EPIDEMIOL, V55, P498, DOI 10.1016/S0895-4356(01)00514-5; Pham B, 2005, J CLIN EPIDEMIOL, V58, P769, DOI 10.1016/j.jclinepi.2004.08.021; Pring J, 1998, J Wound Care, V7, P177; Ratliff CR, 2010, J WOUND OSTOMY CONT, V37, P459, DOI 10.1097/WON.0b013e3181f17cae; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Russell J, 2000, OSTOMY WOUND MANAG, V46, P46; Russell J A, 2000, Ostomy Wound Manage, V46, P46; Russell Linda J, 2003, Adv Skin Wound Care, V16, P317, DOI 10.1097/00129334-200311000-00015; Saha S., 2013, PRESSURE ULCER TREAT; Saleh M, 2009, J CLIN NURS, V18, P1923, DOI 10.1111/j.1365-2702.2008.02717.x; Sanada H, 2003, J TISSUE VIABILITY, V13, P116; Sanada H, 2003, J TISSUE VIABILITY, V13, P118; Sanada Hiromi, 2003, J Tissue Viability, V13, P112; Schoonhoven L, 2002, BMJ-BRIT MED J, V325, P797, DOI 10.1136/bmj.325.7368.797; Seongsook RNJ, 2004, INT J NURS STUD, V41, P199, DOI 10.1016/S0020-7489(03)00135-4; SIDERANKO S, 1992, RES NURS HEALTH, V15, P245, DOI 10.1002/nur.4770150403; Smith A M, 1990, Decubitus, V3, P20; Smith RG, 1986, J CLIN EXPT GERONTOL, V7, P337; Stapleton M, 1986, Geriatr Nurs (Lond), V6, P23; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stratton RJ, 2005, AGEING RES REV, V4, P422, DOI 10.1016/j.arr.2005.03.005; Takala J, 1996, CLIN INTENSIVE CARE, V7, P228; Taylor L, 1999, Br J Nurs, V8, P771; Taylor L, 1999, BR J NURS, V8, P776; Theaker C, 2005, ANAESTHESIA, V60, P395, DOI 10.1111/j.1365-2044.2004.04085.x; Theilla M, 2007, CLIN NUTR, V26, P752, DOI 10.1016/j.clnu.2007.06.015; Torra i Bou J E, 2005, J Wound Care, V14, P117; Tymec A C, 1997, Adv Wound Care, V10, P39; van Leen M, 2011, J TISSUE VIABILITY, V20, P30, DOI 10.1016/j.jtv.2010.04.001; VANDERCAMMEN TJM, 1987, BRIT J CLIN PRACT, V41, P1009; Vanderwee K, 2007, J ADV NURS, V57, P59, DOI 10.1111/j.1365-2648.2006.04060.x; Vanderwee K, 2005, AGE AGEING, V34, P261, DOI 10.1093/ageing/afi057; Vyhlidal SK, 1997, APPL NURS RES, V10, P111, DOI 10.1016/S0897-1897(97)80193-0; Waterlow J, 2013, WATERLOW PRESSURE UL; Webster J, 2011, BMJ QUAL SAF, V20, P297, DOI 10.1136/bmjqs.2010.043109; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Young T., 2004, J TISSUE VIABILITY, V14, P92; Young Trudie, 2004, J Tissue Viability, V14, P92	112	108	116	1	60	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 2	2013	159	1					28	+		10.7326/0003-4819-159-1-201307020-00006	http://dx.doi.org/10.7326/0003-4819-159-1-201307020-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179JJ	23817702				2022-12-28	WOS:000321516200004
J	Devries, KM; Mak, JYT; Garcia-Moreno, C; Petzold, M; Child, JC; Falder, G; Lim, S; Bacchus, LJ; Engell, RE; Rosenfeld, L; Pallitto, C; Vos, T; Abrahams, N; Watts, CH				Devries, K. M.; Mak, J. Y. T.; Garcia-Moreno, C.; Petzold, M.; Child, J. C.; Falder, G.; Lim, S.; Bacchus, L. J.; Engell, R. E.; Rosenfeld, L.; Pallitto, C.; Vos, T.; Abrahams, N.; Watts, C. H.			The Global Prevalence of Intimate Partner Violence Against Women	SCIENCE			English	Editorial Material							HEALTH		[Devries, K. M.; Mak, J. Y. T.; Child, J. C.; Falder, G.; Bacchus, L. J.; Watts, C. H.] Univ London London Sch Hyg & Trop Med, Gender Violence & Hlth Ctr, London WC1E 7HT, England; [Garcia-Moreno, C.; Pallitto, C.] WHO, CH-1211 Geneva, Switzerland; [Petzold, M.] Univ Gothenburg, S-41137 Gothenburg, Sweden; [Lim, S.; Engell, R. E.; Rosenfeld, L.; Vos, T.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Abrahams, N.] MRC, ZA-7505 Tygerberg, South Africa	University of London; London School of Hygiene & Tropical Medicine; World Health Organization; University of Gothenburg; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Devries, KM (corresponding author), Univ London London Sch Hyg & Trop Med, Gender Violence & Hlth Ctr, Keppel St, London WC1E 7HT, England.	karen.devries@lshtm.ac.uk	Bacchus, Loraine/J-9996-2016; Abrahams, Naeemah/AAF-1144-2020; Devries, Karen/K-1083-2016	Bacchus, Loraine/0000-0002-9966-8208; Devries, Karen/0000-0001-8935-2181; Child, Jennifer/0000-0001-5115-8164; Abrahams, Naeemah/0000-0002-6138-6256	ESRC [ES/I003045/1] Funding Source: UKRI; Economic and Social Research Council [ES/I003045/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2011, WORKING PAPER; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Garcia-Moreno C, 2005, SCIENCE, V310, P1282, DOI 10.1126/science.1121400; Graham K, 2011, J INTERPERS VIOLENCE, V26, P1503, DOI 10.1177/0886260510370596; Heise L., 2012, DETERMINANTSS PARTNE; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kim JC, 2007, AM J PUBLIC HEALTH, V97, P1794, DOI 10.2105/AJPH.2006.095521; Kouyoumdjian FG, 2013, AIDS, V27, P1331, DOI 10.1097/QAD.0b013e32835fd851; Stockl H, 2013, LANCET, V382, P859, DOI 10.1016/S0140-6736(13)61030-2; Turquet L., 2013, PROGR WORLDS WOMEN 2; Walby S., 2010, COST DOMESTIC VIOLEN; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; WHO Department of Gender Women and Health, 2001, PUTT WOM 1 ETH SAF R; World Health Organization, 2013, RESP INT PARTN SEX V	15	815	825	6	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1527	1528		10.1126/science.1240937	http://dx.doi.org/10.1126/science.1240937			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172ME	23788730				2022-12-28	WOS:000321007000022
J	Nedergaard, M				Nedergaard, Maiken			Garbage Truck of the Brain	SCIENCE			English	Editorial Material							MECHANISMS; PATHWAY; SYSTEM		Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester	Nedergaard, M (corresponding author), Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA.	nedergaard@urmc.rochester.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075177, R01NS078304, R01NS078167] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH099578] Funding Source: Medline; NINDS NIH HHS [R01 NS078167, R01 NS075177, R01 NS078304] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CSERR HF, 1971, PHYSIOL REV, V51, P273, DOI 10.1152/physrev.1971.51.2.273; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Goldstein L. E., 2012, SCI TRANSL MED, V4; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Loukas M, 2011, CLIN ANAT, V24, P807, DOI 10.1002/ca.21194; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Walker LC, 2013, JAMA NEUROL, V70, P304, DOI 10.1001/jamaneurol.2013.1453; Weller RO, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt6; Yang LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-107; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	15	346	356	5	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1529	1530		10.1126/science.1240514	http://dx.doi.org/10.1126/science.1240514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812703	Green Accepted			2022-12-28	WOS:000321007000023
J	Day, RO; Graham, GG				Day, Richard O.; Graham, Garry G.			Non-steroidal anti-inflammatory drugs (NSAIDs)	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SELECTIVE INHIBITORS; BREAST-MILK; OSTEOARTHRITIS; RECOMMENDATIONS; MANAGEMENT; CELECOXIB; SYSTEM; SAFETY; ADULTS; RISK		[Day, Richard O.; Graham, Garry G.] Univ New S Wales, Dept Pharmacol, Sydney, NSW, Australia; [Day, Richard O.; Graham, Garry G.] St Vincents Hosp, Dept Clin Pharmacol & Toxicol, Sydney, NSW 2010, Australia	University of New South Wales Sydney; St Vincents Hospital Sydney	Day, RO (corresponding author), Univ New S Wales, Dept Pharmacol, Sydney, NSW, Australia.	r.day@unsw.edu.au	Day, Richard/D-8699-2011; Nassar, Mamdouh Ibrahim/H-9864-2019	Day, Richard/0000-0002-6045-6937; Nassar, Mamdouh Ibrahim/0000-0002-4624-740X				Adebajo A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-23; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; BROOKS PM, 1991, NEW ENGL J MED, V324, P1716; ClinRisk, WELC QRISK2 2013 RIS; Derry S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007400.pub2; Fortun PJ, 2005, CURR OPIN GASTROEN, V21, P169, DOI 10.1097/01.mog.0000153314.51198.58; Gardiner SJ, 2006, BRIT J CLIN PHARMACO, V61, P101, DOI 10.1111/j.1365-2125.2005.02520.x; Graham GG, 2013, INFLAMMOPHARMACOLOGY, DOI 10.1007; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; HOPPMANN RA, 1991, ARCH INTERN MED, V151, P1309, DOI 10.1001/archinte.151.7.1309; Hunt RH, 2009, ANN MED, V41, P423, DOI 10.1080/07853890902887295; Laine L, 2008, SEMIN ARTHRITIS RHEU, V38, P165, DOI 10.1016/j.semarthrit.2007.10.004; Latimer N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2538; Marjoribanks J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001751.pub2; Massey T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007402.pub2; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Moore RA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008659.pub2; Nakhai-Pour HR, 2011, CAN MED ASSOC J, V183, P1713, DOI 10.1503/cmaj.110454; National Institute for Health and Clinical Excellence, 2008, OST CAR MAN OST AD C, V59; Risser A, 2009, AM FAM PHYSICIAN, V80, P1371; Roddy E, 2005, ANN RHEUM DIS, V64, P544, DOI 10.1136/ard.2004.028746; Roelofs PD, 2008, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000396.PUB3; Rostom A, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002296, DOI 10.1002/14651858.CD002296]; Solomon DH, 2010, ARCH INTERN MED, V170, P1979, DOI 10.1001/archinternmed.2010.450; Solomon DH, 2005, J RHEUMATOL, V32, P1415; Stevenson DD, 2004, IMMUNOL ALLERGY CLIN, V24, P491, DOI 10.1016/j.iac.2004.03.001; Strand V, 2007, LANCET, V370, P2138, DOI 10.1016/S0140-6736(07)61909-6; Strand V, 2011, J RHEUMATOL, V38, P2625, DOI 10.3899/jrheum.110636; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; TOWNSEND RJ, 1984, AM J OBSTET GYNECOL, V149, P184, DOI 10.1016/0002-9378(84)90195-9; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Wilson SL, 2006, J HYPERTENS, V24, P1457, DOI 10.1097/01.hjh.0000239278.82196.a5; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	34	90	93	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2013	346								f3195	10.1136/bmj.f3195	http://dx.doi.org/10.1136/bmj.f3195			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179AA	23757736	Bronze, Green Submitted			2022-12-28	WOS:000321487300001
J	Roenneberg, T				Roenneberg, Till			The human sleep project	NATURE			English	Editorial Material							SOCIAL JETLAG		Univ Munich, Munich, Germany	University of Munich	Roenneberg, T (corresponding author), Univ Munich, Munich, Germany.	till.roenneberg@med.uni-muenchen.de		Roenneberg, Till/0000-0003-2939-0332				Hillman DR, 2006, SLEEP, V29, P299, DOI 10.1093/sleep/29.3.299; Levandovski R, 2011, CHRONOBIOL INT, V28, P771, DOI 10.3109/07420528.2011.602445; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152	6	67	70	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					427	428		10.1038/498427a	http://dx.doi.org/10.1038/498427a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171LH	23803826				2022-12-28	WOS:000320929400025
J	Smith, D; Yong, K				Smith, Dean; Yong, Kwee			Multiple myeloma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							STEM-CELL TRANSPLANTATION; THALIDOMIDE PLUS DEXAMETHASONE; GROUP CONSENSUS STATEMENT; HIGH-DOSE CHEMOTHERAPY; MONOCLONAL GAMMOPATHY; INITIAL THERAPY; BONE-DISEASE; BORTEZOMIB; GUIDELINES; MANAGEMENT		[Smith, Dean; Yong, Kwee] Univ Coll London Hosp, Dept Haematol, London NW1 2PG, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Smith, D (corresponding author), Univ Coll London Hosp, Dept Haematol, London NW1 2PG, England.	deansmith@doctors.org.uk						Alexander DD, 2007, INT J CANCER, P40, DOI 10.1002/ijc.22718; Anselmetti GC, 2012, EUR J RADIOL, V81, P4083, DOI 10.1016/j.ejrad.2012.07.005; Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Bergsagel PL, 2013, BLOOD, V121, P884, DOI 10.1182/blood-2012-05-432203; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Bird J, 2009, BRIT J HAEMATOL, V147, P22, DOI 10.1111/j.1365-2141.2009.07807.x; Bochtler T, 2008, BLOOD, V111, P4700, DOI 10.1182/blood-2007-11-122101; Brenner H, 2008, BLOOD, V111, P2521, DOI 10.1182/blood-2007-08-104984; Cavo M, 2007, J CLIN ONCOL, V25, P2434, DOI 10.1200/JCO.2006.10.2509; Cavo M, 2011, BLOOD, V117, P6063, DOI 10.1182/blood-2011-02-297325; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Clark WF, 2005, ANN INTERN MED, V143, P777, DOI 10.7326/0003-4819-143-11-200512060-00005; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; Dimopoulos MA, 2013, LEUKEMIA, V27, P423, DOI 10.1038/leu.2012.182; Dimopoulos MA, 2010, J CLIN ONCOL, V28, P4976, DOI 10.1200/JCO.2010.30.8791; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Harousseau JL, 2010, J CLIN ONCOL, V28, P4621, DOI 10.1200/JCO.2009.27.9158; Hussein MA, 2008, LEUKEMIA, V22, P1479, DOI 10.1038/leu.2008.127; Hutchison CA, 2011, J AM SOC NEPHROL, V22, P1129, DOI 10.1681/ASN.2010080857; Hutchison CA, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-55; Kariyawasan CC, 2007, QJM-INT J MED, V100, P635, DOI 10.1093/qjmed/hcm077; Kumar SK, 2012, LEUKEMIA, V26, P149, DOI 10.1038/leu.2011.196; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Lokhorst H, 2010, J CLIN ONCOL, V28, P4521, DOI 10.1200/JCO.2010.29.7929; Ludwig H, 2012, BLOOD, V119, P3003, DOI 10.1182/blood-2011-11-374249; Morgan GJ, 2012, BLOOD, V119, P5374, DOI 10.1182/blood-2011-11-392522; Morgan GJ, 2011, BLOOD, V118, P1231, DOI 10.1182/blood-2011-02-338665; National Cancer Intelligence Network, 2012, ROUT DIAGN 2006 2008; Palumbo A, 2009, LEUKEMIA, V23, P1716, DOI 10.1038/leu.2009.122; Plesner T, ASH2012; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Raje N, 2011, CLIN CANCER RES, V17, P1278, DOI 10.1158/1078-0432.CCR-10-1804; Rajkumar SV, 2008, J CLIN ONCOL, V26, P2171, DOI 10.1200/JCO.2007.14.1853; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Richardson PG, ASH2012; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Snowden JA, 2011, BRIT J HAEMATOL, V154, P76, DOI 10.1111/j.1365-2141.2011.08574.x; Stringer S, 2011, BONE MARROW RES, DOI 10.1155/2011/493697; Waxman AJ, 2010, BLOOD, V116, P5501, DOI 10.1182/blood-2010-07-298760	42	53	57	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2013	346								f3863	10.1136/bmj.f3863	http://dx.doi.org/10.1136/bmj.f3863			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QL	23803862				2022-12-28	WOS:000321246200009
J	Batty, M				Batty, Michael			A Theory of City Size	SCIENCE			English	Editorial Material							GROWTH		UCL, Ctr Adv Spatial Anal, London W1T 4TJ, England	University of London; University College London	Batty, M (corresponding author), UCL, Ctr Adv Spatial Anal, 90 Tottenham Court Rd, London W1T 4TJ, England.	m.batty@ucl.ac.uk	Batty, Michael/D-4422-2011; Batty, Michael/I-5638-2014	Batty, Michael/0000-0002-9931-1305; 	Engineering and Physical Sciences Research Council [EP/G057737/1, EP/I018433/1] Funding Source: researchfish; EPSRC [EP/G057737/1, EP/I018433/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Batty M., 1994, FRACTAL CITIES; Batty M, 2011, ENVIRON PLANN A, V43, P765, DOI 10.1068/a43403; Berry B., 1964, PAPERS P REGIONAL SC, V13, P147, DOI [10.1007/bf01942566, 10.1111/j.1435-5597.1964.tb01283.x, DOI 10.1111/J.1435-5597.1964.TB01283.X]; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Makse HA, 1998, PHYS REV E, V58, P7054, DOI 10.1103/PhysRevE.58.7054; Marshall A., 2009, PRINCIPLES EC UNABRI; Maxwell J. C., 1990, SCI LETT PAPERS JC M, V1, P373	8	72	76	10	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1418	1419		10.1126/science.1239870	http://dx.doi.org/10.1126/science.1239870			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	167QL	23788792				2022-12-28	WOS:000320647000032
J	Husnik, F; Nikoh, N; Koga, R; Ross, L; Duncan, RP; Fujie, M; Tanaka, M; Satoh, N; Bachtrog, D; Wilson, ACC; von Dohlen, CD; Fukatsu, T; McCutcheon, JP				Husnik, Filip; Nikoh, Naruo; Koga, Ryuichi; Ross, Laura; Duncan, Rebecca P.; Fujie, Manabu; Tanaka, Makiko; Satoh, Nori; Bachtrog, Doris; Wilson, Alex C. C.; von Dohlen, Carol D.; Fukatsu, Takema; McCutcheon, John P.			Horizontal Gene Transfer from Diverse Bacteria to an Insect Genome Enables a Tripartite Nested Mealybug Symbiosis	CELL			English	Article							INTRACELLULAR BACTERIA; BETA-PROTEOBACTERIA; HOST-CELL; WOLBACHIA; ENDOSYMBIONTS; EVOLUTION; SEQUENCE; CHROMOSOME; REDUCTION; HEMIPTERA	The smallest reported bacterial genome belongs to Tremblaya princeps, a symbiont of Planococcus citri mealybugs (PCIT). Tremblaya PCIT not only has a 139 kb genome, but possesses its own bacterial endosymbiont, Moranella endobia. Genome and transcriptome sequencing, including genome sequencing from a Tremblaya lineage lacking intracellular bacteria, reveals that the extreme genomic degeneracy of Tremblaya PCIT likely resulted from acquiring Moranella as an endosymbiont. In addition, at least 22 expressed horizontally transferred genes from multiple diverse bacteria to the mealybug genome likely complement missing symbiont genes. However, none of these horizontally transferred genes are from Tremblaya, showing that genome reduction in this symbiont has not been enabled by gene transfer to the host nucleus. Our results thus indicate that the functioning of this three-way symbiosis is dependent on genes from at least six lineages of organisms and reveal a path to intimate endosym-biosis distinct from that followed by organelles.	[Husnik, Filip] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Husnik, Filip] Biol Ctr ASCR, Inst Parasitol, Ceske Budejovice 37005, Czech Republic; [Nikoh, Naruo] Open Univ Japan, Dept Liberal Arts, Chiba 2618586, Japan; [Koga, Ryuichi; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan; [Ross, Laura] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Duncan, Rebecca P.; Wilson, Alex C. C.] Univ Miami, Dept Biol, Coral Gables, FL 33146 USA; [Fujie, Manabu] Grad Univ, Okinawa Inst Sci & Technol, DNA Sequencing Sect, Onna, Okinawa 9040495, Japan; [Tanaka, Makiko; Satoh, Nori] Grad Univ, Okinawa Inst Sci & Technol, Marine Genom Unit, Onna, Okinawa 9040495, Japan; [Bachtrog, Doris] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [von Dohlen, Carol D.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [McCutcheon, John P.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; National Institute of Advanced Industrial Science & Technology (AIST); University of Oxford; University of Miami; Okinawa Institute of Science & Technology Graduate University; Okinawa Institute of Science & Technology Graduate University; University of California System; University of California Berkeley; Utah System of Higher Education; Utah State University; University of Montana System; University of Montana	McCutcheon, JP (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	john.mccutcheon@umontana.edu	Husnik, Filip/U-2851-2017; Satoh, Nori/C-4123-2009	Husnik, Filip/0000-0002-5381-0125; Satoh, Nori/0000-0002-4480-3572; McCutcheon, John/0000-0002-5489-6039; Duncan, Rebecca/0000-0002-7236-7368; von Dohlen, Carol/0000-0002-3961-251X; Ross, Laura/0000-0003-3184-4161	Grant Agency of the Czech Republic [P505/10/1401, 13-01878S]; Program for Promotion of Basic; Applied Researches for Innovations in Bio-oriented Industry (BRAIN); KAKENHI [22128001, 22128007]; Royal Society and Somerville College; University of Oxford; NSF Graduate Research Fellowship; Utah Agricultural Experiment Station; NIH [R01GM076007, R01GM093182]; Packard Fellowship; University of Miami; NSF [IOS-1121847, IOS-1256680]; Montana NSF-EPSCoR [EPS0701906]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076007, R01GM093182, R01GM101255] Funding Source: NIH RePORTER; Natural Environment Research Council [NE/K009516/1] Funding Source: researchfish; NERC [NE/K009516/1] Funding Source: UKRI; Direct For Biological Sciences [1256680] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [22128007] Funding Source: KAKEN	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Program for Promotion of Basic; Applied Researches for Innovations in Bio-oriented Industry (BRAIN); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Royal Society and Somerville College; University of Oxford; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Utah Agricultural Experiment Station; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship(The David & Lucile Packard Foundation); University of Miami; NSF(National Science Foundation (NSF)); Montana NSF-EPSCoR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dan Vanderpool, Yu Matsuura, Kaoru Nikoh, and Dionna Norris for technical and experimental assistance, Minyong Chung for facilitating genome sequencing, Jesse Johnson for access to computing resources, and Nobuo Sawamura and Junko Makino for insect samples. The authors declare no conflicts of interest in this work. F.H. was supported by the Grant Agency of the Czech Republic (P505/10/1401 and 13-01878S). T.F. and N.N. were supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) and by KAKENHI (22128001 and 22128007). L.R. was supported by the Royal Society and Somerville College, University of Oxford. R.P.D. was supported by an NSF Graduate Research Fellowship. C.D.v.D. was supported by the Utah Agricultural Experiment Station. D.B. was supported by NIH grants (R01GM076007 and R01GM093182) and a Packard Fellowship. A.C.C. W. was supported by University of Miami start-up funds and NSF award IOS-1121847. J.P.M. was supported by NSF award IOS-1256680, the Montana NSF-EPSCoR award EPS0701906, and is an Associate in the Integrated Microbial Biodiversity Program of the Canadian Institute for Advanced Research.	Acuna R, 2012, P NATL ACAD SCI USA, V109, P4197, DOI 10.1073/pnas.1121190109; Aikawa T, 2009, P ROY SOC B-BIOL SCI, V276, P3791, DOI 10.1098/rspb.2009.1022; Altincicek B, 2012, BIOL LETTERS, V8, P253, DOI 10.1098/rsbl.2011.0704; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Carbonell P, 2011, J BIOL CHEM, V286, P43994, DOI 10.1074/jbc.M111.274050; Chang YJ, 2011, STAND GENOMIC SCI, V5, P97, DOI 10.4056/sigs.2114901; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Doudoumis V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S3; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Gruwell ME, 2010, APPL ENVIRON MICROB, V76, P7521, DOI 10.1128/AEM.01354-10; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hardy NB, 2008, SYST ENTOMOL, V33, P51, DOI 10.1111/j.1365-3113.2007.00408.x; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2008, CURR BIOL, V18, pR345, DOI 10.1016/j.cub.2008.02.065; Keeling PJ, 2011, CURR BIOL, V21, pR623, DOI 10.1016/j.cub.2011.06.061; Klasson L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-33; Koga R, 2013, FEMS MICROBIOL ECOL, V83, P93, DOI 10.1111/j.1574-6941.2012.01450.x; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Kono M, 2008, APPL ENVIRON MICROB, V74, P4175, DOI 10.1128/AEM.00250-08; Lopez-Madrigal S, 2011, J BACTERIOL, V193, P5587, DOI 10.1128/JB.05749-11; Lopez-Sanchez MJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000721; Macdonald SJ, 2012, P ROY SOC B-BIOL SCI, V279, P2965, DOI 10.1098/rspb.2012.0414; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McCutcheon JP, 2011, CURR BIOL, V21, P1366, DOI 10.1016/j.cub.2011.06.051; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; McCutcheon JP, 2010, CURR OPIN MICROBIOL, V13, P73, DOI 10.1016/j.mib.2009.12.002; McCutcheon JP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000565; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moran NA, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-research0054; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; Nikoh N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-12; Nikoh N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000827; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Ochman H, 2006, SCIENCE, V311, P1730, DOI 10.1126/science.1119966; Penz T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003012; Poliakov A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007039; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rose AB, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00098; Rothman SC, 2003, J MOL BIOL, V327, P593, DOI 10.1016/S0022-2836(03)00095-0; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Sloan DB, 2012, MOL BIOL EVOL, V29, P3781, DOI 10.1093/molbev/mss180; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Thao ML, 2002, APPL ENVIRON MICROB, V68, P3190, DOI 10.1128/AEM.68.7.3190-3197.2002; Theissen U, 2006, CURR BIOL, V16, pR1016, DOI 10.1016/j.cub.2006.11.020; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Woolfit M, 2009, MOL BIOL EVOL, V26, P367, DOI 10.1093/molbev/msn253; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	64	271	281	1	185	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1567	1578		10.1016/j.cell.2013.05.040	http://dx.doi.org/10.1016/j.cell.2013.05.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791183	Bronze			2022-12-28	WOS:000320722000023
J	Patel, AM; Shariff, S; Bailey, DG; Juurlink, DN; Gandhi, S; Mamdani, M; Gomes, T; Fleet, J; Hwang, J; Garg, AX				Patel, Amit M.; Shariff, Salimah; Bailey, David G.; Juurlink, David N.; Gandhi, Sonja; Mamdani, Muhammad; Gomes, Tara; Fleet, Jamie; Hwang, Joseph; Garg, Amit X.			Statin Toxicity From Macrolide Antibiotic Coprescription A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							DRUG-DRUG INTERACTIONS; RHABDOMYOLYSIS; ATORVASTATIN; SIMVASTATIN; CLARITHROMYCIN; ERYTHROMYCIN; PREVALENCE; LOVASTATIN; OUTCOMES; RISK	Background: Clarithromycin and erythromycin, but not azithromycin, inhibit cytochrome P450 isoenzyme 3A4 ( CYP3A4), and inhibition increases blood concentrations of statins that are metabolized by CYP3A4. Objective: To measure the frequency of statin toxicity after coprescription of a statin with clarithromycin or erythromycin. Design: Population-based cohort study. Setting: Ontario, Canada, from 2003 to 2010. Patients: Continuous statin users older than 65 years who were prescribed clarithromycin (n = 72 591) or erythromycin (n = 3267) compared with those prescribed azithromycin (n = 68 478). Measurements: The primary outcome was hospitalization with rhabdomyolysis within 30 days of the antibiotic prescription. Results: Atorvastatin was the most commonly prescribed statin (73%) followed by simvastatin and lovastatin. Compared with azithromycin, coprescription of a statin with clarithromycin or erythromycin was associated with a higher risk for hospitalization with rhabdomyolysis (absolute risk increase, 0.02% [95% CI, 0.01% to 0.03%]; relative risk [RR], 2.17 [CI, 1.04 to 4.53]) or with acute kidney injury (absolute risk increase, 1.26% [CI, 0.58% to 1.95%]; RR, 1.78 [CI, 1.49 to 2.14]) and for all-cause mortality (absolute risk increase, 0.25% [CI, 0.17% to 0.33%]; RR, 1.56 [CI, 1.36 to 1.80]). Limitations: Only older adults were included in the study. The absolute risk increase for rhabdomyolysis may be underestimated because the codes used to identify it were insensitive. Conclusion: In older adults, coprescription of clarithromycin or erythromycin with a statin that is metabolized by CYP3A4 increases the risk for statin toxicity.	Univ Western Ontario, London, ON, Canada; London Hlth Sci Ctr, Lawson Hlth Res Inst, London, ON N6A 4G5, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada	Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); University of Toronto; University of Toronto	Garg, AX (corresponding author), London Hlth Sci Ctr, London Kidney Clin Res Unit, Room ELL 101,800 Commissioners Rd East, London, ON N6A 4G5, Canada.	amit.garg@lhsc.on.ca	Garg, Amit X/G-3295-2011; Fleet, Jamie L/GYJ-7373-2022	Gomes, Tara/0000-0002-1468-1965; Fleet, Jamie/0000-0002-9468-0697; Shariff, Salimah/0000-0002-1219-6763	Academic Medical Organization of Southwestern Ontario; Ontario Ministry of Health and Long-term Care; Canadian Institutes of Health Research Clinician Scientist Award	Academic Medical Organization of Southwestern Ontario; Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research Clinician Scientist Award(Canadian Institutes of Health Research (CIHR))	Academic Medical Organization of Southwestern Ontario.; The investigators received grant support from the Academic Medical Organization of Southwestern Ontario to conduct this research. This project was conducted at the Institute for Clinical Evaluative Sciences site at Western University. The Institute for Clinical Evaluative Sciences is funded by an annual grant from the Ontario Ministry of Health and Long-term Care. The Institute for Clinical Evaluative Sciences site at Western University is funded by an operating grant from the Academic Medical Organization of Southwestern Ontario. Dr. Garg was supported by a Canadian Institutes of Health Research Clinician Scientist Award.	Amsden GW, 2002, J CLIN PHARMACOL, V42, P444, DOI 10.1177/0091270002424011; [Anonymous], DRUG INT CHECK; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bravo AER, 2005, DRUG SAFETY, V28, P263; Campbell G, 2007, AGE AGEING, V36, P597, DOI 10.1093/ageing/afm110; Egger SS, 2007, DRUG AGING, V24, P429, DOI 10.2165/00002512-200724050-00006; Fleet JL, 2012, BMJ OPEN, V2; Floyd JS, 2012, JAMA-J AM MED ASSOC, V307, P1580, DOI 10.1001/jama.2012.489; GABOW PA, 1982, MEDICINE, V61, P141, DOI 10.1097/00005792-198205000-00002; Gandhi S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001921; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Hwang YJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001821; Jacobson TA, 2004, AM J CARDIOL, V94, P1140, DOI 10.1016/j.amjcard.2004.07.080; Jain AK, 2012, KIDNEY INT, V81, P1248, DOI 10.1038/ki.2012.18; Kantola T, 1998, CLIN PHARMACOL THER, V64, P177, DOI 10.1016/S0009-9236(98)90151-5; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Merck & Co, 2012, FDA DRUG SAF COMM IN; Ming JBM, 2003, AIDS PATIENT CARE ST, V17, P207, DOI 10.1089/108729103321655854; Molden E, 2008, DRUG SAFETY, V31, P587, DOI 10.2165/00002018-200831070-00004; Neuvonen PJ, 2008, CLIN PHARMACOKINET, V47, P463, DOI 10.2165/00003088-200847070-00003; Neuvonen PJ, 2006, CLIN PHARMACOL THER, V80, P565, DOI 10.1016/j.clpt.2006.09.003; Paquette A, 2012, PHARM PRACTICE, V28, P45; Pfizer, 2012, FDA DRUG SAF COMM IN; Pfizer, 2013, ZITHR PACK INS; Piacentini N, 2005, EUR J CLIN PHARMACOL, V61, P615, DOI 10.1007/s00228-005-0972-z; Samineni D, 2012, J CLIN PHARMACOL, V52, P922, DOI 10.1177/0091270011407494; Seithel A, 2007, DRUG METAB DISPOS, V35, P779, DOI 10.1124/dmd.106.014407; Shih AWY, 2012, KIDNEY INT, V82, P903, DOI 10.1038/ki.2012.227; Siedlik PH, 1999, J CLIN PHARMACOL, V39, P501; SPACH DH, 1991, WESTERN J MED, V154, P213; Statistics Canada, 2012, POP SEX AG GROUP PRO; Tawadrous D, 2011, AM J KIDNEY DIS, V58, P903, DOI 10.1053/j.ajkd.2011.07.022; Trieu J, 2004, CLIN NUCL MED, V29, P803, DOI 10.1097/00003072-200412000-00008; U.S. Food and Drug Administration, 2012, FDA DRUG SAF COMM IN; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Zhao YY, 2012, ANN INTERN MED, V156, P560, DOI [10.7326/0003-4819-156-8-201204170-00401, 10.7326/0003-4819-156-8-201204170-00003]	40	107	113	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12					869	+		10.7326/0003-4819-158-12-201306180-00004	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778904				2022-12-28	WOS:000320645000015
J	Lazarus, JA				Lazarus, Jeremy A.			Physicians' ethical obligations to hunger strikers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL-ETHICS; GUANTANAMO		[Lazarus, Jeremy A.] Amer Med Assoc, Chicago, IL 60610 USA	American Medical Association								American Medical Association, COD MED ETH OP E 10; American Medical Association, PRINC MED ETH; American Medical Association, CODE MED ETH OP E 2; American Medical Association, CODE MED ETH OP E 8; American Medical Association, COD MED ETH OP E 8 0; Annas GJ, 2006, NEW ENGL J MED, V355, P1377, DOI 10.1056/NEJMhle062316; Center for Constitutional Rights, 2005, GUANT PRIS HUNG STRI; Golden Tim, 2006, NY TIMES; Okie S, 2005, NEW ENGL J MED, V353, P2529, DOI 10.1056/NEJMp058296; Reyes Hernan, 1998, MED ETHICAL ASPECTS, P291; World Medical Association, GUID PHYS TORT CRUEL	11	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2013	346								f3705	10.1136/bmj.f3705	http://dx.doi.org/10.1136/bmj.f3705			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WQ	23766492				2022-12-28	WOS:000320590800001
J	Stolz, LA; Kizza, H; Little, K; Kasekende, J				Stolz, Lori Ann; Kizza, Hilary; Little, Kevin; Kasekende, Joseph			Intussusception detected with ultrasound in a resource-limited setting	LANCET			English	Editorial Material							CARE		[Stolz, Lori Ann] Univ Arizona, Global Emergency Care Collaborat, Tucson, AZ 85724 USA; [Kizza, Hilary; Kasekende, Joseph] Karoli Lwanga Hosp, Global Emergency Care Collaborat, Nyakibale, Uganda; [Little, Kevin] Emory Sch Med, Global Emergency Care Collaborat, Atlanta, GA USA	University of Arizona; Emory University	Stolz, LA (corresponding author), Univ Arizona, Dept Emergency Med, Global Emergency Care Collaborat, 1609 N Warren Ave,Room 118,POB 245057, Tucson, AZ 85724 USA.	lstolz@aemrc.arizona.edu						Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Kobusingye OC, 2005, B WORLD HEALTH ORGAN, V83, P626; Robison JA, 2012, PEDIATRICS, V130, pE676, DOI 10.1542/peds.2012-0026; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Steele A Duncan, 2012, Vaccine, V30 Suppl 1, pA185, DOI 10.1016/j.vaccine.2011.10.004	5	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 8	2013	381	9882					2054	2054		10.1016/S0140-6736(13)60690-X	http://dx.doi.org/10.1016/S0140-6736(13)60690-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171JY	23746905				2022-12-28	WOS:000320924400034
J	Keusekotten, K; Elliott, PR; Glockner, L; Fiil, BK; Damgaard, RB; Kulathu, Y; Wauer, T; Hospenthal, MK; Gyrd-Hansen, M; Krappmann, D; Hofmann, K; Komander, D				Keusekotten, Kirstin; Elliott, Paul Ronald; Glockner, Laura; Fiil, Berthe Katrine; Damgaard, Rune Busk; Kulathu, Yogesh; Wauer, Tobias; Hospenthal, Manuela Kathrin; Gyrd-Hansen, Mads; Krappmann, Daniel; Hofmann, Kay; Komander, David			OTULIN Antagonizes LUBAC Signaling by Specifically Hydrolyzing Met1-Linked Polyubiquitin	CELL			English	Article							LINEAR UBIQUITIN CHAINS; LIGASE; INFLAMMATION; REVEALS; COMPLEX; DOMAIN; DEUBIQUITINASE; RECOGNITION; INHIBITION; MECHANISM	The linear ubiquitin (Ub) chain assembly complex (LUBAC) is an E3 ligase that specifically assembles Met1-linked (also known as linear) Ub chains that regulate nuclear factor kappa B (NF-kappa B) signaling. Deubiquitinases (DUBs) are key regulators of Ub signaling, but a dedicated DUB for Met1 linkages has not been identified. Here, we reveal a previously unannotated human DUB, OTULIN (also known as FAM105B), which is exquisitely specific for Met1 linkages. Crystal structures of the OTULIN catalytic domain in complex with diubiquitin reveal Met1-specific Ub-binding sites and a mechanism of substrate-assisted catalysis in which the proximal Ub activates the catalytic triad of the protease. Mutation of Ub Glu16 inhibits OTULIN activity by reducing k(cat) 240-fold. OTULIN overexpression or knockdown affects NF-kappa B responses to LUBAC, TNF alpha, and poly(I:C) and sensitizes cells to TNF alpha-induced cell death. We show that OTULIN binds LUBAC and that overexpression of OTULIN prevents TNF alpha-induced NEMO association with ubiquitinated RIPK1. Our data suggest that OTULIN regulates Met1-polyUb signaling.	[Keusekotten, Kirstin; Elliott, Paul Ronald; Kulathu, Yogesh; Wauer, Tobias; Hospenthal, Manuela Kathrin; Komander, David] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Glockner, Laura; Krappmann, Daniel] Inst Mol Toxicol & Pharmacol, Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Cellular Signal Integrat, D-85764 Neuherberg, Germany; [Fiil, Berthe Katrine; Damgaard, Rune Busk; Gyrd-Hansen, Mads] Univ Copenhagen, Dept Dis Biol, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50674 Cologne, Germany	MRC Laboratory Molecular Biology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Copenhagen; University of Cologne	Komander, D (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	dk@mrc-lmb.cam.ac.uk	Hospenthal, Manuela/AAU-3210-2020; Krappmann, Daniel/AAT-4354-2021; Krappmann, Daniel/ABF-4038-2021; Damgaard, Rune/AAX-4661-2021	Hospenthal, Manuela/0000-0003-1175-6826; Krappmann, Daniel/0000-0001-7640-3234; Krappmann, Daniel/0000-0001-7640-3234; Damgaard, Rune Busk/0000-0002-1709-6534; Fiil, Berthe Katrine/0000-0002-9499-4848; Elliott, Paul/0000-0002-7641-2103; Gyrd-Hansen, Mads/0000-0001-5641-5019; Kulathu, Yogesh/0000-0002-3274-1642	MRC [U105192732]; European Research Council [309756]; European Molecular Biology Organization Young Investigator program; Lister Institute for Preventive Medicine; German Research Foundation (DFG) [SPP1365]; Novo Nordisk Foundation; Steno Fellowship from the Danish Council for Independent Research; MRC [MC_U105192732] Funding Source: UKRI; Medical Research Council [MC_U105192732] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization Young Investigator program(European Molecular Biology Organization (EMBO)); Lister Institute for Preventive Medicine; German Research Foundation (DFG)(German Research Foundation (DFG)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Steno Fellowship from the Danish Council for Independent Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank S. McLaughlin, R. Williams, A. Finch, F. Randow, G. Murshudov (Medical Research Council [MRC] Laboratory of Molecular Biology), G. Praefcke (University of Cologne), and members of the D. Komander lab for advice, reagents, and critical comments on the manuscript. Liposome reagent for Jurkat T cell transfection was a kind gift of Silence Therapeutics, Berlin. This work was supported by the MRC (U105192732 to D. Komander), the European Research Council (309756 to D. Komander), the European Molecular Biology Organization Young Investigator program (D.K.), the Lister Institute for Preventive Medicine (D. Komander), the German Research Foundation (DFG Priority Programme SPP1365 to K.H. and D. Krappmann), the Novo Nordisk Foundation (M.G.H.), and a Steno Fellowship from the Danish Council for Independent Research (M.G.H.). Crystallographic data were collected at the European Synchrotron Radiation Facility at beam lines ID14-4 and ID23-1 and at Diamond Light Source beam line I04-1.	Amerik AY, 1997, EMBO J, V16, P4826; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Matsumoto ML, 2012, J MOL BIOL, V418, P134, DOI 10.1016/j.jmb.2011.12.053; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Tokunaga F, 2012, MICROBES INFECT, V14, P563, DOI 10.1016/j.micinf.2012.01.011; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; van Wijk SJL, 2012, MOL CELL, V47, P797, DOI 10.1016/j.molcel.2012.06.017; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/NCHEMBIO.426, 10.1038/nchembio.426]; Walczak H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-23; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17	42	315	323	1	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1312	1326		10.1016/j.cell.2013.05.014	http://dx.doi.org/10.1016/j.cell.2013.05.014			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746843	Green Published, hybrid			2022-12-28	WOS:000319979200015
J	Norman, RE; Bradshaw, D				Norman, Rosana E.; Bradshaw, Debbie			What is the scale of intimate partner homicide?	LANCET			English	Editorial Material							SOUTH-AFRICA; RISK-FACTOR; VIOLENCE; DISEASE; INJURY; BURDEN		[Norman, Rosana E.] Univ Queensland, Queensland Childrens Med Res Inst, Herston, Qld 4029, Australia; [Norman, Rosana E.] Univ Queensland, Sch Populat Hlth, Herston, Qld 4029, Australia; [Bradshaw, Debbie] South African Med Res Council, Burden Dis Res Unit, Cape Town, South Africa	University of Queensland; University of Queensland; South African Medical Research Council	Norman, RE (corresponding author), Univ Queensland, Queensland Childrens Med Res Inst, Herston, Qld 4029, Australia.	r.norman@sph.uq.edu.au	PACELLA, ROSANA E./F-2774-2010	PACELLA, ROSANA E./0000-0002-9742-1957; O'donnell, Colm/0000-0002-8004-450X				Abrahams N, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001412; Abrahams N, 2009, VIOLENCE VICTIMS, V24, P546, DOI 10.1891/0886-6708.24.4.546; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Jewkes R, 2013, LANCET; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Norman R, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-32; Stockl H., 2013, LANCET, DOI 10.1016/S0140-6736(13)61030-2; Vigdor ER, 2006, EVALUATION REV, V30, P313, DOI 10.1177/0193841X06287307	10	4	4	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2013	382	9895					836	838		10.1016/S0140-6736(13)61255-6	http://dx.doi.org/10.1016/S0140-6736(13)61255-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215WE	23790261				2022-12-28	WOS:000324240700006
J	Nakashima, R; Sakurai, K; Yamasaki, S; Hayashi, K; Nagata, C; Hoshino, K; Onodera, Y; Nishino, K; Yamaguchi, A				Nakashima, Ryosuke; Sakurai, Keisuke; Yamasaki, Seiji; Hayashi, Katsuhiko; Nagata, Chikahiro; Hoshino, Kazuki; Onodera, Yoshikuni; Nishino, Kunihiko; Yamaguchi, Akihito			Structural basis for the inhibition of bacterial multidrug exporters	NATURE			English	Article							EFFLUX PUMP INHIBITORS; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; RESISTANCE; ACRB; TRANSPORTER; STRATEGIES; REVEAL; SYSTEM	The multidrug efflux transporter AcrB and its homologues are important in the multidrug resistance of Gram-negative pathogens(1,2). However, despite efforts to develop efflux inhibitors(3), clinically useful inhibitors are not available at present(4,5). Pyridopyrimidine derivatives are AcrB- and MexB-specific inhibitors that do not inhibit MexY(6,7); MexB and MexY are principal multidrug exporters in Pseudomonas aeruginosa(8-10). We have previously determined the crystal structure of AcrB in the absence and presence of antibiotics(11-13). Drugs were shown to be exported by a functionally rotating mechanism(12) through tandem proximal and distal multisite drug-binding pockets(13). Here we describe the first inhibitor-bound structures of AcrB and MexB, in which these proteins are bound by a pyridopyrimidine derivative. The pyridopyrimidine derivative binds tightly to a narrow pit composed of a phenylalanine cluster located in the distal pocket and sterically hinders the functional rotation. This pit is a hydrophobic trap that branches off from the substrate-translocation channel. Phe 178 is located at the edge of this trap in AcrB and MexB and contributes to the tight binding of the inhibitor molecule through a pi-pi interaction with the pyridopyrimidine ring. The voluminous side chain of Trp 177 located at the corresponding position in MexY prevents inhibitor binding. The structure of the hydrophobic trap described in this study will contribute to the development of universal inhibitors of MexB and MexY in P. aeruginosa.	[Nakashima, Ryosuke; Sakurai, Keisuke; Yamaguchi, Akihito] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Ibaraki, Osaka 5670047, Japan; [Yamasaki, Seiji; Hayashi, Katsuhiko; Yamaguchi, Akihito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Nagata, Chikahiro; Hoshino, Kazuki; Onodera, Yoshikuni] Daiichi Sankyo Co Ltd, Edogawa Ku, Tokyo 1348630, Japan; [Nishino, Kunihiko] Osaka Univ, Inst Sci & Ind Res, Lab Microbiol & Infect Dis, Ibaraki, Osaka 5670047, Japan	Osaka University; Osaka University; Daiichi Sankyo Company Limited; Osaka University	Yamaguchi, A (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Ibaraki, Osaka 5670047, Japan.	akihito@sanken.osaka-u.ac.jp	Yamasaki, Seiji/GRF-3261-2022	Hayashi, Katsuhiko/0000-0001-7359-5939	Academia Sinica; National Synchrotron Radiation Research Center (Taiwan); CREST from the Japan Science and Technology Agency; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Taiwan); CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Nakae for providing the plasmids encoding mexB, mexY, mexAB-oprM and mexXY-oprM. We also thank N. Kato for discussion regarding the organic chemistry of the inhibitor that was investigated in this study. Our diffraction data were collected using Osaka University's BL44XU beamline at SPring-8, which was equipped with an MX225-HECCD detector (Rayonix) and was financially supported by the Academia Sinica and the National Synchrotron Radiation Research Center (Taiwan). We thank K. Harada for assistance with the liquid chromatography-tandem mass spectrometry assay. This work was supported by CREST from the Japan Science and Technology Agency, the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aeschlimann JR, 2003, PHARMACOTHERAPY, V23, P916, DOI 10.1592/phco.23.7.916.32722; Askoura M, 2011, LIBYAN J MED, V6, DOI 10.3402/ljm.v6i0.5870; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Eda S, 2003, J BIOL CHEM, V278, P2085, DOI 10.1074/jbc.C200661200; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hocquet D, 2006, ANTIMICROB AGENTS CH, V50, P1347, DOI 10.1128/AAC.50.4.1347-1351.2006; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lomovskaya O, 2006, BIOCHEM PHARMACOL, V71, P910, DOI 10.1016/j.bcp.2005.12.008; Lomovskaya O, 2001, J MOL MICROB BIOTECH, V3, P225; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P2242, DOI 10.1128/AAC.44.9.2242-2246.2000; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018547; Mokhonov VV, 2004, BIOCHEM BIOPH RES CO, V322, P483, DOI 10.1016/j.bbrc.2004.07.140; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Nakayama K, 2003, BIOORG MED CHEM LETT, V13, P4201, DOI 10.1016/j.bmcl.2003.07.024; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pages JM, 2009, BBA-PROTEINS PROTEOM, V1794, P826, DOI 10.1016/j.bbapap.2008.12.011; Poole K, 2001, CURR OPIN MICROBIOL, V4, P500, DOI 10.1016/S1369-5274(00)00242-3; Poole Keith, 2001, Current Topics in Medicinal Chemistry, V1, P59, DOI 10.2174/1568026013395605; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Takatsuka Y, 2010, P NATL ACAD SCI USA, V107, P6559, DOI 10.1073/pnas.1001460107; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Vargiu AV, 2011, J AM CHEM SOC, V133, P10704, DOI 10.1021/ja202666x; Yoshida KI, 2007, BIOORGAN MED CHEM, V15, P7087, DOI 10.1016/j.bmc.2007.07.039	33	184	197	3	103	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					102	U131		10.1038/nature12300	http://dx.doi.org/10.1038/nature12300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23812586				2022-12-28	WOS:000322514800037
J	Cowling, BJ; Jin, LM; Lau, EHY; Liao, QH; Wu, P; Jiang, H; Tsang, TK; Zheng, JD; Fang, VJ; Chang, ZR; Ni, MY; Zhang, Q; Ip, DKM; Yu, JX; Li, Y; Wang, LP; Tu, WX; Meng, L; Wu, JT; Luo, HM; Li, Q; Shu, YL; Li, ZJ; Feng, ZJ; Yang, WZ; Wang, Y; Leung, GM; Yu, HJ				Cowling, Benjamin J.; Jin, Lianmei; Lau, Eric H. Y.; Liao, Qiaohong; Wu, Peng; Jiang, Hui; Tsang, Tim K.; Zheng, Jiandong; Fang, Vicky J.; Chang, Zhaorui; Ni, Michael Y.; Zhang, Qian; Ip, Dennis K. M.; Yu, Jianxing; Li, Yu; Wang, Liping; Tu, Wenxiao; Meng, Ling; Wu, Joseph T.; Luo, Huiming; Li, Qun; Shu, Yuelong; Li, Zhongjie; Feng, Zijian; Yang, Weizhong; Wang, Yu; Leung, Gabriel M.; Yu, Hongjie			Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases	LANCET			English	Article							ACUTE-RESPIRATORY-SYNDROME; CASE-FATALITY; RISK-FACTORS; HONG-KONG; POULTRY; ORIGIN; RATIO; SARS	Background The novel influenza A H7N9 virus emerged recently in mainland China, whereas the influenza A H5N1 virus has infected people in China since 2003. Both infections are thought to be mainly zoonotic. We aimed to compare the epidemiological characteristics of the complete series of laboratory-confirmed cases of both viruses in mainland China so far. Methods An integrated database was constructed with information about demographic, epidemiological, and clinical variables of laboratory-confirmed cases of H7N9 (130 patients) and H5N1 (43 patients) that were reported to the Chinese Centre for Disease Control and Prevention until May 24, 2013. We described disease occurrence by age, sex, and geography, and estimated key epidemiological variables. We used survival analysis techniques to estimate the following distributions: infection to onset, onset to admission, onset to laboratory confirmation, admission to death, and admission to discharge. Findings The median age of the 130 individuals with confirmed infection with H7N9 was 62 years and of the 43 with H5N1 was 26 years. In urban areas, 74% of cases of both viruses were in men, whereas in rural areas the proportions of the viruses in men were 62% for H7N9 and 33% for H5N1. 75% of patients infected with H7N9 and 71% of those with H5N1 reported recent exposure to poultry. The mean incubation period of H7N9 was 3.1 days and of H5N1 was 3.3 days. On average, 21 contacts were traced for each case of H7N9 in urban areas and 18 in rural areas, compared with 90 and 63 for H5N1. The fatality risk on admission to hospital was 36% (95% CI 26-45) for H7N9 and 70% (56-83%) for H5N1. Interpretation The sex ratios in urban compared with rural cases are consistent with exposure to poultry driving the risk of infection-a higher risk in men was only recorded in urban areas but not in rural areas, and the increased risk for men was of a similar magnitude for H7N9 and H5N1. However, the difference in susceptibility to serious illness with the two different viruses remains unexplained, since most cases of H7N9 were in older adults whereas most cases of H5N1 were in younger people. A limitation of our study is that we compared laboratory-confirmed cases of H7N9 and H5N1 infection, and some infections might not have been ascertained.	[Cowling, Benjamin J.; Lau, Eric H. Y.; Wu, Peng; Tsang, Tim K.; Fang, Vicky J.; Ni, Michael Y.; Ip, Dennis K. M.; Wu, Joseph T.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China; [Jin, Lianmei; Tu, Wenxiao; Meng, Ling; Li, Qun; Feng, Zijian] Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing 102206, Peoples R China; [Liao, Qiaohong; Jiang, Hui; Zheng, Jiandong; Chang, Zhaorui; Zhang, Qian; Yu, Jianxing; Li, Yu; Wang, Liping; Li, Zhongjie; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing 102206, Peoples R China; [Luo, Huiming] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing 102206, Peoples R China; [Shu, Yuelong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Natl Hlth & Family Planning Commiss, Beijing 102206, Peoples R China; [Yang, Weizhong; Wang, Yu] Chinese Ctr Dis Control & Prevent, Off Director, Beijing 102206, Peoples R China	University of Hong Kong; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Leung, GM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China.	gmleung@hku.hk; yuhj@chinacdc.cn	Cowling, Benjamin John/C-4263-2009; Lau, Eric/AAJ-6588-2021; Yu, Hongjie/GZK-5351-2022; Wu, Joseph/ABD-5880-2021; Ip, Dennis Kai Ming/C-4283-2009	Cowling, Benjamin John/0000-0002-6297-7154; Lau, Eric/0000-0002-6688-9637; Leung, Gabriel/0000-0002-2503-6283; Wu, Peng/0000-0003-1157-9401; Ni, Michael/0000-0002-1217-5858; YU, Jianxing/0000-0002-9696-2460; Ip, Dennis Kai Ming/0000-0003-3592-8709; Tsang, Tim Kam Lun/0000-0001-5037-6776	Ministry of Science and Technology, China; ; Research Fund for the Control of Infectious Disease and University Grants Committee, Hong Kong Special Administrative Region, China; US National Institutes of Health; US National Institutes of Health [U19 AI51915]; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Ministry of Science and Technology, China [2012 ZX10004-201]; National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus [KJYJ-2013-01-02]; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; National Institute of Allergy and Infectious Diseases [HHSN266200700005C, N01-AI-70005]; Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region; Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Ministry of Science and Technology, China(Ministry of Science and Technology, China); ; Research Fund for the Control of Infectious Disease and University Grants Committee, Hong Kong Special Administrative Region, China; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region; Area of Excellence Scheme of the Hong Kong University Grants Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Ministry of Science and Technology, China; Research Fund for the Control of Infectious Disease and University Grants Committee, Hong Kong Special Administrative Region, China; and the US National Institutes of Health.; This study was funded by the US National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19 AI51915); the China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; grants from the Ministry of Science and Technology, China (2012 ZX10004-201); a grant (KJYJ-2013-01-02) from the National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus; the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (U54 GM088558); the National Institute of Allergy and Infectious Diseases under contract number HHSN266200700005C, ADB noumber N01-AI-70005 (NIAID Centers for Excellence in Influenza Research and Surveillance); the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region; and the Area of Excellence Scheme of the Hong Kong University Grants Committee (AoE/M-12/06). We thank staff members of the Bureau of Disease Control and Prevention and Health Emergency Response Office of the National Health and Family Planning Commission, and provincial and local departments of health for providing assistance with administration and data collection; staff members at county level, prefecture level, and provincial level CDCs at the provinces with human H7N9 and H5N1 cases occurred for providing assistance with field investigation, administration, and data collection; and Hoi Wa Wong and Angel Li for technical assistance. The views expressed are those of the authors and do not necessarily represent the policy of the China CDC.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Arima Y, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.005, 10.5365/WPSAR.2013.4.2.005]; Centers for Disease Control and Prevention, 2013, INTERIM GUIDANCE FOR; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, EUROSURVEILLANCE, V18, P2; Cowling BJ, 2007, EPIDEMIOLOGY, V18, P253, DOI 10.1097/01.ede.0000254660.07942.fb; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Fiebig L, 2011, EUROSURVEILLANCE, V16, P13; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Han J, 2013, EUROSURVEILLANCE, V18, P6; He H, 2011, CHINA SURPASSES THE; Hong Kong Centre for Health Protection, 2013, REVISED REPORTING CR; Hsiao A, 2013, TAIPEI TIMES; Huai Y, 2008, EMERG INFECT DIS, V14, P1819, DOI 10.3201/eid1411.080509; Jewell NP, 2007, STAT MED, V26, P1982, DOI 10.1002/sim.2691; Kandeel A, 2010, EMERG INFECT DIS, V16, P1101, DOI 10.3201/eid1607.091695; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kelly H, 2013, EPIDEMIOLOGY, V24, P622, DOI 10.1097/EDE.0b013e318296c2b6; Lau EHY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-50; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liao QY, 2009, EPIDEMICS-NETH, V1, P207, DOI 10.1016/j.epidem.2009.09.002; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Shinde V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014809; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; World Health Organization, 2013, CUMULATIVE NUMBER OF; Xu C, EMERG INFECT DIS IN; Yu H, 2013, LANCET; Yu HJ, 2007, EMERG INFECT DIS, V13, P1061, DOI 10.3201/eid1307.061557; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	35	235	265	2	156	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					129	137		10.1016/S0140-6736(13)61171-X	http://dx.doi.org/10.1016/S0140-6736(13)61171-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187JY	23803488	Bronze, Green Accepted			2022-12-28	WOS:000322115300028
J	Toussaint, JS; Berwick, DM				Toussaint, John S.; Berwick, Donald M.			The Need for Access to Medicare Fee-for-Service Claims Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Toussaint, John S.] ThedaCare Ctr Healthcare Value, Appleton, WI USA; [Berwick, Donald M.] Harvard Univ, Sch Med, Boston, MA USA; [Berwick, Donald M.] Inst Healthcare Improvement, Cambridge, MA USA	Harvard University; Harvard Medical School; Institute for Healthcare Improvement	Berwick, DM (corresponding author), 131 Lake Ave, Newton, MA 02459 USA.	donberwick1@gmail.com						[Anonymous], [No title captured]	1	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					29	30		10.1001/jama.2013.6509	http://dx.doi.org/10.1001/jama.2013.6509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23754075				2022-12-28	WOS:000321253000013
J	Lapuente-Brun, E; Moreno-Loshuertos, R; Acin-Perez, R; Latorre-Pellicer, A; Colas, C; Balsa, E; Perales-Clemente, E; Quiros, PM; Calvo, E; Rodriguez-Hernandez, MA; Navas, P; Cruz, R; Carracedo, A; Lopez-Otin, C; Perez-Martos, A; Fernandez-Silva, P; Fernandez-Vizarra, E; Enriquez, JA				Lapuente-Brun, Esther; Moreno-Loshuertos, Raquel; Acin-Perez, Rebeca; Latorre-Pellicer, Ana; Colas, Carmen; Balsa, Eduardo; Perales-Clemente, Ester; Quiros, Pedro M.; Calvo, Enrique; Rodriguez-Hernandez, M. A.; Navas, Placido; Cruz, Raquel; Carracedo, Angel; Lopez-Otin, Carlos; Perez-Martos, Acisclo; Fernandez-Silva, Patricio; Fernandez-Vizarra, Erika; Antonio Enriquez, Jose			Supercomplex Assembly Determines Electron Flux in the Mitochondrial Electron Transport Chain	SCIENCE			English	Article							CYTOCHROME-C-OXIDASE; RESPIRATORY-CHAIN; COMPLEX-I; MAMMALIAN MITOCHONDRIA; MOUSE FIBROBLASTS; DNA; ASSEMBLY/STABILITY; IDENTIFICATION; RESPIRASOME; COMPONENTS	The textbook description of mitochondrial respiratory complexes (RCs) views them as free-moving entities linked by the mobile carriers coenzyme Q (CoQ) and cytochrome c (cyt c). This model (known as the fluid model) is challenged by the proposal that all RCs except complex II can associate in supercomplexes (SCs). The proposed SCs are the respirasome (complexes I, III, and IV), complexes I and III, and complexes III and IV. The role of SCs is unclear, and their existence is debated. By genetic modulation of interactions between complexes I and III and III and IV, we show that these associations define dedicated CoQ and cyt c pools and that SC assembly is dynamic and organizes electron flux to optimize the use of available substrates.	[Lapuente-Brun, Esther; Acin-Perez, Rebeca; Latorre-Pellicer, Ana; Colas, Carmen; Balsa, Eduardo; Perales-Clemente, Ester; Calvo, Enrique; Antonio Enriquez, Jose] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain; [Lapuente-Brun, Esther; Moreno-Loshuertos, Raquel; Perez-Martos, Acisclo; Fernandez-Silva, Patricio; Antonio Enriquez, Jose] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; [Balsa, Eduardo] Univ Autonoma Madrid, Inst Invest Sanitaria Princesa IIS IP, Hosp Univ La Princesa, Serv Inmunol, Madrid 28006, Spain; [Rodriguez-Hernandez, M. A.; Navas, Placido] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; [Rodriguez-Hernandez, M. A.; Navas, Placido] ISCIII, Ctr Invest Biomed Red Enfermedades Raras, Seville 41013, Spain; [Quiros, Pedro M.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Cruz, Raquel; Carracedo, Angel] Univ Santiago de Compostela, Ctr Invest Biomed Red Enfermedades Raras, Fac Med, Grp Med Xen, Santiago De Compostela 15782, A Coruna, Spain; [Fernandez-Vizarra, Erika] Hosp Univ Miguel Servet, IIS Aragon, Inst Aragones Ciencias Salud, Unidad Invest Traslac, Zaragoza 50009, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Zaragoza; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Oviedo; Instituto Universitario de Oncologia de Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Miguel Servet University Hospital	Enriquez, JA (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain.	jaenriquez@cnic.es	NAVAS, PLACIDO/R-5943-2019; Carracedo, Angel/D-4257-2012; Silva, Patricio Fernandez/U-2256-2017; Rodríguez-Hernández, Ángeles/K-9717-2015; Enríquez, J.A./M-8468-2016; Fernandez-Vizarra, Erika/AAE-5600-2020; López-Otín, Carlos/AAB-2106-2020; Acin-Perez, Rebeca/H-6160-2015; Moreno-Loshuertos, Raquel/H-4545-2015; Acin-Perez, Rebeca/AAU-4913-2020; Pellicer, Ana Latorre/A-8601-2019; Quiros, Pedro M/L-3186-2017; Balsa Martinez, Eduardo/A-8111-2019	NAVAS, PLACIDO/0000-0002-4115-7966; Carracedo, Angel/0000-0003-1085-8986; Silva, Patricio Fernandez/0000-0001-8971-7355; Rodríguez-Hernández, Ángeles/0000-0003-1846-0606; Enríquez, J.A./0000-0002-3671-2961; López-Otín, Carlos/0000-0001-6964-1904; Acin-Perez, Rebeca/0000-0001-9553-8337; Acin-Perez, Rebeca/0000-0001-9553-8337; Pellicer, Ana Latorre/0000-0002-4703-6620; Quiros, Pedro M/0000-0002-7793-6291; Perales-Clemente, Ester/0000-0002-6333-4070; Balsa Martinez, Eduardo/0000-0002-6836-7023; CRUZ, RAQUEL/0000-0002-6964-8898; Fernandez-Vizarra, Erika/0000-0002-2469-142X; Moreno Loshuertos, Raquel/0000-0002-6600-1618				Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; Lenaz G, 2007, AM J PHYSIOL-CELL PH, V292, pC1221, DOI 10.1152/ajpcell.00263.2006; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schafer E, 2007, BIOCHEMISTRY-US, V46, P12579, DOI 10.1021/bi700983h; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Staden R, 2000, Methods Mol Biol, V132, P115; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016	21	519	532	4	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1567	1570		10.1126/science.1230381	http://dx.doi.org/10.1126/science.1230381			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812712				2022-12-28	WOS:000321007000040
J	Ferreon, ACM; Ferreon, JC; Wright, PE; Deniz, AA				Ferreon, Allan Chris M.; Ferreon, Josephine C.; Wright, Peter E.; Deniz, Ashok A.			Modulation of allostery by protein intrinsic disorder	NATURE			English	Article							ADENOVIRUS E1A; STRUCTURAL BASIS; PHASE-DIAGRAMS; P300; BIOLOGY; BINDING; DOMAIN	Allostery is an intrinsic property of many globular proteins and enzymes that is indispensable for cellular regulatory and feedback mechanisms. Recent theoretical(1) and empirical(2) observations indicate that allostery is also manifest in intrinsically disordered proteins, which account for a substantial proportion of the proteome(3,4). Many intrinsically disordered proteins are promiscuous binders that interact with multiple partners and frequently function as molecular hubs in protein interaction networks. The adenovirus early region 1A (E1A) oncoprotein is a prime example of a molecular hub intrinsically disordered protein(5). E1A can induce marked epigenetic reprogramming of the cell within hours after infection, through interactions with a diverse set of partners that include key host regulators such as the general transcriptional coactivator CREB binding protein (CBP), its paralogue p300, and the retinoblastoma protein (pRb; also called RB1)(6,7). Little is known about the allosteric effects at play in E1A-CBP-pRb interactions, or more generally in hub intrinsically disordered protein interaction networks. Here we used single-molecule fluorescence resonance energy transfer (smFRET) to study coupled binding and folding processes in the ternary E1A system. The low concentrations used in these high-sensitivity experiments proved to be essential for these studies, which are challenging owing to a combination of E1A aggregation propensity and high-affinity binding interactions. Our data revealed that E1A-CBP-pRb interactions have either positive or negative cooperativity, depending on the available E1A interaction sites. This striking cooperativity switch enables fine-tuning of the thermodynamic accessibility of the ternary versus binary E1A complexes, and may permit a context-specific tuning of associated downstream signalling outputs. Such a modulation of allosteric interactions is probably a common mechanism in molecular hub intrinsically disordered protein function.	[Ferreon, Allan Chris M.; Ferreon, Josephine C.; Wright, Peter E.; Deniz, Ashok A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Wright, Peter E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Deniz, AA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	wright@scripps.edu; deniz@scripps.edu		Wright, Peter/0000-0002-1368-0223; Allan Chris, Ferreon/0000-0002-8538-1732; Ferreon, Josephine/0000-0002-3175-5700	National Institutes of Health [GM066833, CA96865]; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA096865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Manlapaz for technical support, A. Jansma and G. Bhabha for preparation of plasmid constructs, P. Haberz for mass spectrometry, and J. Dyson and M. Martinez-Yamout for discussions. This work was supported by grants GM066833 (A. A. D.) and CA96865 (P. E. W.) from the National Institutes of Health, and the Skaggs Institute for Chemical Biology.	Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Deniz AA, 2008, J R SOC INTERFACE, V5, P15, DOI 10.1098/rsif.2007.1021; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Ferreon ACM, 2007, BIOPHYS J, V92, P245, DOI 10.1529/biophysj.106.092262; Ferreon ACM, 2010, METHOD ENZYMOL, V472, P179, DOI 10.1016/S0076-6879(10)72010-3; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Green M, 2008, ONCOGENE, V27, P4446, DOI 10.1038/onc.2008.85; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Kadri Z, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000123; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Motlagh HN, 2012, P NATL ACAD SCI USA, V109, P4134, DOI 10.1073/pnas.1120519109; Nguyen DX, 2004, EMBO J, V23, P1609, DOI 10.1038/sj.emboj.7600176; Pelka P, 2008, J VIROL, V82, P7252, DOI 10.1128/JVI.00104-08; Rosgen J, 2003, J MOL BIOL, V328, P255, DOI 10.1016/S0022-2836(03)00246-8; Sang NL, 1997, J CELL BIOCHEM, V66, P277, DOI 10.1002/(SICI)1097-4644(19970901)66:3<277::AID-JCB1>3.0.CO;2-M; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; WANG HGH, 1995, J VIROL, V69, P7917, DOI 10.1128/JVI.69.12.7917-7924.1995; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u	31	239	242	1	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					390	+		10.1038/nature12294	http://dx.doi.org/10.1038/nature12294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23783631	Green Accepted			2022-12-28	WOS:000320592900046
J	McCulloch, P; Cook, JA; Altman, DG; Heneghan, C; Diener, MK				McCulloch, Peter; Cook, Jonathan A.; Altman, Douglas G.; Heneghan, Carl; Diener, Markus K.		IDEAL Grp	IDEAL framework for surgical innovation 1: the idea and development stages	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS	IDEAL is a framework for evaluations of surgical innovations, which follow a distinct development pathway differing from the approach developed for pharmacological interventions. Many pathway and evaluation challenges are shared by other interventional therapies, requiring individual therapist skills and customisation of treatment to the individual, partly through medical devices. This paper provides an overview of the IDEAL framework and recommendations, and focuses on the first two stages: idea and development.	[McCulloch, Peter] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Cook, Jonathan A.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England; [Heneghan, Carl] Univ Oxford, Dept Publ Hlth & Primary Care, Oxford OX1 2JD, England; [Diener, Markus K.] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, German Surg Soc, Study Ctr, D-69120 Heidelberg, Germany	University of Oxford; University of Aberdeen; University of Oxford; University of Oxford; Ruprecht Karls University Heidelberg	Diener, MK (corresponding author), Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, German Surg Soc, Study Ctr, D-69120 Heidelberg, Germany.	Markus.Diener@med.uni-heidelberg.de	Groves, Trish/A-9119-2009; Cook, Jonathan/D-3648-2015	Groves, Trish/0000-0001-7915-6419; Cook, Jonathan/0000-0002-4156-6989; McCulloch, Peter/0000-0002-3210-8273; Lyratzopoulos, Georgios/0000-0002-2873-7421	National Institute for Health Research's Health Technology Assessment programme; Johnson Johnson; Medtronic; Zimmer; Medical Research Council [G1002292]; MRC [G0800800, G1002292] Funding Source: UKRI; Medical Research Council [G0800800] Funding Source: researchfish; National Institute for Health Research [06/301/233] Funding Source: researchfish	National Institute for Health Research's Health Technology Assessment programme; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Medtronic(Medtronic); Zimmer; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The IDEAL group meeting in December 2010 was funded by the National Institute for Health Research's Health Technology Assessment programme, Johnson & Johnson, Medtronic and Zimmer (all unrestricted grants). JAC holds a Medical Research Council Methodology Fellowship (G1002292)	Ahmed HU, 2012, LANCET ONCOL, V13, P622, DOI 10.1016/S1470-2045(12)70121-3; [Anonymous], 1948, Br Med J, V2, P769; Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Blazeby JM, 2011, BRIT J SURG, V98, P544, DOI 10.1002/bjs.7387; Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187; COBB LA, 1959, NEW ENGL J MED, V260, P1115, DOI 10.1056/NEJM195905282602204; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; GILLON R, 1986, BMJ-BRIT MED J, V292, P466, DOI 10.1136/bmj.292.6518.466; Graves Stephen E, 2011, J Bone Joint Surg Am, V93 Suppl 3, P43, DOI 10.2106/JBJS.K.01220; Institute of Medicine, 2011, MED DEV PUBL HLTH FD; Lilford RJ, 1995, BMJ-BRIT MED J, V311, P1621, DOI 10.1136/bmj.311.7020.1621; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; O'Dowd A, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d8329; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; Wente MN, 2003, DIGEST SURG, V20, P263, DOI 10.1159/000071183	17	128	134	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2013	346								f3012	10.1136/bmj.f3012	http://dx.doi.org/10.1136/bmj.f3012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171PQ	23778427	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000320941900003
J	Riezebos, RK; Verheugt, FWA				Riezebos, Robert K.; Verheugt, Freek W. A.			Cangrelor reduced ischemic PCI complications more than clopidogrel without increasing severe bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ACUTE CORONARY SYNDROMES		[Riezebos, Robert K.; Verheugt, Freek W. A.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands	Onze Lieve Vrouwe Gasthuis Hospital	Riezebos, RK (corresponding author), Onze Lieve Vrouw Hosp, Amsterdam, Netherlands.		Verheugt, F.W.A./H-8105-2014					Riezebos RK, 2011, AM J CARDIOL, V107, P509, DOI 10.1016/j.amjcard.2010.10.016; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12							JC5	10.7326/0003-4819-158-12-201306180-02005	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778929				2022-12-28	WOS:000320645000004
J	Kamarulzaman, A				Kamarulzaman, Adeeba			Fighting the HIV epidemic in the Islamic world	LANCET			English	Editorial Material									Univ Malaya, Fac Med, Ctr Excellence Res AIDS, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Kamarulzaman, A (corresponding author), Univ Malaya, Fac Med, Ctr Excellence Res AIDS, Kuala Lumpur 50603, Malaysia.	adeeba@um.edu.my	KAMARULZAMAN, ADEEBA/B-5216-2010					Abu-Raddad LJ, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000386729.56683.33; Busulwa R., 2006, Eastern Mediterranean Health Journal, V12, pS64; El Feki S, 2006, LANCET, V367, P975, DOI 10.1016/S0140-6736(06)68409-2; Global HIV/AIDS Response, EP UPD HLTH SECT PRO; Gray PB, 2004, SOC SCI MED, V58, P1751, DOI 10.1016/S0277-9536(03)00367-8; Kamarulzaman A, 2010, INT J DRUG POLICY, V21, P115, DOI 10.1016/j.drugpo.2009.11.003; Ministry of Health Malaysia, 2013, SEM HIV IMP ASS; Naning H, 2013, 7 IAS C HIV PATH TRE; Obermeyer CM, 2006, BMJ-BRIT MED J, V333, P851, DOI 10.1136/bmj.38994.400370.7C; Rahmati-Najarkolaei F, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-27; Reid G, 2007, INT J DRUG POLICY, V18, P136, DOI 10.1016/j.drugpo.2006.12.015; UNAIDS, 2010, REP GLOB AIDS EP 201	12	30	30	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 15	2013	381	9883					2058	2060		10.1016/S0140-6736(13)61033-8	http://dx.doi.org/10.1016/S0140-6736(13)61033-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KA	23769216				2022-12-28	WOS:000320924800005
J	Mirceta, S; Signore, AV; Burns, JM; Cossins, AR; Campbell, KL; Berenbrink, M				Mirceta, Scott; Signore, Anthony V.; Burns, Jennifer M.; Cossins, Andrew R.; Campbell, Kevin L.; Berenbrink, Michael			Evolution of Mammalian Diving Capacity Traced by Myoglobin Net Surface Charge	SCIENCE			English	Article							MARINE MAMMALS; BODY-SIZE; OXYGEN; ADAPTATIONS; ALLOMETRY; STABILITY; BEHAVIOR; LIMITS; BIRDS; SEALS	Extended breath-hold endurance enables the exploitation of the aquatic niche by numerous mammalian lineages and is accomplished by elevated body oxygen stores and adaptations that promote their economical use. However, little is known regarding the molecular and evolutionary underpinnings of the high muscle myoglobin concentration phenotype of divers. We used ancestral sequence reconstruction to trace the evolution of this oxygen-storing protein across a 130-species mammalian phylogeny and reveal an adaptive molecular signature of elevated myoglobin net surface charge in diving species that is mechanistically linked with maximal myoglobin concentration. This observation provides insights into the tempo and routes to enhanced dive capacity evolution within the ancestors of each major mammalian aquatic lineage and infers amphibious ancestries of echidnas, moles, hyraxes, and elephants, offering a fresh perspective on the evolution of this iconic respiratory pigment.				michaelb@liv.ac.uk	Burns, Jennifer/AAC-8243-2019; Berenbrink, Michael/W-7519-2019	Burns, Jennifer/0000-0001-9652-2943; Cossins, Andrew/0000-0002-0813-5212; Signore, Anthony/0000-0002-0664-0864; Campbell, Kevin/0000-0001-7005-7086	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANDREWS CW, 1906, DESCRIPT CATAL; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Berenbrink M, 2005, SCIENCE, V307, P1752, DOI 10.1126/science.1107793; Berenbrink M, 2006, RESP PHYSIOL NEUROBI, V154, P165, DOI 10.1016/j.resp.2006.01.002; BERTA A, 1989, SCIENCE, V244, P60, DOI 10.1126/science.244.4900.60; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; Campbell B, 1939, AM J ANAT, V64, P1, DOI 10.1002/aja.1000640102; Clementz MT, 2008, PALAIOS, V23, P574, DOI 10.2110/palo.2007.p07-054r; Court Nicholas, 1993, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V226, P125; Domning DP, 2001, NATURE, V413, P625, DOI 10.1038/35098072; FISCHER MS, 1992, MAMMALIA, V8; GALLIVAN GJ, 1986, J COMP PHYSIOL B, V156, P415, DOI 10.1007/BF01101104; Gros G, 2010, J EXP BIOL, V213, P2713, DOI 10.1242/jeb.043075; Halsey LG, 2006, AM NAT, V167, P276, DOI 10.1086/499439; Helbo S, 2012, AM J PHYSIOL-REG I, V302, pR693, DOI 10.1152/ajpregu.00501.2011; HOCHACHKA PW, 1984, MOL PHYSIOL, V5, P165; HOCHACHKA PW, 1988, COLD OCEAN PHYSIOL, P391; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; KOOYMAN GL, 1980, J COMP PHYSIOL, V138, P335, DOI 10.1007/BF00691568; Kramer RM, 2012, BIOPHYS J, V102, P1907, DOI 10.1016/j.bpj.2012.01.060; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Lestyk KC, 2009, J COMP PHYSIOL B, V179, P985, DOI 10.1007/s00360-009-0378-9; Liu AGSC, 2008, P NATL ACAD SCI USA, V105, P5786, DOI 10.1073/pnas.0800884105; MADDISON DR, 2000, MACCLADE 4 ANAL; MADDISON WP, 2011, MESQUITE MOD SYST; McIntyre IW, 2002, J EXP BIOL, V205, P45; MCLELLAN T, 1984, BIOCHEM GENET, V22, P181, DOI 10.1007/BF00499297; Meijaard E, 2010, MAMM BIOL, V75, P471, DOI 10.1016/j.mambio.2009.05.007; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Nagao S, 2012, DALTON T, V41, P11378, DOI 10.1039/c2dt30893b; Noren SR, 2000, COMP BIOCHEM PHYS A, V126, P181, DOI 10.1016/S1095-6433(00)00182-3; OSBORN HF, 1899, P 4 INT C ZOOL CAMBR, P172; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Phillips MJ, 2009, P NATL ACAD SCI USA, V106, P17089, DOI 10.1073/pnas.0904649106; Ponganis PJ, 2011, J EXP BIOL, V214, P3325, DOI 10.1242/jeb.031252; Reeds PJ, 2000, J NUTR, V130, p1835S; Regis WCB, 2005, ARCH BIOCHEM BIOPHYS, V436, P168, DOI 10.1016/j.abb.2005.01.016; REYNAFARJE B, 1963, J LAB CLIN MED, V61, P138; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Scholander PF, 1941, J CELL COMPAR PHYSL, V17, P169, DOI 10.1002/jcp.1030170204; Schreer JF, 1997, CAN J ZOOL, V75, P339, DOI 10.1139/z97-044; SCHWARTZ GT, 1995, J MAMMAL, V76, P1088, DOI 10.2307/1382601; Scott EE, 2000, J BIOL CHEM, V275, P27129; Seiffert ER, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-224; Steller G. W., 1751, NOVI COMMENTARII ACA, V2, P289; STEWART BS, 1995, J MAMMAL, V76, P196, DOI 10.2307/1382328; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Uhen MD, 2007, ANAT REC, V290, P514, DOI 10.1002/ar.20545; VANDENOORD AH, 1969, EUR J BIOCHEM, V10, P140; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Williams TM, 2011, MAR MAMMAL SCI, V27, P334, DOI 10.1111/j.1748-7692.2010.00408.x; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; WITTENBERG JB, 1970, PHYSIOL REV, V50, P559, DOI 10.1152/physrev.1970.50.4.559; Zorrilla S, 2004, PROTEIN SCI, V13, P2960, DOI 10.1110/ps.04809404; [No title captured]	62	124	131	2	246	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138							1234192	10.1126/science.1234192	http://dx.doi.org/10.1126/science.1234192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766330	Green Submitted			2022-12-28	WOS:000320320200036
J	Santamaria, L; Diaz, M; Valladares, F				Santamaria, Luis; Diaz, Mario; Valladares, Fernando			Dark Clouds over Spanish Science	SCIENCE			English	Editorial Material									[Santamaria, Luis] Spanish Assoc Adv Sci & Technol, E-28006 Madrid, Spain; [Santamaria, Luis] Mediterranean Inst Adv Studies, E-07190 Esporles, Spain; [Diaz, Mario] Spanish Soc Ornithol, Sci Comm, E-28053 Madrid, Spain; [Diaz, Mario; Valladares, Fernando] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Valladares, Fernando] Spanish Assoc Terr Ecol, E-28933 Mostoles, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Santamaria, L (corresponding author), Spanish Assoc Adv Sci & Technol, E-28006 Madrid, Spain.	lsantamaria@imedea.uib-csic.es	Diaz, Mario/C-3052-2017; Santamaria, Luis/C-1438-2012; Valladares, Fernando/K-9406-2014	Diaz, Mario/0000-0002-6384-6674; Santamaria, Luis/0000-0002-5072-2912; Valladares, Fernando/0000-0002-5374-4682				Fearn H., 2008, TIMER HIGHER ED 1113; Heijs J., 2013, ERAWATCH COUNTRY REP; INE, 2012, EST ACT 1 D AN 2011; MEC, 2013, NAT PLAN SCI TECHN R; Ministerio de Economia y Competitividad, 2013, SPAN STRAT SCI TECHN; National Institute for Educational Development (NIED), 2020, MATH SYLL ADV SUBS; Owens B., 2012, NATURE NEWS BLO 0404; Pain E., 2012, SCIENCEINSIDER  0928; Royal Society, 2010, INV SCI RISK REL EC; Stobbe A., 2012, GREECE IRELAND PORTU	10	5	5	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1292	1292		10.1126/science.1233726	http://dx.doi.org/10.1126/science.1233726			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766316				2022-12-28	WOS:000320320200027
J	Yong, KJ; Gao, C; Lim, JSJ; Yan, B; Yang, H; Dimitrov, T; Kawasaki, A; Ong, CW; Wong, KF; Lee, S; Ravikumar, S; Srivastava, S; Tian, X; Poon, RT; Fan, ST; Luk, JM; Dan, YY; Salto-Tellez, M; Chai, L; Tenen, DG				Yong, Kol Jia; Gao, Chong; Lim, Joline S. J.; Yan, Benedict; Yang, Henry; Dimitrov, Todor; Kawasaki, Akira; Ong, Chee Wee; Wong, Kwong-Fai; Lee, Sanghoon; Ravikumar, Sharada; Srivastava, Supriya; Tian, Xi; Poon, Ronnie T.; Fan, Sheung Tat; Luk, John M.; Dan, Yock Young; Salto-Tellez, Manuel; Chai, Li; Tenen, Daniel G.			Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							YOLK-SAC TUMORS; EXPRESSION; TRICHOSTATIN; ONCOGENE; LEUKEMIA; UTILITY; CANCER; CELLS	BACKGROUND Hepatocellular carcinoma is the third leading cause of cancer-related deaths worldwide. In the heterogeneous group of hepatocellular carcinomas, those with characteristics of embryonic stem-cell and progenitor-cell gene expression are associated with the worst prognosis. The oncofetal gene SALL4, a marker of a subtype of hepatocellular carcinoma with progenitor-like features, is associated with a poor prognosis and is a potential target for treatment. METHODS We screened specimens obtained from patients with primary hepatocellular carcinoma for the expression of SALL4 and carried out a clinicopathological analysis. Loss-of-function studies were then performed to evaluate the role of SALL4 in hepatocarcinogenesis and its potential as a molecular target for therapy. To assess the therapeutic effects of a peptide that targets SALL4, we used in vitro functional and in vivo xenograft assays. RESULTS SALL4 is an oncofetal protein that is expressed in the human fetal liver and silenced in the adult liver, but it is reexpressed in a subgroup of patients who have hepatocellular carcinoma and an unfavorable prognosis. Gene-expression analysis showed the enrichment of progenitor-like gene signatures with overexpression of proliferative and metastatic genes in SALL4-positive hepatocellular carcinomas. Loss-of-function studies confirmed the critical role of SALL4 in cell survival and tumorigenicity. Blocking SALL4-corepressor interactions released suppression of PTEN (the phosphatase and tensin homologue protein) and inhibited tumor formation in xenograft models in vivo. CONCLUSIONS SALL4 is a marker for a progenitor subclass of hepatocellular carcinoma with an aggressive phenotype. The absence of SALL4 expression in the healthy adult liver enhances the potential of SALL4 as a treatment target in hepatocellular carcinoma. (Funded by the Singapore National Medical Research Council and others.)	[Yong, Kol Jia; Yang, Henry; Kawasaki, Akira; Ong, Chee Wee; Wong, Kwong-Fai; Lee, Sanghoon; Ravikumar, Sharada; Srivastava, Supriya; Luk, John M.; Salto-Tellez, Manuel; Tenen, Daniel G.] Natl Univ Hlth Syst, Canc Sci Inst Singapore, Singapore, Singapore; [Yong, Kol Jia] Natl Univ Hlth Syst, Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Lim, Joline S. J.] Natl Univ Hlth Syst, Natl Univ Canc Inst, Singapore, Singapore; [Yan, Benedict] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore; [Luk, John M.] Natl Univ Hlth Syst, Dept Pharmacol, Singapore, Singapore; [Dan, Yock Young] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore; [Dan, Yock Young] Natl Univ Singapore, Singapore 117599, Singapore; [Gao, Chong; Lim, Joline S. J.; Dimitrov, Todor; Tian, Xi; Chai, Li] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tenen, Daniel G.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Poon, Ronnie T.; Fan, Sheung Tat; Luk, John M.] Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Salto-Tellez, Manuel] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Hong Kong; Queens University Belfast	Tenen, DG (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst Singapore, Ctr Translat Med MD6,Unit 01, 12th Fl,14 Med Dr, Singapore 117599, Singapore.	daniel.tenen@nus.edu.sg	Luk, John/A-4085-2008; Srivastava, Supriya/HDJ-9671-2022	Luk, John/0000-0002-6323-7940; Tenen, Daniel/0000-0002-6423-3888; Srivastava, Supriya/0000-0002-6727-3076; Salto-Tellez, Manuel/0000-0001-8586-282X; Chai, Li/0000-0003-1937-4750	Singapore National Medical Research Council; Singapore Translational Research Award from the Singapore National Medical Research Council [NMRC/STaR/0001/2008]; Singapore Ministry of Education; National Research Foundation; National Institutes of Health [PO1DK080665, RO1HL092437, PO1HL095489]; NATIONAL CANCER INSTITUTE [R01CA118316, P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112719, R01HL092437, R01HL056745, P01HL095489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK080665] Funding Source: NIH RePORTER	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Translational Research Award from the Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); National Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the Singapore National Medical Research Council and others.; Supported by a Singapore Translational Research Award from the Singapore National Medical Research Council (NMRC/STaR/0001/2008, to Dr. Tenen) and grants from the Singapore Ministry of Education and National Research Foundation (to Dr. Tenen) and the National Institutes of Health (PO1DK080665, to Drs. Tenen and Chai; and RO1HL092437 and PO1HL095489, to Dr. Chai).	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Cao DF, 2009, CANCER-AM CANCER SOC, V115, P2640, DOI 10.1002/cncr.24308; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Cui W, 2006, MODERN PATHOL, V19, P1585, DOI 10.1038/modpathol.3800694; de Celis JF, 2009, INT J DEV BIOL, V53, P1385, DOI 10.1387/ijdb.072408jd; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao C, 2013, BLOOD, V121, P1413, DOI 10.1182/blood-2012-04-424275; Keating GM, 2009, DRUGS, V69, P223, DOI 10.2165/00003495-200969020-00006; Kobayashi D, 2011, INT J ONCOL, V38, P933, DOI 10.3892/ijo.2011.929; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Mukhopadhyay NK, 2006, ANN THORAC SURG, V81, P1034, DOI 10.1016/j.athoracsur.2005.06.059; Oikawa T, 2013, HEPATOLOGY, V57, P1469, DOI 10.1002/hep.26159; Oikawa T, 2009, GASTROENTEROLOGY, V136, P1000, DOI 10.1053/j.gastro.2008.11.018; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang FH, 2009, AM J SURG PATHOL, V33, P1529, DOI 10.1097/PAS.0b013e3181ad25d5; Woo HG, 2010, CANCER RES, V70, P3034, DOI 10.1158/0008-5472.CAN-09-2823; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	22	169	188	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2266	2276		10.1056/NEJMoa1300297	http://dx.doi.org/10.1056/NEJMoa1300297			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YN	23758232	Green Accepted, Green Published			2022-12-28	WOS:000320230500002
J	Zapata-Wainberg, G; Vivancos, J				Zapata-Wainberg, Gustavo; Vivancos, Jose			Bilateral Earlobe Creases	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zapata-Wainberg, Gustavo; Vivancos, Jose] Hosp Univ La Princesa, Madrid, Spain	Hospital de La Princesa	Zapata-Wainberg, G (corresponding author), Hosp Univ La Princesa, Madrid, Spain.	gzapatawainberg@gmail.com	Zapata-Wainberg, Gustavo/D-8303-2018	Zapata-Wainberg, Gustavo/0000-0002-2524-3637					0	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					E32	E32		10.1056/NEJMicm1213006	http://dx.doi.org/10.1056/NEJMicm1213006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YN	23758258				2022-12-28	WOS:000320230500007
J	Dworzynski, K; Ritchie, G; Fenu, E; MacDermott, K; Playford, ED				Dworzynski, Katharina; Ritchie, Gill; Fenu, Elisabetta; MacDermott, Keith; Playford, E. Diane		Guideline Dev Grp	Rehabilitation after stroke: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dworzynski, Katharina; Ritchie, Gill; Fenu, Elisabetta] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Playford, E. Diane] UCL Inst Neurol, London WC1N 1PJ, England	Royal College of Physicians; University of London; University College London	Dworzynski, K (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	Katharina.Dworzynski@rcplondon.ac.uk		Playford, E Diane/0000-0001-7314-787X				Department of Health, 2007, 284536 DOH; GRADE Working Group, 2011, GRAD REC ASS DEV EV; National Institute for Health and Care Excellence, 2013, STROK REH LONG TERM; Townsend N, 2012, CORONARY HEART DIS S	4	45	48	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2013	346								f3615	10.1136/bmj.f3615	http://dx.doi.org/10.1136/bmj.f3615			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WH	23760965				2022-12-28	WOS:000320589800003
J	Chatterjee, P				Chatterjee, Patralekha			Added benefits of polio eradication	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												patralekha.chatterjee@gmail.com						Unicef, 2005, COV EV SURV; UNICEF, 2009, COV EV SURV; Vashishtha VM, 2013, INDIAN PEDIATR, V50, P111, DOI 10.1007/s13312-013-0025-0	3	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 7	2013	346								f3378	10.1136/bmj.f3378	http://dx.doi.org/10.1136/bmj.f3378			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YM	23747750				2022-12-28	WOS:000320230400005
J	Utzinger, J; Tanner, M				Utzinger, Juerg; Tanner, Marcel			Socioeconomic development to fight malaria, and beyond	LANCET			English	Editorial Material							HEALTH-CARE; POOR		[Utzinger, Juerg; Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland; [Utzinger, Juerg; Tanner, Marcel] Univ Basel, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Utzinger, J (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland.	juerg.utzinger@unibas.ch						[Anonymous], 2001, MACR HLTH INV HLTH E; de Castro MC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-161; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; MacDonald G., 1950, EC IMPORTANCE MALARI; MCCARTHY FD, 2000, MALARIA GROWTH; Raso G, 2005, TROP MED INT HEALTH, V10, P42, DOI 10.1111/j.1365-3156.2004.01352.x; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Ross R., 1911, PREVENTION MALARIA; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Steinmann P, 2010, ADV PARASIT, V73, P21, DOI 10.1016/S0065-308X(10)73002-5; Tusting LS, 2013, LANCET; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	14	7	7	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2013	382	9896					920	922		10.1016/S0140-6736(13)61211-8	http://dx.doi.org/10.1016/S0140-6736(13)61211-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VD	23790352				2022-12-28	WOS:000324238000007
J	Croskerry, P				Croskerry, Pat			From Mindless to Mindful Practice - Cognitive Bias and Clinical Decision Making	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dalhousie Univ, Div Med Educ, Halifax, NS, Canada	Dalhousie University	Croskerry, P (corresponding author), Dalhousie Univ, Div Med Educ, Halifax, NS, Canada.							Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Croskerry P, 2009, ACAD MED, V84, P1022, DOI 10.1097/ACM.0b013e3181ace703; Pineda LA, 2001, CHEST, V120, P791, DOI 10.1378/chest.120.3.791; Stanovich KE, 2010, REV EDUC RES, P5	4	275	278	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2445	2448		10.1056/NEJMp1303712	http://dx.doi.org/10.1056/NEJMp1303712			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KQ	23802513				2022-12-28	WOS:000320926900003
J	Levine, BL; June, CH				Levine, Bruce L.; June, Carl H.			PERSPECTIVE Assembly line immunotherapy	NATURE			English	Editorial Material									[Levine, Bruce L.; June, Carl H.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Levine, BL (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.							Baker M, 2011, NAT MED, V17, P519, DOI 10.1038/nm0511-519; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Levine BL, 1996, SCIENCE, V272, P1939, DOI 10.1126/science.272.5270.1939; Michalos G, 2010, CIRP J MANUF SCI TEC, V2, P81, DOI 10.1016/j.cirpj.2009.12.001; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849	5	33	33	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					S17	S17		10.1038/498S17a	http://dx.doi.org/10.1038/498S17a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803946	Bronze			2022-12-28	WOS:000320929400010
J	Li, SL; Li, CY				Li, Shu-li; Li, Chunying			Vulvar Swelling, Plaques, and Nodules in a Young Adult Woman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CROHNS-DISEASE; MANIFESTATIONS		[Li, Shu-li; Li, Chunying] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Li, CY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 West Changle Rd, Xian 710032, Shaanxi, Peoples R China.	lichying@fmmu.edu.cn						Amankwah Y, 2010, DERMATOL CLIN, V28, P765, DOI 10.1016/j.det.2010.08.001; Emanuel PO, 2008, J CUTAN PATHOL, V35, P457, DOI 10.1111/j.1600-0560.2007.00849.x; Foo WC, 2011, AM J DERMATOPATH, V33, P588, DOI 10.1097/DAD.0b013e31820a2635; Hou JK, 2009, AM J GASTROENTEROL, V104, P2100, DOI 10.1038/ajg.2009.190; Sandborn WJ, 2003, GASTROENTEROLOGY, V125, P1508, DOI 10.1016/j.gastro.2003.08.025; Selim MA, 2010, DERMATOL CLIN, V28, P649, DOI 10.1016/j.det.2010.07.005; Van Assche G, 2010, J CROHNS COLITIS, V4, P63, DOI 10.1016/j.crohns.2009.09.009	7	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2596	2597		10.1001/jama.2013.7080	http://dx.doi.org/10.1001/jama.2013.7080			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23800936				2022-12-28	WOS:000320848100030
J	Rodgers, MA; Brown, JVE; Heirs, MK; Higgins, JPT; Mannion, RJ; Simmonds, MC; Stewart, LA				Rodgers, Mark A.; Brown, Jennifer V. E.; Heirs, Morag K.; Higgins, Julian P. T.; Mannion, Richard J.; Simmonds, Mark C.; Stewart, Lesley A.			Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BONE MORPHOGENETIC PROTEIN-2; RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; LUMBAR; ARTHRODESIS; CAGES; FORMULATION; SURGERY; DEVICE	Objective To investigate whether published results of industry funded trials of recombinant human bone morphogenetic protein 2 (rhBMP-2) in spinal fusion match underlying trial data by comparing three different data sources: individual participant data, internal industry reports, and publicly available journal publications and conference abstracts. Data collection and synthesis The manufacturer of rhBMP-2 products (Medtronic; Minneapolis, MN) provided complete individual participant data and internal reports for all its studies of rhMBP-2 in spinal fusion. We identified publications and conference abstracts through comprehensive literature searches. We compared outcomes provided in the individual participant data against outcomes reported in publications. For effectiveness outcomes, we compared meta-analyses of randomised controlled trials based on each of the three data sources. For adverse events, meta-analysis of the published aggregate data was not possible and we compared the number and type of adverse events reported between data sources. Results 32 publications reported outcomes from 11 of the 17 existing manufacturer sponsored studies. For individual randomised controlled trials, 56% (9/16) to 88% (15/17) of effectiveness outcomes known to have been collected were reported in the published literature. Meta-analyses of effectiveness data were almost identical for pain outcomes and similar for fusion across the three data sources. A minority of adverse event data known to have been collected were reported in the published literature. Several journal articles reported only "serious," "related," or "unanticipated" adverse events, without defining these terms. Others reported a small proportion of the collected adverse event categories. Around 23% (533/2302) of the total adverse events collected in published randomised controlled trials have been reported in the literature, with randomised controlled trials evaluating the licensed preparation (Infuse) reporting around 11% (122/1108) of collected adverse events. Conclusions The published literature only partially represents the total data known to have been collected on the effects of rhBMP-2. This did not lead to substantially different results for meta-analysis of effectiveness outcomes. In contrast, reporting of adverse event data in trial publications was inadequate and inconsistent to the extent that any systematic review based solely on the publicly available data would not be able to properly evaluate the safety of rhBMP-2. Analysis of individual participant data enabled the most complete, detailed, and in-depth analysis and was not more resource intensive than extracting, collating, and analysing aggregate data from multiple trial publications and conference abstracts. Confidential internal reports presented considerably more adverse event data than publications, and in the absence of individual participant data access to these reports would support more accurate and reliable investigation, with less time and effort than relying on incomplete published data.	[Rodgers, Mark A.; Brown, Jennifer V. E.; Heirs, Morag K.; Higgins, Julian P. T.; Simmonds, Mark C.; Stewart, Lesley A.] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Mannion, Richard J.] Addenbrookes Hosp, Cambridge, England	University of York - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Stewart, LA (corresponding author), Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.	lesley.stewart@york.ac.uk	Brown, Jennifer V E/C-6947-2019; Higgins, Julian PT/H-4008-2011	Brown, Jennifer V E/0000-0003-0943-5177; Higgins, Julian PT/0000-0002-8323-2514; Stewart, Lesley/0000-0003-0287-4724	Yale University Open Data Access project; Medical Research Council [MC_U105285807] Funding Source: researchfish; MRC [MC_U105285807] Funding Source: UKRI	Yale University Open Data Access project; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Yale University Open Data Access project. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2008, CAN J SURG, V51, pS6; Abraham EP, 2010, SPINE J, V10, pS105; Alexander D, 2007, NEUROSURGERY, V61, P200, DOI 10.1227/01.neu.0000279898.84194.a4; [Anonymous], 2012, BAUCUS GRASSLEY INVE; Baskin DS, 2003, SPINE, V28, P1219, DOI 10.1097/00007632-200306150-00003; Boakye M, 2005, J NEUROSURG-SPINE, V2, P521, DOI 10.3171/spi.2005.2.5.0521; Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020; Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; Breau RH, 2010, J UROLOGY, V183, P1693, DOI 10.1016/j.juro.2010.01.030; Burkus JK, 2009, J BONE JOINT SURG AM, V91A, P1181, DOI 10.2106/JBJS.G.01485; Burkus JK, 2005, J BONE JOINT SURG AM, V87A, P1205, DOI 10.2106/JBJS.D.02532; Burkus JK, 2003, J SPINAL DISORD TECH, V16, P113, DOI 10.1097/00024720-200304000-00001; Burkus JK, 2002, J SPINAL DISORD TECH, V15, P337, DOI 10.1097/00024720-200210000-00001; Burkus KJ, 2002, SPINE, V27, P2396; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Center for Devices and Radiological Health Public Health Notifications (Medical devices), FDA PUBL HLTH NOT LI; Dawson E, 2009, J BONE JOINT SURG AM, V91A, P1604, DOI 10.2106/JBJS.G.01157; de Vries TW, 2010, ARCH DIS CHILD, V95, P1023, DOI 10.1136/adc.2009.175562; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimar JR, 2009, J BONE JOINT SURG AM, V91A, P1377, DOI 10.2106/JBJS.H.00200; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Glassman SD, 2007, SPINE, V32, P1693, DOI 10.1097/BRS.0b013e318074c366; Glassman SD, 2010, J BONE JOINT SURG AM, V92A, P77, DOI 10.2106/JBJS.I.01300; Gornet MF, 2011, SPINE, V36, pE1600, DOI 10.1097/BRS.0b013e318217668f; Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025; Medtronic, 2002, CLIN INV REC HUM BON; Medtronic, 2003, PIL PROSP RAND CLIN; Medtronic, 2004, CLIN INV REC HUM BON; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; Shapiro S, 2005, NEUROSURGERY, V57, P398, DOI 10.1093/neurosurgery/57.2.398; Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005; Sinha S, 2009, J AM COLL SURGEONS, V209, P565, DOI 10.1016/j.jamcollsurg.2009.07.019; Yale School of Medicine, 2013, YODA PROJ YAL U OP D	33	44	44	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2013	346								f3981	10.1136/bmj.f3981	http://dx.doi.org/10.1136/bmj.f3981			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171QP	23788229	Green Published, hybrid			2022-12-28	WOS:000320944400007
J	Mahaffey, KW; Wojdyla, D; Hankey, GJ; White, HD; Nessel, CC; Piccini, JP; Patel, MR; Berkowitz, SD; Becker, RC; Halperin, JL; Singer, DE; Califf, RM; Fox, KAA; Breithardt, G; Hacke, W				Mahaffey, Kenneth W.; Wojdyla, Daniel; Hankey, Graeme J.; White, Harvey D.; Nessel, Christopher C.; Piccini, Jonathan P.; Patel, Manesh R.; Berkowitz, Scott D.; Becker, Richard C.; Halperin, Jonathan L.; Singer, Daniel E.; Califf, Robert M.; Fox, Keith A. A.; Breithardt, Guenter; Hacke, Werner			Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy A Subgroup Analysis of a Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ATRIAL-FIBRILLATION; WARFARIN; ANTICOAGULATION; HEMORRHAGE; DABIGATRAN; RISK	Background: In ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation), a large randomized, clinical trial, rivaroxaban was noninferior to warfarin in preventing stroke or systemic embolism in patients with atrial fibrillation. Objective: To determine the efficacy and safety of rivaroxaban compared with warfarin among vitamin K antagonist (VKA)-naive and VKA-experienced patients. Design: Prespecified subgroup analysis. (ClinicalTrials.gov: NCT00403767) Setting: Global. Patients: 14 264 persons with atrial fibrillation. Measurements: Interaction of the relative treatment effect of rivaroxaban and warfarin on stroke or systemic embolism among VKA-naive and VKA-experienced patients. Results: Overall, 7897 (55.4%) patients were VKA-experienced and 6367 (44.6%) were VKA-naive. The effect of rivaroxaban versus warfarin on stroke or systemic embolism was consistent: Rates per 100 patient-years of follow-up were 2.32 versus 2.87 for VKA-naive patients (hazard ratio [HR], 0.81 [95% CI, 0.64 to 1.03]) and 1.98 versus 2.09 for VKA-experienced patients (HR, 0.94 [CI, 0.75 to 1.18]; interaction P = 0.36). During the first 7 days, rivaroxaban was associated with more bleeding than warfarin (HR in VKA-naive patients, 5.83 [CI, 3.25 to 10.44], and in VKA-experienced patients, 6.66 [CI, 3.83 to 11.58]; interaction P = 0.53). After 30 days, rivaroxaban was associated with less bleeding than warfarin in VKA-naive patients (HR, 0.84 [CI, 0.74 to 0.95]) and similar bleeding in VKA-experienced patients (HR, 1.06 [CI, 0.96 to 1.17]; interaction P = 0.003). Limitation: The trial was not designed to detect differences in these subgroups. Conclusion: The efficacy of rivaroxaban in VKA-experienced and VKA-naive patients was similar to that of the overall trial. There were more bleeding events within 7 days of study drug initiation with rivaroxaban, but after 30 days, rivaroxaban was associated with less bleeding in VKA-naive patients and similar bleeding in VKA-experienced patients. This information may be useful to clinicians considering a transition to rivaroxaban for patients receiving VKA therapy.	Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC USA; Royal Perth Hosp, Perth, WA, Australia; Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1030, New Zealand; Johnson & Johnson Pharmaceut Res & Dev, Raritan, NJ USA; Bayer HealthCare Pharmaceut, Montville, NJ 07045 USA; Mt Sinai Med Ctr, Cardiovasc Inst, New York, NY 10029 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Edinburgh, Edinburgh, Midlothian, Scotland; Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland; Hosp Univ Munster, Munster, Germany; Heidelberg Univ, Heidelberg, Germany	Duke University; Duke University; Royal Perth Hospital; University of Western Australia; Auckland City Hospital; Johnson & Johnson; Johnson & Johnson USA; Bayer AG; Bayer Healthcare Pharmaceuticals; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Munster; Ruprecht Karls University Heidelberg	Mahaffey, KW (corresponding author), Duke Clin Res Inst, Room 0311 Terrace Level,2400 Pratt St, Durham, NC 27705 USA.	kenneth.mahaffey@dm.duke.edu	Patel, Manesh/AAC-5385-2019; Hankey, Graeme J/H-4968-2014; Hacke, Werner/ABE-8661-2020; Berkowitz, Scott Darrell/AAS-9397-2021; Halperin, Jonathan/AAJ-4721-2020; Fox, keith A A/I-3742-2013	Hankey, Graeme J/0000-0002-6044-7328; Berkowitz, Scott Darrell/0000-0002-9428-4408; Halperin, Jonathan/0000-0002-8318-5471; Fox, Keith/0000-0002-0140-2752	Johnson Johnson; Bayer HealthCare; Johnson & Johnson Pharmaceutical Research and Development	Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Johnson & Johnson Pharmaceutical Research and Development(Johnson & JohnsonJohnson & Johnson USA)	Johnson & Johnson and Bayer HealthCare.; By Johnson & Johnson Pharmaceutical Research and Development and Bayer HealthCare.	Baker WL, 2009, J MANAGE CARE PHARM, V15, P244, DOI 10.18553/jmcp.2009.15.3.244; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; del Zoppo GJ, 2011, NEW ENGL J MED, V365, P952, DOI 10.1056/NEJMe1107516; Ezekowitz MD, 2010, CIRCULATION, V122, P2246, DOI 10.1161/CIRCULATIONAHA.110.973735; Fang MC, 2006, J AM GERIATR SOC, V54, P1231, DOI 10.1111/j.1532-5415.2006.00828.x; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Patel MR, 2010, AM HEART J, V159, P340, DOI 10.1016/j.ahj.2009.11.025; Raunso J, 2012, EUR HEART J, V33, P1886, DOI 10.1093/eurheartj/ehr454; Rose A, 2011, NEW ENGL J MED, V365, P2333, DOI 10.1056/NEJMc1112233	13	44	47	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12					861	+		10.7326/0003-4819-158-12-201306180-00003	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778903				2022-12-28	WOS:000320645000014
J	Soria, A; Gori, A				Soria, Alessandro; Gori, Andrea			After first-line ART: towards an evidence-based SECOND-LINE	LANCET			English	Editorial Material							RESOURCE-LIMITED SETTINGS; ANTIRETROVIRAL TREATMENT; HIV CARE		[Soria, Alessandro; Gori, Andrea] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, I-20900 Monza, Italy	San Gerardo Hospital; University of Milano-Bicocca	Soria, A (corresponding author), Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, I-20900 Monza, Italy.	a.soria@hsgerardo.org	Gori, Andrea/AAC-6078-2022	SORIA, Alessandro/0000-0002-4447-2574				Boulle C, 2013, JAIDS-J ACQ IMM DEF, V62, P569, DOI 10.1097/QAI.0b013e318285f7b6; Boyd MA, 2013, LANCET, V381, P2091, DOI 10.1016/S0140-6736(13)61164-2; Boyd M, 2009, LANCET, V374, P185, DOI 10.1016/S0140-6736(09)61313-1; Calmy A, 2008, AIDS, V22, P2227, DOI 10.1097/QAD.0b013e32830f4c4d; Europe-Africa Research Network for Evaluation of Second-line Therapy (EARNEST), RAND CONTR TRIAL EV; Ford N, 2012, AIDS, V26, P1719, DOI 10.1097/QAD.0b013e3283543e2c; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Medecins Sans Frontieres Access Campaign, 2012, UNT WEB ANT PRIC RED; WHO, ANT THER HIV INF AD; World Health Organization, GLOB HIV AIDS RESP E	11	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 15	2013	381	9883					2062	2063		10.1016/S0140-6736(13)61210-6	http://dx.doi.org/10.1016/S0140-6736(13)61210-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KA	23769218				2022-12-28	WOS:000320924800007
J	Seddon, N; Lee, TH				Seddon, Nick; Lee, Thomas H.			Envy - A Strategy for Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Seddon, Nick] Reform, London, England; [Lee, Thomas H.] Partners Healthcare Syst, Boston, MA USA; [Lee, Thomas H.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Partners Healthcare System; Harvard University	Seddon, N (corresponding author), Reform, London, England.							[Anonymous], 2010, MIRROR MIRROR WALL P; Bailey M, 2012, REP OFF HLTH EC COMM; Casale AS, 2007, ANN SURG, V246, P613, DOI 10.1097/SLA.0b013e318155a996; Rudd A, 2010, EUR STROK C; WHO, 2010, WOR HEALT REP, P1	5	2	2	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2245	2247		10.1056/NEJMp1302810	http://dx.doi.org/10.1056/NEJMp1302810			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YN	23758230				2022-12-28	WOS:000320230500013
J	Misra, S; Oliver, NS; Dornhorst, A				Misra, S.; Oliver, N. S.; Dornhorst, A.			PRACTICE POINTER Diabetic ketoacidosis: not always due to type 1 diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEAR-NORMOGLYCEMIC REMISSION; AFRICAN-AMERICANS; OBESE; PATHOPHYSIOLOGY; CLASSIFICATION; SUGGESTS; HISTORY		[Misra, S.] Imperial Healthcare NHS Trust, Charing Cross Hosp, Dept Metab Med & Clin Biochem, London W6 8RF, England; [Oliver, N. S.; Dornhorst, A.] Imperial Healthcare NHS Trust, Charing Cross Hosp, Dept Endocrinol & Diabet, London W6 8RF, England	Imperial College London; Imperial College London	Misra, S (corresponding author), Imperial Healthcare NHS Trust, Charing Cross Hosp, Dept Metab Med & Clin Biochem, London W6 8RF, England.	smisra@imperial.ac.uk	Oliver, Nick S/G-9109-2016	Oliver, Nick S/0000-0003-3525-3633				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Balasubramanyam A, 1999, ARCH INTERN MED, V159, P2317, DOI 10.1001/archinte.159.19.2317; Balasubramanyam A, 2006, DIABETES CARE, V29, P2575, DOI 10.2337/dc06-0749; Banerji MA, 1996, DIABETES, V45, P337, DOI 10.2337/diabetes.45.3.337; Choukem SP, 2008, DIABETES CARE, V31, P2332, DOI 10.2337/dc08-0914; Joint British Diabetes Societies for Inpatient Care Group, 2012, MAN HYP HYP STAT HHS; Jones AG, 2013, DIABET MED; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Maldonado MR, 2004, ETHNIC DIS, V14, P243; Mauvais-Jarvis F, 2004, HUM MOL GENET, V13, P3151, DOI 10.1093/hmg/ddh341; Mauvais-Jarvis F, 2004, DIABETES, V53, P645, DOI 10.2337/diabetes.53.3.645; McFarlane SI, 2001, DIABETIC MED, V18, P10, DOI 10.1046/j.1464-5491.2001.00395.x; National Institute for Health and Care Excellence, 2008, TYP 1 DIAB AD FULL G; PinhasHamiel O, 1997, DIABETES CARE, V20, P484, DOI 10.2337/diacare.20.4.484; Savage MW, 2011, DIABETIC MED, V28, P508, DOI 10.1111/j.1464-5491.2011.03246.x; Smiley Dawn, 2011, Diabetes Manag (Lond), V1, P589; Sobngwi E, 2005, J CLIN ENDOCR METAB, V90, P4446, DOI 10.1210/jc.2004-2545; Umpierrez GE, 2006, ANN INTERN MED, V144, P350, DOI 10.7326/0003-4819-144-5-200603070-00011; UMPIERREZ GE, 1995, DIABETES, V44, P790, DOI 10.2337/diabetes.44.7.790; Umpierrez GE, 1999, DIABETES CARE, V22, P1517, DOI 10.2337/diacare.22.9.1517; Umpierrez GE, 1997, DIABETES CARE, V20, P479, DOI 10.2337/diacare.20.4.479; Umpierrez GE, 2006, DIABETES CARE, V29, P2755, DOI 10.2337/dc06-1870	22	26	26	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2013	346								f3501	10.1136/bmj.f3501	http://dx.doi.org/10.1136/bmj.f3501			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VK	23751904				2022-12-28	WOS:000320586700010
J	Chan, KY; Wang, W; Wu, JJ; Liu, L; Theodoratou, E; Car, J; Middleton, L; Russ, TC; Deary, IJ; Campbell, H; Wang, W; Rudan, I				Chan, Kit Yee; Wang, Wei; Wu, Jing Jing; Liu, Li; Theodoratou, Evropi; Car, Josip; Middleton, Lefkos; Russ, Tom C.; Deary, Ian J.; Campbell, Harry; Wang, Wei; Rudan, Igor		Global Hlth Epidemiology Reference	Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis	LANCET			English	Review							MIDDLE-INCOME COUNTRIES; ELDERLY-PEOPLE; RISK-FACTORS; PREVALENCE; BURDEN; HEALTH; MORTALITY; CHILDREN; AFRICA	Background China is increasingly facing the challenge of control of the growing burden of non-communicable diseases. We assessed the epidemiology of Alzheimer's disease and other forms of dementia in China between 1990, and 2010, to improve estimates of the burden of disease, analyse time trends, and inform health policy decisions relevant to China's rapidly ageing population. Methods In our systematic review we searched for reports of Alzheimer's disease or dementia in China, published in Chinese and English between 1990 and 2010. We searched China National Knowledge Infrastructure, Wanfang, and PubMed databases. Two investigators independently assessed case definitions of Alzheimer's disease and dementia: we excluded studies that did not use internationally accepted case definitions. We also excluded reviews and viewpoints, studies with no numerical estimates, and studies not done in mainland China. We used Poisson regression and UN demographic data to estimate the prevalence (in nine age groups), incidence, and standardised mortality ratio of dementia and its subtypes in China in 1990, 2000, and 2010. Findings Our search returned 12 642 reports, of which 89 met the inclusion criteria (75 assessed prevalence, 13 incidence, and nine mortality). In total, the included studies had 340 247 participants, in which 6357 cases of Alzheimer's disease were recorded. 254 367 people were assessed for other forms of dementia, of whom 3543 had vascular dementia, frontotemporal dementia, or Lewy body dementia. In 1990 the prevalence of all forms of dementia was 1.8% (95% CI 0.0-44.4) at 65-69 years, and 42.1% (0.0-88.9) at age 95-99 years. In 2010 prevalence was 2.6% (0.0-28.2) at age 65-69 years and 60.5% (39.7-81.3) at age 95-99 years. The number of people with dementia in China was 3.68 million (95% CI 2.22-5.14) in 1990, 5.62 million (4.42-6.82) in 2000, and 9.19 million (5.92-12.48) in 2010. In the same period, the number of people with Alzheimer's disease was 1.93 million (1.15-2.71) in 1990, 3.71 million (2.84-4.58) people in 2000, and 5.69 million (3.85-7.53) in 2010. The incidence of dementia was 9.87 cases per 1000 person-years, that of Alzheimer's disease was 6.25 cases per 1000 person-years, that of vascular dementia was 2.42 cases per 1000 person-years, and that of other rare forms of dementia was 0.46 cases per 1000 person-years. We retrieved mortality data for 1032 people with dementia and 20 157 healthy controls, who were followed up for 3-7 years. The median standardised mortality ratio was 1.94: 1 (IQR 1.74-2.45). Interpretation Our analysis suggests that previous estimates of dementia burden, based on smaller datasets, might have underestimated the burden of dementia in China. The burden of dementia seems to be increasing faster than is generally assumed by the international health community. Rapid and effective government responses are needed to tackle dementia in low-income and middle-income countries.	[Chan, Kit Yee] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic 3010, Australia; [Wang, Wei; Wu, Jing Jing; Wang, Wei] Capital Med Univ, Sch Publ Hlth, Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Liu, Li] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA; [Theodoratou, Evropi; Campbell, Harry; Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Russ, Tom C.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9AG, Midlothian, Scotland; [Russ, Tom C.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Alzheimer Scotland Dementia Res Ctr, Edinburgh EH8 9AG, Midlothian, Scotland; [Car, Josip; Middleton, Lefkos] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Fac Med, Neuroepidemiol & Ageing Res Unit, London, England; [Russ, Tom C.] NHS Scotland, Scottish Dementia Clin Res Network, Edinburgh, Midlothian, Scotland; [Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA 6027, Australia	University of Melbourne; Capital Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Edinburgh; University of Edinburgh; University of Edinburgh; Imperial College London; NHS National Services Scotland; Edith Cowan University	Rudan, I (corresponding author), Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Chair Int Hlth & Mol Med, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	wei.wang@ecu.edu.au; igor.rudan@ed.ac.uk	Theodoratou, Evropi/C-3430-2014; Deary, Ian J/C-6297-2009; Rudan, Igor/I-1467-2012; Campbell, Harry/E-2959-2010; liu, li/HGC-0900-2022; Russ, Tom/J-7114-2015; Car, Josip/H-6755-2015	Theodoratou, Evropi/0000-0001-5887-9132; Deary, Ian J/0000-0002-1733-263X; Rudan, Igor/0000-0001-6993-6884; Campbell, Harry/0000-0002-6169-6262; Russ, Tom/0000-0001-9797-2188; Car, Josip/0000-0001-8969-371X; wang, wei/0000-0002-1430-1360; Middleton, Lefkos/0000-0002-8615-3723; Chan, Kit Yee/0000-0002-3465-8383	Nossal Institute of Global Health (University of Melbourne, Australia); National 12th Five-Year Major Projects of China; National Health and Medical Research Council Australia-China Exchange Fellowship; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions; Bill & Melinda Gates Foundation; Medical Research Council [MR/K026992/1, G0700704] Funding Source: researchfish; MRC [G0700704] Funding Source: UKRI	Nossal Institute of Global Health (University of Melbourne, Australia); National 12th Five-Year Major Projects of China; National Health and Medical Research Council Australia-China Exchange Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding Nossal Institute of Global Health (University of Melbourne, Australia), the National 12th Five-Year Major Projects of China, National Health and Medical Research Council Australia-China Exchange Fellowship, Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions, and the Bill & Melinda Gates Foundation.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; ADI, 2010, WORLD ALZHEIMER REPO; ADI - Alzheimer's Disease International, 2011, WORLD ALZHEIMER REPO; Allotey P, 2011, LANCET, V377, P450, DOI 10.1016/S0140-6736(10)61856-9; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; *ALZH ASS, 2010, ALZHEIMERS DEMENT, V6, P158, DOI DOI 10.1016/J.JALZ.2010.01.009; Alzheimer's Disease International (ADI), 2009, WORLD ALZHEIMER REPO; Ballard C., 2005, DEMENTIA, P24; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Beaglehole R, 2010, LANCET, V376, P1619, DOI 10.1016/S0140-6736(10)61929-0; Campbell H, 2008, CROAT MED J, V49, P402, DOI 10.3325/cmj.2008.3.402; Chan Kit Yee, 2011, J Glob Health, V1, P28; Chen Z, 2010, AGEING RES REV, V9, pS2, DOI 10.1016/j.arr.2010.07.001; China Ministry of Agriculture, 2008, CHIN HUM DEV REP 200, P1; Dong MJ, 2007, AGE AGEING, V36, P619, DOI 10.1093/ageing/afm128; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fratiglioni L, 1999, DRUG AGING, V15, P365, DOI 10.2165/00002512-199915050-00004; Fung ICH, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-20; George-Carey R, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.02.020401; Hipgrave David, 2011, J Glob Health, V1, P142; Ineichen B, 2000, SOC SCI MED, V50, P1673, DOI 10.1016/S0277-9536(99)00392-5; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Ochayi B, 2006, AGING MENT HEALTH, V10, P616, DOI 10.1080/13607860600736182; Paraiso MN, 2011, NEUROEPIDEMIOLOGY, V36, P245, DOI 10.1159/000328255; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Prince M, 2012, LANCET, V380, P50, DOI 10.1016/S0140-6736(12)60399-7; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Russ TC, 2012, INT J EPIDEMIOL, V41, P1012, DOI 10.1093/ije/dys103; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Song YT, 2010, AGEING RES REV, V9, pS6, DOI 10.1016/j.arr.2010.08.007; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; United Nations, 2011, WORLD POPULATION PRO; WHO, 2011, GLOBAL STATUS REPORT; World Health Organisation, 2012, DEMENTIA A PUBLIC HE; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Xia J, 2008, HEALTH INFO LIBR J, V25, P55, DOI 10.1111/j.1471-1842.2007.00734.x; Xu QW, 2011, INT SOC WORK, V54, P374, DOI 10.1177/0020872810396260; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Zhan Heying J, 2006, J Aging Soc Policy, V18, P85, DOI 10.1300/J031v18n02_06	48	478	579	13	276	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 8	2013	381	9882					2016	2023		10.1016/S0140-6736(13)60221-4	http://dx.doi.org/10.1016/S0140-6736(13)60221-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171JY	23746902				2022-12-28	WOS:000320924400030
J	Saintenac, C; Zhang, WJ; Salcedo, A; Rouse, MN; Trick, HN; Akhunov, E; Dubcovsky, J				Saintenac, Cyrille; Zhang, Wenjun; Salcedo, Andres; Rouse, Matthew N.; Trick, Harold N.; Akhunov, Eduard; Dubcovsky, Jorge			Identification of Wheat Gene Sr35 That Confers Resistance to Ug99 Stem Rust Race Group	SCIENCE			English	Article							POLYPLOID WHEAT; GENOME; TRANSCRIPTS; CC	Wheat stem rust, caused by Puccinia graminis f. sp. tritici (Pgt), is a devastating disease that can cause severe yield losses. A previously uncharacterized Pgt race, designated Ug99, has overcome most of the widely used resistance genes and is threatening major wheat production areas. Here, we demonstrate that the Sr35 gene from Triticum monococcum is a coiled-coil, nucleotide-binding, leucine-rich repeat gene that confers near immunity to Ug99 and related races. This gene is absent in the A-genome diploid donor and in polyploid wheat but is effective when transferred from T. monococcum to polyploid wheat. The cloning of Sr35 opens the door to the use of biotechnological approaches to control this devastating disease and to analyses of the molecular interactions that define the wheat-rust pathosystem.	[Saintenac, Cyrille; Salcedo, Andres; Trick, Harold N.; Akhunov, Eduard] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Zhang, Wenjun; Dubcovsky, Jorge] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Rouse, Matthew N.] ARS, Cereal Dis Lab, USDA, St Paul, MN 55108 USA; [Dubcovsky, Jorge] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Kansas State University; University of California System; University of California Davis; United States Department of Agriculture (USDA); Howard Hughes Medical Institute	Akhunov, E (corresponding author), Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA.	eakhunov@ksu.edu; jdubcovsky@ucdavis.edu	Dubcovsky, Jorge/A-4969-2008; Rouse, Matthew N/G-5474-2011; Dubcovsky, Jorge/T-5214-2019	Dubcovsky, Jorge/0000-0002-7571-4345; Akhunov, Eduard/0000-0002-0416-5211; Trick, Harold/0000-0001-5255-5575	Agricultural and Food Research Initiative from the USDA National Institute of Food and Agriculture [2011-68002-30029, 2012-67013-19401]; Borlaug Global Rust Initiative; HHMI; Gordon and Betty Moore Foundation [GBMF3031]	Agricultural and Food Research Initiative from the USDA National Institute of Food and Agriculture; Borlaug Global Rust Initiative; HHMI(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This project was supported by Agricultural and Food Research Initiative grants 2011-68002-30029 (Triticeae-CAP) and 2012-67013-19401 from the USDA National Institute of Food and Agriculture, by the Borlaug Global Rust Initiative, and by support to J.D. from the HHMI and the Gordon and Betty Moore Foundation grant GBMF3031. We thank J. Nirmala, S. Sehgal, M. Padilla, S. Chao, K. Jordan, H. Lee, and D. Burdan for excellent technical support; B. Bowden and J. Dvorak for providing critical materials; K. Krasileva, A. Akhunova, and C. Li for valuable suggestions; and the University of California, Davis, and Kansas State University Genomic facilities. We also thank M. Pumphrey for his collaboration in the initial stages of the project, including design and initial development of the high-resolution mapping and TILLING populations. Sequences have been deposited in GenBank under accession numbers KC573058, KC816724, KF113354 to KF113357, and KC876115 to KC876121. Author contributions are listed in the supplementary materials.	Costanzo S, 2009, PLANT SCI, V177, P468, DOI 10.1016/j.plantsci.2009.07.012; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; DVORAK J, 1988, GENOME, V30, P680, DOI 10.1139/g88-115; Ferrier-Cana E, 2005, THEOR APPL GENET, V110, P895, DOI 10.1007/s00122-004-1908-1; Gassmann W, 2008, CURR TOP MICROBIOL, V326, P219; Halterman DA, 2006, MOL PLANT PATHOL, V7, P167, DOI [10.1111/j.1364-3703.2006.00329.x, 10.1111/J.1364-3703.2006.00329.X]; Halterman DA, 2003, PLANT PHYSIOL, V131, P558, DOI 10.1104/pp.014407; Huerta-Espino J., 1992, THESIS U MINNESOTA S; Lijavetzky D, 1999, GENOME, V42, P1176, DOI 10.1139/gen-42-6-1176; Loutre C, 2009, PLANT J, V60, P1043, DOI 10.1111/j.1365-313X.2009.04024.x; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; MCINTOSH RA, 1984, Z PFLANZENZUCHT, V92, P1; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; Pretorius ZA, 2000, PLANT DIS, V84, P924, DOI 10.1094/PDIS.2000.84.8.924A; Rouse MN, 2011, PLANT DIS, V95, P941, DOI 10.1094/PDIS-04-10-0260; Rouse MN, 2011, CROP SCI, V51, P2074, DOI 10.2135/cropsci2010.12.0719; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Sela H, 2012, MOL PLANT PATHOL, V13, P276, DOI 10.1111/j.1364-3703.2011.00744.x; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; Zhang WJ, 2010, CROP SCI, V50, P2464, DOI 10.2135/cropsci2010.04.0202	23	196	206	11	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					783	786		10.1126/science.1239022	http://dx.doi.org/10.1126/science.1239022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23811222	Green Accepted			2022-12-28	WOS:000323122200047
J	Kumar, R; DiMenna, L; Schrode, N; Liu, TC; Franck, P; Munoz-Descalzo, S; Hadjantonakis, AK; Zarrin, AA; Chaudhuri, J; Elemento, O; Evans, T				Kumar, Ritu; DiMenna, Lauren; Schrode, Nadine; Liu, Ting-Chun; Franck, Philipp; Munoz-Descalzo, Silvia; Hadjantonakis, Anna-Katerina; Zarrin, Ali A.; Chaudhuri, Jayanta; Elemento, Olivier; Evans, Todd			AID stabilizes stem-cell phenotype by removing epigenetic memory of pluripotency genes	NATURE			English	Article							INDUCED CYTIDINE DEAMINASE; DNA METHYLATION; EXPRESSION	The activation-induced cytidine deaminase (AID; also known as AICDA) enzyme is required for somatic hypermutation and class switch recombination at the immunoglobulin locus(1). In germinal-centre B cells, AID is highly expressed, and has an inherent mutator activity that helps generate antibody diversity(2). However, AID may also regulate gene expression epigenetically by directly deaminating 5-methylcytosine in concert with base-excision repair to exchange cytosine(3). This pathway promotes gene demethylation, thereby removing epigenetic memory. For example, AID promotes active demethylation of the genome in primordial germ cells(4). However, different studies have suggested either a requirement(5) or a lack of function(6) for AID in promoting pluripotency in somatic nuclei after fusion with embryonic stem cells. Here we tested directly whether AID regulates epigenetic memory by comparing the relative ability of cells lacking AID to reprogram from a differentiated murine cell type to an induced pluripotent stem cell. We show that Aid-null cells are transiently hyper-responsive to the reprogramming process. Although they initiate expression of pluripotency genes, they fail to stabilize in the pluripotent state. The genome of Aid-null cells remains hypermethylated in reprogramming cells, and hypermethylated genes associated with pluripotency fail to be stably upregulated, including many MYC target genes. Recent studies identified a late step of reprogramming associated with methylation status(7), and implicated a secondary set of pluripotency network components(8). AID regulates this late step, removing epigenetic memory to stabilize the pluripotent state.	[Kumar, Ritu; Liu, Ting-Chun; Franck, Philipp; Evans, Todd] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [DiMenna, Lauren; Chaudhuri, Jayanta] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA; [Schrode, Nadine; Munoz-Descalzo, Silvia; Hadjantonakis, Anna-Katerina] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Zarrin, Ali A.] Genentech Inc, San Francisco, CA 94080 USA; [Elemento, Olivier] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10065 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech; Cornell University	Evans, T (corresponding author), Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA.	tre2003@med.cornell.edu	Munoz-Descalzo, Silvia/A-3433-2011; Munoz-Descalzo, Silvia/M-8094-2013	Munoz-Descalzo, Silvia/0000-0003-0939-7721; Munoz-Descalzo, Silvia/0000-0003-0939-7721; Schrode, Nadine/0000-0001-5315-6816; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124	National Institutes of Health [HL056182, AI072194]; National Science Foundation CAREER [1054964]; Div Of Biological Infrastructure [1054964] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052115] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056182, R37HL056182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007621, R01AI072194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Mostoslavsky for the gift of reprogramming vectors. A. Melnick provided advice and consultation. We are grateful to T. Honjo for AID-knockout mice, and N. Papavasiliou for assistance in designing genotyping PCR primers. The Epigenomics Core Facility of Weill Cornell Medical College carried out the bisulphite sequencing and provided consultation. This study was supported by National Institutes of Health grant HL056182 (T.E.), AI072194 (J.C.) and National Science Foundation CAREER grant 1054964 (O.E.).	Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Bhutani N, 2013, FASEB J, V27, P1107, DOI 10.1096/fj.12-222125; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Foshay KM, 2012, MOL CELL, V46, P159, DOI 10.1016/j.molcel.2012.02.013; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Joyner AL, 2000, GENE TARGETING PRACT; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagy A., 2003, MANIPULATING MOUSE E; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sun YL, 2013, AUTOIMMUNITY, V46, P157, DOI 10.3109/08916934.2012.750301; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708	28	72	75	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					89	U114		10.1038/nature12299	http://dx.doi.org/10.1038/nature12299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23803762	Green Accepted			2022-12-28	WOS:000322514800034
J	Takeo, M; Chou, WC; Sun, Q; Lee, W; Rabbani, P; Loomis, C; Taketo, MM; Ito, M				Takeo, Makoto; Chou, Wei Chin; Sun, Qi; Lee, Wendy; Rabbani, Piul; Loomis, Cynthia; Taketo, M. Mark; Ito, Mayumi			Wnt activation in nail epithelium couples nail growth to digit regeneration	NATURE			English	Article							HAIR FOLLICLE; MOUSE; CELLS; MICE; AMPUTATION; MUTATION; TIP	The tips of mammalian digits can regenerate after amputation(1,2), like those of amphibians. It is unknown why this capacity is limited to the area associated with the nail(2-4). Here we show that nail stem cells (NSCs) reside in the proximal nail matrix and that the mechanisms governing NSC differentiation are coupled directly with their ability to orchestrate digit regeneration. Early nail progenitors undergo Wnt-dependent differentiation into the nail. After amputation, this Wnt activation is required for nail regeneration and also for attracting nerves that promote mesenchymal blastema growth, leading to the regeneration of the digit. Amputations proximal to the Wnt-active nail progenitors result in failure to regenerate the nail or digit. Nevertheless, beta-catenin stabilization in the NSC region induced their regeneration. These results establish a link between NSC differentiation and digit regeneration, and suggest that NSCs may have the potential to contribute to the development of novel treatments for amputees.	[Takeo, Makoto; Chou, Wei Chin; Sun, Qi; Lee, Wendy; Rabbani, Piul; Loomis, Cynthia; Ito, Mayumi] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA; [Takeo, Makoto; Chou, Wei Chin; Sun, Qi; Lee, Wendy; Rabbani, Piul; Loomis, Cynthia; Ito, Mayumi] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Taketo, M. Mark] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	New York University; New York University; Kyoto University	Ito, M (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA.	Mayumi.Ito@nyumc.org		Sun, Qi/0000-0002-0495-1407; Takeo, Makoto/0000-0002-5597-5994; Rabbani, Piul/0000-0001-8302-8225; Lee, Wendy/0000-0002-8807-0550	Genome Technology Center at NYU (National Institutes of Health (NIH)) [5P30CA0016087-32, P30 CA016087-30]; NYU Kimmel Stem Cell Center; NYSTEM [C026880]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [1R01AR059768-01A1]; Ellison Medical Foundation; Department of Dermatology and Cell Biology; Helen and Martin Kimmel Center for Stem Cell Biology, at NYU; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059768] Funding Source: NIH RePORTER	Genome Technology Center at NYU (National Institutes of Health (NIH)); NYU Kimmel Stem Cell Center; NYSTEM; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Ellison Medical Foundation(Lawrence Ellison Foundation); Department of Dermatology and Cell Biology; Helen and Martin Kimmel Center for Stem Cell Biology, at NYU; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank T. Andl, T. Endo, L. Miller, P. Myung, M. Schober and T. T. Sun for invaluable suggestions and discussion. We thank T. Endo for demonstrating the method of bead implantation. We thank T. T. Sun for the AE13 antibody, K. Muneoka for the Bmp4 plasmid, and A. Mansukhani for 3T3 cells. We thank the Genome Technology Center at NYU (National Institutes of Health (NIH) grant 5P30CA0016087-32 and P30 CA016087-30), and the Center for Functional Genomics at University at Albany for carrying out microarray analyses. We thank F. Liang at the NYU Microscopy Core for transmission electron microscopy (TEM) analysis. We thank the NYU Microscopy Core for the use of a confocal microscope (NCRRS10 RR023704-01A1). M. T. is supported by the NYU Kimmel Stem Cell Center and NYSTEM training grant C026880. M. I. is supported by NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant 1R01AR059768-01A1, the Ellison Medical Foundation and funding from the Department of Dermatology and Cell Biology, and the Helen and Martin Kimmel Center for Stem Cell Biology, at NYU.	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Al-Qattan MM, 2011, J HAND SURG-EUR VOL, V36E, P9, DOI 10.1177/1753193410380502; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; BROCKES JP, 1987, J EXP BIOL, V132, P79; DasGupta R, 1999, DEVELOPMENT, V126, P4557; DOUGLAS BS, 1972, AUST PAEDIATR J, V8, P86; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fleckman P, 2013, ANAT REC, V296, P521, DOI 10.1002/ar.22660; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Lin MH, 2003, DEV BIOL, V263, P343, DOI 10.1016/j.ydbio.2003.07.007; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; Mohammad KS, 2000, WOUND REPAIR REGEN, V8, P277, DOI 10.1046/j.1524-475x.2000.00277.x; Mohammad KS, 1999, CALCIFIED TISSUE INT, V65, P408, DOI 10.1007/s002239900722; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Myung P. S., 2013, J INVEST DERMATOL; Nakamura M, 2008, J INVEST DERMATOL, V128, P728, DOI 10.1038/sj.jid.5701062; NEUFELD DA, 1993, PROG CLIN BIOL RES, V383, P243; NEUFELD DA, 1980, J EXP ZOOL, V212, P31, DOI 10.1002/jez.1402120105; NORTON LA, 1971, J INVEST DERMATOL, V56, P61, DOI 10.1111/1523-1747.ep12291905; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Yokoyama H, 2007, DEV BIOL, V306, P170, DOI 10.1016/j.ydbio.2007.03.014; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459; ZHAO WG, 1995, J EXP ZOOL, V271, P155, DOI 10.1002/jez.1402710212; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	38	152	158	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					228	+		10.1038/nature12214	http://dx.doi.org/10.1038/nature12214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23760480	Green Accepted			2022-12-28	WOS:000321557600066
J	Pulk, A; Cate, JHD				Pulk, Arto; Cate, Jamie H. D.			Control of Ribosomal Subunit Rotation by Elongation Factor G	SCIENCE			English	Article							MESSENGER-RNA TRANSLOCATION; EF-G; GTP HYDROLYSIS; CONFORMATIONAL-CHANGES; INTERSUBUNIT ROTATION; INTERMEDIATE STATES; PROTEIN-SYNTHESIS; KINETIC-ANALYSIS; SWITCH-I; MOVEMENT	Protein synthesis by the ribosome requires the translocation of transfer RNAs and messenger RNA by one codon after each peptide bond is formed, a reaction that requires ribosomal subunit rotation and is catalyzed by the guanosine triphosphatase (GTPase) elongation factor G (EF-G). We determined 3 angstrom resolution x-ray crystal structures of EF-G complexed with a nonhydrolyzable guanosine 5'-triphosphate (GTP) analog and bound to the Escherichia coli ribosome in different states of ribosomal subunit rotation. The structures reveal that EF-G binding to the ribosome stabilizes switch regions in the GTPase active site, resulting in a compact EF-G conformation that favors an intermediate state of ribosomal subunit rotation. These structures suggest that EF-G controls the translocation reaction by cycles of conformational rigidity and relaxation before and after GTP hydrolysis.	[Pulk, Arto; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, 229 Stanley Hall, Berkeley, CA 94720 USA.	jcate@lbl.gov	Classen, Scott/AAY-8176-2020	Pulk, Arto/0000-0001-8793-3038	NIH [R01-GM65050]; NIH project MINOS [R01GM105404]; U.S. Department of Energy [DEAC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404, R01GM065050] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH project MINOS; U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Doudna for helpful discussions and comments, J. Holton and G. Meigs for help with x-ray data collection, and P. Afonine and J. Headd for advice on crystallographic refinement. This work was supported by NIH grant R01-GM65050 to J. H. D. C., by the NIH project MINOS grant R01GM105404 for the Structural Integrated Biology for Life Sciences (SIBYLS) and 8.3.1 beam lines at the Advanced Light Source (ALS), and by the U.S. Department of Energy (DEAC02-05CH11231 for the SIBYLS and 8.3.1 beam-lines at the ALS). Coordinates for the ribosomes have been deposited in the Protein Data Bank (PDB): 4KIX, 4KIY, 4KIZ, 4KJ0, 4KJ1, 4KJ2, 4KJ3, 4KJ4, 4KJ5, 4KJ6, 4KJ7, 4KJ8, 4KJ9, 4KJA, 4KJB, and 4KJC.	Agirrezabala X, 2012, P NATL ACAD SCI USA, V109, P6094, DOI 10.1073/pnas.1201288109; Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Bartish G, 2008, BIOCHIMIE, V90, P736, DOI 10.1016/j.biochi.2008.01.006; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; Chen CL, 2011, MOL CELL, V42, P367, DOI 10.1016/j.molcel.2011.03.024; Clementi N, 2010, RNA BIOL, V7, P521, DOI 10.4161/rna.7.5.12467; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Ermolenko DN, 2007, J MOL BIOL, V370, P530, DOI 10.1016/j.jmb.2007.04.042; Ermolenko DN, 2011, NAT STRUCT MOL BIOL, V18, P457, DOI 10.1038/nsmb.2011; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fei JY, 2011, NAT STRUCT MOL BIOL, V18, P1043, DOI 10.1038/nsmb.2098; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gabashvili IS, 1999, J MOL BIOL, V286, P1285, DOI 10.1006/jmbi.1999.2538; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; GAVRILOV.LP, 1971, FEBS LETT, V17, P324, DOI 10.1016/0014-5793(71)80177-1; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kjeldgaard M, 1996, FASEB J, V10, P1347, DOI 10.1096/fasebj.10.12.8903506; Kolesnikov A, 2002, FEBS LETT, V514, P67, DOI 10.1016/S0014-5793(02)02300-1; Konevega AL, 2007, NAT STRUCT MOL BIOL, V14, P318, DOI 10.1038/nsmb1221; Liang H, 2008, BEILSTEIN J ORG CHEM, V4, DOI 10.3762/bjoc.4.31; Margus T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022789; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Mohr D, 2000, EMBO J, V19, P3458, DOI 10.1093/emboj/19.13.3458; Munro JB, 2010, NAT STRUCT MOL BIOL, V17, P1470, DOI 10.1038/nsmb.1925; Munro JB, 2010, EMBO J, V29, P770, DOI 10.1038/emboj.2009.384; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Peske F, 2004, J MOL BIOL, V343, P1183, DOI 10.1016/j.jmb.2004.08.097; PESTKA S, 1969, J BIOL CHEM, V244, P1533; Petrov A, 2011, CURR OPIN STRUC BIOL, V21, P137, DOI 10.1016/j.sbi.2010.11.007; Ramrath DJF, 2012, NATURE, V485, P526, DOI 10.1038/nature11006; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; ROHRBACH MS, 1976, BIOCHEMISTRY-US, V15, P4565, DOI 10.1021/bi00666a003; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Shoji S, 2006, MOL CELL, V24, P931, DOI 10.1016/j.molcel.2006.11.025; Sohmen D, 2009, CELL, V139, DOI 10.1016/j.cell.2009.08.009; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Ticu C, 2011, J BIOL CHEM, V286, P21697, DOI 10.1074/jbc.M110.214056; Ticu C, 2009, EMBO J, V28, P2053, DOI 10.1038/emboj.2009.169; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Walker SE, 2008, P NATL ACAD SCI USA, V105, P9192, DOI 10.1073/pnas.0710146105; Wang LY, 2011, RNA, V17, P2189, DOI 10.1261/rna.029033.111; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	56	128	130	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1544	+	1235970	10.1126/science.1235970	http://dx.doi.org/10.1126/science.1235970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812721	Green Accepted			2022-12-28	WOS:000321007000033
J	Colbert, JA; Adler, JN				Colbert, James A.; Adler, Jonathan N.			Family Presence during Cardiopulmonary Resuscitation - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Henderson DP, 2005, PEDIATR EMERG CARE, V21, P787, DOI 10.1097/01.pec.0000188877.41095.5a; Jabre P, 2013, NEW ENGL J MED, V368, P1008, DOI 10.1056/NEJMoa1203366	3	19	20	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					E38	+		10.1056/NEJMclde1307088	http://dx.doi.org/10.1056/NEJMclde1307088			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KQ	23802541				2022-12-28	WOS:000320926900002
J	Conrad, CP; Steinberger, B; Torsvik, TH				Conrad, Clinton P.; Steinberger, Bernhard; Torsvik, Trond H.			Stability of active mantle upwelling revealed by net characteristics of plate tectonics	NATURE			English	Article							TRUE POLAR WANDER; EARTHS MANTLE; DEEP MANTLE; SLAB PULL; DYNAMICS; VELOCITY; MOTIONS; TOMOGRAPHY; CONVECTION; ROTATION	Viscous convection within the mantle is linked to tectonic plate motions(1-3) and deforms Earth's surface across wide areas(4-6). Such close links between surface geology and deep mantle dynamics presumably operated throughout Earth's history, but are difficult to investigate for past times because the history of mantle flow is poorly known(7). Here we show that the time dependence of global-scale mantle flow can be deduced from the net behaviour of surface plate motions. In particular, we tracked the geographic locations of net convergence and divergence for harmonic degrees 1 and 2 by computing the dipole and quadrupole moments of plate motions from tectonic reconstructions(8,9) extended back to the early Mesozoic era. For present-day plate motions, we find dipole convergence in eastern Asia and quadrupole divergence in both central Africa and the central Pacific. These orientations are nearly identical to the dipole and quadrupole orientations of underlying mantle flow, which indicates that these 'net characteristics' of plate motions reveal deeper flow patterns. The positions of quadrupole divergence have not moved significantly during the past 250 million years, which suggests long-term stability of mantle upwelling beneath Africa and the Pacific Ocean. These upwelling locations are positioned above two compositionally and seismologically distinct(10) regions of the lowermost mantle, which may organize global mantle flow(11) as they remain stationary over geologic time(12).	[Conrad, Clinton P.] Univ Hawaii Manoa, SOEST, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Steinberger, Bernhard] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam, D-14473 Potsdam, Germany; [Steinberger, Bernhard; Torsvik, Trond H.] Univ Oslo, CEED, N-0316 Oslo, Norway; [Torsvik, Trond H.] Geol Survey Norway, NO-7491 Trondheim, Norway; [Torsvik, Trond H.] Univ Witwatersrand, Sch Geosci, ZA-2050 Johannesburg, South Africa	University of Hawaii System; University of Hawaii Manoa; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Oslo; Geological Survey of Norway; University of Witwatersrand	Conrad, CP (corresponding author), Univ Hawaii Manoa, SOEST, Dept Geol & Geophys, Honolulu, HI 96822 USA.	clintc@hawaii.edu	Conrad, Clinton/ABG-4901-2020; Steinberger, Bernhard/ABB-9204-2021; Steinberger, Bernhard/AAG-7148-2019	Steinberger, Bernhard/0000-0002-3643-3049; Conrad, Clinton/0000-0003-4314-2351	NSF [EAR-1151241]; ERC [267631]; Directorate For Geosciences [1151241] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ERC(European Research Council (ERC)European Commission); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We are grateful for NSF CAREER grant EAR-1151241 (to C. P. C.) and ERC grant 267631 (to T. H. T.), and to the Norwegian Centre for Advanced Study in Oslo for making this collaboration possible.	Becker TW, 2011, EARTH PLANET SC LETT, V310, P453, DOI 10.1016/j.epsl.2011.08.021; Bower DJ, 2013, GEOCHEM GEOPHY GEOSY, V14, P44, DOI 10.1029/2012GC004267; Collins WJ, 2003, EARTH PLANET SC LETT, V205, P225, DOI 10.1016/S0012-821X(02)01043-9; Conrad CP, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002970; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; Deschamps F, 2003, PHYS EARTH PLANET IN, V140, P277, DOI 10.1016/j.pepi.2003.09.004; Dziewonski AM, 2010, EARTH PLANET SC LETT, V299, P69, DOI 10.1016/j.epsl.2010.08.013; Flowers RM, 2012, EARTH PLANET SC LETT, V317, P436, DOI 10.1016/j.epsl.2011.11.015; Garnero EJ, 2008, SCIENCE, V320, P626, DOI 10.1126/science.1148028; Ishii M, 1999, SCIENCE, V285, P1231, DOI 10.1126/science.285.5431.1231; Kennett BLN, 1998, J GEOPHYS RES-SOL EA, V103, P12469, DOI 10.1029/98JB00150; Lassak TM, 2010, EARTH PLANET SC LETT, V289, P232, DOI 10.1016/j.epsl.2009.11.012; Li ZX, 2009, PHYS EARTH PLANET IN, V176, P143, DOI 10.1016/j.pepi.2009.05.004; Lithgow-Bertelloni C, 1998, NATURE, V395, P269, DOI 10.1038/26212; Lithgow-Bertelloni C, 1998, REV GEOPHYS, V36, P27, DOI 10.1029/97RG02282; Liu LJ, 2008, SCIENCE, V322, P934, DOI 10.1126/science.1162921; McNamara AK, 2010, EARTH PLANET SC LETT, V299, P1, DOI 10.1016/j.epsl.2010.07.042; Naliboff JB, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040484; Ritsema J, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002610; Seton M, 2012, EARTH-SCI REV, V113, P212, DOI 10.1016/j.earscirev.2012.03.002; Stadler G, 2010, SCIENCE, V329, P1033, DOI 10.1126/science.1191223; Steinberger B, 1997, NATURE, V387, P169, DOI 10.1038/387169a0; Steinberger B, 2008, NATURE, V452, P620, DOI 10.1038/nature06824; Torsvik TH, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000227; Torsvik TH, 2010, EARTH PLANET SC LETT, V291, P106, DOI 10.1016/j.epsl.2009.12.055; Torsvik TH, 2006, GEOPHYS J INT, V167, P1447, DOI 10.1111/j.1365-246X.2006.03158.x; van Summeren J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003873; Wu BJ, 2008, EARTH PLANET SC LETT, V272, P412, DOI 10.1016/j.epsl.2008.05.009; Zhang N, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006896; Zhong SJ, 2007, EARTH PLANET SC LETT, V261, P551, DOI 10.1016/j.epsl.2007.07.049	30	55	60	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					479	482		10.1038/nature12203	http://dx.doi.org/10.1038/nature12203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803848	Green Submitted			2022-12-28	WOS:000320929400051
J	Franklin, AD				Franklin, Aaron D.			ELECTRONICS The road to carbon nanotube transistors	NATURE			English	Editorial Material									IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Franklin, AD (corresponding author), IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA.	aaronf@us.ibm.com		Franklin, Aaron/0000-0002-1128-9327				Ding L, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4731776; Franklin AD, 2012, NANO LETT, V12, P758, DOI 10.1021/nl203701g; Hannon JB, 2005, LANGMUIR, V21, P8569, DOI 10.1021/la050799y; Jin SH, 2013, NAT NANOTECHNOL, V8, P347, DOI [10.1038/NNANO.2013.56, 10.1038/nnano.2013.56]; Liu J, 2010, MRS BULL, V35, P315, DOI 10.1557/mrs2010.554; Park H, 2012, NAT NANOTECHNOL, V7, P787, DOI [10.1038/nnano.2012.189, 10.1038/NNANO.2012.189]; Service RF, 2009, SCIENCE, V323, P1000, DOI 10.1126/science.323.5917.1000; Wang CA, 2010, NANO RES, V3, P831, DOI 10.1007/s12274-010-0054-0	8	244	252	9	294	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					443	444		10.1038/498443a	http://dx.doi.org/10.1038/498443a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803839				2022-12-28	WOS:000320929400040
J	Kumagai, A; Ando, R; Miyatake, H; Greimel, P; Kobayashi, T; Hirabayashi, Y; Shimogori, T; Miyawaki, A				Kumagai, Akiko; Ando, Ryoko; Miyatake, Hideyuki; Greimel, Peter; Kobayashi, Toshihide; Hirabayashi, Yoshio; Shimogori, Tomomi; Miyawaki, Atsushi			A Bilirubin-Inducible Fluorescent Protein from Eel Muscle	CELL			English	Article							HUMAN SERUM-ALBUMIN; ACID-BINDING PROTEINS; PHYTOCHROME; RED; ANTIOXIDANT; EXPRESSION; INSIGHTS	The fluorescent protein toolbox has revolutionized experimental biology. Despite this advance, no fluorescent proteins have been identified from vertebrates, nor has chromogenic ligand-inducible activation or clinical utility been demonstrated. Here, we report the cloning and characterization of UnaG, a fluorescent protein from Japanese eel. UnaG belongs to the fatty-acid-binding protein (FABP) family, and expression in eel is restricted to small-diameter muscle fibers. On heterologous expression in cell lines or mouse brain, UnaG produces oxygen-independent green fluorescence. Remarkably, UnaG fluorescence is triggered by an endogenous ligand, bilirubin, a membrane-permeable heme metabolite and clinical health biomarker. The holoUnaG structure at 1.2 angstrom revealed a biplanar coordination of bilirubin by reversible p-conjugation, and we used this high-affinity and high-specificity interaction to establish a fluorescence-based human bilirubin assay with promising clinical utility. UnaG will be the prototype for a versatile class of ligand-activated fluorescent proteins, with applications in research, medicine, and bioengineering.	[Kumagai, Akiko; Ando, Ryoko; Hirabayashi, Yoshio; Shimogori, Tomomi; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Miyatake, Hideyuki] RIKEN, Global Res Cluster Collaborat Promot Unit, Wako, Saitama 3510198, Japan; [Greimel, Peter; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Kumagai, Akiko; Miyawaki, Atsushi] JST, ERATO, Wako, Saitama 3510198, Japan	RIKEN; RIKEN; RIKEN; Japan Science & Technology Agency (JST)	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.jp	hideyuki, miyatake/S-4993-2019; Kobayashi, Toshihide/B-6298-2015; KOBAYASHI, TOSHIHIDE/S-8313-2019; Miyawaki, Atsushi/K-3569-2014; Shimogori, Tomomi/L-2893-2013	hideyuki, miyatake/0000-0001-8872-9784; Kobayashi, Toshihide/0000-0002-4811-7270; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Miyawaki, Atsushi/0000-0002-2329-3235; Shimogori, Tomomi/0000-0002-6931-5401; Hirabayashi, Yoshio/0000-0002-5774-7354; Greimel, Peter/0000-0002-4931-6183	Japan MEXT; Human Frontier Science Program	Japan MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program)	We thank Dr. S. Hayashi, Dr. O. Nureki, H. Kato, and S. Karasawa for valuable advice; Y. Ide, H. Iizuka, K. Nagai, H. Sakurai, and Unagi-no-Miyagawa (Wako) for help with acquiring eels; Dr. A. Kikuchi, Dr. N. Domae, H. Takagi, H. Shima, M. Sonoda, H. Watanabe, E. Oshima, and K. Tanaka for assistance; and Dr. D. Mou, Dr. A. Terashima, and Dr. C. Yokoyama for valuable advice and critical reading of the manuscript. This work was partly supported by grants from Japan MEXT Grant-in-Aid for Scientific Research on Priority Areas and the Human Frontier Science Program. A. K. and A. M. conceived and designed the study. A. K. performed all of the experiments and analyzed the data. R. A. performed the molecular cloning and histological experiments. H. M. supervised the crystallographic experiments. P. G. and T. K. contributed to the ligand identification. Y. H. contributed to the experiments using human serum. T. S. performed the in utero electroporation experiment. A. M. analyzed the data, designed and wrote the manuscript, and supervised the project.	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; ARIAS IM, 1980, MOL CELL BIOCHEM, V29, P71; Athar H, 1999, INT J BIOL MACROMOL, V25, P353, DOI 10.1016/S0141-8130(99)00056-2; Auldridge ME, 2012, J BIOL CHEM, V287, P7000, DOI 10.1074/jbc.M111.295121; Balendiran GK, 2000, J BIOL CHEM, V275, P27045; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Fukui M, 2008, KIDNEY INT, V74, P1197, DOI 10.1038/ki.2008.398; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Hayashi S, 2009, FISHERIES SCI, V75, P1461, DOI 10.1007/s12562-009-0176-z; Huber AH, 2012, CLIN CHEM, V58, P869, DOI 10.1373/clinchem.2011.176412; Inoue JG, 2010, BIOL LETTERS, V6, P363, DOI 10.1098/rsbl.2009.0989; Kapitulnik J, 2004, MOL PHARMACOL, V66, P773, DOI 10.1124/mol.104.002832; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Lo SF, 2011, SEMIN PERINATOL, V35, P141, DOI 10.1053/j.semperi.2011.02.008; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; Miyawaki A, 2012, CURR OPIN STRUC BIOL, V22, P679, DOI 10.1016/j.sbi.2012.09.002; Petersen CE, 2000, J BIOL CHEM, V275, P20985, DOI 10.1074/jbc.M001038200; Piatkevich KD, 2013, CHEM SOC REV, V42, P3441, DOI 10.1039/c3cs35458j; Qu H, 2007, MOL CELL BIOCHEM, V299, P45, DOI 10.1007/s11010-005-9036-z; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; ROWLERSON A, 1985, J MUSCLE RES CELL M, V6, P601, DOI 10.1007/BF00711917; Sadhu KK, 2011, CHEMBIOCHEM, V12, P1299, DOI 10.1002/cbic.201100137; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Weisiger RA, 2001, J BIOL CHEM, V276, P29953, DOI 10.1074/jbc.M104628200; Wennberg RP, 2006, PEDIATRICS, V117, P474, DOI 10.1542/peds.2005-0395; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016	37	189	197	3	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1602	1611		10.1016/j.cell.2013.05.038	http://dx.doi.org/10.1016/j.cell.2013.05.038			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23768684	Bronze			2022-12-28	WOS:000320722000026
J	Hamerman, D				Hamerman, David			The Things That Matter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FRAILTY		Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, Int Longev Ctr, New York, NY 10027 USA	Columbia University	Hamerman, D (corresponding author), Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, Int Longev Ctr, New York, NY 10027 USA.	hamermandj@aol.com						Gill TM, 2006, ARCH INTERN MED, V166, P418, DOI 10.1001/.418; Hamerman D, 1999, ANN INTERN MED, V130, P945, DOI 10.7326/0003-4819-130-11-199906010-00022; Hamerman D, 2002, J GERONTOL A-BIOL, V57, pM511, DOI 10.1093/gerona/57.8.M511; Hamerman D., 2007, GERIATRIC BIOSCIENCE, P132; Hamerman D, 2010, J AM GERIATR SOC, V58, P2024, DOI 10.1111/j.1532-5415.2010.03067.x; Mendelson E., 2007, THINGS MATTER WHAT 7	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2447	2448		10.1001/jama.2013.6936	http://dx.doi.org/10.1001/jama.2013.6936			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	165SW	23780456				2022-12-28	WOS:000320505100024
J	Spence, D				Spence, Des			End the scandal of free medical education	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Iacobucci G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2201; Univadis, UNIVADIS PARTNERS WI	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2013	346								f3936	10.1136/bmj.f3936	http://dx.doi.org/10.1136/bmj.f3936			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171QB	23783356				2022-12-28	WOS:000320943000004
J	Ziegler, AG; Rewers, M; Simell, O; Simell, T; Lempainen, J; Steck, A; Winkler, C; Ilonen, J; Veijola, R; Knip, M; Bonifacio, E; Eisenbarth, GS				Ziegler, Anette G.; Rewers, Marian; Simell, Olli; Simell, Tuula; Lempainen, Johanna; Steck, Andrea; Winkler, Christiane; Ilonen, Jorma; Veijola, Riitta; Knip, Mikael; Bonifacio, Ezio; Eisenbarth, George S.			Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; INTERVENTION TRIAL; GENERAL-POPULATION; TYPE-1; INSULIN; AUTOIMMUNITY; ANTIBODIES; MELLITUS; PREDICTION; RELATIVES	Importance Type 1 diabetes usually has a preclinical phase identified by circulating islet autoantibodies, but the rate of progression to diabetes after seroconversion to islet autoantibodies is uncertain. Objective To determine the rate of progression to diabetes after islet autoantibody seroconversion. Design, Setting, and Participants Data were pooled from prospective cohort studies performed in Colorado (recruitment, 1993-2006), Finland (recruitment, 19942009), and Germany (recruitment, 1989-2006) examining children genetically at risk for type 1 diabetes for the development of insulin autoantibodies, glutamic acid decarboxylase 65 (GAD65) autoantibodies, insulinoma antigen 2 (IA2) autoantibodies, and diabetes. Participants were all children recruited and followed up in the 3 studies (Colorado, 1962; Finland, 8597; Germany, 2818). Follow-up assessment in each study was concluded by July 2012. Main Outcomes and Measures The primary analysis was the diagnosis of type 1 diabetes in children with 2 or more autoantibodies. The secondary analysis was the diagnosis of type 1 diabetes in children with 1 autoantibody or no autoantibodies. Results Progression to type 1 diabetes at 10-year follow-up after islet autoantibody seroconversion in 585 children with multiple islet autoantibodies was 69.7% (95% CI, 65.1%-74.3%), and in 474 children with a single islet autoantibody was 14.5% (95% CI, 10.3%-18.7%). Risk of diabetes in children who had no islet autoantibodies was 0.4% (95% CI, 0.2%-0.6%) by the age of 15 years. Progression to type 1 diabetes in the children with multiple islet autoantibodies was faster for children who had islet autoantibody seroconversion younger than age 3 years (hazard ratio [HR], 1.65 [95% CI, 1.30-2.09; P < .001]; 10-year risk, 74.9% [95% CI, 69.7%-80.1%]) vs children 3 years or older (60.9% [95% CI, 51.5%-70.3%]); for children with the human leukocyte antigen (HLA) genotype DR3/ DR4-DQ8 (HR, 1.35 [95% CI, 1.09-1.68; P=.007]; 10-year risk, 76.6% [95% CI, 69.2%-84%]) vs other HLA genotypes (66.2% [95% CI, 60.2%-72.2%]); and for girls (HR, 1.28 [95% CI, 1.04-1.58; P=.02]; 10-year risk, 74.8% [95% CI, 68.0%-81.6%]) vs boys (65.7% [95% CI, 59.3%-72.1%]). Conclusions and Relevance The majority of children at risk of type 1 diabetes who had multiple islet autoantibody seroconversion progressed to diabetes over the next 15 years. Future prevention studies should focus on this high-risk population.	[Ziegler, Anette G.; Winkler, Christiane] Tech Univ Munich, Diabet Res Inst, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Ziegler, Anette G.; Winkler, Christiane] Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, D-85764 Neuherberg, Germany; [Rewers, Marian; Steck, Andrea; Eisenbarth, George S.] Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Simell, Olli; Simell, Tuula; Lempainen, Johanna] Univ Turku, Dept Pediat, Turku, Finland; [Lempainen, Johanna; Ilonen, Jorma] Univ Turku, Immunogenet Lab, Turku, Finland; [Simell, Olli; Simell, Tuula; Lempainen, Johanna] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland; [Ilonen, Jorma] Univ Eastern Finland, Dept Clin Microbiol, Kuopio, Finland; [Veijola, Riitta] Univ Oulu, Dept Pediat, Inst Clin Med, SF-90100 Oulu, Finland; [Knip, Mikael] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Knip, Mikael] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Knip, Mikael] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Bonifacio, Ezio] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany; [Bonifacio, Ezio] Tech Univ Dresden, Paul Langerhans Inst Dresden, German Ctr Diabet Res, Dresden, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Turku; University of Turku; University of Turku; University of Eastern Finland; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University Hospital; Technische Universitat Dresden; Technische Universitat Dresden	Ziegler, AG (corresponding author), Tech Univ Munich, Diabet Res Inst, Helmholtz Zentrum Munchen, Ingolstaedter Landstrase 1, D-85764 Neuherberg, Germany.	anette-g.ziegler@helmholtz-muenchen.de	Ziegler, Anette-Gabriele/M-4614-2014; Knip, Mikael/AAL-3773-2020; Bonifacio, Ezio/E-7700-2010	Ziegler, Anette-Gabriele/0000-0002-6290-5548; Bonifacio, Ezio/0000-0002-8704-4713; Knip, Mikael/0000-0003-0474-0033; Ilonen, Jorma/0000-0002-9973-2062	Juvenile Diabetes Research Foundation [1-2000-619, 4-1999-731, 4-2001-435]; National Institutes of Health [R01 DK32493]; Bundesministerium fur Bildung und Forschung [01KD89030, 1KD9601]; Deutsche Forschungsgemeinschaft [ZI-310/14-1, ZI-310/14-2, ZI-310/14-3, ZI-310/14-4]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032493, U01DK063821] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Primary support for this work was provided by grants 1-2000-619 (BABYDIAB) and 4-1999-731 and 4-2001-435 (DIPP) from the Juvenile Diabetes Research Foundation; R01 DK32493 (DAISY) from the National Institutes of Health; 01KD89030 and 1KD9601 (BABYDIAB) from Bundesministerium fur Bildung und Forschung; and ZI-310/14-1, ZI-310/14-2, ZI-310/14-3, and ZI-310/14-4(BABYDIET) from Deutsche Forschungsgemeinschaft.	Achenbach P, 2004, DIABETES, V53, P384, DOI 10.2337/diabetes.53.2.384; Achenbach P, 2009, DIABETOLOGIA, V52, P1881, DOI 10.1007/s00125-009-1438-0; Bingley PJ, 2006, DIABETOLOGIA, V49, P881, DOI 10.1007/s00125-006-0160-4; Bonifacio E, 1998, J IMMUNOL, V161, P2648; BONIFACIO E, 1990, LANCET, V335, P147, DOI 10.1016/0140-6736(90)90013-U; Colman PG, 2000, DIABETOLOGIA, V43, P203, DOI 10.1007/s001250050030; Decochez K, 2005, DIABETOLOGIA, V48, P687, DOI 10.1007/s00125-005-1702-x; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Hummel M, 2004, ANN INTERN MED, V140, P882, DOI 10.7326/0003-4819-140-11-200406010-00009; Hummel S, 2011, DIABETES CARE, V34, P1301, DOI 10.2337/dc10-2456; Knip M, 2010, DIABETES CARE, V33, P1206, DOI 10.2337/dc09-1040; Koczwara K, 2004, DIABETES, V53, P1; Kukko M, 2005, J CLIN ENDOCR METAB, V90, P2712, DOI 10.1210/jc.2004-1371; Milton B, 2006, DIABETIC MED, V23, P821, DOI 10.1111/j.1464-5491.2006.01796.x; Nanto-Salonen K, 2008, LANCET, V372, P1746, DOI 10.1016/S0140-6736(08)61309-4; Orban T, 2009, DIABETES CARE, V32, P2269, DOI 10.2337/dc09-0934; Puavilai G, 1999, DIABETES RES CLIN PR, V44, P21, DOI 10.1016/S0168-8227(99)00008-X; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; TARN AC, 1988, LANCET, V1, P845; Vehik K, 2011, DIABETES CARE, V34, P1585, DOI 10.2337/dc11-0523; VIVES M, 1992, DIABETES, V41, P1624, DOI 10.2337/diabetes.41.12.1624; Yu LP, 2012, DIABETES CARE, V35, P1213, DOI 10.2337/dc11-2081; Yu LP, 1996, J CLIN ENDOCR METAB, V81, P4264, DOI 10.1210/jc.81.12.4264; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	26	663	688	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2473	2479		10.1001/jama.2013.6285	http://dx.doi.org/10.1001/jama.2013.6285			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23780460	Bronze, Green Accepted			2022-12-28	WOS:000320505100028
J	Robinson, D; Garmo, H; Bill-Axelson, A; Mucci, L; Holmberg, L; Stattin, P				Robinson, David; Garmo, Hans; Bill-Axelson, Anna; Mucci, Lorelei; Holmberg, Lars; Stattin, Par			Use of 5 alpha-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIGH-GRADE; MODELING APPROACH; PREVENTION TRIAL; FINASTERIDE; DUTASTERIDE; HYPERPLASIA; BIAS	Objective To assess the association between 5 alpha-reductase inhibitor (5-ARI) use in men with lower urinary tract symptoms and prostate cancer risk. Design Nationwide, population based case-control study for men diagnosed with prostate cancer in 2007-09 within the Prostate Cancer data Base Sweden 2.0. Setting The National Prostate Cancer Register, National Patient Register, census, and Prescribed Drug Register in Sweden, from which we obtained data on 5-ARI use before date of prostate cancer diagnosis. Participants 26 735 cases and 133 671 matched controls; five controls per case were randomly selected from matched men in the background population. 7815 men (1499 cases and 6316 controls) had been exposed to 5-ARI. 412 men had been exposed to 5-ARI before the diagnosis of a cancer with Gleason score 8-10. Main outcome measures Risk of prostate cancer calculated as odds ratios and 95% confidence intervals by conditional logistic regression analyses. Results Risk of prostate cancer overall decreased with an increasing duration of exposure; men on 5-ARI treatment for more than three years had an odds ratio of 0.72 (95% confidence interval 0.59 to 0.89; P<0.001 for trend). The same pattern was seen for cancers with Gleason scores 2-6 and score 7 (both P<0.001 for trend). By contrast, the risk of tumours with Gleason scores 8-10 did not decrease with increasing exposure time to 5-ARI (for 0-1 year of exposure, odds ratio 0.96 (95% confidence interval 0.83 to 1.11); for 1-2 years, 1.07 (0.88 to 1.31); for 2-3 years, 0.96 (0.72 to 1.27); for >3 years, 1.23 (0.90 to 1.68); P=0.46 for trend). Conclusions Men treated with 5-ARI for lower urinary tract symptoms had a decreased risk of cancer with Gleason scores 2-7, and showed no evidence of an increased risk of cancer with Gleason scores 8-10 after up to four years' treatment.	[Robinson, David; Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, S-90185 Umea, Sweden; [Robinson, David] Ryhov Cty Hosp, Dept Urol, S-55185 Jonkoping, Sweden; [Garmo, Hans; Holmberg, Lars] Univ Uppsala Hosp, Reg Canc Ctr, Uppsala, Sweden; [Bill-Axelson, Anna] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Mucci, Lorelei] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Garmo, Hans; Holmberg, Lars] Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England; [Stattin, Par] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA	Umea University; Uppsala University; Uppsala University Hospital; Uppsala University; Harvard University; Harvard T.H. Chan School of Public Health; University of London; King's College London; Memorial Sloan Kettering Cancer Center	Robinson, D (corresponding author), Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, S-90185 Umea, Sweden.	drobinson@telia.com			Swedish Research Council [2010-5950]; Swedish Cancer Society [11 0471, 11 0718]; Lion's Cancer Research Foundation; Umea University Hospital; Umea University Hospital; Futurum; Jonkoping county council; Cancer Research Foundation, Jonkoping	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Lion's Cancer Research Foundation; Umea University Hospital; Umea University Hospital; Futurum; Jonkoping county council; Cancer Research Foundation, Jonkoping	This study was funded by the Swedish Research Council (2010-5950); the Swedish Cancer Society (11 0471, 11 0718); the Lion's Cancer Research Foundation, Umea University Hospital; Futurum, Jonkoping county council; and the Cancer Research Foundation, Jonkoping. None of these funders had any part in the collection, management, analysis, interpretation of the data and not in preparation, review, or approval of the manuscript.	Adolfsson J, 2007, SCAND J UROL NEPHROL, V41, P456, DOI 10.1080/00365590701673625; Andriole GL, 2011, J UROLOGY, V185, P126, DOI 10.1016/j.juro.2010.09.011; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Bostwick David G, 2004, Clin Prostate Cancer, V2, P228, DOI 10.3816/CGC.2004.n.004; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen YC, 2007, J NATL CANCER I, V99, P1366, DOI 10.1093/jnci/djm130; Cox D. R., 1984, ANAL SURVIVAL DATA; Fleshner NE, 2012, LANCET, V379, P1103, DOI 10.1016/S0140-6736(11)61619-X; Hagel E, 2009, SCAND J UROL NEPHROL, P1; Hamilton RJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-105; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; McConnell JD, 1998, NEW ENGL J MED, V338, P557, DOI 10.1056/NEJM199802263380901; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Mohler J, 2010, J NATL COMPR CANC NE, V8, P162, DOI 10.6004/jnccn.2010.0012; Murtola TJ, 2009, BRIT J CANCER, V101, P843, DOI 10.1038/sj.bjc.6605188; Muthusamy S, 2011, P NATL ACAD SCI USA, V108, P20090, DOI 10.1073/pnas.1117772108; Nacusi LP, 2011, NAT REV UROL, V8, P378, DOI 10.1038/nrurol.2011.67; National Prostate Cancer Register, 2012, PROST CANC NAT QUAL; Orsted DD, 2011, EUR UROL, V60, P691, DOI 10.1016/j.eururo.2011.06.016; Pinsky P, 2008, CANCER PREV RES, V1, P182, DOI 10.1158/1940-6207.CAPR-07-0007; Redman MW, 2008, CANCER PREV RES, V1, P174, DOI 10.1158/1940-6207.CAPR-08-0092; Roehrborn CG, 2011, EUR UROL, V59, P244, DOI 10.1016/j.eururo.2010.10.040; Socialstyrelsen, NAT PAT REG; Thompson IM, 2006, J NATL CANCER I, V98, P1128, DOI 10.1093/jnci/djj307; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Thompson IM, 2003, EUR UROL, V44, P650, DOI 10.1016/j.eururo.2003.11.001; *US FDA, 2011, FDA DRUG SAF COMM 5; Van Hemelrijck M, 2013, INT J EPIDEMIOL, V42, P956, DOI 10.1093/ije/dys068; World Health Organization, 2009, DEF GEN CONS	30	25	26	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2013	346								f3406	10.1136/bmj.f3406	http://dx.doi.org/10.1136/bmj.f3406			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171PQ	23778271	Green Published, hybrid			2022-12-28	WOS:000320941900004
J	Jani, IV; Peter, TF				Jani, Ilesh V.; Peter, Trevor F.			How Point-of-Care Testing Could Drive Innovation in Global Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; DIAGNOSIS; HIV; TUBERCULOSIS; OPPORTUNITIES; CHALLENGES; MALARIA; IMPLEMENTATION; MICROSCOPY; MANAGEMENT		[Jani, Ilesh V.] Inst Nacl Saude, Maputo, Mozambique; [Peter, Trevor F.] Clinton Hlth Access Initiat, Boston, MA USA		Jani, IV (corresponding author), Inst Nacl Saude, Maputo, Mozambique.			Jani, Ilesh/0000-0002-6880-6655				Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; Dalal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027293; De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Gray DJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2651; Gullai N, 2013, HYPERTENS RES, V36, P457, DOI 10.1038/hr.2012.206; Huppert JS, 2010, SEX TRANSM INFECT, V86, P514, DOI 10.1136/sti.2009.042168; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; LABARRE P, 2011, P SOC PHOTO-OPT INS, V8029, P1; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Mccoy D, 2009, HEALTH POLICY PLANN, V24, P407, DOI 10.1093/heapol/czp026; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Mkwanazi NB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003501; MURTAGH M, 2012, HIV AIDS DIAGNOSTIC; Myer L, 2003, SEX TRANSM INFECT, V79, P208, DOI 10.1136/sti.79.3.208; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Nkengasong JN, 2010, AM J CLIN PATHOL, V134, P368, DOI 10.1309/AJCPMPSINQ9BRMU6; Nkengasong JN, 2010, AM J CLIN PATHOL, V134, P359, DOI 10.1309/AJCPY5ASUEJYQ5RK; Pai NP, 2012, DISCOV MED, V13, P35; Parpia ZA, 2010, JAIDS-J ACQ IMM DEF, V55, P413, DOI 10.1097/QAI.0b013e3181f1afbc; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Schito M, 2012, J INFECT DIS, V205, pS169, DOI 10.1093/infdis/jis044; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Tobaiwa O, 2012, IMPLEMENTATION WIREL; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Warrener L, 2011, B WORLD HEALTH ORGAN, V89, P675, DOI 10.2471/BLT.11.088427; Wolpaw BJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-73; Xu J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-87; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6; 2012, TEST TREAT TRACK SCA	40	106	109	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2319	2324		10.1056/NEJMsb1214197	http://dx.doi.org/10.1056/NEJMsb1214197			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YN	23758238				2022-12-28	WOS:000320230500011
J	Kew, ST; Chakravarthi, S				Kew, S. T.; Chakravarthi, Srikumar			Melanosis Coli	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kew, S. T.; Chakravarthi, Srikumar] Int Med Univ, Kuala Lumpur 57000, Malaysia	International Medical University Malaysia	Kew, ST (corresponding author), Int Med Univ, Kuala Lumpur 57000, Malaysia.	kew@imu.edu.my	Chakravarthi, Srikumar/AHB-7872-2022	Chakravarthi, Srikumar/0000-0002-9888-3301					0	5	6	2	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2303	2303		10.1056/NEJMicm1204882	http://dx.doi.org/10.1056/NEJMicm1204882			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YN	23758235				2022-12-28	WOS:000320230500006
J	Hudson, MM; Ness, KK; Gurney, JG; Mulrooney, DA; Chemaitilly, W; Krull, KR; Green, DM; Armstrong, GT; Nottage, KA; Jones, KE; Sklar, CA; Srivastava, DK; Robison, LL				Hudson, Melissa M.; Ness, Kirsten K.; Gurney, James G.; Mulrooney, Daniel A.; Chemaitilly, Wassim; Krull, Kevin R.; Green, Daniel M.; Armstrong, Gregory T.; Nottage, Kerri A.; Jones, Kendra E.; Sklar, Charles A.; Srivastava, Deo Kumar; Robison, Leslie L.			Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM SURVIVORS; CARE	Importance Adult survivors of childhood cancer are known to be at risk for treatment-related adverse health outcomes. A large population of survivors has not been evaluated using a comprehensive systematic clinical assessment to determine the prevalence of chronic health conditions. Objective To determine the prevalence of adverse health outcomes and the proportion associated with treatment-related exposures in a large cohort of adult survivors of childhood cancer. Design, Setting, and Participants Presence of health outcomes was ascertained using systematic exposure-based medical assessments among 1713 adult (median age, 32 [range, 18-60] years) survivors of childhood cancer (median time from diagnosis, 25 [range, 10-47] years) enrolled in the St Jude Lifetime Cohort Study since October 1, 2007, and undergoing follow-up through October 31, 2012. Main Outcomes and Measures Age-specific cumulative prevalence of adverse outcomes by organ system. Results Using clinical criteria, the crude prevalence of adverse health outcomes was highest for pulmonary (abnormal pulmonary function, 65.2% [95% CI, 60.4%-69.8%]), auditory (hearing loss, 62.1% [95% CI, 55.8%-68.2%]), endocrine or reproductive (any endocrine condition, such as hypothalamic-pituitary axis disorders and male germ cell dysfunction, 62.0% [95% CI, 59.5%-64.6%]), cardiac (any cardiac condition, such as heart valve disorders, 56.4% [95% CI, 53.5%-59.2%]), and neurocognitive (neurocognitive impairment, 48.0% [95% CI, 44.9%-51.0%]) function, whereas abnormalities involving hepatic (liver dysfunction, 13.0% [95% CI, 10.8%-15.3%]), skeletal (osteoporosis, 9.6% [95% CI, 8.0%-11.5%]), renal (kidney dysfunction, 5.0% [95% CI, 4.0%-6.3%]), and hematopoietic (abnormal blood cell counts, 3.0% [95% CI, 2.1%-3.9%]) function were less common. Among survivors at risk for adverse outcomes following specific cancer treatment modalities, the estimated cumulative prevalence at age 50 years was 21.6% (95% CI, 19.3%-23.9%) for cardiomyopathy, 83.5% (95% CI, 80.2%-86.8%) for heart valve disorder, 81.3% (95% CI, 77.6%-85.0%) for pulmonary dysfunction, 76.8% (95% CI, 73.6%-80.0%) for pituitary dysfunction, 86.5% (95% CI, 82.3%-90.7%) for hearing loss, 31.9% (95% CI, 28.0%-35.8%) for primary ovarian failure, 31.1% (95% CI, 27.3%-34.9%) for Leydig cell failure, and 40.9% (95% CI, 32.0%-49.8%) for breast cancer. At age 45 years, the estimated cumulative prevalence of any chronic health condition was 95.5% (95% CI, 94.8%-98.6%) and 80.5% (95% CI, 73.0%-86.6%) for a serious/disabling or life-threatening chronic condition. Conclusions and Relevance Among adult survivors of childhood cancer, the prevalence of adverse health outcomes was high, and a systematic risk-based medical assessment identified a substantial number of previously undiagnosed problems that are more prevalent in an older population. These findings underscore the importance of ongoing health monitoring for adults who survive childhood cancer.	[Hudson, Melissa M.; Mulrooney, Daniel A.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Hudson, Melissa M.; Ness, Kirsten K.; Gurney, James G.; Mulrooney, Daniel A.; Chemaitilly, Wassim; Krull, Kevin R.; Green, Daniel M.; Armstrong, Gregory T.; Jones, Kendra E.; Robison, Leslie L.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; [Chemaitilly, Wassim] St Jude Childrens Res Hosp, Dept Pediat Med, Memphis, TN 38105 USA; [Nottage, Kerri A.] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Srivastava, Deo Kumar] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Memphis, TN USA; [Sklar, Charles A.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Memorial Sloan Kettering Cancer Center	Hudson, MM (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, Div Canc Survivorship, 262 Danny Thomas Pl,Mailstop 735, Memphis, TN 38105 USA.	melissa.hudson@stjude.org	Ness, Kirsten K/N-2550-2018; Chemaitilly, Wassim/N-8178-2018; Robison, Leslie/N-8122-2018; Armstrong, Gregory/N-8096-2018; Chemaitilly, Wassim/AAQ-3397-2021; Srivastava, Deo Kumar/P-2435-2017; Hudson, Melissa M/N-4441-2018; Krull, Kevin R/N-3882-2018	Ness, Kirsten K/0000-0002-2084-1507; Srivastava, Deo Kumar/0000-0001-6693-8120; Hudson, Melissa M/0000-0001-6984-2407; Krull, Kevin R/0000-0002-0476-7001	National Cancer Institute (NCI) [CA 21765]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Cancer Center Support (CORE) grant CA 21765 from the National Cancer Institute (NCI) and by the American Lebanese Syrian Associated Charities (ALSAC).	Allison P. D., 1995, SURVIVAL ANAL USING; Armstrong GT, 2013, JNCI-J NATL CANCER I, V105, P899, DOI 10.1093/jnci/djt089; Asbell PA, 2005, LANCET, V365, P599; Children's Oncology Group, LONG TERM FOLL UP GU; de Haas EC, 2010, LANCET ONCOL, V11, P193, DOI 10.1016/S1470-2045(09)70287-6; Dowling E, 2010, CANCER-AM CANCER SOC, V116, P3712, DOI 10.1002/cncr.25141; Frisina RD, 2009, ANN NY ACAD SCI, V1170, P708, DOI 10.1111/j.1749-6632.2009.03931.x; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Glisky E.L., 2007, BRAIN AGING MODELS M; Green DM, 2013, PEDIATR BLOOD CANCER, V60, P1083, DOI 10.1002/pbc.24487; Hogan MJS, 2013, PEDIATR BLOOD CANCER, V60, P682, DOI 10.1002/pbc.24360; Hudson MM, 2012, PEDIATR BLOOD CANCER, V58, P334, DOI 10.1002/pbc.23385; Hudson MM, 2011, PEDIATR BLOOD CANCER, V56, P825, DOI 10.1002/pbc.22875; Landier W, 2012, J CLIN ONCOL, V30, P4401, DOI 10.1200/JCO.2012.43.4951; Marin-Garcia J, 2008, AGING HEART, P209; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; National Cancer Institute, CANC THER EV PROGR C; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Ojha RP, 2013, PEDIATR BLOOD CANCER, V60, P856, DOI 10.1002/pbc.24348; Parry C, 2011, CANCER EPIDEM BIOMAR, V20, P1996, DOI 10.1158/1055-9965.EPI-11-0729; Rebholz CE, 2011, J CLIN ONCOL, V29, P4181, DOI 10.1200/JCO.2011.36.5619; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Sun CL, 2010, BLOOD, V116, P3129, DOI 10.1182/blood-2009-06-229369; Wasilewski-Masker K, 2010, PEDIATR BLOOD CANCER, V54, P976, DOI 10.1002/pbc.22431	24	731	737	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2371	2381		10.1001/jama.2013.6296	http://dx.doi.org/10.1001/jama.2013.6296			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161EV	23757085	Green Accepted, Bronze			2022-12-28	WOS:000320176000027
J	Zanation, A; Fleischman, D; Chavala, SH				Zanation, Adam; Fleischman, David; Chavala, Sai H.			Ptosis, Erythema, and Rapidly Decreasing Vision	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIABETIC-KETOACIDOSIS; MUCORMYCOSIS; MANAGEMENT		[Zanation, Adam] Univ N Carolina, Sch Med, Dept Otolaryngol Head & Neck Surg, Chapel Hill, NC 27599 USA; [Fleischman, David; Chavala, Sai H.] Univ N Carolina, Sch Med, Dept Ophthalmol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Fleischman, D (corresponding author), Univ N Carolina, Sch Med, Dept Ophthalmol, 5151 Bioinformat Bldg,CB 7040, Chapel Hill, NC 27599 USA.	david8fleischman@gmail.com						ARTIS WM, 1982, DIABETES, V31, P1109, DOI 10.2337/diabetes.31.12.1109; Baring DEC, 2011, CLIN OTOLARYNGOL, V36, P57, DOI 10.1111/j.1749-4486.2011.02258.x; Hopley L, MUCORMYCOSIS; Howe L, 2004, CLIN OTOLARYNGOL, V29, P725, DOI 10.1111/j.1365-2273.2004.00889.x; Ibrahim AS, 2008, CURR OPIN INFECT DIS, V21, P620, DOI 10.1097/QCO.0b013e3283165fd1; Mitchell GE, 2008, AM FAM PHYSICIAN, V77, P1584; Pelton RW, 2001, OPHTHALMIC PLAST REC, V17, P62, DOI 10.1097/00002341-200101000-00012; Spellberg B, 2005, CLIN MICROBIOL REV, V18, P556, DOI 10.1128/CMR.18.3.556-569.2005; Wali Upender, 2012, J Infect Public Health, V5, P116, DOI 10.1016/j.jiph.2012.01.003; YOHAI RA, 1994, SURV OPHTHALMOL, V39, P3, DOI 10.1016/S0039-6257(05)80041-4	10	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2382	2383		10.1001/jama.2013.5517	http://dx.doi.org/10.1001/jama.2013.5517			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161EV	23757086				2022-12-28	WOS:000320176000028
J	Chen, DH; Madan, D; Weaver, J; Lin, Z; Schroder, GF; Chiu, W; Rye, HS				Chen, Dong-Hua; Madan, Damian; Weaver, Jeremy; Lin, Zong; Schroeder, Gunnar F.; Chiu, Wah; Rye, Hays S.			Visualizing GroEL/ES in the Act of Encapsulating a Folding Protein	CELL			English	Article							CHAPERONIN ATPASE CYCLE; CRYO-EM STRUCTURE; CRYOELECTRON MICROSCOPY; CENTRAL CAVITY; GROES COMPLEX; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; INTERMEDIATE; POLYPEPTIDE; RESOLUTION	The GroEL/ES chaperonin system is required for the assisted folding of many proteins. How these substrate proteins are encapsulated within the GroEL-GroES cavity is poorly understood. Using symmetry-free, single-particle cryo-electron microscopy, we have characterized a chemically modified mutant of GroEL (EL43Py) that is trapped at a normally transient stage of substrate protein encapsulation. We show that the symmetric pattern of the GroEL subunits is broken as the GroEL cis-ring apical domains reorient to accommodate the simultaneous binding of GroES and an incompletely folded substrate protein (RuBisCO). The collapsed RuBisCO folding intermediate binds to the lower segment of two apical domains, as well as to the normally unstructured GroEL C-terminal tails. A comparative structural analysis suggests that the allosteric transitions leading to substrate protein release and folding involve concerted shifts of GroES and the GroEL apical domains and C-terminal tails.	[Chen, Dong-Hua; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromolecular Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Madan, Damian; Lin, Zong] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Weaver, Jeremy; Rye, Hays S.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77845 USA; [Schroeder, Gunnar F.] Forschungszentrum Julich, Dept Struct Biochem, Inst Complex Syst ICS 6, D-52425 Julich, Germany; [Schroeder, Gunnar F.] Univ Dusseldorf, Dept Phys, D-40225 Dusseldorf, Germany	Baylor College of Medicine; Princeton University; Texas A&M University System; Texas A&M University College Station; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Chiu, W (corresponding author), Baylor Coll Med, Natl Ctr Macromolecular Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	wah@bcm.edu; haysrye@tamu.edu	Schröder, Gunnar F/H-5261-2013	Schröder, Gunnar F/0000-0003-1803-5431; Rye, Hays/0000-0002-9420-3137; Weaver, Jeremy/0000-0002-5556-4757	National Institutes of Health [P41GM103832, PN2EY016525, GM065421]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832, R01GM065421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research has been supported by grants from the National Institutes of Health (P41GM103832 and PN2EY016525 to W.C.) (GM065421 to H.S.R.). We would like to thank Dr. Chavela Carr for her comments on the manuscript and Dr. Steven J. Ludtke and Dr. Michael F. Schmid for helpful discussions.	BADCOE IG, 1991, BIOCHEMISTRY-US, V30, P9195, DOI 10.1021/bi00102a010; Baker ML, 2007, STRUCTURE, V15, P7, DOI 10.1016/j.str.2006.11.008; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; Chen DH, 2008, J MOL BIOL, V381, P707, DOI 10.1016/j.jmb.2008.06.021; Chen DH, 2006, STRUCTURE, V14, P1711, DOI 10.1016/j.str.2006.09.010; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; Cong Y, 2012, EMBO J, V31, P720, DOI 10.1038/emboj.2011.366; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Falke S, 2005, J MOL BIOL, V348, P219, DOI 10.1016/j.jmb.2005.02.027; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Frank GA, 2010, P NATL ACAD SCI USA, V107, P6270, DOI 10.1073/pnas.0910246107; Grason JP, 2008, P NATL ACAD SCI USA, V105, P17339, DOI 10.1073/pnas.0807418105; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Horovitz A, 2001, J STRUCT BIOL, V135, P104, DOI 10.1006/jsbi.2001.4377; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; Kanno R, 2009, STRUCTURE, V17, P287, DOI 10.1016/j.str.2008.12.012; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Madan D, 2008, J BIOL CHEM, V283, P32003, DOI 10.1074/jbc.M802898200; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MCLENNAN NF, 1993, MOL MICROBIOL, V7, P49, DOI 10.1111/j.1365-2958.1993.tb01096.x; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Rye HS, 2001, METHODS, V24, P278, DOI 10.1006/meth.2001.1188; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Sparrer H, 1997, J BIOL CHEM, V272, P14080, DOI 10.1074/jbc.272.22.14080; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; VANDERVIES SM, 1992, BIOCHEMISTRY-US, V31, P3635, DOI 10.1021/bi00129a012; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Yifrach O, 2000, P NATL ACAD SCI USA, V97, P1521, DOI 10.1073/pnas.040449997	53	61	64	0	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1354	1365		10.1016/j.cell.2013.04.052	http://dx.doi.org/10.1016/j.cell.2013.04.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746846	Green Accepted, Bronze			2022-12-28	WOS:000319979200018
J	Burlaga, LF; Ness, NF; Stone, EC				Burlaga, L. F.; Ness, N. F.; Stone, E. C.			Magnetic Field Observations as Voyager 1 Entered the Heliosheath Depletion Region	SCIENCE			English	Article							TERMINATION SHOCK; HELIOSPHERE; VELOCITY; PLASMA; SYSTEM; FLOW; AU	Magnetic fields measured by Voyager 1 (V1) show that the spacecraft crossed the boundary of an unexpected region five times between days 210 and similar to 238 in 2012. The magnetic field strength B increased across this boundary from approximate to 0.2 to approximate to 0.4 nanotesla, and B remained near 0.4 nanotesla until at least day 270, 2012. The strong magnetic fields were associated with unusually low counting rates of >0.5 mega-electron volt per nuclear particle. The direction of B did not change significantly across any of the five boundary crossings; it was very uniform and very close to the spiral magnetic field direction, which was observed throughout the heliosheath. The observations indicate that V1 entered a region of the heliosheath (the heliosheath depletion region), rather than the interstellar medium.	[Burlaga, L. F.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Ness, N. F.] Catholic Univ Amer, Washington, DC 20064 USA; [Stone, E. C.] CALTECH, Pasadena, CA 91125 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Catholic University of America; California Institute of Technology	Burlaga, LF (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	lburlagahsp@verizon.net			NASA [NNX12AC63G, NNG11PN48P]	NASA(National Aeronautics & Space Administration (NASA))	T. McClanahan and S. Kramer provided support in the processing of the data and D. Berdichevsky computed correction tables for the three sensors on each of the two magnetometers. N.F.N. was partially supported by NASA grant NNX12AC63G to the Catholic University of America. L. F. B. was supported by NASA contract NNG11PN48P. The data are available at NASA's Virtual Heliospheric Observatory (http://vho.nasa.gov/), maintained within the Heliospheric Physics Laboratory at NASA's Goddard Space Flight Center.	Behannon K., 1997, SPACE SCI REV, V21, P235; Berdichevsky DB., 2009, CISC VIS NETW IND GL; Borovikov SN, 2008, ASTROPHYS J, V682, P1404, DOI 10.1086/589634; Burlaga LF, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/13; Burlaga LF, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016309; Burlaga LF, 2005, SCIENCE, V309, P2027, DOI 10.1126/science.1117542; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; Decker RB, 2012, NATURE, V489, P124, DOI 10.1038/nature11441; Florinski V, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010879; Frisch P. C., 2012, P 10 ANN INT ASTR C, V1436, P239; Heerikhuisen J, 2010, ASTROPHYS J LETT, V708, pL126, DOI 10.1088/2041-8205/708/2/L126; Izmodenov VV, 2009, SPACE SCI REV, V146, P329, DOI 10.1007/s11214-009-9528-3; Krimigis SM, 2011, NATURE, V474, P359, DOI 10.1038/nature10115; McComas DJ, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/19; Opher M, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/71; Opher M, 2009, NATURE, V462, P1036, DOI 10.1038/nature08567; Parker E.N., 1963, ASTROPHYS J SUPPL S, DOI DOI 10.1086/190087; Pogorelov NV, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L4; Pogorelov NV, 2009, ASTROPHYS J LETT, V695, pL31, DOI 10.1088/0004-637X/695/1/L31; Stone EC, 2013, SCIENCE, V341, P150, DOI 10.1126/science.1236408; Stone E C, 2011, P 32 INT COSM RAY C, V12, P29; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; STONE EC, 1977, SPACE SCI REV, V21, P355, DOI 10.1007/BF00211546; Washimi H, 2011, MON NOT R ASTRON SOC, V416, P1475, DOI 10.1111/j.1365-2966.2011.19144.x; Washimi H, 1996, SPACE SCI REV, V78, P85, DOI 10.1007/BF00170795; Webber WR, 2013, GEOPHYS RES LETT, V40, P1665, DOI 10.1002/grl.50383; Zank GP, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/20	27	140	140	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					147	150		10.1126/science.1235451	http://dx.doi.org/10.1126/science.1235451			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23811226				2022-12-28	WOS:000321965300035
J	Lawrence, MS; Stojanov, P; Polak, P; Kryukov, GV; Cibulskis, K; Sivachenko, A; Carter, SL; Stewart, C; Mermel, CH; Roberts, SA; Kiezun, A; Hammerman, PS; McKenna, A; Drier, Y; Zou, LH; Ramos, AH; Pugh, TJ; Stransky, N; Helman, E; Kim, J; Sougnez, C; Ambrogio, L; Nickerson, E; Shefler, E; Cortes, ML; Auclair, D; Saksena, G; Voet, D; Noble, M; DiCara, D; Lin, P; Lichtenstein, L; Heiman, DI; Fennell, T; Imielinski, M; Hernandez, B; Hodis, E; Baca, S; Dulak, AM; Lohr, J; Landau, DA; Wu, CJ; Melendez-Zajgla, J; Hidalgo-Miranda, A; Koren, A; McCarroll, SA; Mora, J; Lee, RS; Crompton, B; Onofrio, R; Parkin, M; Winckler, W; Ardlie, K; Gabriel, SB; Roberts, CWM; Biegel, JA; Stegmaier, K; Bass, AJ; Garraway, LA; Meyerson, M; Golub, TR; Gordenin, DA; Sunyaev, S; Lander, ES; Getz, G				Lawrence, Michael S.; Stojanov, Petar; Polak, Paz; Kryukov, Gregory V.; Cibulskis, Kristian; Sivachenko, Andrey; Carter, Scott L.; Stewart, Chip; Mermel, Craig H.; Roberts, Steven A.; Kiezun, Adam; Hammerman, Peter S.; McKenna, Aaron; Drier, Yotam; Zou, Lihua; Ramos, Alex H.; Pugh, Trevor J.; Stransky, Nicolas; Helman, Elena; Kim, Jaegil; Sougnez, Carrie; Ambrogio, Lauren; Nickerson, Elizabeth; Shefler, Erica; Cortes, Maria L.; Auclair, Daniel; Saksena, Gordon; Voet, Douglas; Noble, Michael; DiCara, Daniel; Lin, Pei; Lichtenstein, Lee; Heiman, David I.; Fennell, Timothy; Imielinski, Marcin; Hernandez, Bryan; Hodis, Eran; Baca, Sylvan; Dulak, Austin M.; Lohr, Jens; Landau, Dan-Avi; Wu, Catherine J.; Melendez-Zajgla, Jorge; Hidalgo-Miranda, Alfredo; Koren, Amnon; McCarroll, Steven A.; Mora, Jaume; Lee, Ryan S.; Crompton, Brian; Onofrio, Robert; Parkin, Melissa; Winckler, Wendy; Ardlie, Kristin; Gabriel, Stacey B.; Roberts, Charles W. M.; Biegel, Jaclyn A.; Stegmaier, Kimberly; Bass, Adam J.; Garraway, Levi A.; Meyerson, Matthew; Golub, Todd R.; Gordenin, Dmitry A.; Sunyaev, Shamil; Lander, Eric S.; Getz, Gad			Mutational heterogeneity in cancer and the search for new cancer-associated genes	NATURE			English	Article							SOMATIC MUTATIONS; HUMAN-PAPILLOMAVIRUS; DNA; GENOME; LANDSCAPE; PATTERNS; IMPACT	Major international projects are underway that are aimed at creating a comprehensive catalogue of all the genes responsible for the initiation and progression of cancer(1-9). These studies involve the sequencing of matched tumour-normal samples followed by mathematical analysis to identify those genes in which mutations occur more frequently than expected by random chance. Here we describe a fundamental problem with cancer genome studies: as the sample size increases, the list of putatively significant genes produced by current analytical methods burgeons into the hundreds. The list includes many implausible genes (such as those encoding olfactory receptors and the muscle protein titin), suggesting extensive false-positive findings that overshadow true driver events. We show that this problem stems largely from mutational heterogeneity and provide a novel analytical methodology, MutSigCV, for resolving the problem. We apply MutSigCV to exome sequences from 3,083 tumour-normal pairs and discover extraordinary variation in mutation frequency and spectrum within cancer types, which sheds light on mutational processes and disease aetiology, and in mutation frequency across the genome, which is strongly correlated with DNA replication timing and also with transcriptional activity. By incorporating mutational heterogeneity into the analyses, MutSigCV is able to eliminate most of the apparent artefactual findings and enable the identification of genes truly associated with cancer.	[Lawrence, Michael S.; Stojanov, Petar; Polak, Paz; Kryukov, Gregory V.; Cibulskis, Kristian; Sivachenko, Andrey; Carter, Scott L.; Stewart, Chip; Mermel, Craig H.; Kiezun, Adam; Hammerman, Peter S.; McKenna, Aaron; Drier, Yotam; Zou, Lihua; Ramos, Alex H.; Pugh, Trevor J.; Stransky, Nicolas; Helman, Elena; Kim, Jaegil; Sougnez, Carrie; Ambrogio, Lauren; Nickerson, Elizabeth; Shefler, Erica; Cortes, Maria L.; Auclair, Daniel; Saksena, Gordon; Voet, Douglas; Noble, Michael; DiCara, Daniel; Lin, Pei; Lichtenstein, Lee; Heiman, David I.; Fennell, Timothy; Imielinski, Marcin; Hernandez, Bryan; Hodis, Eran; Baca, Sylvan; Dulak, Austin M.; Lohr, Jens; Landau, Dan-Avi; Koren, Amnon; McCarroll, Steven A.; Onofrio, Robert; Parkin, Melissa; Winckler, Wendy; Ardlie, Kristin; Gabriel, Stacey B.; Stegmaier, Kimberly; Bass, Adam J.; Garraway, Levi A.; Meyerson, Matthew; Golub, Todd R.; Sunyaev, Shamil; Lander, Eric S.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Stojanov, Petar; Hammerman, Peter S.; Pugh, Trevor J.; Hodis, Eran; Baca, Sylvan; Dulak, Austin M.; Lohr, Jens; Landau, Dan-Avi; Wu, Catherine J.; Lee, Ryan S.; Crompton, Brian; Roberts, Charles W. M.; Stegmaier, Kimberly; Bass, Adam J.; Garraway, Levi A.; Meyerson, Matthew; Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Polak, Paz; Kryukov, Gregory V.; Drier, Yotam; Pugh, Trevor J.; Wu, Catherine J.; Koren, Amnon; McCarroll, Steven A.; Lee, Ryan S.; Roberts, Charles W. M.; Bass, Adam J.; Garraway, Levi A.; Meyerson, Matthew; Golub, Todd R.; Sunyaev, Shamil; Lander, Eric S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Polak, Paz; Kryukov, Gregory V.; Sunyaev, Shamil] Brigham & Womens Hosp, Boston, MA 02115 USA; [Mermel, Craig H.; Drier, Yotam; Imielinski, Marcin; Getz, Gad] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Roberts, Steven A.; Gordenin, Dmitry A.] NIEHS, Lab Mol Genet, NIH, DHHS, Res Triangle Pk, NC 27709 USA; [McKenna, Aaron] Univ Washington, Seattle, WA 98195 USA; [Drier, Yotam; Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Stransky, Nicolas] Blueprint Med, Cambridge, MA 02142 USA; [Helman, Elena; Lander, Eric S.] MIT, Cambridge, MA 02139 USA; [Landau, Dan-Avi] Yale Canc Ctr, Dept Hematol, New Haven, CT 06510 USA; [Melendez-Zajgla, Jorge; Hidalgo-Miranda, Alfredo] Inst Nacl Med Genom, Mexico City 14610, DF, Mexico; [Mora, Jaume] Hosp St Joan de Deu, Dept Pediat Oncol, Barcelona 08950, Spain; [Lee, Ryan S.; Crompton, Brian; Roberts, Charles W. M.; Stegmaier, Kimberly] Boston Childrens Hosp, Boston, MA 02115 USA; [Biegel, Jaclyn A.] Childrens Hosp, Philadelphia, PA 19104 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Yale University; Instituto Nacional de Medicina Genomica; University of Barcelona; Harvard University; Boston Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Lander, ES (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02141 USA.	lander@broadinstitute.org; gadgetz@broadinstitute.org	Kryukov, Gregory V/A-9592-2008; Lawrence, Michael/AAC-8202-2020; Drier, Yotam/K-5208-2012; Melendez-Zajgla, Jorge/A-5708-2008; Dmitry, Gordenin/C-3907-2018; Lee, Ryan/AAE-4319-2019; Stojanov, Petar/GQI-4462-2022; Roberts, Charles/N-2541-2018; Pugh, Trevor/Y-2535-2019; Hidalgo-Miranda, Alfredo/B-2123-2010; Mermel, Craig/AAZ-7322-2020; Watanabe, Naoki/L-6185-2014; Cibulskis, Kristian/AAC-7380-2019; Polak, Paz/AAH-9380-2020	Drier, Yotam/0000-0003-1725-2995; Dmitry, Gordenin/0000-0002-8399-1836; Stojanov, Petar/0000-0001-7815-776X; Roberts, Charles/0000-0003-1135-1896; Pugh, Trevor/0000-0002-8073-5888; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Mermel, Craig/0000-0002-0816-3395; Watanabe, Naoki/0000-0002-5849-6112; Cibulskis, Kristian/0000-0003-1343-1582; Heiman, David/0000-0001-7895-4259; Kryukov, Gregory/0000-0002-6131-9483; Meyerson, Matthew/0000-0002-9133-8108; Mora, Jaume/0000-0002-9386-5980	Intramural Research Program of the National Institute of Environmental Health Sciences (National Institutes of Health, United States Department of Health and Human Services) [ES065073]; NATIONAL CANCER INSTITUTE [U24CA143845, T32CA009216, T32CA009172] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065073, Z01ES065073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Environmental Health Sciences (National Institutes of Health, United States Department of Health and Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was conducted as part of TCGA, a project of the National Cancer Institute and National Human Genome Research Institute. This work was conducted as part of the Slim Initiative for Genomic Medicine, a joint US-Mexico project founded by the Carlos Slim Health Institute. Support to D. A. G. and S. A. R. was through the Intramural Research Program of the National Institute of Environmental Health Sciences (National Institutes of Health, United States Department of Health and Human Services) project ES065073 (principal investigator M. Resnick).	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen CL, 2010, GENOME RES, V20, P447, DOI 10.1101/gr.098947.109; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Jimenez-Pacheco A, 2012, KOREAN J UROL, V53, P240, DOI 10.4111/kju.2012.53.4.240; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016	30	3541	3611	13	432	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					214	218		10.1038/nature12213	http://dx.doi.org/10.1038/nature12213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23770567	Green Accepted, Green Submitted			2022-12-28	WOS:000321557600063
J	Orlando, L; Ginolhac, A; Zhang, GJ; Froese, D; Albrechtsen, A; Stiller, M; Schubert, M; Cappellini, E; Petersen, B; Moltke, I; Johnson, PLF; Fumagalli, M; Vilstrup, JT; Raghavan, M; Korneliussen, T; Malaspinas, AS; Vogt, J; Szklarczyk, D; Kelstrup, CD; Vinther, J; Dolocan, A; Stenderup, J; Velazquez, AMV; Cahill, J; Rasmussen, M; Wang, XL; Min, JM; Zazula, GD; Seguin-Orlando, A; Mortensen, C; Magnussen, K; Thompson, JF; Weinstock, J; Gregersen, K; Roed, KH; Eisenmann, V; Rubin, CJ; Miller, DC; Antczak, DF; Bertelsen, MF; Brunak, S; Al-Rasheid, KAS; Ryder, O; Andersson, L; Mundy, J; Krogh, A; Gilbert, MTP; Kjaer, K; Sicheritz-Ponten, T; Jensen, LJ; Olsen, JV; Hofreiter, M; Nielsen, R; Shapiro, B; Wang, J; Willerslev, E				Orlando, Ludovic; Ginolhac, Aurelien; Zhang, Guojie; Froese, Duane; Albrechtsen, Anders; Stiller, Mathias; Schubert, Mikkel; Cappellini, Enrico; Petersen, Bent; Moltke, Ida; Johnson, Philip L. F.; Fumagalli, Matteo; Vilstrup, Julia T.; Raghavan, Maanasa; Korneliussen, Thorfinn; Malaspinas, Anna-Sapfo; Vogt, Josef; Szklarczyk, Damian; Kelstrup, Christian D.; Vinther, Jakob; Dolocan, Andrei; Stenderup, Jesper; Velazquez, Amhed M. V.; Cahill, James; Rasmussen, Morten; Wang, Xiaoli; Min, Jiumeng; Zazula, Grant D.; Seguin-Orlando, Andaine; Mortensen, Cecilie; Magnussen, Kim; Thompson, John F.; Weinstock, Jacobo; Gregersen, Kristian; Roed, Knut H.; Eisenmann, Vera; Rubin, Carl J.; Miller, Donald C.; Antczak, Douglas F.; Bertelsen, Mads F.; Brunak, Soren; Al-Rasheid, Khaled A. S.; Ryder, Oliver; Andersson, Leif; Mundy, John; Krogh, Anders; Gilbert, M. Thomas P.; Kjaer, Kurt; Sicheritz-Ponten, Thomas; Jensen, Lars Juhl; Olsen, Jesper V.; Hofreiter, Michael; Nielsen, Rasmus; Shapiro, Beth; Wang, Jun; Willerslev, Eske			Recalibrating Equus evolution using the genome sequence of an early Middle Pleistocene horse	NATURE			English	Article							READ ALIGNMENT; DNA; HISTORY; LIKELIHOOD; REVEAL; PERFORMANCE; PATTERNS; CLIMATE; DAMAGE; MARKER	The rich fossil record of equids has made them a model for evolutionary processes(1). Here we present a 1.12-times coverage draft genome from a horse bone recovered from permafrost dated to approximately 560-780 thousand years before present (kyr BP)(2,3). Our data represent the oldest full genome sequence determined so far by almost an order of magnitude. For comparison, we sequenced the genome of a Late Pleistocene horse (43 kyr BP), and modern genomes of five domestic horse breeds (Equus ferus caballus), a Przewalski's horse (E. f. prze-walskii) and a donkey (E. asinus). Our analyses suggest that the Equus lineage giving rise to all contemporary horses, zebras and donkeys originated 4.0-4.5 million years before present (Myr BP), twice the conventionally accepted time to the most recent common ancestor of the genus Equus(4,5). We also find that horse population size fluctuated multiple times over the past 2 Myr, particularly during periods of severe climatic changes. We estimate that the Przewalski's and domestic horse populations diverged 38-72 kyr BP, and find no evidence of recent admixture between the domestic horse breeds and the Przewalski's horse investigated. This supports the contention that Przewalski's horses represent the last surviving wild horse population(6). We find similar levels of genetic variation among Przewalski's and domestic populations, indicating that the former are genetically viable and worthy of conservation efforts. We also find evidence for continuous selection on the immune system and olfaction throughout horse evolution. Finally, we identify 29 genomic regions among horse breeds that deviate from neutrality and show low levels of genetic variation compared to the Przewalski's horse. Such regions could correspond to loci selected early during domestication.	[Orlando, Ludovic; Ginolhac, Aurelien; Schubert, Mikkel; Cappellini, Enrico; Vilstrup, Julia T.; Raghavan, Maanasa; Korneliussen, Thorfinn; Malaspinas, Anna-Sapfo; Stenderup, Jesper; Velazquez, Amhed M. V.; Rasmussen, Morten; Seguin-Orlando, Andaine; Mortensen, Cecilie; Magnussen, Kim; Gregersen, Kristian; Krogh, Anders; Gilbert, M. Thomas P.; Kjaer, Kurt; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark; [Zhang, Guojie; Wang, Xiaoli; Min, Jiumeng; Wang, Jun] BGI Shenzhen, Shenzhen Key Lab Trans Biotechnol, Shenzhen 518083, Peoples R China; [Froese, Duane] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Albrechtsen, Anders; Moltke, Ida; Krogh, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Stiller, Mathias; Cahill, James; Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Petersen, Bent; Vogt, Josef; Brunak, Soren; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Moltke, Ida] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Johnson, Philip L. F.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Fumagalli, Matteo; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Szklarczyk, Damian; Kelstrup, Christian D.; Jensen, Lars Juhl; Olsen, Jesper V.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Vinther, Jakob] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Dolocan, Andrei] Univ Texas Austin, Texas Mat Inst, Austin, TX 78712 USA; [Zazula, Grant D.] Govt Yukon, Dept Tourism & Culture, Yukon Palaeontol Program, Whitehorse, YT Y1A 2C6, Canada; [Seguin-Orlando, Andaine; Mortensen, Cecilie; Magnussen, Kim] Univ Copenhagen, Danish Natl High Throughput DNA Sequencing Ctr, DK-1353 Copenhagen K, Denmark; [Thompson, John F.] NABsys Inc, Providence, RI 02903 USA; [Weinstock, Jacobo] Univ Southampton, Southampton SO17 1BF, Hants, England; [Gregersen, Kristian] Univ Copenhagen, Nat Hist Museum Denmark, Zool Museum, DK-2100 Copenhagen, Denmark; [Roed, Knut H.] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, N-0033 Oslo, Norway; [Eisenmann, Vera] CNRS, MNHN, Dept Hist Terre, UMR 5143,CP 38, F-75005 Paris, France; [Rubin, Carl J.; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, SE-75123 Uppsala, Sweden; [Miller, Donald C.; Antczak, Douglas F.] Cornell Univ, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Bertelsen, Mads F.] Copenhagen Zoo, Ctr Zoo & Wild Anim Hlth, DK-2000 Frederiksberg, Denmark; [Brunak, Soren; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark; [Al-Rasheid, Khaled A. S.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Ryder, Oliver] San Diego Zoos Inst Conservat Res, Escondido, CA 92027 USA; [Mundy, John; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Hofreiter, Michael] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Wang, Jun] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China	University of Copenhagen; Beijing Genomics Institute (BGI); University of Alberta; University of Copenhagen; University of California System; University of California Santa Cruz; Technical University of Denmark; University of Chicago; Emory University; University of California System; University of California Berkeley; University of Copenhagen; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Copenhagen; University of Southampton; University of Copenhagen; Norwegian University of Life Sciences; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Uppsala University; Cornell University; Technical University of Denmark; King Saud University; Zoological Society of San Diego; University of Copenhagen; University of York - UK; University of California System; University of California Berkeley; King Abdulaziz University; Macau University of Science & Technology	Orlando, L (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.	Lorlando@snm.ku.dk; wangjun30@gmail.com; ewillerslev@snm.ku.dk	Korneliussen, Thorfinn Sand/ABB-7656-2021; Zhang, Guojie/J-7273-2019; Cahill, James/AAC-3145-2021; mundy, john/A-2361-2013; Willerslev, Eske/A-9619-2011; Bertelsen, Mads/AAA-5746-2022; Willerslev, Eske/AAA-5686-2019; Moltke, Ida/C-6158-2011; Orlando, Ludovic/A-8932-2013; Kjaer, Kurt/A-4199-2013; Albrechtsen, Anders/K-4281-2013; Wang, Jun/A-7261-2013; Vinther, Jakob/GZG-4679-2022; Olsen, Jesper/ABH-4638-2020; Korneliussen, Thorfinn Sand/F-6421-2014; Jensen, Lars Juhl/C-6492-2008; Schubert, Mikkel/I-6911-2013; AL-Rasheid, Khaled/C-2486-2008; Zhang, Guojie/B-6188-2014; Vilstrup Mouatt, Julia T./N-4553-2017; Gilbert, Marcus TP/A-8936-2013; Fumagalli, Matteo/H-6448-2019; Cappellini, Enrico/F-9346-2013; Sicheritz-Ponten, Thomas/A-4325-2017; Hofreiter, Michael/A-3996-2017; Wang, Jun/B-9503-2016; Brunak, Soren/O-6621-2016; Krogh, Anders/M-1541-2014; Wang, Jun/C-8434-2016; Nielsen, Rasmus/D-4405-2009	Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Zhang, Guojie/0000-0001-6860-1521; mundy, john/0000-0001-7490-4588; Willerslev, Eske/0000-0002-7081-6748; Bertelsen, Mads/0000-0001-9201-7499; Moltke, Ida/0000-0001-7052-8554; Orlando, Ludovic/0000-0003-3936-1850; Kjaer, Kurt/0000-0002-8871-5179; Albrechtsen, Anders/0000-0001-7306-031X; Olsen, Jesper/0000-0002-4747-4938; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Jensen, Lars Juhl/0000-0001-7885-715X; Schubert, Mikkel/0000-0003-2401-9921; AL-Rasheid, Khaled/0000-0002-3404-3397; Zhang, Guojie/0000-0001-6860-1521; Vilstrup Mouatt, Julia T./0000-0001-6534-8452; Gilbert, Marcus TP/0000-0002-5805-7195; Fumagalli, Matteo/0000-0002-4084-2953; Cappellini, Enrico/0000-0001-7885-7811; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Hofreiter, Michael/0000-0003-0441-4705; Kelstrup, Christian Dahl/0000-0003-4647-1425; Raghavan, Maanasa/0000-0003-1997-0739; Vogt, Josef Korbinian/0000-0002-6472-381X; Wang, Jun/0000-0002-2113-5874; Thompson, John/0000-0001-8568-3311; Antczak, Douglas/0000-0003-3336-5818; Brunak, Soren/0000-0003-0316-5866; Cahill, James/0000-0002-7145-0215; Petersen, Bent/0000-0002-2472-8317; Vargas Velazquez, Amhed Missael/0000-0001-7692-0012; Krogh, Anders/0000-0002-5147-6282; Wang, Jun/0000-0002-8540-8931; Shapiro, Beth/0000-0002-2733-7776; Gregersen, Kristian Murphy/0000-0003-3318-1197; Rubin, Carl-Johan/0000-0001-8238-5052; Vinther, Jakob/0000-0002-3584-9616; Malaspinas, Anna-Sapfo/0000-0003-1001-7511; Nielsen, Rasmus/0000-0003-0513-6591	Danish Council for Independent Research, Natural Sciences (FNU); Danish National Research Foundation; Novo Nordisk Foundation; Lundbeck Foundation [R52-A5062, R82-5062]; Marie-Curie Career Integration grant [FP7 CIG-293845]; National Science Foundation [ARC-0909456, DBI-0906041]; Searle Scholars Program; King Saud University Distinguished Scientist Fellowship Program (DSFP); Natural Science and Engineering Research Council of Canada; US National Science Foundation [DMR-0923096]; National Human Genetics Research Institute (NHGRI) [RC2 HG005598]; Marie-Curie Intra-European Fellowship [FP7 IEF-299176]; EMBO Long-Term Post-doctoral Fellowship [ALTF 229-2011]; Swiss National Science Foundation (SNSF); Lundbeck Foundation [R24-2008-2527, R155-2013-16338, R70-2010-6286, R109-2012-9995, R38-2008-3048] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; Villum Fonden [00007171] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI S�ren Brunak, PI Lars Juhl Jensen, PI Jesper Velgaard Olsen] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005598] Funding Source: NIH RePORTER	Danish Council for Independent Research, Natural Sciences (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Marie-Curie Career Integration grant; National Science Foundation(National Science Foundation (NSF)); Searle Scholars Program; King Saud University Distinguished Scientist Fellowship Program (DSFP); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Science Foundation(National Science Foundation (NSF)); National Human Genetics Research Institute (NHGRI); Marie-Curie Intra-European Fellowship(European Commission); EMBO Long-Term Post-doctoral Fellowship(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); Villum Fonden(Villum Fonden); Novo Nordisk Foundation Center for Protein Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Brand, the laboratory technicians at the Danish National High-throughput DNA Sequencing Centre and the Illumina sequencing platform at SciLifeLab-Uppsala for technical assistance; J. Clausen for help with the donkey samples; S. Rasmussen for computational assistance; J. N. MacLeod and T. Kalbfleisch for discussions involving the re-sequencing of the horse reference genome; and S. Sawyer for providing published ancient horse data. This work was supported by the Danish Council for Independent Research, Natural Sciences (FNU); the Danish National Research Foundation; the Novo Nordisk Foundation; the Lundbeck Foundation (R52-A5062); a Marie-Curie Career Integration grant (FP7 CIG-293845); the National Science Foundation ARC-0909456; National Science Foundation DBI-0906041; the Searle Scholars Program; King Saud University Distinguished Scientist Fellowship Program (DSFP); Natural Science and Engineering Research Council of Canada; the US National Science Foundation DMR-0923096; and a grant RC2 HG005598 from the National Human Genetics Research Institute (NHGRI). A. G. was supported by a Marie-Curie Intra-European Fellowship (FP7 IEF-299176). M. F. was supported by EMBO Long-Term Post-doctoral Fellowship (ALTF 229-2011). A.-S.M. was supported by a fellowship from the Swiss National Science Foundation (SNSF). Mi.S. was supported by the Lundbeck foundation (R82-5062).	Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Bowling AT, 2003, CYTOGENET GENOME RES, V102, P226, DOI 10.1159/000075754; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Cappellini E, 2012, J PROTEOME RES, V11, P917, DOI 10.1021/pr200721u; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eisenmann V., 1992, COUR FORSCH SENCKENB, V153, P161; FORSTEN A, 1991, ANN ZOOL FENN, V28, P301; Franzen JL., 2010, RISE HORSES 55 MILLI; Froese DG, 2008, SCIENCE, V321, P1648, DOI 10.1126/science.1157525; Ginolhac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-177; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Goto H, 2011, GENOME BIOL EVOL, V3, P1096, DOI 10.1093/gbe/evr067; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; International Union for Conservation of Nature, IUCN RED LIST THREAT; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Macfadden Bruce J., 2002, Bulletin of the Florida Museum of Natural History, V43, P163; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Meyer M., 2010, COLD SPRING HARB PRO, V6; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Rambaut A, 2009, TRACER V1 5; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reyes AV, 2010, QUATERNARY SCI REV, V29, P3256, DOI 10.1016/j.quascirev.2010.07.013; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Stamatakis A, 2012, BIOINFORMATICS, V28, P2064, DOI 10.1093/bioinformatics/bts309; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; van Doorn NL, 2012, RAPID COMMUN MASS SP, V26, P2319, DOI 10.1002/rcm.6351; Vilstrup JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055950; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241; Westgate JA, 2009, CAN J EARTH SCI, V46, P465, DOI 10.1139/E09-029; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Zhang Z., 2006, COMPUTATIONAL MOL EV	65	512	540	21	528	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					74	+		10.1038/nature12323	http://dx.doi.org/10.1038/nature12323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23803765				2022-12-28	WOS:000321285600036
J	Housden, NG; Hopper, JTS; Lukoyanova, N; Rodriguez-Larrea, D; Wojdyla, JA; Klein, A; Kaminska, R; Bayley, H; Saibil, HR; Robinson, CV; Kleanthous, C				Housden, Nicholas G.; Hopper, Jonathan T. S.; Lukoyanova, Natalya; Rodriguez-Larrea, David; Wojdyla, Justyna A.; Klein, Alexander; Kaminska, Renata; Bayley, Hagan; Saibil, Helen R.; Robinson, Carol V.; Kleanthous, Colin			Intrinsically Disordered Protein Threads Through the Bacterial Outer-Membrane Porin OmpF	SCIENCE			English	Article							COMPETITIVE RECRUITMENT; COLICIN TRANSLOCATION; DOMAIN; TOLB; COMPLEXES; IMMUNITY; E9	Porins are beta-barrel outer-membrane proteins through which small solutes and metabolites diffuse that are also exploited during cell death. We have studied how the bacteriocin colicin E9 (ColE9) assembles a cytotoxic translocon at the surface of Escherichia coli that incorporates the trimeric porin OmpF. Formation of the translocon involved ColE9's unstructured N-terminal domain threading in opposite directions through two OmpF subunits, capturing its target TolB on the other side of the membrane in a fixed orientation that triggers colicin import. Thus, an intrinsically disordered protein can tunnel through the narrow pores of an oligomeric porin to deliver an epitope signal to the cell to initiate cell death.	[Housden, Nicholas G.; Wojdyla, Justyna A.; Klein, Alexander; Kaminska, Renata; Kleanthous, Colin] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Hopper, Jonathan T. S.; Rodriguez-Larrea, David; Bayley, Hagan; Robinson, Carol V.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Lukoyanova, Natalya; Saibil, Helen R.] Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; [Lukoyanova, Natalya; Saibil, Helen R.] Univ London Birkbeck Coll, Inst Struct Mol Biol, London WC1E 7HX, England	University of Oxford; University of Oxford; University of London; Birkbeck University London; University of London; Birkbeck University London	Kleanthous, C (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	colin.kleanthous@bioch.ox.ac.uk	Rodriguez-Larrea, David/ABH-3171-2020	Rodriguez-Larrea, David/0000-0002-5580-7413; robinson, carol/0000-0001-7829-5505; Housden, Nicholas/0000-0002-4706-8278; Kaminska, Renata/0000-0001-7252-379X; Lukoyanova, Natalya/0000-0002-2051-0812; Bayley, Hagan/0000-0003-2499-6116	Department of Biochemistry (University of Oxford); National Institutes of Health [ROI HG003709]; Medical Research Council; European Research Council (ERC) Impress; Royal Society; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D00873/1]; ERC [294408]; Wellcome Trust [079605/2/06/2, WT082045]; BBSRC [BB/G020671/1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003709] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G020671/2, BB/D008573/1, BB/G020671/1] Funding Source: researchfish; Medical Research Council [G1000819] Funding Source: researchfish; BBSRC [BB/D008573/1, BB/G020671/2] Funding Source: UKRI; MRC [G1000819] Funding Source: UKRI	Department of Biochemistry (University of Oxford); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council (ERC) Impress(European Research Council (ERC)); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Johnson (Department of Pathology, University of Oxford) for help with SEC-MALS experiments and D. Ashford (Department of Biology, York University) for LC-MS data. N.G.H. acknowledges the Department of Biochemistry (University of Oxford) for financial support. D. R.-L. was supported by the National Institutes of Health (grant ROI HG003709). C. V. R. acknowledges the Medical Research Council, European Research Council (ERC) Impress, and the Royal Society for financial support. H. R. S. acknowledges support from the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/D00873/1), ERC (294408), and The Wellcome Trust (079605/2/06/2). This work was supported by grants to C. K. from The Wellcome Trust (WT082045) and the BBSRC (BB/G020671/1). Atomic coordinates and structural amplitudes have been deposited in the Protein Data Bank (PDB) under accession number 4JML. The EM map has been deposited in the EM databank under accession number EMD-2372.	Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Bonsor DA, 2007, J AM CHEM SOC, V129, P4800, DOI 10.1021/ja070153n; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Cornforth DM, 2013, NAT REV MICROBIOL, V11, P285, DOI 10.1038/nrmicro2977; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Farrance OE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001489; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107; Jakes KS, 2012, ANNU REV GENET, V46, P209, DOI 10.1146/annurev-genet-110711-155427; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; Kleanthous C, 1999, NAT STRUCT BIOL, V6, P243, DOI 10.1038/6683; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; Laganowsky A, 2013, NAT PROTOC, V8, P639, DOI 10.1038/nprot.2013.024; Loftus SR, 2006, P NATL ACAD SCI USA, V103, P12353, DOI 10.1073/pnas.0603433103; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Papadakos G, 2012, J MOL BIOL, V418, P269, DOI 10.1016/j.jmb.2012.01.039; SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347; Schulz GE, 1993, CURR OPIN CELL BIOL, V5, P701, DOI 10.1016/0955-0674(93)90143-E; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Vankemmelbeke M, 2009, J BIOL CHEM, V284, P18932, DOI 10.1074/jbc.M806149200; Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137; Zakharov SD, 2004, BIOPHYS J, V87, P3901, DOI 10.1529/biophysj.104.046151; Zeth K, 2010, BIOCHEM J, V431, P13, DOI 10.1042/BJ20100371	25	92	94	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1570	1574		10.1126/science.1237864	http://dx.doi.org/10.1126/science.1237864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812713	Green Accepted			2022-12-28	WOS:000321007000041
J	Evans, DG; Graham, J; O'Connell, S; Arnold, S; Fitzsimmons, D				Evans, D. Gareth; Graham, John; O'Connell, Susan; Arnold, Stephanie; Fitzsimmons, Deborah			GUIDELINES Familial breast cancer: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Evans, D. Gareth] St Marys Hosp, Dept Med Genet, Manchester M13 9WL, Lancs, England; [Graham, John; O'Connell, Susan; Arnold, Stephanie] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales; [Fitzsimmons, Deborah] Swansea Univ, Swansea Ctr Hlth Econ, Swansea SA2 8PP, W Glam, Wales	University of Manchester; Swansea University	Graham, J (corresponding author), Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales.	john.graham@nhs.net	Evans, D Gareth/AAB-4308-2022; O'Connell, Susan/V-8945-2019	Evans, D Gareth/0000-0002-8482-5784; Graham, John/0000-0003-3381-9787				Evans DGR, 2009, J MED GENET, V46, P811, DOI 10.1136/jmg.2009.067850; National Institute for Health and Care Excellence, 2004, FAM BREAST CANC CLAS; National Institute for Health and Care Excellence, 2006, FAM BREAST CANC CLAS; National Institute for Health and Care Excellence, 2009, EARL LOC ADV BREAT C; National Institute for Health and Care Excellence, 2019, FAM BREAST CANC CLAS; NHS Breast Screening Programme, 2013, NHSBSP PUBL, V74; Public Health and Primary Care University of Cambridge, BOADICEA BOADICEA IS; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668	8	47	49	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2013	346								f3829	10.1136/bmj.f3829	http://dx.doi.org/10.1136/bmj.f3829			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QI	23801680				2022-12-28	WOS:000321245900002
J	Hildner, R; Brinks, D; Nieder, JB; Cogdell, RJ; van Hulst, NF				Hildner, Richard; Brinks, Daan; Nieder, Jana B.; Cogdell, Richard J.; van Hulst, Niek F.			Quantum Coherent Energy Transfer over Varying Pathways in Single Light-Harvesting Complexes	SCIENCE			English	Article							PIGMENT-PROTEIN COMPLEXES; MATTHEWS-OLSON COMPLEX; DYNAMICS; PHOTOSYNTHESIS; SPECTROSCOPY; LH2; TEMPERATURE; MOLECULES; SYSTEMS	The initial steps of photosynthesis comprise the absorption of sunlight by pigment-protein antenna complexes followed by rapid and highly efficient funneling of excitation energy to a reaction center. In these transport processes, signatures of unexpectedly long-lived coherences have emerged in two-dimensional ensemble spectra of various light-harvesting complexes. Here, we demonstrate ultrafast quantum coherent energy transfer within individual antenna complexes of a purple bacterium under physiological conditions. We find that quantum coherences between electronically coupled energy eigenstates persist at least 400 femtoseconds and that distinct energy-transfer pathways that change with time can be identified in each complex. Our data suggest that long-lived quantum coherence renders energy transfer in photosynthetic systems robust in the presence of disorder, which is a prerequisite for efficient light harvesting.	[Hildner, Richard; Brinks, Daan; Nieder, Jana B.; van Hulst, Niek F.] ICFO Inst Ciencies Foton, Castelldefels 08860, Barcelona, Spain; [Cogdell, Richard J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8TA, Lanark, Scotland; [van Hulst, Niek F.] ICREA Inst Catalana Recerca & Estudis Avancats, Barcelona 08015, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); University of Glasgow; ICREA	van Hulst, NF (corresponding author), ICFO Inst Ciencies Foton, Mediterranean Technol Pk, Castelldefels 08860, Barcelona, Spain.	niek.vanhulst@icfo.eu	Hildner, Richard/O-6386-2014; van Hulst, Niek/J-2121-2012; Nieder, Jana/N-1652-2013; Nieder, Jana B./N-3464-2019	Hildner, Richard/0000-0002-7282-3730; van Hulst, Niek/0000-0003-4630-1776; Nieder, Jana/0000-0002-4973-1889; Nieder, Jana B./0000-0002-4973-1889; Brinks, Daan/0000-0002-5550-5140	Ministerio de Ciencia e Innovacion [CSD2007-046-NanoLight.es, MAT2006-08184, FIS2009-08203]; European Union (European Research Council) [247330]; Fundacio CELLEX (Barcelona); Biotechnology and Biological Sciences Research Council (Glasgow); Netherlands Organization for Scientific Research (NWO); German Research Foundation (DFG) [GRK 1640]; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Union (European Research Council)(European Research Council (ERC)European Commission); Fundacio CELLEX (Barcelona)(Foundation CELLEXEuropean Commission); Biotechnology and Biological Sciences Research Council (Glasgow)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); German Research Foundation (DFG)(German Research Foundation (DFG)); ICREA(ICREA)	We thank F. D. Stefani, F. Kulzer, and T. H. Taminiau for discussions and assistance with the experimental setup. Funding by Ministerio de Ciencia e Innovacion (CSD2007-046-NanoLight.es, MAT2006-08184, and FIS2009-08203), the European Union (European Research Council advanced grant no. 247330, FP6 Bio-Light-Touch), Fundacio CELLEX (Barcelona) and the Biotechnology and Biological Sciences Research Council (Glasgow) is gratefully acknowledged. D.B. acknowledges support by a Rubicon grant of the Netherlands Organization for Scientific Research (NWO), and R.H. by the German Research Foundation (DFG, GRK 1640).	Beljonne D, 2009, J PHYS CHEM B, V113, P6583, DOI 10.1021/jp900708f; Bopp MA, 1999, P NATL ACAD SCI USA, V96, P11271, DOI 10.1073/pnas.96.20.11271; Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Chin AW, 2013, NAT PHYS, V9, P113, DOI 10.1038/nphys2515; Cogdell RJ, 2006, Q REV BIOPHYS, V39, P227, DOI 10.1017/S0033583506004434; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Curutchet C, 2011, J AM CHEM SOC, V133, P3078, DOI 10.1021/ja110053y; Fransted KA, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4752107; Harel E, 2012, P NATL ACAD SCI USA, V109, P706, DOI 10.1073/pnas.1110312109; Herek JL, 2000, BIOPHYS J, V78, P2590, DOI 10.1016/S0006-3495(00)76803-2; Herek JL, 2002, NATURE, V417, P533, DOI 10.1038/417533a; Hildner R, 2011, NAT PHYS, V7, P172, DOI [10.1038/nphys1858, 10.1038/NPHYS1858]; Hoyer S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041911; Katz G, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/1/015003; Kim HW, 2012, J AM CHEM SOC, V134, P11640, DOI 10.1021/ja303025q; Kosumi D, 2011, ANGEW CHEM INT EDIT, V50, P1097, DOI 10.1002/anie.201003771; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; Mohseni M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3002335; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Plenio MB, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/11/113019; Prokhorenko VI, 2006, SCIENCE, V313, P1257, DOI 10.1126/science.1130747; Rebentrost P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033003; Rutkauskas D, 2006, BIOPHYS J, V90, P2475, DOI 10.1529/biophysj.105.075903; Scholes GD, 2003, ANNU REV PHYS CHEM, V54, P57, DOI 10.1146/annurev.physchem.54.011002.103746; Scholes GD, 2010, J PHYS CHEM LETT, V1, P2, DOI 10.1021/jz900062f; Shim S, 2012, BIOPHYS J, V102, P649, DOI 10.1016/j.bpj.2011.12.021; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; van Oijen AM, 1999, SCIENCE, V285, P400, DOI 10.1126/science.285.5426.400; Wu HM, 1996, J PHYS CHEM-US, V100, P12022, DOI 10.1021/jp9608178; Zigmantas D, 2006, P NATL ACAD SCI USA, V103, P12672, DOI 10.1073/pnas.0602961103	31	240	245	4	321	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1448	1451		10.1126/science.1235820	http://dx.doi.org/10.1126/science.1235820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23788794				2022-12-28	WOS:000320647000041
J	Larson, EB				Larson, Eric B.			Building Trust in the Power of "Big Data" Research to Serve the Public Good	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE-SYSTEM		Grp Hlth Res Inst, Seattle, WA 98101 USA		Larson, EB (corresponding author), Grp Hlth Res Inst, 1730 Minor Ave,Ste 1600, Seattle, WA 98101 USA.	larson.e@ghc.org			National Center for Complementary & Integrative Health [U54AT007748] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375] Funding Source: NIH RePORTER; NCCIH NIH HHS [U54AT007748-01] Funding Source: Medline; NHGRI NIH HHS [U01 HG006375] Funding Source: Medline	National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Greene SM, 2012, ANN INTERN MED, V157, P207, DOI 10.7326/0003-4819-157-3-201208070-00012; Ludman EJ, 2010, J EMPIR RES HUM RES, V5, P9, DOI 10.1525/jer.2010.5.3.9; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Okun S, 2013, MAKING CASE CONTINOU; Olsen L, LEARNING HEALTHCARE; Psaty BM, 2013, JAMA-J AM MED ASSOC, V309, P1895, DOI 10.1001/jama.2013.3445; Smith M, 2012, JAMA-J AM MED ASSOC, V308, P1637, DOI 10.1001/jama.2012.13664; Solomon MZ, 2013, HASTINGS CENT REP, V43, pS2, DOI 10.1002/hast.132; Taplin SH, 2004, CANCER EPIDEM BIOMAR, V13, P225, DOI 10.1158/1055-9965.EPI-03-0206	10	56	57	1	120	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2443	2444		10.1001/jama.2013.5914	http://dx.doi.org/10.1001/jama.2013.5914			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23780455				2022-12-28	WOS:000320505100022
J	Tinetti, M				Tinetti, Mary			Review: Acute geriatric unit care reduces falls, delirium, and functional decline	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Tinetti, M (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.			Fox, Mary/0000-0003-0572-3892				Lin Jennifer S, 2012, J Am Geriatr Soc, V60, P2157, DOI 10.1111/j.1532-5415.2012.04214.x	1	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12							JC11	10.7326/0003-4819-158-12-201306180-02011	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778923				2022-12-28	WOS:000320645000010
J	White, A; Danis, M				White, Amina; Danis, Marion			Enhancing Patient-Centered Communication and Collaboration by Using the Electronic Health Record in the Examination Room	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACTIVATION		[White, Amina; Danis, Marion] NIH, Dept Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	White, A (corresponding author), NIH, 10 Ctr Dr,Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	amina.white@nih.gov			Intramural NIH HHS [Z99 CL999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alegria M, 2008, MED CARE, V46, P247, DOI 10.1097/MLR.0b013e318158af52; Delbanco T, 2012, ANN INTERN MED, V157, P461, DOI 10.7326/0003-4819-157-7-201210020-00002; Greene J, 2012, J GEN INTERN MED, V27, P520, DOI 10.1007/s11606-011-1931-2; Montague E, 2011, HUM FACTORS, V53, P502, DOI 10.1177/0018720811405986; Peterson D, 2011, ACAD PSYCHIATR, V35, P76, DOI 10.1176/appi.ap.35.2.76; Puhl R, 2013, INT J OBESITY, V37, P612, DOI 10.1038/ijo.2012.110; Shachak A, 2009, J EVAL CLIN PRACT, V15, P641, DOI 10.1111/j.1365-2753.2008.01065.x; Ventres W, 2006, ANN FAM MED, V4, P124, DOI 10.1370/afm.425	8	72	72	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2327	2328		10.1001/jama.2013.6030	http://dx.doi.org/10.1001/jama.2013.6030			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161EV	23757080	Green Accepted			2022-12-28	WOS:000320176000019
J	Preitner, N; Quan, J; Flanagan, JG				Preitner, Nicolas; Quan, Jie; Flanagan, John G.			This Message Will Self-Destruct: NMD Regulates Axon Guidance	CELL			English	Editorial Material							PROTEIN-SYNTHESIS; EXPRESSION	The navigation of axons to their final destination can involve a sequence of steps that require different sets of guidance receptors. In this issue, Colak et al. show that regulated intra- axonal protein synthesis coupled to nonsense- mediated mRNA decay (NMD) controls a switch in Robo3.2 expression that is critical for navigation.	[Preitner, Nicolas; Quan, Jie; Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol & Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol & Program Neurosci, Boston, MA 02115 USA.	flanagan@hms.harvard.edu	Flanagan, John/AAM-2995-2020		NEI NIH HHS [R01 EY011559] Funding Source: Medline; NICHD NIH HHS [P30 HD018655, R37 HD029417] Funding Source: Medline; NINDS NIH HHS [R01 NS069913] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069913] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Black DL, 2008, NEURON, V58, P297, DOI 10.1016/j.neuron.2008.04.019; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Colak D, 2013, CELL, V153, P1252, DOI 10.1016/j.cell.2013.04.056; Dickson BJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002055; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Reeber SL, 2008, J NEUROSCI, V28, P8698, DOI 10.1523/JNEUROSCI.1479-08.2008	10	4	4	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1185	1187		10.1016/j.cell.2013.05.019	http://dx.doi.org/10.1016/j.cell.2013.05.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746834	Green Accepted, Bronze			2022-12-28	WOS:000319979200003
J	Lieberman, J; Slack, F; Pandolfi, PP; Chinnaiyan, A; Agami, R; Mendell, JT				Lieberman, Judy; Slack, Frank; Pandolfi, Pier Paolo; Chinnaiyan, Arul; Agami, Reuven; Mendell, Joshua T.			Noncoding RNAs and Cancer	CELL			English	News Item									[Lieberman, Judy] Boston Childrens Hosp, Beth Israel Deaconess Med Ctr, Boston, MA 06520 USA; [Slack, Frank] Yale Univ, New Haven, CT 02138 USA; [Pandolfi, Pier Paolo] Harvard Univ, Cambridge, MA 48109 USA; [Chinnaiyan, Arul] Univ Michigan, SW Med Ctr, Ann Arbor, MI USA; [Agami, Reuven] Netherlands Canc Inst, Amsterdam, Netherlands; [Mendell, Joshua T.] Univ Texas Dallas, Dallas, TX USA	Harvard University; Beth Israel Deaconess Medical Center; Boston Children's Hospital; Yale University; Harvard University; University of Michigan System; University of Michigan; University of Texas System; University of Texas Southwestern Medical Center Dallas; Netherlands Cancer Institute; University of Texas System; University of Texas Dallas			Lieberman, Judy/A-2717-2015; agami, reuven/GOG-8289-2022	Agami, Reuven/0000-0002-2848-2473; Pandolfi, Pier Paolo/0000-0002-5352-5295; Slack, Frank/0000-0001-8263-0409					0	35	36	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					9	10		10.1016/j.cell.2013.03.019	http://dx.doi.org/10.1016/j.cell.2013.03.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23781554	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000316853700024
J	Petrisor, BA; Drew, B; Rajaratnam, K; Williams, D; Wong, I; Kwok, D; Denkers, M; Cameron, A; Resendes, S; Ramnath, I; Chien, T; Pham, NK; Avram, V; Ayeni, OR; de Beer, J; Winemaker, M; Ogilvie, R; Peterson, D; Swaleh, R; Schemitsch, EH; Hall, J; McKee, M; Waddell, J; Daniels, T; Whelan, D; Bogoch, E; Nauth, A; Vicente, M; Hidy, J; Puskas, D; LeFrancois, T; Coles, C; Glazebrook, M; Leighton, R; Johnston, D; Dobbin, G; Trask, K; MacDonald, S; Stairs, J; Duffy, P; Buckley, R; Korley, R; Puloski, S; Carcary, K; McColl, J; Brister, D; Lemke, HM; Boyer, D; McCormack, R; Perey, B; Moola, F; Stone, T; Viskontas, D; Apostle, K; Zomar, M; Oatt, A; Moon, K; Della Rocca, GJ; Crist, BD; Volgas, DA; Anderson, LK; Beshears, JL; Evans, JL; Poolman, RW; Scholtes, VA; Opdam, K; de Waal, E; Haverlag, R; Goslings, JC; Beerekamp, MSH; Brink, O; Sancheti, P; Rocha, S; Shende, M				Petrisor, Brad A.; Drew, Brian; Rajaratnam, Krishan; Williams, Dale; Wong, Ivan; Kwok, Desmond; Denkers, Matt; Cameron, Alicia; Resendes, Sarah; Ramnath, Ivanna; Chien, Teresa; Pham, Ngan K.; Avram, Victoria; Ayeni, Olufemi R.; de Beer, Justin; Winemaker, Mitchell; Ogilvie, Rick; Peterson, Devin; Swaleh, Rukia; Schemitsch, Emil H.; Hall, Jeremy; McKee, Michael; Waddell, James; Daniels, Timothy; Whelan, Daniel; Bogoch, Earl; Nauth, Aaron; Vicente, Milena; Hidy, Jennifer; Puskas, David; LeFrancois, Tina; Coles, Chad; Glazebrook, Mark; Leighton, Ross; Johnston, David; Dobbin, Gwen; Trask, Kelly; MacDonald, Shelley; Stairs, Jocelyn; Duffy, Paul; Buckley, Richard; Korley, Robert; Puloski, Shannon; Carcary, Kimberly; McColl, Jeanine; Brister, Danica; Lemke, H. Michael; Boyer, Dory; McCormack, Robert; Perey, Bertrand; Moola, Farhad; Stone, Trevor; Viskontas, Darius; Apostle, Kelly; Zomar, Mauri; Oatt, Amber; Moon, Karyn; Della Rocca, Gregory J.; Crist, Brett D.; Volgas, David A.; Anderson, Linda K.; Beshears, Jacqueline L.; Evans, Jessica L.; Poolman, Rudolf W.; Scholtes, Vanessa A.; Opdam, Kim; de Waal, Esri; Haverlag, Robert; Goslings, J. Carel; Beerekamp, M. S. H.; Brink, Ole; Sancheti, Parag; Rocha, Steve; Shende, Mangesh		PRAISE Investigators	Prevalence of abuse and intimate partner violence surgical evaluation (PRAISE) in orthopaedic fracture clinics: a multinational prevalence study	LANCET			English	Article							DOMESTIC VIOLENCE; HEALTH; WOMEN; KNOWLEDGE	Background Intimate partner violence (IPV) is the leading cause of non-fatal injury to women worldwide. Musculoskeletal injuries, which are often seen by orthopaedic surgeons, are the second most common manifestation of IPV. We aimed to establish the 12-month and lifetime prevalence of IPV in women presenting to orthopaedic fracture clinics. Methods The PRAISE team of 80 investigators did a cross-sectional study of a consecutive sample of 2945 female participants at 12 orthopaedic fracture clinics in Canada, the USA, the Netherlands, Denmark, and India. Participants who met the eligibility criteria anonymously answered direct questions about physical, emotional, and sexual IPV, and completed two previously developed questionnaires (Women Abuse Screening Tool [WAST] and Partner Violence Screen [PVS]). We did a multivariable logistic regression analysis to investigate the risk factors associated with IPV. Findings The overall response rate was 85% (2344 of 2759 patients provided informed consent). One in six women (455/2839, 16.0%, 95% CI 14.7-17.4%) disclosed a history of IPV within the past year, and one in three (882/2550, 34.6%, 32.8-36.5%) had experienced IPV in their lifetime. 49 women (1.7%, 1.3-2.2%) attended their clinic visit as a direct consequence of IPV, only seven of whom (14%) had ever been asked about IPV in a health-care setting. Women in short-term relationships (OR 0.584, 99% CI 0.396-0.860, p=0.0001) were at increased risk of IPV and physical abuse in the past 12 months in this study. Compared with women in Canada and the USA, those in the Netherlands and Denmark were at reduced risk of any abuse in the past 12 months, physical abuse in lifetime, and any abuse in lifetime (OR 0.595, 99% CI 0.427-0.830, p<0.0001; 0.630, 0.445-0.890, p=0.001; and 0.464, 0.352-0.612, p<0.0001, respectively). Interpretation PRAISE is the largest prevalence study done so far in orthopaedics. Orthopaedic surgeons should be confident in the assumption that one in six women have a history of physical abuse, and that one in 50 injured women will present to the clinic as a direct result of IPV. Our findings warrant serious consideration for fracture clinics to improve identification of, respond to, and provide referral services for, victims of IPV.					Poolman, Rudolf/AAM-7815-2020; Rajaratnam, Krishan/AAQ-5211-2021; Petrisor, Brad/AAQ-2278-2021; Crist, Brett D/AAC-7535-2019; Winemaker, Mitchell/AAQ-5131-2021; Schemitsch, Emil/G-5706-2017; Della Rocca, Gregory/AAM-5281-2021; ayeni, olufemi/AAQ-5090-2021; Madden, Kim/N-5761-2015	Poolman, Rudolf/0000-0003-3178-2247; Crist, Brett D/0000-0002-3340-1156; Schemitsch, Emil/0000-0002-6435-9069; ayeni, olufemi/0000-0003-4219-8564; Madden, Kim/0000-0002-2861-9636; Coles, Chad/0000-0003-0454-3507; Stairs, Jocelyn/0000-0002-6748-2310; Nauth, Aaron/0000-0002-9186-7747	Orthopaedic Trauma Association; Canadian Orthopaedic Foundation; McMaster University Surgical Associates; Canada Research Chair	Orthopaedic Trauma Association; Canadian Orthopaedic Foundation; McMaster University Surgical Associates; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	Orthopaedic Trauma Association, Canadian Orthopaedic Foundation, and the McMaster University Surgical Associates. MB is partly funded by a Canada Research Chair.	ABBOTT J, 1995, JAMA-J AM MED ASSOC, V273, P1763, DOI 10.1001/jama.273.22.1763; Bhandari M, 2006, J TRAUMA, V61, P1473, DOI 10.1097/01.ta.0000196419.36019.5a; Bhandari M, 2011, J BONE JOINT SURG AM, V93A, P132, DOI 10.2106/JBJS.I.01713; Bhandari M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-77; Bonomi AE, 2007, J WOMENS HEALTH, V16, P987, DOI 10.1089/jwh.2006.0239; Bota GW, CAN FAM PHYS, V50, P90; Brown J B, 1996, Fam Med, V28, P422; Campbell JC, 2009, J INTERPERS VIOLENCE, V24, P653, DOI 10.1177/0886260508317180; Canadian Orthopaedic Association (COA), 2009, INT PART VIOL POS ST; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; Della Rocca GJ, 2013, CLIN ORTHOP RELAT R, V471, P1074, DOI 10.1007/s11999-012-2749-x; Feder G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13160; Feldhaus KM, 1997, JAMA-J AM MED ASSOC, V277, P1357, DOI 10.1001/jama.277.17.1357; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Houry D, 2006, AM J EMERG MED, V24, P444, DOI 10.1016/j.ajem.2005.12.026; International Center for Research on Women, 2000, DOM VIOL IND SUMM RE; Kimuna SR, 2013, J INTERPERS VIOLENCE, V28, P773, DOI 10.1177/0886260512455867; Leppakoski T, 2013, J CLIN NURS, V22, P2273, DOI 10.1111/j.1365-2702.2012.04202.x; Liebschutz JM, 2012, NEW ENGL J MED, V367, P2071, DOI 10.1056/NEJMp1204278; MCCAULEY J, 1995, ANN INTERN MED, V123, P737, DOI 10.7326/0003-4819-123-10-199511150-00001; Moracco KE, 2009, JAMA-J AM MED ASSOC, V302, P568, DOI 10.1001/jama.2009.1135; Naing L, 2006, ARCH OROFAC SCI, V1, P9; Ontario Domestic Violence Death Review Committee, 2012, 2011 ANN REP ONT DOM; Rabin RF, 2009, AM J PREV MED, V36, P439, DOI 10.1016/j.amepre.2009.01.024; Richardson J, 2002, BRIT MED J, V324, P274, DOI 10.1136/bmj.324.7332.274; Rivara FP, 2007, AM J PREV MED, V32, P89, DOI 10.1016/j.amepre.2006.10.001; Rodriguez MA, 1999, JAMA-J AM MED ASSOC, V282, P468, DOI 10.1001/jama.282.5.468; Sohani Z, 2013, J INTERPERS VIOLENCE, V28, P1455, DOI 10.1177/0886260512468244; Sprague S, VIOLENCE WO IN PRESS; Sprague S, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-23; U.S. Preventive Services Task Force (USPSTF), 2013, SCREEN INT PARTN VIO; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Waalen J, 2000, AM J PREV MED, V19, P230, DOI 10.1016/S0749-3797(00)00229-4; Yut-Lin W, 2008, ASIA-PAC J PUBLIC HE, V20, P102, DOI 10.1177/1010539507311899	35	46	46	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2013	382	9895					866	876		10.1016/S0140-6736(13)61205-2	http://dx.doi.org/10.1016/S0140-6736(13)61205-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215WE	23768757				2022-12-28	WOS:000324240700028
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for Hepatitis C Virus Infection in Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; ALL-CAUSE MORTALITY; PERSONS BORN; MANAGEMENT; ASSOCIATION; ANTIBODY; FIBROSIS	Description: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for and treatment of hepatitis C virus (HCV) infection in asymptomatic adults. Methods: The Agency for Healthcare Research and Quality commissioned 2 systematic reviews on screening for and treatment of HCV infection in asymptomatic adults, focusing on evidence gaps identified in the previous USPSTF recommendation and new studies published since 2004. The evidence on screening for HCV in pregnant women was also considered. Population: This recommendation applies to all asymptomatic adults without known liver disease or functional abnormalities. Recommendation: The USPSTF recommends screening for HCV infection in persons at high risk for infection. The USPSTF also recommends offering 1-time screening for HCV infection to adults born between 1945 and 1965. (B recommendation)	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.			Pignone, Michael/0000-0002-6657-7342; Martin, Natasha/0000-0001-8344-1810	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Academy of Family Physicians, 2004, CLIN PREV SERV HEP; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Berg AO, 2004, ANN INTERN MED, V140, P462, DOI 10.7326/0003-4819-140-6-200403160-00013; Brodt E, AHRQ PUBLICATION; Centers for Disease Control and Prevention, 2010, VIR HEP SURV US 2010; Chou R, 2012, AHRQ PUBLICATION; Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P225, DOI 10.1053/j.gastro.2005.11.011; Gangadharan D, 2013, MMWR RECOMM REP, V62, P1; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Groessl EJ, 2011, J VIRAL HEPATITIS, V18, P358, DOI 10.1111/j.1365-2893.2010.01328.x; Kimer N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001313; Liu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058975; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Myers RP, 2002, AM J GASTROENTEROL, V97, P2419, DOI 10.1111/j.1572-0241.2002.05997.x; Pembrey L, 2005, CLIN INFECT DIS, V41, P45, DOI 10.1086/430601; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Smith BD, 2011, HEPATOLOGY, V54, p554A; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; 1998, MMWR RECOMM REP, V98, P1	20	364	365	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2013	159	5					349	+		10.7326/0003-4819-159-5-201309030-00672	http://dx.doi.org/10.7326/0003-4819-159-5-201309030-00672			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215YA	23798026				2022-12-28	WOS:000324245900006
J	Sun, XJ; Wang, ZX; Wang, L; Jiang, YW; Kost, N; Soong, TD; Chen, WY; Tang, ZY; Nakadai, T; Elemento, O; Fischle, W; Melnick, A; Patel, DJ; Nimer, SD; Roeder, RG				Sun, Xiao-Jian; Wang, Zhanxin; Wang, Lan; Jiang, Yanwen; Kost, Nils; Soong, T. David; Chen, Wei-Yi; Tang, Zhanyun; Nakadai, Tomoyoshi; Elemento, Olivier; Fischle, Wolfgang; Melnick, Ari; Patel, Dinshaw J.; Nimer, Stephen D.; Roeder, Robert G.			A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; FUSION PARTNER; ETO; PROTEINS; T(8/21); BINDING; DIFFERENTIATION; DOMAIN; SEQ; TRANSLOCATION	Transcription factors are frequently altered in leukaemia through chromosomal translocation, mutation or aberrant expression(1). AML1-ETO, a fusion protein generated by the t(8;21) translocation in acute myeloid leukaemia, is a transcription factor implicated in both gene repression and activation(2). AML1-ETO oligomerization, mediated by the NHR2 domain, is critical for leukaemogenesis(3-6), making it important to identify co-regulatory factors that 'read' the NHR2 oligomerization and contribute to leukaemogenesis(4). Here we show that, in human leukaemic cells, AML1-ETO resides in and functions through a stable AML1-ETO-containing transcription factor complex (AETFC) that contains several haematopoietic transcription (co)factors. These AETFC components stabilize the complex through multivalent interactions, provide multiple DNA-binding domains for diverse target genes, co-localize genome wide, cooperatively regulate gene expression, and contribute to leukaemogenesis. Within the AETFC complex, AML1-ETO oligomerization is required for a specific interaction between the oligomerized NHR2 domain and a novel NHR2-binding (N2B) motif in E proteins. Crystallographic analysis of the NHR2-N2B complex reveals a unique interaction pattern in which an N2B peptide makes direct contact with side chains of two NHR2 domains as a dimer, providing a novel model of how dimeric/oligomeric transcription factors create a new protein-binding interface through dimerization/oligomerization. Intriguingly, disruption of this interaction by point mutations abrogates AML1-ETO-induced haematopoietic stem/progenitor cell self-renewal and leukaemogenesis. These results reveal new mechanisms of action of AML1-ETO, and provide a potential therapeutic target in t(8;21)-positive acute myeloid leukaemia.	[Sun, Xiao-Jian; Chen, Wei-Yi; Tang, Zhanyun; Nakadai, Tomoyoshi; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA; [Wang, Zhanxin; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Wang, Lan; Nimer, Stephen D.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Wang, Lan; Nimer, Stephen D.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Jiang, Yanwen; Melnick, Ari] Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA; [Kost, Nils; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany; [Soong, T. David; Elemento, Olivier] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Miami; Cornell University; Max Planck Society; Cornell University	Roeder, RG (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA.	roeder@rockefeller.edu	Sun, Xiao-Jian/D-1560-2011; Melnick, Ari/AAA-5763-2020	Sun, Xiao-Jian/0000-0001-8826-4614; Chen, Wei-Yi/0000-0002-0661-6899	National Institutes of Health (NIH) [CA163086, CA129325, CA113872, CA166835]; Starr Cancer Consortium [I5-A554]; Leukemia and Lymphoma Society (LLS) SCOR [7013-02, 7132-08]; Rockefeller University Center for Clinical and Translational Science from NIH [UL1RR024143]; Abby Rockefeller Mauze Trust; Maloris Foundation; NATIONAL CANCER INSTITUTE [R01CA113872, R01CA129325, P30CA008748, R01CA166835, R01CA163086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Leukemia and Lymphoma Society (LLS) SCOR; Rockefeller University Center for Clinical and Translational Science from NIH; Abby Rockefeller Mauze Trust; Maloris Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank N. A. Speck and J. H. Bushweller for providing the AML1-ETO m7 plasmid, and R. Baer for providing anti-SCL antibodies. This work was supported by National Institutes of Health (NIH) grants CA163086 (R.G.R.), CA129325 (R.G.R.), CA113872 (R.G.R.) and CA166835 (S.D.N.), Starr Cancer Consortium grant I5-A554 (R.G.R., D.J.P. and S.D.N.), Leukemia and Lymphoma Society (LLS) SCOR grants 7013-02 (R.G.R. and S.D.N.) and 7132-08 (R.G.R., A.M. and D.J.P.), and Rockefeller University Center for Clinical and Translational Science Pilot Project grant UL1RR024143 from NIH (X.-J.S.). X.-J.S. was a Starr Cancer Consortium Visiting Fellow. L.W. was an Empire State Stem Cell Scholar and an LLS Fellow. Y.J. was an American Society of Haematology Scholar. W.-Y.C. was an LLS Fellow. D.J.P. was supported by funds from the Abby Rockefeller Mauze Trust and the Maloris Foundation.	Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Follows GA, 2003, EMBO J, V22, P2798, DOI 10.1093/emboj/cdg250; Funnell APW, 2012, ADV EXP MED BIOL, V747, P105, DOI 10.1007/978-1-4614-3229-6_7; Gardini A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000275; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Guo C, 2009, MOL CELL BIOL, V29, P2644, DOI 10.1128/MCB.00073-09; Heidenreich O, 2003, BLOOD, V101, P3157, DOI 10.1182/blood-2002-05-1589; Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kwok C, 2009, P NATL ACAD SCI USA, V106, P2853, DOI 10.1073/pnas.0810558106; Liu YZ, 2006, CANCER CELL, V9, P249, DOI 10.1016/j.ccr.2006.03.012; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Mao SF, 1999, MOL CELL BIOL, V19, P3635; Martens JHA, 2012, BLOOD, V120, P4038, DOI 10.1182/blood-2012-05-429050; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Okumura AJ, 2008, BLOOD, V112, P1392, DOI 10.1182/blood-2007-11-124735; Park S, 2009, BLOOD, V113, P3558, DOI 10.1182/blood-2008-06-161307; Peterson LF, 2004, ONCOGENE, V23, P4255, DOI 10.1038/sj.onc.1207727; Sanchez MJ, 1999, DEVELOPMENT, V126, P3891; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Shia WJ, 2012, BLOOD, V119, P4953, DOI 10.1182/blood-2011-04-347476; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Wang L, 2011, SCIENCE, V333, P765, DOI 10.1126/science.1201662; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Yan M, 2009, BLOOD, V113, P883, DOI 10.1182/blood-2008-04-153742; Zhang JS, 2004, SCIENCE, V305, P1286, DOI 10.1126/science.1097937; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	37	100	108	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					93	U120		10.1038/nature12287	http://dx.doi.org/10.1038/nature12287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23812588	Green Accepted, Green Published			2022-12-28	WOS:000322514800035
J	Modi, SR; Lee, HH; Spina, CS; Collins, JJ				Modi, Sheetal R.; Lee, Henry H.; Spina, Catherine S.; Collins, James J.			Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome	NATURE			English	Article							HUMAN GUT MICROBIOTA; GENES; DIVERSITY; VIRUSES	The mammalian gut ecosystem has considerable influence on host physiology(1-4), but the mechanisms that sustain this complex environment in the face of different stresses remain obscure. Perturbations to the gut ecosystem, such as through antibiotic treatment or diet, are at present interpreted at the level of bacterial phylogeny(5-7). Less is known about the contributions of the abundant population of phages to this ecological network. Here we explore the phageome as a potential genetic reservoir for bacterial adaptation by sequencing murine faecal phage populations following antibiotic perturbation. We show that antibiotic treatment leads to the enrichment of phage-encoded genes that confer resistance via disparate mechanisms to the administered drug, as well as genes that confer resistance to antibiotics unrelated to the administered drug, and we demonstrate experimentally that phages from treated mice provide aerobically cultured naive microbiota with increased resistance. Systems-wide analyses uncovered post-treatment phage-encoded processes related to host colonization and growth adaptation, indicating that the phageome becomes broadly enriched for functionally beneficial genes under stress-related conditions. We also show that antibiotic treatment expands the interactions between phage and bacterial species, leading to a more highly connected phage-bacterial network for gene exchange. Our work implicates the phageome in the emergence of multidrug resistance, and indicates that the adaptive capacity of the phageome may represent a community-based mechanism for protecting the gut microflora, preserving its functional robustness during antibiotic stress.	[Modi, Sheetal R.; Lee, Henry H.; Spina, Catherine S.; Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Modi, Sheetal R.; Lee, Henry H.; Spina, Catherine S.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Spina, Catherine S.; Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Spina, Catherine S.; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02118 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; Harvard University	Collins, JJ (corresponding author), Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu	Lee, Henry/GVS-2114-2022	Spina, Catherine/0000-0001-6067-5024; Lee, Henry/0000-0002-0577-2275	Howard Hughes Medical Institute; National Institutes of Health Director's Pioneer Award Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health Director's Pioneer Award Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Bodi and J. Schiemer at the Tufts Genomic Core for their sequencing assistance and A. Green and K. Pardee for ultracentrifugation help. This work was supported by the Howard Hughes Medical Institute and the National Institutes of Health Director's Pioneer Award Program.	Antunes LCM, 2011, ANTIMICROB AGENTS CH, V55, P1494, DOI 10.1128/AAC.01664-10; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chen J, 2009, SCIENCE, V323, P139, DOI 10.1126/science.1164783; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Hanaki H, 1998, J ANTIMICROB CHEMOTH, V42, P199, DOI 10.1093/jac/42.2.199; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Stern A, 2012, GENOME RES, V22, P1985, DOI 10.1101/gr.138297.112; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Zimmer M, 2002, J BACTERIOL, V184, P4359, DOI 10.1128/JB.184.16.4359-4368.2002	31	331	352	23	321	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					219	+		10.1038/nature12212	http://dx.doi.org/10.1038/nature12212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23748443	Green Accepted, Green Submitted			2022-12-28	WOS:000321557600064
J	Orsi, WD; Edgcomb, VP; Christman, GD; Biddle, JF				Orsi, William D.; Edgcomb, Virginia P.; Christman, Glenn D.; Biddle, Jennifer F.			Gene expression in the deep biosphere	NATURE			English	Article							ARCHAEA; LIFE; ABUNDANCE; SEDIMENTS; BIOMASS	Scientific ocean drilling has revealed a deep biosphere of widespread microbial life in sub-seafloor sediment. Microbial metabolism in the marine subsurface probably has an important role in global biogeochemical cycles(1-3), but deep biosphere activities are not well understood(1). Here we describe and analyse the first sub-seafloor metatranscriptomes from anaerobic Peru Margin sediment up to 159 metres below the sea floor, represented by over 1 billion complementary DNA (cDNA) sequence reads. Anaerobic metabolismof amino acids, carbohydrates and lipids seem to be the dominant metabolic processes, and profiles of dissimilatory sulfite reductase (dsr) transcripts are consistent with pore-water sulphate concentration profiles(1). Moreover, transcripts involved in cell division increase as a function of microbial cell concentration, indicating that increases in sub-seafloor microbial abundance are a function of cell division across all three domains of life. These data support calculations(1) and models(4) of sub-seafloor microbial metabolism and represent the first holistic picture of deep biosphere activities.	[Orsi, William D.; Edgcomb, Virginia P.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Christman, Glenn D.; Biddle, Jennifer F.] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA	Woods Hole Oceanographic Institution; University of Delaware	Orsi, WD (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	william.orsi@gmail.com	Biddle, Jennifer F/F-8323-2010; Edgcomb, Virginia/Q-2434-2019	Biddle, Jennifer F/0000-0002-4344-8724; Edgcomb, Virginia/0000-0001-6805-381X	Center for Dark Energy Biosphere Investigations (CDEBI) [OCE-0939564]; National Science Foundation IOS [1238801]	Center for Dark Energy Biosphere Investigations (CDEBI); National Science Foundation IOS(National Science Foundation (NSF))	This work was fostered by a Center for Dark Energy Biosphere Investigations (CDEBI) grant OCE-0939564 to W.D.O. and a National Science Foundation IOS grant 1238801 to J.F.B. We thank C. House and A. Teske for providing samples. We also thank M. Sogin and R. Fox at the Josephine Bay Paul Center for providing access to computing resources. E. Leadbetter and S. Hallam provided comments on the manuscript, and we also thank S. D'Hondt for discussions on the deep biosphere. This is CDEBI contribution 137.	Biddle JF, 2005, GEOBIOLOGY, V3, P287, DOI 10.1111/j.1472-4669.2006.00062.x; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Hinrichs KU, 2012, SCIENCE, V338, P204, DOI 10.1126/science.1229296; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Jorgensen B. B., 2006, P OCEAN DRILLING PRO, V201, P1; Jorgensen BB, 2006, SCIENCE, V314, P932, DOI 10.1126/science.1133796; Jorgensen BB, 2011, P NATL ACAD SCI USA, V108, P18193, DOI 10.1073/pnas.1115421108; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Lever MA, 2013, FEMS MICROBIOL ECOL, V84, P1, DOI 10.1111/1574-6941.12051; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; Martino AJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00017; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Moran MA, 2013, ISME J, V7, P237, DOI 10.1038/ismej.2012.94; OREMLAND RS, 1982, APPL ENVIRON MICROB, V44, P1270, DOI 10.1128/AEM.44.6.1270-1276.1982; Orsi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056335; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; PARKES RJ, 2004, MICROBIAL DIVERSITY, P120; Schrenk MO, 2010, ANNU REV MAR SCI, V2, P279, DOI 10.1146/annurev-marine-120308-081000; Teske A., 2006, P OCEAN DRILLING PRO, V201, P1; Valentine DL, 2011, ANNU REV MAR SCI, V3, P147, DOI 10.1146/annurev-marine-120709-142734; Webster G, 2006, FEMS MICROBIOL ECOL, V58, P65, DOI 10.1111/j.1574-6941.2006.00147.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	30	188	190	8	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					205	+		10.1038/nature12230	http://dx.doi.org/10.1038/nature12230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23760485				2022-12-28	WOS:000321557600061
J	Sharma, S; Quintana, A; Findlay, GM; Mettlen, M; Baust, B; Jain, M; Nilsson, R; Rao, A; Hogan, PG				Sharma, Sonia; Quintana, Ariel; Findlay, Gregory M.; Mettlen, Marcel; Baust, Beate; Jain, Mohit; Nilsson, Roland; Rao, Anjana; Hogan, Patrick G.			An siRNA screen for NFAT activation identifies septins as coordinators of store-operated Ca2+ entry	NATURE			English	Article							CHANNEL ACTIVATION; ORAI1; STIM1; CALCIUM; CYTOSKELETON; RELEASE; CRAC; FORCHLORFENURON; ORGANIZATION; DOMAINS	The STIM1-ORAI1 pathway of store-operated Ca2+ entry is an essential component of cellular Ca2+ signalling(1). STIM1 senses depletion of intracellular Ca2+ stores in response to physiological stimuli, and relocalizes within the endoplasmic reticulum to plasma-membrane-apposed junctions, where it recruits and gates open plasma membrane ORAI1 Ca2+ channels. Here we use a genome-wide RNA interference screen in HeLa cells to identify filamentous septin proteins as crucial regulators of store-operated Ca2+ entry. Septin filaments and phosphatidylinositol-4,5-bisphosphate (also known as PtdIns(4,5)P-2) rearrange locally at endoplasmic reticulum-plasma membrane junctions before and during formation of STIM1-ORAI1 clusters, facilitating STIM1 targeting to these junctions and promoting the stable recruitment of ORAI1. Septin rearrangement at junctions is required for PtdIns(4,5) P2 reorganization and efficient STIM1-ORAI1 communication. Septins are known to demarcate specialized membrane regions such as dendritic spines, the yeast bud and the primary cilium, and to serve as membrane diffusion barriers and/or signalling hubs in cellular processes such as vesicle trafficking, cell polarity and cytokinesis2-4. Our data show that septins also organize the highly localized plasma membrane domains that are important in STIM1-ORAI1 signalling, and indicate that septins may organize membrane microdomains relevant to other signalling processes.	[Sharma, Sonia; Quintana, Ariel; Rao, Anjana; Hogan, Patrick G.] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Sharma, Sonia; Quintana, Ariel; Findlay, Gregory M.; Baust, Beate; Rao, Anjana; Hogan, Patrick G.] Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; [Mettlen, Marcel] Scripps Res Inst, La Jolla, CA 92037 USA; [Jain, Mohit] Broad Inst, Cambridge, MA 02142 USA; [Jain, Mohit] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Nilsson, Roland] Karolinska Inst, S-17176 Stockholm, Sweden	La Jolla Institute for Immunology; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Karolinska Institutet	Rao, A (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	arao@liai.org; phogan@liai.org	Mettlen, Marcel B/A-2357-2011; Findlay, Gregory/AAX-9029-2020; Nilsson, Roland/AAJ-3519-2021	Mettlen, Marcel B/0000-0001-7047-2749; Findlay, Gregory/0000-0002-7767-8608; Nilsson, Roland/0000-0002-6020-7498	National Institutes of Health (NIH) [AI040127, AI084167]; NIH [AI092763, K08 HL107451, R01GM73165]; Canadian Institutes for Health Research; Leukemia & Lymphoma Society; Deutsche Forschungsgemeinschaft [QU298/1-1]; Knut & Alice Wallenberg Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084167, R01AI040127, RC4AI092763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073165] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Shamu, S. Rudnicki, S. Johnston and D. Wrobel for screening support; A. Carpenter and M. Bray for CellProfiler optimization; P. Meraner and Y. Zhou for cell lines and constructs; S. Schmid, J. Fitzpatrick and the Waitt Advanced Biophotonics Center at the Salk Institute for access to TIRF microscopes; C. Junker for the RFP-ER construct; S. Field for the PLC delta-PH-eGFP plasmid; and S. Schmid for manuscript review. The work was supported by National Institutes of Health (NIH) R01 grants AI040127 and AI084167(to A. R. and P. G. H.), NIH RC4 grant AI092763 (to A. R. and S. S.); a Fellowship from the Canadian Institutes for Health Research and a Special Fellowship from The Leukemia & Lymphoma Society (to S. S.); postdoctoral fellowship QU298/1-1 from the Deutsche Forschungsgemeinschaft (to A. Q.); NIH grant K08 HL107451 (to M. J.); a postdoctoral scholarship from the Knut & Alice Wallenberg Foundation (to R. N.); NIH R01 grant R01GM73165 (to S. Schmid, which supports M.M.).	Bertin A, 2010, J MOL BIOL, V404, P711, DOI 10.1016/j.jmb.2010.10.002; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Demay BS, 2010, CYTOSKELETON, V67, P383, DOI 10.1002/cm.20452; Ercan E, 2009, TRAFFIC, V10, P1802, DOI 10.1111/j.1600-0854.2009.00995.x; Estey MP, 2011, CURR BIOL, V21, pR384, DOI 10.1016/j.cub.2011.03.067; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Walsh CM, 2010, BIOCHEM J, V425, P159, DOI 10.1042/BJ20090884; Yang YM, 2010, NEURON, V67, P100, DOI 10.1016/j.neuron.2010.06.003; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	30	169	169	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2013	499	7457					238	+		10.1038/nature12229	http://dx.doi.org/10.1038/nature12229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23792561	Green Accepted			2022-12-28	WOS:000321557600068
J	Schroy, PC; Coe, A; Chen, CA; O'Brien, MJ; Heeren, TC				Schroy, Paul C., III; Coe, Alison; Chen, Clara A.; O'Brien, Michael J.; Heeren, Timothy C.			Prevalence of Advanced Colorectal Neoplasia in White and Black Patients Undergoing Screening Colonoscopy in a Safety-Net Hospital	ANNALS OF INTERNAL MEDICINE			English	Article							HARVARD CANCER-RISK; PRIMARY PREVENTION; AFRICAN-AMERICANS; ADENOMAS; DISPARITIES; SURVEILLANCE; COLLEGE; POLYPS; INDEX	Background: Black persons are more likely than white persons to be diagnosed with colorectal cancer and to die from it. The extent to which genetic or biological factors versus disparities in screening rates explain this variance remains controversial. Objective: To define the prevalence and location of presymptomatic advanced colorectal neoplasia (ACN) among white and black persons undergoing screening colonoscopy, controlling for other epidemiologic risk factors. Design: Cross-sectional survey between 22 March 2005 and 31 January 2012. Setting: Urban, open-access, academic, safety-net hospital in Massachusetts. Participants: Asymptomatic, average-risk white (n = 1172) and black (n = 1681) persons aged 50 to 79 years undergoing screening colonoscopy. Measurements: Adjusted prevalence and location of ACN, defined as a tubular adenoma 10 mm or more in size, any adenoma with villous features or high-grade dysplasia, any dysplastic serrated lesion, or invasive cancer. Results: The prevalence of ACN was higher among white patients than black patients (6.8% vs. 5.0%; P = 0.039) but varied by sex (white vs. black men, 9.3% vs. 5.7%; white vs. black women, 3.5% vs. 4.3%; interaction P = 0.034). After controlling for many risk factors, black men were 41% less likely than white men (adjusted odds ratio [AOR], 0.59 [95% CI, 0.39 to 0.89]) to have ACN. No statistically significant difference was seen for women (AOR, 1.32 [CI, 0.73 to 2.40]). Black patients with ACN had a higher percentage of proximal disease (52% vs. 39%) after adjustment for age and sex (P = 0.055). Limitation: Single-institution study with inadequate statistical power for subgroup analyses and recall bias. Conclusion: Black men are less likely than white men to have ACN at screening colonoscopy in a safety-net health care setting. Disparities in access to screening and differential exposure to modifiable risk factors rather than genetic or biological factors may be largely responsible for the higher incidence of CRC among black men. Genetic or biological factors may explain the predilection for proximal disease.	Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA	Boston University; Boston University	Schroy, PC (corresponding author), Boston Univ, Sch Med, Dept Med, Gastroenterol Sect, 85 East Concord St, Boston, MA 02118 USA.	paul.schroy@bmc.org		O'Brien, Michael J/0000-0003-1124-3537; Schroy, Paul/0000-0001-9273-7832; Heeren, Timothy/0000-0001-5643-3559	National Cancer Institute [R01 CA13119]; NATIONAL CANCER INSTITUTE [R01CA131197] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By the National Cancer Institute (grant R01 CA13119; Dr. Schroy).	Agrawal S, 2005, AM J GASTROENTEROL, V100, P515, DOI 10.1111/j.1572-0241.2005.41829.x; American Cancer Society, 2011, COL CANC FACTS FIG 2; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; Botteri E, 2008, GASTROENTEROLOGY, V134, P388, DOI 10.1053/j.gastro.2007.11.007; Butterly LF, 2006, CLIN GASTROENTEROL H, V4, P343, DOI 10.1016/j.cgh.2005.12.021; Colditz GA, 2000, CANCER CAUSE CONTROL, V11, P477, DOI 10.1023/A:1008984432272; Cottet V, 2007, GASTROENTEROLOGY, V133, P1086, DOI 10.1053/j.gastro.2007.07.023; Dimou A, 2009, WORLD J GASTROENTERO, V15, P3734, DOI 10.3748/wjg.15.3734; Doubeni CA, 2010, AM J PREV MED, V38, P184, DOI 10.1016/j.amepre.2009.10.037; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Elwing JE, 2006, AM J GASTROENTEROL, V101, P1866, DOI 10.1111/j.1572-0241.2006.00651.x; Friedenberg FK, 2012, DIGEST DIS SCI, V57, P489, DOI 10.1007/s10620-011-1952-z; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Howlader N, 2012, SEER CANC STAT REV 1; Joseph D. A., 2008, Morbidity and Mortality Weekly Report, V57, P253; Kim DH, 2007, AM J ROENTGENOL, V188, P940, DOI 10.2214/AJR.06.0764; Kim DJ, 2004, J CLIN EPIDEMIOL, V57, P332, DOI 10.1016/j.jclinepi.2003.08.013; Laiyemo AO, 2010, JNCI-J NATL CANCER I, V102, P538, DOI 10.1093/jnci/djq068; Lansdorp-Vogelaar I, 2012, CANCER EPIDEM BIOMAR, V21, P728, DOI 10.1158/1055-9965.EPI-12-0023; Lebwohl B, 2012, ALIMENT PHARM THER, V35, P1467, DOI 10.1111/j.1365-2036.2012.05119.x; Levitzky BE, 2011, AM J GASTROENTEROL, V106, P1099, DOI 10.1038/ajg.2011.20; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2008, JAMA-J AM MED ASSOC, V300, P1417, DOI 10.1001/jama.300.12.1417; Massachusetts Cancer Registry, 2012, CANC INC MORT MASS 2; Massachusetts Cancer Registry, 2007, CANC INC MORT MASS 2; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Qaseem A, 2012, ANN INTERN MED, V156, P378, DOI 10.7326/0003-4819-156-5-201203060-00010; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Rim SH, 2009, CANCER-AM CANCER SOC, V115, P1967, DOI 10.1002/cncr.24216; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Shapiro JA, 2008, CANCER EPIDEM BIOMAR, V17, P1623, DOI 10.1158/1055-9965.EPI-07-2838; Shavers VL, 2007, J NATL MED ASSOC, V99, P733; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siteman Cancer Center, 2013, YOUR DIS RISK; Snover D, 2010, WHO CLASSIFICATION T; Weber TK, 1999, JAMA-J AM MED ASSOC, V281, P2316, DOI 10.1001/jama.281.24.2316; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301	39	53	54	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 2	2013	159	1					13	+		10.7326/0003-4819-159-1-201307020-00004	http://dx.doi.org/10.7326/0003-4819-159-1-201307020-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179JJ	23817700	Green Accepted			2022-12-28	WOS:000321516200002
J	Bayraktar, OA; Doe, CQ				Bayraktar, Omer Ali; Doe, Chris Q.			Combinatorial temporal patterning in progenitors expands neural diversity	NATURE			English	Article							AMPLIFYING NEUROBLAST LINEAGES; DROSOPHILA BRAIN-DEVELOPMENT; TWIN-OF-EYELESS; CENTRAL COMPLEX; STEM-CELLS; TRANSCRIPTION FACTORS; FACTOR GRAINYHEAD; GENE-EXPRESSION; MUSHROOM BODIES; NERVOUS-SYSTEM	Human outer subventricular zone (OSVZ) neural progenitors and Drosophila type II neuroblasts both generate intermediate neural progenitors (INPs) that populate the adult cerebral cortex or central complex, respectively. It is unknown whether INPs simply expand or also diversify neural cell types. Here we show that Drosophila INPs sequentially generate distinct neural subtypes, that INPs sequentially express Dichaete, Grainy head and Eyeless transcription factors, and that these transcription factors are required for the production of distinct neural subtypes. Moreover, parental type II neuroblasts also sequentially express transcription factors and generate different neuronal/glial progeny over time, providing a second temporal identity axis. We conclude that neuroblast and INP temporal patterning axes act together to generate increased neural diversity within the adult central complex; OSVZ progenitors may use similar mechanisms to increase neural diversity in the human brain.	[Bayraktar, Omer Ali; Doe, Chris Q.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA; [Bayraktar, Omer Ali; Doe, Chris Q.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Doe, Chris Q.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon; University of Oregon; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA.	cdoe@uoregon.edu		Bayraktar, Omer/0000-0001-6055-277X	National Institutes of Health (NIH) [T32HD216345, T32GM007413]; NIH [R01HD27056]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD027056] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007413, T32GM007759] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Manning and K. Hirono for larval brain stains and imaging; S.-L. Lai, J. Eisen, T. Herman and B. Bowerman for comments on the manuscript; T. Carney and M. Miller for discussions; and the fly community for reagents. This work was supported by National Institutes of Health (NIH) grants T32HD216345 and T32GM007413 (to O.A.B.), NIH R01HD27056 (to C. Q. D.) and the Howard Hughes Medical Institute (to C.Q.D.).	Ali YO, 2011, JOVE-J VIS EXP, DOI 10.3791/2504; Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Bayraktar OA, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-26; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Chai PC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001494; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Furukubo-Tokunaga K, 2009, FLY, V3, P263, DOI 10.4161/fly.10385; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Izergina N, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-44; JONES B, 1993, DEVELOPMENT, V117, P793; Kao CF, 2012, NEURON, V73, P677, DOI 10.1016/j.neuron.2011.12.018; KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006; Kurusu M, 2000, P NATL ACAD SCI USA, V97, P2140, DOI 10.1073/pnas.040564497; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Noveen A, 2000, DEVELOPMENT, V127, P3475; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Russell SRH, 1996, DEVELOPMENT, V122, P3669; Spindler SR, 2009, DEV BIOL, V334, P355, DOI 10.1016/j.ydbio.2009.07.035; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Tran KD, 2008, DEVELOPMENT, V135, P3491, DOI 10.1242/dev.024349; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; UV AE, 1994, MOL CELL BIOL, V14, P4020, DOI 10.1128/MCB.14.6.4020; Viktorin G, 2011, DEV BIOL, V356, P553, DOI 10.1016/j.ydbio.2011.06.013; Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045; Zhu SJ, 2011, P NATL ACAD SCI USA, V108, P20615, DOI 10.1073/pnas.1118595109	47	107	108	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					449	+		10.1038/nature12266	http://dx.doi.org/10.1038/nature12266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23783519	Green Accepted			2022-12-28	WOS:000320929400045
J	Puig, A; Dighe, AS				Puig, Alberto; Dighe, Anand S.			Case 20-2013: A 29-Year-Old Man with Anemia and Jaundice	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Puig, Alberto] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Dighe, Anand S.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Puig, Alberto] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Dighe, Anand S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Puig, A (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Dighe, Anand/AAP-9640-2020	Dighe, Anand/0000-0003-4130-0758				Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Dhaliwal G, 2004, AM FAM PHYSICIAN, V69, P2599; Frank JE, 2005, AM FAM PHYSICIAN, V72, P1277; RINGELHAHN B, 1972, CLIN CHIM ACTA, V36, P272, DOI 10.1016/0009-8981(72)90193-3; Steensma DP, 2001, MAYO CLIN PROC, V76, P285, DOI 10.4065/76.3.285; Yazdi SS, 2010, J DERMATOL, V13, P54	6	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2502	2509		10.1056/NEJMcpc1302333	http://dx.doi.org/10.1056/NEJMcpc1302333			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23802518				2022-12-28	WOS:000320926900012
J	Spence, D				Spence, Des			Reefer madness: doctors need more drugs training	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Frank, DRUGS A Z; Home Office, 2012, TABL DRUG MIS DECL F	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2013	346								f4105	10.1136/bmj.f4105	http://dx.doi.org/10.1136/bmj.f4105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179AA	23814068				2022-12-28	WOS:000321487300005
J	Zheng, JS; Hu, XJ; Zhao, YM; Yang, J; Li, D				Zheng, Ju-Sheng; Hu, Xiao-Jie; Zhao, Yi-Min; Yang, Jing; Li, Duo			Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTMENOPAUSAL WOMEN; DIETARY-FAT; SERUM PHOSPHOLIPIDS; CONSUMPTION; MEAT; OMEGA-3-FATTY-ACIDS; GROWTH; ASSOCIATION; PREVENTION; OMEGA-6	Objectives To investigate the association between intake of fish and n-3 polyunsaturated fatty acids (n-3 PUFA) and the risk of breast cancer and to evaluate the potential dose-response relation. Design Meta-analysis and systematic review of prospective cohort studies. Data sources PubMed and Embase up to December 2012 and references of retrieved relevant articles. Eligibility criteria for selecting studies Prospective cohort studies with relative risk and 95% confidence intervals for breast cancer according to fish intake, n-3 PUFA intake, or tissue biomarkers. Results Twenty six publications, including 20 905 cases of breast cancer and 883 585 participants from 21 independent prospective cohort studies were eligible. Eleven articles (13 323 breast cancer events and 687 770 participants) investigated fish intake, 17 articles investigated marine n-3 PUFA (16 178 breast cancer events and 527 392 participants), and 12 articles investigated alpha linolenic acid (14 284 breast cancer events and 405 592 participants). Marine n-3 PUFA was associated with 14% reduction of risk of breast cancer (relative risk for highest v lowest category 0.86 (95% confidence interval 0.78 to 0.94), I-2 = 54), and the relative risk remained similar whether marine n-3 PUFA was measured as dietary intake (0.85, 0.76 to 0.96, I-2 = 67%) or as tissue biomarkers (0.86, 0.71 to 1.03, I-2 = 8%). Subgroup analyses also indicated that the inverse association between marine n-3 PUFA and risk was more evident in studies that did not adjust for body mass index (BMI) (0.74, 0.64 to 0.86, I-2 = 0) than in studies that did adjust for BMI (0.90, 0.80 to 1.01, I-2 = 63.2%). Dose-response analysis indicated that risk of breast cancer was reduced by 5% per 0.1g/day (0.95, 0.90 to 1.00, I-2 = 52%) or 0.1% energy/day (0.95, 0.90 to 1.00, I-2 = 79%) increment of dietary marine n-3 PUFA intake. No significant association was observed for fish intake or exposure to alpha linolenic acid. Conclusions Higher consumption of dietary marine n-3 PUFA is associated with a lower risk of breast cancer. The associations of fish and alpha linolenic acid intake with risk warrant further investigation of prospective cohort studies. These findings could have public health implications with regard to prevention of breast cancer through dietary and lifestyle interventions.	[Zheng, Ju-Sheng; Hu, Xiao-Jie; Zhao, Yi-Min; Yang, Jing; Li, Duo] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310058, Zhejiang, Peoples R China; [Zheng, Ju-Sheng; Hu, Xiao-Jie; Zhao, Yi-Min; Yang, Jing; Li, Duo] APCNS Ctr Nutr & Food Safety, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Li, D (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	duoli@zju.edu.cn	Li, Duo/N-3682-2013; Zheng, Ju-Sheng/J-3970-2015	Li, Duo/0000-0001-5227-5565; Zhao, Yimin/0000-0002-6146-9860; Zheng, Ju-Sheng/0000-0001-6560-4890	National Natural Science Foundation of China (NSFC) [81273054]; PhD. Programs Foundation of Ministry of Education of China [20120101110107]; National Basic Research Program of China (973 Program) [2011CB504002]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); PhD. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was funded by National Natural Science Foundation of China (NSFC, No 81273054), the PhD. Programs Foundation of Ministry of Education of China (20120101110107), and the National Basic Research Program of China (973 Program 2011CB504002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan SF, 2010, AM J CLIN NUTR, V91, P1294, DOI 10.3945/ajcn.2009.28796; Cave WT, 1997, BREAST CANCER RES TR, V46, P239, DOI 10.1023/A:1005923418886; Chajes V, 1999, INT J CANCER, V83, P585, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;585::AID-IJC2&gt;3.0.CO;2-Z; Chajes V, 2008, AM J EPIDEMIOL, V167, P1312, DOI 10.1093/aje/kwn069; Cheraghi Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051446; Cho EY, 2003, JNCI-J NATL CANCER I, V95, P1079, DOI 10.1093/jnci/95.14.1079; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Engeset D, 2006, INT J CANCER, V119, P175, DOI 10.1002/ijc.21819; Folsom AR, 2004, AM J EPIDEMIOL, V160, P1005, DOI 10.1093/aje/kwh307; Gago-Dominguez M, 2003, BRIT J CANCER, V89, P1686, DOI 10.1038/sj.bjc.6601340; Holmes MD, 2003, INT J CANCER, V104, P221, DOI 10.1002/ijc.10910; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KAIZER L, 1989, NUTR CANCER, V12, P61, DOI 10.1080/01635588909514002; KARMALI RA, 1984, J NATL CANCER I, V73, P457, DOI 10.1093/jnci/73.2.457; Key TJ, 1999, BRIT J CANCER, V81, P1248, DOI 10.1038/sj.bjc.6690837; Kim EHJ, 2006, AM J EPIDEMIOL, V164, P990, DOI 10.1093/aje/kwj309; Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009; KORT WJ, 1987, J NATL CANCER I, V79, P593; Kuriki K, 2007, INT J CANCER, V121, P377, DOI 10.1002/ijc.22682; Lambrechts S, 2011, ACTA CLIN BELG, V66, P283, DOI 10.2143/ACB.66.4.2062570; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; MacLean CH, 2006, JAMA-J AM MED ASSOC, V295, P403, DOI 10.1001/jama.295.4.403; Maillard V, 2002, INT J CANCER, V98, P78, DOI 10.1002/ijc.10130; MILLS P, 1989, CANCER-AM CANCER SOC, V64, P582, DOI 10.1002/1097-0142(19890801)64:3&lt;582::AID-CNCR2820640304&gt;3.0.CO;2-V; Missmer SA, 2002, INT J EPIDEMIOL, V31, P78, DOI 10.1093/ije/31.1.78; Murff HJ, 2011, INT J CANCER, V128, P1434, DOI 10.1002/ijc.25703; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Pala V, 2001, J NATL CANCER I, V93, P1088, DOI 10.1093/jnci/93.14.1088; Park SY, 2012, CANCER PREV RES, V5, P216, DOI 10.1158/1940-6207.CAPR-11-0260; Patterson RE, 2011, J NUTR, V141, P201, DOI 10.3945/jn.110.128777; Saadatian-Elahi M, 2004, INT J CANCER, V111, P584, DOI 10.1002/ijc.20284; Saadatian-Elahi M, 2002, CANCER EPIDEM BIOMAR, V11, P1353; SASAKI S, 1993, PREV MED, V22, P187, DOI 10.1006/pmed.1993.1016; Schley PD, 2005, BREAST CANCER RES TR, V92, P187, DOI 10.1007/s10549-005-2415-z; Sczaniecka AK, 2012, NUTR CANCER, V64, P1131, DOI 10.1080/01635581.2012.718033; Shannon J, 2007, AM J CLIN NUTR, V85, P1090, DOI 10.1093/ajcn/85.4.1090; Stripp C, 2003, J NUTR, V133, P3664, DOI 10.1093/jn/133.11.3664; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takata Y, 2009, CANCER CAUSE CONTROL, V20, P497, DOI 10.1007/s10552-009-9314-2; Terry PD, 2003, AM J CLIN NUTR, V77, P532, DOI 10.1093/ajcn/77.3.532; Thiebaut ACM, 2009, INT J CANCER, V124, P924, DOI 10.1002/ijc.23980; TONIOLO P, 1994, EPIDEMIOLOGY, V5, P391, DOI 10.1097/00001648-199407000-00003; VATTEN LJ, 1993, EUR J CANCER, V29A, P532, DOI 10.1016/S0959-8049(05)80146-7; VATTEN LJ, 1990, INT J CANCER, V46, P12, DOI 10.1002/ijc.2910460105; Voorrips LE, 2002, AM J CLIN NUTR, V76, P873, DOI 10.1093/ajcn/76.4.873; Wakai K, 2005, CANCER SCI, V96, P590, DOI 10.1111/j.1349-7006.2005.00084.x; Wells G.A., 2011, NEWCASTLE OTTAWA SCA; Wirfalt E, 2004, EUR J CLIN NUTR, V58, P761, DOI 10.1038/sj.ejcn.1601874; Wirfalt E, 2002, CANCER CAUSE CONTROL, V13, P883, DOI 10.1023/A:1021922917489; Witt PM, 2009, CANCER CAUSE CONTROL, V20, P1715, DOI 10.1007/s10552-009-9423-y; Zheng JS, 2012, PUBLIC HEALTH NUTR, V15, P725, DOI 10.1017/S1368980011002254	52	214	221	2	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2013	346								f3706	10.1136/bmj.f3706	http://dx.doi.org/10.1136/bmj.f3706			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179AA	23814120	hybrid			2022-12-28	WOS:000321487300003
J	Ilie, G; Boak, A; Adlaf, EM; Asbridge, M; Cusimano, MD				Ilie, Gabriela; Boak, Angela; Adlaf, Edward M.; Asbridge, Mark; Cusimano, Michael D.			Prevalence and Correlates of Traumatic Brain Injuries Among Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ilie, Gabriela] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Boak, Angela; Adlaf, Edward M.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Dalhousie University	Ilie, G (corresponding author), St Michaels Hosp, Injury Prevent Res Off, 30 Bond St, Toronto, ON M5B 1W8, Canada.	gilie@utsc.utoronto.ca	Ilie, Gabriela/AAM-9122-2021; Cusimano, Michael/GWR-1025-2022; Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Faul M., TRAUMATIC BRAIN INJU; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Institute of Medicine of the National Academies, COMM SPORTS REL CONC; Levy DT, 2004, MED SCI MONITOR, V10, pCR17; Paglia-Boak A, CAMH RES DOCUMENT SE, V32; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171	6	65	66	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2550	2552		10.1001/jama.2013.6750	http://dx.doi.org/10.1001/jama.2013.6750			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23800930	Bronze			2022-12-28	WOS:000320848100018
J	Winkler, JT				Winkler, J. T.			FOOD AND NUTRITION Brutal pragmatism on food	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; TAXES		[Winkler, J. T.] London Metropolitan Univ, London, England	London Metropolitan University		jtw@blueyonder.co.uk						Brinsden HC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002936; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Sadler K, 2012, NATIONAL DIET AND NU; Smed S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6885; Stafford N, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7889; Winkler J, 1997, SUGAR CLAIMS STRAIGH; Winkler JT, 2012, BRIT J NUTR, V108, P395, DOI 10.1017/S0007114511006477	7	8	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2013	346								f3728	10.1136/bmj.f3728	http://dx.doi.org/10.1136/bmj.f3728			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QI	23801679				2022-12-28	WOS:000321245900001
J	Wyatt, RJ; Julian, BA				Wyatt, Robert J.; Julian, Bruce A.			IgA Nephropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GALACTOSE-DEFICIENT IGA1; IMMUNOGLOBULIN-A NEPHROPATHY; GENOME-WIDE ASSOCIATION; KIDNEY-TRANSPLANTATION; OXFORD CLASSIFICATION; MESANGIAL CELLS; PROGNOSTIC INDICATORS; RETROSPECTIVE COHORT; DISEASE PROGRESSION; PURPURA NEPHRITIS		[Wyatt, Robert J.] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [Wyatt, Robert J.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Julian, Bruce A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA	University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham	Wyatt, RJ (corresponding author), Childrens Fdn Res Inst, Rm 520,50 North Dunlap, Memphis, TN 38103 USA.	rwyatt@uthsc.edu						Alamartine E, 2011, CLIN J AM SOC NEPHRO, V6, P2384, DOI 10.2215/CJN.01170211; ALLEN AC, 1995, CLIN EXP IMMUNOL, V100, P470; Amore A, 2000, AM J KIDNEY DIS, V36, P1242, DOI 10.1053/ajkd.2000.19840; [Anonymous], 2012, KIDNEY INT S, V2, pS209; Asao R, 2012, CLIN J AM SOC NEPHRO, V7, P1385, DOI 10.2215/CJN.08110811; Barratt J, 2009, NEPHROL DIAL TRANSPL, V24, P3620, DOI 10.1093/ndt/gfp441; Bellur SS, 2011, NEPHROL DIAL TRANSPL, V26, P2533, DOI 10.1093/ndt/gfq812; BERGER J, 1988, AM J KIDNEY DIS, V12, P371, DOI 10.1016/S0272-6386(88)80027-1; Berthoux F, 2008, TRANSPLANTATION, V85, P1505, DOI 10.1097/TP.0b013e3181705ad4; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Bjorneklett R, 2011, CLIN TRANSPLANT, V25, pE356, DOI 10.1111/j.1399-0012.2011.01424.x; Boyd JK, 2012, KIDNEY INT, V81, P833, DOI 10.1038/ki.2011.501; Boyd JK, 2011, KIDNEY INT, V80, P8, DOI 10.1038/ki.2011.83; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Camilla R, 2011, CLIN J AM SOC NEPHRO, V6, P1903, DOI 10.2215/CJN.11571210; Cattran DC, 2008, NEPHROL DIAL TRANSPL, V23, P2247, DOI 10.1093/ndt/gfm919; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Cheng GY, 2013, CLIN NEPHROL; Clayton P, 2011, AM J TRANSPLANT, V11, P1645, DOI 10.1111/j.1600-6143.2011.03667.x; CONLEY ME, 1980, J CLIN INVEST, V66, P1432, DOI 10.1172/JCI109998; Coppo R, 2010, KIDNEY INT, V77, P921, DOI 10.1038/ki.2010.43; DAMICO G, 1986, Q J MED, V59, P363; DAMICO G, 1987, Q J MED, V64, P709; Davin JC, 2011, CLIN J AM SOC NEPHRO, V6, P679, DOI 10.2215/CJN.06710810; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; El Karoui K, 2012, J AM SOC NEPHROL, V23, P137, DOI 10.1681/ASN.2010111130; Espinosa M, 2009, NEPHROL DIAL TRANSPL, V24, P886, DOI 10.1093/ndt/gfn563; Feehally J, 2011, AM J KIDNEY DIS, V58, P310, DOI 10.1053/j.ajkd.2011.03.024; Feehally J, 2010, J AM SOC NEPHROL, V21, P1791, DOI 10.1681/ASN.2010010076; Fischer EG, 2009, CLIN NEPHROL, V72, P163, DOI 10.2379/CN106139; Geddes CC, 2003, NEPHROL DIAL TRANSPL, V18, P1541, DOI 10.1093/ndt/gfg207; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Hastings MC, 2010, CLIN J AM SOC NEPHRO, V5, P2069, DOI 10.2215/CJN.03270410; Haubitz M, 2005, KIDNEY INT, V67, P2313, DOI 10.1111/j.1523-1755.2005.00335.x; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; Hiremath S, 2007, AM J TRANSPLANT, V7, P2350, DOI 10.1111/j.1600-6143.2007.01928.x; Hotta O, 2002, AM J KIDNEY DIS, V39, P493, DOI 10.1053/ajkd.2002.31399; Jennette JC., 2007, HEPTINSTALLS PATHOLO, P423; Julian BA, 2007, ELECTROPHORESIS, V28, P4469, DOI 10.1002/elps.200700237; Kaneko Y, 2012, INT IMMUNOL, V24, P219, DOI 10.1093/intimm/dxr125; Kataoka H, 2012, CLIN EXP NEPHROL, V16, P706, DOI 10.1007/s10157-012-0613-7; Kiryluk K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002765; Kiryluk Krzysztof, 2010, Pediatr Nephrol, V25, P2257, DOI 10.1007/s00467-010-1500-7; Kokubo T, 1998, J AM SOC NEPHROL, V9, P2048; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Lai KN, 2012, NAT REV NEPHROL, V8, P275, DOI 10.1038/nrneph.2012.58; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Lin XJ, 2009, NEPHROL DIAL TRANSPL, V24, P3372, DOI 10.1093/ndt/gfp294; Liu LL, 2012, CLIN EXP IMMUNOL, V169, P148, DOI 10.1111/j.1365-2249.2012.04604.x; Lundberg S, 2012, CLIN J AM SOC NEPHRO, V7, P727, DOI 10.2215/CJN.10331011; Lv JC, 2008, NEPHROLOGY, V13, P242, DOI 10.1111/j.1440-1797.2007.00898.x; Mackinnon B, 2008, NEPHRON CLIN PRACT, V109, pC148, DOI 10.1159/000145458; MIYAMOTO H, 1988, VIRCHOWS ARCH A, V413, P77, DOI 10.1007/BF00844284; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Moura IC, 2001, J EXP MED, V194, P417, DOI 10.1084/jem.194.4.417; Nair R, 2006, KIDNEY INT, V69, P1455, DOI 10.1038/sj.ki.5000292; Novak J, 2012, SEMIN IMMUNOPATHOL, V34, P365, DOI 10.1007/s00281-012-0306-z; Odani H, 2010, J NEPHROL, V23, P70; Peters HPE, 2009, NETH J MED, V67, P54; Ponticelli C, 2001, KIDNEY INT, V60, P1948, DOI 10.1046/j.1523-1755.2001.00006.x; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Roberts IS, 2013, CURR OPIN NEPHROL HY; Rocchetti MT, 2008, PROTEOMICS, V8, P206, DOI 10.1002/pmic.200700492; Ronkainen J, 2006, PEDIATR NEPHROL, V21, P1266, DOI 10.1007/s00467-006-0163-x; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; Shi YJ, 2012, KIDNEY BLOOD PRESS R, V35, P153, DOI 10.1159/000331453; SILVA FG, 1982, TRANSPLANTATION, V33, P214; Smith AC, 2006, J AM SOC NEPHROL, V17, P3520, DOI 10.1681/ASN.2006060658; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; Suzuki K, 2003, KIDNEY INT, V63, P2286, DOI 10.1046/j.1523-1755.63.6s.2.x; Torres DD, 2008, KIDNEY INT, V73, P327, DOI 10.1038/sj.ki.5002621; Utsunomiya Y, 2003, PEDIATR NEPHROL, V18, P511, DOI 10.1007/s00467-003-1127-z; Vuong MT, 2010, KIDNEY INT, V78, P1281, DOI 10.1038/ki.2010.314; Wada Y, 2013, CLIN EXP NEPHROL, V17, P73, DOI 10.1007/s10157-012-0660-0; WYATT RJ, 1995, J PEDIATR-US, V127, P913, DOI 10.1016/S0022-3476(95)70027-7; Wyatt RJ, 1998, J AM SOC NEPHROL, V9, P853; Yu XQ, 2012, NAT GENET, V44, P178, DOI 10.1038/ng.1047; Zwirner J, 1997, KIDNEY INT, V51, P1257, DOI 10.1038/ki.1997.171	84	708	774	13	130	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2402	2414		10.1056/NEJMra1206793	http://dx.doi.org/10.1056/NEJMra1206793			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782179				2022-12-28	WOS:000320601700010
J	Glasziou, P				Glasziou, Paul			Mediterranean diets reduced cardiovascular events more than a low-fat diet in high-risk persons	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS		Bond Univ, Gold Coast, Qld, Australia	Bond University	Glasziou, P (corresponding author), Bond Univ, Gold Coast, Qld, Australia.		Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X				de Lorgeril M, 1994, LANCET, V343, P1454; Nordmann AJ, 2011, AM J MED, V124, P841, DOI 10.1016/j.amjmed.2011.04.024; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374	3	0	0	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12							JC3	10.7326/0003-4819-158-12-201306180-02003	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778927				2022-12-28	WOS:000320645000002
J	Simmonds, MC; Brown, JVE; Heirs, MK; Higgins, JPT; Mannion, RJ; Rodgers, MA; Stewart, LA				Simmonds, Mark C.; Brown, Jennifer V. E.; Heirs, Morag K.; Higgins, Julian P. T.; Mannion, Richard J.; Rodgers, Mark A.; Stewart, Lesley A.			Safety and Effectiveness of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Fusion A Meta-analysis of Individual-Participant Data	ANNALS OF INTERNAL MEDICINE			English	Review							LUMBAR INTERBODY FUSION; PROTEIN-2/COMPRESSION RESISTANT MATRIX; ANTERIOR CERVICAL DISKECTOMY; COST-EFFECTIVENESS ANALYSIS; ABSORBABLE COLLAGEN SPONGE; RHBMP-2 FORMULATION; PATIENT DATA; RADIOGRAPHIC OUTCOMES; RANDOMIZED-TRIALS; CLINICAL-TRIALS	Background: Recombinant human bone morphogenetic protein-2 (rhBMP-2) is widely used to promote fusion in spinal surgery, but its safety has been questioned. Purpose: To evaluate the effectiveness and safety of rhBMP-2. Data Sources: Individual-participant data obtained from the sponsor or investigators and data extracted from study publications identified by systematic bibliographic searches through June 2012. Study Selection: Randomized, controlled trials of rhBMP-2 versus iliac crest bone graft (ICBG) in spinal fusion surgery for degenerative disc disease and related conditions and observational studies in similar populations for investigation of adverse events. Data Extraction: Individual-participant data from 11 eligible of 17 provided trials sponsored by Medtronic (Minneapolis, Minnesota) (n = 1302) and 1 of 2 other eligible trials (n = 106) were included. Additional aggregate adverse event data were extracted from 35 published observational studies. Data Synthesis: Primary outcomes were pain (assessed with the Oswestry Disability Index [ODI] or Short Form-36), fusion, and adverse events. At 24 months, ODI scores were 3.5% lower (better) with rhBMP-2 than with ICBG (95% CI, 0.5% to 6.5%) and radiographic fusion was 12% higher (CI, 2% to 23%). At or shortly after surgery, pain was more common with rhBMP-2 (odds ratio, 1.78 [CI, 1.06 to 2.95]). Cancer was more common after rhBMP-2 (relative risk, 1.98 [CI, 0.86 to 4.54]), but the small number of events precluded definite conclusions. Limitation: The observational studies were diverse and at risk of bias. Conclusion: At 24 months, rhBMP-2 increases fusion rates, reduces pain by a clinically insignificant amount, and increases early postsurgical pain compared with ICBG. Evidence of increased cancer incidence is inconclusive.	[Stewart, Lesley A.] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; MRC Biostat Unit, Cambridge, England; Addenbrookes Hosp, Cambridge, England	University of York - UK; MRC Biostatistics Unit; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Stewart, LA (corresponding author), Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.		Higgins, Julian PT/H-4008-2011; Brown, Jennifer V E/C-6947-2019	Higgins, Julian PT/0000-0002-8323-2514; Brown, Jennifer V E/0000-0003-0943-5177; Stewart, Lesley/0000-0003-0287-4724	Yale University Open Data Access Project; YODA Project; MRC [MC_U105285807] Funding Source: UKRI; Medical Research Council [MC_U105285807] Funding Source: researchfish	Yale University Open Data Access Project; YODA Project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Yale University Open Data Access Project.; By a competitive grant from the YODA Project.	Abraham E, 2008, CAN J SURG, V51, pS6; Abraham EP, 2010, SPINE J, V10, pS105; Alexander D, 2007, NEUROSURGERY, V61, P200, DOI 10.1227/01.neu.0000279898.84194.a4; Alexander JT, 2002, SPINE J, V2, P48; Alt V, 2009, EUR SPINE J, V18, P800, DOI 10.1007/s00586-009-0935-7; Anand N, 2006, SPINE, V31, pE748, DOI 10.1097/01.brs.0000240211.23617.ae; [Anonymous], 2009, SYSTEMATIC REV CRDS; Assiri I, 2004, CAN J SURG S, V47, P7; Bae HW, 2007, SPINE J, V7, p9S, DOI DOI 10.1016/J.SPINEE.2007.07.024; Baskin DS, 2003, SPINE, V28, P1219, DOI 10.1097/00007632-200306150-00003; Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020; Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; Bowden J, 2011, RES SYNTH METHODS, V2, P150, DOI 10.1002/jrsm.45; Brown JV, SYSTEMATIC REV METAA; Burkus J, 2004, SPINE J, V4, pS35; Burkus JK, 2009, J BONE JOINT SURG AM, V91A, P1181, DOI 10.2106/JBJS.G.01485; Burkus JK, 2006, SPINE, V31, P775, DOI 10.1097/01.brs.0000206357.88287.5a; Burkus JK, 2005, J BONE JOINT SURG AM, V87A, P1205, DOI 10.2106/JBJS.D.02532; Burkus JK, 2004, J NEUROSURG-SPINE, V1, P254, DOI 10.3171/spi.2004.1.3.0254; Burkus JK, 2003, J SPINAL DISORD TECH, V16, P113, DOI 10.1097/00024720-200304000-00001; Burkus JK, 2003, SPINE, V28, P372, DOI 10.1097/00007632-200302150-00012; Burkus JK, 2002, J SPINAL DISORD TECH, V15, P337, DOI 10.1097/00024720-200210000-00001; Burkus JK, 2002, SPINE, V27, P2396, DOI 10.1097/00007632-200211010-00015; Burkus JK, 2001, ANN M N AM SPIN SOC, P145; Buttermann GR, 2008, SPINE J, V8, P426, DOI 10.1016/j.spinee.2006.12.006; Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Centre for Reviews and Dissemination, 2012, SYST REV MET SAF EFF; Chhabra A, 2007, VALUE HEALTH, V10, pA97, DOI 10.1016/S1098-3015(10)68833-X; Chhabra A, 2006, VALUE HEALTH, V9, pA201, DOI 10.1016/S1098-3015(10)63198-1; Comer GC, 2012, SPINE J, V12, P881, DOI 10.1016/j.spinee.2012.09.040; Crawford CH, 2009, SPINE, V34, P1390, DOI 10.1097/BRS.0b013e3181a2da08; Dawson E, 2009, J BONE JOINT SURG AM, V91A, P1604, DOI 10.2106/JBJS.G.01157; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deyo RA, 2012, SPINE, V37, P222, DOI 10.1097/BRS.0b013e31821bfa3a; Dickman CA, 2001, NEUROSURGERY, V49, P521; Dimar JR, 2006, NEUROSURGERY, V59, P459, DOI 10.1227/00006123-200608000-00056; Dimar JR, 2006, SPINE, V31, P2534, DOI 10.1097/01.brs.0000240715.78657.81; Dimar JR, 2009, J BONE JOINT SURG AM, V91A, P1377, DOI 10.2106/JBJS.H.00200; Fisher DJ, 2011, J CLIN EPIDEMIOL, V64, P949, DOI 10.1016/j.jclinepi.2010.11.016; Gerszten PC, 2011, SPINE J, V11, P1027, DOI 10.1016/j.spinee.2011.10.006; Glassman SD, 2005, SPINE, V30, P1694, DOI 10.1097/01.brs.0000172157.39513.80; Glassman SD, 2007, SPINE J, V7, P44, DOI 10.1016/j.spinee.2006.06.381; Glassman SD, 2007, SPINE, V32, P1693, DOI 10.1097/BRS.0b013e318074c366; Glassman SD, 2008, SPINE, V33, P2843, DOI 10.1097/BRS.0b013e318190705d; Golder S, 2009, J MED LIBR ASSOC, V97, P84, DOI 10.3163/1536-5050.97.2.004; Gornet M, 2001, ANN M N AM SPIN SOC; Gornet MF, 2007, SPINE J, V7, p1S, DOI 10.1016/j.spinee.2007.07.005; Gornet MF, 2011, SPINE, V36, pE1600, DOI 10.1097/BRS.0b013e318217668f; Gray RJ, 2010, SPINE J, V10, p8S; Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025; Higgins JPT, 2001, STAT MED, V20, P2219, DOI 10.1002/sim.918; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hiremath GK, 2009, SPINE, V34, P885, DOI 10.1097/BRS.0b013e31819e334a; Joseph V, 2007, SPINE, V32, P2885, DOI 10.1097/BRS.0b013e31815b7596; Kleeman TJ, 2001, SPINE, V26, P2751, DOI 10.1097/00007632-200112150-00026; Lee KB, 2010, EUR SPINE J, V19, P924, DOI 10.1007/s00586-009-1248-6; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Loke YK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-32; Longley MC, 2009, SPINE PHILA PA 1976; Lu DC, 2010, J NEUROSURG, V113, pA406; Mannion RJ, 2011, SPINE J, V11, P527, DOI 10.1016/j.spinee.2010.07.005; McInnis MM, 2010, VALUE HEALTH, V13, pA305, DOI 10.1016/S1098-3015(11)72170-2; Mindea SA, 2009, SPINE, V34, P1480, DOI 10.1097/BRS.0b013e3181a396a1; Mummaneni PV, 2004, J NEUROSURG-SPINE, V1, P19, DOI 10.3171/spi.2004.1.1.0019; Ong KL, 2010, SPINE, V35, P1794, DOI 10.1097/BRS.0b013e3181ecf6e4; Pimenta L, 2011, SPINE J, V11, p130S; Pradhan BB, 2006, SPINE, V31, pE277, DOI 10.1097/01.brs.0000216442.12092.01; Rihn JA, 2009, SPINE J, V9, P623, DOI 10.1016/j.spinee.2009.04.004; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Rowan FE, 2011, J BONE JOINT SURG BR, V93B, P490; Shapiro S, 2005, NEUROSURGERY, V57, P398, DOI 10.1093/neurosurgery/57.2.398; Simmonds MC, 2011, RES SYNTH METHODS, V2, P139, DOI 10.1002/jrsm.44; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Singh K, 2006, J SPINAL DISORD TECH, V19, P416, DOI 10.1097/00024720-200608000-00008; Slosar PJ, 2007, SPINE J, V7, P301, DOI 10.1016/j.spinee.2006.10.015; Smucker JD, 2006, SPINE, V31, P2813, DOI 10.1097/01.brs.0000245863.52371.c2; Stewart L, 2012, SYSTEMATIC REV METAA; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Taghavi CE, 2010, SPINE, V35, P1144, DOI 10.1097/BRS.0b013e3181bb5203; Taylor SJ, 1999, SPINE, V24, P1805, DOI 10.1097/00007632-199909010-00010; Thawani JP, 2010, NEUROSURGERY, V66, P233, DOI 10.1227/01.NEU.0000363722.42097.C2; Thompson SG, 2005, LANCET, V365, P341, DOI 10.1016/S0140-6736(05)17790-3; Turner RM, 2000, STAT MED, V19, P3417, DOI 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L; U.S. Food and Drug Administration, 2012, INFUSE BON GRAFT LT; Vaidya R, 2007, J BONE JOINT SURG BR, V89B, P342, DOI 10.1302/0301-620X.89B3.18270; Vaidya R, 2007, EUR SPINE J, V16, P1257, DOI 10.1007/s00586-007-0351-9; Van Genugten M, 2008, VALUE HEALTH, V11, pA532, DOI 10.1016/S1098-3015(10)66759-9; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994; Wells G.A., 2011, NEWCASTLE OTTAWA SCA; Whitehead A, 2001, STAT MED, V20, P2243, DOI 10.1002/sim.919; Williams BJ, 2011, SPINE, V36, P1685, DOI 10.1097/BRS.0b013e318216d825; Xu Risheng, 2011, Surg Neurol Int, V2, P109, DOI 10.4103/2152-7806.83726; Yale School of Medicine, 2012, YAL U OP DAT ACC YOD; Yaremchuk KL, 2010, LARYNGOSCOPE, V120, P1954, DOI 10.1002/lary.21096; Zdeblick T, 2001, ANN M N AM SPIN SOC	99	240	244	4	40	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12					877	+		10.7326/0003-4819-158-12-201306180-00005	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-00005			29	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778905				2022-12-28	WOS:000320645000016
J	Johnson, TE				Johnson, Thomas E.			Rapid Aging Rescue?	SCIENCE			English	Editorial Material							PRELAMIN		[Johnson, Thomas E.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Johnson, Thomas E.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Johnson, TE (corresponding author), Univ Colorado, Inst Behav Genet, Box 447, Boulder, CO 80309 USA.	johnsont@colorado.edu		/0000-0001-7147-8237				Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Couzin-Frankel J, 2012, SCIENCE, V337, P1594, DOI 10.1126/science.337.6102.1594; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Gordon LB, 2012, P NATL ACAD SCI USA, V109, P16666, DOI 10.1073/pnas.1202529109; Ibrahim MX, 2013, SCIENCE, V340, P1330, DOI 10.1126/science.1238880; Martin G. M., 1978, GENETIC EFFECTS AGIN, V15, P5; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Pollex RL, 2004, CLIN GENET, V66, P375, DOI 10.1111/j.1399-0004.2004.00315.x; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679	11	2	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1299	1300		10.1126/science.1240843	http://dx.doi.org/10.1126/science.1240843			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766322				2022-12-28	WOS:000320320200033
J	Rezende, EL				Rezende, Enrico L.			Better Oxygen Delivery	SCIENCE			English	Editorial Material							VERTEBRATES; ENDOTHERMY; METABOLISM; EVOLUTION; CAPACITY		[Rezende, Enrico L.] Univ Roehampton, Dept Life Sci, London SW15 4JD, England; [Rezende, Enrico L.] Univ Fed Santa Catarina, Dept Ecol & Zool, BR-88010970 Florianopolis, SC, Brazil	Roehampton University; Universidade Federal de Santa Catarina (UFSC)	Rezende, EL (corresponding author), Univ Roehampton, Dept Life Sci, Holybourne Ave, London SW15 4JD, England.	enrico.rezende@gmail.com	Rezende, Enrico L./S-3219-2019; Rezende, Enrico L/B-8029-2012	Rezende, Enrico L./0000-0002-6245-9605; Rezende, Enrico L/0000-0002-6245-9605				BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Berenbrink M, 2005, SCIENCE, V307, P1752, DOI 10.1126/science.1107793; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Hillenius WJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1019, DOI 10.1086/425185; Kieffer JD, 2000, COMP BIOCHEM PHYS A, V126, P161, DOI 10.1016/S1095-6433(00)00202-6; Koch LG, 2008, J PHYSIOL-LONDON, V586, P83, DOI 10.1113/jphysiol.2007.144709; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Natarajan C, 2013, SCIENCE, V340, P1324, DOI 10.1126/science.1236862; Rummer JL, 2013, SCIENCE, V340, P1327, DOI 10.1126/science.1233692; Sears MW, 2006, FUNCT ECOL, V20, P97, DOI 10.1111/j.1365-2435.2006.01067.x; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Thannickal VJ, 2009, AM J RESP CELL MOL, V40, P507, DOI 10.1165/rcmb.2008-0360PS	12	5	7	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1293	1294		10.1126/science.1240631	http://dx.doi.org/10.1126/science.1240631			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766317				2022-12-28	WOS:000320320200028
J	Doherty, T; Tabana, H; Jackson, D; Naik, R; Zembe, W; Lombard, C; Swanevelder, S; Fox, MP; Thorson, A; Ekstrom, AM; Chopra, M				Doherty, Tanya; Tabana, Hanani; Jackson, Debra; Naik, Reshma; Zembe, Wanga; Lombard, Carl; Swanevelder, Sonja; Fox, Matthew P.; Thorson, Anna; Ekstrom, Anna Mia; Chopra, Mickey			Effect of home based HIV counselling and testing intervention in rural South Africa: cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEXUAL-BEHAVIOR; INFECTIONS	Objective To assess the effect of home based HIV counselling and testing on the prevalence of HIV testing and reported behavioural changes in a rural subdistrict of South Africa. Design Cluster randomised controlled trial. Setting 16 communities (clusters) in uMzimkhulu subdistrict, KwaZulu-Natal province, South Africa. Participants 4154 people aged 14 years or more who participated in a community survey. Intervention Lay counsellors conducted door to door outreach and offered home based HIV counselling and testing to all consenting adults and adolescents aged 14-17 years with guardian consent. Control clusters received standard care, which consisted of HIV counselling and testing services at local clinics. Main outcome measures Primary outcome measure was prevalence of testing for HIV. Other outcomes were HIV awareness, stigma, sexual behaviour, vulnerability to violence, and access to care. Results Overall, 69% of participants in the home based HIV counselling and testing arm versus 47% in the control arm were tested for HIV during the study period (prevalence ratio 1.54, 95% confidence interval 1.32 to 1.81). More couples in the intervention arm had counselling and testing together than in the control arm (2.24, 1.49 to 3.03). The intervention had broader effects beyond HIV testing, with a 55% reduction in multiple partners (0.45, 0.33 to 0.62) and a stronger effect among those who had an HIV test (0.37, 0.24 to 0.58) and a 45% reduction in casual sexual partners (0.55, 0.42 to 0.73). Conclusions Home based HIV counselling and testing increased the prevalence of HIV testing in a rural setting with high levels of stigma. Benefits also included higher uptake of couple counselling and testing and reduced sexual risk behaviour.	[Doherty, Tanya; Tabana, Hanani; Zembe, Wanga; Lombard, Carl; Swanevelder, Sonja] MRC, ZA-7535 Cape Town, South Africa; [Doherty, Tanya; Jackson, Debra] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa; [Tabana, Hanani; Thorson, Anna; Ekstrom, Anna Mia] Karolinska Inst, Dept Publ Hlth IHCAR, Stockholm, Sweden; [Naik, Reshma; Fox, Matthew P.] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; [Naik, Reshma; Fox, Matthew P.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Chopra, Mickey] UNICEF, Hlth Sect, New York, NY USA	University of the Western Cape; Karolinska Institutet; Boston University; Boston University; UNICEF	Doherty, T (corresponding author), MRC, ZA-7535 Cape Town, South Africa.	tanya.doherty@mrc.ac.za	Ekström, Anna Mia/H-6901-2013; Tabana, Hanani/AAP-8143-2020; Tabana, Hanani/AAJ-5361-2020; Fox, Matthew/K-2004-2019	Tabana, Hanani/0000-0003-1576-2238; Tabana, Hanani/0000-0003-1576-2238; Jackson, Debra/0000-0003-3307-632X; Fox, Matthew/0000-0001-9887-0634; Thorson, Anna/0000-0002-8703-6561; Lombard, Carl/0000-0002-2136-6533	South African Medical Research Council; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [5U2GPS001137]; South African National Research Foundation	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); South African National Research Foundation(National Research Foundation - South Africa)	The study was funded by the South African Medical Research Council and by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of 5U2GPS001137. TD and DJ were also supported by the South African National Research Foundation. The study sponsors had no role in study design, data collection, data analysis, data interpretation or writing the report.	Bateganya M, 2010, COCHRANE DATABASE SY; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Department of Health, 2010, NAT ANT SENT HIV SYP; Department of Health (South Africa), 2009, NAT ANT SENT HIV SYP; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hayes R, 2011, CURR HIV RES, V9, P429, DOI 10.2174/157016211798038515; Human Sciences Research Council, 2009, S AFR NAT HIV PREV I; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Karim SSA, 2012, LANCET, V379, P2047, DOI 10.1016/S0140-6736(12)60786-7; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; McCord GC, 2013, B WORLD HEALTH ORGAN, V91, P244, DOI 10.2471/BLT.12.109660; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Shisana O, 2009, S AFRICAN NATL HIV P; Singh P, 2013, LANCET; South African National AIDS Council, 2010, OUTL NAT HIV COUNS T; South African National Department of Health, 2010, REENG PRIM HLTH CAR; South African National Department of Health, 2010, NAT ANT SENT HIV SYP; Steinberg J, 2011, 3 LETT PLAGUE YOUNG; Tabana H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-73; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; The Lancet, 2012, LANCET, V379, P1365; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Umzimkhulu Local Municipality, 2010, REV INT DEV PLAN 201; UNAIDS, 2012, UNAIDS REP GLOB AIDS; UNAIDS, 2012, TOG WE WILL END AIDS; UNAIDS, 2010, GLOB REP UNAIDS REP; USAID, 2006, CAN WE MEAS HIV AIDS; World Health Organization, 2012, PLANN IMPL MIN HOM B; World Health Organization, 2012, GUID OR PREEXP PROPH; Zwarenstein M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2022	33	56	56	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2013	346								f3481	10.1136/bmj.f3481	http://dx.doi.org/10.1136/bmj.f3481			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WQ	23766483	Green Published, hybrid			2022-12-28	WOS:000320590800008
J	Guessoum, N				Guessoum, Nidhal			Time for an Arab astronomy renaissance	NATURE			English	Editorial Material									Amer Univ Sharjah, Sharjah, U Arab Emirates	American University of Sharjah	Guessoum, N (corresponding author), Amer Univ Sharjah, Sharjah, U Arab Emirates.	nguessoum@aus.edu	Guessoum, Nidhal/C-3051-2013	Guessoum, Nidhal/0000-0003-1585-8205				AIAD A, 1990, IAU COLLOQ, V105, P398, DOI 10.1017/S0252921100087376; Al-Naimiy H. M. K., 2011, P IAU S, V260, P429; Guessoum N, 2012, NATURE MIDDLE E; Hady AA, 2008, ADV SPACE RES, V42, P1800, DOI 10.1016/j.asr.2008.06.015; Hassan S.M., 2004, DEC UN ESA WORKSH, P237; Sayili S., 1981, OBSERVATORY ISLAM	6	5	5	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					161	164		10.1038/498161a	http://dx.doi.org/10.1038/498161a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	162RR	23765476	Bronze			2022-12-28	WOS:000320283400018
J	Czarna, A; Berndt, A; Singh, HR; Grudziecki, A; Ladurner, AG; Timinszky, G; Kramer, A; Wolf, E				Czarna, Anna; Berndt, Alex; Singh, Hari Raj; Grudziecki, Astrid; Ladurner, Andreas G.; Timinszky, Gyula; Kramer, Achim; Wolf, Eva			Structures of Drosophila Cryptochrome and Mouse Cryptochrome1 Provide Insight into Circadian Function	CELL			English	Article							LIGHT-DEPENDENT MAGNETOSENSITIVITY; CIRCULAR-DICHROISM SPECTRA; CRYSTAL-STRUCTURE; C-TERMINUS; MAMMALIAN CRY1; 6-4 PHOTOLYASE; FEEDBACK LOOP; CLOCK; PROTEIN; MECHANISM	Drosophila cryptochrome (dCRY) is a FAD-dependent circadian photoreceptor, whereas mammalian cryptochromes (CRY1/2) are integral clock components that repress mCLOCK/mBMAL1-dependent transcription. We report crystal structures of full-length dCRY, a dCRY loop deletion construct, and the photolyase homology region of mouse CRY1 (mCRY1). Our dCRY structures depict Phe534 of the regulatory tail in the same location as the photolesion in DNA-repairing photolyases and reveal that the sulfur loop and tail residue Cys523 plays key roles in the dCRYphotoreaction. OurmCRY1structure visualizes previously characterized mutations, an NLS, and MAPK and AMPK phosphorylation sites. We show that the FAD and antenna chromophore-binding regions, a predicted coiled-coil helix, the C-terminal lid, and charged surfaces are involved in FAD-independent mPER2 and FBXL3 binding and mCLOCK/mBMAL1 transcriptional repression. The structure of a mammalian cryptochrome1 protein may catalyze the development of CRY chemical probes and the design of therapeutic metabolic modulators.	[Czarna, Anna; Singh, Hari Raj; Ladurner, Andreas G.; Timinszky, Gyula; Wolf, Eva] Univ Munich, Dept Physiol Chem, D-81377 Munich, Germany; [Czarna, Anna; Singh, Hari Raj; Ladurner, Andreas G.; Timinszky, Gyula; Wolf, Eva] Univ Munich, CIPSM, Butenandt Inst, D-81377 Munich, Germany; [Czarna, Anna] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Berndt, Alex] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Grudziecki, Astrid; Kramer, Achim] Charite Univ Med Berlin, Lab Chronobiol, D-10115 Berlin, Germany	University of Munich; University of Munich; Max Planck Society; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wolf, E (corresponding author), Univ Munich, Dept Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	eva.wolf@med.uni-muenchen.de		Timinszky, Gyula/0000-0001-6342-8985; Czarna, Anna/0000-0003-1068-0671; Kramer, Achim/0000-0001-9671-6078; Ladurner, Andreas/0000-0003-3835-232X	Deutsche Forschungsgemeinschaft [WO695-3/4/5/6]; DFG-funded CIPSM [SFB740/D2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-funded CIPSM	We thank the beamline staff at the Swiss Light Source (SLS, Villingen, CH) and the European Synchrotron Radiation Facility (ESRF, Grenoble) for excellent assistance and our colleagues at the Max Planck Institute of Biochemistry and the Max Planck Institute of Molecular Physiology for help with data collection. We also thank the staff of the Crystallization Facility and the Microchemistry Core Facility of the Max-Planck-Institute of Biochemistry for technical assistance. We are indebted to Michaela Rode for assistance with insect cell culture, Walter Erhardt for the construction of illumination devices, and Jo rg Tittor for introduction to the UV/VIS spectrophotometer. We also thank Katja Schellenberg for the G336D mutant, Helena Breitkreuz for the mCRY1 expression plasmid, Simone Grau for technical assistance, and Ira Schmalen, Torsten Merbitz-Zahradnik, and Justine Witosch for discussions. This work was supported by grants from the Deutsche Forschungsgemeinschaft (WO695-3/4/5/6 to E.W., DFG-funded CIPSM to A.G.L., and SFB740/D2 to A.K.).	Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Czarna A, 2011, J BIOL CHEM, V286, P22414, DOI 10.1074/jbc.M111.244749; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Foley LE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1364; Froy O, 2002, CURR BIOL, V12, P147, DOI 10.1016/S0960-9822(01)00656-X; Gatfield D, 2007, SCIENCE, V316, P1135, DOI 10.1126/science.1144165; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Glas AF, 2009, CHEM-EUR J, V15, P10387, DOI 10.1002/chem.200901004; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hemsley MJ, 2007, BIOCHEM BIOPH RES CO, V355, P531, DOI 10.1016/j.bbrc.2007.01.189; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kucera N, 2012, P NATL ACAD SCI USA, V109, P3311, DOI 10.1073/pnas.1113280109; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; McCarthy EV, 2009, MOL CELL BIOL, V29, P5465, DOI 10.1128/MCB.00641-09; Miyazaki K, 2001, MOL CELL BIOL, V21, P6651, DOI 10.1128/MCB.21.19.6651-6659.2001; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Ozber N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-69; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Sanada K, 2004, GENES CELLS, V9, P697, DOI 10.1111/j.1356-9597.2004.00758.x; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	44	128	135	1	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1394	1405		10.1016/j.cell.2013.05.011	http://dx.doi.org/10.1016/j.cell.2013.05.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746849	Bronze, Green Published			2022-12-28	WOS:000319979200021
J	Leucht, S; Cipriani, A; Spineli, L; Mavridis, D; Orey, D; Richter, F; Samara, M; Barbui, C; Engel, RR; Geddes, JR; Kissling, W; Stapf, MP; Lassig, B; Salanti, G; Davis, JM				Leucht, Stefan; Cipriani, Andrea; Spineli, Loukia; Mavridis, Dimitris; Oerey, Deniz; Richter, Franziska; Samara, Myrto; Barbui, Corrado; Engel, Rolf R.; Geddes, John R.; Kissling, Werner; Stapf, Marko Paul; Laessig, Bettina; Salanti, Georgia; Davis, John M.			Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis	LANCET			English	Article							2ND-GENERATION; TRIALS; 1ST-GENERATION; PALIPERIDONE; MEDICATIONS; BLIND	Background The question of which antipsychotic drug should be preferred for the treatment of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide a hierarchy based on the randomised evidence. We aimed to integrate the available evidence to create hierarchies of the comparative efficacy, risk of all-cause discontinuation, and major side-effects of antipsychotic drugs. Methods We did a Bayesian-framework, multiple-treatments meta-analysis (which uses both direct and indirect comparisons) of randomised controlled trials to compare 15 antipsychotic drugs and placebo in the acute treatment of schizophrenia. We searched the Cochrane Schizophrenia Group's specialised register, Medline, Embase, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov for reports published up to Sept 1, 2012. Search results were supplemented by reports from the US Food and Drug Administration website and by data requested from pharmaceutical companies. Blinded, randomised controlled trials of patients with schizophrenia or related disorders were eligible. We excluded trials done in patients with predominant negative symptoms, concomitant medical illness, or treatment resistance, and those done in stable patients. Data for seven outcomes were independently extracted by two reviewers. The primary outcome was efficacy, as measured by mean overall change in symptoms. We also examined all-cause discontinuation, weight gain, extrapyramidal side-effects, prolactin increase, QTc prolongation, and sedation. Findings We identified 212 suitable trials, with data for 43 049 participants. All drugs were significantly more effective than placebo. The standardised mean differences with 95% credible intervals were: clozapine 0.88, 0.73-1.03; amisulpride 0.66, 0.53-0.78; olanzapine 0.59, 0.53-0.65; risperidone 0.56, 0.50-0.63; paliperidone 0.50, 0.39-0.60; zotepine 0.49, 0.31-0.66; haloperidol 0.45, 0.39-0.51; quetiapine 0.44, 0.35-0.52; aripiprazole 0.43, 0.34-0.52; sertindole 0.39, 0.26-0.52; ziprasidone 0.39, 0.30-0.49; chlorpromazine 0.38, 0.23-0.54; asenapine 0.38, 0.25-0.51; lurasidone 0.33, 0.21-0.45; and iloperidone 0.33, 0.22-0.43. Odds ratios compared with placebo for all-cause discontinuation ranged from 0.43 for the best drug (amisulpride) to 0.80 for the worst drug (haloperidol); for extrapyramidal side-effects 0.30 (clozapine) to 4.76 (haloperidol); and for sedation 1.42 (amisulpride) to 8.82 (clozapine). Standardised mean differences compared with placebo for weight gain varied from -0.09 for the best drug (haloperidol) to -0.74 for the worst drug (olanzapine), for prolactin increase 0.22 (aripiprazole) to -1.30 (paliperidone), and for QTc prolongation 0.10 (lurasidone) to -0.90 (sertindole). Efficacy outcomes did not change substantially after removal of placebo or haloperidol groups, or when dose, percentage of withdrawals, extent of blinding, pharmaceutical industry sponsorship, study duration, chronicity, and year of publication were accounted for in meta-regressions and sensitivity analyses. Interpretation Antipsychotics differed substantially in side-effects, and small but robust differences were seen in efficacy. Our findings challenge the straightforward classification of antipsychotics into first-generation and second-generation groupings. Rather, hierarchies in the different domains should help clinicians to adapt the choice of antipsychotic drug to the needs of individual patients. These findings should be considered by mental health policy makers and in the revision of clinical practice guidelines.	[Leucht, Stefan; Oerey, Deniz; Richter, Franziska; Samara, Myrto; Kissling, Werner; Stapf, Marko Paul; Laessig, Bettina] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany; [Cipriani, Andrea; Barbui, Corrado] Univ Verona, Dept Med & Publ Hlth, Sect Psychiat, I-37100 Verona, Italy; [Spineli, Loukia; Mavridis, Dimitris; Salanti, Georgia] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Engel, Rolf R.] Univ Munich, Psychiat Klin, Munich, Germany; [Cipriani, Andrea; Geddes, John R.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Davis, John M.] Univ Illinois, Inst Psychiat, Chicago, IL USA; [Davis, John M.] Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA	Technical University of Munich; University of Munich; University of Verona; University of Ioannina; University of Munich; University of Oxford; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Leucht, S (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany.	stefan.leucht@lrz.tum.de	Cipriani, Andrea/P-6944-2015; Spineli, Loukia/S-9443-2019; Mavrids, Dimitris/H-5452-2019; Leucht, Stefan/Y-2408-2019; Geddes, John/B-8240-2011	Cipriani, Andrea/0000-0001-5179-8321; Spineli, Loukia/0000-0001-9515-582X; Mavrids, Dimitris/0000-0003-1041-4592; Leucht, Stefan/0000-0002-4934-4352; Geddes, John/0000-0002-5281-5960; Engel, Rolf/0000-0001-8022-3228; Salanti, Georgia/0000-0002-3830-8508	German Ministry of Education and Research [01KG0606]; MRC [G0700477] Funding Source: UKRI; Medical Research Council [G0700477] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10150] Funding Source: researchfish	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank Julian Higgins for his work on the protocol; Anna Chaimani for assistance with the statistical analysis; and Claudia Leucht, Maximilian Huhn, Markus Dold, Haoyin Cao, and Magdolna Tardy for their help in preparing the report. For sending us information about their studies, we thank Ebrahim Abdolahian, Christian Barnas, Michael Berk, Warrick Brewer, Roberto Cavallaro, Eva Ceskova, Mark Corrigan, Jair de Jesus Mari, Wolfgang Fleischhacker, Kotaro Hatta, Tzung-Jeng Hwang, Peter Jones, Michael Kluge, Ronnachai Kongsakon, Joseph McEvoy, Herbert Meltzer, David Owens, Hans-Jurgen Moller, Dieter Naber, Halise Ozguven, Joseph Peuskens, Michael Wagner, Sophie Remillard, Stephan Ruhrmann, Emilio Sacchetti, Nina Schooler, Scott Stroup, and Jaromir Svestka, and the pharmaceutical companies Astellas, AstraZeneca, Eli Lilly, Lundbeck, Ortho-McNeil Janssen Scientific Affairs, Johnson & Johnson, Novartis, Sanofi-Aventis, and Sunovion. We also thank the numerous researchers who sent information for our previous reviews on which the present one was built. The German Ministry of Education and Research provided a grant for a previous meta-analysis (01KG0606), some of the data from which were used again in this study.	Adams CE, 2007, COCHRANE DB SYST REV, V2; BCC Research, ANT DRUGS TECHN GLOB; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Caldwell DM, 2007, LANCET, V369, P270, DOI 10.1016/S0140-6736(07)60138-X; Chaimani A, 2012, RES SYNTH METHODS, V3, P161, DOI 10.1002/jrsm.57; CHOUINARD G, 1980, AM J PSYCHIAT, V137, P16; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cochrane Schizophrenia Group, COCHR SCHIZ GROUP SP; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; De Hert M, 2012, CNS DRUGS, V26, P733, DOI 10.2165/11634500-000000000-00000; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dolder C, 2008, AM J HEALTH-SYST PH, V65, P403, DOI 10.2146/ajhp070261; Donnelly L, 2002, COCHRANE DB SYST REV, V2; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; Glick ID, 2011, J CLIN PSYCHIAT, V72, P1616, DOI 10.4088/JCP.11r06927; Haddad PM, 2004, DRUGS, V64, P2291, DOI 10.2165/00003495-200464200-00003; Hartling L, 2012, ANN INTERN MED, V157, P498, DOI 10.7326/0003-4819-157-7-201210020-00525; Hartung B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003443.pub2; Hasan A, 2012, WORLD J BIOL PSYCHIA, V13, P318, DOI 10.3109/15622975.2012.696143; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Irving CB, 2006, COCHRANE DB SYST REV, V4; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Khin NA, 2012, J CLIN PSYCHIAT, V73, P856, DOI 10.4088/JCP.11r07539; Klein DF, 1969, DIAGNOSIS DRUG TREAT; Klein HE, 1985, PSYCHIAT STATE ART, P687; Leucht C, COCHRANE DATABASE SY, V1; Leucht S, 2009, MOL PSYCHIATR, V14, P429, DOI 10.1038/sj.mp.4002136; Leucht S, 2003, LANCET, V361, P1581, DOI 10.1016/S0140-6736(03)13306-5; Leucht S, 2009, AM J PSYCHIAT, V166, P152, DOI 10.1176/appi.ajp.2008.08030368; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lin CC, 2013, J CLIN PSYCHOPHARM, V33, P211, DOI 10.1097/JCP.0b013e31828700c7; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; NICE, 2009, SCHIZ COR INT TREATM; Nussbaum A, COCHRANE DATABASE SY, V6; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Page CB, 2010, J CLIN PSYCHOPHARM, V30, P387, DOI [10.1097/JCP.0b013e3181e5f7a5, 10.1097/JCP.0b013e3181e5c14c]; Pappa S, 2009, PSYCHOL MED, V39, P1065, DOI 10.1017/S0033291708004716; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Song Fujian, 2011, BMJ, V343, pd4909, DOI 10.1136/bmj.d4909; Strom BL, 2011, AM J PSYCHIAT, V168, P193, DOI 10.1176/appi.ajp.2010.08040484; Tandon R, 2005, SCHIZOPHR RES, V79, P145, DOI 10.1016/j.schres.2005.07.025; Thomas SHL, 2010, ACTA PSYCHIAT SCAND, V122, P345, DOI 10.1111/j.1600-0447.2010.01563.x; Trikalinos TA, 2004, J CLIN EPIDEMIOL, V57, P1124, DOI 10.1016/j.jclinepi.2004.02.018; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wetzel H, 1998, PSYCHOPHARMACOLOGY, V137, P223, DOI 10.1007/s002130050614; Wu TX, 2006, 14 COCHR C DUBL OCT	59	1590	1655	21	375	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2013	382	9896					951	962		10.1016/S0140-6736(13)60733-3	http://dx.doi.org/10.1016/S0140-6736(13)60733-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VD	23810019				2022-12-28	WOS:000324238000028
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Primary Care Interventions to Prevent Child Maltreatment: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							NURSE HOME VISITATION; RANDOMIZED CONTROLLED-TRIAL; HEALTH-CARE; DOMESTIC VIOLENCE; VISITING PROGRAM; COMMUNITY SAMPLE; UNITED-STATES; ABUSE; NEGLECT; IMPACT	Description: Update of the child abuse and neglect portion of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for family and intimate partner violence. Methods: The USPSTF commissioned a systematic review on interventions to prevent child maltreatment for children at risk, focusing on new studies and evidence gaps that were unresolved at the time of the 2004 recommendation. Beneficial outcomes considered include reduced exposure to maltreatment and reduced harms to physical or mental health or mortality. Population: This recommendation applies to children in the general U.S. population from newborn to age 18 years who do not have signs or symptoms of maltreatment. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care interventions to prevent child maltreatment. (I statement)						Pignone, Michael/0000-0002-6657-7342	USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Academy of Family Physicians, 2013, CLIN PREV SERV; American Medical Association, 2008, OP 2 02 PHYS OBL PRE; [Anonymous], NAT CONS GUID ID RES; Bair-Merritt MH, 2004, AMBUL PEDIATR, V4, P24, DOI 10.1367/1539-4409(2004)004<0024:PRTODV>2.0.CO;2; Barlow J, 2007, ARCH DIS CHILD, V92, P229, DOI 10.1136/adc.2006.095117; BARTH RP, 1991, CHILD ABUSE NEGLECT, V15, P363, DOI 10.1016/0145-2134(91)90021-5; Battle CL, 2004, J PERS DISORD, V18, P193, DOI 10.1521/pedi.18.2.193.32777; Berg AO, 2004, ANN INTERN MED, V140, P382, DOI 10.7326/0003-4819-140-5-200403020-00021; Bierer LM, 2003, CNS SPECTRUMS, V8, P737, DOI 10.1017/S1092852900019118; Brown J, 2005, CLIN J PAIN, V21, P374, DOI 10.1097/01.ajp.0000149797.16370.dc; Bugental DB, 2009, DEV PSYCHOL, V45, P284, DOI 10.1037/a0014031; Centre for Disease Control and Prevention, 2012, CHILD MALTR RISK PRO; Chartier MJ, 2007, AM J EPIDEMIOL, V165, P1031, DOI 10.1093/aje/kwk113; Child Welfare Information Gateway, 2011, DEF CHILD AB NEGL; Council of International Neonatal Nurses, 2010, COUNC INT NEON NURS; CT Department of Children and Families, 2008, CHILD ABUSE NEGLECT; Cutajar MC, 2010, CHILD ABUSE NEGLECT, V34, P813, DOI 10.1016/j.chiabu.2010.04.004; Davis DA, 2005, CLIN J PAIN, V21, P398, DOI 10.1097/01.ajp.0000149795.08746.31; Dubowitz H, 2009, PEDIATRICS, V123, P858, DOI 10.1542/peds.2008-1376; Duggan A, 2004, CHILD ABUSE NEGLECT, V28, P597, DOI 10.1016/j.chiabu.2003.08.007; Duggan A, 2007, CHILD ABUSE NEGLECT, V31, P801, DOI 10.1016/j.chiabu.2006.06.011; DuMont K, 2008, CHILD ABUSE NEGLECT, V32, P295, DOI 10.1016/j.chiabu.2007.07.007; Eckenrode J, 2000, JAMA-J AM MED ASSOC, V284, P1385, DOI 10.1001/jama.284.11.1385; Emergency Nurses Association, 2006, EM NURS ASS POS STAT; Fergusson DM, 2005, PEDIATRICS, V116, pE803, DOI 10.1542/peds.2005-0948; Flaherty EG, 2010, PEDIATRICS, V126, P833, DOI 10.1542/peds.2010-2087; Goodwin RD, 2004, PSYCHOL MED, V34, P509, DOI 10.1017/S003329170300134X; Guide to Community Preventive Services, 2010, VIOL PREV EARL CHILD; Hussey JM, 2006, PEDIATRICS, V118, P933, DOI 10.1542/peds.2005-2452; Lapidus G, 2002, ARCH PEDIAT ADOL MED, V156, P332, DOI 10.1001/archpedi.156.4.332; Leeb RebeccaT., 2008, CHILD MALTREATMENT; Lowell DI, 2011, CHILD DEV, V82, P193, DOI 10.1111/j.1467-8624.2010.01550.x; Lown EA, 2011, ALCOHOL CLIN EXP RES, V35, P317, DOI 10.1111/j.1530-0277.2010.01347.x; MacMillan HL, 2000, CAN MED ASSOC J, V163, P1451; Nelson HD., 2013, RISK ASSESSMENT GENE; OLDS DL, 1994, PEDIATRICS, V93, P89; OLDS DL, 1986, PEDIATRICS, V78, P65; Palazzi S, 2005, ARCH DIS CHILD, V90, P406, DOI 10.1136/adc.2003.040790; Pederson CL, 2009, PSYCHOL REP, V105, P111, DOI 10.2466/PR0.105.1.111-126; Schneider Renee, 2007, Violence Vict, V22, P620, DOI 10.1891/088667007782312140; Sickel AE, 2002, J HEALTH PSYCHOL, V7, P583, DOI 10.1177/1359105302007005677; SIEGEL E, 1980, PEDIATRICS, V66, P183; Sullivan PM, 2000, CHILD ABUSE NEGLECT, V24, P1257, DOI 10.1016/S0145-2134(00)00190-3; Taylor J, 2008, J CLIN NURS, V17, P1193, DOI 10.1111/j.1365-2702.2007.02192.x; Thompson R, 2010, CHILD ABUSE NEGLECT, V34, P907, DOI 10.1016/j.chiabu.2010.06.006; Trickett P., 2005, CHILD ABUSE TEAM MAY; U. S. Department of Health and Human Services Administration for Children and Families Administration on Children Youth and Families Children's Bureau, 2012, CHILDR MALTR 2011; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46	48	25	25	2	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					289	+		10.7326/0003-4819-159-4-201308200-00667	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00667			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	205DM	23752681				2022-12-28	WOS:000323421700019
J	Ebert, DH; Gabel, HW; Robinson, ND; Kastan, NR; Hu, LS; Cohen, S; Navarro, AJ; Lyst, MJ; Ekiert, R; Bird, AP; Greenberg, ME				Ebert, Daniel H.; Gabel, Harrison W.; Robinson, Nathaniel D.; Kastan, Nathaniel R.; Hu, Linda S.; Cohen, Sonia; Navarro, Adrija J.; Lyst, Matthew J.; Ekiert, Robert; Bird, Adrian P.; Greenberg, Michael E.			Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR	NATURE			English	Article							METHYL-CPG; BDNF TRANSCRIPTION; RETT-SYNDROME; BINDING; REPRESSION; CHROMATIN; ASSOCIATION; INHIBITION; MUTATIONS; DISORDER	Rett syndrome (RTT) is an X-linked human neurodevelopmental disorder with features of autism and severe neurological dysfunction in females. RTT is caused by mutations in methyl-CpG-binding protein 2 (MeCP2), a nuclear protein that, in neurons, regulates transcription, is expressed at high levels similar to that of histones, and binds to methylated cytosines broadly across the genome(1-5). By phosphotryptic mapping, we identify three sites (S86, S274 and T308) of activity-dependent MeCP2 phosphorylation. Phosphorylation of these sites is differentially induced by neuronal activity, brain-derived neurotrophic factor, or agents that elevate the intracellular level of 3',5'-cyclic AMP (cAMP), indicating that MeCP2 may function as an epigenetic regulator of gene expression that integrates diverse signals from the environment. Here we show that the phosphorylation of T308 blocks the interaction of the repressor domain of MeCP2 with the nuclear receptor co-repressor (NCoR) complex and suppresses the ability of MeCP2 to repress transcription. In knock-in mice bearing the common human RTT missense mutation R306C, neuronal activity fails to induce MeCP2 T308 phosphorylation, suggesting that the loss of T308 phosphorylation might contribute to RTT. Consistent with this possibility, the mutation of MeCP2 T308A in mice leads to a decrease in the induction of a subset of activity-regulated genes and to RTT-like symptoms. These findings indicate that the activity-dependent phosphorylation of MeCP2 at T308 regulates the interaction of MeCP2 with the NCoR complex, and that RTT in humans may be due, in part, to the loss of activity-dependent MeCP2 T308 phosphorylation and a disruption of the phosphorylation-regulated interaction of MeCP2 with the NCoR complex.	[Ebert, Daniel H.; Gabel, Harrison W.; Robinson, Nathaniel D.; Kastan, Nathaniel R.; Hu, Linda S.; Cohen, Sonia; Navarro, Adrija J.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Ebert, Daniel H.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Lyst, Matthew J.; Ekiert, Robert; Bird, Adrian P.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Edinburgh	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu		Bird, Adrian/0000-0002-8600-0372; Lyst, Matthew/0000-0001-9018-4138; Ekiert, Robert/0000-0002-8879-0646	NIH [RO1NS048276, K08MH90306, P30-HD 18655]; Rett Syndrome Research Trust; Dupont-Warren Fellowship in the Department of Psychiatry at Harvard Medical School; Nancy Lurie Marks Fellowship in Autism at Harvard Medical School; Damon Runyon Cancer Research Foundation [DRG-2048-10]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH090306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rett Syndrome Research Trust; Dupont-Warren Fellowship in the Department of Psychiatry at Harvard Medical School; Nancy Lurie Marks Fellowship in Autism at Harvard Medical School; Damon Runyon Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant RO1NS048276 and the Rett Syndrome Research Trust to M. E. G. D. H. E was supported by NIH grant K08MH90306, the Dupont-Warren Fellowship in the Department of Psychiatry at Harvard Medical School, and the Nancy Lurie Marks Fellowship in Autism at Harvard Medical School. H. W. G. was supported by Damon Runyon Cancer Research Foundation Grant DRG-2048-10. The Mouse Gene Manipulation Facility of the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (IDDRC), funded by NIH grant P30-HD 18655, assisted in generation of the knock-in mice. We thank members of the Greenberg laboratory, particularly C. Mandel-Brehm and E. Griffith, and also G. Mandel and R. S. Greenberg for helpful discussions.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballestar E, 2000, BIOCHEMISTRY-US, V39, P7100, DOI 10.1021/bi0001271; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dudek H, 2001, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0311s03; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Lyst M. J., 2013, NATURE NEUROSCI; Meisenhelder J, 2001, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1809s48; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	26	153	158	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					341	U116		10.1038/nature12348	http://dx.doi.org/10.1038/nature12348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23770587	Green Accepted			2022-12-28	WOS:000321910700037
J	Vicoso, B; Bachtrog, D				Vicoso, Beatriz; Bachtrog, Doris			Reversal of an ancient sex chromosome to an autosome in Drosophila	NATURE			English	Article							DETERMINING MECHANISMS; X-CHROMOSOME; Y-CHROMOSOMES; GENES; MELANOGASTER; EVOLUTION; ALIGNMENT; DIPTERA; REPTILES; INSECTS	Although transitions of sex-determination mechanisms are frequent in species with homomorphic sex chromosomes(1-3), heteromorphic sex chromosomes are thought to represent a terminal evolutionary stage owing to chromosome-specific adaptations such as dosage compensation or an accumulation of sex-specific mutations(1,4). Here we show that an autosome of Drosophila, the dot chromosome, was ancestrally a differentiated X chromosome. We analyse the whole genome of true fruitflies (Tephritidae), flesh flies (Sarcophagidae) and soldier flies (Stratiomyidae) to show that genes located on the dot chromosome of Drosophila are X-linked in outgroup species, whereas Drosophila X-linked genes are autosomal. We date this chromosomal transition to early drosophilid evolution by sequencing the genome of other Drosophilidae. Our results reveal several puzzling aspects of Drosophila dot chromosome biology to be possible remnants of its former life as a sex chromosome, such as its minor feminizing role in sex determination(5) or its targeting by a chromosome-specific regulatory mechanism(6). We also show that patterns of biased gene expression of the dot chromosome during early embryogenesis, oogenesis and spermatogenesis resemble that of the current X chromosome. Thus, although sex chromosomes are not necessarily evolutionary end points and can revert back to an autosomal inheritance, the highly specialized genome architecture of this former X chromosome suggests that severe fitness costs must be overcome for such a turnover to occur.	[Vicoso, Beatriz; Bachtrog, Doris] Univ Calif Berkeley, Dept Integrat Biol, Ctr Theoret Evolutionary Genom, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bachtrog, D (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Ctr Theoret Evolutionary Genom, Berkeley, CA 94720 USA.	dbachtrog@berkeley.edu		Vicoso, Beatriz/0000-0002-4579-8306	National Institutes of Health [R01GM076007, R01GM093182]; Packard Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076007, R01GM093182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kunhi Purayil, I. Kadow, P. Mavragani, J. Larsson and U. Schmidt-Ott for samples, C. Zonneveld, L. Mazzon, D. Obbard, V. Aguiar, N. Gompel and J. Larsson for images, and Q. Zhou and Z. Walton for technical assistance. Funded by National Institutes of Health grants (R01GM076007 and R01GM093182) and a Packard Fellowship to D.B.	Assis R, 2012, GENOME BIOL EVOL, V4, P1189, DOI 10.1093/gbe/evs093; Bellott DW, 2009, COLD SH Q B, V74, P345, DOI 10.1101/sqb.2009.74.048; Bridges CB, 1925, AM NAT, V59, P127, DOI 10.1086/280023; Bull J.J., 1983, EVOLUTION SEX DETERM; CLINE TW, 1993, TRENDS GENET, V9, P385, DOI 10.1016/0168-9525(93)90138-8; Deng XX, 2009, GENETICS, V182, P481, DOI 10.1534/genetics.109.102087; Drosopoulou E, 2012, GENETICA, V140, P169, DOI 10.1007/s10709-012-9668-3; Dubendorfer A, 2002, INT J DEV BIOL, V46, P75; Gabrieli P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017747; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; GETHMANN RC, 1988, J HERED, V79, P344, DOI 10.1093/oxfordjournals.jhered.a110526; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huxley J, 1940, NEW SYSTEMATICS, P185; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koerich LB, 2008, NATURE, V456, P949, DOI 10.1038/nature07463; KRIVSHENKO J, 1959, GENETICS, V44, P1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larracuente AM, 2010, MOL BIOL EVOL, V27, P1612, DOI 10.1093/molbev/msq045; Larsson J, 2004, P NATL ACAD SCI USA, V101, P9728, DOI 10.1073/pnas.0400978101; Larsson J, 2001, P NATL ACAD SCI USA, V98, P6273, DOI 10.1073/pnas.111581298; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Lott SE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000590; Ohno S., 1967, SEX CHROMOSOMES SEX; Parise-Maltempi PP., 2007, Braz. J. Biol., V67, P945, DOI 10.1590/S1519-69842007000500020; Parise-Maltempi PP, 2000, GENET MOL BIOL, V23, P563, DOI 10.1590/S1415-47572000000300011; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Pokorna M, 2009, ZOOL J LINN SOC-LOND, V156, P168, DOI 10.1111/j.1096-3642.2008.00481.x; Riddle NC, 2009, BIOCHEM CELL BIOL, V87, P229, DOI 10.1139/O08-119; Roy V, 2005, HEREDITY, V94, P388, DOI 10.1038/sj.hdy.6800612; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Sarre SD, 2011, ANNU REV GENOM HUM G, V12, P391, DOI 10.1146/annurev-genom-082410-101518; Traut W, 2010, J GENET, V89, P307, DOI 10.1007/s12041-010-0042-x; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; Vicoso B, 2011, GENOME BIOL EVOL, V3, P230, DOI 10.1093/gbe/evr010; WHITE MJD, 1949, EVOLUTION, V3, P252, DOI 10.2307/2405562; ZACHAROPOULOU A, 1987, GENOME, V29, P67, DOI 10.1139/g87-011; Zhou Q, 2012, SCIENCE, V337, P341, DOI 10.1126/science.1225385	38	129	131	3	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					332	+		10.1038/nature12235	http://dx.doi.org/10.1038/nature12235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23792562	Green Accepted			2022-12-28	WOS:000321910700035
J	Yu, HJ; Cowling, BJ; Feng, LZ; Lau, EHY; Liao, QH; Tsang, TK; Peng, ZB; Wu, P; Liu, FF; Fang, VJ; Zhang, HL; Li, M; Zeng, LJ; Xu, Z; Li, ZJ; Luo, HM; Li, Q; Feng, ZJ; Cao, B; Yang, WZ; Wu, JT; Wang, Y; Leung, GM				Yu, Hongjie; Cowling, Benjamin J.; Feng, Luzhao; Lau, Eric H. Y.; Liao, Qiaohong; Tsang, Tim K.; Peng, Zhibin; Wu, Peng; Liu, Fengfeng; Fang, Vicky J.; Zhang, Honglong; Li, Ming; Zeng, Lingjia; Xu, Zhen; Li, Zhongjie; Luo, Huiming; Li, Qun; Feng, Zijian; Cao, Bin; Yang, Weizhong; Wu, Joseph T.; Wang, Yu; Leung, Gabriel M.			Human infection with avian influenza A H7N9 virus: an assessment of clinical severity	LANCET			English	Article							CASE-FATALITY RATIO; RISK; CHINA	Background Characterisation of the severity profile of human infections with influenza viruses of animal origin is a part of pandemic risk assessment, and an important part of the assessment of disease epidemiology. Our objective was to assess the clinical severity of human infections with avian influenza A H7N9 virus, which emerged in China in early 2013. Methods We obtained information about laboratory-confirmed cases of avian influenza A H7N9 virus infection reported as of May 28, 2013, from an integrated database built by the Chinese Center for Disease Control and Prevention. We estimated the risk of fatality, mechanical ventilation, and admission to the intensive care unit for patients who required hospital admission for medical reasons. We also used information about laboratory-confirmed cases detected through sentinel influenza-like illness surveillance to estimate the symptomatic case fatality risk. Findings Of 123 patients with laboratory-confirmed avian influenza A H7N9 virus infection who were admitted to hospital, 37 (30%) had died and 69 (56%) had recovered by May 28, 2013. After we accounted for incomplete data for 17 patients who were still in hospital, we estimated the fatality risk for all ages to be 36% (95% CI 26-45) on admission to hospital. Risks of mechanical ventilation or fatality (69%, 95% CI 60-77) and of admission to an intensive care unit, mechanical ventilation, or fatality (83%, 76-90) were high. With assumptions about coverage of the sentinel surveillance network and health-care-seeking behaviour for patients with influenza-like illness associated with influenza A H7N9 virus infection, and pro-rata extrapolation, we estimated that the symptomatic case fatality risk could be between 160 (63-460) and 2800 (1000-9400) per 100 000 symptomatic cases. Interpretation Human infections with avian influenza A H7N9 virus seem to be less serious than has been previously reported. Many mild cases might already have occurred. Continued vigilance and sustained intensive control efforts are needed to minimise the risk of human infection.	[Yu, Hongjie; Feng, Luzhao; Liao, Qiaohong; Peng, Zhibin; Liu, Fengfeng; Zhang, Honglong; Li, Ming; Zeng, Lingjia; Xu, Zhen; Li, Zhongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing 102206, Peoples R China; [Luo, Huiming] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing 102206, Peoples R China; [Li, Qun; Feng, Zijian] Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing 102206, Peoples R China; [Yang, Weizhong; Wang, Yu] Chinese Ctr Dis Control & Prevent, Off Director, Beijing 102206, Peoples R China; [Cowling, Benjamin J.; Lau, Eric H. Y.; Tsang, Tim K.; Wu, Peng; Fang, Vicky J.; Wu, Joseph T.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China; [Cao, Bin] Capital Med Univ, Beijing Inst Resp Med, Beijing Chao Yang Hosp, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; University of Hong Kong; Capital Medical University	Wu, JT (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China.	joewu@hku.hk; wangyu@chinacdc.cn	Cowling, Benjamin John/C-4263-2009; Lau, Eric/AAJ-6588-2021; Wu, Joseph/ABD-5880-2021; Yu, Hongjie/GZK-5351-2022	Cowling, Benjamin John/0000-0002-6297-7154; Lau, Eric/0000-0002-6688-9637; Leung, Gabriel/0000-0002-2503-6283; Tsang, Tim Kam Lun/0000-0001-5037-6776; Wu, Peng/0000-0003-1157-9401	Chinese Ministry of Science and Technology; Research Fund for the Control of Infectious Disease; Hong Kong University Grants Committee; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Harvard Center for Communicable Disease Dynamics; US National Institute of Allergy and Infectious Disease; US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Research Fund for the Control of Infectious Disease; Hong Kong University Grants Committee; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Harvard Center for Communicable Disease Dynamics; US National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Chinese Ministry of Science and Technology; Research Fund for the Control of Infectious Disease; Hong Kong University Grants Committee; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Harvard Center for Communicable Disease Dynamics; US National Institute of Allergy and Infectious Disease; and the US National Institutes of Health.	Alcorn T, 2013, LANCET, V381, P1347, DOI 10.1016/S0140-6736(13)60868-5; [Anonymous], 2013, LANCET INFECT DIS, V13, P465, DOI [10.1016/S1473-3099(13)70134-8, 10.1016/1473-3099(13)70134-8]; [Anonymous], 2013, LANCET; Wiwanitkit V, 2013, WEST PAC SURVEILL RE, V4, P24, DOI 10.5365/wpsar.2013.4.4.003; Arima Y, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.005, 10.5365/WPSAR.2013.4.2.005]; Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Boni MF, 2013, J INFECT DIS, V208, P554, DOI 10.1093/infdis/jit224; Centers for Disease Control and Prevention, INFL RISK ASS TOOL I; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, EUROSURVEILLANCE, V18, P2; Eurosurveillance editorial team, 2013, EUROSURVEILLANCE, V18, P5; Fleming DM, 2008, EPIDEMIOL INFECT, V136, P866, DOI 10.1017/S0950268807009910; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Han J, 2013, EUROSURVEILLANCE, V18, P6; Horby P, 2013, NATURE, V496, P399, DOI 10.1038/496399a; Hvistendahl M, 2013, SCIENCE, V340, P414, DOI 10.1126/science.340.6131.414; Jewell NP, 2007, STAT MED, V26, P1982, DOI 10.1002/sim.2691; Kahn RE, 2013, VECTOR-BORNE ZOONOT, V13, P347, DOI 10.1089/vbz.2013.999.ceezad; Kelly H, 2013, EPIDEMIOLOGY, V24, P622, DOI 10.1097/EDE.0b013e318296c2b6; Koopmans M, 2013, LANCET, V381, P1882, DOI 10.1016/S0140-6736(13)60936-8; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007; Nicoll A, 2013, EUROSURVEILLANCE, V18, P15; Osterholm MT, 2013, JAMA-J AM MED ASSOC, V309, P2557, DOI 10.1001/jama.2013.6589; Parry J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2222; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; Skowronski D, 2013, EUROSURVEILLANCE, V18, P4; Trock SC, 2012, AVIAN DIS, V56, P1058, DOI 10.1637/10204-041412-ResNote.1; Van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P231, DOI 10.1111/irv.12068; Van Kerkhove MD, 2012, SCIENCE, V336, DOI 10.1126/science.1221434; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; WHO, 2013, CUM NUMB CONF HUM CA; WHO Implementation of the International Health Regulations, 2011, IMPL INT HLTH REG 20; Wong JY, 2013, AM J EPIDEMIOL, V177, P834, DOI 10.1093/aje/kws314; Wong JY, EPIDEMIOLOG IN PRESS; Wu SQ, 2013, LANCET, V381, P1539, DOI 10.1016/S0140-6736(13)60767-9; Xu C, 2013, MONITORING AVIAN INF; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919; Xu JG, 2013, LANCET, V381, P1815, DOI 10.1016/S0140-6736(13)60950-2; Yip PSF, 2005, AM J EPIDEMIOL, V161, P700, DOI 10.1093/aje/kwi088; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Zhang Wenyi, 2013, Clin Infect Dis, V57, P619, DOI 10.1093/cid/cit277	51	202	216	1	91	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					138	145		10.1016/S0140-6736(13)61207-6	http://dx.doi.org/10.1016/S0140-6736(13)61207-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187JY	23803487	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000322115300029
J	Rai, AK; Cook-Deegan, R				Rai, Arti K.; Cook-Deegan, Robert			Moving Beyond "Isolated" Gene Patents	SCIENCE			English	Editorial Material									[Rai, Arti K.] Duke Univ, Sch Law, Durham, NC 27708 USA; [Cook-Deegan, Robert] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Cook-Deegan, Robert] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Rai, AK (corresponding author), Duke Univ, Sch Law, Durham, NC 27708 USA.	rai@law.duke.edu; bob.cd@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003391] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Langreth R., 2013, BLOOMBERG NEWS; Pollack A., 2013, NY TIMES	3	8	8	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					137	138		10.1126/science.1242217	http://dx.doi.org/10.1126/science.1242217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185KA	23811224	Green Accepted			2022-12-28	WOS:000321965300029
J	Constantinople, CM; Bruno, RM				Constantinople, Christine M.; Bruno, Randy M.			Deep Cortical Layers Are Activated Directly by Thalamus	SCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; PRIMARY VISUAL-CORTEX; BARREL CORTEX; STRIATE CORTEX; PYRAMIDAL NEURONS; RAT NEOCORTEX; MOUSE; CAT; PROJECTIONS; MACAQUE	The thalamocortical (TC) projection to layer 4 (L4) is thought to be the main route by which sensory organs communicate with cortex. Sensory information is believed to then propagate through the cortical column along the L4 -> L2/3 -> L5/6 pathway. Here, we show that sensory-evoked responses of L5/6 neurons in rats derive instead from direct TC synapses. Many L5/6 neurons exhibited sensory-evoked postsynaptic potentials with the same latencies as L4. Paired in vivo recordings from L5/6 neurons and thalamic neurons revealed substantial convergence of direct TC synapses onto diverse types of infragranular neurons, particularly in L5B. Pharmacological inactivation of L4 had no effect on sensory-evoked synaptic input to L5/6 neurons. L4 is thus not an obligatory distribution hub for cortical activity, and thalamus activates two separate, independent "strata" of cortex in parallel.	[Bruno, Randy M.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA	Columbia University; Columbia University	Bruno, RM (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	randybruno@columbia.edu	Bruno, Randy M./ABC-2117-2021	Bruno, Randy M./0000-0002-5122-4632	National Institute of Neurological Disorders and Stroke, NIH [NS069679]; Rita Allen Foundation; Klingenstein Fund; NSF Student Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069679] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Rita Allen Foundation; Klingenstein Fund(Klingenstein Philanthropies); NSF Student Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Abbott, R. Axel, A. Losonczy, and K. Miller for manuscript comments; D. Baughman for technical support; and M. Ilardi for morphological reconstruction. Supported by National Institute of Neurological Disorders and Stroke, NIH, NS069679; Rita Allen Foundation; Klingenstein Fund; and an NSF Student Fellowship.	AGMON A, 1992, J NEUROSCI, V12, P319; Beierlein M, 2002, J NEUROPHYSIOL, V88, P1924, DOI 10.1152/jn.2002.88.4.1924; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Callaway EM, 2004, NEURAL NETWORKS, V17, P625, DOI 10.1016/j.neunet.2004.04.004; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; FERSTER D, 1978, J COMP NEUROL, V182, P923, DOI 10.1002/cne.901820510; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Garcia-Marin V, 2013, J COMP NEUROL, V521, P130, DOI 10.1002/cne.23165; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; HERKENHAM M, 1980, SCIENCE, V207, P532, DOI 10.1126/science.7352263; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Huang W, 1998, J NEUROPHYSIOL, V80, P3261, DOI 10.1152/jn.1998.80.6.3261; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Lee S, 2008, NAT NEUROSCI, V11, P1430, DOI 10.1038/nn.2227; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Oberlaender M, 2012, NEURON, V74, P648, DOI 10.1016/j.neuron.2012.03.022; Oberlaender M, 2011, P NATL ACAD SCI USA, V108, P4188, DOI 10.1073/pnas.1100647108; SCHWARK HD, 1986, J NEUROPHYSIOL, V56, P1074, DOI 10.1152/jn.1986.56.4.1074; Viaene AN, 2011, J NEUROSCI, V31, P12738, DOI 10.1523/JNEUROSCI.1565-11.2011; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068	33	264	267	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1591	1594		10.1126/science.1236425	http://dx.doi.org/10.1126/science.1236425			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812718	Green Accepted			2022-12-28	WOS:000321007000047
J	Ernst, T				Ernst, Thomas			Controlling the Polarity of Silicon Nanowire Transistors	SCIENCE			English	Editorial Material									CEA LETI, MINATEC, F-38054 Grenoble, France	CEA; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble	Ernst, T (corresponding author), CEA LETI, MINATEC, 17 Rue Martyrs, F-38054 Grenoble, France.	thomas.ernst@cea.fr						Batude P, 2012, IEEE J EM SEL TOP C, V2, P714, DOI 10.1109/JETCAS.2012.2223593; Ben Jamaa MH, 2009, DES AUT TEST EUROPE, P622; De Marchi M., 2012, IEEE INT ELECT DEVIC, V2012, P183; Dupre C., 2008, IEEE INT ELECT DEVIC, V2008, P749; Harada N, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3280042; Kedzierski J., 2000, IEEE INT ELECT DEVIC, V2000, P57; Lin YM, 2005, IEEE T NANOTECHNOL, V4, P481, DOI 10.1109/TNANO.2005.851427; Nishisaka M., 1998, IEEE DEVICE RES C DI, V1998, P74; Pirovano A, 2010, NAT NANOTECHNOL, V5, P177, DOI 10.1038/nnano.2010.36; Yang H, 2012, SCIENCE, V336, P1140, DOI 10.1126/science.1220527	10	18	18	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1414	1415		10.1126/science.1238630	http://dx.doi.org/10.1126/science.1238630			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23788789				2022-12-28	WOS:000320647000029
J	Altmeyer, M; Lukas, J				Altmeyer, Matthias; Lukas, Jiri			Guarding against Collateral Damage during Chromatin Transactions	CELL			English	Review							UBIQUITIN-DEPENDENT RESPONSE; DNA-DAMAGE; LIMITS; RNF169; RIF1	Signal amplifications are vital for chromatin function, yet they also bear the risk of transforming into unrestrained, self-escalating, and potentially harmful responses. Examples of inbuilt limitations are emerging, revealing how chromatin transactions are confined within physiological boundaries.	[Altmeyer, Matthias; Lukas, Jiri] Univ Copenhagen, Chromosome Stabil & Dynam Grp, Dept Dis Biol, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	University of Copenhagen	Altmeyer, M (corresponding author), Univ Copenhagen, Chromosome Stabil & Dynam Grp, Dept Dis Biol, Novo Nordisk Fdn Ctr Prot Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	matthias.altmeyer@cpr.ku.dk; jiri.lukas@cpr.ku.dk	Altmeyer, Matthias/AAE-8186-2019	Altmeyer, Matthias/0000-0003-3780-1170; Lukas, Jiri/0000-0001-9087-506X	Novo Nordisk Foundation; Danish Cancer Society; Danish National Research Foundation; EMBO Long-Term Fellowship; Novo Nordisk Foundation Center for Protein Research [PI Jiri Lukas] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Novo Nordisk Foundation Center for Protein Research	We thank C. Lukas, T. Gudjonsson, and L. Toledo for valuable comments, and we apologize to authors whose work could not be cited due to space limitations. Research in the Lukas lab is supported by the Novo Nordisk Foundation, the Danish Cancer Society, and the Danish National Research Foundation. M.A. is recipient of an EMBO Long-Term Fellowship.	Allis CD, 2011, CHEMBIOCHEM, V12, P264, DOI 10.1002/cbic.201000761; Chen J, 2012, J BIOL CHEM, V287, P27715, DOI 10.1074/jbc.M112.373530; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Lopez-Contreras AJ, 2012, J EXP MED, V209, P455, DOI 10.1084/jem.20112147; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Ohouo PY, 2013, NATURE, V493, P120, DOI 10.1038/nature11658; Pak J, 2012, CELL, V151, P885, DOI 10.1016/j.cell.2012.10.022; Panier S, 2012, MOL CELL, V47, P383, DOI 10.1016/j.molcel.2012.05.045; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Rincon-Arano H, 2012, CELL, V151, P1214, DOI 10.1016/j.cell.2012.11.009; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Yang Q, 2013, NAT CELL BIOL, V15, P519, DOI 10.1038/ncb2737; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	18	12	12	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1431	1434		10.1016/j.cell.2013.05.044	http://dx.doi.org/10.1016/j.cell.2013.05.044			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791174	Bronze			2022-12-28	WOS:000320722000012
J	Buchan, JR; Kolaitis, RM; Taylor, JP; Parker, R				Buchan, J. Ross; Kolaitis, Regina-Maria; Taylor, J. Paul; Parker, Roy			Eukaryotic Stress Granules Are Cleared by Autophagy and Cdc48/VCP Function	CELL			English	Article							P-BODIES; MESSENGER-RNAS; TDP-43; DEGRADATION; REVEALS; LOCALIZATION; AGGREGATION; INHIBITION; ATPASE; FUSION	Stress granules and P bodies are conserved cytoplasmic aggregates of nontranslating messenger ribonucleoprotein complexes (mRNPs) implicated in the regulation of mRNA translation and decay and are related to RNP granules in embryos, neurons, and pathological inclusions in some degenerative diseases. Using baker's yeast, 125 genes were identified in a genetic screen that affected the dynamics of P bodies and/or stress granules. Analyses of such mutants, including CDC48 alleles, provide evidence that stress granules can be targeted to the vacuole by autophagy, in a process termed granulophagy. Moreover, stress granule clearance in mammalian cells is reduced by inhibition of autophagy or by depletion or pathogenic mutations in valosin-containing protein (VCP), the human ortholog of CDC48. Because mutations in VCP predispose humans to amyotrophic lateral sclerosis, frontotemporal lobar degeneration, inclusion body myopathy, and multisystem proteinopathy, this work suggests that autophagic clearance of stress granule related and pathogenic RNP granules that arise in degenerative diseases may be important in reducing their pathology.	[Buchan, J. Ross; Parker, Roy] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA; [Buchan, J. Ross; Parker, Roy] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA; [Kolaitis, Regina-Maria; Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; St Jude Children's Research Hospital	Taylor, JP (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jpaul.taylor@stjude.org; roy.parker@colorado.edu	Taylor, J. Paul/N-2482-2018	Taylor, J. Paul/0000-0002-5794-0349	ALS Association; Packard Center for ALS Research; Howard Hughes Medical Institute	ALS Association; Packard Center for ALS Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank the Chen lab (Institute of Molecular Biology, Taiwan) for Cdc48, Ufd1, and Npl4 conditional allele strains, the Klionsky lab (University of Michigan) for a GFP-Atg19 expressing plasmid, the Komatsu lab (Tokyo Metropolitan Institute of Medical Sciences) for Atg 3<SUP>-/-</SUP> MEF cell lines, and the Green lab (St. Jude Children's Research Hospital) for Atg<SUP>7-/-</SUP> MEF cell lines. We also thank the Cell and Tissue Imaging Core Facility at St. Jude Children's Research Hospital and all Parker lab members for feedback, particularly Saumya Jain for bioinformatics assistance. This work was supported by funds from the ALS Association to R.-M. K., the Packard Center for ALS Research to J.P.T., and the Howard Hughes Medical Institute to J.R.B. and R.P.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Armakola M, 2012, NAT GENET, V44, P1302, DOI 10.1038/ng.2434; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Bhattacharyya SN, 2006, COLD SPRING HARB SYM, V71, P513, DOI 10.1101/sqb.2006.71.038; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chou TF, 2013, CHEMMEDCHEM, V8, P297, DOI 10.1002/cmdc.201200520; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Didiot MC, 2009, MOL BIOL CELL, V20, P428, DOI 10.1091/mbc.E08-07-0737; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Erickson SL, 2011, J CELL SCI, V124, P293, DOI 10.1242/jcs.072140; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; Gkogkas C, 2010, J BIOL CHEM, V285, P31913, DOI 10.1074/jbc.R110.154476; Ito D, 2011, NEUROLOGY, V77, P1636, DOI 10.1212/WNL.0b013e3182343365; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Krick R, 2010, J CELL BIOL, V190, P965, DOI 10.1083/jcb.201002075; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.e06-12-1079; Medioni C, 2012, DEVELOPMENT, V139, P3263, DOI 10.1242/dev.078626; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Mijaljica D, 2011, AUTOPHAGY, V7, P666, DOI 10.4161/auto.7.6.15812; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Salajegheh M, 2009, MUSCLE NERVE, V40, P19, DOI 10.1002/mus.21386; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	61	453	461	5	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1461	1474		10.1016/j.cell.2013.05.037	http://dx.doi.org/10.1016/j.cell.2013.05.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791177	Green Accepted, Bronze			2022-12-28	WOS:000320722000015
J	Taylor, RC; Dillin, A				Taylor, Rebecca C.; Dillin, Andrew			XBP-1 Is a Cell-Nonautonomous Regulator of Stress Resistance and Longevity	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; RESTRICTION-INDUCED LONGEVITY; ELEGANS LIFE-SPAN; CAENORHABDITIS-ELEGANS; DAF-16; THAPSIGARGIN; PROTEOSTASIS; SEROTONIN; DISEASE; GENE	The ability to ensure proteostasis is critical for maintaining proper cell function and organismal viability but is mitigated by aging. We analyzed the role of the endoplasmic reticulum unfolded protein response (UPRER) in aging of C. elegans and found that age-onset loss of ER proteostasis could be reversed by expression of a constitutively active form of XBP-1, XBP-1s. Neuronally derived XBP-1s was sufficient to rescue stress resistance, increase longevity, and activate the UPRER in distal, non-neuronal cell types through a cell-nonautonomous mechanism. Loss of UPR ER signaling components in distal cells blocked cell-nonautonomous signaling from the nervous system, thereby blocking increased longevity of the entire animal. Reduction of small clear vesicle (SCV) release blocked nonautonomous signaling downstream of xbp-1s, suggesting that the release of neurotransmitters is required for this intertissue signaling event. Our findings point toward a secreted ER stress signal (SERSS) that promotes ER stress resistance and longevity.	[Taylor, Rebecca C.; Dillin, Andrew] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Dillin, A (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	dillin@berkeley.edu		Taylor, Rebecca/0000-0003-3429-3123	NIH [R01 AG042679]; NATIONAL INSTITUTE ON AGING [R01AG042679] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Kapernick, Z. Liu, K. Berendzen, and Drs. S. Panowski, C. Riera, and V. Ramachandran for technical assistance. We also thank Dr. T. Lamitina, E. Morton, and R. S. Taylor for help with MATLAB analysis. We are grateful to Drs. S. Wolff and V. Ramachandran for insightful comments on the manuscript, to Dr. J. Durieux for help with the graphical abstract, and to Drs. Y. Jin and S. Chalasani and the Caenorhabditis Genetics Center for strains. R.C.T. is an Ellison Medical Foundation/AFAR Postdoctoral Fellow. A.D. is cofounder of Proteostasis Therapeutics, Inc. and declares no financial interest related to this work. This work was supported by NIH R01 AG042679.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Caruso ME, 2008, MOL CELL BIOL, V28, P4261, DOI 10.1128/MCB.02252-07; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Galbadage T, 2008, MECH AGEING DEV, V129, P507, DOI 10.1016/j.mad.2008.04.012; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Hansen M, 2007, WESTERN HUM REV, V61, P6; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107; HONDA S, 1990, P NATL ACAD SCI USA, V87, P876, DOI 10.1073/pnas.87.3.876; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; KIJIMA Y, 1991, J BIOL CHEM, V266, P22912; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; LEWIS JA, 1980, GENETICS, V95, P905; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; Nonet ML, 1997, J NEUROSCI, V17, P8061; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Richardson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002391; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007	46	342	346	3	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1435	1447		10.1016/j.cell.2013.05.042	http://dx.doi.org/10.1016/j.cell.2013.05.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791175	Green Accepted, Bronze			2022-12-28	WOS:000320722000013
J	Shafazand, S				Shafazand, Shirin			Review: Inhaled medications vary substantively in their effects on mortality in COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; METAANALYSIS		Univ Miami, Miami, FL USA	University of Miami	Shafazand, S (corresponding author), Univ Miami, Miami, FL USA.			Lai, Mei-shu/0000-0001-6130-3468; CHANG, CHIA-HSUIN/0000-0003-0024-6177				Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Karner C, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009285.pub2, 10.1002/14651858.CD009285.pub3]; Rodrigo GJ, 2008, CHEST, V133, P1079, DOI 10.1378/chest.07-1167; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Verhamme K, 2012, EUR RESP SOC ANN SCI	6	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12							JC2	10.7326/0003-4819-158-12-201306180-02002	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778926				2022-12-28	WOS:000320645000001
J	Yang, GH; Wang, Y; Zeng, YX; Gao, GF; Liang, XF; Zhou, MG; Wan, X; Yu, SC; Jiang, YH; Naghavi, M; Vos, T; Wang, HD; Lopez, AD; Murray, CJL				Yang, Gonghuan; Wang, Yu; Zeng, Yixin; Gao, George F.; Liang, Xiaofeng; Zhou, Maigeng; Wan, Xia; Yu, Shicheng; Jiang, Yuhong; Naghavi, Mohsen; Vos, Theo; Wang, Haidong; Lopez, Alan D.; Murray, Christopher J. L.			Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010	LANCET			English	Article							CORONARY-HEART-DISEASE; SYSTEMATIC ANALYSIS; MENTAL-DISORDERS; 187 COUNTRIES; 21 REGIONS; MORTALITY; REFORM; CARE; PREVALENCE; DISABILITY	Background China has undergone rapid demographic and epidemiological changes in the past few decades, including striking declines in fertility and child mortality and increases in life expectancy at birth. Popular discontent with the health system has led to major reforms. To help inform these reforms, we did a comprehensive assessment of disease burden in China, how it changed between 1990 and 2010, and how China's health burden compares with other nations. Methods We used results of the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) for 1990 and 2010 for China and 18 other countries in the G20 to assess rates and trends in mortality, causes of death, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE). We present results for 231 diseases and injuries and for 67 risk factors or clusters of risk factors relevant to China. We assessed relative performance of China against G20 countries (significantly better, worse, or indistinguishable from the G20 mean) with age-standardised rates and 95% uncertainty intervals. Findings The leading causes of death in China in 2010 were stroke (1.7 million deaths, 95% UI 1.5-1.8 million), ischaemic heart disease (948 700 deaths, 774 500-1 024 600), and chronic obstructive pulmonary disease (934 000 deaths, 846 600-1 032 300). Age-standardised YLLs in China were lower in 2010 than all emerging economies in the G20, and only slightly higher than noted in the USA. China had the lowest age-standardised YLD rate in the G20 in 2010. China also ranked tenth (95% UI eighth to tenth) for HALE and 12th (11th to 13th) for life expectancy. YLLs from neonatal causes, infectious diseases, and injuries in children declined substantially between 1990 and 2010. Mental and behavioural disorders, substance use disorders, and musculoskeletal disorders were responsible for almost half of all YLDs. The fraction of DALYs from YLDs rose from 28.1% (95% UI 24.2-32.5) in 1990 to 39.4% (34.9-43.8) in 2010. Leading causes of DALYs in 2010 were cardiovascular diseases (stroke and ischaemic heart disease), cancers (lung and liver cancer), low back pain, and depression. Dietary risk factors, high blood pressure, and tobacco exposure are the risk factors that constituted the largest number of attributable DALYs in China. Ambient air pollution ranked fourth (third to fifth; the second highest in the G20) and household air pollution ranked fifth (fourth to sixth; the third highest in the G20) in terms of the age-standardised DALY rate in 2010. Interpretation The rapid rise of non-communicable diseases driven by urbanisation, rising incomes, and ageing poses major challenges for China's health system, as does a shift to chronic disability. Reduction of population exposures from poor diet, high blood pressure, tobacco use, cholesterol, and fasting blood glucose are public policy priorities for China, as are the control of ambient and household air pollution. These changes will require an integrated government response to improve primary care and undertake required multisectoral action to tackle key risks. Analyses of disease burden provide a useful framework to guide policy responses to the changing disease spectrum in China.	[Yang, Gonghuan; Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Yang, Gonghuan; Wan, Xia] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Wang, Yu; Zeng, Yixin; Gao, George F.; Liang, Xiaofeng; Zhou, Maigeng; Yu, Shicheng] Chinese Ctr Dis Prevent & Control, Beijing, Peoples R China; [Jiang, Yuhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Naghavi, Mohsen; Vos, Theo; Wang, Haidong; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Lopez, Alan D.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Melbourne	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Lopez, Alan/AAA-2734-2022; Gao, George Fu/ABD-5229-2021; Zhou, Maigeng/HCH-7703-2022; Lopez, Alan D/F-1487-2010	Lopez, Alan D/0000-0001-5818-6512	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding Bill & Melinda Gates Foundation.	Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8; Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; [Anonymous], 2006, LANCET, V367, P623; [Anonymous], 2008, CHIN CHIN 3 RETR SUR; [Anonymous], 2021, CANC INCIDENCE 5 CON; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Chinese Center for Disease Control and Prevention, 2009, NAT DIS SURV SYST DE; Chinese Center for Disease Control and Prevention, 2007, NAT DIS SURV SYST DE; Chinese Center for Disease Control and Prevention, 2005, NAT DIS SURV SYST DE; Chinese Center for Disease Control and Prevention, 2006, NAT DIS SURV SYST DE; Chinese Center for Disease Control and Prevention, 2012, NAT DIS SURV SYST DE; Chinese Center for Disease Control and Prevention, 2008, NAT DIS SURV SYST DE; Chinese Center for Disease Control and Prevention, 2011, NAT DIS SURV SYST DE; Chinese Center for Disease Control and Prevention, 2010, NAT DIS SURV SYST DE; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; Cutler DM, TECHNOLOGY BIRTH IS; Dai SM, 2003, J RHEUMATOL, V30, P2245; Disease Prevention and Control Bureau Ministry of Health, 2010, CANC INC MORT CHIN C; Disease Prevention and Control Bureau Ministry of Health, 2011, CANC INC MORT CHIN C; Disease Prevention and Control Bureau Ministry of Health, 2009, CANC INC MORT CHIN C; Disease Prevention and Control Bureau Ministry of Health, 2008, CANC INC MORT CHIN C; Fang PQ, 2010, HEALTH POLICY, V94, P14, DOI 10.1016/j.healthpol.2009.08.002; Feng XL, 2011, LANCET, V378, P1493, DOI 10.1016/S0140-6736(11)61096-9; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; GOLDMAN L, 1984, ANN INTERN MED, V101, P825, DOI 10.7326/0003-4819-101-6-825; Hu FB, 2000, NEW ENGL J MED, V343, P530, DOI 10.1056/NEJM200008243430802; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Huang Y., SICK MAN ASIA CHINAS; Institute for Health Metrics and Evaluation, GBD COMP; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Jiang B, 2006, STROKE, V37, P63, DOI 10.1161/01.STR.0000194955.34820.78; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu Q, 2011, LANCET, V377, P2064, DOI 10.1016/S0140-6736(11)60167-0; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marmot MG., 2006, SOCIAL DETERMINANTS; Ministry of Health, 2012, CHIN HLTH STAT YB 20; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; National Bureau of Statistics of China, 2013, CHIN POP EMPL STAT Y; National Office for Cancer Prevention and Control & National Central Cancer Registry, 2012, ANN REP CANC REG CHI; National Office for Census and National Bureau of Statistics of China, 2012, TAB 2010 POP CENS PE; National Office for Census and National Bureau of Statistics of China, 2002, TAB 2000 POP CENS PE; NBSC, 2010, NAT STAT YB; Parkin DM, 2005, IARC CANCERBASE, V1-8; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Shen YC, 2006, PSYCHOL MED, V36, P257, DOI 10.1017/S0033291705006367; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD POP PROSP 2010, VII; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD POP PROSP 2010; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Wang HY, 2002, INT DENT J, V52, P283, DOI 10.1111/j.1875-595X.2002.tb00632.x; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; WHO, WHO INF; World Health Organization, WORLD HLTH SURV; World Health Organization, WHO MORT DAT; Xiao Y, 2007, SOC SCI MED, V64, P665, DOI 10.1016/j.socscimed.2006.09.019; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yeh A. G. O., 2011, CHINAS POSTREFORM UR; Yip W, 2009, CHINA ECON REV, V20, P613, DOI 10.1016/j.chieco.2009.08.003; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; Zhou L, 1992, Kurume Med J, V39, P279; Zhu LP, 2010, INT J INFECT DIS, V14, pE45, DOI 10.1016/j.ijid.2009.09.009	72	1361	1711	38	970	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 8	2013	381	9882					1987	2015		10.1016/S0140-6736(13)61097-1	http://dx.doi.org/10.1016/S0140-6736(13)61097-1			29	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171JY	23746901	Green Published, Bronze			2022-12-28	WOS:000320924400029
J	Busse, R; Geissler, A; Aaviksoo, A; Cots, F; Hakkinen, U; Kobel, C; Mateus, C; Or, Z; O'Reilly, J; Serden, L; Street, A; Tan, SS; Quentin, W				Busse, Reinhard; Geissler, Alexander; Aaviksoo, Ain; Cots, Francesc; Hakkinen, Unto; Kobel, Conrad; Mateus, Ceu; Or, Zeynep; O'Reilly, Jacqueline; Serden, Lisbeth; Street, Andrew; Tan, Siok Swan; Quentin, Wilm			Diagnosis related groups in Europe: moving towards transparency, efficiency, and quality in hospitals?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROSPECTIVE PAYMENT SYSTEM; BUNDLED PAYMENT; CARE; STROKE		[Busse, Reinhard; Geissler, Alexander; Quentin, Wilm] Dept Hlth Care Management, D-10623 Berlin, Germany; [Aaviksoo, Ain] PRAXIS Ctr Policy Study, Hlth Policy Programme, Tallinn, Estonia; [Cots, Francesc] Parc Salut Mar, Barcelona, Spain; [Hakkinen, Unto] Natl Inst Hlth & Welf, Ctr Hlth & Social Econ, Helsinki, Finland; [Kobel, Conrad] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Mateus, Ceu] Univ Nova Lisboa, CMDT LA, Escola Nacl Saude Publ, P-1200 Lisbon, Portugal; [Or, Zeynep] Inst Rech & Documentat Econ Sante, Paris, France; [O'Reilly, Jacqueline] Econ & Social Res Inst, Hlth Res & Informat Div, Dublin, Ireland; [Serden, Lisbeth] Natl Board Hlth & Welf, Dept Stat Monitoring & Evaluat, Stockholm, Sweden; [Street, Andrew] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Tan, Siok Swan] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Finland National Institute for Health & Welfare; Medical University of Innsbruck; Universidade Nova de Lisboa; Economic & Social Research Institute (ESRI); National Board of Health & Welfare; University of York - UK; Erasmus University Rotterdam	Quentin, W (corresponding author), Dept Hlth Care Management, Str 17 Juni 135, D-10623 Berlin, Germany.	wilm.quentin@tu-berlin.de	Quentin, Wilm/AGN-0489-2022; Quentin, Wilm/AAD-1355-2019; Mateus, Ceu/J-2554-2012; Mateus, Ceu/AAC-8146-2021	Quentin, Wilm/0000-0002-1705-6524; Mateus, Ceu/0000-0001-6219-219X; Mateus, Ceu/0000-0001-6219-219X; Geissler, Alexander/0000-0002-7445-2929; Street, Andrew David/0000-0002-2540-0364; Tan, Siok Swan/0000-0002-9522-2321				Abler S, 2011, ARCH DIS CHILD-FETAL, V96, pF186, DOI 10.1136/adc.2010.192500; Brugger U., 2010, IMPACT DRGS INTRO DR; Bundesministerium fur Gesundheit, 2010, EV DRG BAS HOSP PAYM; Busse R, 2011, DIAGNOSIS RELATED GR, P149; Busse R, 2011, DIAGNOSIS RELATED GR; Busse R, 2012, HEALTH ECON, V21, P1, DOI 10.1002/hec.2861; Charpentier C., 1996, FINANCIAL ACCOUNTABI, V12, P157; Cots F., 2011, DIAGNOSIS RELATED GR, P75; COULAM RF, 1991, HLTH CARE FINANCIN S, V13, P45; de Bakker DH, 2012, HEALTH AFFAIR, V31, P426, DOI 10.1377/hlthaff.2011.0912; Department of Health, 2012, PAYM RES GUID 2012 1; Farrar S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3047; Fetter J, 1980, MED CARE S2, V18, pi; FETTER RB, 1991, INTERFACES, V21, P6, DOI 10.1287/inte.21.1.6; Fetter RB., 1996, PHYS PROFILING RISK, P101; Geissler A., 2011, DIAGNOSIS RELATED GR, P9; Goldfield Norbert, 2010, Qual Manag Health Care, V19, P3, DOI 10.1097/QMH.0b013e3181ccbcc3; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hussey PS, 2011, HEALTH AFFAIR, V30, P2116, DOI 10.1377/hlthaff.2011.0784; LAVE JR, 1989, ANNU REV PUBL HEALTH, V10, P141, DOI 10.1146/annurev.pu.10.050189.001041; Ljunggren B, 2003, INT J QUAL HEALTH C, V15, P433, DOI 10.1093/intqhc/mzg066; Mason A, 2010, J ROY SOC MED, V103, P322, DOI 10.1258/jrsm.2010.100044; Mateus C, 2011, PORTUGAL RESULTS 25, P381; Medicare Payment Advisory Commission, 2010, PSYCH HOSP SERV PAYM; Medicare Payment Advisory Commission, 2008, REH FAC INP PAYM SYS; Medizinischer Dienst des Spitzenverbandes Bund der Krankenkassen, 2011, ABR MDK KRANK SIND A; Or Z, IRDES WORKI IN PRESS; Peltola M, 2013, CEREBROVASC DIS, V35, P113, DOI 10.1159/000346092; Quentin W, 2013, EUR HEART J; ROGERS WH, 1990, JAMA-J AM MED ASSOC, V264, P1989, DOI 10.1001/jama.264.15.1989; UK Research and Innovation (UKRI), 2022, FRAMEWORK RESPONSIBL	32	103	106	10	82	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 7	2013	346								f3197	10.1136/bmj.f3197	http://dx.doi.org/10.1136/bmj.f3197			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YM	23747967	Green Submitted			2022-12-28	WOS:000320230400002
J	Briggs, F; Mangun, GR; Usrey, WM				Briggs, Farran; Mangun, George R.; Usrey, W. Martin			Attention enhances synaptic efficacy and the signal-to-noise ratio in neural circuits	NATURE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; MACAQUE AREA V4; SELECTIVE ATTENTION; SPATIAL ATTENTION; NEURONAL RESPONSES; SIMPLE CELLS; MONKEY; V1; PERFORMANCE	Attention is a critical component of perception(1). However, the mechanisms by which attention modulates neuronal communication to guide behaviour are poorly understood. To elucidate the synaptic mechanisms of attention, we developed a sensitive assay of attentional modulation of neuronal communication. In alert monkeys performing a visual spatial attention task, we probed thalamocortical communication by electrically stimulating neurons in the lateral geniculate nucleus of the thalamus while simultaneously recording shock-evoked responses from monosynaptically connected neurons in primary visual cortex. We found that attention enhances neuronal communication by increasing the efficacy of presynaptic input in driving postsynaptic responses, by increasing synchronous responses among ensembles of postsynaptic neurons receiving independent input, and by decreasing redundant signals between postsynaptic neurons receiving common input. The results demonstrate that attention finely tunes neuronal communication at the synaptic level by selectively altering synaptic weights, enabling enhanced detection of salient events in the noisy sensory environment.	[Briggs, Farran; Usrey, W. Martin] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA; [Briggs, Farran] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH 03756 USA; [Mangun, George R.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95618 USA; [Mangun, George R.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Mangun, George R.; Usrey, W. Martin] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Usrey, W. Martin] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; Dartmouth College; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Usrey, WM (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95618 USA.	wmusrey@ucdavis.edu		Briggs, Farran/0000-0002-4037-4731	National Institutes of Health [EY18683, EY013588, MH055714]; NSF [BCS-0727115, 1228535]; NATIONAL EYE INSTITUTE [R00EY018683, K99EY018683, R01EY013588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH055714, R01MH055714] Funding Source: NIH RePORTER; Division Of Behavioral and Cognitive Sci [1228535] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank K. E. Neverkovec, D. J. Sperka and R. Oates-O'Brien for technical and veterinary assistance. This work was supported by National Institutes of Health grants EY18683 (F. B.), EY013588 (W. M. U.), MH055714 (G. R. M.) and NSF grants BCS-0727115 and 1228535 (G. R. M. and W.M.U.).	Briggs F, 2007, J NEUROSCI, V27, P5431, DOI 10.1523/JNEUROSCI.1035-07.2007; Briggs F, 2009, NEURON, V62, P135, DOI 10.1016/j.neuron.2009.02.024; Brody CD, 1998, J NEUROPHYSIOL, V80, P3345, DOI 10.1152/jn.1998.80.6.3345; BULLIER J, 1980, J COMP NEUROL, V193, P913, DOI 10.1002/cne.901930407; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Kelly SP, 2008, CEREB CORTEX, V18, P2629, DOI 10.1093/cercor/bhn022; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pestilli F, 2011, NEURON, V72, P832, DOI 10.1016/j.neuron.2011.09.025; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Skottun BC, 1991, VISION RES, V31, P1078; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Thiele A, 2009, CEREB CORTEX, V19, P2970, DOI 10.1093/cercor/bhp070; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Vanduffel W, 2000, CEREB CORTEX, V10, P109, DOI 10.1093/cercor/10.2.109; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; Yoshor D, 2007, J NEUROSCI, V27, P13205, DOI 10.1523/JNEUROSCI.2944-07.2007; Zenon A, 2012, NATURE, V489, P434, DOI 10.1038/nature11497; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	34	115	118	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2013	499	7459					476	+		10.1038/nature12276	http://dx.doi.org/10.1038/nature12276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23803766	Green Accepted			2022-12-28	WOS:000322157900040
J	O'Dell, JR; Mikuls, TR; Taylor, TH; Ahluwalia, V; Brophy, M; Warren, SR; Lew, RA; Cannella, AC; Kunkel, G; Phibbs, CS; Anis, AH; Leatherman, S; Keystone, E				O'Dell, James R.; Mikuls, Ted R.; Taylor, Thomas H.; Ahluwalia, Vandana; Brophy, Mary; Warren, Stuart R.; Lew, Robert A.; Cannella, Amy C.; Kunkel, Gary; Phibbs, Ciaran S.; Anis, Aslam H.; Leatherman, Sarah; Keystone, Edward			Therapies for Active Rheumatoid Arthritis after Methotrexate Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLLEGE-OF-RHEUMATOLOGY; MODIFYING ANTIRHEUMATIC DRUGS; DOUBLE-BLIND; PLUS METHOTREXATE; DISEASE-ACTIVITY; COMBINATION THERAPY; INADEQUATE RESPONSE; NECROSIS-FACTOR; PHASE-III; PLACEBO	BACKGROUND Few blinded trials have compared conventional therapy consisting of a combination of disease-modifying antirheumatic drugs with biologic agents in patients with rheumatoid arthritis who have active disease despite treatment with methotrexate a common scenario in the management of rheumatoid arthritis. METHODS We conducted a 48-week, double-blind, noninferiority trial in which we randomly assigned 353 participants with rheumatoid arthritis who had active disease despite methotrexate therapy to a triple regimen of disease-modifying antirheumatic drugs (methotrexate, sulfasalazine, and hydroxychloroquine) or etanercept plus methotrexate. Patients who did not have an improvement at 24 weeks according to a prespecified threshold were switched in a blinded fashion to the other therapy. The primary outcome was improvement in the Disease Activity Score for 28-joint counts (DAS28, with scores ranging from 2 to 10 and higher scores indicating more disease activity) at week 48. RESULTS Both groups had significant improvement over the course of the first 24 weeks (P=0.001 for the comparison with baseline). A total of 27% of participants in each group required a switch in treatment at 24 weeks. Participants in both groups who switched therapies had improvement after switching (P<0.001), and the response after switching did not differ significantly between the two groups (P=0.08). The change between baseline and 48 weeks in the DAS28 was similar in the two groups (-2.1 with triple therapy and -2.3 with etanercept and methotrexate, P=0.26); triple therapy was noninferior to etanercept and methotrexate, since the 95% upper confidence limit of 0.41 for the difference in change in DAS28 was below the margin for noninferiority of 0.6 (P=0.002). There were no significant between-group differences in secondary outcomes, including radiographic progression, pain, and health-related quality of life, or in major adverse events associated with the medications. CONCLUSIONS With respect to clinical benefit, triple therapy, with sulfasalazine and hydroxychloroquine added to methotrexate, was noninferior to etanercept plus methotrexate in patients with rheumatoid arthritis who had active disease despite methotrexate therapy. (Funded by the Cooperative Studies Program, Department of Veterans Affairs Office of Research and Development, and others; CSP 551 RACAT ClinicalTrials.gov number, NCT00405275.)	[O'Dell, James R.; Ahluwalia, Vandana; Cannella, Amy C.] Univ Nebraska, Med Ctr, Nebraska Western Iowa Hlth Care Syst, Omaha, NE USA; [Taylor, Thomas H.] White River Junct VA Med Ctr, White River Jct, VT USA; [Ahluwalia, Vandana] Brampton Civic Hosp, Vancouver, BC, Canada; [Anis, Aslam H.] Univ British Columbia, Vancouver, BC, Canada; [Keystone, Edward] Mt Sinai Hosp, Toronto, ON, Canada; [Brophy, Mary; Lew, Robert A.; Leatherman, Sarah] Coordinating Ctr, Cooperat Studies Program, Boston, MA USA; [Kunkel, Gary] George E Whalen VA Med Ctr, Salt Lake City, UT USA; [Kunkel, Gary] Univ Utah, Sch Med, Salt Lake City, UT USA; [Phibbs, Ciaran S.] Palo Alto VA Healthcare Syst, Palo Alto, CA USA	University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of British Columbia; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Utah System of Higher Education; University of Utah	O'Dell, JR (corresponding author), Vet Affairs Nebraska Western Iowa Hlth Care Syst, 4101 Woolworth, Omaha, NE 68105 USA.	james.o'dell@va.gov	Ahluwalia, Vandana/S-3611-2019	GUPTA, SAMAR/0000-0002-0489-6786; Phibbs, Ciaran/0000-0002-4353-3507	Cooperative Studies Program, Department of Veterans Affairs Office of Research and Development; Canadian Institutes for Health Research; Roche-Genentech; Bristol-Myers Squibb; Janssen; Roche; UCB; Pfizer; AbbVie; Schering Plough; Hoffmann-La Roche; Merck; AstraZeneca; Amgen; Abbott	Cooperative Studies Program, Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Roche-Genentech(Roche HoldingGenentech); Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Roche(Roche Holding); UCB(UCB Pharma SA); Pfizer(Pfizer); AbbVie(AbbVie); Schering Plough(Merck & CompanySchering Plough Corporation); Hoffmann-La Roche(Hoffmann-La Roche); Merck(Merck & Company); AstraZeneca(AstraZeneca); Amgen(Amgen); Abbott(Abbott Laboratories)	Funded by the Cooperative Studies Program, Department of Veterans Affairs Office of Research and Development, and others; CSP 551 RACAT ClinicalTrials.gov number, NCT00405275.); Supported by the Cooperative Studies Program, Department of Veterans Affairs Office of Research and Development, and the Canadian Institutes for Health Research and by an interagency agreement with the National Institutes of Health-American Recovery and Reinvestment Act.; Dr. Mikuls reports receiving grant support from Roche-Genentech. Dr. Ahluwalia reports receiving consulting fees from AbbVie, Bristol-Myers Squibb, Janssen, Roche, UCB, and Pfizer; lecture fees from AbbVie, Janssen, Roche and UCB; and grant support from AbbVie, Janssen, Roche, UCB, and Bristol-Myers Squibb. Dr. Lew reports holding stock options from Johnson & Johnson, Lexicon, Merck, Pfizer, and Rochester Medical. Dr. Anis reports receiving consulting fees from Pfizer, AbbVie and Schering Plough; and lecture fees and payment for the development of educational presentations from Pfizer. Dr. Keystone reports receiving consulting fees and reimbursement for travel expenses from Amgen, Pfizer, UCB, Hoffmann-La Roche, AbbVie, Bristol-Myers Squibb, and Merck; and grant support from Abbott, Amgen, AstraZeneca, Bristol-Myers Squibb, Hoffmann-La Roche, Janssen, Lilly, Novartis, Pfizer, and UCB. No other potential conflict of interest relevant to this article was reported.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; [Anonymous], 2008, ANN RHEUM DIS; [Anonymous], 1995, ARTHRITIS RHEUM; [Anonymous], 2000, ARTHRITIS RHEUM; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Chow S-C, 2008, SAMPLE SIZE CALCULAT; Cohen S, 2002, ARTHRITIS RHEUM, V46, P614, DOI 10.1002/art.10141; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Kay J, 2008, ARTHRITIS RHEUM-US, V58, P964, DOI 10.1002/art.23383; Keystone E, 2008, ARTHRITIS RHEUM, V58, P3319, DOI 10.1002/art.23964; Kosinski M, 2000, ARTHRITIS RHEUM-US, V43, P1478, DOI 10.1002/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M; Kremer JM, 2002, ANN INTERN MED, V137, P726, DOI 10.7326/0003-4819-137-9-200211050-00007; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Lehman AJ, 2005, ARTHRITIS RHEUM-US, V52, P1360, DOI 10.1002/art.21018; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Maska L, 2011, ARTHRIT CARE RES, V63, pS4, DOI 10.1002/acr.20620; McInnes IB, 2011, ANN RHEUM DIS, V70, P399, DOI 10.1136/ard.2010.134684corr1; Moreland LW, 2012, ARTHRITIS RHEUM-US, V64, P2824, DOI 10.1002/art.34498; O'Dell JR, 2011, ARTHRITIS RHEUM-US, V63, P2151, DOI 10.1002/art.30402; O'Dell J.R., 2013, KELLEYS TXB RHEUMATO, P1137; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P1164, DOI 10.1002/art.10228; Ozminkowski RJ, 2006, J OCCUP ENVIRON MED, V48, P135, DOI 10.1097/01.jom.0000194161.12923.52; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Schiff M, 2008, ANN RHEUM DIS, V67, P1096, DOI 10.1136/ard.2007.080002; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; TUGWELL P, 1995, NEW ENGL J MED, V333, P137, DOI 10.1056/NEJM199507203330301; van der Heijde D, 1999, J RHEUMATOL, V26, P743; van Vollenhoven RF, 2009, LANCET, V374, P459, DOI 10.1016/S0140-6736(09)60944-2; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Vermeer M, 2011, ARTHRITIS RHEUM-US, V63, P2865, DOI 10.1002/art.30494; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697	38	257	266	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					307	318		10.1056/NEJMoa1303006	http://dx.doi.org/10.1056/NEJMoa1303006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188VJ	23755969				2022-12-28	WOS:000322223900006
J	Schuenemann, VJ; Singh, P; Mendum, TA; Krause-Kyora, B; Jager, G; Bos, KI; Herbig, A; Economou, C; Benjak, A; Busso, P; Nebel, A; Boldsen, JL; Kjellstrom, A; Wu, HH; Stewart, GR; Taylor, GM; Bauer, P; Lee, OYC; Wu, HHT; Minnikin, DE; Besra, GS; Tucker, K; Roffey, S; Sow, SO; Cole, ST; Nieselt, K; Krause, J				Schuenemann, Verena J.; Singh, Pushpendra; Mendum, Thomas A.; Krause-Kyora, Ben; Jaeger, Guenter; Bos, Kirsten I.; Herbig, Alexander; Economou, Christos; Benjak, Andrej; Busso, Philippe; Nebel, Almut; Boldsen, Jesper L.; Kjellstrom, Anna; Wu, Huihai; Stewart, Graham R.; Taylor, G. Michael; Bauer, Peter; Lee, Oona Y. -C.; Wu, Houdini H. T.; Minnikin, David E.; Besra, Gurdyal S.; Tucker, Katie; Roffey, Simon; Sow, Samba O.; Cole, Stewart T.; Nieselt, Kay; Krause, Johannes			Genome-Wide Comparison of Medieval and Modern Mycobacterium leprae	SCIENCE			English	Article							ANCIENT-DNA; LEPROSY; DECAY; TUBERCULOSIS	Leprosy was endemic in Europe until the Middle Ages. Using DNA array capture, we have obtained genome sequences of Mycobacterium leprae from skeletons of five medieval leprosy cases from the United Kingdom, Sweden, and Denmark. In one case, the DNA was so well preserved that full de novo assembly of the ancient bacterial genome could be achieved through shotgun sequencing alone. The ancient M. leprae sequences were compared with those of 11 modern strains, representing diverse genotypes and geographic origins. The comparisons revealed remarkable genomic conservation during the past 1000 years, a European origin for leprosy in the Americas, and the presence of an M. leprae genotype in medieval Europe now commonly associated with the Middle East. The exceptional preservation of M. leprae biomarkers, both DNA and mycolic acids, in ancient skeletons has major implications for palaeomicrobiology and human pathogen evolution.	[Schuenemann, Verena J.; Bos, Kirsten I.; Krause, Johannes] Univ Tubingen, Inst Archaeol Sci, D-72070 Tubingen, Germany; [Singh, Pushpendra; Benjak, Andrej; Busso, Philippe; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Mendum, Thomas A.; Wu, Huihai; Stewart, Graham R.; Taylor, G. Michael] Univ Surrey, Fac Hlth & Med Sci, Dept Microbial & Cellular Sci, Guildford GU2 7XH, Surrey, England; [Krause-Kyora, Ben; Nebel, Almut] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Jaeger, Guenter; Herbig, Alexander; Nieselt, Kay] Univ Tubingen, Ctr Bioinformat, D-72076 Tubingen, Germany; [Economou, Christos] Stockholm Univ, Archaeol Res Lab, SE-10691 Stockholm, Sweden; [Boldsen, Jesper L.] Med Univ Southern Denmark, Inst Forens, Antropol Afdelin, DK-5260 Odense S, Denmark; [Kjellstrom, Anna] Stockholm Univ, Osteoarchaeol Res Lab, Dept Archaeol & Class Studies, SE-10691 Stockholm, Sweden; [Bauer, Peter] Univ Tubingen, Inst Med Genet & Appl Genom, D-72076 Tubingen, Germany; [Lee, Oona Y. -C.; Wu, Houdini H. T.; Minnikin, David E.; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TU, W Midlands, England; [Tucker, Katie; Roffey, Simon] Univ Winchester, Dept Archaeol, Winchester SO22 4NR, Hants, England; [Sow, Samba O.] Ctr Natl Appui Lutte Malad Ex Inst Marchoux, Minist Hlth, Ctr Vaccine Dev Mali, Bamako, Mali	Eberhard Karls University of Tubingen; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Surrey; University of Kiel; Eberhard Karls University of Tubingen; Stockholm University; University of Southern Denmark; Stockholm University; Eberhard Karls University of Tubingen; University of Birmingham; University of Winchester	Cole, ST (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland.	stewart.cole@epfl.ch; kay.nieselt@uni-tuebingen.de; johannes.krause@uni-tuebingen.de	Nebel, Almut/E-4196-2010; Krause-Kyora, Ben/AAH-3660-2021; Krause, Johannes/AFP-2642-2022; Kjellström, Anna/C-4343-2016; Singh, Pushpendra/J-6484-2015; Krause-Kyora, Ben/C-3341-2013	Krause-Kyora, Ben/0000-0001-9435-2872; Krause, Johannes/0000-0001-9144-3920; Kjellström, Anna/0000-0001-8964-3771; Singh, Pushpendra/0000-0001-9453-8669; Krause-Kyora, Ben/0000-0001-9435-2872; Stewart, Graham/0000-0002-6867-6248; Besra, Gurdyal/0000-0002-5605-0395; Roffey, Simon/0000-0002-6400-126X; Herbig, Alexander/0000-0003-1176-1166; Bos, Kirsten/0000-0003-2937-3006; White-Iribhogbe, Katie/0000-0001-6651-0132; Benjak, Andrej/0000-0003-4522-6575	European Research Council (ERC-APGREID); Carl Zeiss Foundation; Fondation Raoul Follereau; Swiss National Science Foundation; Deutsche Forschungsgemeinschaft Priority Program 1335 Scalable Visual Analytics; Central Innovation Program [KF2701103BZ1]; Graduate School Human Development in Landscapes; Excellence Cluster Inflammation at Interfaces; Medical Faculty of the Christian-Albrechts-University Kiel, a British Academy Small Research Grant; Leverhulme Trust [F/00094/BL]; Social Sciences and Humanities Research Council of Canada [756-2011-0501]	European Research Council (ERC-APGREID); Carl Zeiss Foundation; Fondation Raoul Follereau; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft Priority Program 1335 Scalable Visual Analytics; Central Innovation Program; Graduate School Human Development in Landscapes; Excellence Cluster Inflammation at Interfaces; Medical Faculty of the Christian-Albrechts-University Kiel, a British Academy Small Research Grant; Leverhulme Trust(Leverhulme Trust); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	We are grateful to the following people for providing samples, support, and advice: C. Bauer, H. Burbano, J. Hinds, S. Junker, M. Kodio, A. Fomba, C. Lanz, P. McLaren, J. Rougemont, and S. Schreiber. All raw read files have been deposited in the trace archive of the National Center for Biotechnology Information Sequence Read Archive under accession no. SRP022139. This work was supported by the European Research Council (ERC-APGREID), the Carl Zeiss Foundation, the Fondation Raoul Follereau, the Swiss National Science Foundation (Brazilian Swiss Joint Research Program), the Deutsche Forschungsgemeinschaft Priority Program 1335 Scalable Visual Analytics, the Central Innovation Program (grant KF2701103BZ1), the Graduate School Human Development in Landscapes, the Excellence Cluster Inflammation at Interfaces, the Medical Faculty of the Christian-Albrechts-University Kiel, a British Academy Small Research Grant, the Leverhulme Trust (Grant F/00094/BL), and the Social Sciences and Humanities Research Council of Canada (postdoctoral fellowship grant 756-2011-0501). Human remains were obtained under license from the UK Ministry of Justice.	Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Boldsen JL, 2008, AM J PHYS ANTHROPOL, V135, P301, DOI 10.1002/ajpa.20744; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cooper A, 2000, SCIENCE, V289, P1139; Daffe M, 2008, MYCOBACTERIAL CELL ENVELOPE, P3; Donoghue HD, 2004, LANCET INFECT DIS, V4, P584, DOI 10.1016/S1473-3099(04)01133-8; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Economou C, 2013, J ARCHAEOL SCI, V40, P465, DOI 10.1016/j.jas.2012.07.005; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Groathouse NA, 2004, J CLIN MICROBIOL, V42, P1666, DOI 10.1128/JCM.42.4.1666-1672.2004; Hart B. E., 2012, J TROP MED, V2012, P1; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Maeda S, 2001, ANTIMICROB AGENTS CH, V45, P3635, DOI 10.1128/AAC.45.12.3635-3639.2001; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Misch EA, 2010, MICROBIOL MOL BIOL R, V74, P589, DOI 10.1128/MMBR.00025-10; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Nguyen-Hieu Tung, 2012, BMC Res Notes, V5, P528, DOI 10.1186/1756-0500-5-528; Robbins G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005669; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Stone AC, 2009, YEARB PHYS ANTHROPOL, V52, P66, DOI 10.1002/ajpa.21185; Taylor GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062406; Taylor GM, 2009, J ARCHAEOL SCI, V36, P2408, DOI 10.1016/j.jas.2009.06.026; Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536; WHO, 2011, WKLY EPIDEMIOL REC, V86, P389	29	208	210	3	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					179	183		10.1126/science.1238286	http://dx.doi.org/10.1126/science.1238286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23765279				2022-12-28	WOS:000321965300044
J	Takahashi, Y; Inui, Y; Chihara, M; Asano, T; Terawaki, R; Noda, S				Takahashi, Yasushi; Inui, Yoshitaka; Chihara, Masahiro; Asano, Takashi; Terawaki, Ryo; Noda, Susumu			A micrometre-scale Raman silicon laser with a microwatt threshold	NATURE			English	Article							PHOTONIC CRYSTAL NANOCAVITIES; WAVE-GUIDES; HETEROSTRUCTURE NANOCAVITIES; ON-INSULATOR; AMPLIFICATION; ABSORPTION; SCATTERING; EMISSION; DESIGN; CAVITY	The application of novel technologies to silicon electronics has been intensively studied with a view to overcoming the physical limitations of Moore's law, that is, the observation that the number of components on integrated chips tends to double every two years. For example, silicon devices have enormous potential for photonic integrated circuits on chips compatible with complementary metal-oxide-semiconductor devices, with various key elements having been demonstrated in the past decade(1-6). In particular, a focus on the exploitation of the Raman effect has added active optical functionality to pure silicon(7-10), culminating in the realization of a continuous-wave all-silicon laser(11). This achievement is an important step towards silicon photonics, but the desired miniaturization to micrometre dimensions and the reduction of the threshold for laser action to microwatt powers have yet to be achieved: such lasers remain limited to centimetre-sized cavities with thresholds higher than 20 milliwatts(12), even with the assistance of reverse-biased p-i-n diodes. Here we demonstrate a continuous-wave Raman silicon laser using a photonic-crystal, high-quality-factor nanocavity without any p-i-n diodes, yielding a device with a cavity size of less than 10 micrometres and an unprecedentedly low lasing threshold of 1 microwatt. Our nanocavity design exploits the principle that the strength of light-matter interactions is proportional to the ratio of quality factor to the cavity volume and allows drastic enhancement of the Raman gain beyond that predicted theoretically(13,14). Such a device may make it possible to construct practical silicon lasers and amplifiers for large-scale integration in photonic circuits.	[Takahashi, Yasushi; Chihara, Masahiro; Terawaki, Ryo] Osaka Prefecture Univ, Res Org 21st Century, Nanosci & Nanotechnol Res Ctr, Sakai, Osaka 5998570, Japan; [Takahashi, Yasushi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Inui, Yoshitaka; Asano, Takashi; Noda, Susumu] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan; [Noda, Susumu] Kyoto Univ, Photon & Elect Sci & Engn Ctr, Kyoto 6158510, Japan	Osaka Metropolitan University; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University	Takahashi, Y (corresponding author), Osaka Prefecture Univ, Res Org 21st Century, Nanosci & Nanotechnol Res Ctr, Sakai, Osaka 5998570, Japan.	y-takahashi@21c.osakafu-u.ac.jp; snoda@kuee.kyoto-u.ac.jp		Takahashi, Yasushi/0000-0003-4249-2755	NanoSquare programme; Funds for the Development of Human Resources in Science and Technology; JST, PRESTO; MEXT KAKENHI [23104721, 21104512]; JSPS KAKENHI [23686015, 20226002]; Asahi Grass Foundation; Ministry of Economy, Trade and Industry (METI) through its 'Future Pioneering Projects'; CPHoST programme	NanoSquare programme; Funds for the Development of Human Resources in Science and Technology; JST, PRESTO(Japan Science & Technology Agency (JST)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Asahi Grass Foundation; Ministry of Economy, Trade and Industry (METI) through its 'Future Pioneering Projects'; CPHoST programme	We especially thank H. Takano for a preliminary calculation done before the start of this project. We thank K. Ishizaki and K. Kitamura for assistance in device fabrication, Y. Tanaka for assistance with finite-difference time-domain calculations, A. Oskooi and H. Ishihara for comments, and Y. Sakamoto for software assistance. Y. T. is supported by the NanoSquare programme, Funds for the Development of Human Resources in Science and Technology, commissioned by MEXT. This work was supported by JST, PRESTO, the NanoSquare programme and MEXT KAKENHI (grant numbers 23104721 and 21104512). The spectral measurements were partly supported by JSPS KAKENHI (grant number 23686015) and the Asahi Grass Foundation. The device fabrication was greatly supported by JSPS KAKENHI (grant number 20226002), the Ministry of Economy, Trade and Industry (METI) through its 'Future Pioneering Projects', and the CPHoST programme.	Akahane Y, 2003, NATURE, V425, P944, DOI 10.1038/nature02063; Asano T, 2006, OPT EXPRESS, V14, P1996, DOI 10.1364/OE.14.001996; Baba T, 2008, NAT PHOTONICS, V2, P465, DOI 10.1038/nphoton.2008.146; Barkai A, 2007, J OPT NETW, V6, P25, DOI 10.1364/JON.6.000025; Boyraz O, 2004, OPT EXPRESS, V12, P5269, DOI 10.1364/OPEX.12.005269; Claps R, 2004, OPT EXPRESS, V12, P2774, DOI 10.1364/OPEX.12.002774; Claps R, 2003, OPT EXPRESS, V11, P1731, DOI 10.1364/OE.11.001731; Claps R, 2002, OPT EXPRESS, V10, P1305, DOI 10.1364/OE.10.001305; Fang AW, 2007, MATER TODAY, V10, P28, DOI 10.1016/S1369-7021(07)70177-3; Hagino H, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085112; Han Z, 2011, OPT LETT, V36, P1749, DOI 10.1364/OL.36.001749; Jalali B, 2006, J LIGHTWAVE TECHNOL, V24, P4600, DOI 10.1109/JLT.2006.885782; Liang TK, 2004, APPL PHYS LETT, V84, P2745, DOI 10.1063/1.1702133; Liu AS, 2004, NATURE, V427, P615, DOI 10.1038/nature02310; LOUDON R, 1964, ADV PHYS, V13, P423, DOI 10.1080/00018736400101051; Michel J, 2010, NAT PHOTONICS, V4, P527, DOI [10.1038/nphoton.2010.157, 10.1038/NPHOTON.2010.157]; Noda S, 2000, NATURE, V407, P608, DOI 10.1038/35036532; RALSTON JM, 1970, PHYS REV B, V2, P1858, DOI 10.1103/PhysRevB.2.1858; Rong HS, 2007, NAT PHOTONICS, V1, P232, DOI 10.1038/nphoton.2007.29; Rong HS, 2005, NATURE, V433, P292, DOI 10.1038/nature03273; Rong HS, 2005, NATURE, V433, P725, DOI 10.1038/nature03346; Song BS, 2011, OPT LETT, V36, P91, DOI 10.1364/OL.36.000091; Song BS, 2005, NAT MATER, V4, P207, DOI 10.1038/nmat1320; Taguchi Y, 2011, OPT EXPRESS, V19, P11916, DOI 10.1364/OE.19.011916; Takahashi Y, 2009, OPT EXPRESS, V17, P18093, DOI 10.1364/OE.17.018093; Takano H., 2007, SPRING M JPN SOC APP; Terawaki R, 2012, OPT EXPRESS, V20, P22743, DOI 10.1364/OE.20.022743; Won R, 2010, NAT PHOTONICS, V4, P498, DOI 10.1038/nphoton.2010.189; Yang XD, 2005, OPT EXPRESS, V13, P4723, DOI 10.1364/OPEX.13.004723; Yang XD, 2007, OPT EXPRESS, V15, P4763, DOI 10.1364/OE.15.004763	30	166	168	1	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					470	474		10.1038/nature12237	http://dx.doi.org/10.1038/nature12237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803846				2022-12-28	WOS:000320929400049
J	Wright, J				Wright, Jessica			EPIGENETICS Reversible tags	NATURE			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; MUTATIONS; METHYLATION											Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020	7	19	19	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					S10	S11		10.1038/498S10a	http://dx.doi.org/10.1038/498S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803942	Bronze			2022-12-28	WOS:000320929400006
J	Cawston, T; Maynard, A				Cawston, Thomas; Maynard, Alan			Should the chancellor of the exchequer lift the ringfence on England's health budget?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cawston, Thomas] Reform, London, England; [Maynard, Alan] Univ York, York YO10 5DD, N Yorkshire, England	University of York - UK	Cawston, T (corresponding author), Reform, London, England.	thomas.cawston@reform.co.uk; alan.maynard@york.ac.uk						Bassett D, 2011, REFORM SCORECARD 201; Baumol William J., 1966, PERFORMING ARTS THE; Campbell DT, 1969, AM PSYCHOL, V24, P4; Cawston T, 2013, FLAT LINING LACK OF; Department of Health, 2010, ACHIEVING WORLD CLAS; Ham C, 2012, TRANSFORMING THE DEL; HM Inspectorate of Constabulary, 2012, POLICING IN AUSTERIT; Institute of Medicine, 1999, TO ERR IS HUMAN BUIL; May T., 2013, COMMUNICATION; Maynard A, 2013, J HEALTH SERV RES PO, V18, P1, DOI 10.1258/jhsrp.2012.012041; National Audit Office, 2012, PROGRESS IN MAKING N; Percival Thomas, 1803, MEDICAL ETHICS OR A; Welch HG, 2011, OVER DIAGNOSIS MAKIN; Wennberg J. E, 2010, TRACKING MED RES QUE	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2013	346								f4126	10.1136/bmj.f4126	http://dx.doi.org/10.1136/bmj.f4126			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QL	23804294				2022-12-28	WOS:000321246200014
J	Tuff, J; Wade, J; Wood, BJ				Tuff, J.; Wade, J.; Wood, B. J.			Volcanism on Mars controlled by early oxidation of the upper mantle	NATURE			English	Article							IRON-RICH MANTLE; MARTIAN METEORITES; SULFIDE SATURATION; SULFUR-CONTENT; PETROGENESIS; CONSTRAINTS; ORIGIN; ROCKS; CRUST; MELT	Detailed information about the chemical composition and evolution of Mars has been derived principally from the SNC (shergottite-nakhlite-chassignite) meteorites, which are genetically related igneous rocks of Martian origin(1,2). They are chemically and texturally similar to terrestrial basalts and cumulates, except that they have higher concentrations of iron and volatile elements such as phosphorus and chlorine and lower concentrations of nickel and other chalcophile (sulphur-loving) elements(3). Most Martian meteorites have relatively young crystallization ages (1.4 billion years to 180 million years ago(4)) and are considered to be derived from young, lightly cratered volcanic regions, such as the Tharsis plateau(4,5). Surface rocks from the Gusev crater analysed by the Spirit rover are much older (about 3.7 billion years old(6)) and exhibit marked compositional differences from the meteorites(7). Although also basaltic in composition, the surface rocks are richer in nickel and sulphur and have lower manganese/iron ratios than the meteorites. This has led to doubts that Mars can be described adequately using the 'SNC model'. Here we show, however, that the differences between the compositions of meteorites and surface rocks can be explained by differences in the oxygen fugacity duringmelting of the same sulphur-rich mantle. This ties the sources of Martian meteorites to those of the surface rocks through an early (>3.7 billion years ago) oxidation of the uppermost mantle that had less influence on the deeper regions, which produce the more recent volcanic rocks.	[Tuff, J.; Wade, J.; Wood, B. J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England	University of Oxford	Wood, BJ (corresponding author), Univ Oxford, Dept Earth Sci, S Parks Rd, Oxford OX1 3AN, England.	berniew@earth.ox.ac.uk	Wood, Bernard J/E-8173-2010; Wade, Jon/H-7012-2012	Wood, Bernard J/0000-0003-1038-7301; Wade, Jon/0000-0002-6998-236X	UK Science and Technology Facilities Council [ST/G00272X/1]; European Research Council [267764]	UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); European Research Council(European Research Council (ERC)European Commission)	We acknowledge support from the UK Science and Technology Facilities Council (grant ST/G00272X/1) and from the European Research Council (grant 267764).	Agee CB, 2013, SCIENCE, V339, P780, DOI 10.1126/science.1228858; Agee CB, 2004, EARTH PLANET SC LETT, V224, P415, DOI 10.1016/j.epsl.2004.05.022; BECKER RH, 1984, EARTH PLANET SC LETT, V69, P225, DOI 10.1016/0012-821X(84)90183-3; BERTKA CM, 1994, CONTRIB MINERAL PETR, V115, P323, DOI 10.1007/BF00310771; Bertka CM, 1998, EARTH PLANET SC LETT, V157, P79, DOI 10.1016/S0012-821X(98)00030-2; BERTKA CM, 1994, CONTRIB MINERAL PETR, V115, P313, DOI 10.1007/BF00310770; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; Brenan JM, 2003, GEOCHIM COSMOCHIM AC, V67, P2663, DOI 10.1016/S0016-7037(02)01416-3; CARMICHAEL ISE, 1991, CONTRIB MINERAL PETR, V106, P129, DOI 10.1007/BF00306429; Danyushevsky LV, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003516; DREIBUS G, 1985, METEORITICS, V20, P367; Gellert R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002555; Greeley R, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002401; Herd CDK, 2002, GEOCHIM COSMOCHIM AC, V66, P2025, DOI 10.1016/S0016-7037(02)00828-1; Jugo PJ, 2010, GEOCHIM COSMOCHIM AC, V74, P5926, DOI 10.1016/j.gca.2010.07.022; Jugo PJ, 2009, GEOLOGY, V37, P415, DOI 10.1130/G25527A.1; Konopliv AS, 2011, ICARUS, V211, P401, DOI 10.1016/j.icarus.2010.10.004; Li Y, 2012, EARTH PLANET SC LETT, V355, P327, DOI 10.1016/j.epsl.2012.08.008; LUHR JF, 1984, J VOLCANOL GEOTH RES, V23, P69, DOI 10.1016/0377-0273(84)90057-X; MATHEZ EA, 1976, J GEOPHYS RES, V81, P4269, DOI 10.1029/JB081i023p04269; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; McSween HY, 2009, SCIENCE, V324, P736, DOI 10.1126/science.1165871; McSween HY, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002477; MCSWEEN HY, 1984, GEOLOGY, V12, P3, DOI 10.1130/0091-7613(1984)12<3:SMATMR>2.0.CO;2; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; MCSWEEN HY, 1979, EARTH PLANET SC LETT, V45, P275, DOI 10.1016/0012-821X(79)90129-8; Ming DW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002560; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; O'Neill HSC, 2002, J PETROL, V43, P1049, DOI 10.1093/petrology/43.6.1049; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Rivoldini A, 2011, ICARUS, V213, P451, DOI 10.1016/j.icarus.2011.03.024; SHIH CY, 1982, GEOCHIM COSMOCHIM AC, V46, P2323, DOI 10.1016/0016-7037(82)90205-8; Treiman AH, 2005, CHEM ERDE-GEOCHEM, V65, P203, DOI 10.1016/j.chemer.2005.01.004; Wadhwa M, 2001, SCIENCE, V291, P1527, DOI 10.1126/science.1057594; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29; Wood BJ, 2006, NATURE, V441, P825, DOI 10.1038/nature04763; [No title captured]	37	54	55	0	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					342	+		10.1038/nature12225	http://dx.doi.org/10.1038/nature12225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23783628				2022-12-28	WOS:000320592900035
J	Karim, SSA				Karim, Salim S. Abdool			HIV pre-exposure prophylaxis in injecting drug users	LANCET			English	Editorial Material									[Karim, Salim S. Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, ZA-4013 Durban, South Africa; [Karim, Salim S. Abdool] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	University of Kwazulu Natal; Columbia University	Karim, SSA (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, ZA-4013 Durban, South Africa.	karims1@ukzn.ac.za	Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/P-3117-2019; Karim, Salim Abdool/AAE-7118-2019	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Karim, Salim Abdool/0000-0002-4986-2133; 				Choopanya K, 2013, LANCET; Karim SSA, 2011, LANCET, V378, pE23, DOI 10.1016/S0140-6736(11)61136-7; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mofenson LM, 1999, LANCET, V353, P766, DOI 10.1016/S0140-6736(99)90028-4; Sendziuk P, 2007, CAN BULL MED HIST, V24, P113, DOI 10.3138/cbmh.24.1.113; UNAIDS, HIV PREV INJ DRUG US	6	10	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 15	2013	381	9883					2060	2062		10.1016/S0140-6736(13)61140-X	http://dx.doi.org/10.1016/S0140-6736(13)61140-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KA	23769217				2022-12-28	WOS:000320924800006
J	Rummer, JL; McKenzie, DJ; Innocenti, A; Supuran, CT; Brauner, CJ				Rummer, Jodie L.; McKenzie, David J.; Innocenti, Alessio; Supuran, Claudiu T.; Brauner, Colin J.			Root Effect Hemoglobin May Have Evolved to Enhance General Tissue Oxygen Delivery	SCIENCE			English	Article							TROUT SALMO-GAIRDNERI; RAINBOW-TROUT; CARBONIC-ANHYDRASE; ONCORHYNCHUS-MYKISS; SKELETAL-MUSCLE; CATECHOLAMINES; ERYTHROCYTES; SECRETION; EXERCISE; FISHES	The Root effect is a pH-dependent reduction in hemoglobin-O-2 carrying capacity. Specific to ray-finned fishes, the Root effect has been ascribed specialized roles in retinal oxygenation and swimbladder inflation. We report that when rainbow trout are exposed to elevated water carbon dioxide (CO2), red muscle partial pressure of oxygen (PO2) increases by 65%-evidence that Root hemoglobins enhance general tissue O-2 delivery during acidotic stress. Inhibiting carbonic anhydrase (CA) in the plasma abolished this effect. We argue that CA activity in muscle capillaries short-circuits red blood cell (RBC) pH regulation. This acidifies RBCs, unloads O-2 from hemoglobin, and elevates tissue PO2, which could double O-2 delivery with no change in perfusion. This previously undescribed mechanism to enhance O-2 delivery during stress may represent the incipient function of Root hemoglobins in fishes.	[Rummer, Jodie L.; Brauner, Colin J.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Rummer, Jodie L.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [McKenzie, David J.] Univ Montpellier 2, Equipe Diversite & Ecol Poissons, UMR Ecol Syst Marins Cotiers 5119, F-34095 Montpellier 5, France; [Innocenti, Alessio; Supuran, Claudiu T.] Univ Florence, Neurofarba Dept, Sez Sci Farmaceut, I-50019 Florence, Italy	University of British Columbia; James Cook University; Universite de Montpellier; University of Florence	Rummer, JL (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	jodie.rummer@jcu.edu.au	McKenzie, David J./K-3090-2012; Rummer, Jodie L/A-6524-2015; McKenzie, David/AAA-5179-2021	McKenzie, David J./0000-0003-0961-9101; Rummer, Jodie L/0000-0001-6067-5892; McKenzie, David/0000-0003-0961-9101; Supuran, Claudiu/0000-0003-4262-0323	Natural Sciences and Engineering Research Council of Canada; University of British Columbia; Australian Research Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of British Columbia; Australian Research Council(Australian Research Council)	This project was funded by a Natural Sciences and Engineering Research Council of Canada Discovery grant to C.J.B. and a University of British Columbia Graduate Fellowship and Australian Research Council grant to J.L.R. The authors wish to thank S. F. Perry for catecholamine analysis, W. K. Milsom for tubocurarine advice, and D. J. Randall, M. Regan, D. W. Baker, C. Ciuhandu, A. P. Farrell, K. Gilmour, A. Morash, P. Allen, N. Farrell, C. Fu, L. Hanson, K. Kamo, M. Roshan-Moniri, K. Suvadzjic, and the University of British Columbia Zoology workshop for interesting discussions and editorial and technical assistance. Additional information and all supporting data can be found in the supplementary materials.	BAROIN A, 1984, J PHYSIOL-LONDON, V356, P21, DOI 10.1113/jphysiol.1984.sp015450; Behnke BJ, 2001, RESP PHYSIOL, V126, P53, DOI 10.1016/S0034-5687(01)00195-5; Berenbrink M, 2005, SCIENCE, V307, P1752, DOI 10.1126/science.1107793; Berenbrink M, 2007, J EXP BIOL, V210, P1641, DOI 10.1242/jeb.003319; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; Helfman G, 2009, DIVERSITY FISHES BIO; Henry RP, 2000, RESP PHYSIOL, V121, P1, DOI 10.1016/S0034-5687(00)00110-9; Hutter J, 1999, J APPL PHYSIOL, V86, P860, DOI 10.1152/jappl.1999.86.3.860; LAPENNAS GN, 1983, RESP PHYSIOL, V54, P161, DOI 10.1016/0034-5687(83)90054-3; McKenzie DJ, 2004, J EXP BIOL, V207, P3629, DOI 10.1242/jeb.01199; NIKINMAA M, 1992, PHYSIOL REV, V72, P301, DOI 10.1152/physrev.1992.72.2.301; PERRY SF, 1989, RESP PHYSIOL, V77, P365, DOI 10.1016/0034-5687(89)90123-0; PRIMMETT DRN, 1986, J EXP BIOL, V122, P139; RAHIM SM, 1988, HISTOCHEMISTRY, V89, P451, DOI 10.1007/BF00492602; Romero MG, 1996, J EXP BIOL, V199, P415; Root RW, 1931, BIOL BULL-US, V61, P427, DOI 10.2307/1536959; Rummer J.L, 2010, THESIS U BRIT COLUMB; Rummer JL, 2011, J EXP BIOL, V214, P2319, DOI 10.1242/jeb.054049; SCHOLANDER PF, 1954, BIOL BULL, V107, P247, DOI 10.2307/1538611; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Wang YX, 1998, AM J PHYSIOL-REG I, V275, pR1766, DOI 10.1152/ajpregu.1998.275.6.R1766; Weaver YR, 1999, J EXP BIOL, V202, P21; WITTENBERG JB, 1974, BIOL BULL-US, V146, P116, DOI 10.2307/1540402	23	103	104	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1327	1329		10.1126/science.1233692	http://dx.doi.org/10.1126/science.1233692			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766325				2022-12-28	WOS:000320320200044
J	Thachil, J; Fitzmaurice, D				Thachil, Jecko; Fitzmaurice, David			10-MINUTE CONSULTATION Thrombocytopenia in an adult	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Thachil, Jecko] Cent Manchester Univ Hosp NHS Fdn Trust, Dept Haematol, Manchester M13 9WL, Lancs, England; [Fitzmaurice, David] Univ Birmingham, Birmingham B15 2TT, W Midlands, England	University of Manchester; University of Birmingham	Thachil, J (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Dept Haematol, Manchester M13 9WL, Lancs, England.	jecko.thachil@cmft.nhs.uk						Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2013	346								f3407	10.1136/bmj.f3407	http://dx.doi.org/10.1136/bmj.f3407			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VK	23751903				2022-12-28	WOS:000320586700009
J	Charlesworth, A; Dixon, J				Charlesworth, Anita; Dixon, Jennifer			Commentary: Nudging hospitals to better quality	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Charlesworth, Anita; Dixon, Jennifer] Nuffield Trust, London W1G 7LP, England		Dixon, J (corresponding author), Nuffield Trust, London W1G 7LP, England.	jennifer.dixon@nuffieldtrust.org.uk						Altman SH, 2012, HEALTH AFFAIR, V31, P1923, DOI 10.1377/hlthaff.2012.0323; Appleby J, 2012, PAYMENT BY RESULTS H; Busse R, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3197; Charlesworth A, 2012, REFORMING PAYMENT FO; Department of Health, 2013, PAYMENT BY RESULTS G	5	2	2	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 7	2013	346								f3344	10.1136/bmj.f3344	http://dx.doi.org/10.1136/bmj.f3344			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YM	23747968				2022-12-28	WOS:000320230400003
J	Alberts, MJ				Alberts, Mark J.			Genetics of warfarin dosing-one polymorphism at a time	LANCET			English	Editorial Material							REPLICATION; SENSITIVITY; HAPLOTYPES		UTSW Med Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Alberts, MJ (corresponding author), UTSW Med Ctr, Dallas, TX 75390 USA.	mark.alberts@utsouthwestern.edu						Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Lane S, 2012, BRIT J CLIN PHARMACO, V73, P66, DOI 10.1111/j.1365-2125.2011.04051.x; Limdi NA, 2008, PHARMACOGENOMICS, V9, P1445, DOI 10.2217/14622416.9.10.1445; Loebstein R, 2001, CLIN PHARMACOL THER, V70, P159, DOI 10.1067/mcp.2001.117444; Mlynarsky L, 2012, EUR J CLIN PHARMACOL, V68, P617, DOI 10.1007/s00228-011-1143-z; Nakamura K, 2012, J CLIN PHARM THER, V37, P481, DOI 10.1111/j.1365-2710.2011.01317.x; Newman DH, 2006, ANN EMERG MED, V48, P182, DOI 10.1016/j.annemergmed.2005.12.010; Ott J, 2004, NEUROLOGY, V63, P955, DOI 10.1212/WNL.63.6.955; Perera MA, 2013, LANCET, DOI 10.1016/S0140-6736(13)60681-9 (2013); Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Steffel J, 2011, EUR HEART J, V32, P1968, DOI 10.1093/eurheartj/ehr052; Tan GM, 2010, PHARMACOGENOMICS, V11, P439, DOI 10.2217/PGS.10.8; Thompson CA, 2007, AM J HEALTH-SYST PH, V64, P1994, DOI 10.2146/news070085; Voora D, 2010, CLIN PHARMACOL THER, V87, P445, DOI 10.1038/clpt.2009.291; Yang LM, 2010, THROMB RES, V125, pE159, DOI 10.1016/j.thromres.2009.10.017	15	4	4	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2013	382	9894					749	751		10.1016/S0140-6736(13)60942-3	http://dx.doi.org/10.1016/S0140-6736(13)60942-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VP	23755829				2022-12-28	WOS:000324239200007
J	Clary, DC				Clary, David C.			100 Years of Atomic Theory	SCIENCE			English	Editorial Material							CONSTITUTION; MOLECULES		Univ Oxford, Dept Phys & Theoret Chem, Oxford OX1 3QZ, England	University of Oxford	Clary, DC (corresponding author), Univ Oxford, Dept Phys & Theoret Chem, Oxford OX1 3QZ, England.	david.clary@chem.ox.ac.uk	Clary, David C/AAC-3903-2019	Clary, David C/0000-0003-4439-741X				Bianchi E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.011301; Bohr N, 1913, PHILOS MAG, V26, P1, DOI 10.1080/14786441308634955; Bohr N, 1913, PHILOS MAG, V26, P476, DOI 10.1080/14786441308634993; Bohr N, 1913, PHILOS MAG, V26, P857, DOI 10.1080/14786441308635031; Bohr N., 1913, NATURE, V92, P231; Clary DC, 2006, SCIENCE, V314, P265, DOI 10.1126/science.1133434; Kragh H., 2012, N BOHR QUANTUM ATOM; Kragh H, 2013, PHYS TODAY, V66, P36, DOI 10.1063/PT.3.1978; Schrodinger E, 1926, ANN PHYS-BERLIN, V79, P361, DOI 10.1002/andp.19263840404	9	0	0	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					244	245		10.1126/science.1240200	http://dx.doi.org/10.1126/science.1240200			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23788732				2022-12-28	WOS:000321959300030
J	Gross, ML				Gross, Michael L.			Force-Feeding, Autonomy, and the Public Interest	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Haifa, Sch Polit Sci, IL-31999 Haifa, Israel	University of Haifa	Gross, ML (corresponding author), Univ Haifa, Sch Polit Sci, IL-31999 Haifa, Israel.							[Anonymous], 2005, FORC FEED HUNG STRIK; Glick SM, 1997, NEW ENGL J MED, V336, P954; Howe EG, 2009, INTERROGATIONS FORCE, P75; Visser SL., 2003, TXB MILITARY MED MIL, P251; World Medical Association, 2006, WMA DECL MALT HUNG S	5	14	14	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					103	105		10.1056/NEJMp1306325	http://dx.doi.org/10.1056/NEJMp1306325			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180BH	23758204				2022-12-28	WOS:000321567300004
J	Zhang, LB; Prak, L; Rayon-Estrada, V; Thiru, P; Flygare, J; Lim, B; Lodish, HF				Zhang, Lingbo; Prak, Lina; Rayon-Estrada, Violeta; Thiru, Prathapan; Flygare, Johan; Lim, Bing; Lodish, Harvey F.			ZFP36L2 is required for self-renewal of early burst-forming unit erythroid progenitors	NATURE			English	Article							GLUCOCORTICOID-RECEPTOR; TRANSCRIPTION FACTOR; DIFFERENTIATION; ERYTHROPOIETIN; PROTEINS; CELLS; GENE; RED	Stem cells and progenitors in many lineages undergo self-renewing divisions, but the extracellular and intracellular proteins that regulate this process are largely unknown. Glucocorticoids stimulate red blood cell formation by promoting self-renewal of early burst-forming unit-erythroid (BFU-E) progenitors(1-4). Here we show that the RNA-binding protein ZFP36L2 is a transcriptional target of the glucocorticoid receptor (GR) in BFU-Es and is required for BFU-E self-renewal. ZFP36L2 is normally downregulated during erythroid differentiation from the BFU-E stage, but its expression is maintained by all tested GR agonists that stimulate BFU-E self-renewal, and the GR binds to several potential enhancer regions of ZFP36L2. Knockdown of ZFP36L2 in cultured BFU-E cells did not affect the rate of cell division but disrupted glucocorticoid-induced BFU-E self-renewal, and knockdown of ZFP36L2 in transplanted erythroid progenitors prevented expansion of erythroid lineage progenitors normally seen following induction of anaemia by phenylhydrazine treatment. ZFP36L2 preferentially binds to messenger RNAs that are induced or maintained at high expression levels during terminal erythroid differentiation and negatively regulates their expression levels. ZFP36L2 therefore functions as part of a molecular switch promoting BFU-E self-renewal and a subsequent increase in the total numbers of colony-forming unit-erythroid (CFU-E) progenitors and erythroid cells that are generated.	[Zhang, Lingbo; Prak, Lina; Rayon-Estrada, Violeta; Thiru, Prathapan; Flygare, Johan; Lodish, Harvey F.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Zhang, Lingbo; Prak, Lina; Rayon-Estrada, Violeta; Thiru, Prathapan; Flygare, Johan; Lodish, Harvey F.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Zhang, Lingbo; Lim, Bing; Lodish, Harvey F.] Singapore Massachusetts Inst Technol Alliance, Singapore 117576, Singapore; [Zhang, Lingbo; Lim, Bing] ASTAR, Genome Inst Singapore, Singapore 138627, Singapore; [Lim, Bing] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lodish, HF (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	lodish@wi.mit.edu	Flygare, Johan/C-6584-2014	Flygare, Johan/0000-0002-1962-5276	NIH [P01 HL 32262]; Singapore-Massachusetts Institute of Technology Alliance; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-Massachusetts Institute of Technology Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by NIH grant P01 HL 32262 to H. F. L.; L.Z. is supported by a graduate fellowship from Singapore-Massachusetts Institute of Technology Alliance. We thank C. Sieff, J. Zhang, and P. Ji for providing reagents, T. Chavarria and F. Reinhardt for assisting with mouse transplantation experiments, J. Shih for helping with the making of constructs, M. Bousquet and C. Patterson for discussion and assistance with mouse transplantation experiment and antibody testing, S. Gupta, J. Kwon and I. Barrasa for processing raw RNA-seq data, processing microarray and discussion of bioinformatics analyses, and Sanofi Aventis for providing many GR agonists.	Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Kumkhaek C, 2013, BLOOD, V121, P3216, DOI 10.1182/blood-2011-10-385252; Narla A, 2011, BLOOD, V118, P2296, DOI 10.1182/blood-2010-11-318543; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Teittinen KJ, 2012, J CELL BIOCHEM, V113, P3843, DOI 10.1002/jcb.24298; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wessely O, 1997, EMBO J, V16, P267, DOI 10.1093/emboj/16.2.267; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Zhang LB, 2011, GENE DEV, V25, P119, DOI 10.1101/gad.1998711; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	22	75	76	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					92	+		10.1038/nature12215	http://dx.doi.org/10.1038/nature12215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23748442	Green Accepted, Green Submitted			2022-12-28	WOS:000321285600040
J	Chowdri, HR; Gugliotta, JL; Berardi, VP; Goethert, HK; Molloy, PJ; Sterling, SL; Telford, SR				Chowdri, Hanumara Ram; Gugliotta, Joseph L.; Berardi, Victor P.; Goethert, Heidi K.; Molloy, Philip J.; Sterling, Sherri L.; Telford, Sam R., III			Borrelia miyamotoi Infection Presenting as Human Granulocytic Anaplasmosis A Case Report	ANNALS OF INTERNAL MEDICINE			English	Article							FEVER GROUP SPIROCHETE; RELAPSING-FEVER; LYME-DISEASE; SENSU-LATO; BURGDORFERI; TICK; EHRLICHIOSIS; SERODIAGNOSIS; VECTOR	Background: The diverse tickborne infections of the northeastern United States can present as undifferentiated flu-like illnesses. In areas endemic for Lyme and other tickborne diseases, patients presenting with acute febrile illness with myalgia, headache, neutropenia, thrombocytopenia, and elevated hepatic aminotransferase levels are presumptively diagnosed as having human granulocytic anaplasmosis (HGA). Objective: To assign a cause for illness experienced by 2 case patients who were initially diagnosed with HGA but did not rapidly defervesce with doxycycline treatment and had no laboratory evidence of Anaplasma phagocytophilum infection. Design: Case report. Setting: 2 primary care medical centers in Massachusetts and New Jersey. Patients: 2 case patients acutely presenting with fever. Measurements: Identification of the causative agent by polymerase chain reaction and DNA sequencing. Results: Molecular diagnostic assays detected Borrelia miyamotoi in the peripheral blood of both patients. There was no evidence of infection with other tickborne pathogens commonly diagnosed in the referral areas. Limitation: One of the case patients may have had concurrent Lyme disease. Conclusion: The presence of B. miyamotoi DNA in the peripheral blood and the patients' eventual therapeutic response to doxycycline are consistent with the hypothesis that their illness was due to this newly recognized spirochete. Samples from tick-exposed patients acutely presenting with signs of HGA but who have a delayed response to doxycycline therapy or negative confirmatory test results for HGA should be analyzed carefully for evidence of B. miyamotoi infection.	Hawthorn Med Associates, New Bedford, MA USA; St Lukes Hosp, New Bedford, MA USA; Hunterdon Med Ctr, Flemington, NJ USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; IMUGEN, Norwood, MA USA; Tufts Univ, Cummings Sch Vet Med, North Grafton, MA 01536 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Tufts University	Telford, SR (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, 200 Westboro Rd, North Grafton, MA 01536 USA.	sam.telford@tufts.edu		Goethert, Heidi/0000-0001-5145-9047	National Institutes of Health [R41 AI 078631, R21 AI 082436]; Evelyn Lilly Lutz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI078631, R21AI082436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evelyn Lilly Lutz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant Support: By National Institutes of Health (R41 AI 078631 and R21 AI 082436) and the Evelyn Lilly Lutz Foundation.	Aguero-Rosenfeld ME, 2000, J CLIN MICROBIOL, V38, P635, DOI 10.1128/JCM.38.2.635-638.2000; Alhumaidan H, 2013, TRANSFUSION, V53, P181, DOI 10.1111/j.1537-2995.2012.03685.x; ANDERSON TR, 1955, AM J PATHOL, V31, P1083; Bakken Johan S., 2006, Morbidity and Mortality Weekly Report, V55, P1; BAKKEN JS, 1994, JAMA-J AM MED ASSOC, V272, P212, DOI 10.1001/jama.272.3.212; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; BERARDI VP, 1988, J INFECT DIS, V158, P754, DOI 10.1093/infdis/158.4.754; BRYCESON AD, 1970, Q J MED, V39, P129; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; El Khoury MY, 2013, CLIN INFECT DIS, V56, pE40, DOI 10.1093/cid/cis938; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Hilton E, 1997, J CLIN MICROBIOL, V35, P774, DOI 10.1128/JCM.35.3.774-776.1997; Horowitz HW, 2013, CLIN INFECT DIS, V56, P93, DOI 10.1093/cid/cis852; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Lodes MJ, 2001, J CLIN MICROBIOL, V39, P2466, DOI 10.1128/JCM.39.7.2466-2476.2001; Molloy PJ, 2000, CLIN INFECT DIS, V31, P42, DOI 10.1086/313920; Mun J, 2006, J MED ENTOMOL, V43, P120, DOI 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2; Ogden NH, 2011, APPL ENVIRON MICROB, V77, P3244, DOI 10.1128/AEM.02636-10; Paddock CD, 2011, CRITICAL NEEDS GAPS, P1; PERSING DH, 1990, J CLIN MICROBIOL, V28, P566, DOI 10.1128/JCM.28.3.566-572.1990; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Richter D, 2003, EMERG INFECT DIS, V9, P697; Sarksyan DS, 2012, TERAPEVT ARKH, V84, P34; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; STEERE AC, 1990, J INFECT DIS, V161, P1203, DOI 10.1093/infdis/161.6.1203; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavakoli NP, 2009, NEW ENGL J MED, V360, P2099, DOI 10.1056/NEJMoa0806326; Telford SR, 1998, EMERG INFECT DIS, V4, P132, DOI 10.3201/eid0401.980126; Thomas RJ, 2009, EXPERT REV ANTI-INFE, V7, P709, DOI [10.1586/eri.09.44, 10.1586/ERI.09.44]; Ullmann AJ, 2005, J MED ENTOMOL, V42, P1057, DOI 10.1603/0022-2585(2005)042[1057:TMAFDO]2.0.CO;2; Walls JJ, 1999, J CLIN MICROBIOL, V37, P2968, DOI 10.1128/JCM.37.9.2968-2973.1999; Young C, 2012, TRANSFUSION, V52, P1523, DOI 10.1111/j.1537-2995.2012.03612.x	34	104	106	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 2	2013	159	1					21	+		10.7326/0003-4819-159-1-201307020-00005	http://dx.doi.org/10.7326/0003-4819-159-1-201307020-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179JJ	23817701				2022-12-28	WOS:000321516200003
J	Goldberg, SE; Bradshaw, LE; Kearney, FC; Russell, C; Whittamore, KH; Foster, PER; Mamza, J; Gladman, JRF; Jones, RG; Lewis, SA; Porock, D; Harwood, RH				Goldberg, Sarah E.; Bradshaw, Lucy E.; Kearney, Fiona C.; Russell, Catherine; Whittamore, Kathy H.; Foster, Pippa E. R.; Mamza, Jil; Gladman, John R. F.; Jones, Rob G.; Lewis, Sarah A.; Porock, Davina; Harwood, Rowan H.		Med Crises Older People Study Grp	Care in specialist medical and mental health unit compared with standard care for older people with cognitive impairment admitted to general hospital: randomised controlled trial (NIHR TEAM trial)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEMENTIA; DELIRIUM; INTERVENTION; PREVALENCE; VALIDATION; EMERGENCY	Objective To develop and evaluate a best practice model of general hospital acute medical care for older people with cognitive impairment. Design Randomised controlled trial, adapted to take account of constraints imposed by a busy acute medical admission system. Setting Large acute general hospital in the United Kingdom. Participants 600 patients aged over 65 admitted for acute medical care, identified as "confused" on admission. Interventions Participants were randomised to a specialist medical and mental health unit, designed to deliver best practice care for people with delirium or dementia, or to standard care (acute geriatric or general medical wards). Features of the specialist unit included joint staffing by medical and mental health professionals; enhanced staff training in delirium, dementia, and person centred dementia care; provision of organised purposeful activity; environmental modification to meet the needs of those with cognitive impairment; delirium prevention; and a proactive and inclusive approach to family carers. Main outcome measures Primary outcome: number of days spent at home over the 90 days after randomisation. Secondary outcomes: structured non-participant observations to ascertain patients' experiences; satisfaction of family carers with hospital care. When possible, outcome assessment was blind to allocation. Results There was no significant difference in days spent at home between the specialist unit and standard care groups (median 51 v 45 days, 95% confidence interval for difference -12 to 24; P = 0.3). Median index hospital stay was 11 versus 11 days, mortality 22% versus 25% (-9% to 4%), readmission 32% versus 35% (-10% to 5%), and new admission to care home 20% versus 28% (-16% to 0) for the specialist unit and standard care groups, respectively. Patients returning home spent a median of 70.5 versus 71.0 days at home (-6.0 to 6.5). Patients on the specialist unit spent significantly more time with positive mood or engagement (79% v 68%, 2% to 20%; P = 0.03) and experienced more staff interactions that met emotional and psychological needs (median 4 v 1 per observation; P < 0.001). More family carers were satisfied with care (overall 91% v 83%, 2% to 15%; P = 0.004), and severe dissatisfaction was reduced (5% v 10%, -10% to 0%; P = 0.05). Conclusions Specialist care for people with delirium and dementia improved the experience of patients and satisfaction of carers, but there were no convincing benefits in health status or service use. Patients' experience and carers' satisfaction might be more appropriate measures of success for frail older people approaching the end of life.	[Goldberg, Sarah E.; Bradshaw, Lucy E.; Whittamore, Kathy H.; Foster, Pippa E. R.; Mamza, Jil; Gladman, John R. F.] Univ Nottingham, Div Rehabil & Ageing, Nottingham NG7 2UH, England; [Kearney, Fiona C.; Russell, Catherine; Harwood, Rowan H.] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham NG7 2UH, England; [Jones, Rob G.] Univ Nottingham, Div Psychiat, Nottingham NG7 2UH, England; [Lewis, Sarah A.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England; [Porock, Davina] SUNY Buffalo, Sch Nursing, Buffalo, NY 14260 USA	University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham; University of Nottingham; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Harwood, RH (corresponding author), Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham NG7 2UH, England.	rowan.harwood@nuh.nhs.uk	Mamza, JB/GPG-1650-2022; Gladman, John/M-7429-2015	Goldberg, Sarah/0000-0001-5109-798X; Porock, Davina/0000-0003-4161-9697; Avery, Anthony/0000-0001-7591-4438; Gladman, John/0000-0002-8506-7786; Elliott, Rachel Ann/0000-0002-3650-0168; Harwood, Rowan/0000-0002-4920-6718	UK National Institute for Health Research (NIHR) [RP-PG-0407-10147, PB-PG-0110-21229]; National Institute for Health Research [PB-PG-0110-21229, RP-PG-0407-10147] Funding Source: researchfish	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This independent research was funded by the UK National Institute for Health Research (NIHR) under its programme grants for applied research funding scheme (RP-PG-0407-10147) and research for patient benefit scheme (PB-PG-0110-21229). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health.	Alzheimer's Society, 2009, COUNT COST; [Anonymous], 2005, WHO CAR WINS; [Anonymous], 2012, NHS OUTC FRAM 2011 2; Bradshaw LE, 2013, INT J GERIATR PSYCH, V28, P681, DOI 10.1002/gps.3871; Brooker D., 2006, PERSON CTR DEMENTIA; Buis ML, 2010, S457156 BOST COLL DE; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Ellis G, 2011, BRIT MED J, V343, P1034, DOI DOI 10.1136/BMJ.D6553; Flaherty JH, 2010, J GERONTOL A-BIOL, V65, P1387, DOI 10.1093/gerona/glq136; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; George J, 2011, AGE AGEING, V40, P543, DOI 10.1093/ageing/afr080; Gladman J., 2012, CARE OLDER PEOPLE CO; Gladman JRF, 2010, MED CRISES OLDER PEO, V3; Goldberg D, 1998, USERS GUIDE GEN HLTH; Goldberg SE, 2012, AGE AGEING, V41, P80, DOI 10.1093/ageing/afr106; Harwood RH, 1995, MANUAL LONDON HANDIC; Harwood RH, 2010, MED CRISES OLDER PEO; Harwood RH, 2012, CLIN MED, V12, P35, DOI 10.7861/clinmedicine.12-1-35; Harwood RH, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-123; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Holmes J, 2000, PSYCHOL MED, V30, P921, DOI 10.1017/S0033291799002548; Holmes J, 2010, LIAISON MENTAL HLTH; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Niam DMWT, 2009, AUSTRALAS J AGEING, V28, P206, DOI 10.1111/j.1741-6612.2009.00394.x; Nichols Jeffrey N, 2002, J Palliat Med, V5, P181, DOI 10.1089/10966210252785187; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Royston P, 2009, STATA J, V9, P466, DOI 10.1177/1536867X0900900308; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Rudolph JL, 2010, J AM GERIATR SOC, V58, P1542, DOI 10.1111/j.1532-5415.2010.02924.x; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Slaets JPJ, 1997, PSYCHOSOM MED, V59, P585, DOI 10.1097/00006842-199711000-00005; Sloane PD, 2007, INT J GERIATR PSYCH, V22, P580, DOI 10.1002/gps.1721; Smith SC, 2005, HEALTH TECHNOL ASSES, V9, P1; Tadd W, DIGNITY PRACTICE EXP; Tong TG, 2012, ANN INTERN MED, V156, P848; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Wade D T, 1988, Int Disabil Stud, V10, P64; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Worksafe BC, 2010, DEMENTIA UNDERSTANDI; ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203	41	72	72	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2013	347								f4132	10.1136/bmj.f4132	http://dx.doi.org/10.1136/bmj.f4132			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180CL	23819964	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000321570400003
J	Elert, E				Elert, Emily			LIVING WITH LEUKAEMIA	NATURE			English	Editorial Material																			0	13	15	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					S2	S3		10.1038/498S2a	http://dx.doi.org/10.1038/498S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171LH	23803947	Bronze			2022-12-28	WOS:000320929400002
J	Giessibl, FJ				Giessibl, Franz J.			Seeing the Reaction	SCIENCE			English	Editorial Material							ATOMIC-FORCE MICROSCOPY; RESOLUTION		Univ Regensburg, Dept Phys, D-93053 Regensburg, Germany	University of Regensburg	Giessibl, FJ (corresponding author), Univ Regensburg, Dept Phys, D-93053 Regensburg, Germany.	franz.giessibl@physik.uni-regensburg.de	Giessibl, Franz J/K-8022-2013	Giessibl, Franz J/0000-0002-5585-1326				Binnig G, 1999, REV MOD PHYS, V71, pS324, DOI 10.1103/RevModPhys.71.S324; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; de Oteyza DG, 2013, SCIENCE, V340, P1434, DOI 10.1126/science.1238187; Giessibl FJ, 2005, MATER TODAY, V8, P32, DOI 10.1016/S1369-7021(05)00844-8; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Gross L, 2010, NAT CHEM, V2, P821, DOI [10.1038/NCHEM.765, 10.1038/nchem.765]; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Mohn F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266102; Moll N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125020; Morita S, 2009, NANOSCI TECHNOL, V2, P1, DOI 10.1007/978-3-642-01495-6_1; Pavlicek N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.086101; Smalley RE, 2001, SCI AM, V285, P76, DOI 10.1038/scientificamerican0901-76; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530; Sweetman A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.136101; Welker J, 2012, SCIENCE, V336, P444, DOI 10.1126/science.1219850	15	0	0	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1417	1418		10.1126/science.1239961	http://dx.doi.org/10.1126/science.1239961			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23788791	Green Published			2022-12-28	WOS:000320647000031
J	Burre, J; Vivona, S; Diao, JJ; Sharma, M; Brunger, AT; Sudhof, TC				Burre, Jacqueline; Vivona, Sandro; Diao, Jiajie; Sharma, Manu; Brunger, Axel T.; Suedhof, Thomas C.			Properties of native brain alpha-synuclein	NATURE			English	Letter							PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; RANDOM-COIL; STABILIZATION; BINDING; PROTEIN; HELIX; NACP		[Burre, Jacqueline; Vivona, Sandro; Diao, Jiajie; Sharma, Manu; Brunger, Axel T.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Vivona, Sandro; Diao, Jiajie; Brunger, Axel T.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Vivona, Sandro; Diao, Jiajie; Brunger, Axel T.] Stanford Univ, Sch ofMedicine, Dept Photon Sci, Stanford, CA 94305 USA; [Vivona, Sandro; Diao, Jiajie; Brunger, Axel T.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Brunger, Axel T.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Burre, J (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	tcs1@stanford.edu	Diao, Jiajie/A-3425-2008	Diao, Jiajie/0000-0003-4288-3203; Brunger, Axel/0000-0001-5121-2036	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R37 MH063105] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063105] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Devine MJ, 2011, MOVEMENT DISORD, V26, P2160, DOI 10.1002/mds.23948; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Johnson H, 2010, METHODS MOL BIOL, V658, P93, DOI 10.1007/978-1-60761-780-8_5; Kim J, 1997, MOL CELLS, V7, P78; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Uversky VN, 2001, J BIOL CHEM, V276, P43495, DOI 10.1074/jbc.C100551200; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n	14	217	221	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					E4	E6		10.1038/nature12125	http://dx.doi.org/10.1038/nature12125			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23765500	Green Accepted			2022-12-28	WOS:000320283400001
J	Halfdanarson, TR; Pannala, R				Halfdanarson, Thorvardur R.; Pannala, Rahul			Incretins and risk of neoplasia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PANCREATITIS; CANCER; THERAPIES; TUMORS		[Halfdanarson, Thorvardur R.] Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ 85259 USA; [Pannala, Rahul] Mayo Clin, Div Gastroenterol, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix	Halfdanarson, TR (corresponding author), Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ 85259 USA.	thorvardur.halfdanarson@mayo.edu	Halfdanarson, Thorvardur/AAO-8706-2020	Halfdanarson, Thorvardur/0000-0001-8460-1257				[Anonymous], 2013, QUARTER WATCH; Busch SJ, 2013, DIABETES OBES METAB, V15, P72, DOI 10.1111/j.1463-1326.2012.01678.x; Butler AE, 2013, DIABETES IN PRESS; Cohen D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3680; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Engel SS, 2013, DIABETES THER; Gier B, 2012, DIABETES, V61, P1250, DOI 10.2337/db11-1109; Halfdanarson TR, 2008, ANN ONCOL, V19, P1727, DOI 10.1093/annonc/mdn351; Halfdanarson TR, 2012, J CLIN ONCOL, V30; KIMURA W, 1991, DIGEST DIS SCI, V36, P933, DOI 10.1007/BF01297144; Lando HM, 2012, ENDOCR PRACT, V18, P472, DOI 10.4158/EP11290.OR; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Spranger J, 2011, GASTROENTEROLOGY, V141, P20, DOI 10.1053/j.gastro.2011.05.019; Yu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021255	14	7	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2013	346								f3750	10.1136/bmj.f3750	http://dx.doi.org/10.1136/bmj.f3750			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VK	23751908				2022-12-28	WOS:000320586700012
J	Sarkar, SK; Bumb, A; Mill, M; Neuman, KC				Sarkar, Susanta K.; Bumb, Ambika; Mills, Maria; Neuman, Keir C.			SnapShot: Single-Molecule Fluorescence	CELL			English	Editorial Material									NHLBI, NIH, Lab Mol Biophys, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sarkar, SK (corresponding author), NHLBI, NIH, Lab Mol Biophys, Bethesda, MD USA.		Neuman, Keir C./F-7400-2011	Neuman, Keir C./0000-0002-0863-5671; Mills, Kathleen/0000-0003-3840-0248	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006087] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Axelrod D, 2013, BIOPHYS J, V104, P1401, DOI 10.1016/j.bpj.2013.02.044; Benitez JJ, 2010, METHOD ENZYMOL, V472, P41, DOI 10.1016/S0076-6879(10)72016-4; Chao J, 2013, NAT METHODS, V10, P335, DOI [10.1038/NMETH.2396, 10.1038/nmeth.2396]; FORLEY JN, 2001, BIOL SINGLE MOL LEVE, V1; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Kim H, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/1/016601; MORANMIRABAL JM, 2008, BIOCHENISTREY, V46, P11; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; Walter NG, 2008, NAT METHODS, V5, P475, DOI 10.1038/nmeth.1215; Xia T, 2013, ANNU REV PHYS CHEM, V64, P459, DOI 10.1146/annurev-physchem-040412-110127	10	5	5	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1408	+		10.1016/j.cell.2013.05.024	http://dx.doi.org/10.1016/j.cell.2013.05.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746850	Bronze			2022-12-28	WOS:000319979200024
J	Tian, X; Azpurua, J; Hine, C; Vaidya, A; Myakishev-Rempel, M; Ablaeva, J; Mao, ZY; Nevo, E; Gorbunova, V; Seluanov, A				Tian, Xiao; Azpurua, Jorge; Hine, Christopher; Vaidya, Amita; Myakishev-Rempel, Max; Ablaeva, Julia; Mao, Zhiyong; Nevo, Eviatar; Gorbunova, Vera; Seluanov, Andrei			High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat	NATURE			English	Article							CONTACT INHIBITION; CD44; TRANSFORMATION; INSIGHTS; GROWTH; CELLS	The naked mole rat (Heterocephalus glaber) displays exceptional longevity, with a maximum lifespan exceeding 30 years(1-3). This is the longest reported lifespan for a rodent species and is especially striking considering the small body mass of the naked mole rat. In comparison, a similarly sized house mouse has a maximum lifespan of 4 years(4,5). In addition to their longevity, naked mole rats show an unusual resistance to cancer. Multi-year observations of large naked mole-rat colonies did not detect a single incidence of cancer(2,6). Here we identify a mechanism responsible for the naked mole rat's cancer resistance. We found that naked mole-rat fibroblasts secrete extremely high-molecular-mass hyaluronan (HA), which is over five times larger than human or mouse HA. This high-molecular-mass HA accumulates abundantly in naked mole-rat tissues owing to the decreased activity of HA-degrading enzymes and a unique sequence of hyaluronan synthase 2 (HAS2). Furthermore, the naked mole-rat cells are more sensitive to HA signalling, as they have a higher affinity to HA compared with mouse or human cells. Perturbation of the signalling pathways sufficient for malignant transformation of mouse fibroblasts fails to transform naked mole-rat cells. However, once high molecular-mass HA is removed by either knocking down HAS2 or overexpressing the HA-degrading enzyme, HYAL2, naked mole-rat cells become susceptible to malignant transformation and readily form tumours in mice. We speculate that naked mole rats have evolved a higher concentration of HA in the skin to provide skin elasticity needed for life in underground tunnels. This trait may have then been co-opted to provide cancer resistance and longevity to this species.	[Tian, Xiao; Azpurua, Jorge; Hine, Christopher; Vaidya, Amita; Myakishev-Rempel, Max; Ablaeva, Julia; Mao, Zhiyong; Gorbunova, Vera; Seluanov, Andrei] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Mao, Zhiyong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31905 Haifa, Israel	University of Rochester; Tongji University; University of Haifa	Gorbunova, V (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	vera.gorbunova@rochester.edu; andrei.seluanov@rochester.edu	Tian, Xiao/E-3998-2017; Myakishev-Rempel, Max/E-9696-2014	Tian, Xiao/0000-0001-5300-3596; Hine, Christopher/0000-0003-1926-7939; Mao, Zhiyong/0000-0002-5298-1918; Myakishev-Rempel, Max/0000-0002-7893-2049; Seluanov, Andrei/0000-0003-3400-538X; Gorbunova, Vera/0000-0001-8979-0333	US National Institutes of Health; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [R01AG031227, R01AG027237] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the grants from the US National Institutes of Health and Ellison Medical Foundation to V. G. We thank M. Van Meter for critically reading the manuscript.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Buffenstein Rochelle, 2002, Sci Aging Knowledge Environ, V2002, ppe7, DOI 10.1126/sageke.2002.21.pe7; de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017; Delaney M. A., 2013, VET PATHOL; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; HOLMES MWA, 1988, BIOCHEM J, V250, P435, DOI 10.1042/bj2500435; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945	21	460	485	6	351	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					346	U122		10.1038/nature12234	http://dx.doi.org/10.1038/nature12234			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23783513	Green Accepted			2022-12-28	WOS:000321910700038
J	Hull, SC; Colloca, L; Avins, A; Gordon, NP; Somkin, CP; Kaptchuk, TJ; Miller, FG				Hull, Sara Chandros; Colloca, Luana; Avins, Andrew; Gordon, Nancy P.; Somkin, Carol P.; Kaptchuk, Ted J.; Miller, Franklin G.			Patients' attitudes about the use of placebo treatments: telephone survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUESTIONNAIRE SURVEY; CLINICAL-PRACTICE; INTERVENTIONS; PHYSICIANS; ETHICS	Objective To examine the attitudes of US patients about the use of placebo treatments in medical care. Design One time telephone surveys. Setting Northern California. Participants 853 members of Kaiser Permanente Northern California, aged 18-75, who had been seen by a primary care provider for a chronic health problem at least once in the prior six months. Results The response rate was 53.4% (853/1598) of all members who were eligible to participate, and 73.2% (853/1165) of all who could be reached by telephone. Most respondents (50-84%) judged it acceptable for doctors to recommend placebo treatments under conditions that varied according to doctors' level of certainty about the benefits and safety of the treatment, the purpose of the treatment, and the transparency with which the treatment was described to patients. Only 21.9% of respondents judged that it was never acceptable for doctors to recommend placebo treatments. Respondents valued honesty by physicians regarding the use of placebos and believed that non-transparent use could undermine the relationship between patients and physicians. Conclusions Most patients in this survey seemed favorable to the idea of placebo treatments and valued honesty and transparency in this context, suggesting that physicians should consider engaging with patients to discuss their values and attitudes about the appropriateness of using treatments aimed at promoting placebo responses in the context of clinical decision making.	[Hull, Sara Chandros] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Hull, Sara Chandros; Colloca, Luana; Miller, Franklin G.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Colloca, Luana; Miller, Franklin G.] NIMH, NIH, Bethesda, MD 20892 USA; [Colloca, Luana] NIH, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA; [Avins, Andrew; Gordon, Nancy P.; Somkin, Carol P.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Kaptchuk, Ted J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Program Placebo Studies, Boston, MA 02215 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; Kaiser Permanente; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Hull, SC (corresponding author), NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA.	shull@mail.nih.gov	Colloca, Luana/S-1389-2018	Colloca, Luana/0000-0002-6503-4709	National Center for Complementary and Alternative Medicine; Clinical Center; National Human Genome Research Institute, National Institutes of Health; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [ZIAAT000019] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIDHG200347, P20HG007243] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Clinical Center; National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the National Center for Complementary and Alternative Medicine, the Clinical Center, and the intramural research program of the National Human Genome Research Institute, National Institutes of Health. The opinions expressed are those of the authors and do not necessarily reflect the policies or views of the National Institutes of Health or the Department of Health and Human Services. The study funders played no role in the study design; collection, analysis, and interpretation of data; writing of the report; or the decision to submit the article for publication. Researchers were independent of influence from study funders.	American Medical Association, 2007, AM MED ASS COD MED E; Berthelot JM, 2001, JOINT BONE SPINE, V68, P65, DOI 10.1016/S1297-319X(00)00225-6; Bishop FL, 2012, SOC SCI MED, V8, P1138; Boozang Kathleen M, 2002, Fla Law Rev, V54, P687; BRODY H, 1982, ANN INTERN MED, V97, P112, DOI 10.7326/0003-4819-97-1-112; Brody H, 2012, J GEN INTERN MED, V27, P739, DOI 10.1007/s11606-011-1977-1; Chen GF, 2009, NEW ZEAL MED J, V122, P35; Colloca L, 2011, PHILOS T R SOC B, V366, P1922, DOI 10.1098/rstb.2010.0399; Fassler M, 2011, BRIT J GEN PRACT, V61, P101, DOI 10.3399/bjgp11X556209; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Gordon NP, 2012, SIMILARITY ADULT KAI; Hrobjartsson A, 2003, EVAL HEALTH PROF, V26, P153, DOI 10.1177/0163278703026002002; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kermen R, 2010, FAM MED, V42, P636; Kolber AJ., 2007, YALE LAW POLICY REV, V26; Louhiala P, 2012, J MED ETHICS, V38, P403, DOI 10.1136/medethics-2011-100420; LYNOE N, 1993, SOC SCI MED, V36, P767, DOI 10.1016/0277-9536(93)90037-5; Miller FG, 2009, AM J BIOETHICS, V9, P39, DOI 10.1080/15265160903316263; Nitzan U, 2004, BMJ-BRIT MED J, V329, P944, DOI 10.1136/bmj.38236.646678.55; ONEILL O, 1984, J MED ETHICS, V10, P173, DOI 10.1136/jme.10.4.173; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938	22	63	63	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2013	347								f3757	10.1136/bmj.f3757	http://dx.doi.org/10.1136/bmj.f3757			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180CL	23819963	Green Published, hybrid			2022-12-28	WOS:000321570400002
J	Malaguarnera, M; Drago, F; Malaguarnera, G; Volti, GL; Salomone, S; Caraci, F; Galvano, F; Vacante, M; Bucolo, C; Malaguarnera, M				Malaguarnera, Michele; Drago, Filippo; Malaguarnera, Giulia; Volti, Giovanni Li; Salomone, Salvatore; Caraci, Filippo; Galvano, Fabio; Vacante, Marco; Bucolo, Claudio; Malaguarnera, Mariano			Metal fume fever	LANCET			English	Editorial Material							EXPOSURE; CADMIUM		[Malaguarnera, Michele; Drago, Filippo; Malaguarnera, Giulia; Salomone, Salvatore; Bucolo, Claudio] Univ Catania, Osped Cannizzaro, Dept Clin & Mol Biomed, Sect Pharmacol & Biochem, I-95123 Catania, Italy; [Volti, Giovanni Li; Galvano, Fabio] Univ Catania, Osped Cannizzaro, Dept Biol Chem Med Chem & Mol Biol, I-95123 Catania, Italy; [Caraci, Filippo] Univ Catania, Osped Cannizzaro, Dept Educ Sci, I-95123 Catania, Italy; [Vacante, Marco; Malaguarnera, Mariano] Univ Catania, Osped Cannizzaro, Dept Internal Med & Syst Dis, I-95123 Catania, Italy	University of Catania; University of Catania; University of Catania; University of Catania	Malaguarnera, G (corresponding author), Univ Catania, Int PhD Programme Neuropharmacol, Via S Sofi 78, I-95123 Catania, Italy.	giulia.malaguarnera@live.it	Malaguarnera, Giulia/ABD-4968-2020; Vacante, Marco/S-4377-2019; Drago, Francesco/H-7563-2019; Caraci, Filippo/K-2262-2016; Galvano, Fabio/F-8122-2010; Volti, Giovanni Li/A-2435-2008; Drago, Filippo/AAC-5090-2022; Malaguarnera, Michele/A-1376-2019; Drago, Filippo/K-5619-2018	Malaguarnera, Giulia/0000-0003-3655-4307; Caraci, Filippo/0000-0002-9867-6054; Galvano, Fabio/0000-0003-0644-0755; Volti, Giovanni Li/0000-0002-8678-2183; Malaguarnera, Michele/0000-0002-7145-6377; Drago, Filippo/0000-0003-2887-5223; Bucolo, Claudio/0000-0002-4879-4140; Salomone, Salvatore/0000-0001-5307-6103; Vacante, Marco/0000-0002-6815-5012; MALAGUARNERA, Lucia/0000-0002-5171-7963				Di Rosa M, 2011, IMMUNOLOGY, V134, P123, DOI 10.1111/j.1365-2567.2011.03482.x; HARRIS DK, 1951, LANCET, V2, P1008; LYLE WH, 1976, LANCET, V1, P1324; Nawrot T, 2006, LANCET ONCOL, V7, P119, DOI 10.1016/S1470-2045(06)70545-9; Uchida H, 2010, TOXICOL PATHOL, V38, P730, DOI 10.1177/0192623310374328; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	6	6	6	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 29	2013	381	9885					2298	2298		10.1016/S0140-6736(13)60689-3	http://dx.doi.org/10.1016/S0140-6736(13)60689-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173SU	23809563				2022-12-28	WOS:000321100300035
J	Menon, S; Manning, BD				Menon, Suchithra; Manning, Brendan D.			CELL SIGNALLING Nutrient sensing lost in cancer	NATURE			English	Editorial Material							DEPRIVATION; COMPLEX; MTORC1		[Menon, Suchithra; Manning, Brendan D.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Menon, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956				Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Li F, 2004, CANCER RES, V64, P6438, DOI 10.1158/0008-5472.CAN-03-3869; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008	9	8	9	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					444	445		10.1038/498444a	http://dx.doi.org/10.1038/498444a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803840				2022-12-28	WOS:000320929400041
J	Moyer, MW				Moyer, Melinda Wenner			CELL BANKS Life blood	NATURE			English	Editorial Material							UMBILICAL-CORD BLOOD; TRANSPLANTATION											Ballen KK, 2008, BIOL BLOOD MARROW TR, V14, P356, DOI 10.1016/j.bbmt.2007.11.005; Brunstein C. G., BLOOD, V116, P4693; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Kaimal AJ, 2009, OBSTET GYNECOL, V114, P848, DOI 10.1097/AOG.0b013e3181b8fc0d; Perales MA, 2012, BLOOD, V120, P4882, DOI 10.1182/blood-2012-06-437236; Smith AR, 2009, BRIT J HAEMATOL, V147, P246, DOI 10.1111/j.1365-2141.2009.07828.x	6	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					S16	S16		10.1038/498S16a	http://dx.doi.org/10.1038/498S16a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803945	Bronze			2022-12-28	WOS:000320929400009
J	Joynt, KE; Gawande, AA; Orav, EJ; Jha, AK				Joynt, Karen E.; Gawande, Atul A.; Orav, E. John; Jha, Ashish K.			Contribution of Preventable Acute Care Spending to Total Spending for High-Cost Medicare Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY-DEPARTMENT VISITS; SENSITIVE CONDITIONS; HEALTH-CARE; HOSPITALIZATIONS; BENEFICIARIES; PROGRAMS	Importance A small proportion of patients account for the majority of US health care spending, and understanding patterns of spending among this cohort is critical to reducing health care costs. The degree to which preventable acute care services account for spending among these patients is largely unknown. Objective To quantify preventable acute care services among high-cost Medicare patients. Design, Setting, and Participants We summed standardized costs for each inpatient and outpatient service contained in standard 5% Medicare files from 2009 and 2010 across the year for each patient in our sample, and defined those in the top decile of spending in 2010 as high-cost patients and those in the top decile in both 2009 and 2010 as persistently high-cost patients. We used standard algorithms to identify potentially preventable emergency department (ED) visits and acute care inpatient hospitalizations. A total of 1 114 469 Medicare fee-for-service beneficiaries aged 65 years or older were included. Main Outcomes and Measures Proportion of acute care hospital and ED costs deemed preventable among high-cost patients. Results The 10% of Medicare patients in the high-cost group were older, more often male, more often black, and had more comorbid illnesses than non-high-cost patients. In 2010, 32.9% (95% CI, 32.9%-32.9%) of total ED costs were incurred by high-cost patients. Based on validated algorithms, 41.0% (95% CI, 40.9%-41.0%) of these costs among high-cost patients were potentially preventable compared with 42.6% (95% CI, 42.6%-42.6%) among non-high-cost patients. High-cost patients accounted for 79.0% (95% CI, 79.0%-79.0%) of inpatient costs, 9.6% (95% CI, 9.6%-9.6%) of which were due to preventable hospitalizations; 16.8% (95% CI, 16.8%-16.8%) of costs within the non-high-cost group were due to preventable hospitalizations. Comparable proportions of ED spending (43.3%; 95% CI, 43.3%-43.3%) and inpatient spending (13.5%; 95% CI, 13.5%-13.5%) were preventable among persistently high-cost patients. Regions with high primary care physician supply had higher preventable spending for high-cost patients. Conclusions and Relevance Among a sample of patients in the top decile of Medicare spending in 2010, only a small percentage of costs appeared to be related to preventable ED visits and hospitalizations. The ability to lower costs for these patients through better outpatient care may be limited.	[Joynt, Karen E.; Gawande, Atul A.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Orav, E. John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Orav, E. John; Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Gawande, Atul A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Gawande, Atul A.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Joynt, KE (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org		Gawande, Atul/0000-0002-1824-9176	Rx Foundation; West Wireless Foundation	Rx Foundation; West Wireless Foundation	This study was funded by the Rx Foundation and the West Wireless Foundation.	Agency for Healthcare Research and Quality, 2011, PREV QUAL IND OV; Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; Ballard DW, 2010, MED CARE, V48, P58, DOI 10.1097/MLR.0b013e3181bd49ad; Basu J, 2002, MED CARE, V40, P1260, DOI 10.1097/00005650-200212000-00013; Bhattacharya J, 2010, RES FINDINGS EC AGIN, P387; Billings J, 1996, HEALTH AFFAIR, V15, P239, DOI 10.1377/hlthaff.15.3.239; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1; Brown RS, 2012, HEALTH AFFAIR, V31, P1156, DOI 10.1377/hlthaff.2012.0393; Cebul RD, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.4.93; Congressional Budget Office, 2012, LESS MED DEM PROJ DI; Congressional Budget Office,, 2005, HIGH COST MED BEN; Dartmouth Institute for Health Policy and Clinical Practice, 2012, DARTM ATL HLTH CAR; Garber AM, 1998, NBER FR HLTH POL RES, V1, P153; Miller DC, 2011, HEALTH AFFAIR, V30, P2107, DOI 10.1377/hlthaff.2011.0783; Niefeld MR, 2003, DIABETES CARE, V26, P1344, DOI 10.2337/diacare.26.5.1344; NYU Wagner, 2000, NYU ED ALG BACKGR; Oster A, 2003, MED CARE, V41, P198, DOI 10.1097/00005650-200302000-00002; Riley GF, 2007, HEALTH AFFAIR, V26, P808, DOI 10.1377/hlthaff.26.3.808; Smulowitz PB, 2011, ANN EMERG MED, V58, P225, DOI 10.1016/j.annemergmed.2011.02.020; Wharam JF, 2007, JAMA-J AM MED ASSOC, V297, P1093, DOI 10.1001/jama.297.10.1093	21	151	151	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2572	2578		10.1001/jama.2013.7103	http://dx.doi.org/10.1001/jama.2013.7103			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	170KD	23797716	Green Published, Bronze			2022-12-28	WOS:000320848100027
J	Sarri, G; Westby, M; Bermingham, S; Hill-Cawthorne, G; Thomas, H				Sarri, Grammati; Westby, Maggie; Bermingham, Sarah; Hill-Cawthorne, Grant; Thomas, Howard		Guideline Dev Grp	GUIDELINES Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VIRUS INFECTION; DISEASE		[Sarri, Grammati; Westby, Maggie; Bermingham, Sarah] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Hill-Cawthorne, Grant] Univ Sydney, Sydney Emerging Infect & Biosecur Inst, Sydney, NSW 2006, Australia; [Hill-Cawthorne, Grant] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Thomas, Howard] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Hepatol & Gastroenterol, London SW7 2AZ, England; [Thomas, Howard] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Hepatol & Gastroenterol, Guideline Dev Grp, London SW7 2AZ, England	Royal College of Physicians; University of Sydney; University of Sydney; Imperial College London; Imperial College London	Sarri, G (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	Grammati.sarri@rcplondon.ac.uk	Westby, Maggie/GWZ-2119-2022; Westby, Maggie/O-8794-2014; Hill-Cawthorne, Grant/B-8039-2009	Westby, Maggie/0000-0003-4273-3942; ALA, AFTAB/0000-0001-6257-3160; Hill-Cawthorne, Grant/0000-0002-3828-5473				Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Hepatitis B Foundation UK, 2008, RIS CURV CHRON HEP B; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; National Institute for Health and Care Excellence, 2012, NAT I HLTH CAR EXC P; National Institute for Health and Care Excellence, 2013, NAT I HLTH CAR EXC C; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010	6	46	61	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2013	346								f3893	10.1136/bmj.f3893	http://dx.doi.org/10.1136/bmj.f3893			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QL	23804177				2022-12-28	WOS:000321246200010
J	Chang, HC; Guarente, L				Chang, Hung-Chun; Guarente, Leonard			SIRT1 Mediates Central Circadian Control in the SCN by a Mechanism that Decays with Aging	CELL			English	Article							REV-ERB-ALPHA; WHEEL-RUNNING ACTIVITY; CALORIE RESTRICTION; DEACETYLASE SIRT1; GENE-EXPRESSION; CLOCK; MICE; METABOLISM; MELATONIN; BRAIN	SIRT1 is a NAD(+)-dependent protein deacetylase that governs many physiological pathways, including circadian rhythm in peripheral tissues. Here, we show that SIRT1 in the brain governs central circadian control by activating the transcription of the two major circadian regulators, BMAL1 and CLOCK. This activation comprises an amplifying circadian loop involving SIRT1, PGC-1 alpha, and Nampt. In aged wildtype mice, SIRT1 levels in the suprachiasmatic nucleus are decreased, as are those of BMAL1 and PER2, giving rise to a longer intrinsic period, a more disrupted activity pattern, and an inability to adapt to changes in the light entrainment schedule. Young mice lacking brain SIRT1 phenocopy these aging-dependent circadian changes, whereas mice that overexpress SIRT1 in the brain are protected from the effects of aging. Our findings indicate that SIRT1 activates the central pacemaker to maintain robust circadian control in young animals, and a decay in this activity may play an important role in aging.	[Chang, Hung-Chun; Guarente, Leonard] MIT, Dept Biol, Glenn Lab Sci Aging, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, Glenn Lab Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu		zhang, hong jun/0000-0003-0030-8323	National Institutes of Health; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING [R01AG015339, R01AG011119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Puigserver and C.-C. Lee for Pgc-1 alpha constructs and PER2 antibody, respectively. We also thank E. Bell, E. Williams, and Y.-C. Tang for reagents and comments on experiments and members in the Guarente laboratory for discussions. This work was supported by grants from the National Institutes of Health and the Glenn Foundation for Medical Research to L.G. H.-C.C. is an Ellison Medical Foundation Fellow of the Life Science Research Foundation. L.G. consults for Sirtris (a GlaxoSmithKline company).	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P3333, DOI 10.1073/pnas.1214266110; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Chang HM, 2009, J PINEAL RES, V47, P211, DOI 10.1111/j.1600-079X.2009.00704.x; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Grace MS, 1999, VISUAL NEUROSCI, V16, P909, DOI 10.1017/S0952523899165106; Guarente L, 2012, NAT REV MOL CELL BIO, V13, P207, DOI 10.1038/nrm3308; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Libert S, 2012, AGING CELL, V11, P794, DOI 10.1111/j.1474-9726.2012.00846.x; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Miki T, 2012, EMBO J, V31, P1427, DOI 10.1038/emboj.2012.1; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; PIERPAOLI W, 1994, P NATL ACAD SCI USA, V91, P787, DOI 10.1073/pnas.91.2.787; Pifferi F, 2011, J BIOL RHYTHM, V26, P271, DOI 10.1177/0748730411401788; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SACK RL, 1986, J PINEAL RES, V3, P379, DOI 10.1111/j.1600-079X.1986.tb00760.x; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; Sujino M, 2003, CURR BIOL, V13, P664, DOI 10.1016/S0960-9822(03)00222-7; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wyse CA, 2010, BRAIN RES, V1337, P21, DOI 10.1016/j.brainres.2010.03.113	54	380	400	3	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1448	1460		10.1016/j.cell.2013.05.027	http://dx.doi.org/10.1016/j.cell.2013.05.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791176	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000320722000014
J	Giordano, F; Saheki, Y; Idevall-Hagren, O; Colombo, SF; Pirruccello, M; Milosevic, I; Gracheva, EO; Bagriantsev, SN; Borgese, N; De Camilli, P				Giordano, Francesca; Saheki, Yasunori; Idevall-Hagren, Olof; Colombo, Sara Francesca; Pirruccello, Michelle; Milosevic, Ira; Gracheva, Elena O.; Bagriantsev, Sviatoslav N.; Borgese, Nica; De Camilli, Pietro			PI(4,5) P-2-Dependent and Ca2+-Regulated ER-PM Interactions Mediated by the Extended Synaptotagmins	CELL			English	Article							ENDOPLASMIC-RETICULUM; PHOSPHOLIPID-BINDING; MEMBRANE-PROTEINS; CONTACT SITES; CA2+ SENSOR; STORE; DOMAINS; COMPLEX; STIM1; FORM	Most available information on endoplasmic reticulum (ER)-plasma membrane (PM) contacts in cells of higher eukaryotes concerns proteins implicated in the regulation of Ca2+ entry. However, growing evidence suggests that such contacts play more general roles in cell physiology, pointing to the existence of additionally ubiquitously expressed ER-PM tethers. Here, we show that the three extended synaptotagmins (E-Syts) are ER proteins that participate in such tethering function via C2 domain-dependent interactions with the PM that require PI(4,5) P-2 in the case of E-Syt2 and E-Syt3 and also elevation of cytosolic Ca2+ in the case of E-Syt1. As they form heteromeric complexes, the E-Syts confer cytosolic Ca2+ regulation to ER-PM contact formation. E-Syts-dependent contacts, however, are not required for store-operated Ca2+ entry. Thus, the ER-PM tethering function of the E-Syts (tricalbins in yeast) mediates the formation of ER-PM contacts sites, which are functionally distinct from those mediated by STIM1 and Orai1.	[Giordano, Francesca; Saheki, Yasunori; Idevall-Hagren, Olof; Pirruccello, Michelle; Milosevic, Ira; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Gracheva, Elena O.; Bagriantsev, Sviatoslav N.] Yale Univ, Sch Med, Dept Physiol, New Haven, CT 06510 USA; [Giordano, Francesca; Saheki, Yasunori; Idevall-Hagren, Olof; Pirruccello, Michelle; Milosevic, Ira; Gracheva, Elena O.; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; [Giordano, Francesca; Saheki, Yasunori; Idevall-Hagren, Olof; Pirruccello, Michelle; Milosevic, Ira; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Colombo, Sara Francesca; Borgese, Nica] Univ Milan, CNR, Inst Neurosci, I-20129 Milan, Italy; [Colombo, Sara Francesca; Borgese, Nica] Univ Milan, BIOMETRA Dept, I-20129 Milan, Italy; [Borgese, Nica] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; Magna Graecia University of Catanzaro	De Camilli, P (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Cruz e Silva, Odete/AAH-5595-2020; Borgese, Nica/GWZ-8895-2022; Saheki, Yasunori/D-5430-2016; Giordano, Francesca/E-4039-2017	Borgese, Nica/0000-0002-7537-3974; Saheki, Yasunori/0000-0002-1229-6668; Giordano, Francesca/0000-0002-5942-1753; GIORDANO, Francesca/0000-0002-7621-1969; Milosevic, Ira/0000-0001-6440-3763; COLOMBO, SARA FRANCESCA/0000-0001-9714-3961; Gracheva, Elena O/0000-0002-0846-3427; Pirruccello-Straub, Michelle/0000-0002-7996-857X; Bagriantsev, Sviatoslav/0000-0002-6661-3403	NIH [NS36251, DK082700, DK45735, DA018343]; Simons Foundation; Italian Association for Cancer Research [IG9040]; Uehara Memorial Foundation; Japan Society for Promotion and Science; Swedish Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK082700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for Promotion and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Scott Emr (Cornell University) for his critical input in this work with discussion of unpublished data. We also thank Frank Wilson for outstanding technical support; Abel Alcazar-Roman for discussion and help; Heather Czapla, Yumei Wu, Morven Graham, Xinran Liu, and Stacy Wilson for help with microscopy experiments; Nicholas Ingolia (Carnegie Institution for Science) for consultation; and Thomas Sudhof (Stanford University), Richard S. Lewis (Stanford University), Volker Haucke (Leibniz Institute, Berlin), Erik Snapp (Albert Einstein College of Medicine), Isabelle Derre, and Herve Agaisse (Yale University) for the generous gift of reagents, including unpublished reagents. We also acknowledge the Yale Center for Cellular and Molecular Imaging and Yale Center for Genomics and Proteomics. This work was supported in part by grants from the NIH (NS36251, DK082700, DK45735, and DA018343) and the Simons Foundation to P.D.C., the Italian Association for Cancer Research (AIRC grant IG9040) to N.B., fellowships from the Uehara Memorial Foundation and the Japan Society for Promotion and Science to Y.S., and the Swedish Research Council to O.I.-H.	Anderie I, 2007, EXP CELL RES, V313, P3189, DOI 10.1016/j.yexcr.2007.05.025; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Creutz CE, 2004, CELL MOL LIFE SCI, V61, P1208, DOI 10.1007/s00018-004-4029-8; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; Giordano F, 2009, HUM MOL GENET, V18, P4530, DOI 10.1093/hmg/ddp415; Groer GJ, 2008, FEBS LETT, V582, P3941, DOI 10.1016/j.febslet.2008.10.038; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Jean S, 2010, DEV CELL, V19, P426, DOI 10.1016/j.devcel.2010.08.007; Kida Y, 2005, EMBO J, V24, P3202, DOI 10.1038/sj.emboj.7600788; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lee I, 2006, FASEB J, V20, P202, DOI 10.1096/fj.05-4581hyp; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Michel AH, 2012, BIOCHEM SOC T, V40, P445, DOI 10.1042/BST20110758; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROSENBLUTH J, 1962, J CELL BIOL, V13, P405, DOI 10.1083/jcb.13.3.405; Schikorski T, 2007, J NEUROSCI METH, V165, P210, DOI 10.1016/j.jneumeth.2007.06.004; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shen WW, 2011, BIOL CELL, V103, P365, DOI 10.1042/BC20100152; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	54	353	366	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1494	1509		10.1016/j.cell.2013.05.026	http://dx.doi.org/10.1016/j.cell.2013.05.026			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791178	Bronze, Green Accepted			2022-12-28	WOS:000320722000018
J	Wang, Y				Wang, Yu			The H7N9 Influenza Virus in China - Changes since SARS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Wang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.							Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; World Health Organization, CUM NUMB CONF HUM CA	4	22	23	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2348	2349		10.1056/NEJMp1305311	http://dx.doi.org/10.1056/NEJMp1305311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167AE	23782176				2022-12-28	WOS:000320601700002
J	Green, R; Cornelsen, L; Dangour, AD; Turner, R; Shankar, B; Mazzocchi, M; Smith, RD				Green, Rosemary; Cornelsen, Laura; Dangour, Alan D.; Turner, Rachel; Shankar, Bhavani; Mazzocchi, Mario; Smith, Richard D.			The effect of rising food prices on food consumption: systematic review with meta-regression	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FAT TAX; DEMAND; ELASTICITY	Objective To quantify the relation between food prices and the demand for food with specific reference to national and household income levels. Design Systematic review with meta-regression. Data sources Online databases of peer reviewed and grey literature (ISI Web of Science, EconLit, PubMed, Medline, AgEcon, Agricola, Google, Google Scholar, IdeasREPEC, Eldis, USAID, United Nations Food and Agriculture Organization, World Bank, International Food Policy Research Institute), hand searched reference lists, and contact with authors. Study selection We included cross sectional, cohort, experimental, and quasi-experimental studies with English abstracts. Eligible studies used nationally representative data from 1990 onwards derived from national aggregate data sources, household surveys, or supermarket and home scanners. Data analysis The primary outcome extracted from relevant papers was the quantification of the demand for foods in response to changes in food price (own price food elasticities). Descriptive and study design variables were extracted for use as covariates in analysis. We conducted meta-regressions to assess the effect of income levels between and within countries on the strength of the relation between food price and demand, and predicted price elasticities adjusted for differences across studies. Results 136 studies reporting 3495 own price food elasticities from 162 different countries were identified. Our models predict that increases in the price of all foods result in greater reductions in food consumption in poor countries: in low and high income countries, respectively, a 1% increase in the price of cereals results in reductions in consumption of 0.61% (95% confidence interval 0.56% to 0.66%) and 0.43% (0.36% to 0.48%), and a 1% increase in the price of meat results in reductions in consumption of 0.78% (0.73% to 0.83%) and 0.60% (0.54% to 0.66%). Within all countries, our models predict that poorer households will be the most adversely affected by increases in food prices. Conclusions Changes in global food prices will have a greater effect on food consumption in lower income countries and in poorer households within countries. This has important implications for national responses to increases in food prices and for the definition of policies designed to reduce the global burden of undernutrition.	[Green, Rosemary; Dangour, Alan D.; Turner, Rachel] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Green, Rosemary; Cornelsen, Laura; Dangour, Alan D.; Shankar, Bhavani; Smith, Richard D.] Leverhulme Ctr Integrat Res Agr & Hlth, London, England; [Cornelsen, Laura; Smith, Richard D.] Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1E 7HT, England; [Shankar, Bhavani] Univ London Sch Oriental & African Studies, Ctr Dev Environm & Policy, London, England; [Mazzocchi, Mario] Univ Bologna, Dept Stat Sci, Bologna, Italy	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; University of London School Oriental & African Studies (SOAS); University of Bologna	Green, R (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	rosemary.green@lshtm.ac.uk	Mazzocchi, Mario/F-7067-2012	Mazzocchi, Mario/0000-0002-0498-8031; Dangour, Alan/0000-0001-6908-1273; Shankar, Bhavani/0000-0001-8102-321X; Smith, Richard/0000-0003-3837-6559; Cornelsen, Laura/0000-0003-3769-8740	Leverhulme Centre for Integrative Research on Agriculture and Health	Leverhulme Centre for Integrative Research on Agriculture and Health	This study was partly supported by the Leverhulme Centre for Integrative Research on Agriculture and Health. The funder had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Allais O, 2010, AM J AGR ECON, V92, P228, DOI 10.1093/ajae/aap004; Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; [Anonymous], 2012, MYPLATE NUTR GUID; Capacci S, 2012, NUTR REV, V70, P188, DOI 10.1111/j.1753-4887.2011.00442.x; Compton J, 2012, IMPACT GLOBAL FOOD C; Consonni G, 2001, J ROY STAT SOC D-STA, V50, P243, DOI 10.1111/1467-9884.00275; Davis Mike, 2000, LATE VICTORIAN HOLOC; DEATON A, 1980, AM ECON REV, V70, P312; Dharmasena S, 2012, HEALTH ECON, V21, P669, DOI 10.1002/hec.1738; FAOSTAT, 2012, FOOD BAL SHEETS; Food and Agriculture Organization, 2008, NUMB HUNGR PEOPL RIS; Gallet CA, 2010, AM J AGR ECON, V92, P258, DOI 10.1093/ajae/aap008; Gallet Craig A., 2009, Aquaculture Economics and Management, V13, P235, DOI 10.1080/13657300903123985; Herforth A., 2012, GUIDING PRINCIPLES L; Holt E, 2011, LANCET, V378, P755, DOI 10.1016/S0140-6736(11)61359-7; Mazzocchi M., 2012, FAO COMMODITY TRADE; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Muhammad A., 2011, TB1929 USDA EC RES S; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; Naska A, 2009, BRIT J NUTR, V102, P166, DOI 10.1017/S000711450809466X; Organisation for Economic Cooperation and Development Food and Agriculture Organization, OECD FAO AGR OUTL 20; Remler DK, 2004, AM J PUBLIC HEALTH, V94, P225, DOI 10.2105/AJPH.94.2.225; Seale J, 2003, TB1904 USDA EC RES S; Smed S, 2012, NUTR BULL, V37, P142, DOI 10.1111/j.1467-3010.2012.01962.x; Smith R, 2012, SCIENCE, V337, P1501, DOI 10.1126/science.1222569	26	173	175	3	65	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2013	346								f3703	10.1136/bmj.f3703	http://dx.doi.org/10.1136/bmj.f3703			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171OV	23775799	Green Published, hybrid			2022-12-28	WOS:000320939700001
J	Bishop, DVM				Bishop, Dorothy V. M.			Cerebral Asymmetry and Language Development: Cause, Correlate, or Consequence?	SCIENCE			English	Review							TRANSCRANIAL DOPPLER SONOGRAPHY; HEMISPHERIC LATERALIZATION; ARCUATE FASCICULUS; GENETIC INFLUENCES; BRAIN ASYMMETRY; SPEECH; DYSLEXIA; IMPAIRMENT; TWINS; HANDEDNESS	In most people, language is processed predominantly by the left hemisphere of the brain, but we do not know how or why. A popular view is that developmental language disorders result from a poorly lateralized brain, but until recently, evidence has been weak and indirect. Modern neuroimaging methods have made it possible to study normal and abnormal development of lateralized function in the developing brain and have confirmed links with language and literacy impairments. However, there is little evidence that weak cerebral lateralization has common genetic origins with language and literacy impairments. Our understanding of the association between atypical language lateralization and developmental disorders may benefit if we reconceptualize the nature of cerebral asymmetry to recognize its multidimensionality and consider variation in lateralization over developmental time. Contrary to popular belief, cerebral lateralization may not be a highly heritable, stable characteristic of individuals; rather, weak lateralization may be a consequence of impaired language learning.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Bishop, DVM (corresponding author), Univ Oxford, Dept Expt Psychol, 9 South Parks Rd, Oxford OX1 3UD, England.	dorothy.bishop@psy.ox.ac.uk		Bishop, Dorothy/0000-0002-2448-4033	Wellcome Trust [082498/Z/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	I am supported by a Principal Research Fellowship and Programme Grant 082498/Z/07/Z from the Wellcome Trust. I would like to thank K. Watkins, S. Paracchini, D. Newbury, W. Brandler, and E. van Bergen for valuable comments on a draft of this paper and T. Brock for his generous help with the design of Fig. 2.	Abou-Khalil B, 2007, CURR NEUROL NEUROSCI, V7, P483, DOI 10.1007/s11910-007-0075-6; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; AMUNTS K, 2010, TWO HALVES BRAIN, P145; ANNETT M, 1985, LEFT RIGHT HAND; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Badcock NA, 2012, BRAIN LANG, V120, P310, DOI 10.1016/j.bandl.2011.10.006; Badzakova-Trajkov G, 2010, NEUROPSYCHOLOGIA, V48, P3086, DOI 10.1016/j.neuropsychologia.2010.06.020; Badzakova-Trajkov G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009682; BERKER EA, 1986, ARCH NEUROL-CHICAGO, V43, P1065, DOI 10.1001/archneur.1986.00520100069017; Bishop DVM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035851; Bishop D, 2009, ANN NY ACAD SCI, V1156, P1, DOI 10.1111/j.1749-6632.2009.04419.x; Bishop DVM, 2006, CURR DIR PSYCHOL SCI, V15, P217, DOI 10.1111/j.1467-8721.2006.00439.x; Bishop DVM, 2009, NEUROPSYCHOLOGIA, V47, P587, DOI 10.1016/j.neuropsychologia.2008.09.013; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; BISHOP DVM, 1990, J SPEECH HEAR RES, V33, P210, DOI 10.1044/jshr.3302.210; BISHOP DVM, 1990, HANDED NESS DEV; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Briscoe J, 2001, J CHILD PSYCHOL PSYC, V42, P329, DOI 10.1111/1469-7610.00726; BRYDEN MP, 1983, BRAIN LANG, V20, P249, DOI 10.1016/0093-934X(83)90044-5; Cai Q, 2013, P NATL ACAD SCI USA, V110, pE322, DOI 10.1073/pnas.1212956110; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Darki F, 2012, BIOL PSYCHIAT, V72, P671, DOI 10.1016/j.biopsych.2012.05.008; de Guibert C, 2011, BRAIN, V134, P3044, DOI 10.1093/brain/awr141; Dennis EL, 2011, BRAIN CONNECT, V1, P245, DOI [10.1089/brain.2011.0064, 10.1089/brain.2011.0030]; Dorsaint-Pierre R, 2006, BRAIN, V129, P1164, DOI 10.1093/brain/awl055; Dubois J, 2009, CEREB CORTEX, V19, P414, DOI 10.1093/cercor/bhn097; Eckert M, 2004, NEUROSCIENTIST, V10, P362, DOI 10.1177/1073858404263596; Eckert MA, 2000, MENT RETARD DEV D R, V6, P198, DOI 10.1002/1098-2779(2000)6:3<198::AID-MRDD7>3.3.CO;2-T; Floel A, 2005, BEHAV BRAIN RES, V158, P269, DOI 10.1016/j.bbr.2004.09.016; Folia V, 2011, BIOLINGUISTICS, V5, P105; Francks C, 2009, LATERALITY, V14, P11, DOI 10.1080/13576500802536439; GEORGE I, 2010, TWO HALVES BRAIN, P92; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Groen MA, 2012, BRAIN BEHAV, V2, P256, DOI 10.1002/brb3.56; Habas PA, 2012, CEREB CORTEX, V22, P13, DOI 10.1093/cercor/bhr053; Haberling IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052315; Jahanshad N, 2010, NEUROIMAGE, V52, P455, DOI 10.1016/j.neuroimage.2010.04.236; Kasprian G, 2011, CEREB CORTEX, V21, P1076, DOI 10.1093/cercor/bhq179; Keller SS, 2011, J COGNITIVE NEUROSCI, V23, P2013, DOI 10.1162/jocn.2010.21563; Kivilevitch Z, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.001; Knecht S, 1998, STROKE, V29, P82, DOI 10.1161/01.STR.29.1.82; Knecht S, 2001, BRAIN, V124, P1657, DOI 10.1093/brain/124.8.1657; Knecht S, 1998, STROKE, V29, P1155, DOI 10.1161/01.STR.29.6.1155; Kos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046995; Lebel C, 2009, HUM BRAIN MAPP, V30, P3563, DOI 10.1002/hbm.20779; Leonard CM, 2002, J COMMUN DISORD, V35, P501, DOI 10.1016/S0021-9924(02)00120-X; Ligthart L, 2012, TWIN RES HUM GENET, V15, P158, DOI 10.1375/twin.15.2.158; LLINGWORTH S, 2009, BRAIN LANG, V111, P61; Locke JL, 1997, BRAIN LANG, V58, P265, DOI 10.1006/brln.1997.1791; MacSweeney M, 2008, TRENDS COGN SCI, V12, P432, DOI 10.1016/j.tics.2008.07.010; Markman TM, 2011, J NEURODEV DISORD, V3, P388, DOI 10.1007/s11689-011-9098-z; Medland SE, 2009, NEUROPSYCHOLOGIA, V47, P330, DOI 10.1016/j.neuropsychologia.2008.09.005; Medland SE, 2006, TWIN RES HUM GENET, V9, P46, DOI 10.1375/183242706776402885; MILNER B, 1964, DISORDERS LANGUAGE, P200; Minagawa-Kawai Y, 2011, DEV COGN NEUROS-NETH, V1, P217, DOI 10.1016/j.dcn.2011.03.005; Newbury DF, 2011, BEHAV GENET, V41, P90, DOI 10.1007/s10519-010-9424-3; Orton ST, 1925, ARCH NEURO PSYCHIATR, V14, P581, DOI 10.1001/archneurpsyc.1925.02200170002001; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; Pernet CR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-67; Pinel P, 2012, J NEUROSCI, V32, P817, DOI 10.1523/JNEUROSCI.5996-10.2012; Pinel P, 2010, J COGNITIVE NEUROSCI, V22, P48, DOI 10.1162/jocn.2009.21184; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; PREVIC FH, 1991, PSYCHOL REV, V98, P299, DOI 10.1037/0033-295X.98.3.299; Propper RE, 2010, BRAIN COGNITION, V73, P85, DOI 10.1016/j.bandc.2010.03.004; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rasmussen T., 1975, CEREBRAL LOCALIZATIO, P238, DOI DOI 10.1007/978-3-642-66204-1.J9; Rice ML, 2009, J NEURODEV DISORD, V1, P264, DOI 10.1007/s11689-009-9031-x; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Rosch RE, 2012, NEUROPSYCHOLOGIA, V50, P810, DOI 10.1016/j.neuropsychologia.2012.01.015; Scerri TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050321; Scerri TS, 2011, HUM MOL GENET, V20, P608, DOI 10.1093/hmg/ddq475; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; STEINMETZ H, 1995, CEREB CORTEX, V5, P296, DOI 10.1093/cercor/5.4.296; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Sun YF, 2010, PEDIATR NEONATOL, V51, P89, DOI 10.1016/S1875-9572(10)60017-4; Tan GCY, 2010, NEUROIMAGE, V53, P1030, DOI 10.1016/j.neuroimage.2010.02.018; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; Wada JA, 2009, CAN J NEUROL SCI, V36, pS25; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Webster RI, 2004, J CHILD NEUROL, V19, P471, DOI 10.1177/08830738040190070101; Whalley HC, 2011, AM J MED GENET B, V156B, P941, DOI 10.1002/ajmg.b.31241; Whitehouse AJO, 2011, GENES BRAIN BEHAV, V10, P451, DOI 10.1111/j.1601-183X.2011.00684.x; Whitehouse AJO, 2009, NEUROPSYCHOLOGIA, V47, P1938, DOI 10.1016/j.neuropsychologia.2009.03.005; Whitehouse AJO, 2008, BRAIN, V131, P3193, DOI 10.1093/brain/awn266; Zhang ZH, 2011, EUR J RADIOL, V80, pE432, DOI 10.1016/j.ejrad.2010.11.024	90	230	231	4	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138							1230531	10.1126/science.1230531	http://dx.doi.org/10.1126/science.1230531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766329	Green Accepted			2022-12-28	WOS:000320320200035
J	Schweizer, M; Perencevich, E; McDanel, J; Carson, J; Formanek, M; Hafner, J; Braun, B; Herwaldt, L				Schweizer, Marin; Perencevich, Eli; McDanel, Jennifer; Carson, Jennifer; Formanek, Michelle; Hafner, Joanne; Braun, Barbara; Herwaldt, Loreen			Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; STERNAL WOUND-INFECTION; ANTIBIOTIC-PROPHYLAXIS; INTRANASAL MUPIROCIN; ANTIMICROBIAL PROPHYLAXIS; ADVISORY STATEMENT; NASAL CARRIERS; DOUBLE-BLIND; VANCOMYCIN; IMPACT	Objective To evaluate studies assessing the effectiveness of a bundle of nasal decolonization and glycopeptide prophylaxis for preventing surgical site infections caused by Gram positive bacteria among patients undergoing cardiac operations or total joint replacement procedures. Design Systematic review and meta-analysis. Data sources PubMed (1995 to 2011), the Cochrane database of systematic reviews, CINAHL, Embase, and clinicaltrials.gov were searched to identify relevant studies. Pertinent journals and conference abstracts were hand searched. Study authors were contacted if more data were needed. Eligibility criteria Randomized controlled trials, quasi-experimental studies, and cohort studies that assessed nasal decolonization or glycopeptide prophylaxis, or both, for preventing Gram positive surgical site infections compared with standard care. Participants Patients undergoing cardiac operations or total joint replacement procedures. Data extraction and study appraisal Two authors independently extracted data from each paper and a random effects model was used to obtain summary estimates. Risk of bias was assessed using the Downs and Black or the Cochrane scales. Heterogeneity was assessed using the Cochran Q and I-2 statistics. Results 39 studies were included. Pooled effects of 17 studies showed that nasal decolonization had a significantly protective effect against surgical site infections associated with Staphylococcus aureus (pooled relative risk 0.39, 95% confidence interval 0.31 to 0.50) when all patients underwent decolonization (0.40, 0.29 to 0.55) and when only S aureus carriers underwent decolonization (0.36, 0.22 to 0.57). Pooled effects of 15 prophylaxis studies showed that glycopeptide prophylaxis was significantly protective against surgical site infections related to methicillin (meticillin) resistant S aureus (MRSA) compared with prophylaxis using beta lactam antibiotics (0.40, 0.20 to 0.80), and a non-significant risk factor for methicillin susceptible S aureus infections (1.47, 0.91 to 2.38). Seven studies assessed a bundle including decolonization and glycopeptide prophylaxis for only patients colonized with MRSA and found a significantly protective effect against surgical site infections with Gram positive bacteria (0.41, 0.30 to 0.56). Conclusions Surgical programs that implement a bundled intervention including both nasal decolonization and glycopeptide prophylaxis for MRSA carriers may decrease rates of surgical site infections caused by S aureus or other Gram positive bacteria.	[Schweizer, Marin; Perencevich, Eli; Carson, Jennifer; Herwaldt, Loreen] Univ Iowa, Carver Coll Med, Iowa City, IA 52242 USA; [Schweizer, Marin; Perencevich, Eli; McDanel, Jennifer; Formanek, Michelle; Herwaldt, Loreen] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA; [Schweizer, Marin; Perencevich, Eli; Formanek, Michelle] Iowa City VA Hlth Care Syst, Iowa City, IA 52246 USA; [Perencevich, Eli; Herwaldt, Loreen] Univ Iowa Hosp & Clin, Off Clin Qual Safety & Performance Improvement, Iowa City, IA 52242 USA; [Perencevich, Eli; Herwaldt, Loreen] Univ Iowa Hosp & Clin, Dept Med, Iowa City, IA 52242 USA; [Hafner, Joanne; Braun, Barbara] Int Joint Commiss, Oak Brook Terrace, IL USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa	Schweizer, M (corresponding author), Univ Iowa, Carver Coll Med, Iowa City, IA 52242 USA.	marin-schweizer@uiowa.edu		Perencevich, Eli/0000-0002-3721-3355; Schweizer, Marin/0000-0002-3604-0093; Herwaldt, Loreen/0000-0002-9530-6859	Agency for Healthcare Research and Quality of the US Department of Health and Human Services [HHSA290200600021I]; University of Iowa clinical and translational science award [NIH/NCRR-3KL2 RR024980-04S1]; VA Health Services and Research and Development Service grant [09-099]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024980] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality of the US Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); University of Iowa clinical and translational science award; VA Health Services and Research and Development Service grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was funded by the Agency for Healthcare Research and Quality (contract No HHSA290200600021I) of the US Department of Health and Human Services. The sponsors played no role in the study design, data collection and analysis, or decision to submit the article for publication. MLS was supported by the University of Iowa clinical and translational science award (NIH/NCRR-3KL2 RR024980-04S1). ENP was funded through a VA Health Services and Research and Development Service grant (No 09-099).	Acebedo EC, 2009, MRSA SCREENING DECOL; American Academy of Orthopaedic Surgeons, 2012, REC US INTR ANT PROP; [Anonymous], 2012, HEALTHC COST UT PROJ; [Anonymous], 2011, REV MAN REVM COMP PR; Bellchambers J, 1999, EUR J CARDIO-THORAC, V15, P45, DOI 10.1016/S1010-7940(98)00255-3; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Bolon MK, 2004, CLIN INFECT DIS, V38, P1357, DOI 10.1086/383318; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Bratzler DW, 2005, AM J SURG, V189, P395, DOI 10.1016/j.amjsurg.2005.01.015; Bull A, 2010, INT C ANT AG CHEM; Centers for Medicare and Medicaid Services, 2012, CMS IMPR PAT SAF MED; Chang FY, 2003, MEDICINE, V82, P333, DOI 10.1097/01.md.0000091184.93122.09; Cimochowski GE, 2001, ANN THORAC SURG, V71, P1572, DOI 10.1016/S0003-4975(01)02519-X; Coskun D, 2005, J HOSP INFECT, V60, P287, DOI 10.1016/j.jhin.2004.12.009; Coskun D, 2004, J HOSP INFECT, V58, P90, DOI 10.1016/j.jhin.2004.05.007; Courville XF, 2012, INFECT CONT HOSP EP, V33, P152, DOI 10.1086/663704; Crawford T, 2012, CLIN INFECT DIS, V54, P1474, DOI 10.1093/cid/cis027; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhadwal K, 2007, HEART, V93, P1126, DOI 10.1136/hrt.2006.103002; Diekema D, 2011, INFECT CONT HOSP EP, V32, P1042, DOI 10.1086/661917; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Engelman R, 2007, ANN THORAC SURG, V83, P1569, DOI 10.1016/j.athoracsur.2006.09.046; Finkelstein R, 2002, J THORAC CARDIOV SUR, V123, P326, DOI 10.1067/mtc.2002.119698; Garey KW, 2008, ANTIMICROB AGENTS CH, V52, P446, DOI 10.1128/AAC.00495-07; Gernaat-van der Sluis AJ, 1998, ACTA ORTHOP SCAND, V69, P412; Graf Karolin, 2009, Interact Cardiovasc Thorac Surg, V9, P282, DOI 10.1510/icvts.2009.205286; Gupta K, 2011, INFECT CONT HOSP EP, V32, P791, DOI 10.1086/660362; Hacek DM, 2009, J CLIN MICROBIOL, V47, P3749, DOI 10.1128/JCM.01223-08; Hadley S, 2010, ARTHRITIS, DOI 10.1155/2010/924518; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Jog S, 2008, J HOSP INFECT, V69, P124, DOI 10.1016/j.jhin.2008.02.008; Kalmeijer MD, 2002, CLIN INFECT DIS, V35, P353, DOI 10.1086/341025; Kim DH, 2010, J BONE JOINT SURG AM, V92A, P1820, DOI 10.2106/JBJS.I.01050; Kluytmans JAJW, 1996, INFECT CONT HOSP EP, V17, P780; Konvalinka A, 2006, J HOSP INFECT, V64, P162, DOI 10.1016/j.jhin.2006.06.010; Lador A, 2012, J ANTIMICROB CHEMOTH, V67, P541, DOI 10.1093/jac/dkr470; Lee AS, 2011, CLIN INFECT DIS, V52, P1422, DOI 10.1093/cid/cir233; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Martorell C, 2004, AM J INFECT CONTROL, V32, P63, DOI 10.1016/j.ajic.2003.09.005; Merrer J, 2006, INFECT CONT HOSP EP, V27, P1366, DOI 10.1086/509846; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nicholson MR, 2006, AM J INFECT CONTROL, V34, P44, DOI 10.1016/j.ajic.2005.07.004; Niederhauser U, 1997, J THORAC CARDIOV SUR, V114, P162, DOI 10.1016/S0022-5223(97)70140-5; Pear SM, 1998, INFECT CONT HOSP EP, V19, P513; Periti P, 1999, EUR J CLIN MICROBIOL, V18, P113, DOI 10.1007/s100960050238; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Price CS, 2008, CLIN ORTHOP RELAT R, V466, P2842, DOI 10.1007/s11999-008-0337-x; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Rao N, 2011, J ARTHROPLASTY, V26, P1501, DOI 10.1016/j.arth.2011.03.014; Ridderstolpe L, 2001, EUR J CARDIO-THORAC, V20, P1168, DOI 10.1016/S1010-7940(01)00991-5; Saginur R, 2000, J THORAC CARDIOV SUR, V120, P1120, DOI 10.1067/mtc.2000.110384; Salminen US, 1999, J ANTIMICROB CHEMOTH, V44, P287, DOI 10.1093/jac/44.2.287; Sankar B, 2005, INT ORTHOP, V29, P160, DOI 10.1007/s00264-005-0649-3; Schweizer ML, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-279; Segers P, 2006, JAMA-J AM MED ASSOC, V296, P2460, DOI 10.1001/jama.296.20.2460; Sewick A, 2012, CLIN ORTHOP RELAT R, V470, P2702, DOI 10.1007/s11999-012-2255-1; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Soriano A, 2006, EUR J CLIN MICROBIOL, V25, P35, DOI 10.1007/s10096-005-0073-z; Spelman D, 2002, INFECT CONT HOSP EP, V23, P402, DOI 10.1086/502074; Sporer S, 2011, AM AC ORTH SURG AAOS, P465; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TAYLOR GJ, 1990, AM J CARDIOL, V65, P309, DOI 10.1016/0002-9149(90)90293-A; Tyllianakis ME, 2010, J ARTHROPLASTY, V25, P1078, DOI 10.1016/j.arth.2010.01.105; van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2; Vuorisalo S, 1998, INFECT CONT HOSP EP, V19, P234; Walsh EE, 2011, ARCH INTERN MED, V171, P68, DOI 10.1001/archinternmed.2010.326; Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033; Wilcox MH, 2003, J HOSP INFECT, V54, P196, DOI 10.1016/S0195-6701(03)00147-6; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	71	123	124	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2013	346								f2743	10.1136/bmj.f2743	http://dx.doi.org/10.1136/bmj.f2743			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WQ	23766464	Green Published, hybrid			2022-12-28	WOS:000320590800009
J	Frolkis, JP				Frolkis, Joseph P.			The Columbo Phenomenon	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY-CARE		Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Frolkis, JP (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	jfrolkis@partners.org						American College of Physicians, 2008, IS SHORT PRIM CAR PH; Barnes KA, 2012, NEW ENGL J MED, V367, P891, DOI 10.1056/NEJMp1204487; Grumbach K, 2004, JAMA-J AM MED ASSOC, V291, P1246, DOI 10.1001/jama.291.10.1246; Margolius D, 2010, HEALTH AFFAIR, V29, P779, DOI 10.1377/hlthaff.2010.0045; Nutting PA, 2011, HEALTH AFFAIR, V30, P439, DOI 10.1377/hlthaff.2010.0159; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158	6	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2333	2334		10.1001/jama.2013.3940	http://dx.doi.org/10.1001/jama.2013.3940			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161EV	23757081				2022-12-28	WOS:000320176000022
J	Aktan, AO				Aktan, Ahmet Ozdemir			PERSONAL VIEW Tear gas is a chemical weapon, and Turkey should not use it to torture civilians	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aktan, Ahmet Ozdemir] Turkish Med Assoc, Istanbul, Turkey; [Aktan, Ahmet Ozdemir] Marmara Univ Hosp, Dept Surg, Istanbul, Turkey	The Health Foundation Of Turkey; Marmara University	Aktan, AO (corresponding author), Turkish Med Assoc, Istanbul, Turkey.	aoaktan@turk.net						Hurley R, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3674; Morgan R, 2002, COMBATING TORTURE EU; United Nations Office for Disarmament Affairs, 1925 GEN PROT PROT P	3	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2013	346								f3801	10.1136/bmj.f3801	http://dx.doi.org/10.1136/bmj.f3801			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VQ	23757759				2022-12-28	WOS:000320587600002
J	Uprichard, WO; Uprichard, J				Uprichard, W. Owen; Uprichard, James			Investigating microcytic anaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IRON-DEFICIENCY ANEMIA; DIAGNOSIS; PREVALENCE; THALASSEMIA; MANAGEMENT; DISEASE; ADULTS		[Uprichard, James] St Georges Healthcare NHS Trust, Dept Haematol, London SW17 0QT, England	St Georges University London	Uprichard, J (corresponding author), St Georges Healthcare NHS Trust, Dept Haematol, London SW17 0QT, England.	j.uprichard@nhs.net						[Anonymous], 2001, WHO TECHN REP SER; [Anonymous], 2013, NHS SICKLE CELL THAL; Bain BJ, 2005, HEMATOLOGY, V10, P178, DOI 10.1080/10245330512331390348; Bain BJ, 2006, BLOOD CELLS PRACTICA, P61; Beguin Y, 1999, HAEMATOLOGICA, V84, P541; British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2012, BRIT NATL FORMULARY; Cullis JO, 2011, BRIT J HAEMATOL, V154, P289, DOI 10.1111/j.1365-2141.2011.08741.x; El-Agouza I, 2002, CLIN LAB HAEMATOL, V24, P285, DOI 10.1046/j.1365-2257.2002.00464.x; Gill PS, 1998, BRIT MED J, V317, P761, DOI 10.1136/bmj.317.7161.761; Goddard AF, 2011, GUT, V60, P1309, DOI 10.1136/gut.2010.228874; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Hershko C, 2009, SEMIN HEMATOL, V46, P339, DOI 10.1053/j.seminhematol.2009.06.002; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; JACOBS A, 1965, POSTGRAD MED J, V41, P418, DOI 10.1136/pgmj.41.477.418; Jaime-Perez JC, 2005, ARCH MED RES, V36, P598, DOI 10.1016/j.arcmed.2005.03.023; James MW, 2005, EUR J GASTROEN HEPAT, V17, P1197, DOI 10.1097/00042737-200511000-00008; Joosten E, 1999, AM J MED, V107, P24, DOI 10.1016/S0002-9343(99)00162-X; Kuku I, 2009, PLATELETS, V20, P401, DOI 10.1080/09537100903137306; Liu K, 2012, EUR J GASTROEN HEPAT, V24, P109, DOI 10.1097/MEG.0b013e32834f3140; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; OSKI FA, 1993, NEW ENGL J MED, V329, P190, DOI 10.1056/NEJM199307153290308; Pang WW, 2012, CURR OPIN HEMATOL, V19, P133, DOI 10.1097/MOH.0b013e3283522471; Urrechaga E, 2011, AM J CLIN PATHOL, V135, P374, DOI 10.1309/AJCPJRH1I0XTNFGA; WALTER T, 1993, PEDIATRICS, V91, P976; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809	25	2	2	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2013	346								f3154	10.1136/bmj.f3154	http://dx.doi.org/10.1136/bmj.f3154			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YM	23747966				2022-12-28	WOS:000320230400001
J	Kheirbek, MA; Hen, R				Kheirbek, Mazen A.; Hen, Rene			(Radio)active Neurogenesis in the Human Hippocampus	CELL			English	Editorial Material							OLFACTORY-BULB; CELLS; ANTIDEPRESSANTS; NEURONS	Fifteen years ago, the generation of new neurons in adulthood was documented in the human hippocampus, but lingering questions have remained about the extent of this process. In this issue of Cell, Spalding et al. provide elegant evidence for continued neurogenesis into adulthood at rates that suggest it may play a significant role in human behavior.	[Kheirbek, Mazen A.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Kheirbek, Mazen A.; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Kheirbek, Mazen A.; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Kheirbek, MA (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	mk3156@columbia.edu; rh95@columbia.edu	Kheirbek, Mazen A/J-3656-2015	Kheirbek, Mazen A/0000-0001-9157-7363	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH068542, K01MH099371] Funding Source: NIH RePORTER; NIMH NIH HHS [1K01MH099371-01, R37 MH068542, K01 MH099371] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028	11	11	12	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1183	1184		10.1016/j.cell.2013.05.033	http://dx.doi.org/10.1016/j.cell.2013.05.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746833	Green Accepted, Bronze			2022-12-28	WOS:000319979200002
J	Wang, ML; Rule, S; Martin, P; Goy, A; Auer, R; Kahl, BS; Jurczak, W; Advani, RH; Romaguera, JE; Williams, ME; Barrientos, JC; Chmielowska, E; Radford, J; Stilgenbauer, S; Dreyling, M; Jedrzejczak, WW; Johnson, P; Spurgeon, SE; Li, L; Zhang, L; Newberry, K; Ou, ZS; Cheng, N; Fang, BL; McGreivy, J; Clow, F; Buggy, JJ; Chang, BY; Beaupre, DM; Kunkel, LA; Blum, KA				Wang, Michael L.; Rule, Simon; Martin, Peter; Goy, Andre; Auer, Rebecca; Kahl, Brad S.; Jurczak, Wojciech; Advani, Ranjana H.; Romaguera, Jorge E.; Williams, Michael E.; Barrientos, Jacqueline C.; Chmielowska, Ewa; Radford, John; Stilgenbauer, Stephan; Dreyling, Martin; Jedrzejczak, Wieslaw Wiktor; Johnson, Peter; Spurgeon, Stephen E.; Li, Lei; Zhang, Liang; Newberry, Kate; Ou, Zhishuo; Cheng, Nancy; Fang, Bingliang; McGreivy, Jesse; Clow, Fong; Buggy, Joseph J.; Chang, Betty Y.; Beaupre, Darrin M.; Kunkel, Lori A.; Blum, Kristie A.			Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; TYROSINE KINASE INHIBITOR; THERAPEUTIC TARGET; FOLLOW-UP; PHASE-II; PCI-32765; RECEPTOR; MALIGNANCIES; BORTEZOMIB; ESHAP	BACKGROUND Bruton's tyrosine kinase (BTK) is a mediator of the B-cell-receptor signaling pathway implicated in the pathogenesis of B-cell cancers. In a phase 1 study, ibrutinib, a BTK inhibitor, showed antitumor activity in several types of non-Hodgkin's lymphoma, including mantle-cell lymphoma. METHODS In this phase 2 study, we investigated oral ibrutinib, at a daily dose of 560 mg, in 111 patients with relapsed or refractory mantle-cell lymphoma. Patients were enrolled into two groups: those who had previously received at least 2 cycles of bortezomib therapy and those who had received less than 2 complete cycles of bortezomib or had received no prior bortezomib therapy. The primary end point was the overall response rate. Secondary end points were duration of response, progression-free survival, overall survival, and safety. RESULTS The median age was 68 years, and 86% of patients had intermediate-risk or high-risk mantle-cell lymphoma according to clinical prognostic factors. Patients had received a median of three prior therapies. The most common treatment-related adverse events were mild or moderate diarrhea, fatigue, and nausea. Grade 3 or higher hematologic events were infrequent and included neutropenia (in 16% of patients), thrombocytopenia (in 11%), and anemia (in 10%). A response rate of 68% (75 patients) was observed, with a complete response rate of 21% and a partial response rate of 47%; prior treatment with bortezomib had no effect on the response rate. With an estimated median follow-up of 15.3 months, the estimated median response duration was 17.5 months (95% confidence interval [CI], 15.8 to not reached), the estimated median progression-free survival was 13.9 months (95% CI, 7.0 to not reached), and the median overall survival was not reached. The estimated rate of overall survival was 58% at 18 months. CONCLUSIONS Ibrutinib shows durable single-agent efficacy in relapsed or refractory mantle-cell lymphoma.	[Wang, Michael L.; Romaguera, Jorge E.; Zhang, Liang; Newberry, Kate; Ou, Zhishuo] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Wang, Michael L.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Li, Lei] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Fang, Bingliang] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Cheng, Nancy] Baylor Coll Med, Houston, TX 77030 USA; [Rule, Simon] Derriford Hosp, Dept Haematol, Plymouth PL6 8DH, Devon, England; [Auer, Rebecca] Barts Hlth Natl Hlth Serv NHS Trust, Dept Haematooncol, London, England; [Radford, John] Christie NHS Fdn Trust, Manchester, Lancs, England; [Radford, John] Univ Manchester, Manchester M13 9PL, Lancs, England; [Johnson, Peter] Univ Southampton, Canc Res UK Ctr, Southampton, Hants, England; [Martin, Peter] Weill Cornell Med Coll, Div Hematol Oncol, New York, NY USA; [Barrientos, Jacqueline C.] Hofstra North Shore Long Isl Jewish Med Ctr, Dept Med, Div Hematol & Med Oncol, Chron Lymphocyt Leukemia Res & Treatment Program, New Hyde Pk, NY USA; [Goy, Andre] Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA; [Kahl, Brad S.] Univ Wisconsin, Div Hematol & Oncol, Dept Med, Madison, WI 53706 USA; [Jurczak, Wojciech] Jagiellonian Univ, Dept Hematol, Krakow, Poland; [Chmielowska, Ewa] Oddzial Klin Onkol Ctr Onkol, Bydgoszcz, Poland; [Jedrzejczak, Wieslaw Wiktor] Med Univ Warsaw, Warsaw, Poland; [Advani, Ranjana H.] Stanford Univ, Med Ctr, Dept Med, Div Oncol, Stanford, CA 94305 USA; [McGreivy, Jesse; Clow, Fong; Buggy, Joseph J.; Chang, Betty Y.; Beaupre, Darrin M.; Kunkel, Lori A.] Pharmacyclics, Sunnyvale, CA USA; [Williams, Michael E.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Stilgenbauer, Stephan] Univ Ulm Klinikum, Klin Innere Med 2, Ulm, Germany; [Dreyling, Martin] Klinikum Univ Munchen, Munich, Germany; [Spurgeon, Stephen E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Blum, Kristie A.] Ohio State Univ, Ctr Comprehens Canc, Div Hematol, Columbus, OH 43210 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Derriford Hospital; Barts Health NHS Trust; Christie NHS Foundation Trust; University of Manchester; Cancer Research UK; University of Southampton; Cornell University; Hofstra University; Hackensack University Medical Center; University of Wisconsin System; University of Wisconsin Madison; Jagiellonian University; Collegium Medicum Jagiellonian University; Medical University of Warsaw; Stanford University; Pharmacyclics; University of Virginia; Ulm University; University of Munich; Oregon Health & Science University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Wang, ML (corresponding author), Univ Texas MD Anderson Canc Ctr, Unit 429, 1515 Holcombe Blvd, Houston, TX 77030 USA.	miwang@mdanderson.org	Goy, Andre/AAS-4464-2020; Jurczak, Wojciech/L-7645-2019; Goy, Andre/AHC-0473-2022; Radford, John A/N-1331-2015; Stilgenbauer, Stephan/ABE-6609-2020; Barrientos, Jacqueline/AAE-6683-2022; Jurczak, Wojciech/ABB-2136-2020; Johnson, Peter/O-3529-2019; Jurczak, Wojciech/M-1625-2019; Jurczak, Wojciech/AAV-7973-2020; Johnson, Peter/L-2403-2018	Goy, Andre/0000-0001-5125-6522; Goy, Andre/0000-0001-5125-6522; Radford, John A/0000-0001-7898-2786; Jurczak, Wojciech/0000-0003-1879-8084; Johnson, Peter/0000-0003-2306-4974; Jurczak, Wojciech/0000-0003-1879-8084; Johnson, Peter/0000-0003-2306-4974; Barrientos, Jacqueline Claudia/0000-0001-6018-5535; Advani, Ranjana/0000-0002-3219-2292	Pharmacyclics; Janssen Biotech; Roche; Napp Pharmaceuticals; GlaxoSmithKline; Celgene; Johnson Johnson; Millennium; Gilead; Infinity Pharmaceuticals; Genentech; Abbott; Novartis; Amgen; Pierre Fabre; Boehringer Ingelheim; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Pharmacyclics; Janssen Biotech(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Roche(Roche Holding); Napp Pharmaceuticals; GlaxoSmithKline(GlaxoSmithKline); Celgene(Bristol-Myers SquibbCelgene Corporation); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Millennium(Takeda Pharmaceutical Company Ltd); Gilead(Gilead Sciences); Infinity Pharmaceuticals; Genentech(Roche HoldingGenentech); Abbott(Abbott Laboratories); Novartis(Novartis); Amgen(Amgen); Pierre Fabre; Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Pharmacyclics and others; ClinicalTrials.gov number, NCT01236391.; Supported by Pharmacyclics and Janssen Biotech and by philanthropic funding provided to the M.D. Anderson Cancer Center by Edward Crutchfield.; Dr. Wang reports receiving grant support through his institution from Pharmacyclics and Janssen Biotech. Dr. Rule reports receiving consulting fees from Roche, Napp Pharmaceuticals, GlaxoSmithKline, and Celgene, and lecture fees from Roche, Napp Pharmaceuticals, and Johnson & Johnson. Dr. Martin reports receiving lecture fees from Janssen Biotech. Dr. Goy reports receiving payment for board membership from Millennium, Pharmacyclics, Johnson & Johnson, Seattle Genetics, Pfizer, and Celgene, and lecture fees from Millennium. Dr. Auer reports receiving payment for board membership from Gilead, consulting fees from Celgene, lecture fees from Roche, and travel support through her institution from Roche. Dr. Kahl reports receiving payment for board membership from Roche, Seattle Genetics, Millennium, and Cell Therapeutics, and consulting fees from Pharmacyclics, Gilead, Infinity Pharmaceuticals, and Genentech. Dr. Advani reports receiving grant support through his institution from Seattle Genetics and Genentech. Dr. Williams reports receiving consulting fees from Pharmacyclics and grant support through his institution from Pharmacyclics and Janssen Biotech. Dr. Barrientos reports receiving consulting fees from Gilead and grant support through her institution from Abbott and Gilead. Dr. Radford reports receiving consulting fees from Millennium, Roche, Novartis, and GlaxoSmithKline, receiving lecture fees from Seattle Genetics, receiving payment for the development of educational presentations from Millennium, holding stock in GlaxoSmithKline and AstraZeneca, receiving grant support through his institution from Millennium and Amgen, and providing expert advice for Millennium and Mundipharma in licensing submissions to the European Medicines Agency. Drs. Stilgenbauer, McGreivy, Clow, Buggy, Chang, Beaupre, and Kunkel report being employees of and holding stock and stock options in Pharmacyclics. Dr. Dreyling reports receiving payment for board membership and lectures fees from Janssen Biotech, as well as grant support through his institution from Janssen Biotech. Dr. Jedrzejczak reports receiving consulting fees from Novartis, Janssen Biotech, and Amgen, lecture fees from Celgene and Novartis, and travel support from Roche and Pierre Fabre. Dr. Johnson reports receiving consulting fees from Janssen Biotech and Boehringer Ingelheim, lecture fees from Pfizer and Millennium, and grant support through his institution from Janssen Biotech. No other potential conflict of interest relevant to this article was reported.	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Alinari L, 2012, ONCOTARGET, V3, P203; [Anonymous], 2009, CANC THERAPY EVALUAT; [Anonymous], 1997, BLOOD, V89, P3909; Aspegren OP, 2012, CLIN NEUROL NEU 1102; Buggy J, 2012, INT REV IMMUNOL, V31, P428, DOI 10.3109/08830185.2012.718015; Buggy JJ, 2012, INT REV IMMUNOL, V31, P119, DOI 10.3109/08830185.2012.664797; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Chang BY, 2011, BLOOD, V118, P436; Chang BY, 2013, AM ASS CANC RES ANN; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Hadzidimitriou A, 2011, BLOOD, V118, P3088, DOI 10.1182/blood-2011-03-343434; Harrison C, 2012, NAT REV DRUG DISCOV, V11, P96, DOI 10.1038/nrd3656; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kenkre VP, 2012, CURR HEMATOL MALIG R, V7, P216, DOI 10.1007/s11899-012-0127-0; Rinaldi A, 2006, BRIT J HAEMATOL, V132, P303, DOI 10.1111/j.1365-2141.2005.05883.x; RODRIGUEZ MA, 1995, J CLIN ONCOL, V13, P1734, DOI 10.1200/JCO.1995.13.7.1734; Romaguera JE, 2010, BRIT J HAEMATOL, V151, P111, DOI 10.1111/j.1365-2141.2010.08392.x; Romaguera JE, 2010, BRIT J HAEMATOL, V150, P200, DOI 10.1111/j.1365-2141.2010.08228.x; Rushworth SA, 2013, CELL SIGNAL, V25, P106, DOI 10.1016/j.cellsig.2012.09.008; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; VELASQUEZ WS, 1994, J CLIN ONCOL, V12, P1169, DOI 10.1200/JCO.1994.12.6.1169; Vose J, 2004, ANN ONCOL, V15, P541, DOI 10.1093/annonc/mdh129; Wang M, 2008, CANCER-AM CANCER SOC, V113, P2734, DOI 10.1002/cncr.23880; Wang M, 2008, CLIN CANCER RES, V14, P2154, DOI 10.1158/1078-0432.CCR-07-4409; Wiestner A, 2013, J CLIN ONCOL, V31, P128, DOI 10.1200/JCO.2012.44.4281	31	1143	1222	5	139	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					507	516		10.1056/NEJMoa1306220	http://dx.doi.org/10.1056/NEJMoa1306220			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197HX	23782157	Green Accepted, Green Published			2022-12-28	WOS:000322842000007
J	Wang, YJ; Wang, YL; Zhao, XQ; Liu, LP; Wang, D; Wang, CX; Wang, C; Li, H; Meng, X; Cui, LY; Jia, JP; Dong, Q; Xu, AD; Zeng, JS; Li, YS; Wang, ZM; Xia, HQ; Johnston, SC				Wang, Yongjun; Wang, Yilong; Zhao, Xingquan; Liu, Liping; Wang, David; Wang, Chunxue; Wang, Chen; Li, Hao; Meng, Xia; Cui, Liying; Jia, Jianping; Dong, Qiang; Xu, Anding; Zeng, Jinsheng; Li, Yansheng; Wang, Zhimin; Xia, Haiqin; Johnston, S. Claiborne		CHANCE Investigators	Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SHORT-TERM PROGNOSIS; HIGH-RISK PATIENTS; DOUBLE-BLIND; BURDEN; RECURRENCE; EMERGENCY; THERAPY; CHINA	BACKGROUND Stroke is common during the first few weeks after a transient ischemic attack (TIA) or minor ischemic stroke. Combination therapy with clopidogrel and aspirin may provide greater protection against subsequent stroke than aspirin alone. METHODS In a randomized, double-blind, placebo-controlled trial conducted at 114 centers in China, we randomly assigned 5170 patients within 24 hours after the onset of minor ischemic stroke or high-risk TIA to combination therapy with clopidogrel and aspirin (clopidogrel at an initial dose of 300 mg, followed by 75 mg per day for 90 days, plus aspirin at a dose of 75 mg per day for the first 21 days) or to placebo plus aspirin (75 mg per day for 90 days). All participants received open-label aspirin at a clinician-determined dose of 75 to 300 mg on day 1. The primary outcome was stroke (ischemic or hemorrhagic) during 90 days of follow-up in an intention-to-treat analysis. Treatment differences were assessed with the use of a Cox proportional-hazards model, with study center as a random effect. RESULTS Stroke occurred in 8.2% of patients in the clopidogrel-aspirin group, as compared with 11.7% of those in the aspirin group (hazard ratio, 0.68; 95% confidence interval, 0.57 to 0.81; P<0.001). Moderate or severe hemorrhage occurred in seven patients (0.3%) in the clopidogrel-aspirin group and in eight (0.3%) in the aspirin group (P = 0.73); the rate of hemorrhagic stroke was 0.3% in each group. CONCLUSIONS Among patients with TIA or minor stroke who can be treated within 24 hours after the onset of symptoms, the combination of clopidogrel and aspirin is superior to aspirin alone for reducing the risk of stroke in the first 90 days and does not increase the risk of hemorrhage.	[Wang, Yongjun; Wang, Yilong; Zhao, Xingquan; Liu, Liping; Wang, Chunxue; Wang, Chen; Li, Hao; Meng, Xia] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China; [Jia, Jianping] Capital Med Univ, Xuan Wu Hosp, Beijing, Peoples R China; [Cui, Liying] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Dong, Qiang] Fudan Univ, Huashan Hosp, Shanghai 200433, Peoples R China; [Li, Yansheng] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai 200030, Peoples R China; [Xu, Anding] Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zeng, Jinsheng] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Zhimin] Taizhou First Peoples Hosp, Taizhou, Peoples R China; [Xia, Haiqin] Gen Hosp, Taiyuan Iron & Steel Grp, Taiyuan, Peoples R China; [Wang, David] Univ Illinois, Coll Med, Sisters Order St Francis Healthcare Syst 3, Illinois Neurol Inst Stroke Network, Peoria, IL 61656 USA; [Johnston, S. Claiborne] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Johnston, S. Claiborne] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA	Capital Medical University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Fudan University; Shanghai Jiao Tong University; Jinan University; Sun Yat Sen University; University of Illinois System; University of Illinois Peoria; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wang, YJ (corresponding author), 6 Tiantanxili, Beijing 100050, Peoples R China.	yongjunwang1962@gmail.com; clay.johnston@ucsfmedctr.org	Li, Hao/GPS-9834-2022	Xu, An-Ding/0000-0003-3154-0985; Jia, Jianping/0000-0003-4624-0336	Ministry of Science and Technology of the People's Republic of China [2008ZX09312-008, 2011BAI08B02, 2012ZX09303, 200902004]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	Funded by the Ministry of Science and Technology of the People's Republic of China; CHANCE ClinicalTrials.gov number, NCT00979589.; Supported by grants (2008ZX09312-008, 2011BAI08B02, 2012ZX09303, and 200902004) from the Ministry of Science and Technology of the People's Republic of China.	Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Edlow JA, 2006, ACAD EMERG MED, V13, P666, DOI 10.1197/j.aem.2006.01.014; Hankey G J, 2008, Pract Neurol, V8, P103, DOI 10.1136/jnnp.2007.139378; Herbert JM, 1998, THROMB HAEMOSTASIS, V80, P512; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Johnston SC, 2003, NEUROLOGY, V60, P1429, DOI 10.1212/01.WNL.0000063309.41867.0F; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Josephson SA, 2008, STROKE, V39, P3096, DOI 10.1161/STROKEAHA.108.514562; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Kleindorfer D, 2005, STROKE, V36, P720, DOI 10.1161/01.STR.0000158917.59233.b7; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Lovett JK, 2004, NEUROLOGY, V62, P569, DOI 10.1212/01.WNL.0000110311.09970.83; Makkar RR, 1998, EUR HEART J, V19, P1538, DOI 10.1053/euhj.1998.1042; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; Rosemary J, 2007, CURR CLIN PHARMACOL, V2, P93, DOI 10.2174/157488407779422302; Sandercock P, 1997, LANCET, V349, P1569; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Wang YL, 2007, INT J STROKE, V2, P211, DOI 10.1111/j.1747-4949.2007.00142.x; Wang YJ, 2010, AM HEART J, V160, P380, DOI 10.1016/j.ahj.2010.05.017; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807	28	915	995	14	186	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					11	19		10.1056/NEJMoa1215340	http://dx.doi.org/10.1056/NEJMoa1215340			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175WE	23803136	Bronze			2022-12-28	WOS:000321263500006
J	Bright, AT; Winzeler, EA				Bright, A. Taylor; Winzeler, Elizabeth A.			EPIDEMIOLOGY Resistance mapping in malaria	NATURE			English	Editorial Material							ZINC-FINGER NUCLEASES; PLASMODIUM-FALCIPARUM; SPREAD; POPULATIONS; CAMBODIA		[Bright, A. Taylor; Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Bright, AT (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	ewinzeler@ucsd.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113				Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mita T, 2011, J INFECT DIS, V204, P1980, DOI 10.1093/infdis/jir664; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; WHO, 2012, WORLD MALARIA REPORT 2012, P1	12	10	10	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					446	447		10.1038/498446b	http://dx.doi.org/10.1038/498446b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171LH	23803843				2022-12-28	WOS:000320929400043
J	Katsnelson, A				Katsnelson, Alla			DRUG DEVELOPMENT Target practice	NATURE			English	Editorial Material																		Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Deshpande AJ, 2013, BLOOD, V121, P2533, DOI 10.1182/blood-2012-11-465120; Estey EH, 2003, BLOOD, V102, P442, DOI 10.1182/blood-2002-09-2937; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Tyner JW, 2013, CANCER RES, V73, P285, DOI 10.1158/0008-5472.CAN-12-1906	5	5	6	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					S8	S9		10.1038/498S8a	http://dx.doi.org/10.1038/498S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803950	Bronze			2022-12-28	WOS:000320929400005
J	Jacobs, BL; Zhang, Y; Schroeck, FR; Skolarus, TA; Wei, JT; Montie, JE; Gilbert, SM; Strope, SA; Dunn, RL; Miller, DC; Hollenbeck, BK				Jacobs, Bruce L.; Zhang, Yun; Schroeck, Florian R.; Skolarus, Ted A.; Wei, John T.; Montie, James E.; Gilbert, Scott M.; Strope, Seth A.; Dunn, Rodney L.; Miller, David C.; Hollenbeck, Brent K.			Use of Advanced Treatment Technologies Among Men at Low Risk of Dying From Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MODULATED RADIATION-THERAPY; RADICAL PROSTATECTOMY; LIFE EXPECTANCY; HEALTH; CLINICIAN; OUTCOMES; ILLNESS; INDEX	Importance The use of advanced treatment technologies (ie, intensity-modulated radiotherapy [IMRT] and robotic prostatectomy) for prostate cancer is increasing. The extent to which these advanced treatment technologies have disseminated among patients at low risk of dying from prostate cancer is uncertain. Objective To assess the use of advanced treatment technologies, compared with prior standards (ie, traditional external beam radiation treatment [EBRT] and open radical prostatectomy) and observation, among men with a low risk of dying from prostate cancer. Design, Setting, and Patients Using Surveillance, Epidemiology, and End Results (SEER)-Medicare data, we identified a retrospective cohort of men diagnosed with prostate cancer between 2004 and 2009 who underwent IMRT (n=23 633), EBRT (n=3926), robotic prostatectomy (n=5881), open radical prostatectomy (n=6123), or observation (n=16 384). Follow-up data were available through December 31, 2010. Main Outcomes and Measures The use of advanced treatment technologies among men unlikely to die from prostate cancer, as assessed by low-risk disease (clinical stage <= T2a, biopsy Gleason score <= 6, and prostate-specific antigen level <= 10 ng/mL), high risk of noncancer mortality (based on the predicted probability of death within 10 years in the absence of a cancer diagnosis), or both. Results In our cohort, the use of advanced treatment technologies increased from 32% (95% CI, 30%-33%) to 44% (95% CI, 43%-46%) among men with low-risk disease (P < .001) and from 36% (95% CI, 35%-38%) to 57% (95% CI, 55%-59%) among men with high risk of noncancer mortality (P < .001). The use of these advanced treatment technologies among men with both low-risk disease and high risk of noncancer mortality increased from 25% (95% CI, 23%-28%) to 34% (95% CI, 31%-37%) (P < .001). Among all patients diagnosed in SEER, the use of advanced treatment technologies for men unlikely to die from prostate cancer increased from 13% (95% CI, 12%-14%), or 129.2 per 1000 patients diagnosed with prostate cancer, to 24% (95% CI, 24%-25%), or 244.2 per 1000 patients diagnosed with prostate cancer (P < .001). Conclusion and Relevance Among men diagnosed with prostate cancer between 2004 and 2009 who had low-risk disease, high risk of noncancer mortality, or both, the use of advanced treatment technologies has increased.	[Jacobs, Bruce L.; Schroeck, Florian R.; Skolarus, Ted A.; Montie, James E.; Miller, David C.; Hollenbeck, Brent K.] Univ Michigan, Dept Urol, Div Oncol, Ann Arbor, MI 48109 USA; [Jacobs, Bruce L.; Zhang, Yun; Schroeck, Florian R.; Skolarus, Ted A.; Wei, John T.; Montie, James E.; Dunn, Rodney L.; Miller, David C.; Hollenbeck, Brent K.] Univ Michigan, Div Hlth Serv Res, Ann Arbor, MI 48109 USA; [Wei, John T.] Univ Michigan, Div Gen Urol, Ann Arbor, MI 48109 USA; [Skolarus, Ted A.] VA Ann Arbor Healthcare Syst, Ctr Clin Management Res, Ann Arbor, MI USA; [Gilbert, Scott M.] Univ Florida, Dept Urol, Gainesville, FL USA; [Strope, Seth A.] Washington Univ, Sch Med, Dept Surg, Div Urol Surg, St Louis, MO 63110 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; State University System of Florida; University of Florida; Washington University (WUSTL)	Hollenbeck, BK (corresponding author), Univ Michigan, Dept Urol, Bldg 16,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	bhollen@med.umich.edu	Björklund, Johan K/G-3097-2015; Wei, John T/E-8967-2012; Schroeck, Florian R./I-5342-2019	Björklund, Johan K/0000-0003-3254-3993; Schroeck, Florian R./0000-0002-1860-2611; Strope, Seth/0000-0002-5176-1550	American Cancer Society [121805-PF-12-008-01-CPHPS, PF-12-118-01-CPPB]; National Institutes of Health [NIH 5 T32 DK007782-12]; National Cancer Institute [R01-CA-168691-01]; NATIONAL CANCER INSTITUTE [R01CA168691] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007782] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Jacobs is supported in part by an American Cancer Society Postdoctoral Fellowship Grant (121805-PF-12-008-01-CPHPS). Dr Schroeck is supported in part by an American Cancer Society Postdoctoral Fellowship Grant (PF-12-118-01-CPPB) and by a National Institutes of Health Training Grant (NIH 5 T32 DK007782-12). Dr Miller is supported in part by Blue Cross Blue Shield of Michigan for efforts as director of the Michigan Urological Surgery Improvement Collaborative. Dr Hollenbeck is supported in part by the National Cancer Institute (R01-CA-168691-01).	Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Allison P. D., 1999, LOGISTIC REGRESSION; Altekruse S, 2010, SEER CANC STAT REV 1; [Anonymous], OBS RAD TREATM PAT P; Barbash GI, 2010, NEW ENGL J MED, V363, P701, DOI 10.1056/NEJMp1006602; Carreyrou J, 2010, WALL STREET J; Carter HB, 2012, J CLIN ONCOL, V30, P4294, DOI 10.1200/JCO.2012.44.0586; Chamie K, 2012, J GEN INTERN MED, V27, P492, DOI 10.1007/s11606-011-1869-4; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Etzioni R, 2012, CLIN CANCER RES, V18, P6742, DOI 10.1158/1078-0432.CCR-12-1537; Fendrick AM, 2012, HEALTH SERV RES, V47, P404, DOI 10.1111/j.1475-6773.2011.01358.x; Gross CP, 2006, ANN INTERN MED, V145, P646, DOI 10.7326/0003-4819-145-9-200611070-00006; Grossfeld GD, 2001, J UROLOGY, V165, P851, DOI 10.1016/S0022-5347(05)66543-3; Heidenreich A, 2011, EUR UROL, V59, P61, DOI 10.1016/j.eururo.2010.10.039; Hu JC, 2009, JAMA-J AM MED ASSOC, V302, P1557, DOI 10.1001/jama.2009.1451; Jacobs BL, 2014, EUR UROL, V65, P162, DOI 10.1016/j.eururo.2012.06.055; Jacobs BL, 2012, HEALTH AFFAIR, V31, P750, DOI 10.1377/hlthaff.2011.1062; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim SP, 2012, J CLIN ONCOL, V30; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Konski A, 2006, INT J RADIAT ONCOL, V66, P408, DOI 10.1016/j.ijrobp.2006.04.049; Krahn MD, 2002, UROLOGY, V60, P258, DOI 10.1016/S0090-4295(02)01712-0; Litwin MS, 2007, CANCER-AM CANCER SOC, V109, P1777, DOI 10.1002/cncr.22615; Lu-Yao GL, 2009, JAMA-J AM MED ASSOC, V302, P1202, DOI 10.1001/jama.2009.1348; Mell LK, 2005, CANCER-AM CANCER SOC, V104, P1296, DOI 10.1002/cncr.21284; Mohler JL, 2010, J NATL COMPR CANC NE, V8, P145, DOI 10.6004/jnccn.2010.0010; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; R Development Core Team, 2009, R LANG ENV STAT COMP; Ries LA, 2008, SEER CANC STAT REV 1; Roehrig C, 2009, HEALTH AFFAIR, V28, pW358, DOI 10.1377/hlthaff.28.2.w358; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Smedley B.D, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875	35	109	109	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2587	2595		10.1001/jama.2013.6882	http://dx.doi.org/10.1001/jama.2013.6882			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23800935	Green Accepted			2022-12-28	WOS:000320848100029
J	Fuhrer, MS				Fuhrer, Michael S.			Critical Mass in Graphene	SCIENCE			English	Editorial Material							SUPERLATTICES		Monash Univ, Sch Phys, Monash, Vic 3800, Australia	Monash University	Fuhrer, MS (corresponding author), Monash Univ, Sch Phys, Monash, Vic 3800, Australia.	michael.fuhrer@monash.au	Fuhrer, Michael S/E-7634-2010	Fuhrer, Michael S/0000-0001-6183-2773				Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Giovannetti G, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.073103; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Semenoff GW, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087204; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134; Yao W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096801	8	16	16	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1413	1414		10.1126/science.1240317	http://dx.doi.org/10.1126/science.1240317			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23788788				2022-12-28	WOS:000320647000028
J	Atkinson, JD; Murray, BJ; Woodhouse, MT; Whale, TF; Baustian, KJ; Carslaw, KS; Dobbie, S; O'Sullivan, D; Malkin, TL				Atkinson, James D.; Murray, Benjamin J.; Woodhouse, Matthew T.; Whale, Thomas F.; Baustian, Kelly J.; Carslaw, Kenneth S.; Dobbie, Steven; O'Sullivan, Daniel; Malkin, Tamsin L.			The importance of feldspar for ice nucleation by mineral dust in mixed-phase clouds	NATURE			English	Article							BIOLOGICAL PARTICLES; AEROSOL; CLIMATE; NUCLEI; MODEL	The amount of ice present in mixed-phase clouds, which contain both supercooled liquid water droplets and ice particles, affects cloud extent, lifetime, particle size and radiative properties(1,2). The freezing of cloud droplets can be catalysed by the presence of aerosol particles known as ice nuclei(2). One of the most important ice nuclei is thought to be mineral dust aerosol from arid regions(2,3). It is generally assumed that clay minerals, which contribute approximately two-thirds of the dust mass, dominate ice nucleation by mineral dust, and many experimental studies have therefore focused on these materials(1,2,4-6). Here we use an established droplet-freezing technique(4,7) to show that feldspar minerals dominate ice nucleation by mineral dusts under mixed-phase cloud conditions, despite feldspar being a minor component of dust emitted from arid regions. We also find that clay minerals are relatively unimportant ice nuclei. Our results from a global aerosol model study suggest that feldspar ice nuclei are globally distributed and that feldspar particles may account for a large proportion of the ice nuclei in Earth's atmosphere that contribute to freezing at temperatures below about -15 degrees C.	[Atkinson, James D.; Murray, Benjamin J.; Woodhouse, Matthew T.; Whale, Thomas F.; Baustian, Kelly J.; Carslaw, Kenneth S.; Dobbie, Steven; O'Sullivan, Daniel; Malkin, Tamsin L.] Univ Leeds, Sch Earth & Environm, Inst Climate & Atmospher Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Murray, BJ (corresponding author), Univ Leeds, Sch Earth & Environm, Inst Climate & Atmospher Sci, Leeds LS2 9JT, W Yorkshire, England.	b.j.murray@leeds.ac.uk	Woodhouse, Matthew T/E-4808-2013; Whale, Thomas/C-6205-2015; Atkinson, James/D-1668-2011; Murray, Benjamin/C-1219-2010; Malkin, Tamsin/C-9514-2011; Carslaw, Ken S/C-8514-2009; O'Sullivan, Daniel/G-3884-2012	Woodhouse, Matthew T/0000-0002-9892-4492; Whale, Thomas/0000-0002-1062-2685; Murray, Benjamin/0000-0002-8198-8131; Malkin, Tamsin/0000-0001-7314-0870; Carslaw, Ken S/0000-0002-6800-154X; O'Sullivan, Daniel/0000-0002-6884-8046	European Research Council [240449 ICE]; Natural Environment Research Council [NE/I013466/1, NE/I020059/1, NE/I019057/1]; Royal Society; NERC [NE/H001050/1, NE/K004417/1, NE/I013466/1, NE/I020059/1] Funding Source: UKRI; Natural Environment Research Council [NE/K004417/1, 1047972, NE/H001050/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. Cuadros, L. Neve and R. Finch for help sourcing mineral samples, P. DeMott for providing ice nuclei observational data, and T. W. Wilson for discussions. We acknowledge the European Research Council (FP7, 240449 ICE) and the Natural Environment Research Council (NE/I013466/1, NE/I020059/1, NE/I019057/1) for funding. K. S. C. is a Royal Society Wolfson Research Merit Award holder.	Arnold SR, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005998; Broadley SL, 2012, ATMOS CHEM PHYS, V12, P287, DOI 10.5194/acp-12-287-2012; Burrows SM, 2013, ATMOS CHEM PHYS, V13, P245, DOI 10.5194/acp-13-245-2013; Choi YS, 2010, P NATL ACAD SCI USA, V107, P11211, DOI 10.1073/pnas.1006241107; Connolly PJ, 2009, ATMOS CHEM PHYS, V9, P2805, DOI 10.5194/acp-9-2805-2009; Crawford I, 2012, ATMOS CHEM PHYS, V12, P4963, DOI 10.5194/acp-12-4963-2012; de Boer G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046016; DeMott PJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017410; DEMOTT PJ, 1995, ATMOS RES, V38, P63, DOI 10.1016/0169-8095(94)00088-U; Dentener F, 2006, ATMOS CHEM PHYS, V6, P4321, DOI 10.5194/acp-6-4321-2006; Ginoux P, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000388; GLACCUM RA, 1980, MAR GEOL, V37, P295, DOI 10.1016/0025-3227(80)90107-3; Hoose C, 2012, ATMOS CHEM PHYS, V12, P9817, DOI 10.5194/acp-12-9817-2012; Hoose C, 2010, J ATMOS SCI, V67, P2483, DOI 10.1175/2010JAS3425.1; Jeong GY, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008606; Kandler K, 2011, TELLUS B, V63, P459, DOI 10.1111/j.1600-0889.2011.00546.x; Kanitz T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048532; Luond F, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012959; Mahowald NM, 2010, ATMOS CHEM PHYS, V10, P10875, DOI 10.5194/acp-10-10875-2010; Murray BJ, 2012, CHEM SOC REV, V41, P6519, DOI 10.1039/c2cs35200a; Murray BJ, 2011, ATMOS CHEM PHYS, V11, P4191, DOI 10.5194/acp-11-4191-2011; Nickovic S, 2012, ATMOS CHEM PHYS, V12, P845, DOI 10.5194/acp-12-845-2012; Niemand M, 2012, J ATMOS SCI, V69, P3077, DOI 10.1175/JAS-D-11-0249.1; Pinti V, 2012, ATMOS CHEM PHYS, V12, P5859, DOI 10.5194/acp-12-5859-2012; Pratt KA, 2009, NAT GEOSCI, V2, P397, DOI 10.1038/NGEO521; Shi ZB, 2011, ATMOS CHEM PHYS, V11, P8459, DOI 10.5194/acp-11-8459-2011; Spracklen DV, 2005, ATMOS CHEM PHYS, V5, P2227, DOI 10.5194/acp-5-2227-2005; Sullivan RC, 2010, ATMOS CHEM PHYS, V10, P11471, DOI 10.5194/acp-10-11471-2010; VALI G, 1971, J ATMOS SCI, V28, P402, DOI 10.1175/1520-0469(1971)028<0402:QEOERA>2.0.CO;2; Zhu C, 2006, GEOCHIM COSMOCHIM AC, V70, P4600, DOI 10.1016/j.gca.2006.07.013	30	414	416	17	323	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					355	358		10.1038/nature12278	http://dx.doi.org/10.1038/nature12278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23760484	Green Submitted			2022-12-28	WOS:000320592900038
J	Hayes, JH; Ollendorf, DA; Pearson, SD; Barry, MJ; Kantoff, PW; Lee, PA; McMahon, PM				Hayes, Julia H.; Ollendorf, Daniel A.; Pearson, Steven D.; Barry, Michael J.; Kantoff, Philip W.; Lee, Pablo A.; McMahon, Pamela M.			Observation Versus Initial Treatment for Men With Localized, Low-Risk Prostate Cancer A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVE SURVEILLANCE; RADICAL PROSTATECTOMY; CONTROLLED-TRIAL; MANAGEMENT; OUTCOMES; MORTALITY; THERAPY; RADIATION; BIOPSY; GRADE	Background: Observation is underutilized among men with localized, low-risk prostate cancer. Objective: To assess the costs and benefits of observation versus initial treatment. Design: Decision analysis simulating treatment or observation. Data Sources: Medicare schedules, published literature. Target Population: Men aged 65 and 75 years who had newly diagnosed low-risk prostate cancer (prostate-specific antigen level <10 mu g/L, stage <= T2a, Gleason score <= 3 + 3). Time Horizon: Lifetime. Perspective: Societal. Intervention: Treatment (brachytherapy, intensity-modulated radiation therapy, or radical prostatectomy) or observation (active surveillance [AS] or watchful waiting [WW]). Outcome Measures: Quality-adjusted life expectancy and costs. Results of Base-Case Analysis: Observation was more effective and less costly than initial treatment. Compared with AS, WW provided 2 additional months of quality-adjusted life expectancy (9.02 vs. 8.85 years) at a savings of $15 374 ($24 520 vs. $39 894) in men aged 65 years and 2 additional months (6.14 vs. 5.98 years) at a savings of $11 746 ($18 302 vs. $30 048) in men aged 75 years. Brachytherapy was the most effective and least expensive initial treatment. Results of Sensitivity Analysis: Treatment became more effective than observation when it led to more dramatic reductions in prostate cancer death (hazard ratio, 0.47 vs. WW and 0.64 vs. AS). Active surveillance became as effective as WW in men aged 65 years when the probability of progressing to treatment on AS decreased below 63% or when the quality of life with AS versus WW was 4% higher in men aged 65 years or 1% higher in men aged 75 years. Watchful waiting remained least expensive in all analyses. Limitation: Results depend on outcomes reported in the published literature, which is limited. Conclusion: Among these men, observation is more effective and costs less than initial treatment, and WW is most effective and least expensive under a wide range of clinical scenarios.	Harvard Univ, Sch Med, Dana Farber Canc Inst,Inst Technol Assessment, Lank Ctr Genitourinary Oncol,Inst Clin & Econ Rev, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital	Hayes, JH (corresponding author), Dana Farber Canc Inst, Dana 1230,450 Brookline Ave, Boston, MA 02115 USA.	Julia_Hayes@dfci.harvard.edu		Kantoff, Philip/0000-0001-7275-0597	National Cancer Institute; U.S. Department of Defense [W81XWH-09-1-0512]; Prostate Cancer Foundation; Institute for Clinical and Economic Review; National Cancer Institute at the National Institutes of Health [R25 CA92203-08]; Blue Shield of California Foundation; Agency for Healthcare Research and Quality; Health Dialog; NATIONAL CANCER INSTITUTE [R25CA092203] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense(United States Department of Defense); Prostate Cancer Foundation; Institute for Clinical and Economic Review; National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Blue Shield of California Foundation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Health Dialog; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute, U.S. Department of Defense, Prostate Cancer Foundation, and Institute for Clinical and Economic Review.; By grant R25 CA92203-08 (National Cancer Institute at the National Institutes of Health), grant W81XWH-09-1-0512 (U.S. Department of Defense), a Young Investigators Award to Dr. Hayes (Prostate Cancer Foundation), and funding to the Institute for Clinical and Economic Review from the Blue Shield of California Foundation.; Dr. Hayes: Grants (money to institution): U.S. Department of Defense, Prostate Cancer Foundation; Royalties: UpToDate. Dr. Ollendorf: Grants (money to institution): Blue Shield of California Foundation. Dr. Pearson: Consultancy: National Institutes of Health, Yale University; Employment: Massachusetts General Hospital; Grants/grants pending (money to institution): Agency for Healthcare Research and Quality. Dr. Barry: Board membership: Informed Medical Decisions Foundation; Employment: Informed Medical Decisions Foundation; Royalties (money to institution): Health Dialog. Dr. McMahon: Grants (money to institution): Blue Shield of California Foundation, Harvard Community Health Plan. All other authors have no disclosures. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-0857.	Alibhai SMH, 2003, J CLIN ONCOL, V21, P3318, DOI 10.1200/JCO.2003.09.034; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], 2012, PROTECT TRIAL EVALUA; Berglund RK, 2008, J UROLOGY, V180, P1964, DOI 10.1016/j.juro.2008.07.051; Carter HB, 2007, J UROLOGY, V178, P2359, DOI 10.1016/j.juro.2007.08.039; Centers for Medicare & Medicaid Services, 2008, HOSP OUTP PROSP PAYM; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Corcoran AT, 2010, UROLOGY, V76, P703, DOI 10.1016/j.urology.2009.12.071; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Dahabreh IJ, 2012, ANN INTERN MED, V156, P582, DOI [10.7326/0003-4819-156-8-201204170-00009, 10.7326/0003-4819-156-8-201204170-00397]; Dale W, 2008, MED DECIS MAKING, V28, P102, DOI 10.1177/0272989X07309639; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P2664, DOI 10.1002/cncr.23502; Fleshner NE, 2012, LANCET, V379, P1103, DOI 10.1016/S0140-6736(11)61619-X; Gold MR, 1996, COST EFFECTIVENESS H, P425; Hardie C, 2005, BJU INT, V95, P956, DOI 10.1111/j.1464-410X.2005.05446.x; Hayes JH, 2010, JAMA-J AM MED ASSOC, V304, P2373, DOI 10.1001/jama.2010.1720; Horwitz EM, 2005, J UROLOGY, V173, P797, DOI 10.1097/01.ju.0000152556.53602.64; Institute for Clinical and Economic Review, 2009, ACT SURV RAD PROST F; Institute for Clinical and Economic Review, 2009, FIN APPR DOC BRACH P; Institute for Clinical and Economic Review, 2007, IMRT FIN APPR FULL R; Keegan KA, 2012, CANCER-AM CANCER SOC, V118, P3512, DOI 10.1002/cncr.26688; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Koerkamp BG, 2007, MED DECIS MAKING, V27, P101, DOI 10.1177/0272989X06297394; Lu-Yao GL, 2009, JAMA-J AM MED ASSOC, V302, P1202, DOI 10.1001/jama.2009.1348; Patel MI, 2004, J UROLOGY, V171, P1520, DOI 10.1097/01.ju.0000118224.54949.78; Penson DF, 2007, J UROLOGY, V177, P2020, DOI 10.1016/j.juro.2007.01.121; Porten SP, 2011, J CLIN ONCOL, V29, P2795, DOI 10.1200/JCO.2010.33.0134; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sheridan TB, 2008, J UROLOGY, V179, P901, DOI 10.1016/j.juro.2007.10.062; Shteynshlyuger A, 2011, J UROLOGY, V185, P828, DOI 10.1016/j.juro.2010.10.079; Stattin P, 2010, JNCI-J NATL CANCER I, V102, P950, DOI 10.1093/jnci/djq154; U.S. Bureau of Labor Statistics, 2013, CONS PRIC IND MED CA; U.S. Bureau of Labor Statistics, 2013, HOUS DAT TABLE 3 MED; van As NJ, 2008, EUR UROL, V54, P1297, DOI 10.1016/j.eururo.2008.02.039; van den Bergh RCN, 2010, BJU INT, V105, P956, DOI 10.1111/j.1464-410X.2009.08887.x; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Wilson LS, 2007, CANCER-AM CANCER SOC, V109, P518, DOI 10.1002/cncr.22433; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Xia J, 2012, CLIN CANCER RES, V18, P5471, DOI 10.1158/1078-0432.CCR-12-1502	39	96	97	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12					853	+		10.7326/0003-4819-158-12-201306180-00002	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-00002			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778902	Green Accepted			2022-12-28	WOS:000320645000013
J	Porto, JV				Porto, J. V.			Cold-Atom Magnetism	SCIENCE			English	Editorial Material							OPTICAL LATTICES; MOTT INSULATOR; ULTRACOLD ATOMS; TRANSITION; SUPERFLUID		NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA	Porto, JV (corresponding author), NIST, Joint Quantum Inst, 100 Bur Dr,Stop 8424, Gaithersburg, MD 20899 USA.	trey@nist.gov	Porto, Trey/AAH-2101-2021	Porto, James/0000-0002-6290-7535				Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Bernier JS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.061601; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; Greif D, 2013, SCIENCE, V340, P1307, DOI 10.1126/science.1236362; Griessner A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220403; Ho TL, 2009, P NATL ACAD SCI USA, V106, P6916, DOI 10.1073/pnas.0809862105; McKay DC, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/5/054401; Medley P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.195301; Pichler H, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.063605; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841	14	0	0	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1297	1298		10.1126/science.1239873	http://dx.doi.org/10.1126/science.1239873			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766320				2022-12-28	WOS:000320320200031
J	Brenner, SE				Brenner, Steven E.			Be prepared for the big genome leak	NATURE			English	Editorial Material									Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Brenner, SE (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	brenner@compbio.berkeley.edu	Brenner, Steven E/A-8729-2008	Brenner, Steven E/0000-0001-7559-6185					0	20	20	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					139	139		10.1038/498139a	http://dx.doi.org/10.1038/498139a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	162RR	23765454	Bronze			2022-12-28	WOS:000320283400007
J	Pera, M; Trounson, A				Pera, Martin; Trounson, Alan			Stem-cell researchers must stay engaged	NATURE			English	Editorial Material							NUCLEAR TRANSFER		[Pera, Martin] Univ Melbourne, Melbourne, Vic 3010, Australia; [Trounson, Alan] Calif Inst Regenerat Med, San Francisco, CA USA	University of Melbourne	Pera, M (corresponding author), Univ Melbourne, Melbourne, Vic 3010, Australia.	mpera@unimelb.edu.au; atrounson@cirm.ca.gov	PERA, MARTIN/A-9812-2012	PERA, MARTIN/0000-0001-6239-0428; Trounson, Alan/0000-0001-5469-0500				Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Grieshammer U, 2011, NAT BIOTECHNOL, V29, P701, DOI 10.1038/nbt.1933; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Narbonne P, 2012, CURR OPIN GENET DEV, V22, P450, DOI 10.1016/j.gde.2012.09.002; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Ronen D, 2012, CURR OPIN GENET DEV, V22, P444, DOI 10.1016/j.gde.2012.09.003; Scott CT, 2009, NAT BIOTECHNOL, V27, P696, DOI 10.1038/nbt0809-696; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647	9	3	3	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					159	161		10.1038/498159a	http://dx.doi.org/10.1038/498159a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	162RR	23765475	Bronze			2022-12-28	WOS:000320283400017
J	Spence, D				Spence, Des			Consultants' contracts: could do better	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Academy of Medical Royal Colleges, 2010, ADV SUPP PROF ACT CO; Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Department of Health National Audit Office, 2012, MAN NHS HOSP CONS HC; Jacques H., 2012, BMJ CAREERS; Medical Careers, 2013, NAT TRENDS TERMS GEN	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2013	346								f3701	10.1136/bmj.f3701	http://dx.doi.org/10.1136/bmj.f3701			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WH	23761188				2022-12-28	WOS:000320589800004
J	King, A; Azuara-Blanco, A; Tuulonen, A				King, Anthony; Azuara-Blanco, Augusto; Tuulonen, Anja			Glaucoma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION; COST-EFFECTIVENESS; RISK-FACTORS; ONSET		[King, Anthony] Univ Nottingham Hosp, Nottingham NG7 2UH, England; [King, Anthony] Univ Nottingham, Nottingham NG7 2UH, England; [Azuara-Blanco, Augusto] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland; [Tuulonen, Anja] Tampere Univ Hosp, Tays Eye Ctr, Tampere, Finland	University of Nottingham; University of Nottingham; Queens University Belfast; Tampere University; Tampere University Hospital	King, A (corresponding author), Univ Nottingham Hosp, Nottingham NG7 2UH, England.	anthony.king@nottingham.ac.uk		Graham, Stuart/0000-0001-7519-969X; Azuara-Blanco, Augusto/0000-0002-4805-9322; King, Anthony/0000-0002-3091-911X				Bhargava JS, 2006, INVEST OPHTH VIS SCI, V47, P2885, DOI 10.1167/iovs.05-1244; Bunce C, 2010, EYE, V24, P1692, DOI 10.1038/eye.2010.122; Burr JM, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16290; Burr J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004399.pub3; Burr J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11410; Centofanti M, 2005, OPHTHALMOLOGY, V112, P366, DOI 10.1016/j.ophtha.2004.11.030; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Ernest PJ, 2012, OPHTHALMOLOGY; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fraser S, 1999, INVEST OPHTH VIS SCI, V40, P2251; Gedde SJ, 2012, CURR OPIN OPHTHALMOL, V23, P118, DOI 10.1097/ICU.0b013e32834ff2d1; Gray TA, 2009, COCHRANE DB SYST REV, V2; Hattenhauer MG, 1998, OPHTHALMOLOGY, V105, P2099, DOI 10.1016/S0161-6420(98)91133-2; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Heijl Anders, 2012, Acta Ophthalmol Suppl (Oxf ), P1, DOI 10.1111/j.1755-3768.2012.02415.x; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; KASS MA, 1986, AM J OPHTHALMOL, V101, P524, DOI 10.1016/0002-9394(86)90940-2; Maier PC, 2005, BMJ-BRIT MED J, V331, P134, DOI 10.1136/bmj.38506.594977.E0; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Institute for Health and Clinical Excellence Glaucoma, 2009, DIAGN MAN CHRON OP A; Ng WS, 2010, BRIT J OPHTHALMOL, V94, P85, DOI 10.1136/bjo.2008.153312; Olthoff CMG, 2005, OPHTHALMOLOGY, V112, P953, DOI 10.1016/j.ophtha.2004.12.035; Rolim de Moura C, 2007, COCHRANE DB SYST REV, V4; Rudnicka AR, 2006, INVEST OPHTH VIS SCI, V47, P4254, DOI 10.1167/iovs.06-0299; Sena DF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006539.pub3; Spry PGD, 1999, BRIT J OPHTHALMOL, V83, P707, DOI 10.1136/bjo.83.6.707; Sukumar S, 2009, EYE, V23, P1038, DOI 10.1038/eye.2008.245; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Tanabe S, 2011, INVEST OPHTH VIS SCI, V52, P4177, DOI 10.1167/iovs.10-6264; Tuulonen A, 2003, ACTA OPHTHALMOL SCAN, V81, P3, DOI 10.1034/j.1600-0420.2003.00021.x; Tuulonen A, 2011, INDIAN J OPHTHALMOL, V59, pS24, DOI 10.4103/0301-4738.73684; Vaahtoranta-Lehtonen H, 2007, ACTA OPHTHALMOL SCAN, V85, P508, DOI 10.1111/j.1600-0420.2007.00947.x; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wittenborn JS, 2011, OPTOMETRY VISION SCI, V88, P155, DOI 10.1097/OPX.0b013e3181fc30f3; Wong MH, 2013, OPHTHALMOLOGY; World Health Organization, GLOB DAT VIS IMP 201	38	63	65	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2013	346								f3518	10.1136/bmj.f3518	http://dx.doi.org/10.1136/bmj.f3518			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VQ	23757737				2022-12-28	WOS:000320587600021
J	Chang, CH; Curtis, JD; Maggi, LB; Faubert, B; Villarino, AV; O'Sullivan, D; Huang, SCC; van der Windt, GJW; Blagih, J; Qiu, J; Weber, JD; Pearce, EJ; Jones, RG; Pearce, EL				Chang, Chih-Hao; Curtis, Jonathan D.; Maggi, Leonard B., Jr.; Faubert, Brandon; Villarino, Alejandro V.; O'Sullivan, David; Huang, Stanley Ching-Cheng; van der Windt, Gerritje J. W.; Blagih, Julianna; Qiu, Jing; Weber, Jason D.; Pearce, Edward J.; Jones, Russell G.; Pearce, Erika L.			Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis	CELL			English	Article							MESSENGER-RNA STABILITY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ENERGY-METABOLISM; OVARIAN-CANCER; ACTIVATION; DIFFERENTIATION; EXPRESSION; GLUTAMINE; MECHANISM; BINDING	A "switch'' from oxidative phosphorylation (OXPHOS) to aerobic glycolysis is a hallmark of T cell activation and is thought to be required to meet the metabolic demands of proliferation. However, why proliferating cells adopt this less efficient metabolism, especially in an oxygen-replete environment, remains incompletely understood. We show here that aerobic glycolysis is specifically required for effector function in T cells but that this pathway is not necessary for proliferation or survival. When activated T cells are provided with costimulation and growth factors but are blocked from engaging glycolysis, their ability to produce IFN-gamma is markedly compromised. This defect is translational and is regulated by the binding of the glycolysis enzyme GAPDH to AU-rich elements within the 3' UTR of IFN-gamma mRNA. GAPDH, by engaging/disengaging glycolysis and through fluctuations in its expression, controls effector cytokine production. Thus, aerobic glycolysis is a metabolically regulated signaling mechanism needed to control cellular function.	[Chang, Chih-Hao; Curtis, Jonathan D.; O'Sullivan, David; Huang, Stanley Ching-Cheng; van der Windt, Gerritje J. W.; Qiu, Jing; Pearce, Edward J.; Pearce, Erika L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Maggi, Leonard B., Jr.; Weber, Jason D.] Washington Univ, Sch Med, Div Mol Oncol, BRIGHT Inst, St Louis, MO 63110 USA; [Faubert, Brandon; Blagih, Julianna; Jones, Russell G.] McGill Univ, Dept Physiol, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Villarino, Alejandro V.] NIAMSD, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); Washington University (WUSTL); McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Pearce, EL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	erikapearce@path.wustl.edu	Jones, Russell/AAC-2861-2022; Huang, Stanley Ching-Cheng/AAE-7866-2019; Maggi, Leonard/L-5217-2019; Jones, Russell Graham/ABD-5261-2021; Villarino, Alejandro/AAE-3517-2020	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Maggi, Leonard/0000-0003-0138-0984; Jones, Russell Graham/0000-0003-2250-4675; Villarino, Alejandro/0000-0001-8068-2176; Weber, Jason/0000-0002-1069-6983; Faubert, Brandon/0000-0002-2886-886X; CHANG, CHIH-HAO/0000-0002-0139-7439	NIH [AI091965, CA158823, CA164062]; CIHR [MOP-93799]; Emerald Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE [R01CA164062, R21CA158823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Emerald Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Andrey Shaw, Ken Murphy, Skip Virgin, Abul Abbas, Eyal Amiel, Rong Zeng, Qiongyu Chen, Monika Vig, Georgia Perona-Wright, Bart Everts, and the Goodman Cancer Research Centre Metabolomics Core Facility at McGIll University. This work was supported in part by grants from the NIH (AI091965 and CA158823 to E.L.P. and CA164062 to E.J.P.), CIHR (MOP-93799 to R.G.J.), The Arthritis Society of Canada (R.G.J.), NWO (G.J.W.v.d.W.), and the Emerald Foundation Young Investigator Award ( E.L.P.). C.- H.C., L.B.M., J.D.W., A.V.V., E.J.P., R. G. J., and E. L. P. designed the research. C.C., J.D.C., S.C.- C.H., G. J.W.v.d., D.O., J.B., B.F., J.Q., and E.L.P. analyzed data. C. C., J. D. C., L.B.M., B.F., S.C.- C.H., D.O., G.J.W.v.d. W., J.Q., and E.L.P. performed experiments. C.C., E.J.P., and E.L.P. contributed to the preparation of the manuscript. C.C. and E.L.P. wrote the manuscript.	Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Arif A, 2012, MOL CELL BIOL, V32, P5046, DOI 10.1128/MCB.01168-12; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bonafe N, 2005, CANCER RES, V65, P3762, DOI 10.1158/0008-5472.CAN-04-3954; Bustamente E, 1977, Adv Exp Med Biol, V92, P363; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; GarciaSanz JA, 1996, J EXP MED, V184, P159, DOI 10.1084/jem.184.1.159; Gatza E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001975; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kondo S, 2011, BIOCHEM BIOPH RES CO, V405, P382, DOI 10.1016/j.bbrc.2011.01.034; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Le Goffe C, 1999, BIOCHEM J, V344, P643, DOI 10.1042/0264-6021:3440643; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Miceli AP, 2012, MOL CELL BIOL, V32, P348, DOI 10.1128/MCB.06030-11; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nagy E, 2000, BIOCHEM BIOPH RES CO, V275, P253, DOI 10.1006/bbrc.2000.3246; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rodriguez-Pascual F, 2008, MOL CELL BIOL, V28, P7139, DOI 10.1128/MCB.01145-08; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Tripmacher R, 2008, EUR J IMMUNOL, V38, P1631, DOI 10.1002/eji.200738047; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Villarino AV, 2011, IMMUNITY, V34, P50, DOI 10.1016/j.immuni.2010.12.014; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Zhou Y, 2008, MOL CANCER RES, V6, P1375, DOI 10.1158/1541-7786.MCR-07-2170	42	1250	1304	18	164	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1239	1251		10.1016/j.cell.2013.05.016	http://dx.doi.org/10.1016/j.cell.2013.05.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746840	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000319979200010
J	Spalding, KL; Bergmann, O; Alkass, K; Bernard, S; Salehpour, M; Huttner, HB; Bostrom, E; Westerlund, I; Vial, C; Buchholz, BA; Possnert, G; Mash, DC; Druid, H; Frisen, J				Spalding, Kirsty L.; Bergmann, Olaf; Alkass, Kanar; Bernard, Samuel; Salehpour, Mehran; Huttner, Hagen B.; Bostrom, Emil; Westerlund, Isabelle; Vial, Celine; Buchholz, Bruce A.; Possnert, Goran; Mash, Deborah C.; Druid, Henrik; Frisen, Jonas			Dynamics of Hippocampal Neurogenesis in Adult Humans	CELL			English	Article							ENHANCED SYNAPTIC PLASTICITY; GRANULE CELLS; OLFACTORY-BULB; DENTATE GYRUS; NEURONS; C-14; AGE; RADIOCARBON; BRAIN	Adult-born hippocampal neurons are important for cognitive plasticity in rodents. There is evidence for hippocampal neurogenesis in adult humans, although whether its extent is sufficient to have functional significance has been questioned. We have assessed the generation of hippocampal cells in humans by measuring the concentration of nuclearbomb-test-derived C-14 in genomic DNA, and we present an integrated model of the cell turnover dynamics. We found that a large subpopulation of hippocampal neurons constituting one-third of the neurons is subject to exchange. In adult humans, 700 new neurons are added in each hippocampus per day, corresponding to an annual turnover of 1.75% of the neurons within the renewing fraction, with a modest decline during aging. We conclude that neurons are generated throughout adulthood and that the rates are comparable in middle-aged humans and mice, suggesting that adult hippocampal neurogenesis may contribute to human brain function.	[Spalding, Kirsty L.; Bergmann, Olaf; Alkass, Kanar; Huttner, Hagen B.; Bostrom, Emil; Westerlund, Isabelle; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Alkass, Kanar; Druid, Henrik] Karolinska Inst, Dept Oncol Pathol, S-17177 Stockholm, Sweden; [Bernard, Samuel; Vial, Celine] Univ Lyon, CNRS UMR 5208, Inst Camille Jordan, F-69622 Villeurbanne, France; [Salehpour, Mehran; Possnert, Goran] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Huttner, Hagen B.] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Buchholz, Bruce A.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA; [Mash, Deborah C.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA	Karolinska Institutet; Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Uppsala University; University of Erlangen Nuremberg; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Miami	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Bergmann, Olaf/A-5706-2009; spalding, kirsty/I-6046-2017; Spalding, Kirsty/CAF-4248-2022; Bernard, Samuel/A-5623-2009; Buchholz, Bruce A/G-1356-2011	Bergmann, Olaf/0000-0003-1065-4107; Spalding, Kirsty/0000-0002-5189-7028; Bernard, Samuel/0000-0002-8442-9968; Buchholz, Bruce A/0000-0002-9531-551X; Druid, Henrik/0000-0002-9198-023X; alkass, kanar/0000-0002-9154-5393	Swedish Research Council; T. Stiftelsen, Hjarnfonden; Swedish Foundation for Strategic Research; National Alliance for Research on Schizophrenia and Depression; AFA Forsakringar; Knut and Alice Wallenberg Foundation; National Institute on Drug Abuse [DA031429]; European Research Council; National Institutes of Health (NIH); National Center for Research Resources [5P41RR013461]; National Institute of General Medical Sciences [8P41GM103483]; regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institute [ALF 20080508]; Lawrence Livermore National Laboratory [AC5207NA27344]; German Research Foundation (DFG) [Hu 1961/1-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031429] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); T. Stiftelsen, Hjarnfonden; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); National Alliance for Research on Schizophrenia and Depression(NARSAD); AFA Forsakringar; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institute; Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Toro, S. Giatrellis, A. Busch, E. Kiss, and H. Ismail for flow cytometry; K. Hakansson for AMS sample preparation; A. Racz for tissue procurement; and F. Gage, G. Kempermann, and L. Slomianka for valuable discussions. The staff at the Swedish National Board of Forensic Medicine is acknowledged for cooperation in tissue donation. This study was supported by the Swedish Research Council, T. Stiftelsen, Hjarnfonden, the Swedish Foundation for Strategic Research, the National Alliance for Research on Schizophrenia and Depression, AFA Forsakringar, the Knut and Alice Wallenberg Foundation, the National Institute on Drug Abuse (DA031429), the European Research Council, the National Institutes of Health (NIH) and the National Center for Research Resources (5P41RR013461), the NIH and the National Institute of General Medical Sciences (8P41GM103483), and the regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institute (ALF 20080508). This work was performed, in part, with the support of the U.S.Department of Energy by the Lawrence Livermore National Laboratory (under contract DE-AC5207NA27344). H.B.H. was funded by a grant from the German Research Foundation (DFG: Hu 1961/1-1).	Amrein I, 2011, EUR J NEUROSCI, V34, P978, DOI 10.1111/j.1460-9568.2011.07804.x; Appleby PA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001063; Arellano JI, 2011, NATURE, V478, P333, DOI 10.1038/478333a; BAYER SA, 1985, ANN NY ACAD SCI, V457, P163, DOI 10.1111/j.1749-6632.1985.tb20804.x; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Brown TA, 1997, NUCL INSTRUM METH B, V123, P208, DOI 10.1016/S0168-583X(96)00676-3; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fallon SJ, 2007, NUCL INSTRUM METH B, V259, P106, DOI 10.1016/j.nimb.2007.01.149; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Goritz C, 2012, CELL STEM CELL, V10, P657, DOI 10.1016/j.stem.2012.04.005; HARKNESS DD, 1972, NATURE, V240, P302, DOI 10.1038/240302a0; Hua Q, 2004, NUCL INSTRUM METH B, V223, P284, DOI 10.1016/j.nimb.2004.04.057; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jabes A, 2010, EUR J NEUROSCI, V31, P273, DOI 10.1111/j.1460-9568.2009.07061.x; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; Levin I, 2010, TELLUS B, V62, P26, DOI 10.1111/j.1600-0889.2009.00446.x; LIBBY WF, 1964, SCIENCE, V146, P1171; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; Salehpour M, 2013, NUCL INSTRUM METH B, V294, P97, DOI 10.1016/j.nimb.2012.08.054; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Santos GM, 2007, NUCL INSTRUM METH B, V259, P293, DOI 10.1016/j.nimb.2007.01.172; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spalding KL, 2005, NATURE, V437, P333, DOI 10.1038/437333a; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; VRIES HD, 1958, SCIENCE, V128, P250; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83	44	1146	1184	4	208	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1219	1227		10.1016/j.cell.2013.05.002	http://dx.doi.org/10.1016/j.cell.2013.05.002			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746839	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000319979200008
J	Warren, RB; Chinoy, H				Warren, Richard B.; Chinoy, Hector			Ustekinumab for psoriatic arthritis: close to the PSUMMIT?	LANCET			English	Editorial Material							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; DOUBLE-BLIND; ASSOCIATION; EFFICACY; SAFETY		[Warren, Richard B.] Salford Royal Natl Hlth Serv Fdn Trust, Dermatol Ctr, Salford, Lancs, England; [Chinoy, Hector] Salford Royal Natl Hlth Serv Fdn Trust, Ctr Rheumat Dis, Salford, Lancs, England; [Warren, Richard B.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M6 8HD, Lancs, England	Salford Royal NHS Foundation Trust; Salford Royal NHS Foundation Trust; University of Manchester	Warren, RB (corresponding author), Salford Royal Natl Hlth Serv Fdn Trust, Dermatol Ctr, Salford, Lancs, England.	richard.warren@manchester.ac.uk	Warren, Richard B/G-4929-2015; Chinoy, Hector/C-7832-2013	Warren, Richard B/0000-0002-2918-6481; Chinoy, Hector/0000-0001-6492-1288	National Institute for Health Research [CL-2006-06-010, CL-2008-06-002] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bowes J, 2011, ANN RHEUM DIS, V70, P1641, DOI 10.1136/ard.2011.150102; Burden AD, 2012, BRIT J DERMATOL, V166, P545, DOI 10.1111/j.1365-2133.2012.10835.x; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Gottlieb A, 2009, LANCET, V373, P633, DOI 10.1016/S0140-6736(09)60140-9; Hebert HL, 2012, BRIT J DERMATOL, V166, P474, DOI 10.1111/j.1365-2133.2011.10712.x; Kavanaugh A, 2012, ARTHRITIS RHEUM-US, V64, P2504, DOI 10.1002/art.34436; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; McInnes IB, 2013, LANCET; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Ryan C, 2011, JAMA-J AM MED ASSOC, V306, P864, DOI 10.1001/jama.2011.1211; Warren RB, 2013, BRIT J DERMATOL, V168, P683, DOI 10.1111/bjd.12170	12	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2013	382	9894					748	749		10.1016/S0140-6736(13)60739-4	http://dx.doi.org/10.1016/S0140-6736(13)60739-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VP	23769295				2022-12-28	WOS:000324239200006
J	Daschle, T; Domenici, P; Frist, W; Rivlin, A				Daschle, Thomas; Domenici, Pete; Frist, William; Rivlin, Alice			Prescription for Patient-Centered Care and Cost Containment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Leaders of the Bipartisan Policy Center Health Care Cost Containment Initiative summarize their recommendations to improve quality, reduce waste, and control cost. They envision health care that is value-driven and coordinated . . . , rather than volume-driven and fragmented. Despite high national spending, health care in the United States is uneven in quality and often wasteful, uncoordinated, and inefficient. Leaders on both sides of the political aisle, and in the health and economic policy communities, recognize the urgency of improving the quality and effectiveness of care while slowing the growth of spending. Far too often, however, attempts to address our national health and budget issues have been fragmented and unproductive, frequently owing to partisan disagreements over how to approach these highly sensitive issues. We, the four leaders of the Bipartisan Policy Center Health Care Cost Containment Initiative, came together ...	[Daschle, Thomas; Domenici, Pete; Frist, William; Rivlin, Alice] Bipartisan Policy Ctr, Washington, DC USA		Daschle, T (corresponding author), Bipartisan Policy Ctr, Washington, DC USA.								0	8	8	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					471	474		10.1056/NEJMsb1306639	http://dx.doi.org/10.1056/NEJMsb1306639			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193GQ	23803133				2022-12-28	WOS:000322547400017
J	Chen, JL; Carta, S; Soldado-Magraner, J; Schneider, BL; Helmchen, F				Chen, Jerry L.; Carta, Stefano; Soldado-Magraner, Joana; Schneider, Bernard L.; Helmchen, Fritjof			Behaviour-dependent recruitment of long-range projection neurons in somatosensory cortex	NATURE			English	Article							PRIMARY MOTOR CORTEX; BARREL CORTEX; TACTILE DISCRIMINATION; OBJECT LOCALIZATION; SENSORIMOTOR SYSTEM; NEURAL ACTIVITY; RAT PRIMARY; WHISKER; MICE; AWAKE	In the mammalian neocortex, segregated processing streams are thought to be important for forming sensory representations of the environment(1,2), but how local information in primary sensory cortex is transmitted to other distant cortical areas during behaviour is unclear. Here we show task-dependent activation of distinct, largely non-overlapping long-range projection neurons in the whisker region of primary somatosensory cortex (S1) in awake, behaving mice. Using two-photon calcium imaging, we monitored neuronal activity in anatomically identified S1 neurons projecting to secondary somatosensory (S2) or primary motor (M1) cortex in mice using their whiskers to perform a texture-discrimination task or a task that required them to detect the presence of an object at a certain location. Whisking-related cells were found among S2-projecting (S2P) but not M1-projecting (M1P) neurons. A higher fraction of S2P than M1P neurons showed touch-related responses during texture discrimination, whereas a higher fraction of M1P than S2P neurons showed touch-related responses during the detection task. In both tasks, S2P and M1P neurons could discriminate similarly between trials producing different behavioural decisions. However, in trials producing the same decision, S2P neurons performed better at discriminating texture, whereas M1P neurons were better at discriminating location. Sensory stimulus features alone were not sufficient to elicit these differences, suggesting that selective transmission of S1 information to S2 and M1 is driven by behaviour.	[Chen, Jerry L.; Carta, Stefano; Soldado-Magraner, Joana; Helmchen, Fritjof] Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; [Carta, Stefano; Helmchen, Fritjof] Univ Zurich, ETH Zurich, Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Soldado-Magraner, Joana] Univ Zurich, ETH Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; [Schneider, Bernard L.] Ecole Polytech Fed Lausanne, Brain Mind Inst, EPFL SV BMI LEN, CH-1015 Lausanne, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Helmchen, F (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	helmchen@hifo.uzh.ch	Schneider, Bernard/H-6168-2011; Helmchen, Fritjof/A-6255-2008	Schneider, Bernard/0000-0001-5485-8748; Helmchen, Fritjof/0000-0002-8867-9569; Chen, Jerry/0000-0002-7409-7859	Swiss National Science Foundation [310030-127091]; EU [223524, 243914]; Swiss SystemsX.ch initiative; National Center of Competence in Research 'Neural Plasticity and Repair'; Forschungskredit of the University of Zurich [541541808]; US National Science Foundation [1158914]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Swiss SystemsX.ch initiative; National Center of Competence in Research 'Neural Plasticity and Repair'(Swiss National Science Foundation (SNSF)); Forschungskredit of the University of Zurich; US National Science Foundation(National Science Foundation (NSF))	We thank S. Soldado-Magraner and L. Sumanovski for assistance with data analysis, H. Kasper, M. Wieckhorst, S. Giger and F. Voigt for technical assistance, A. Miyawaki for plasmid reagents, and D. Margolis, H. Lutcke and K. Schulz for help with initial experiments, helpful discussions and comments on the manuscript and V. Padrun and F. Pidoux for virus production. This work was supported by grants from the Swiss National Science Foundation (310030-127091 to F. H.), the EU-FP7 program(PLASTICISE project 223524 to F. H. and B. L. S.; and the BRAIN-I-NETS project 243914 to F. H.), the Swiss SystemsX.ch initiative (project 2008/2011-Neurochoice to F. H. and B. L. S.), the National Center of Competence in Research 'Neural Plasticity and Repair' (F. H.), Forschungskredit of the University of Zurich (grant 541541808 to J.L.C.) and a fellowship from the US National Science Foundation, International Research Fellowship Program (grant 1158914 to J.L.C.).	Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138; Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Chakraibarti S, 2006, J COMP NEUROL, V498, P624, DOI 10.1002/cne.21052; Conte WL, 2009, NAT PROTOC, V4, P1157, DOI 10.1038/nprot.2009.93; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Green DM, 1966, SIGNAL DETECTION THE; Guic E, 2008, BIOL RES, V41, P425, DOI /S0716-97602008000400008; GUICROBLES E, 1992, BEHAV BRAIN RES, V48, P145, DOI 10.1016/S0166-4328(05)80150-0; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Langer D, 2013, J NEUROSCI METH, V215, P38, DOI 10.1016/j.jneumeth.2013.02.006; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Margolis DJ, 2012, NAT NEUROSCI, V15, P1539, DOI 10.1038/nn.3240; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Melzer P, 2006, EXP BRAIN RES, V172, P370, DOI 10.1007/s00221-005-0334-1; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Sato TR, 2010, J NEUROSCI, V30, P4256, DOI 10.1523/JNEUROSCI.3774-09.2010; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Wiest MC, 2010, J NEUROPHYSIOL, V104, P300, DOI 10.1152/jn.00194.2010; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601	39	187	188	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					336	+		10.1038/nature12236	http://dx.doi.org/10.1038/nature12236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23792559	Green Accepted, Green Published			2022-12-28	WOS:000321910700036
J	Trinajstic, K; Sanchez, S; Dupret, V; Tafforeau, P; Long, J; Young, G; Senden, T; Boisvert, C; Power, N; Ahlberg, PE				Trinajstic, Kate; Sanchez, Sophie; Dupret, Vincent; Tafforeau, Paul; Long, John; Young, Gavin; Senden, Tim; Boisvert, Catherine; Power, Nicola; Ahlberg, Per Erik			Fossil Musculature of the Most Primitive Jawed Vertebrates	SCIENCE			English	Article							EVOLUTION; ORIGIN; GNATHOSTOMES; NECK	The transition from jawless to jawed vertebrates (gnathostomes) resulted in the reconfiguration of the muscles and skeleton of the head, including the creation of a separate shoulder girdle with distinct neck muscles. We describe here the only known examples of preserved musculature from placoderms (extinct armored fishes), the phylogenetically most basal jawed vertebrates. Placoderms possess a regionalized muscular anatomy that differs radically from the musculature of extant sharks, which is often viewed as primitive for gnathostomes. The placoderm data suggest that neck musculature evolved together with a dermal joint between skull and shoulder girdle, not as part of a broadly flexible neck as in sharks, and that transverse abdominal muscles are an innovation of gnathostomes rather than of tetrapods.	[Trinajstic, Kate] Curtin Univ, Dept Chem, Western Australian Organ & Isotope Geochem, Perth, WA 6102, Australia; [Trinajstic, Kate] Western Australian Museum, Perth, WA 6000, Australia; [Sanchez, Sophie; Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Sanchez, Sophie; Dupret, Vincent; Ahlberg, Per Erik] Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, S-75236 Uppsala, Sweden; [Long, John] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Long, John; Young, Gavin; Power, Nicola] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Senden, Tim] Australian Natl Univ, Res Sch Phys & Engn, Dept Appl Math, Canberra, ACT 0200, Australia; [Boisvert, Catherine] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia	Curtin University; Western Australian Museum; European Synchrotron Radiation Facility (ESRF); Uppsala University; Flinders University South Australia; Australian National University; Australian National University; Australian Regenerative Medicine Institute; Monash University	Ahlberg, PE (corresponding author), Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Norbyvagen 18A, S-75236 Uppsala, Sweden.	per.ahlberg@ebc.uu.se	Sanchez, Sophie/AAE-1168-2022; Senden, Tim J/A-7319-2008; Boisvert, Catherine A/A-9782-2019; Dupret, Vincent/L-2306-2015	Senden, Tim J/0000-0001-6808-7219; Boisvert, Catherine A/0000-0002-0618-7270; Ahlberg, Per/0000-0001-9054-2900; Sanchez, Sophie/0000-0002-3611-6836; Trinajstic, Kate/0000-0002-6519-6396; Tafforeau, Paul/0000-0002-5962-1683; Long, John/0000-0001-8012-0114; Dupret, Vincent/0000-0002-6859-1041	Australian Research Council (ARC) QEII Fellowship [DP 110101127]; ARC [DP 1092870, DP 1096002]; European Research Council [233111]; Knut and Alice Wallenberg Foundation; Human Frontiers Research Program; European Synchrotron Radiation Facility in Grenoble, France [EC770]; The Australian Geographic Society	Australian Research Council (ARC) QEII Fellowship(Australian Research Council); ARC(Australian Research Council); European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Human Frontiers Research Program; European Synchrotron Radiation Facility in Grenoble, France; The Australian Geographic Society	We acknowledge M. Siversson at the Western Australian Museum, Perth, and Z. Johanson at the Natural History Museum, London, for lending us specimens in their care. We thank I. Montero Verdu for his picture of the muscle bundles (Fig. 3D) and A. Ritchie for an Eastmanosteus image. K. T., P. E. A., and C. B. are supported by Australian Research Council (ARC) QEII Fellowship DP 110101127; J.L., K. T., T. S., and G.Y. by ARC DP 1092870; S. S., V. D., and P. E. A. by European Research Council Advanced Investigator Grant 233111; P. E. A. by a Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation; and C. B. by a Human Frontiers Research Program and an ARC Discovery Project, DP 1096002. The scan performed at the European Synchrotron Radiation Facility in Grenoble, France, was part of project EC770. K. T. acknowledges the 2010 Prime Minister's Science Prize, and J.L. acknowledges funding from The Australian Geographic Society, which supported fieldwork at the Gogo Formation. Specimens are housed in the collections of the Western Australian Museum, Australian National University, Australian Museum, and Museum Victoria, Australia, and the Natural History Museum, UK.	Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; CHRIST B, 1983, ANAT EMBRYOL, V166, P87, DOI 10.1007/BF00317946; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Edgeworth F. H., 1935, CRANAIL MUSCLES VERT; Gemballa S, 2003, P ROY SOC B-BIOL SCI, V270, P1229, DOI 10.1098/rspb.2003.2345; Heintz A., 1930, BASHFORD DEAN MEMORI, P115; Janvier P., 1996, EARLY VERTEBRATES; Kuratani S, 2004, J ANAT, V205, P335, DOI 10.1111/j.0021-8782.2004.00345.x; Kuratani S, 2008, DEV GROWTH DIFFER, V50, pS189, DOI 10.1111/j.1440-169X.2008.00985.x; Mallatt J, 1996, ZOOL J LINN SOC-LOND, V117, P329, DOI 10.1111/j.1096-3642.1996.tb01658.x; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Miles R.S., 1968, EARTH ENV SCI T R SO, V67, P373, DOI [10.1017/S0080456800024078, DOI 10.1017/S0080456800024078]; Oisi Y, 2013, NATURE, V493, P175, DOI 10.1038/nature11794; Onimaru K, 2011, DEV BIOL, V359, P124, DOI 10.1016/j.ydbio.2011.08.003; Schilling N, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-4; Trinajstic K, 2007, BIOL LETTERS, V3, P197, DOI 10.1098/rsbl.2006.0604; WAINWRIGHT SA, 1978, SCIENCE, V202, P747, DOI 10.1126/science.202.4369.747; Zhu M, 2012, BIOL LETTERS, V8, P453, DOI 10.1098/rsbl.2011.1033	19	40	42	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					160	164		10.1126/science.1237275	http://dx.doi.org/10.1126/science.1237275			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23765280	Green Submitted			2022-12-28	WOS:000321965300039
J	Read, BA; Kegel, J; Klute, MJ; Kuo, A; Lefebvre, SC; Maumus, F; Mayer, C; Miller, J; Monier, A; Salamov, A; Young, J; Aguilar, M; Claverie, JM; Frickenhaus, S; Gonzalez, K; Herman, EK; Lin, YC; Napier, J; Ogata, H; Sarno, AF; Shmutz, J; Schroeder, D; de Vargas, C; Verret, F; von Dassow, P; Valentin, K; Van de Peer, Y; Wheeler, G; Dacks, JB; Delwiche, CF; Dyhrman, ST; Glockner, G; John, U; Richards, T; Worden, AZ; Zhang, XY; Grigoriev, IV; Allen, AE; Bidle, K; Borodovsky, M; Bowler, C; Brownlee, C; Cock, JM; Elias, M; Gladyshev, VN; Groth, M; Guda, C; Hadaegh, A; Iglesias-Rodriguez, MD; Jenkins, J; Jones, BM; Lawson, T; Leese, F; Lindquist, E; Lobanov, A; Lomsadze, A; Malik, SB; Marsh, ME; Mackinder, L; Mock, T; Mueller-Roeber, B; Pagarete, A; Parker, M; Probert, I; Quesneville, H; Raines, C; Rensing, SA; Riano-Pachon, DM; Richier, S; Rokitta, S; Shiraiwa, Y; Soanes, DM; van der Giezen, M; Wahlund, TM; Williams, B; Wilson, W; Wolfe, G; Wurch, LL				Read, Betsy A.; Kegel, Jessica; Klute, Mary J.; Kuo, Alan; Lefebvre, Stephane C.; Maumus, Florian; Mayer, Christoph; Miller, John; Monier, Adam; Salamov, Asaf; Young, Jeremy; Aguilar, Maria; Claverie, Jean-Michel; Frickenhaus, Stephan; Gonzalez, Karina; Herman, Emily K.; Lin, Yao-Cheng; Napier, Johnathan; Ogata, Hiroyuki; Sarno, Analissa F.; Shmutz, Jeremy; Schroeder, Declan; de Vargas, Colomban; Verret, Frederic; von Dassow, Peter; Valentin, Klaus; Van de Peer, Yves; Wheeler, Glen; Dacks, Joel B.; Delwiche, Charles F.; Dyhrman, Sonya T.; Gloeckner, Gernot; John, Uwe; Richards, Thomas; Worden, Alexandra Z.; Zhang, Xiaoyu; Grigoriev, Igor V.; Allen, Andrew E.; Bidle, Kay; Borodovsky, M.; Bowler, C.; Brownlee, Colin; Cock, J. Mark; Elias, Marek; Gladyshev, Vadim N.; Groth, Marco; Guda, Chittibabu; Hadaegh, Ahmad; Iglesias-Rodriguez, Maria Debora; Jenkins, J.; Jones, Bethan M.; Lawson, Tracy; Leese, Florian; Lindquist, Erika; Lobanov, Alexei; Lomsadze, Alexandre; Malik, Shehre-Banoo; Marsh, Mary E.; Mackinder, Luke; Mock, Thomas; Mueller-Roeber, Bernd; Pagarete, Antonio; Parker, Micaela; Probert, Ian; Quesneville, Hadi; Raines, Christine; Rensing, Stefan A.; Riano-Pachon, Diego Mauricio; Richier, Sophie; Rokitta, Sebastian; Shiraiwa, Yoshihiro; Soanes, Darren M.; van der Giezen, Mark; Wahlund, Thomas M.; Williams, Bryony; Wilson, Willie; Wolfe, Gordon; Wurch, Louie L.		Emiliania Huxleyi Annotation	Pan genome of the phytoplankton Emiliania underpins its global distribution	NATURE			English	Article							HUXLEYI PRYMNESIOPHYCEAE; HIGH LIGHT; INDICATORS; GROWTH	Coccolithophores have influenced the global climate for over 200 million years(1). These marine phytoplankton can account for 20 per cent of total carbon fixation in some systems(2). They form blooms that can occupy hundreds of thousands of square kilometres and are distinguished by their elegantly sculpted calcium carbonate exoskeletons (coccoliths), rendering them visible from space(3). Although coccolithophores export carbon in the form of organic matter and calcite to the sea floor, they also release CO2 in the calcification process. Hence, they have a complex influence on the carbon cycle, driving either CO2 production or uptake, sequestration and export to the deep ocean(4). Here we report the first haptophyte reference genome, from the coccolithophore Emiliania huxleyi strain CCMP1516, and sequences from 13 additional isolates. Our analyses reveal a pan genome (core genes plus genes distributed variably between strains) probably supported by an atypical complement of repetitive sequence in the genome. Comparisons across strains demonstrate that E. huxleyi, which has long been considered a single species, harbours extensive genome variability reflected in different metabolic repertoires. Genome variability within this species complex seems to underpin its capacity both to thrive in habitats ranging from the equator to the subarctic and to form large-scale episodic blooms under a wide variety of environmental conditions.	[Read, Betsy A.; Sarno, Analissa F.; Wahlund, Thomas M.] Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA; [Kegel, Jessica; Frickenhaus, Stephan; Valentin, Klaus; John, Uwe; Rokitta, Sebastian] Helmholtz Ctr Polar & Marine Res AWI, Alfred Wegener Inst, D-27570 Bremerhaven, Germany; [Klute, Mary J.; Aguilar, Maria; Herman, Emily K.; Dacks, Joel B.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Kuo, Alan; Salamov, Asaf; Shmutz, Jeremy; Grigoriev, Igor V.; Lindquist, Erika] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Lefebvre, Stephane C.; Allen, Andrew E.] J Craig Venter Inst, San Diego, CA 92121 USA; [Maumus, Florian; Quesneville, Hadi] INRA, Unite Rech Genom Info, F-78026 Versailles, France; [Mayer, Christoph] Forsch Museum, D-53113 Bonn, Germany; [Mayer, Christoph; Leese, Florian] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, D-44801 Bochum, Germany; [Miller, John; Delwiche, Charles F.] Univ Maryland, College Pk, MD 20742 USA; [Miller, John; Delwiche, Charles F.] Univ Maryland, Maryland Agr Expt Stn, College Pk, MD 20742 USA; [Monier, Adam; Worden, Alexandra Z.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Young, Jeremy] UCL, Dept Earth Sci, London WC1E 6BT, England; [Claverie, Jean-Michel; Ogata, Hiroyuki] Aix Marseille Univ, Mediterranean Inst Microbiol, CNRS, Struct & Genom Informat Lab, FR-3479 Marseille, France; [Frickenhaus, Stephan] Hsch Bremerhaven, D-27568 Bremerhaven, Germany; [Gonzalez, Karina] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lin, Yao-Cheng; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Napier, Johnathan] Rothamsted Res, Dept Biol Chem, Harpenden AL5 2JQ, Herts, England; [Shmutz, Jeremy; Jenkins, J.] HudsonAlpha Genome Sequencing Ctr, Huntsville, AL 35806 USA; [Schroeder, Declan; Wheeler, Glen; Brownlee, Colin; Mackinder, Luke] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [de Vargas, Colomban; Probert, Ian] CNRS, UMR 7144, F-29682 Roscoff, France; [de Vargas, Colomban; Probert, Ian] Univ Paris 06, EPEP Team, Stn Biol Roscoff, F-29682 Roscoff, France; [Verret, Frederic] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [von Dassow, Peter] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Wheeler, Glen] Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; [Dyhrman, Sonya T.; Wurch, Louie L.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Dyhrman, Sonya T.] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; [Dyhrman, Sonya T.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Gloeckner, Gernot] Univ Cologne, Fac Med, Inst Biochem 1, D-50931 Cologne, Germany; [Gloeckner, Gernot] Leibniz Inst Freshwater Ecol & Inland Fisheries, D-12587 Berlin, Germany; [Richards, Thomas] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Zhang, Xiaoyu; Hadaegh, Ahmad] Calif State Univ San Marcos, Dept Comp Sci & Informat Syst, San Marcos, CA 92096 USA; [Bidle, Kay] Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Grp, New Brunswick, NJ 08901 USA; [Borodovsky, M.; Lomsadze, Alexandre] Georgia Tech, Joint Georgia Tech & Emory Dept Biomed Engn, Sch Computat Sci & Engn, Atlanta, GA 30322 USA; [Borodovsky, M.] Moscow Inst Phys & Technol, Dept Bioinformat, Moscow 117303, Russia; [Bowler, C.] Inst Natl Sante & Rech Med U1024, Environm & Evolutionary Genom Sect, Inst Biol lEcole Normale Super, Ctr Natl Rech Sci,UMR8197, F-75230 Paris, France; [Cock, J. Mark] CNRS, UMR 7139, Lab Int Associe Dispersal & Adaptat Marin Species, Stn Biol Roscoff, F-29682 Roscoff, France; [Cock, J. Mark] UPMC Univ Paris 06, Marine Plants & Biomol Lab, UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, France; [Elias, Marek] Univ Ostrava, Fac Sci, Dept Biol & Ecol, Life Sci Res Ctr, Ostrava 71000, Czech Republic; [Gladyshev, Vadim N.; Lobanov, Alexei] Brigham & Womens Hosp, Harvard Med Sch, Dept Med, Div Genet, Boston, MA 02115 USA; [Groth, Marco] Leibniz Inst Age Res, Fritz Lipmann Inst, D-07745 Jena, Germany; [Guda, Chittibabu] Univ Nebraska Med Ctr, Dept Genet, Cell Biol & Anat, Omaha, NE 68198 USA; [Iglesias-Rodriguez, Maria Debora] Univ California Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Iglesias-Rodriguez, Maria Debora; Jones, Bethan M.; Richier, Sophie] Univ Southampton, Ocean & Earth Sci Natl Oceanog Ctr Southampton, Southampton SO17 1BJ, Hants, England; [Jones, Bethan M.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Lawson, Tracy; Raines, Christine] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Malik, Shehre-Banoo] Dalhousie Univ, Canadian Inst Adv Res, Integrated Microbial Biodivers Program, Halifax, NS B3H 4R2, Canada; [Marsh, Mary E.] Univ Texas Houston Med Sch, Houston, TX 77030 USA; [Mock, Thomas] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Mueller-Roeber, Bernd] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Pagarete, Antonio] Univ Bergen, Dept Biol, N-5006 Bergen, Norway; [Parker, Micaela] Univ Washington, Ctr Environm Genom, PNW Ctr Human Hlth & Ocean Studies, Seattle, WA 98195 USA; [Rensing, Stefan A.] Univ Freiburg, Fac Biol, BIOSS Ctr Biol Signalling Studies, D-79098 Freiburg, Germany; [Rensing, Stefan A.] Univ Marburg, Fac Biol, D-35043 Marburg, Germany; [Riano-Pachon, Diego Mauricio] Univ Los Andes, Dept Ciencias Biol, Bogota 111711, DC, Colombia; [Richier, Sophie] CNRS, INSU, UMR 7093, Lab Oceanog Villefranche, F-06230 Villefranche Sur Mer, France; [Richier, Sophie] Univ Paris 06, Observ Oceanol Villefranche, F-06230 Villefranche Sur Mer, France; [Shiraiwa, Yoshihiro] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Soanes, Darren M.; van der Giezen, Mark; Williams, Bryony] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England; [Wilson, Willie] Bigelow Lab Ocean Sci, Provasoli Guillard Natl Ctr, E Boothbay, ME 04544 USA; [Wolfe, Gordon] California State Univ, Dept Biol Sci, Chico, CA 95929 USA; [Wurch, Louie L.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	California State University System; California State University San Marcos; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Alberta; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; J. Craig Venter Institute; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ruhr University Bochum; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Monterey Bay Aquarium Research Institute; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Harvard University; Harvard Medical School; Flanders Institute for Biotechnology (VIB); Ghent University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; HudsonAlpha Institute for Biotechnology; Marine Biological Association United Kingdom; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Essex; Pontificia Universidad Catolica de Chile; Plymouth Marine Laboratory; Woods Hole Oceanographic Institution; Columbia University; Columbia University; University of Cologne; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Natural History Museum London; California State University System; California State University San Marcos; Rutgers State University New Brunswick; University System of Georgia; Georgia Institute of Technology; Moscow Institute of Physics & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Ostrava; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California Santa Barbara; University of Southampton; Oregon State University; University of Essex; Canadian Institute for Advanced Research (CIFAR); Dalhousie University; University of Texas System; University of Texas Health Science Center Houston; University of East Anglia; University of Potsdam; University of Bergen; University of Washington; University of Washington Seattle; University of Freiburg; Philipps University Marburg; Universidad de los Andes (Colombia); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Tsukuba; University of Exeter; Bigelow Laboratory for Ocean Sciences; California State University System; California State University Chico; California State University East Bay; United States Department of Energy (DOE); Oak Ridge National Laboratory	Read, BA (corresponding author), Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA.	bread@csusm.edu	Shiraiwa, Yoshihiro/AAD-2501-2022; Rokitta, Sebastian/ABC-6832-2020; Bowler, Chris/AAC-6256-2019; Quesneville, Hadi/AAG-1048-2020; van der Giezen, Mark/J-9550-2019; Riaño-Pachón, Diego Mauricio/B-4891-2014; Probert, Ian/M-9807-2019; Schmutz, Jeremy/N-3173-2013; Worden, Alexandra Z./AAD-6567-2019; Claverie, Jean Michel/Z-2183-2019; Claverie, Jean-Michel/AAG-4889-2019; LIN, Yao-Cheng/B-4394-2008; Kegel, Jessica U./L-1726-2014; Zhang, xiaoyu/GXA-3206-2022; Mayer, Christoph/AAD-6696-2019; Leese, Florian/D-4277-2012; Delwiche, Charles F/C-6549-2008; Pagarete, António/B-9358-2009; von Dassow, Peter/A-5399-2012; Van de Peer, Yves/AAE-7666-2019; Schroeder, Declan C./O-9131-2019; Glöckner, Gernot/A-7800-2010; john, uwe/S-3009-2016; Mock, Thomas/A-3127-2008; Van de Peer, Yves/D-4388-2009; Riaño-Pachón, Diego M/A-1755-2010; Valentin, Klaus/G-5862-2014; Maumus, Florian/O-5426-2016; Mueller-Roeber, Bernd/Z-4052-2019; Raines, Christine/AAF-7036-2019; Dacks, Joel/AAE-3308-2021; Elias, Marek/D-6851-2014; Allen, Andrew E/C-4896-2012	Rokitta, Sebastian/0000-0002-7540-9033; Quesneville, Hadi/0000-0003-3001-4908; van der Giezen, Mark/0000-0002-1033-1335; Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; Schmutz, Jeremy/0000-0001-8062-9172; Claverie, Jean-Michel/0000-0003-1424-0315; LIN, Yao-Cheng/0000-0002-9390-795X; Kegel, Jessica U./0000-0002-4740-9554; Mayer, Christoph/0000-0001-5104-6621; Leese, Florian/0000-0002-5465-913X; Delwiche, Charles F/0000-0001-7854-8584; Pagarete, António/0000-0003-1347-0282; Van de Peer, Yves/0000-0003-4327-3730; Schroeder, Declan C./0000-0001-5991-2838; Glöckner, Gernot/0000-0002-9061-1061; john, uwe/0000-0002-1297-4086; Mock, Thomas/0000-0001-9604-0362; Van de Peer, Yves/0000-0003-4327-3730; Riaño-Pachón, Diego M/0000-0001-9803-3465; Valentin, Klaus/0000-0001-7401-9423; Maumus, Florian/0000-0001-7325-0527; Dacks, Joel/0000-0003-4520-5694; Elias, Marek/0000-0003-0066-6542; Allen, Andrew E/0000-0001-5911-6081; Groth, Marco/0000-0002-9199-8990; Worden, Alexandra/0000-0002-9888-9324; Young, Jeremy/0000-0001-9320-9804; Cock, J. Mark/0000-0002-2650-0383; Monier, Adam/0000-0002-6018-5153; Malik, Shehre-Banoo/0000-0003-0833-0648; Verret, Frederic/0000-0002-8175-7325; Gladyshev, Vadim/0000-0002-0372-7016; Napier, Johnathan/0000-0003-3580-3607; Parker, Micaela/0000-0003-1007-4612; Bowler, Chris/0000-0003-3835-6187; von Dassow, Peter/0000-0002-1858-1953; Williams, Bryony/0000-0003-1123-2176; Grigoriev, Igor/0000-0002-3136-8903; Frickenhaus, Stephan/0000-0002-0356-9791; Lawson, Tracy/0000-0002-4073-7221; Richards, Thomas/0000-0002-9692-0973; Probert, Ian/0000-0002-1643-1759	Office of Science of the US Department of Energy (DOE) [7DE-AC02-05CH11231]; BBSRC [BBS/E/C/00005207] Funding Source: UKRI; NERC [NBAF010005, pml010004, NE/E018319/1] Funding Source: UKRI; Division Of Ocean Sciences [1061883] Funding Source: National Science Foundation; Emerging Frontiers & Multidisciplinary Activities [0938157] Funding Source: National Science Foundation; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005207] Funding Source: researchfish; Natural Environment Research Council [NE/E018319/1, pml010004, NBAF010005] Funding Source: researchfish; Alberta Innovates [201001324] Funding Source: researchfish	Office of Science of the US Department of Energy (DOE)(United States Department of Energy (DOE)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Emerging Frontiers & Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Alberta Innovates	Joint Genome Institute (JGI) contributions were supported by the Office of Science of the US Department of Energy (DOE) under contract no. 7DE-AC02-05CH11231. We thank A. Gough for assistance with figures, C. Gentemann for Fig. 3 ocean colour analysis and P. Keeling for discussions.	Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; CONTE MH, 1992, ORG GEOCHEM, V19, P287, DOI 10.1016/0146-6380(92)90044-X; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; Danbara A, 1999, PLANT CELL PHYSIOL, V40, P762, DOI 10.1093/oxfordjournals.pcp.a029603; Erdner DL, 1999, LIMNOL OCEANOGR, V44, P1609, DOI 10.4319/lo.1999.44.7.1609; Havaux M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-130; HOLLIGAN PM, 1983, NATURE, V304, P339, DOI 10.1038/304339a0; Karl D, 2002, DYNAMICS DOP BIOGEOC, P249; Kislyuk AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-32; Lessard EJ, 2005, LIMNOL OCEANOGR, V50, P1020, DOI 10.4319/lo.2005.50.3.1020; Nanninga HJ, 1996, MAR ECOL PROG SER, V136, P195, DOI 10.3354/meps136195; Oura T, 2010, MICROBIOL-SGM, V156, P1234, DOI 10.1099/mic.0.033985-0; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Poulton AJ, 2007, DEEP-SEA RES PT II, V54, P538, DOI 10.1016/j.dsr2.2006.12.003; Reid EL, 2011, MAR DRUGS, V9, P586, DOI 10.3390/md9040586; Rost B, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P99; Sayanova O, 2011, PHYTOCHEMISTRY, V72, P594, DOI 10.1016/j.phytochem.2011.01.022; Schulz KG, 2004, NATURE, V430, P673, DOI 10.1038/nature02631; SUNDA WG, 1992, LIMNOL OCEANOGR, V37, P25, DOI 10.4319/lo.1992.37.1.0025; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Turner D. R., 2001, BIOGEOCHEMISTRY IRON, V7, P1; Vaananen H. K., 1991, CARBONIC ANHYDRASES, P351; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Wu QY, 1999, MAR BIOTECHNOL, V1, P346, DOI 10.1007/PL00011785; Xu Y, 2006, J PHYCOL, V42, P835, DOI 10.1111/j.1529-8817.2006.00243.x; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	28	331	350	9	277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					209	213		10.1038/nature12221	http://dx.doi.org/10.1038/nature12221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23760476	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000321557600062
J	Harvey, HB; Cohen, IG				Harvey, H. Benjamin; Cohen, I. Glenn			The Looming Threat of Liability for Accountable Care Organizations and What to Do About It	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Harvey, H. Benjamin] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Cohen, I. Glenn] Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Cohen, IG (corresponding author), Harvard Univ, Sch Law, 1525 Massachusetts Ave,Griswold Hall,Room 503, Cambridge, MA 02138 USA.	igcohen@law.harvard.edu						[Anonymous], 2012, NEW RISK MAN FRONT A; Blue Cross Blue Shield of Massachusetts, 2012, MASS PAYM REF MOD RE; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P2263, DOI 10.1001/jama.2012.4313; Hellinger FJ, 2005, AM J PUBLIC HEALTH, V95, P217, DOI 10.2105/AJPH.2004.037895; Orszag P, 2010, NY TIMES; Smith Christopher, 2011, Ann Health Law, V20, P165; Weisman R, 2012, BOSTON GLOBE	7	7	7	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					141	142		10.1001/jama.2013.7339	http://dx.doi.org/10.1001/jama.2013.7339			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23775236				2022-12-28	WOS:000321511500008
J	Creighton, CJ; Morgan, M; Gunaratne, PH; Wheeler, DA; Gibbs, RA; Robertson, AG; Chu, A; Beroukhim, R; Cibulskis, K; Signoretti, S; Vandin, F; Wu, HT; Raphael, BJ; Verhaak, RGW; Tamboli, P; Torres-Garcia, W; Akbani, R; Weinstein, JN; Reuter, V; Hsieh, JJ; Brannon, AR; Hakimi, AA; Jacobsen, A; Ciriello, G; Reva, B; Ricketts, CJ; Linehan, WM; Stuart, JM; Rathmell, WK; Shen, H; Laird, PW; Muzny, D; Davis, C; Morgan, M; Xi, L; Chang, K; Kakkar, N; Trevino, LR; Benton, S; Reid, JG; Morton, D; Doddapaneni, H; Han, Y; Lewis, L; Dinh, H; Kovar, C; Zhu, YM; Santibanez, J; Wang, M; Hale, W; Kalra, D; Creighton, CJ; Wheeler, DA; Gibbs, RA; Getz, G; Cibulskis, K; Lawrence, MS; Sougnez, C; Carter, SL; Sivachenko, A; Lichtenstein, L; Stewart, C; Voet, D; Fisher, S; Gabriel, SB; Lander, E; Beroukhim, R; Schumacher, SE; Tabak, B; Saksena, G; Onofrio, RC; Carter, SL; Cherniack, AD; Gentry, J; Ardlie, K; Sougnez, C; Getz, G; Gabriel, SB; Meyerson, M; Robertson, AG; Chu, AD; Chun, HJE; Mungall, AJ; Sipahimalani, P; Stoll, D; Ally, A; Balasundaram, M; Butterfield, YSN; Carlsen, R; Carter, C; Chuah, E; Coope, RJN; Dhalla, N; Gorski, S; Guin, R; Hirst, C; Hirst, M; Holt, RA; Lebovitz, C; Lee, D; Li, HYI; Mayo, M; Moore, RA; Pleasance, E; Plettner, P; Schein, JE; Shafiei, A; Slobodan, JR; Tam, A; Thiessen, N; Varhol, RJ; Wye, N; Zhao, YJ; Birol, I; Jones, SJM; Marra, MA; Auman, JT; Tan, DH; Jones, CD; Hoadley, KA; Mieczkowski, PA; Mose, LE; Jefferys, SR; Topal, M; Liquori, C; Turman, YJ; Shi, Y; Waring, S; Buda, E; Walsh, J; Wu, JY; Bodenheimer, T; Hoyle, AP; Simons, JV; Soloway, M; Balu, S; Parker, JS; Hayes, DN; Perou, CM; Kucherlapati, R; Park, P; Shen, H; Triche, T; Weisenberger, DJ; Lai, PH; Bootwalla, MS; Maglinte, DT; Mahurkar, S; Berman, BP; Van den Berg, DJ; Cope, L; Baylin, SB; Laird, PW; Creighton, CJ; Wheeler, DA; Getz, G; Noble, MS; DiCara, D; Zhang, HL; Cho, J; Heiman, DI; Gehlenborg, N; Voet, D; Mallard, W; Lin, P; Frazer, S; Stojanov, P; Liu, YC; Zhou, LH; Kim, J; Lawrence, MS; Chin, L; Vandin, F; Wu, HT; Raphael, BJ; Benz, C; Yau, C; Reynolds, SM; Shmulevich, I; Verhaak, RGW; Torres-Garcia, W; Vegesna, R; Kim, H; Zhang, W; Cogdell, D; Jonasch, E; Ding, ZY; Lu, YL; Akbani, R; Zhang, NX; Unruh, AK; Casasent, TD; Wakefield, C; Tsavachidou, D; Chin, L; Mills, GB; Weinstein, JN; Jacobsen, A; Brannon, AR; Ciriello, G; Schultz, N; Hakimi, AA; Reva, B; Antipin, Y; Gao, JJ; Cerami, E; Gross, B; Aksoy, BA; Sinha, R; Weinhold, N; Sumer, SO; Taylor, BS; Shen, RL; Ostrovnaya, I; Hsieh, JJ; Berger, MF; Ladanyi, M; Sander, C; Fei, SS; Stout, A; Spellman, PT; Rubin, DL; Liu, TT; Stuart, JM; Ng, S; Paull, EO; Carlin, D; Goldstein, T; Waltman, P; Ellrott, K; Zhu, J; Haussler, D; Gunaratne, PH; Xiao, WM; Shelton, C; Gardner, J; Penny, R; Sherman, M; Mallery, D; Morris, S; Paulauskis, J; Burnett, K; Shelton, T; Signoretti, S; Kaelin, WG; Choueiri, T; Atkins, MB; Penny, R; Burnett, K; Mallery, D; Curley, E; Tickoo, S; Reuter, V; Rathmell, WK; Thorne, L; Boice, L; Huang, M; Fisher, JC; Linehan, WM; Vocke, CD; Peterson, J; Worrell, R; Merino, MJ; Schmidt, LS; Tamboli, P; Czerniak, BA; Aldape, KD; Wood, CG; Boyd, J; Weaver, J; Iacocca, MV; Petrelli, N; Witkin, G; Brown, J; Czerwinski, C; Huelsenbeck-Dill, L; Rabeno, B; Myers, J; Morrison, C; Bergsten, J; Eckman, J; Harr, J; Smith, C; Tucker, K; Zach, LA; Bshara, W; Gaudioso, C; Morrison, C; Dhir, R; Maranchie, J; Nelson, J; Parwani, A; Potapova, O; Fedosenko, K; Cheville, JC; Thompson, RH; Signoretti, S; Kaelin, WG; Atkins, MB; Tickoo, S; Reuter, V; Linehan, WM; Vocke, CD; Peterson, J; Merino, MJ; Schmidt, LS; Tamboli, P; Mosquera, JM; Rubin, MA; Blute, ML; Rathmell, WK; Pihl, T; Jensen, M; Sfeir, R; Kahn, A; Chu, A; Kothiyal, P; Snyder, E; Pontius, J; Ayala, B; Backus, M; Walton, J; Baboud, J; Berton, D; Nicholls, M; Srinivasan, D; Raman, R; Girshik, S; Kigonya, P; Alonso, S; Sanbhadti, R; Barletta, S; Pot, D; Sheth, M; Demchok, JA; Davidsen, T; Wang, ZN; Yang, LM; Tarnuzzer, RW; Zhang, JS; Eley, G; Ferguson, ML; Shaw, KRM; Guyer, MS; Ozenberger, BA; Sofia, HJ				Creighton, Chad J.; Morgan, Margaret; Gunaratne, Preethi H.; Wheeler, David A.; Gibbs, Richard A.; Robertson, A. Gordon; Chu, Andy; Beroukhim, Rameen; Cibulskis, Kristian; Signoretti, Sabina; Vandin, Fabio; Wu, Hsin-Ta; Raphael, Benjamin J.; Verhaak, Roel G. W.; Tamboli, Pheroze; Torres-Garcia, Wandaliz; Akbani, Rehan; Weinstein, John N.; Reuter, Victor; Hsieh, James J.; Brannon, A. Rose; Hakimi, A. Ari; Jacobsen, Anders; Ciriello, Giovanni; Reva, Boris; Ricketts, Christopher J.; Linehan, W. Marston; Stuart, Joshua M.; Rathmell, W. Kimryn; Shen, Hui; Laird, Peter W.; Muzny, Donna; Davis, Caleb; Morgan, Margaret; Xi, Liu; Chang, Kyle; Kakkar, Nipun; Trevino, Lisa R.; Benton, Susan; Reid, Jeffrey G.; Morton, Donna; Doddapaneni, Harsha; Han, Yi; Lewis, Lora; Dinh, Huyen; Kovar, Christie; Zhu, Yiming; Santibanez, Jireh; Wang, Min; Hale, Walker; Kalra, Divya; Creighton, Chad J.; Wheeler, David A.; Gibbs, Richard A.; Getz, Gad; Cibulskis, Kristian; Lawrence, Michael S.; Sougnez, Carrie; Carter, Scott L.; Sivachenko, Andrey; Lichtenstein, Lee; Stewart, Chip; Voet, Doug; Fisher, Sheila; Gabriel, Stacey B.; Lander, Eric; Beroukhim, Rameen; Schumacher, Steve E.; Tabak, Barbara; Saksena, Gordon; Onofrio, Robert C.; Carter, Scott L.; Cherniack, Andrew D.; Gentry, Jeff; Ardlie, Kristin; Sougnez, Carrie; Getz, Gad; Gabriel, Stacey B.; Meyerson, Matthew; Robertson, A. Gordon; Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Sipahimalani, Payal; Stoll, Dominik; Ally, Adrian; Balasundaram, Miruna; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chuah, Eric; Coope, Robin J. N.; Dhalla, Noreen; Gorski, Sharon; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lebovitz, Chandra; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Pleasance, Erin; Plettner, Patrick; Schein, Jacqueline E.; Shafiei, Arash; Slobodan, Jared R.; Tam, Angela; Thiessen, Nina; Varhol, Richard J.; Wye, Natasja; Zhao, Yongjun; Birol, Inanc; Jones, Steven J. M.; Marra, Marco A.; Auman, J. Todd; Tan, Donghui; Jones, Corbin D.; Hoadley, Katherine A.; Mieczkowski, Piotr A.; Mose, Lisle E.; Jefferys, Stuart R.; Topal, MichaelD.; Liquori, Christina; Turman, Yidi J.; Shi, Yan; Waring, Scot; Buda, Elizabeth; Walsh, Jesse; Wu, Junyuan; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, MathewG.; Balu, Saianand; Parker, Joel S.; Hayes, D. Neil; Perou, Charles M.; Kucherlapati, Raju; Park, Peter; Shen, Hui; Triche, Timothy, Jr.; Weisenberger, Daniel J.; Lai, Phillip H.; Bootwalla, Moiz S.; Maglinte, Dennis T.; Mahurkar, Swapna; Berman, Benjamin P.; Van den Berg, David J.; Cope, Leslie; Baylin, Stephen B.; Laird, Peter W.; Creighton, Chad J.; Wheeler, David A.; Getz, Gad; Noble, Michael S.; DiCara, Daniel; Zhang, Hailei; Cho, Juok; Heiman, David I.; Gehlenborg, Nils; Voet, Doug; Mallard, William; Lin, Pei; Frazer, Scott; Stojanov, Petar; Liu, Yingchun; Zhou, Lihua; Kim, Jaegil; Lawrence, Michael S.; Chin, Lynda; Vandin, Fabio; Wu, Hsin-Ta; Raphael, Benjamin J.; Benz, Christopher; Yau, Christina; Reynolds, Sheila M.; Shmulevich, Ilya; Verhaak, Roel G. W.; Torres-Garcia, Wandaliz; Vegesna, Rahul; Kim, Hoon; Zhang, Wei; Cogdell, David; Jonasch, Eric; Ding, Zhiyong; Lu, Yiling; Akbani, Rehan; Zhang, Nianxiang; Unruh, Anna K.; Casasent, Tod D.; Wakefield, Chris; Tsavachidou, Dimitra; Chin, Lynda; Mills, Gordon B.; Weinstein, John N.; Jacobsen, Anders; Brannon, A. Rose; Ciriello, Giovanni; Schultz, Nikolaus; Hakimi, A. Ari; Reva, Boris; Antipin, Yevgeniy; Gao, Jianjiong; Cerami, Ethan; Gross, Benjamin; Aksoy, B. Arman; Sinha, Rileen; Weinhold, Nils; Sumer, S. Onur; Taylor, Barry S.; Shen, Ronglai; Ostrovnaya, Irina; Hsieh, James J.; Berger, Michael F.; Ladanyi, Marc; Sander, Chris; Fei, Suzanne S.; Stout, Andrew; Spellman, Paul T.; Rubin, Daniel L.; Liu, Tiffany T.; Stuart, Joshua M.; Sam Ng; Paull, Evan O.; Carlin, Daniel; Goldstein, Theodore; Waltman, Peter; Ellrott, Kyle; Zhu, Jing; Haussler, David; Gunaratne, Preethi H.; Xiao, Weimin; Shelton, Candace; Gardner, Johanna; Penny, Robert; Sherman, Mark; Mallery, David; Morris, Scott; Paulauskis, Joseph; Burnett, Ken; Shelton, Troy; Signoretti, Sabina; Kaelin, William G.; Choueiri, Toni; Atkins, Michael B.; Penny, Robert; Burnett, Ken; Mallery, David; Curley, Erin; Tickoo, Satish; Reuter, Victor; Rathmell, W. Kimryn; Thorne, Leigh; Boice, Lori; Huang, Mei; Fisher, Jennifer C.; Linehan, W. Marston; Vocke, Cathy D.; Peterson, James; Worrell, Robert; Merino, Maria J.; Schmidt, Laura S.; Tamboli, Pheroze; Czerniak, Bogdan A.; Aldape, Kenneth D.; Wood, Christopher G.; Boyd, Jeff; Weaver, JoEllen; Iacocca, Mary V.; Petrelli, Nicholas; Witkin, Gary; Brown, Jennifer; Czerwinski, Christine; Huelsenbeck-Dill, Lori; Rabeno, Brenda; Myers, Jerome; Morrison, Carl; Bergsten, Julie; Eckman, John; Harr, Jodi; Smith, Christine; Tucker, Kelinda; Zach, Leigh Anne; Bshara, Wiam; Gaudioso, Carmelo; Morrison, Carl; Dhir, Rajiv; Maranchie, Jodi; Nelson, Joel; Parwani, Anil; Potapova, Olga; Fedosenko, Konstantin; Cheville, John C.; Thompson, R. Houston; Signoretti, Sabina; Kaelin, William G.; Atkins, Michael B.; Tickoo, Satish; Reuter, Victor; Linehan, W. Marston; Vocke, Cathy D.; Peterson, James; Merino, Maria J.; Schmidt, Laura S.; Tamboli, Pheroze; Mosquera, Juan M.; Rubin, Mark A.; Blute, Michael L.; Rathmell, W. Kimryn; Pihl, Todd; Jensen, Mark; Sfeir, Robert; Kahn, Ari; Chu, Anna; Kothiyal, Prachi; Snyder, Eric; Pontius, Joan; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique; Nicholls, Matthew; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter; Alonso, Shelley; Sanbhadti, Rashmi; Barletta, Sean; Pot, David; Sheth, Margi; Demchok, John A.; Davidsen, Tanja; Wang, Zhining; Yang, Liming; Tarnuzzer, Roy W.; Zhang, Jiashan; Eley, Greg; Ferguson, Martin L.; Shaw, Kenna R. Mills; Guyer, Mark S.; Ozenberger, Bradley A.; Sofia, Heidi J.		Canc Genome Atlas Res Network; Anal Working Grp	Comprehensivemolecular characterization of clear cell renal cell carcinoma	NATURE			English	Article							KIDNEY CANCER; TUMOR-SUPPRESSOR; GENETIC-BASIS; METHYLATION; PROTEIN; ARM	Genetic changes underlying clear cell renal cell carcinoma(ccRCC) include alterations in genes controlling cellular oxygen sensing (for example, VHL) and the maintenance of chromatin states (for example, PBRM1). We surveyed more than 400 tumours using different genomic platforms and identified 19 significantly mutated genes. The PI(3) K/AKT pathway was recurrently mutated, suggesting this pathway as a potential therapeutic target. Widespread DNA hypomethylation was associated with mutation of the H3K36 methyltransferase SETD2, and integrative analysis suggested that mutations involving the SWI/SNF chromatin remodelling complex (PBRM1, ARID1A, SMARCA4) could have far-reaching effects on other pathways. Aggressive cancers demonstrated evidence of a metabolic shift, involving downregulation of genes involved in the TCA cycle, decreased AMPK and PTEN protein levels, upregulation of the pentose phosphate pathway and the glutamine transporter genes, increased acetyl-CoA carboxylase protein, and altered promoter methylation of miR-21 (also known as MIR21) and GRB10. Remodelling cellular metabolism thus constitutes a recurrent pattern in ccRCC that correlates with tumour stage and severity and offers new views on the opportunities for disease treatment.	[Creighton, Chad J.; Morgan, Margaret; Gunaratne, Preethi H.; Wheeler, David A.; Gibbs, Richard A.; Muzny, Donna; Davis, Caleb; Xi, Liu; Chang, Kyle; Kakkar, Nipun; Trevino, Lisa R.; Benton, Susan; Reid, Jeffrey G.; Morton, Donna; Doddapaneni, Harsha; Han, Yi; Lewis, Lora; Dinh, Huyen; Kovar, Christie; Zhu, Yiming; Santibanez, Jireh; Wang, Min; Hale, Walker; Kalra, Divya] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Xiao, Weimin] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Robertson, A. Gordon; Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Sipahimalani, Payal; Stoll, Dominik; Ally, Adrian; Balasundaram, Miruna; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chuah, Eric; Coope, Robin J. N.; Dhalla, Noreen; Gorski, Sharon; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lebovitz, Chandra; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Pleasance, Erin; Plettner, Patrick; Schein, Jacqueline E.; Shafiei, Arash; Slobodan, Jared R.; Tam, Angela; Thiessen, Nina; Varhol, Richard J.; Wye, Natasja; Zhao, Yongjun; Birol, Inanc; Jones, Steven J. M.; Marra, Marco A.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z, Canada; [Beroukhim, Rameen; Beroukhim, Rameen; Carter, Scott L.] Harvard Univ, Dept Med, Sch Med, Boston, MA 02215 USA; [Beroukhim, Rameen; Cibulskis, Kristian; Getz, Gad; Lawrence, Michael S.; Sougnez, Carrie; Carter, Scott L.; Sivachenko, Andrey; Lichtenstein, Lee; Stewart, Chip; Voet, Doug; Fisher, Sheila; Gabriel, Stacey B.; Lander, Eric; Beroukhim, Rameen; Schumacher, Steve E.; Tabak, Barbara; Saksena, Gordon; Onofrio, Robert C.; Cherniack, Andrew D.; Gentry, Jeff; Ardlie, Kristin; Meyerson, Matthew; Noble, Michael S.; DiCara, Daniel; Zhang, Hailei; Cho, Juok; Heiman, David I.; Gehlenborg, Nils; Mallard, William; Lin, Pei; Frazer, Scott; Stojanov, Petar; Liu, Yingchun; Zhou, Lihua; Kim, Jaegil; Chin, Lynda] Eli & Edythe L Broad Inst Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Beroukhim, Rameen; Carter, Scott L.; Sivachenko, Andrey; Lichtenstein, Lee; Stewart, Chip; Fisher, Sheila; Lander, Eric; Beroukhim, Rameen; Schumacher, Steve E.; Tabak, Barbara; Saksena, Gordon; Onofrio, Robert C.; Cherniack, Andrew D.; Gentry, Jeff; Ardlie, Kristin; Meyerson, Matthew; Noble, Michael S.; DiCara, Daniel; Zhang, Hailei; Cho, Juok; Heiman, David I.; Gehlenborg, Nils; Mallard, William; Lin, Pei; Frazer, Scott; Stojanov, Petar; Liu, Yingchun; Zhou, Lihua; Kim, Jaegil] Harvard Univ, Cambridge, MA 02142 USA; [Signoretti, Sabina; Meyerson, Matthew] Harvard Univ, Dept Pathol, Sch Med, Boston, MA 02215 USA; [Vandin, Fabio; Wu, Hsin-Ta; Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Verhaak, Roel G. W.; Torres-Garcia, Wandaliz; Akbani, Rehan; Weinstein, John N.; Vegesna, Rahul; Kim, Hoon; Jonasch, Eric; Ding, Zhiyong; Zhang, Nianxiang; Unruh, Anna K.; Casasent, Tod D.; Wakefield, Chris] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Tamboli, Pheroze; Zhang, Wei; Cogdell, David; Czerniak, Bogdan A.; Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Reuter, Victor; Brannon, A. Rose; Berger, Michael F.; Tickoo, Satish] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Hsieh, James J.; Hakimi, A. Ari; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Jacobsen, Anders; Ciriello, Giovanni; Reva, Boris; Schultz, Nikolaus; Antipin, Yevgeniy; Gao, Jianjiong; Cerami, Ethan; Gross, Benjamin; Aksoy, B. Arman; Sinha, Rileen; Weinhold, Nils; Sumer, S. Onur; Taylor, Barry S.; Shen, Ronglai; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Ricketts, Christopher J.; Linehan, W. Marston; Vocke, Cathy D.; Peterson, James; Worrell, Robert; Merino, Maria J.; Schmidt, Laura S.] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Stuart, Joshua M.; Sam Ng; Paull, Evan O.; Carlin, Daniel; Goldstein, Theodore; Waltman, Peter; Ellrott, Kyle; Zhu, Jing; Haussler, David] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Sam Ng; Paull, Evan O.; Carlin, Daniel; Goldstein, Theodore; Waltman, Peter; Ellrott, Kyle; Zhu, Jing; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Rathmell, W. Kimryn; Hoadley, Katherine A.; Liquori, Christina; Turman, Yidi J.; Shi, Yan; Waring, Scot; Buda, Elizabeth; Walsh, Jesse; Wu, Junyuan; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, MathewG.; Balu, Saianand; Parker, Joel S.; Hayes, D. Neil; Perou, Charles M.; Thorne, Leigh; Boice, Lori; Huang, Mei; Fisher, Jennifer C.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Shen, Hui; Laird, Peter W.; Triche, Timothy, Jr.; Weisenberger, Daniel J.; Lai, Phillip H.; Bootwalla, Moiz S.; Maglinte, Dennis T.; Mahurkar, Swapna; Berman, Benjamin P.; Van den Berg, David J.] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Auman, J. Todd] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Tan, Donghui] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Jones, Corbin D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Mose, Lisle E.; Topal, MichaelD.; Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Mieczkowski, Piotr A.; Jefferys, Stuart R.; Topal, MichaelD.; Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Hayes, D. Neil] Univ N Carolina, Dept Internal Med, Div Med Oncol, Chapel Hill, NC 27599 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Kucherlapati, Raju; Park, Peter] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Park, Peter; Gehlenborg, Nils] Harvard Univ, Ctr Biomed Informat, Sch Med, Boston, MA 02115 USA; [Park, Peter] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Cope, Leslie; Baylin, Stephen B.] Johns Hopkins Univ, Canc Biol Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Reynolds, Sheila M.; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA; [Lu, Yiling; Tsavachidou, Dimitra; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77054 USA; [Ostrovnaya, Irina] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Fei, Suzanne S.; Stout, Andrew; Spellman, Paul T.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portand, OR 97239 USA; [Rubin, Daniel L.; Liu, Tiffany T.] Stanford Univ, Dept Radiol, Med Ctr, Stanford, CA 94305 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Shelton, Candace; Gardner, Johanna; Penny, Robert; Sherman, Mark; Mallery, David; Morris, Scott; Paulauskis, Joseph; Burnett, Ken; Shelton, Troy; Curley, Erin] Int Genom Consortium, Phoenix, AZ 85004 USA; [Atkins, Michael B.] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; SAIC Frederick Inc, Basic Sci Program, Frederick Natl Lab, Frederick, MD 21702 USA; [Wood, Christopher G.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Boyd, Jeff; Weaver, JoEllen] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Iacocca, Mary V.; Petrelli, Nicholas; Witkin, Gary; Brown, Jennifer; Czerwinski, Christine; Huelsenbeck-Dill, Lori; Rabeno, Brenda] Christiana Care, Helen F Graham Canc Ctr, Newark, DC 19713 USA; [Myers, Jerome; Morrison, Carl; Bergsten, Julie; Eckman, John; Harr, Jodi; Smith, Christine; Tucker, Kelinda; Zach, Leigh Anne] Penrose St Francis Hlth Serv, Colorado Springs, CO 80907 USA; [Bshara, Wiam; Gaudioso, Carmelo; Morrison, Carl] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Dhir, Rajiv; Maranchie, Jodi; Nelson, Joel; Parwani, Anil] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Potapova, Olga] Cureline Inc, San Francisco, CA 94080 USA; [Fedosenko, Konstantin] St Petersburg City Clin Oncol Dispensary, St Petersburg 198255, Russia; [Mosquera, Juan M.; Rubin, Mark A.] Weill Cornell Coll Med, Dept Pathol & Lab Med, New York, NY 10065 USA; [Blute, Michael L.] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Pihl, Todd; Jensen, Mark; Sfeir, Robert; Kahn, Ari; Chu, Anna; Kothiyal, Prachi; Snyder, Eric; Pontius, Joan; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique; Nicholls, Matthew; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter; Alonso, Shelley; Sanbhadti, Rashmi; Barletta, Sean; Pot, David] SRA Int, Fairfax, VA 22033 USA; [Sheth, Margi; Demchok, John A.; Davidsen, Tanja; Wang, Zhining; Yang, Liming; Tarnuzzer, Roy W.; Zhang, Jiashan; Shaw, Kenna R. Mills] NCI, Canc Genome Atlas Program Off, Ctr Canc Genom, Bethesda, MD 20892 USA; [Eley, Greg] TCGA Consultant Scimentis LLC, Atlanta, GA 30666 USA; [Ferguson, Martin L.] MLF Consulting, Arlington, MA 02474 USA; [Guyer, Mark S.; Ozenberger, Bradley A.; Sofia, Heidi J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Beroukhim, Rameen; Meyerson, Matthew; Stojanov, Petar; Kaelin, William G.; Choueiri, Toni] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Benz, Christopher; Yau, Christina] Buck Inst Res Aging, Novato, CA 94945 USA; [Beroukhim, Rameen; Schumacher, Steve E.; Tabak, Barbara] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Cheville, John C.; Thompson, R. Houston] Mayo Clin, Rochester, MN 55905 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; British Columbia Cancer Agency; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Brown University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Johns Hopkins University; Johns Hopkins Medicine; Institute for Systems Biology (ISB); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Stanford University; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; International Genomics Consortium; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Texas System; UTMD Anderson Cancer Center; Fox Chase Cancer Center; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Harvard University; Massachusetts General Hospital; SRA International; International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Dana-Farber Cancer Institute; Buck Institute for Research on Aging; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Mayo Clinic; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Gibbs, RA (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	agibbs@bcm.edu; linehanm@mail.nih.gov	Van Den Berg, David J/G-8598-2017; Berman, Benjamin P/D-5942-2014; Schultz, Nikolaus/ABE-6347-2020; Gao, JianJiong/B-5673-2016; Choueiri, Toni/K-5238-2019; Cibulskis, Kristian/AAC-7380-2019; Jones, Steven J/C-3621-2009; Skanderup, Anders Jacobsen/K-1081-2013; , Pathology Services Core/CEZ-2246-2022; Kalra, D/H-6661-2019; Lawrence, Michael/AAC-8202-2020; Verhaak, Roel/ABE-7058-2020; Wheeler, David A/M-9740-2018; Maranchie, Jodi/AAG-1035-2020; Reva, Boris A./B-6436-2014; Birol, Inanc/G-5440-2011; Mungall, Andrew J./U-7067-2018; Kucherlapati, Raju/ABC-8807-2021; BERMAN, BENJAMIN/AAT-3720-2021; Cherniack, Andrew D./AAY-8132-2020; Ladanyi, Marc/AAG-8585-2019; Hirst, Martin/B-7684-2016; Weisenberger, Daniel/AAA-8314-2020; Shen, Hui/AAO-4387-2020; Perou, Charles M/H-9934-2014; Stojanov, Petar/GQI-4462-2022; Parker, Joel/AAG-1108-2019; Schein, Jacquie E/G-3674-2015; Ricketts, Christopher/AAV-9580-2020; parwani, anil/AAH-5464-2020; Reva, Boris/AAB-8932-2022; Akbani, Rehan/AAG-1490-2019; Cherniack, Andrew/AAC-5310-2019; Kalra, Divya/N-5453-2014; Kim, Hoon/AAL-9283-2020; Holt, Robert A/C-3303-2009; Schumacher, Steven/E-9821-2013; Laird, Peter W/G-8683-2012; Torres-Garcia, Wandaliz/L-6347-2017; Marra, Marco A/B-5987-2008; Gorski, Sharon M/E-9375-2012	Van Den Berg, David J/0000-0002-5404-5218; Berman, Benjamin P/0000-0002-2099-9005; Gao, JianJiong/0000-0002-5739-1781; Choueiri, Toni/0000-0002-9201-3217; Jones, Steven J/0000-0003-3394-2208; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Kalra, D/0000-0001-5254-4067; Wheeler, David A/0000-0002-9056-6299; Reva, Boris A./0000-0002-8805-389X; Birol, Inanc/0000-0003-0950-7839; Mungall, Andrew J./0000-0002-0905-2742; BERMAN, BENJAMIN/0000-0002-2099-9005; Cherniack, Andrew D./0000-0003-0470-0111; Weisenberger, Daniel/0000-0001-8303-2603; Perou, Charles M/0000-0001-9827-2247; Stojanov, Petar/0000-0001-7815-776X; Kim, Hoon/0000-0003-4244-6126; Holt, Robert A/0000-0002-7259-1247; Schumacher, Steven/0000-0002-6819-5647; Laird, Peter W/0000-0001-9117-3641; Marra, Marco A/0000-0001-7146-7175; Gorski, Sharon M/0000-0002-3821-8289; Lebovitz, Chandra/0000-0002-8679-0431; Jensen, Mark/0000-0001-5215-101X; Pot, David/0000-0002-1480-9826; Hoadley, Katherine/0000-0002-1216-477X; Mieczkowski, Piotr/0000-0003-2418-0096; parwani, anil/0000-0002-7616-1666; Gehlenborg, Nils/0000-0003-0327-8297; Meyerson, Matthew/0000-0002-9133-8108; Sinha, Rileen/0000-0001-5497-5055; doddapaneni, harshavardhan/0000-0002-2433-633X; Kothiyal, Prachi/0000-0002-5457-3029; Tarnuzzer, Roy/0000-0002-3725-4173; Stoll, Dominik/0000-0003-0701-4301; Cibulskis, Kristian/0000-0003-1343-1582; Shen, Hui/0000-0001-9767-4084; Casasent, Anna/0000-0002-7857-179X; Schultz, Nikolaus/0000-0002-0131-4904; Mahurkar-Joshi, Swapna/0000-0001-9591-4590; Auman, James/0000-0002-9328-8829; Fei, Suzanne/0000-0002-9688-2890; Heiman, David/0000-0001-7895-4259; Rubin, Mark/0000-0002-8321-9950; Chang, Kyle/0000-0001-5295-9676; Triche, Tim/0000-0001-5665-946X; Ciriello, Giovanni/0000-0003-2021-8683; Stuart, Joshua/0000-0002-2171-565X; Maranchie, Jodi/0000-0002-8534-9468; Benton, Susan/0000-0002-7694-2091; Davis, Caleb/0000-0002-5125-0494; Weinstein, John/0000-0001-9401-6908; Stout, Andrew/0000-0001-9470-1032	Div Of Biological Infrastructure [0845783] Funding Source: National Science Foundation; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NCI NIH HHS [U24 CA143883, U24 CA143799, U24 CA143840, U24 CA143843, U24 CA144025, U24 CA143845, U24 CA143835, U24 CA143866, U24 CA143867, K24 CA172355, U24 CA143882, R01 CA068490, P30 CA016672, T32 CA082088, U24 CA143848, U24 CA143858, T32 CA071341, P30 CA008748] Funding Source: Medline; NHGRI NIH HHS [U54 HG003079, U54 HG003067, R01 HG005690, U54 HG003273] Funding Source: Medline	Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brannon A Rose, 2010, Genes Cancer, V1, P152; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Clark J, 1997, ONCOGENE, V15, P2233, DOI 10.1038/sj.onc.1201394; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hakimi A.A., 2013, CLIN CANC RES; He X, 2011, ONCOGENE, V30, P535, DOI 10.1038/onc.2010.427; Herbers J, 1997, GENE CHROMOSOME CANC, V19, P29, DOI 10.1002/(SICI)1098-2264(199705)19:1<29::AID-GCC5>3.0.CO;2-2; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Linehan WM, 2003, J UROLOGY, V170, P2163, DOI 10.1097/01.ju.0000096060.92397.ed; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Modena P, 2003, ONCOGENE, V22, P4586, DOI 10.1038/sj.onc.1206472; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Ravaud A, 2008, J CLIN ONCOL, V26, P2285, DOI 10.1200/JCO.2007.14.5029; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Tong WH, 2011, CANCER CELL, V20, P315, DOI 10.1016/j.ccr.2011.07.018; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0	33	1916	1932	12	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					43	+		10.1038/nature12222	http://dx.doi.org/10.1038/nature12222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23792563	hybrid, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000321285600029
J	Dupont, S; Portner, H				Dupont, Sam; Poertner, Hans			Get ready for ocean acidification	NATURE			English	Editorial Material									[Dupont, Sam] Univ Gothenburg, Kristineberg, Sweden; [Poertner, Hans] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	University of Gothenburg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Dupont, S (corresponding author), Univ Gothenburg, Kristineberg, Sweden.	sam.dupont@bioenv.gu.se	Dupont, Sam T/F-5527-2013; Pörtner, Hans-O./K-9429-2016	Pörtner, Hans-O./0000-0001-6535-6575				Dupont S., 2012, MAR BIOL; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010	3	84	86	2	148	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					429	429		10.1038/498429a	http://dx.doi.org/10.1038/498429a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803827	Bronze			2022-12-28	WOS:000320929400026
J	Roach, NT; Venkadesan, M; Rainbow, MJ; Lieberman, DE				Roach, Neil T.; Venkadesan, Madhusudhan; Rainbow, Michael J.; Lieberman, Daniel E.			Elastic energy storage in the shoulder and the evolution of high-speed throwing in Homo	NATURE			English	Article							HUMERAL TORSION; BASEBALL; BIOMECHANICS; RETROVERSION	Some primates, including chimpanzees, throw objects occasionally(1,2), but only humans regularly throw projectiles with high speed and accuracy. Darwin noted that the unique throwing abilities of humans, which were made possible when bipedalism emancipated the arms, enabled foragers to hunt effectively using projectiles(3). However, there has been little consideration of the evolution of throwing in the years since Darwin made his observations, in part because of a lack of evidence of when, how and why hominins evolved the ability to generate high-speed throws(4-8). Here we use experimental studies of humans throwing projectiles to show that our throwing capabilities largely result from several derived anatomical features that enable elastic energy storage and release at the shoulder. These features first appear together approximately 2 million years ago in the species Homo erectus. Taking into consideration archaeological evidence suggesting that hunting activity intensified around this time(9), we conclude that selection for throwing as a means to hunt probably had an important role in the evolution of the genus Homo.	[Roach, Neil T.; Lieberman, Daniel E.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Roach, Neil T.] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC 20052 USA; [Venkadesan, Madhusudhan] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Rainbow, Michael J.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Natl Running Ctr, Cambridge, MA 02138 USA	Harvard University; George Washington University; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Harvard University	Roach, NT (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	ntroach@email.gwu.edu	Venkadesan, Madhusudhan/B-4697-2008	Venkadesan, Madhusudhan/0000-0001-5754-7478	National Science Foundation [BCS-0961943]; American School for Prehistoric Research; Wellcome Trust/DBT India Alliance [500158/Z/09/Z]	National Science Foundation(National Science Foundation (NSF)); American School for Prehistoric Research; Wellcome Trust/DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance)	We would like to thank the Wyss Institute, L. Stirling, A. Biewener, R. Wrangham, S. Larson, B. Roach, L. Meszoly, A. Lobell and many undergraduate research assistants for their feedback, help and support. Funding was provided by the National Science Foundation (BCS-0961943 to N.T.R. and D. E. L.), the American School for Prehistoric Research (to N.T.R. and D. E. L.) and the Wellcome Trust/DBT India Alliance (500158/Z/09/Z to M.V.).	Astley HC, 2012, BIOL LETTERS, V8, P386, DOI 10.1098/rsbl.2011.0982; BENNETT MB, 1986, J ZOOL, V209, P537, DOI 10.1111/j.1469-7998.1986.tb03609.x; Bingham PM, 2000, EVOL ANTHROPOL, V9, P248, DOI 10.1002/1520-6505(2000)9:6<248::AID-EVAN1003>3.0.CO;2-X; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Calvin W. H., 1983, THROWING MADONNA ESS; Churchill SE, 2009, VERTEBR PALEOBIOL PA, P201, DOI 10.1007/978-1-4020-9699-0_15; Cowgill LW, 2007, AM J PHYS ANTHROPOL, V134, P472, DOI 10.1002/ajpa.20689; Darwin C., 1871, P475; Dempster W.T., 1955, SPACE REQUIREMENTS S; Digiovine N M, 1992, J Shoulder Elbow Surg, V1, P15, DOI 10.1016/S1058-2746(09)80011-6; DILLMAN CJ, 1993, J ORTHOP SPORT PHYS, V18, P402, DOI 10.2519/jospt.1993.18.2.402; Fifer F.C., 1987, HUMAN EVOLUTION, V2, P135; FLEISIG GS, 1995, AM J SPORT MED, V23, P233, DOI 10.1177/036354659502300218; Goodall J., 1986, CHIMPANZEES GOMBE PA; GOWAN ID, 1987, AM J SPORT MED, V15, P586, DOI 10.1177/036354658701500611; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; Hirashima M, 2002, J SPORT SCI, V20, P301, DOI 10.1080/026404102753576071; Hirashima M, 2007, J NEUROPHYSIOL, V97, P680, DOI 10.1152/jn.00348.2006; Larson SG, 2007, EVOL ANTHROPOL, V16, P172, DOI 10.1002/evan.20149; Osbahr DC, 2002, AM J SPORT MED, V30, P347, DOI 10.1177/03635465020300030801; PAPPAS AM, 1985, AM J SPORT MED, V13, P216, DOI 10.1177/036354658501300402; Patek SN, 2007, J EXP BIOL, V210, P3677, DOI 10.1242/jeb.006486; Pieper HG, 1998, AM J SPORT MED, V26, P247, DOI 10.1177/03635465980260021501; Reagan KM, 2002, AM J SPORT MED, V30, P354, DOI 10.1177/03635465020300030901; Richmond BG, 2001, YEARB PHYS ANTHROPOL, V44, P70, DOI 10.1002/ajpa.10019; Roach NT, 2012, J ANAT, V220, P293, DOI 10.1111/j.1469-7580.2011.01464.x; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; SNYDER S J, 1990, Arthroscopy, V6, P274, DOI 10.1016/0749-8063(90)90056-J; Stanford C. B., 2001, HUMAN EVOLUTION SERI; Walker A., 1993, NARIOKOTOME HOMO ERE; WERNER SL, 1993, J ORTHOP SPORT PHYS, V17, P274, DOI 10.2519/jospt.1993.17.6.274; Westergaard GC, 2000, NEUROPSYCHOLOGIA, V38, P1511, DOI 10.1016/S0028-3932(00)00056-7; Winter DA, 1990, BIOMECHANICS MOTOR C	33	161	162	5	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					483	+		10.1038/nature12267	http://dx.doi.org/10.1038/nature12267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803849	Green Accepted, Green Submitted			2022-12-28	WOS:000320929400052
J	Heckmann, D; Schulze, S; Denton, A; Gowik, U; Westhoff, P; Weber, APM; Lercher, MJ				Heckmann, David; Schulze, Stefanie; Denton, Alisandra; Gowik, Udo; Westhoff, Peter; Weber, Andreas P. M.; Lercher, Martin J.			Predicting C-4 Photosynthesis Evolution: Modular, Individually Adaptive Steps on a Mount Fuji Fitness Landscape	CELL			English	Article							GLYCINE DECARBOXYLASE; BENEFICIAL MUTATIONS; CO2 ASSIMILATION; SIGN EPISTASIS; USE EFFICIENCY; ADAPTATION; MODEL; LEAVES; CARBON; PHOTORESPIRATION	An ultimate goal of evolutionary biology is the prediction and experimental verification of adaptive trajectories on macroevolutionary timescales. This aim has rarely been achieved for complex biological systems, as models usually lack clear correlates of organismal fitness. Here, we simulate the fitness landscape connecting two carbon fixation systems: C-3 photosynthesis, used by most plant species, and the C-4 system, which is more efficient at ambient CO2 levels and elevated temperatures and which repeatedly evolved from C-3. Despite extensive sign epistasis, C-4 photosynthesis is evolutionarily accessible through individually adaptive steps from any intermediate state. Simulations show that biochemical subtraits evolve in modules; the order and constitution of modules confirm and extend previous hypotheses based on species comparisons. Plant-species-designated C-3-C-4 intermediates lie on predicted evolutionary trajectories, indicating that they indeed represent transitory states. Contrary to expectations, we find no slowdown of adaptation and no diminishing fitness gains along evolutionary trajectories.	[Heckmann, David; Lercher, Martin J.] Univ Dusseldorf, Inst Comp Sci, D-40225 Dusseldorf, Germany; [Schulze, Stefanie; Gowik, Udo; Westhoff, Peter] Univ Dusseldorf, Inst Plant Mol & Dev Biol, D-40225 Dusseldorf, Germany; [Denton, Alisandra; Weber, Andreas P. M.] Univ Dusseldorf, Inst Plant Biochem, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Lercher, MJ (corresponding author), Univ Dusseldorf, Inst Comp Sci, D-40225 Dusseldorf, Germany.	lercher@cs.uni-duesseldorf.de	Weber, Andreas PM/A-6250-2011; Lercher, Martin/K-7939-2013; Weber, Andreas Paul Michael/O-3043-2019	Weber, Andreas PM/0000-0003-0970-4672; Lercher, Martin/0000-0003-3940-1621; Weber, Andreas Paul Michael/0000-0003-0970-4672; Gowik, Udo/0000-0002-8986-7318; Schulze, Stefanie/0000-0002-7659-8825	Deutsche Forschungsgemeinschaft [IRTG 1525, FOR 1186, EXC 1028, CRC 680]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Veronica Maurino, Itai Yanai, Eugene Koonin, Joachim Krug, and Andrea Brautigam for helpful discussions. Computational support and infrastructure was provided by the "Center for Information and Media Technology" (ZIM) at the Heinrich Heine University Dusseldorf. This work was supported by the Deutsche Forschungsgemeinschaft (IRTG 1525 to D.H. and A.D.; FOR 1186 to S.S.; EXC 1028 to M.J.L., A.P.M.W., and P.W.; and CRC 680 to M.J.L.).	[Anonymous], 2010, R LANG ENV STAT COMP; Ashton A.R., 1990, J EXP BOT, P39; BEALE CV, 1995, PLANT CELL ENVIRON, V18, P641, DOI 10.1111/j.1365-3040.1995.tb00565.x; Berry J., 1978, Photosynthesis 77. Proceedings of the fourth international congress on photosynthesis. [Hall, D. O.; Coombs, J.; Goodwin, T. J. (Editors)]., P119; Brodribb TJ, 2010, FUNCT PLANT BIOL, V37, P488, DOI 10.1071/FP10010; BROWN RH, 1978, CROP SCI, V18, P93, DOI 10.2135/cropsci1978.0011183X001800010025x; BROWN RH, 1991, PLANT PHYSIOL, V97, P985, DOI 10.1104/pp.97.3.985; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Christin PA, 2013, P NATL ACAD SCI USA, V110, P1381, DOI 10.1073/pnas.1216777110; Christin PA, 2011, EVOLUTION, V65, P643, DOI 10.1111/j.1558-5646.2010.01168.x; Dal'Molin CGD, 2010, PLANT PHYSIOL, V154, P1871, DOI 10.1104/pp.110.166488; Drincovich MF, 2011, ADV PHOTOSYNTH RESP, V32, P277; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Edwards G., 1987, BIOCH PLANTS, P275, DOI DOI 10.1016/B978-0-12-675410-0.50011-7; EHLERINGER J, 1983, PLANT PHYSIOL, V73, P555, DOI 10.1104/pp.73.3.555; EHLERINGER JR, 1991, TRENDS ECOL EVOL, V6, P95, DOI 10.1016/0169-5347(91)90183-X; Engel N, 2007, PLANT PHYSIOL, V144, P1328, DOI 10.1104/pp.107.099317; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Furbank RT, 2011, J EXP BOT, V62, P3103, DOI 10.1093/jxb/err080; Ghannoum O, 2001, AUST J PLANT PHYSIOL, V28, P213, DOI 10.1071/PP00078; Ghannoum O, 2011, ADV PHOTOSYNTH RESP, V32, P129; GILLESPIE JH, 1983, THEOR POPUL BIOL, V23, P202, DOI 10.1016/0040-5809(83)90014-X; Gowik U, 2011, PLANT PHYSIOL, V155, P56, DOI 10.1104/pp.110.165308; Hatch MD., 1975, AUST J PLANT PHYSIOL, V2, P111, DOI [DOI 10.1071/PP9750111, 10.1071/PP9750111]; Hibberd JM, 2008, CURR OPIN PLANT BIOL, V11, P228, DOI 10.1016/j.pbi.2007.11.002; Hindre T, 2012, NAT REV MICROBIOL, V10, P352, DOI 10.1038/nrmicro2750; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; HYLTON CM, 1988, PLANTA, V175, P452, DOI 10.1007/BF00393064; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kiirats O, 2002, PLANT PHYSIOL, V130, P964, DOI 10.1104/pp.008201; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; KU MSB, 1983, PLANT PHYSIOL, V71, P944, DOI 10.1104/pp.71.4.944; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lobkovsky AE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002302; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Maurino VG, 2010, CURR OPIN PLANT BIOL, V13, P249, DOI 10.1016/j.pbi.2010.01.006; McKown AD, 2005, AM J BOT, V92, P1911, DOI 10.3732/ajb.92.11.1911; Muhaidat R, 2011, PLANT CELL ENVIRON, V34, P1723, DOI 10.1111/j.1365-3040.2011.02367.x; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033; PEISKER M, 1986, PLANT CELL ENVIRON, V9, P627, DOI 10.1111/j.1365-3040.1986.tb01620.x; Pick TR, 2011, PLANT CELL, V23, P4208, DOI 10.1105/tpc.111.090324; Poelwijk FJ, 2011, J THEOR BIOL, V272, P141, DOI 10.1016/j.jtbi.2010.12.015; Sage R.F., 2007, CHARTING NEW PATHWAY, P195; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Savir Y, 2010, P NATL ACAD SCI USA, V107, P3475, DOI 10.1073/pnas.0911663107; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; von Caemmerer S., 2000, BIOCH MODELS LEAF PH; VONCAEMMERER S, 1989, PLANTA, V178, P463, DOI 10.1007/BF00963816; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165; Yin X, 2009, NJAS-WAGEN J LIFE SC, V57, P27, DOI 10.1016/j.njas.2009.07.001; Yizhak K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.11	59	125	124	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1579	1588		10.1016/j.cell.2013.04.058	http://dx.doi.org/10.1016/j.cell.2013.04.058			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791184	Bronze			2022-12-28	WOS:000320722000024
J	Wessel, DL; Berger, F; Li, JS; Dahnert, I; Rakhit, A; Fontecave, S; Newburger, JW				Wessel, David L.; Berger, Felix; Li, Jennifer S.; Daehnert, Ingo; Rakhit, Amit; Fontecave, Sylvie; Newburger, Jane W.		CLARINET Investigators	Clopidogrel in Infants with Systemic-to-Pulmonary-Artery Shunts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL HEART-DISEASE; ANTIPLATELET THERAPY; CHILDREN	Background Infants with cyanotic congenital heart disease palliated with placement of a systemic-to-pulmonary-artery shunt are at risk for shunt thrombosis and death. We investigated whether the addition of clopidogrel to conventional therapy reduces mortality from any cause and morbidity related to the shunt. Methods In a multicenter, double-blind, event-driven trial, we randomly assigned infants 92 days of age or younger with cyanotic congenital heart disease and a systemic-to-pulmonary-artery shunt to receive clopidogrel at a dose of 0.2 mg per kilogram of body weight per day (467 infants) or placebo (439 infants), in addition to conventional therapy (including aspirin in 87.9% of infants). The primary efficacy end point was a composite of death or heart transplantation, shunt thrombosis, or performance of a cardiac procedure due to an event considered to be thrombotic in nature before 120 days of age. Results The rate of the composite primary end point did not differ significantly between the clopidogrel group (19.1%) and the placebo group (20.5%) (absolute risk difference, 1.4 percentage points; relative risk reduction with clopidogrel, 11.1%; 95% confidence interval, -19.2 to 33.6; P = 0.43), nor did the rates of the three components of the composite primary end point. There was no significant benefit of clopidogrel treatment in any subgroup, including subgroups defined by shunt type. Clopidogrel recipients and placebo recipients had similar rates of overall bleeding (18.8% and 20.2%, respectively) and severe bleeding (4.1% and 3.4%, respectively). Conclusions Clopidogrel therapy in infants with cyanotic congenital heart disease palliated with a systemic-to-pulmonary-artery shunt, most of whom received concomitant aspirin therapy, did not reduce either mortality from any cause or shunt-related morbidity.	[Wessel, David L.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Berger, Felix] German Heart Inst, Berlin, Germany; [Berger, Felix] Charite, Berlin, Germany; [Daehnert, Ingo] Univ Leipzig, Ctr Heart, Dept Pediat Cardiol, D-04109 Leipzig, Germany; [Li, Jennifer S.] Duke Clin Res Inst, Durham, NC USA; [Rakhit, Amit] Bristol Myers Squibb Co, Princeton, NJ USA; [Fontecave, Sylvie] Sanofi Res & Dev, Chilly Mazarin, France; [Newburger, Jane W.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Newburger, Jane W.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Children's National Health System; German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Duke University; Bristol-Myers Squibb; Sanofi-Aventis; Sanofi France; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Wessel, DL (corresponding author), Childrens Natl Med Ctr, 111 Michigan Ave NW, Washington, DC 20010 USA.	dwessel@childrensnational.org	Zuk, Malgorzata/I-3476-2015; Napoleone, Carlo Pace/J-4518-2018; de wolf, daniel/F-7481-2013; Baptista, Maria João/H-8620-2015; da Cruz, Eduardo/I-3601-2019; Cheung, Yiu Fai/C-4240-2009; Caneo, Luiz Fernando/C-4076-2012; Stocco Guilhen, Jose Cicero/F-2714-2015	Zuk, Malgorzata/0000-0002-2203-9382; Napoleone, Carlo Pace/0000-0001-7039-5309; de wolf, daniel/0000-0002-0846-8914; Baptista, Maria João/0000-0001-9703-882X; Garcia Guereta, Luis/0000-0003-4675-365X; Cheung, Yiu Fai/0000-0002-7279-4992; Mertens, Luc/0000-0001-7308-1268; Danton, Mark/0000-0003-0866-2394; da Cruz, Eduardo/0000-0002-9008-2294; Caneo, Luiz Fernando/0000-0001-5545-8172; Human, Derek/0000-0002-4688-8530; Gewillig, Marc/0000-0002-4595-5922; Justino, Henri/0000-0002-5617-6932; Carrasco, Jose Ignacio/0000-0002-5587-5846; MEDRANO-LOPEZ, CONSTANCIO/0000-0003-4097-2448; Stocco Guilhen, Jose Cicero/0000-0001-7502-5585; Rinelli, Gabriele/0000-0003-2991-4917; Berger, Felix/0000-0001-7881-1557; Maschietto, Nicola/0000-0002-5468-3658; Mazurek-Kula, Anna/0000-0001-9445-6815	Sanofi-Aventis; Bristol-Myers Squibb	Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb)	Funded by Sanofi-Aventis and Bristol-Myers Squibb; ClinicalTrials.gov number, NCT00396877.	Al Jubair KA, 1998, CARDIOL YOUNG, V8, P486; Azakie A, 2001, ANN THORAC SURG, V72, P1349, DOI 10.1016/S0003-4975(01)02795-3; Dastgiri S, 2003, ARCH DIS CHILD, V88, P391, DOI 10.1136/adc.88.5.391; Fenton KN, 2003, ANN THORAC SURG, V76, P152, DOI 10.1016/S0003-4975(03)00168-1; Gentilomo C, 2011, PEDIATR CARDIOL, V32, P167, DOI 10.1007/s00246-010-9836-0; Israels SJ, 2006, THROMB RES, V118, P75, DOI 10.1016/j.thromres.2004.12.016; Jennings LK, 2012, PLATELETS, V23, P430, DOI 10.3109/09537104.2011.650244; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Li JS, 2008, CIRCULATION, V117, P553, DOI 10.1161/CIRCULATIONAHA.107.715821; Li JS, 2007, CIRCULATION, V116, P293, DOI 10.1161/CIRCULATIONAHA.106.652172; Mertens L, 2008, J PEDIATR-US, V153, P61, DOI 10.1016/j.jpeds.2007.12.050; Sano S, 2004, ANN THORAC SURG, V78, P1951, DOI 10.1016/j.athoracsur.2004.05.055; Schidlow DN, 2011, CONGENIT HEART DIS, V6, P98, DOI 10.1111/j.1747-0803.2011.00509.x; Squizzato A, 2011, COCHRANE DB SYST REV, V1; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; Wells WJ, 2005, ANN THORAC SURG, V79, P2072, DOI 10.1016/j.athoracsur.2004.12.050; Yuan SM, 2009, J CARDIAC SURG, V24, P101, DOI 10.1111/j.1540-8191.2008.00758.x; Yusuf S, 2001, NEW ENGL J MED, V345, P1716	20	43	45	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2377	2384		10.1056/NEJMoa1114588	http://dx.doi.org/10.1056/NEJMoa1114588			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782178	Bronze			2022-12-28	WOS:000320601700007
J	Moynihan, R				Moynihan, Ray			Australia moves closer to full disclosure of drug company payments to doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					American Medical Association, 2013, PHYS PREP SUNSH ACT; Godlee F, 2011, BMJ-BRIT MED J, V343, pd6593; Lo B, 2009, CONFLICT INTEREST ME; Medicines Australia, ED EV REP	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2013	346								f3960	10.1136/bmj.f3960	http://dx.doi.org/10.1136/bmj.f3960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171QB	23783360				2022-12-28	WOS:000320943000008
J	Fu, RW; Selph, S; McDonagh, M; Peterson, K; Tiwari, A; Chou, R; Helfand, M				Fu, Rongwei; Selph, Shelley; McDonagh, Marian; Peterson, Kimberly; Tiwari, Arpita; Chou, Roger; Helfand, Mark			Effectiveness and Harms of Recombinant Human Bone Morphogenetic Protein-2 in Spine Fusion A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							LUMBAR INTERBODY FUSION; ANTERIOR CERVICAL DISKECTOMY; OFF-LABEL USE; RADIOGRAPHIC OUTCOMES; RETROGRADE EJACULATION; INTEGRATED ANALYSIS; RHBMP-2; SURGERY; AUTOGRAFT; ALLOGRAFT	Background: Recombinant human bone morphogenetic protein-2 (rhBMP-2) is used as a bone graft substitute in spinal fusion, which unites (fuses) bones in the spine. The accuracy and completeness of journal publications of industry-sponsored trials on the effectiveness and harms of rhBMP-2 has been called into question. Purpose: To independently assess the effectiveness and harms of rhBMP-2 in spinal fusion and reporting bias in industry-sponsored journal publications. Data Sources: Individual-patient data (IPD) from 17 industry-sponsored studies; related internal documents; and searches of MEDLINE (1996 to August 2012), other databases, and reference lists. Study Selection: Randomized, controlled trials (RCTs) and cohort studies of rhBMP-2 versus any control and uncontrolled studies of harms. Data Extraction: Effectiveness outcomes in IPD were recalculated using consistent definitions. Study characteristics and results were abstracted by 1 investigator and confirmed by another. Two investigators independently assessed quality using predefined criteria. Data Synthesis: Thirteen RCTs and 31 cohort studies were included. For lumbar spine fusion, rhBMP-2 and iliac crest bone graft were similar in overall success, fusion, and other effectiveness measures and in risk for any adverse event, although rates were high across interventions (77% to 93% at 24 months from surgery). For anterior lumbar interbody fusion, rhBMP-2 was associated with nonsignificantly increased risk for retrograde ejaculation and urogenital problems. For anterior cervical spine fusion, rhBMP-2 was associated with increased risk for wound complications and dysphagia. At 24 months, the cancer risk was increased with rhBMP-2 (risk ratio, 3.45 [95% CI, 1.98 to 6.00]), but event rates were low and cancer was heterogeneous. Early journal publications misrepresented the effectiveness and harms through selective reporting, duplicate publication, and underreporting. Limitations: Outcome assessment was not blinded, and ascertainment of harms in trials was poor. No trials were truly independent of industry sponsorship. Conclusion: In spinal fusion, rhBMP-2 has no proven clinical advantage over bone graft and may be associated with important harms, making it difficult to identify clear indications for rhBMP-2. Earlier disclosure of all relevant data would have better informed clinicians and the public than the initial published trial reports did.	[Fu, Rongwei] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; Portland VA Med Ctr, Portland, OR USA; Oregon State Univ, Corvallis, OR 97331 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon State University	Fu, RW (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code CSB669, Portland, OR 97239 USA.	fur@ohsu.edu		Chou, Roger/0000-0001-9889-8610	Yale University; Medtronic; Oregon Health & Science University	Yale University; Medtronic(Medtronic); Oregon Health & Science University	Yale University and Medtronic.; By a research subcontract to Oregon Health & Science University under a sponsored research agreement between Yale University and Medtronic.	[Anonymous], 2013, PROSP INT PROSP REG; Baskin DS, 2003, SPINE, V28, P1219, DOI 10.1097/00007632-200306150-00003; Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020; Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; Bokobza SM, 2009, CURR SIGNAL TRANSD T, V4, P174, DOI 10.2174/157436209789057485; Burkus JK, 2006, SPINE, V31, P775, DOI 10.1097/01.brs.0000206357.88287.5a; Burkus JK, 2005, SPINE, V30, pS7, DOI 10.1097/01.brs.0000175093.48994.4d; Burkus JK, 2005, J BONE JOINT SURG AM, V87A, P1205, DOI 10.2106/JBJS.D.02532; Burkus JK, 2004, J NEUROSURG-SPINE, V1, P254, DOI 10.3171/spi.2004.1.3.0254; Burkus JK, 2004, ORTHOPEDICS, V27, P723; Burkus JK, 2003, J SPINAL DISORD TECH, V16, P113, DOI 10.1097/00024720-200304000-00001; Burkus JK, 2003, SPINE, V28, P372, DOI 10.1097/00007632-200302150-00012; Burkus JK, 2002, J SPINAL DISORD TECH, V15, P337, DOI 10.1097/00024720-200210000-00001; Burkus JK, 2002, SPINE, V27, P2396, DOI 10.1097/00007632-200211010-00015; Buttermann GR, 2008, SPINE J, V8, P426, DOI 10.1016/j.spinee.2006.12.006; Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956; Carragee EJ, 2011, SPINE J, V11, P511, DOI 10.1016/j.spinee.2011.02.013; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006; Dawson E, 2009, J BONE JOINT SURG AM, V91A, P1604, DOI 10.2106/JBJS.G.01157; Deyo RA, 2004, NEW ENGL J MED, V350, P722, DOI 10.1056/NEJMsb031771; Dickersin K., 2008, REPORTING OTHER BIAS; Dimar JR, 2009, J BONE JOINT SURG AM, V91A, P1377, DOI 10.2106/JBJS.H.00200; Fu R, 2013, EFFECTIVENESS HARMS; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Glassman SD, 2007, SPINE J, V7, P44, DOI 10.1016/j.spinee.2006.06.381; Glassman SD, 2007, SPINE, V32, P1693, DOI 10.1097/BRS.0b013e318074c366; Glassman SD, 2011, SPINE, V36, P1849, DOI 10.1097/BRS.0b013e3181d133d0; Glassman SD, 2008, SPINE, V33, P2843, DOI 10.1097/BRS.0b013e318190705d; Gornet MF, 2011, SPINE, V36, pE1600, DOI 10.1097/BRS.0b013e318217668f; Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025; Hamilton DK, 2008, SURG NEUROL, V69, P457, DOI 10.1016/j.surneu.2007.09.008; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Higgins JPT, 2001, STAT MED, V20, P2219, DOI 10.1002/sim.918; Kahanovitz N, 2004, SPINE J, V4, P538; Katayama Y, 2009, INT ORTHOP, V33, P1061, DOI 10.1007/s00264-008-0600-5; Khan SN, 2002, ORTHOP CLIN N AM, V33, P447, DOI 10.1016/S0030-5898(01)00010-4; Kleeman TJ, 2001, SPINE, V26, P2751, DOI 10.1097/00007632-200112150-00026; Kokorina NA, 2012, LARYNGOSCOPE, V122, P95, DOI 10.1002/lary.22345; Lanman Todd H, 2004, Neurosurg Focus, V16, pE6; Latzman JM, 2010, SPINE, V35, pE231, DOI 10.1097/BRS.0b013e3181c71447; Lee KB, 2012, J SPINAL DISORD TECH; Lee KB, 2010, EUR SPINE J, V19, P924, DOI 10.1007/s00586-009-1248-6; Lindley EM, 2012, SPINE, V37, P1785, DOI 10.1097/BRS.0b013e31825752bc; McKay B, 2002, SPINE, V27, pS66, DOI 10.1097/00007632-200208151-00014; Medtronic, 2012, COMMENTS IN PRESS; Medtronic, 2010, NON RAND PIL STUD RE, P1; Medtronic, 2001, PIL INV REC HUM BON, P1; Medtronic, 2011, SUMM INF MEDTR CLIN; Medtronic, 2001, 2 B REP PIV CLIN TRI, P2072; Mulconrey DS, 2008, SPINE, V33, P2153, DOI 10.1097/BRS.0b013e31817bd91e; Ong KL, 2010, SPINE, V35, P1794, DOI 10.1097/BRS.0b013e3181ecf6e4; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; Pradhan BB, 2006, SPINE, V31, pE277, DOI 10.1097/01.brs.0000216442.12092.01; Ratko TA., 2010, BONE MORPHOGENETIC P; ROCHON PA, 1994, JAMA-J AM MED ASSOC, V272, P108, DOI 10.1001/jama.272.2.108; Rogozinski Abraham, 2009, Orthopedics, V32, P809, DOI 10.3928/01477447-20090922-07; Rothhammer T, 2005, CANCER RES, V65, P448; Rowan FE, 2012, EUR SPINE J, V21, P1331, DOI 10.1007/s00586-011-2113-y; Sandhu HS, 2002, SPINE, V27, pS39, DOI 10.1097/00007632-200208151-00009; Sandhu HS, 2003, SPINE, V28, pS64, DOI 10.1097/00007632-200308011-00012; Schultz D, INFUSETRADE BONE GRA; Shen HX, 2010, SPINE, V35, P747, DOI 10.1097/BRS.0b013e3181bc3420; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Singh K, 2006, J SPINAL DISORD TECH, V19, P416, DOI 10.1097/00024720-200608000-00008; Smith R, 2003, BRIT MED J, V326, P1202, DOI 10.1136/bmj.326.7400.1202; Smucker JD, 2006, SPINE, V31, P2813, DOI 10.1097/01.brs.0000245863.52371.c2; Stachniak JB, 2011, J NEUROSURG-SPINE, V14, P244, DOI 10.3171/2010.9.SPINE09828; Stambough JL, 2010, SPINE, V35, P124, DOI 10.1097/BRS.0b013e3181c46c3a; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Taghavi CE, 2010, SPINE, V35, P1144, DOI 10.1097/BRS.0b013e3181bb5203; Tumialan LM, 2008, J NEUROSURG-SPINE, V8, P529, DOI 10.3171/SPI/2008/8/6/529; U.S. Food and Drug Administration, 2010, EX SUMM P050036 MEDT; U.S. Food and Drug Administration, 2013, PREM APPR PMA INF BO; US Food and Drug Administration, 2008, REC HUM BON MORPH PR; Vaidya R, 2007, J BONE JOINT SURG BR, V89B, P342, DOI 10.1302/0301-620X.89B3.18270; Vaidya R, 2007, EUR SPINE J, V16, P1257, DOI 10.1007/s00586-007-0351-9; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994	82	324	332	4	43	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12					890	+		10.7326/0003-4819-158-12-201306180-00006	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-00006			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778906				2022-12-28	WOS:000320645000017
J	Kocher, KE; Asplin, BR				Kocher, Keith E.; Asplin, Brent R.			What Is Our Plan for Acute Unscheduled Care?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EMERGENCY-DEPARTMENT; OUTPATIENT VISITS; RETAIL CLINICS		Univ Michigan, Ann Arbor, MI 48109 USA; Fairview Hlth Serv, Minneapolis, MN 55454 USA	University of Michigan System; University of Michigan	Kocher, KE (corresponding author), Univ Michigan, Dept Emergency Med, North Campus Res Complex,2800 Plymouth Rd,Bldg 16, Ann Arbor, MI 48109 USA.	kkocher@umich.edu		Kocher, Keith/0000-0001-7256-8859				Agency for Healthcare Quality and Research, AHRQ HLTH CAR INN EX; Bamezai A, 2006, MED CARE, V44, P835, DOI 10.1097/01.mlr.0000218854.55306.a8; Bodenheimer T, 2010, HEALTH AFFAIR, V29, P799, DOI 10.1377/hlthaff.2010.0026; Dresden SM, 2013, ANN EMERG MED, V61, P324, DOI 10.1016/j.annemergmed.2012.09.011; Margolius D, 2011, ANN INTERN MED, V155, P131, DOI 10.7326/0003-4819-155-2-201107190-00011; Mehrotra A, 2012, HEALTH AFFAIR, V31, P2123, DOI 10.1377/hlthaff.2011.1128; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; National Center for Health Statistics, 2010, NAT AMB MED CAR SURV; O'Malley AS, 2013, HEALTH AFFAIR, V32, P175, DOI 10.1377/hlthaff.2012.0494; Pitts SR, 2010, HEALTH AFFAIR, V29, P1620, DOI 10.1377/hlthaff.2009.1026	10	10	10	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12					907	+		10.7326/0003-4819-158-12-201306180-00008	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167PW	23778907				2022-12-28	WOS:000320645000018
J	Abramson, J; Vartanian, AS				Abramson, Jeff; Vartanian, Armand S.			Watch Water Flow	SCIENCE			English	Editorial Material							ION CONDUCTION; CHANNEL; SELECTIVITY; MECHANISM; ANGSTROM		[Abramson, Jeff; Vartanian, Armand S.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Abramson, Jeff] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Ctr Cellular & Mol Platforms, Bangalore 560065, Karnataka, India	University of California System; University of California Los Angeles; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Abramson, J (corresponding author), Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA.	jabramson@mednet.ucla.edu						Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Eriksson UK, 2013, SCIENCE, V340, P1346, DOI 10.1126/science.1234306; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Forrest LR, 2013, SCIENCE, V339, P399, DOI 10.1126/science.1228465; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Lee JK, 2005, P NATL ACAD SCI USA, V102, P18932, DOI 10.1073/pnas.0509469102; Li H, 2011, J MOL BIOL, V407, P607, DOI 10.1016/j.jmb.2011.01.036; Miller C, 2001, NATURE, V414, P23, DOI 10.1038/35102126; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	13	9	14	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1294	1295		10.1126/science.1239270	http://dx.doi.org/10.1126/science.1239270			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766318				2022-12-28	WOS:000320320200029
J	Judson, TJ; Detsky, AS; Press, MJ				Judson, Timothy J.; Detsky, Allan S.; Press, Matthew J.			Encouraging Patients to Ask Questions How to Overcome "White-Coat Silence"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SHARED DECISION-MAKING; PHYSICIANS; CARE		[Press, Matthew J.] Weill Cornell Med Coll, Dept Publ Hlth, Div Outcomes & Effectiveness Res, New York, NY 10065 USA; [Press, Matthew J.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Judson, Timothy J.] Weill Cornell Med Coll, New York, NY 10065 USA; [Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	Cornell University; Cornell University; Cornell University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Press, MJ (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, 402 E 67th St, New York, NY 10065 USA.	map9069@med.cornell.edu						Ahmed H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3996; Detsky AS, 2011, JAMA-J AM MED ASSOC, V306, P94, DOI 10.1001/jama.2011.883; Entwistle VA, 2005, JT COMM J QUAL PATIE, V31, P483, DOI 10.1016/S1553-7250(05)31063-4; Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576; Legare F, 2013, HEALTH AFFAIR, V32, P276, DOI 10.1377/hlthaff.2012.1078; Longtin Y, 2010, MAYO CLIN PROC, V85, P53, DOI 10.4065/mcp.2009.0248; Mirivel JC, 2008, HEALTH COMMUN, V23, P153, DOI 10.1080/10410230801968203; Morsi E, 2012, J HOSP MED, V7, P370, DOI 10.1002/jhm.1931; Weiss B, 2007, HLTH LITERACY PATIEN	9	40	40	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2325	2326		10.1001/jama.2013.5797	http://dx.doi.org/10.1001/jama.2013.5797			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161EV	23757079				2022-12-28	WOS:000320176000018
J	Marx, V				Marx, Vivien			A BETTER BREW	NATURE			English	Editorial Material							CELL CULTURE											Buganim Y, 2012, CELL CYCLE, V11, P4485, DOI 10.4161/cc.22665; Daquinag A. C., 2013, TISSUE ENG PART C-ME, P336; Goral VN, 2013, LAB CHIP, V13, P1039, DOI 10.1039/c2lc41102d; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Villa-Diaz LG, 2013, STEM CELLS, V31, P1, DOI 10.1002/stem.1260	7	365	380	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 11	2013	496	7444					253	258		10.1038/496253a	http://dx.doi.org/10.1038/496253a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23765498	Bronze			2022-12-28	WOS:000317346300050
